Bio-Statistician/MathematicianT his w i t n e s s w i l l b e i d e n t i f i e d in the n e a r f uture. At that tim e a c u r r i c u l u m v i t a e w i l l b e supplied. T his w i t n e s s w i l l d e s c r i b e the m a t h e m a t i c a l / s t a t i s t i c a l m o d e l w h i c h w i l l b e u s e d in the p r e s e n t a t i o n o f the f i g u r e s to w h i c h the w i t n e s s w i l l testify. The theory subserving the testi­ m o n y is that the m u l t i - f a c e t e d p r e s e n t a t i o n of s y m ptoms a n d signs and t e s t results in the same v e t e r a n m a k e s a r a n d o m c o m p o ­ s i t i o n of s u c h an array e x t r e m e l y u n l i k e l y in v i e w of t h e r e l a t i v e i n - f r e q u e n c y of eac h facet of the array. As such, this t e s t i m o n y wil l b e u s e d in the g e n e r i c and s p e c i f i c p r o x i m a t e c a u s a t i o n areas. 12387 HENDERSON & GOLDBERG, P.C 1 6 1 2 Frick Building Pittsburgh, PA 1 5 2 1 9 February 27, 1984 Thomas W.- Henderson Theodore Goldberg Robert L. Jennings, Jr. Joel Persky Antonio D. Pyle Thomas W . White t/" Ms. Nancy Petrilla U.S. District Clerk U.S. District Courthouse 225 Cadman Plaza Brooklyn, New York 11201 Re: MDL No. //381, Agent Orange Product Liability Litigation Dear Ms. Petrilla: Please find enclosed for the Court file, Plaintiffs’ Compliance with Guideline No. 34 on Plaintiffs’ Government Causation witnesses which are to begin being deposed on March 1, 1984 in Washington, D.C. Also... please find ..anpInspH an additional rn-nv _nf P1 a-In f f 4 ’ E x p and ed Summaries on the following Plaintiffs’ Cansai-lnn Kvrwart-s which I > pronuLs.ed Magistrate Shindlin she would receive before Wednesday., \ February 7Q..lQR./i_ Apparently, the original court copies were missing some pages. I apologize for this inconvenience. Please be advised that by copy of this letter and the enclosed documents I have notified all parties on the attached service list of the filing of said documents with the Court and I have served the U.S. Department of Justice, Ms. Gretched Witt, on or before noon, February 27, 1984, with the enclosed documents as per our agreement. Thank you in advance for your kindness and cooperation in this matter. Alison Pettiette cc: Enclosures Ms. Gretchen Witt See attached Service List Hand Delivery V HENDERSON & GOLDBERG, P.C. 1 6 1 2 Frick Building Pittsburgh, PA 1 5 2 1 9 ; Thomas W . Henderson Theodore Goldberg Robert L. Jennings, Jr. Joel Persky Antonio 0 . Pyle Thomas W. White February 27, 1984 HAND DELIVERY M s . Gretchen Witt Mr. Arvin Maskin U.S. Department of Justice 521 12th Street Room 824 Washington, D.C. Re: MDL No. 381, In re: Agent Orange Product Liability Litigation Dear Ms. Witt: Enclosed please find Plaintiffs' Outlines in conformity to Page 34 of the U.S. Guidelines and Order of the Court in the above.entitled and numbered cause on each Plaintiffs' Government Causation Witness whose deposition is to be scheduled and taken on or before March 15, 1984. With regard to the listed documents for each of Plaintiffs' nine witnesses, we will supplement within 7 days of each deposition any other documents Plaintiffs' may wish to have the witness review prior to his/her deposition. However, as to Janet Springer, the list of documents is complete. This will confirm the deposition of Ms. Springer beginning Thursday, March 1, 1984 at 9am at the Hyatt Regency Hotel in Washington, in a conference room. Thank you for your cooperation in this matter. Very truly yours, Alison Pettiette Thomas Henderson' ' Enclosures cc: Ms. Nancy Petrilla, U.S. District Clerk See Attached Service List 12383 PI.AlTf I F F 'S GOVSRiitlEKT CAUSATIO:! W I T M E D S E S Teruim U. Ilouk A. Center for D'.sease Contr ol B. Bc'tth factual C. Gaateral Events and ^sae.t (CDC) teat iwony Atlanta. GA Is sought iiuy fc C".■Jai icnow 1edgc of the hict ory o f lic »> ic idc pjju y in G in J . S . iinu cb road; - . 1c 1ud in o : b #•U *M- no t limited to, Cl ind uotri. a I o an cl Cixp '3sior.s; (2 ; rag 1st ra Uion r*^ xy osu r■,4 D, ’3t -T vri £ i. the Department of k* gri* r* u . 1£ . V »'2 n d c.n y o t ar gover::men a gene .! s i:j h u ’an 11-i Lhr. D o.f . - -‘5 an U /- c a - V - A::'.y T, or !; ■. c Z_c.. a act u a ■; c p . c. ;;0•:.‘l dge of the IkiStC r y o i in ;he U.S. ar d a b v o ad : a. Li 'J .1 ... V in , b ■j, t Ti ^ limited t o , i i , u . s . E r X Jl l; a —j use 0 A g fc-. nt Or nge and o t h c r p h s *• C\ " J u - C -■ ,.1 r n V r tl iin.:, C --) change 3 .1 . t he ■■ *• cq u ir GTCants it ’ t h e oi herl ..o I d e 3 p rr f* sn „ din u d its agencies inc lu g o v c rum r* «-fce o f i r*c\S '•11o .7 ;.:»l v 3 riA.EPA, and CJIIi ; and o : ci:..y % •, ou .. c d C •n n .k11 iust-ial and o iher hum.v r> n. ZV'i - Ci t o /. D > 2 ,4 ,5 -T in :h e U f . ar.c:[ - 1c ii i S Sec Answer and Sun :I.ccantsl Answer of P l a i n t i f f s 1 to' Dof r :riants * “nterrc.gctoi-y Ho. 19 attached : hereto and inccrpcrated herein for all pur­ poses re: events or occurrences which these ca.■cation witnesses may be expected to give any factual information they may have regardin the safc■'etc outlined in said Answer. Huaar: Rick A s oc a s a c n t cf Eupcsu ra to 2 ,4— D , 2,4, i»~T and d io xin s and any factual k n o w l e d g e in support thereof. D. Expert T ee ti mc ny 1} Tost icon;.- is sought in witness' pe rs ona l and official capacity. 2) ' .'«Meet Matter 2 ,4-D , 2,4,5 * T , TCDD !s and d i ox i n s ; Agent .Or ar. l! 11 (also rhiue, B l u e , Pink, Greer.,' and T u r p i r z a i o t j sf^iH /'"'N 7 S'" ■; •*•••,• «y ■ÿ. • •S and related chlorophenols and human risk aaiicssnent regarding exposure,, ¿.¿eluding, but not limited to, cue or more of the following cubj set ar-oas: a) Chemistry/E t: Manufacture c> X d) M od es of Hr. e; Pate in the Environment d-a. ; -Xc. y (Humans f Plants', Artmain)_ Slate of Art/State of Medical and Scie -tifi Literature 1) //. 3’ , Liana P h y s i o l o g y / S t u d i e s A;...ni l PL'a.ic.togy/Studiec E-.n... St*. Ins L-piC- cn 1 o ..egy/Eiostatistics L.Ï 1) Plants, arrimais, hü m an s Cate or Epidemiology 1 c.preductive E p i d e m i o l o g y Acau't - Health Efra'-ir witness will be naked opinions about bctl. published anà/or eu-go i n ; studi. 3) 4) ¿3 j.e s .ritac.cs will b t asked opinions about any studies or research witness has personally performed cr actually participated in. witness will be ashod opinions about other governmental studies. fitness is exported to review the following dosuiacscr prior to giving testimony : St';, E1A , Research 'and revolopaient. Health Assessment Docum ent ou -Dibs.:' ir, for the Offices q l: -Air' uà-lîty,' Plena in y 'ar.cl ar.darc-sv, pVepared 'by the Enviroiiaeat.al Criteria and A 3 a as site Office, Cincinnati, Ohio 45218 •( July -- 12371 EPA, Rennerch and Development, Health and Environmental Effects Profile for; Tetra Pcnta, and Hcxaehlcrodibenr.o-p-dioxins, for the Office c£ Sol i d .Waste and Emer­ gency Response, by the Enr_.:cntaental ■ Criteria and Assessment Office, Cincinnat Ohio 45240 (Jcnu 1983). ) EPA, Research and Development, Ambient Water Quality Criteria for 2 ,3 ,7,8 TC DD, pre­ pared for Office of Water Regulations and Standards, Ivy the Environmental Criteria and Assessment Office, Cineinnat Ohio mSPiS (July 1903).. ETA, copy o .. there Re se a r ch and Deve lo pme nt , Dioxin.., I n d u st r i a l E n v i r o n m e n t a l Research Cine:* vmeti Ohio (1978). dr cum ont s ,s a si: r.ah- d . :r h. Major Alvin T,cung x. Dr. Rodney Eovoy Kenneth V. Therein n. David T. Buzzaiii o. Dr. Michael Gross g-.. Dr. Renee stringham r. Dr- Van Miller ■ ............ ’* ........ ) SUPPLEMENTAL «BSWLR IX; im^ERRQg.JORY NO. ID SlainSiffs r :"t preliminarily that the extant Order on producing fa-t witnesses rtates that f:._t vr :nesses are not due until Karel 2, 1984. Hcwsvc:.', laintiffs nrxy o;J.i one ox* ntrrx. of .die fol .owing persons (or these iron* vr "ions categories Listed tele*:) at Urns of t . rl. to testify as to factual knowledge they ma / have including: Ranch Hand ?e:-: onnol: Thorne persons will testify tc their Icnowlec'ga of t & Ranch Hand Operation,- Ranch Hcnderr:-1 exposure to Agent Crar.; i. ¿no/or taio,.-:lodgo relating to the spraying, testing, and e ' foots c£ Agent Or-cngs cn htensns. Makers of the LI a. trrad forces: These persons mag- testify tc the circumstances and conditions surrounding’the spraying of Agent Orange. Perrons nrasent :x- Vietnam during tfcs sespe.rure period in questioi-.“ 1931-197?. including. }-rt not limited to, military and paramilitary personnel of * • 11 3... Net: Zealand and Australia, v:ho have knowledge < ■ the spraying operatione of idio herbicides, the exposure o:' he Plaintiffs' class, the lazarac acocrapanylr.g any such exposure, tbs Plaintiffs’ themselves, and tiie Defendant company representatives present in Vietnam to cversr.. the deliveries and spraying operations of the !. --bioidos thev mrxuifactured. 4 Person.:; together with their c.=manstrative and documentary evidence who gave testimony 1 ;hich will form the substance of their testimony herein) at the EPA Cancellation Hearings of 2,4,5-T (1379-1901 ■ yr.xsr F:TTA, including but r.o.t limited 12373 Dr. Roy Albert ■ or. K. Diana Courtney 'bert i. Brnirrhmni^ *3N Any current or previous employee, contractor, uubccn tract rr, in-housc. car private consultant of etch of the Defendants or any other person who lias factual knowledge of how ctioxins v/orj: upon plants, animals, and/or humane. i ” ftny (Cinarr. iat or previous employee, rentrector, subornitrac■:or, iu-tarso ar private consultant of each of the defendants or any other person who has factual kna-zledgo of any statist os concerning '-he effects of dioxins upon plants, animals, ai. Vor humans. ;vÿ Any cccrrit or previous employé.., ccnt.rc.ctor, subœntactor, itt-haasa or private consultant of each of ¡do Defendants or anv ctlr;.. parse : including, out not limited to, msnbers of E&\ arid other gaver :cientai are c;-.«5,who has factual lonowledge cf *•« fallowing incidents: a. . Love Canal b. ïiniSS Beech, Mir.s r.ri c. Sevesco, real" d. BAiT USS3, IS'il - Badiorh u Cerrearry) o.. r.ucSacticr. risliaps and/or explosions r. .nee ISliS at -.ny of the plants of aiy cf :;ho Defer/-: ,its manui?...tu:ciiTi5 J TC?, 2,4-D, 2,4,£-‘dL’ phenol, chlorin'., roe-tic acid, benzene, sodium hydroxide, potassium hydroxide, ar/./or ;tusnt Orange, including mishaps in the g -okaying, ar/. f ';nrpcrt-h.g :f the Defendants' products f' if:: u. : Anted L'crucs bases for eventual shipment to Vietnam. f. Sprevir of Viotna-.: fret: 13£„ 1/71, Any c f -ant or prr-v.ous enplcyae, cc.^rarn-.or, subcontractor, in--hour... c: private nsultnnt of each of ti:r. r fendants or any other person who has factual kac:v ."ga cf any surveys, teste, epidemiological studies of any kic/l relating to the effects cf •sjçosure to Agent Grange, 2,4-D, 2,1,5-T or any constituent thereof inc.ludr'iia the stcc-r.dsry by-product known r.s dioxins. 1/: Any person with factual Icicwledgo of how decisions are fade within- the United Cistes yc/ornmonfparticularly the decision to t:se and. to continue to use phenrxy herbicides in Vietnam, particularly Agent Orange; any person with factual knowledge cf government procurement contracts and the invitation to bidders, particularly those pc./sons who negotiated the gewsrnnent contract: for ail phenacy herbicic.£s (agents v.hite, blue, purple, pink, green, orange 1 and v.lfcn the individual defendants repre.- • ■sentavives Joetueon 1911-1 r72„ -U- 12374 ■'/"V 15. / !7&' Any person with factual knowledge through any surveys, tedcs, epic-aniologica] studies or otherwise undertaken by. any state government, any private public or foreign evaporation, the U. 1. Congress or the government of any nation concerning the chemical cccr,pound;-, 2 , 1 , 4 , 5-T, dioxins, or related chiorenhenóla relating to the creation of dioxins, the detection of dic:cin:i, the dangers of 'dioxins* esqposurs, and/or the tcadLcity, carcinogenicity, fstctcxieity, teratfigenicity .• acute and/or chronic ef fects on plants, animals and the htroan popula.fcion 25.. Any end all persons listed in the Chemical ¿.cythe by Alastair Kay as having factual taowiadga regarding 2,4,5-T, 2 andfir: -j-mtarainant dioxins. 17. £21 worker ocapcncaticn carriers for the Defendants ar.d dccuEesata-bion or a.ll occupational exposures filed since '•925 which '.•acdcncc industrial injuries or diseases at the TCP, 2,4,5-1, 2,.4-Dr, Phenol, packaging, •n d h r r u v p o r a f c i e n plants c~ the Steferfkotc. IB. Ary ssa£ al 1 current or pricr wcrJcars compensatici ciaimvnts cf thè Dcferdmto who airred relevsnt occupaidonai f t a y. C. House of R&presentati/es Ctamdttee . . . i lunar,-. bie Panic:-: of the E?k actions .'1583) and/o:, any person toge'hou with tha:r documentary and deccnstrativs • evidence giving t ...rtieeny a 1: e.aid hearing {which will fern the substance cf their tost: r.my liarein- on the failure of the EPA to take prarnpt and effective action to 'ban the production of 2,4~D, 2 ;4,5-T, end .its contaminant eicidns. 20. Any and aJJ. persons haviry .ewiedge o.. relevant facto regarding the financial status of the Defendants and their ability to respond in punitive dasryas, including, but not limited to, their past, present, and future p:c fits and earnings in the "sited States and abroad nines 132”> through and including the present iron the sale of die products rrs.de the basis of this lawsuit, .i.e., 2,4-D, 2,4,5-T, p'lenoxy herbicides and the relevant herbicide market. hi. Any and all person:: having imovriedge of relevant facts regarding .the ownership interests of the Defendants •nd their ability to reepor.'. in punitive oarages. itcl'iding, fcv.. .„oi limited tc,dsfendants! domestic snd foreign subsidiaries, joint. /enturers, licensing r.grascents, ar.d/cr ether public or private corporations in the U, S. and breed, in rhich those defendants c m a sub­ stantial fir .uncial interc ut since 1325 t’-vouch and including the prevent,, .2375 V. I 2.:. Any and ail persons listed by Plaintiffs1 hi both original and rat:,idea witness licer., as etpert witness {medical, scientific **r causation', , geventtant witness,. government causation witness, defendants5 employees and/or related parsonnai and/or any witnesses listed by all Defendants, may ba called at tinti of trial to cress: it fact*-al : .ToirmaAion as t.> any issue involved in this case. 21. Any and ail members of the scientific and/or medical ccnra.nify who ha-Te knowledge of lv.-.lovaut facts,- including i n f e c t i o n ci; m y of the. previously listed subjects in tils Answer, including, lent not liiaited to : a. David Kriefaei.. Ph.D. b. Dr. Alan Poiane. Tir. ‘nul BA.0A -.u. Dr. C.. Popps r. Dr. Cortei, BASS’ f. Di:. K. --I. i-V.rom: . 1 *j, *.h • g. Dr, Alvin Ali.t i-jurilyn ¿Auigrrhut 21. Any ancl oil perrons clic :::.o■■ fv.ct*:.nd knowledge ronceming ilia individuo I representative L-laintiifffs damages, including, but not li .' or to, tie 1 Hewing: a. Any and 11 med'caJ. parse ns who have examined, observed, treated and/cr tasted the Plaintiffs7 for injuries diseases and/or related Aysi-.a.l sr.d emotional conditions té. in resulted from Plaivli o.. " «gestro to Arant Orange, and/or puenexy herbicides, their constituents, secondary byproducts, wastes., residuals and r-ntsminants. b. Any erd nil hospital personnel where Plaintiffs have bsen confined for treatment .•relat' ig to tie:.:: exposure to ¿defendants* products in Vietnam. o. Any and ail perrons with knowledge of tha economic losses, psychological and/or infcangibb damages sustained by y*-ur Plaint*’ffr: as result •>£ Miei: iir! -•ics and diseases ..usuiting i .so their .'-roosure to Defendants * on :ducts in Vietnam A;.y a :d all parse:u; with knoveedge of the past,, present and/or ■future eerne tic losses your Flo:, itiffs have or will sustain in 'die future as a re e f 1 of tlv:.i" f ss of wage earnings unf/cr v/vj.gc,3 earning capacity r',:s"-it:.ng from the injuries and diseases made the basis of this ?." /suit which'■■'¿sre caused by1 T\*'..mtrfrs exposure to Defendants5 preducts 1‘" Vietnam. 12376 -<"W Unito«; Slates I- 1 • .tri'» -nviro'-.iiicn- :¡ Prelection A*},.rio*/ i• r.'::oiv •!.nc.nni»i' OH 45ZC3 ri ■ !?nsiîüien ■He .'■i«oit»**,il /«ù^ mpw \ J ‘£ Z a , D i o r a n s i 0 0 7 7 X. £*} %J i & '1 7~> PLAIN TIFF'S COVE P: .'MRHT CAUSATION WITNESSES 0 ebciscs Muker j eu I. EVA, W a sh in gt on , D.C. IV. Eotfa fi c ‘:ua.I and c;:per;: t e s t i mo n y is sought. C. Cstioral Events Pre-1951: A.ny factual knov/iedge of the history of h e r b i ci d e sp ra yin g in U.S. and abroad; i n c l u d i n g b u t not l i mit ed to, (1) induatri. expo su res and explosi on s; (2) registration 2 ,4~D, 2, 4.5-T with the De pa rt m en t of Agricui- tire and any other g o v e rn m e nt agencies b; ary and/cr ell » f tic Defendants; 196 '.-fro s n::t : Ar.y factual knew! edge of the history of L'-rbiciie spraying in the U.S. and abroad; i n c l u d i n g , but net limited to, (1) U.S. m i l i t a r y use of Agent O r a n g e ant. other pher he rbicide" in Vietnam; (2) changes in the ; istrat .on rc.qr irements of herbicides wit: U.S. government and its ag en cie s Includin; Icnoviobf of FIFE A, FDA,E? A, and OS rIA; an: ( any k n ow le dge cf indust riel and other human ex posures to 2 :4--D , 2,4 ,f - T ir. the U.S. and abroad; ns e See Human hi Expert and. Su pp lemental Answ er of Plaintiffs' to Defendants' I n te r r o g a t o r y No. 19 attached hereto ar.d inco rp ora te d h e r e i n for ail pur­ poses re: events rr o c c u r r e n c e s which these ca usation witn es ses may b e ex pected to give any factual inf or mat io n t h e y may have regard: the subi acts outlined in said Answer, A s se s s m en t of Ex posure to 2,4-0 > 2 r.4 ,5-T ar.d .'levins and any factual k n o w l e d g e in support t .iereof. Te s ti mo ny i: Testimony ir sc capa c1 -y . ?^ Subject in witness' personal and of fiait Matter 2,4 ■ D . 2,4 ,.5- T , TCDD s and dioxins; Agent Ora (also White, Elue, Pi.nkr Oreen, and Purr and related c'nlorophenols and human r isk assessment r e g ar d i n g ex po s u re » I n c l u d i n g , bun noi: U n i t e d to, >ue cr 3 0 re c . ■ the fo l l o wu n g subject a r e a s : a ) C h e ini s t r y / B i 0 che 1 1 s t r y 0; Manufacture c) i. f.' l i ¿) Modes of Human, Er.pòsui e) Fate in thè Environner. 1 An im ais ) f) Stata of A r t / S t a t o . Lit aratu re C j. ü y *\ . 3) ( L iu ti, m s , 0 f M e d i c a ’ and P I act s , Scienti Plant Physio’or;7/ Stud ics An:., al Physiology/Studies H ut _u Studies Epidar ..0 10 e ;7/E i 0 s t c t i s t i c s 7 •. ) •-y h; 3) a n d /or Pro duct : 1. d.VGrs' Plants, animais, humans 0 a u a ar H v i d e r , ¿ c i o gy Lapa odvetiva Epidemiology Heal t h Effects e." j w i t n e ss will be atkad op in i o ns ab-* ut both p u bl is hed ,r.:id/or ou -g e i ng otudi..s. 4) Y a s , uitncf,3 will be asked op in i o ns about or re se arc h w i tn e s s l as p e rs o n a l l y or actually p a r t i c i p a t e d in. any studie perf :rmod rs •> ) Yes. wif.nacr. will be asked o p i n i o n s g o v -ornaienta 1- .studies. ot her 6) Yes. w i tn es s is e x p e c t e d to re v ie w the f o l l o w i n g d o cu me nts prior tr giving t a n t i m o n y : Sre , about R e s e a r c h and D e ve l o p m e n t , Hea lt h Ae_sessraeat Documant: on D i o x i n n_¡lor th 1. f f i c eo o f A ir 0 u a l ity,' Pla n nin r- 'and _ da , pf epaged by the ISr.viroumeni.al C r i t e r i a end 1' 0 as sin Of fie*- , Ci nc innati, Ohio 45140 ( j u lv 1 1 0 ?7 9 E P A . Renaai’ci. i:nv Dcvelopuent, II- i.th and linvi r a 1 Ei fecto Profile for; Tec Pent.-', and H e x a c ..lorodiL er.r.o-p-uioxir.s for the O f fi c e of Solid Wistc and lime:: gency ilesponpo, by the Environmental Cr it er i a and A s se s s m en t Office, Cinein Ohio 45240 (June 1383). EPA, research and De ve lopment, Ambient Water Quali ty Cr it e r ia for 2,3,7,8 TCDD, pro pared for Of f ic e of Water R e g - 1 at ions L\\.j Standards, by the Envisoni-entnl Criteria and A s ::a n ament Iff ice, Cincin Chic 45243 (July 1383). EPA, Research and Development, Dioxins, Industrial Environmental Research Ciucin:ia..i , Ohio (1978) . copy of these do" .msnts ..s a t t a c h e d . SL-PLOffiMTK. ANSWER TO INt ET 'OYi'ORY NO. 19 Plaintiffs note preliminarily tliat the extant Order on producing fa«- witnesses that fact witne: ;es are not-duo until March ' 1934.. However, Plaintiffs may caji one or more of the following persons (or those Yrav. various'categories listed b e ■■•) at time of trial to testify as to factual ;newiedge they may have, including: i. Ranch Hard Persona:.*.: these persans will testify tc their knowledge of the Ranch Hand Operation, Ranch. Handers exposure to Agent Crange, and/or hicwledge relating to the sp: lying, testing, and effects of i'gont C range on hiuians. M-'iinbers of O. ; .ace., .-’ore.j: These persons mo testify to the circumstance.? ana c.:edit ions .«-urrounding the : ¡raying of Agent trance. 1. Persons present in Via:c:am during the closure peried in question 2.SS1--L272, including.. but not limited to, ir<~ j.t-;ry and paramilitary personnel of the U. C ., l ew Zealand _nd Australia, who have knowledge of idle cpraying operations of the herbicides, the exposure cf the Plaintiffs1 class, the hazards ecccmpanyiug any such exposure, the Plaintiff-;’ ■.■.hentselver;, and. the Defendant company representative:: piftseni: ii. Vietnam i oversee 'he deliveries rnd spr "(no operation?-: of the herbicides they manufactured. 4. Persons together \.-Vdi their demonstrative and documentary evidence whe gave testimony (which will form the substance cf their testimony herein} at the EPA Cancellation Hearings of 2 ,4,5-T (1979-1S30) under FIFR.V including but not limited : rrt• a. <■■■b ... c. d. e. Dr. Roy AlbertDr. K. Diane Courtney Robert K. Baughman, Ph.D. Dr. Clav Axeiscn Dr. Renats Kimbrough f. Dr. Dawn G. Goodman g. Dr. Kirk T. Kitchin h. Dr. Fonal.6 Thomas i. Dr. Rainer Frentzei-Eeyms j , Dr. Matthew Keseison, Harvard k. Major Alvin Young l. Dr. Rodney Bovey m. Kenneth V. Thamein n. David T. Buzzelli o. Dr.Michael Gross p. Dr. Renee Stringham r. Dr. Van Miller Any current or previous employee, contractor, in-house or private consultant of each c? the Defer. Yes or ary other person who has !mov: 1edge of the rnanufacti m y ■processes, chemistry, occupational exposure and/or -jxicity of 2,4--D and/or 2,4,5-T or related dilcrophenols; irx uding, but not limited to- laborers;, operators; supervisors; ontract adrair.istrators? q u a l i t y control personnel; engineer ; (process, chemical, mechanical and/or safetv). Any cuz rent or previou 5 cnployee,. contractor, subcontractor, in-hou: :& cr private cc isvf.hanh. of each of the Defendants cr any cd >er parser, who h :.s trowiedga of the possible means <.• - ----- -- 1- J .1 . V- .otic protección from the has or Is of diaxizis' exposure; including, but not limited to, laborers, operators, sapervi sors, contract a.minis trators, quality control personnel, engine; s (process, civ ...cal, mechanical and/cr safety) . Any currant, or previous crplevee, contractor, subcontractor, in-house cr private consultant c ' each of the Defendants or any other person who has krowla/ce of the means to warn those who might be exposed, to use the herbicides in question, particulariy Agent Orange, includine, but not limited to, laborers, operators, supervisors, cor.react administrators, quality control personnel, engineers (process, chsnical, mechanical and/or safety). Any current or previou employee, contracted, subcontractor, in-house or private cot zultant of cadi of the Defendants or an* other person who has factual, knowledge of any other manufacturing processes which could reduce the risks of exposure to Agent Orange and/or other phenoxy herbicides being contaminated with dioxins and further reduce, 'die risk and hazard to human health of any such exposure. Any current or previous employee, contractor, subcontractor, in-house tr private consu.ltar.-f. of each of the Defendants or any other perron who has factual ¡new!edge of cononiratorial conduct of tdie Dc. .ndants, individually and/or duplicative eff r is (acts which are era ilel in nature) which tended to or did in fact result in ;aisleading the public and the fJnited States government iron gaining knowledge of 'die danger.-.; attendant from exposure to Agent Orange and ether phevzoziy herbicides. 12382 ir Cr^. 10. 12. Any current or previous employee, contractor, si;’ xsntrs or, in-house or private consultant of each of the Defendant., or any other person who has factual îcncwledge of hoi-; dioxi work upon plants, animals, and/or humans. Any current or pre-levs employee, c:..;.tractor, sufccontr. in-bouse or private consul.tant of each of the Defendan any other person who has ..'actual knowledge of any stat ooncecning tha effects of dioxins upon plants, animals humans. nr, r ,cs ld/or Any current or previous employes, contractor, subcontac in-house or private consultant of each o f t h e Defendant other pe.:on including, but rot limited to, members of other get emmsntal agencies, who has factual Icnowiedge c following incidents: r, or any ?A and 'oris a. Love Canal b. Times Beach, Missouri c. Sevescc, Italy d. BASF (1953, 135': - Sadi. ;che in Germany) tv Production mishaps end,--y; or'p.’ooicn.s silica 1925 at ai the plants of any of the Defendants manufacturing, T 2,4-D. 2,4,5-T phenol, chlorine,- acetic: acid, benzene hydroxi.de, potassium hydroxide, and/or Agent Orange, mishaps_in the packaging, and transporting of the Dei products to the U. S. Armed Forces bases for eventual to Vietnam. f. Spraying of Vietnam from 1951-1972. of sodium c udin.g i-iants1 . hipmant 13. Any current or previous employee, contractor, subcontrac r, in-house or private concul'tant of each of the Defendants r any other parson who has factual torwiedge of any surveys, tv tc, epidemuo.logiaal studies of any kind relating to the effec s of exposure to Agent Orange, 2,4-D, 2,4,5-T or any conntituf. it thereof including the secondary by-predu known as dioxins. 14. Any person with factual knowledge. of how decisions are made within the United States government, particularly tiie decision to use and to continue to use phone:g/ herbicides in Vietnam, particularly Agent Grange; any person v.ith factual knowledge of government procurement contracts and toe irritation to bidders, particularly those persons who negotiated toe government contracts for all phenory herbiciats (scents white, blue, purple, pink, green, orange I and II) with the 'individual defendants! repre­ sentatives between '351- 1372. 11- 15. Any person with factual lr.ov/1edqe through any surv ■3, tests, epidemiological studies or otherwise- undertaken by -iiy state government , any private public or foreign corporat 3n, the U. Congress or the government of any nation concernin' the chenùcaì compounds, 2 ,5-D, 2,4,5--T, dioxins, or related chib :cphonols relating to the creation of dioxins, the detection )f dioxin:.;, (lie oangers of die.wins' exposure, and/or the toxicity, arcinogenicity, fetotoxicity, teratogenicity, acute and/or c'ironic ffects on plants, animals and the hiraan population. 16. fey and all person., listed in The Chemical ffcvche ' Aiastair ttw, as having factual !uiov/le'ge regarding 2,4,5-T i,4-D, and its contaminant dioxins. 17. Ail worker csnpansaf.ion carriers for the Defendant and docu­ mentation cf ail occupational exposures filed sine 1925 which evidence industrial injuries or diseases at the TC 2,4,5-T, 2,4-D, Phenol, paricaging- and/or transporatic:. pla- s of the Defendants. 10. Any and aid t errant o.: or ior workers, co mensa tion t .irnanss of tiie Defen.dc r ■ '•- ’-.’ho c?.am -a.1 relrvant occupational er ,-sures and/o relav.m oc.-.ut.rtiourd irrVtries and/or disease;:; and,- .- symptoms a above. the rc.lo.VFHt dents l. st.. 1 j.n nr.swor to No. 19 (sul 19. fey ar:d all numbers of the U. S. douse of Represent eves .983) and/cr Contnittoe or. Oversights Review of the E?A actions air/ person together with their documentary and demo trativo form th evidence giving testimony at •said hearing (which wi substance cf their testimony herein; on the failure .; the EF i to take prompt and effective action to ban idle prod; :icn of 2,4,5-T, and its contarminant dioicins. 20. Any and all persons having knowledge ov relevant fat •; regarding the financial status of the Defendants and their ab: ity to respond in punitive damages, inducing, but not line sd to, their past, present, and future profits and earnings in tl • United States and tie abroad anroaa since 192:" through tnrouen and ana including inciucung the tne pres nt fran tran the sa] sale of the produces made the basis of this lawsuit, i.e., 2,4,5-T. phenoxy herbicides and the relevant ■ irbicide 2!,4-D, , market. Any and all persons having knowledge of relevant fac\ ; regarding the ownership interests ■f the Defendants and their *bility to respond in positive damages. including, but not limi' d to, defendants' domestic and foreign subsidiaries, joint ¿nturess, licensing agreements, --nd/or other public or private corporations in the u. S. and abroad, in which these defendants own a subsi antial financial interest since 1923 through .and including the oresent. -12 e. f. Any and all persons w?tn knowledge of past, prc and/or future reasonable ¿;nc necessary costs of doctors, hospitals, nursery care, medical equip drugs, and any other related medical services r< or to be rendered in the future to Plaintiffs a; result of their injuries and disease resulting;, their exposure to Defendants' products in Vietrv ■’ ed Any and all persons with knowledge of the physic .al disfigurement (past and present;, physical and i impairment (past and present), physical pain (p: an.l present} and mental anguish (past and present) v „ft Plaintiffs have sustained as a result of their o. osura to Defend:sits' products in Vietnam and which in reasonable probability Plaintiffs will continue ) sustain for an indefinite time into -the future i : beyond the cate of th::■; trial. rtespsctfuJ.lv sub rm f \ .tted; , ' Ujj-.rf~y-.izi j t O Z i Thcnas W. Header: .1, Esquire Allison Pettiett". Esquire CERTIFICATE OF SERVICE I hereby certify that a true and correct copy of the oregoing Supplement to Plainti-ff's Int arrogatories wara mailed Federal Ex ress to hr. William itrehley, Kelley, Drye A Warren, hr. Gene Locks, Plai .tiffs' fifenagarisnc Corraratt.ee Agent Orange Office, with copies to personally servo tie remaining Defendant.:.: at the Tuesday depositions and Ms. Nano/ Petrilla, TJ.S. District Clerk.-U.S. Courthouse, 225 'teaman Plaza, Brooklyn, Maw York 11201 this 2Gth day cf February, 130- y^\ ' J* ^ — -v 1 t.. ^ * \JJLl -:j t a -^ ii Al li f.on Petv.iette 12385 -14- r > ~r\ (J o t'ü i Srarws ■•lustrial En\ • nmuMt:. ‘■'lviftn.nfüit.il f’ rr.i'-r'iort :..:noronrv -■» lenr.v C iiir.innati ( '• 4 5 2 6 3 r, Jnv’luoaiiTH iT t vi H .. -V V' -1 ■'v'1 12386 P L A I N T I F ? ;S GO VERNMENT C A U S A T ION WITHES,'3ES Jiiaet Springer EPAj B. Both C- General Washington!, D.C. factual and expert te stimony is £.ough Events ire- 1^ 61 : iny factual knowledge of the. h herbicide spraying in Ü . S . and including j ¡-at not limited to, exposures and explosions ; ( 2 ) : 2,4-Z', 2 ,4,S--T with the Dcpartr culture and any oth :r govemmei any and/-.r all cf Che Defendant. 1961 présent.; An y fcctusl I-nowl’ c dge or t'i h a t T ici do cprxying in the ü .3 . iv.ciud i..„, but uct limited to, Kilitary use of Agent Orange an ucrbici...cs tu Vietnam; (2) chan gistraclon rc.yaireaents of herb J .Ci. gcverncext and its agencia haow 1 adgo o f FI IRA.,. F D A ,EPA, an ar.y knowledge of industrial and exptaures to 2 ..4-D ,- 2 ,4 . !'-T in t ry of road; ) industrial istraticn of t of Agriagencies by uistory of i abroad; ) II. T-. otl:er phene a in the >ides v:i t h the Including JSHA; and (3] ther human i 0 . C . and abroad See Answer and Supplemental Answer of Plai: If S : t ttachcd Defendantr. ’ Interrogatory Nc.'l: ' oxreto and inccrpora red h e re i n i • all purposes re: events or occurrences /hich these causation witnesses nay be expec ed tc give any factual informa'tion they map lave regardin; the subjects outlined in said Ar. rer. Ilirasn Risk Ascesumeut of ■Exposure to 2,4-D. ioxinr and any factual kuowledg t h c:v e o f . D ;,4,5 -T and in support Expert Testimony 1) o • 4L. J Testimony is sought in w i t n e s s ’ persona' cayaci v. . Subject hatter 2,4--D, 2,4,£-T, ^CDD's and dioxii T/II (also W h i t e , blue, Pink, Grc and official Agent Oran; and Purpli and.related e h l o r o p h e n o ‘3 and human risk assessment regarding exposure, including, but not limited to, one or more of the following s bject areas: a) Chemi stry/Biochemistry b) Manufacture and/or Production c) To xic ity d) Mo des of Human Exposure e) T ~* t e 4.,’ C f) Oi-J O *' n * w, \ (Humans, Plants, Plant Physiology/Shudic Animal P h y s i o l o g y /Studies Hunan Studies ideurology/' Bio statistics i) o 4. • ■r. s ■ Plants, animals, hur :na Cancer Epidemiology Reproductive Epidemiology Ac ■■/ersa Health Effects 3) Yes, witness will be asked opinions about both published and/or on-going studies. 4) ‘res, witness will be asked opinions about any ctuc_cs or res 2 “v:h witness has personally performed or actually p a r t i cipated in. 5} Yes, witness V7ill be asked opinions governmental studies. 6) Yes, witness is expected to review, the following documents prior to giving testimony: ' ,.1 about other See. F.?A, Research and Development, Health A s s e s s m e n t Document- on- -Dioxins for the Of fic as- o f A i r Q u a l i t y . P l a n n i n g ’and -itan d a rc*s", ^pirepare'■ - fr.'.'yl’ •-iv. .i.-sV. , ' < t J» * ’ „*1 > . 'V ' k EPA, Research and Development., Health and;, Environmental Efiects Profile for; Te Penta, and Hexachlorodibenzo-p-dloxin for the Office of Solid Waste and Erne geney Response, by the 13nvirom.i ntal Criteria and Assessment Office, Cinci Ohio 45i'.‘ >8 (June 1983). • ,.i • • 4. EPA> v ’' .iese;.rch and Developroeat , Ambient Water Quality Criteria fot 2*3,7,»8 TCDD, pr pared for Office of Watar Regulations and Standards, by the Environmental Criteria and AaseaGnent Office, Cinci 0;:io 432<.>r. (July 2983). EPA , Rcnea-cl and DaVcloptrjia.nC , Dlo:cinnr ii i ■ .i.1.'ij. i'lliv Ilfun»i iut ai uaMuu.i:l. C i .innuti, Ohio (1978). A copy of these documents is attached. ■■ ' "«,i :V.f vi " ■■ • V.. .' .■’•■ .K• '■.J• ' • k ‘ ». • • --V. .•••.!.■ •-,.;'y "’ V •' '; ■4 .?•’■:?&&[*%$• 4 "■ é r ' 1, ’' . . . -, - .. ■■ .. . 'a ••' ■;/ • "; V,.' :i'-a ■; w ' a v:’ . ■Vi V ■’ ,..... •. • ’■ ' ■ ;• ■-'X':’ :i .■:■ W;-y .’• ZJ*■:: . f•• :-f .s ' '"i . ’. ■ « •..:• . "« ' • • r■ ::: .... .■ ,■ .v's ■-V.t-‘ . • 9h. 2. * j- Dr. Roy Albert: /Jjm K. Diane Courtney Robart K. Baughman... Ph.D. Die Olav keelson Dr, Senate iiirbrcurh Dr. Dawn G. Gcodr"... Dr. dirk T. Kitchiii Dr., Donald Theme.' Dr. S:i..n?r Fren'csel--Bevrae r M-rktliSv: Msselscn, Harvard m Y 1- <: .,*•;• i. » . -Vl- ¡:. Ma. jar Alvin Young i. Dr. Rodney Povey m, Kenneth V. Therein a. David T. Euuzelli o. 'Dr.. Michael Gross p. Dr. Renee Stringhnm r. Dr. Van' Milier i. Any current o;: previous employee, con-tractor, subcontractor, in-horse or private consultant of each of the Defendants or any other person who has knowledge of the manufacturing .•■recesses, chemistry, occupational esrpesure and/or tojcicity cf ,-«-D and/cr 2,4,5-T or related chiorophenols; including, bat not limited to, laborers;, operators; supervisors; rntract adrinistraters? quality control personnel; engineer^ {process, chemical, r.edianioa.1 and/or safety). Any current or previous employee, contractor, subcontractor in-house cr private .snsuitant of each of the Defendants or c-ny ether person who las hnov/ledge of the possible means of prc^hiactic so tec-cion from, the hazards of dioxins' exposure; including, or'., net limited to, laborers, operator's, supervisors; contract cdmir.i:'trators, quality control personnel, engineers (process, chemical, media: deal and/cr safety';. . . 7. Any current cr p:nviou..j <....ployca, contractor, subcontractor, in-house or private consultant cf each of tiio Defendants or any ether person who lias loicwiedga cf the means to v;am those v/ho might be exposed to use of tijs herbicides in question, particularly Agent Orange, including, but not limited to, laborers, operators, suparvisors, contract administrators, quality control personnel, engineers (process, chemical, metiianical and/or safety). 1. Any current or previous employee, '■u.itractor, subcontractor, in-house or private consultant of each cf the Defendants cr ajry other person who has factual knowledge of any other rmufacturing processes which could reduce the risks of exposure ‘ to Agent Orange and/or other phenoxy herbicides being contaminated with dioxins and further reduce the risk and hazard to human health cf any such exposure. 9. Any -Torrent or previous employes, contractor, subcontractor, in-heir:a cr private consultant of each of the Defendants or- any cviie.::- person who has factual loiowledgs of conspiratorial conduct of the Defendants, individually and/or duplicative eiforts (acts which are parallel in nature) which tended to or did in fact result in misleading the public and the United States government from gaining knowledge of the dangers attendant from exposure to ■ Agent Grange and othor phenoxy herbicides. 12391 -10- » ... g'W/ *V:. 'v‘ f *■ 10.. Any current or previous employee, contractor, subcontractor, in-house or private consultant of each of the Defendants or any other person who lias factual .aiowledga' of how dicacins .work upon plants, animals, end/or humans. , . , .. . :•'/ y. . 11. Any current or previous employe, contracter, sufccontractor, in-house or private consultant of each of the' Defendant:; or any other parson who hi 3 factual knowledge of any statistics oonoeming the effects of dioxins' upon plants, animals, and/or humans. 12. Any current or previous employee., contractor, suLcontactor, in-house or private consultant of eacli of the Defendant.-? or any ocher person isiciuding, but rot limited to, members of EPA and other govor.cmental agencies. v:ho has factual knowledge of the following incidents; a. Love Canal b. Times Beach, Missouri c. Sevesco, Italy d. BASF (.1953, 1951 - Badische in Germany) e. Frccucticr. vishapo and/or explosions since 1325 at a 7 of the plants of any of the oiler,“ants ltianufacturing, T'. 2,4-D, 2,4,5“'.? phenol, cltorino, acetic acid, fcansene.. sodium hydroxide, potassium hydroxide, and/or Agent Grange, nicluding Irish-ps in the packaging, and tear,"-porting of the Defendants' products to the rj. s . Armed Forces ‘ oases for eventual shipment tv Vietnam. f. Spraying of Viettra 'free. 1951-13.2. ■L .13 14. Any current or previous employee, contractor, subcontractor, in-house or private consultant of each of the Defendants or any ether person who has factual knowledge of any surveys, tests, epidemiological studies of any kind relating to the effects of exposure to Agent Orange, 2»4-D, 2,4,5-T or any constituent thereof including the secondary by-product known as dioidns. Any person with foetus! kr o.-ledge of how decisions are made within the United Steves government, particularly the decision \:o use and to continue to use pkanoxy herbicides in Vietnam, particularly Agent Grange; any person with factual knowledge of y vtexsnsnt procurement contracts and the invitation to bidders, . particularly those perrons who negotiated the government contracts for ail phenoxy herticictes (agents white, blue, purple, pink, green, oi.vnge I and XI) with the individual defendants repre­ sentative;.; bscveen 1961-1972, 12392 tr 15.. Any person with factual knowledge tltrough any surveys, tests/" epic,u:.u.clexical studies or otherwise undertaken by any state gover.rnent, any private public or foreign corporation, tine U. S. Cong.;ess or the government of any nation eonoermng tile chemical compounds, 2,5-D, 2,4,5-?, dioxins, or related chioronhenole relating to the ersc.tion of dioxins, the detection of dioxins, tile dangers of dioxins' exposure, and/or tile toxicity, carcinogenicity,, fetotoxicit.y, teratogenicity, acute and/or c.ircilc , rfect: cn plrots, anrials and tlie human population. 1.6. Any and all persons listed in The Chemical Scythe v ALasteir 2ty, a;., having factual Itiowledge regarding 2,4,5-1 2,4-D, and its contaminant dioxin.':. 17. .Hi worker compensation couriers for .the Defendant.; and dccujirr.taticn of all occupational exposures filed since 1925 which evidence industrial injuries or diseases at the TCP, 2,4,5-f, Phenol, pac-aging, and/or fransporntion pl?--i;s of ti- -t nafunchnt 19. Any and all current or rrior worker:- ocmoe-isatian claimants cf the Defondants who claim.:./ relevant •-.ccupaticnal e"'oosures rnd/f relevant . and rh-roan., m v-hic:h Jhese r efendants own a substc'.rsti.al financial 'ntes'st. since 1925 through and includir j the uresent. 123 e. Any and all persona with knowledge of past, present and/or future reasonable and necessary costs of doctors, hospitals, nursery care, medical equipment,' . drugs, arid any other related medical se: "d.crso rendered or to be rendered in the future to Plaintiffs as <_ result of their injuries ana disease resulting iron their exposure to Defendants' products in Vietnam. f. Any and all parsons with knowledge of the physical disfigurement (cast and present}, physical and mental impairment (past and present), physical pain (past and present/ ~.ne mental anguish (post end present) vjhi.cn Plaintiffs have sustained as a result of their exposure to Defendants* products in Vietnam and which in reasonable probability Plaintiffs vjv.1 1 continue to sustain for an indefinite time into idea future far beyond the data of this trial. respectfully submitted, /■ Uj- jfa. rjXTFj "n, Esq idre Esauire Allison Pettiet lira:. VI. Menci-v CZRIOIOGATS OF SSbvICE I hereby certify that a true arc correct copy of the foregoing i Gupnlatent to Plaintiff’s .Interrogatories were mailed Federal Express to Mr. William IOroirloy, Kelley, Drya s Warren, Mr. Gene Locks, Plaintiffs’ ifepfc -ament Co.triff.ee Agent rrange Off.ice, with copi.es to personally serve the rsnaifcixig Defendants at '-'.a Titesday depositions and Mn. Nancy Petrilia, U.f.. 'istrici Clerk, U.S. Court ouso, 225 Cadi an Plaza, Brooklyn, New York 11201 this 1.0th day of February, 1984. s\ v ix i ^ r r ^ U x f o n t X c illison Pettiette 12334 r\ ni ¿ ... , í ..idustiwl (£nvironrru!i'<.i 7.r:v .' -cicni*!- • • ifuciion ¿-i.. ! JO'jratorv Cim: ruiáU O h 4 5 2 '.3 rti:vii::ilttí,¿wiu‘iinn-■( T'-O. p ' Q \a/ ¿'\ J j J O .J 12395 PLAIN T I F F 1S GOVERNMENT CAUSATION WITNESSES t P et er Infante A. Na ti o na l I n s t i t u te for Occupafri c n a l Safety & Health, Ua3h E. Bo th factual C. .General Events Pre-1961: and expert testimony is sought. Any factual k n owl ed 'c of the histor y of he r b i ci d e sp ra yin g in U.S. and abroad; including, but not limited to, (1) industrial e x po su res and ex pl osions; (2) r e gi str at ion of 2 , A - 0 : 2,',5-T with the D e pa r t m e n t of A g r i ­ culture an:’ any other g o v e rn m e n t agencies by any and/or ail of the De fe ndants; 1 9 6 1 - p r e s e n t : Any ia-.cu-.l k n o w l e d g e of the hi sto ry of and abroad; h e r bi c i d e spr ay inx in the rr q includit g , but net limited to , (1) U.S. mill t n r y v.s 2 f Agent C-rar. go tn d other pher !li:-•b ."< ■ : ■Jn V ’et-.mn; (2" char- gas in t . : gistra'.lo:. 7: vjc .'.remer.ta c.. herb icldea with U ..3 . g- ’.-erncent and its agencie'" including k n o w l ed g e of FIFRA, FDA,ERA, and OCHA; and (3) any know le dge of incustsic,1 and other human exp os ure s to 2 2,4, 5-T in the U.S. cud abroadSee Answer and Su pp le m en t a l A n s w e r of P l a i n t i f f s ’ to D e f e n d a n t s ’ I n t e r r o g a t o r y No. IS attached hereto a '' i n c o r po r a t ed h e r e i n for all pur ­ poses re.. events or o c c u r r e n c e s w hi c h these c a u s a t i o n w i t ne s s e s may be ex pe c t ed to .ive any factual i n f o r m a t i o n they may have r-gardin. the subjects ou tl ine d in said Answer. H um an Rick A s s e ss m e n t of Ex po s u re tc 2.4--D, 2,4.5-7 and diox:.ns and any factual k n o w l e d g e in support thereof, D. Expert Test im ony 1) Testimony is sought capacity. in w i t n e s s ’ p e r s o n a l and off ici al ?.) Subject Hatter 2,4-D, 2 , 4 , 5-T, T C D B ’e and dioxins; Agent Oran I/II (also White, Blue, Pink, Green, an-’ Purpl and related chlorophenols and human risk assessment regarding exposure, including, but not limited to, one or more of the following subject areas: a) Chemistry/BiocIvemi-v;:r\ b) Manufacture c) Toxicity d; Modes of Human Exposure e) 1’ate in the Environment Animals) f) State o': Art/State of Med i c al and Sclent: Literature and/or Production (Hue:ans, Plants, I) Plant P h y s i o l o g y /St\ lies 1) . Animal Physiology/Studies H u ma n Studies d; g) Eyidr:miology/Bior t a t i c t i c c 1) ...j cj > - r/ >*, h) Plants, animals, h u ma n s Cancer E p i d e m i o l o g y R e p r o du c t i ve E p i d e m i o l o g y Advcr ■;e Hea lt h Effec ts 2} Yes, witness will be asked opinions about both published and/or on-going studies. Ay 1c s , witness will be asked opinions about any s'udie or research witness has personally performed or actually participated in. 5) Yes, witness will be asked opinions about other governmental studies. 6) Yes, wi t n e ss is ex pe c t ed to r e vi e w the following do c u m en t s prior to givi ng testim ony : bee, E P A , I^eGj^jtrch and " e v el opine n t , Health An sea ament 'Document- on' D lcx ins for the Offices- of Air Quality,' Plannin., ‘and Standards , prepared 'by the Environmental Criteria and Acsessmc Office, Cincinnati, Ohio 45268 ( J u l y 1£ top C i->' ■r> V r , v.^riy-. y ':’ ï EPA, Research and Development, I 'aith and Environnental Effeets Prt ile for; Terra Penta, and Kexachlo rodib ;zo-p-d ioxins> ;:ce and Emerfor the Office cf Solid gency Response, by the E ironmental fice, Cincinn.it Criteria and Assessment Ohio /••52A3 (June 1983). '% -.blent Water EPAj Research ani Development, ,8 ÏCDD, preQuality Criteria for 2,3 Regulations pared for Office of Wate and Standard.:, by the En ronman:al ifice, Cincinnat Criteria and Assessment uhio 45 7:48 (July 1933). EPA, Research and Development, '.crins, Industrial Environmental Research :innati - Ohio (1978). A copy of :eae documenta is attached. 123 b t A r \ SUPPLEMENTM, ANSWER TO INTERROGATORY NO. 19 Plaintiffs note preliminarily that the extant Order on pr xSucimg fact witnesses starts that fact witnesses are not cue until ..larch 2 1984. However, Plaintiffs may call one or more of the following persons r those from to arious categories listed belcw) at that; of -trial to testify ;. factual 1-trcwiedga the" may have, Including; 1. Ranch Hand Personnel: These persons will testify to their 'uiowledcje of the Ranch. Hand Operation,- Ranch Handers’ exposure to Agent Orange, and/cr lo.cv/led o relating to the spi .ying, testing, and effects of Agent Orange on humans. 2. Members of the U. 0. Armed Forces: theca parsons may testify tc. the circumstances and c ; .ditions surrounding the spraying of Agent Orange. 2. Persons present in Vietnam during the exposure peric-. in question 1961-1972. including, but not limited to, military and paramilitary personnel of the U. S., New Zealand end Australia r who have knowledge of the .spraying operations of the herbicides, the eqpccurc cf the Plaintiffs11 class, the hazards acoanpanying any such exposure, the plaintiff - ! themselves, and the Defendant canpany representative present in Vietnam tc oversee the deliveries and spraying operations cf the herbicides they manufactured. 4. Persons together with -heir demonstrative and documentary evidence who gave testimony (which will form the substance of their testimony herein) at the EPA Cancellation Hearings of 2,4,5-T {1979-1980) under FILto & t ^ 1 1 i-• f ‘-1 !’ -fp !•' '1' id ■M ( i ■‘A- P a Dr. Ito" Albert; Dr. K. Diane Courtney Robert K. E-aughraar., Ph..D. Dr. 01av AxeIson Dr. Renate Kimbrou/'i Dr. Dawn G. Goodman g- Dr. Kirk T. hitebin h. Dr. Ron old T otaas i. Dr. Rainer Frentzel-Eayms j # Dr. Matthew Mesalson, Harvai >- b. - c. d. e. . LC ,«. Sft i 12399 -9■ ... -io k. Major Alvin Young l. Dr. Rodney Bovey m. i’enneth V. Therein n. David T. Buzzelii o. Dr. Michael Gross p. Dr. Renee Stringnani r. Dr. Van Miller Any current or previous employee; contractor, subcon actc;:, .un-fiouse or private c0nsu.lv.3 nt : each of the Defend .its or any other parson who has know! •ja of the manufactur ig processes, chemistry, occupatir ...al '-xposure and/or 1 -deity of 2,4-D ard/or 2.4,5-T or related chlorophenols; incl Ling, but not limited to, laborers;. operators; supervisors; < . ¿exact administrators: quality control personnel; engineer: {process, chemical, mschmical and/or safety) . Lvny current or previous employee, contractor, subcontractor, inr-house cr private consultant of each of the Defendants or any c-th.r person wiio has iuicwlodga of the possible mean .of prqdjiactio protection f.vcr. the hazards of dioxins’ expo sure: including, but not limited to, laborers., operators, supervisors, contract administrators, quality control personnel, engineer, (process, chanical, mechaiv ial and/or safety}. i. Any crjrrevit cr previous employee, cov.oractcr, subcontractor inrheuse or private consultant of c-ach .of the Defendants or any other person who has knowledge cf the means to wan. these v:ho might bo exposed tc use of the herbicides in question, particularly Agent Orange, including, but not limited to, laborers, operators, supervisors., contract administrators, quality control personnel, engineers (process, chemical, mechanical and/or safety). O u • Any current or previous employee, contractor, subcor.tractor, in-house or private consultant of each of the Defendants or any other person who has factual. iciCwledge of any other manufacturing processes which could reduce 'the risks of exposure to Agent Orange and/or other phenoxy herbicides being contaminated with dioxins and further reduce the risk and hazard to human health of m v such exposure. Any current or previous employee, contractor, subcontractor, in-house or private consultant of each of the Defendants or any other perse: who has factual knowledge of conspiratorial conduct of the '<3sfeivdants, individually and/or duplicative efforts (acts which are parallel in nature) which tended to or did in fact result in mj.sleac!Lng the public and the United States government from gaining knowledge of the dangers attendant from exposure to Agent Orange and other phenoxv herbicides.. •! ; .7* 12400 -10- 0 ^ 10. Any current or previous employee, contractor, subcontractor, in-l*ruoe cr private consultant of each of the. Defendants,or any ther per:.on who has factual knowledge of hew dioxi: r work upon plants, animals, and/or humans. 11. Any current or previous employee, contractor, subcontractor, in-house or private consultant of each of the Defendant, or any other person who lias factual knowledge of any state ics oonœmi.r.g the effects of dioxins upon plants, animal's, rml/or huanans. 12. Any current or previous employee, contractor, subcontac ;r, \ in-heuse or private consultant of each of the Defendant or any other person including.- but not .limited to, rasnbors of PA and other governmental agencies w o has factual icncwiedge c idle following incident:: a. Love Canal b. Timas tea'll, Missouri c. Sevssco, Italy a. BAS? (1553- 1924 • Badischo- in Ger..rrr/> ¿n Production mishaps and/or explosion:; since 1925 at a:: of the plants of any of the Defendants iRar^ofacturiiig, ft ', 2,4-D, 2,4,5- ? phenol, chlorine, acetic acid, benzene, sodium iTydroxi.de.. potassium hydrcuLde, and/or Agent Orange, including mishaps in the packaging, and transporting of the Defend nits’ products' to the U. S. /¿ted Forces bases for eventual shipment to Vietnam.' f. Spraying of Vietnam from IS 51-1972. Any current or previous employee, contractor, subcontractor, in-house or private consultant of each of the Defendants ir any ether person who has factual knowledge of any surveys, tests, epidemiological studies of any kind relating to the effects of exposure to Agent Orange, 2,4-D, 2,4,5-T or any constituent thereof including the secondary by -product known as diox is. 14 . Any parson with factual knowledge of hew decisions are made v.dthin tlie United States government, particularly tiia decisi to use and to continue to use phenoxy herbicides in Vietnam, particularly Age. t Orange; -any person with factual knowledge of govemriient procurement contracts and the invitation to bidders, pa rticularly those persons who negotiated the government contrac for all phenexy herbicints (agents white, blue., purple, pink, craan, orange I and 7.1] with the .individual defendants repre­ sentatives between 1961-1971. -11- A S't 15. Any person with factual knowledge through any surveys,, tests, epidemiological studies cr otherwise undertaten by any state government, any private public or foreign corporation, the 0. S. Congress or the government of any nation concerning the chemical compounds, 2,5—D , 2,4,5--T, dioxins, or related chlo phenols relating to the creation of dioxins, the detection ■ : dioxins, the dangers of dioxins’ eseposure, and/or the toxicity, carcinogenicity; fetofcoxicity, teratogenicity, acute -and/or chronic c ^ects on plants, animals and the human population. 16. JteT/ and ai.l -¡arsons 1:'.ted in '¡.he Chemical Scrythe by 'lastair Bay, as having factual knowledge regerding 2,4,5-'-?, .HD, and its contaminant dioxins. 17. M l worker compensation carriers for die Defendants .and docu­ mentation cf ail occupation?.! exposures filed since 1915 which evidence industrial injuries or diseases at 'the TCP, 2,4,5-T,'' 2.4- D, Phenol, pedarging, and/'er t .ensporation pi-ants of the Defendant: ■„ 10. Any and nil current'cr prior v.or.b. crr.rx-nsat.ion claimants of the Defender:-’-s who olaiir.td re :-vc: . occupational exposures and/or relevant occrpaticr.nl injuries inl/cr diseases and/cr symptoms at tV.a re?.evei:.f. plrà.fslisted in uuowor to No. 19 (sub 17) above. 19. Any and ail members f the S. i_-r.ee .f Repräsentatives Ocnsnittae c:i Oversights It. -iev; r£ the £?A :étions (1SC3) and/or any per.. r.\ together with their documentary : id demonstrative evident-: giving ter. i ny et said nearing (which will form the siibsta.se cf '-.licit testimony herein) on the failure of the EPA to take premp- and effective action ho ban the production if 2.4- D, 2,4,5-T, and its contaminant dioxins. 20 . Any and all parser havnng knowledge of relevant facts regarding the financial status of the Defendants and their at -lity to respond in punitive damages, including, but not limited to, their past, present, and future profits and earnings in tile united States and abroad iroe 1921 through and including the present fron the sale cf the products race the basis of this lawsuit, i.e., 2,4-c, 2,4..5-'..'. phenoxy herbicide:: and the relevant herbicide market. 21. Any and ell persons havii g krsswledge of relevant facts regarding the ownership interests cf the Defendants and their ability to respond in punitive damages, including, but not l/nited to, .fer.dantc: dcmentic and foreign subsidiaries, joint venturers, licencing agreements, and/or other pubi-.c or private corporations i . :ho U. G. and abroad, in which these defendants own a sub­ stantial financial interest since 1925 through and including the "¡resent. 1n -12- Any and ail persons listed by Plaintiffs1 in h-oth original and afforded witness lists,, as expert witness (medical, scientific or causation).. government witness,. government causation witness, defendants1 employees and/or related personnel and/or any witnesses listed! by all Defendants, may be called at time of 'trial to ¡present factual information as to any issue involved in this caseBny and all members of the scientific and/or medical oonraunit..' wte have inowladge of relevant facts, including information . ••css. ' of -tire previously listed subjects ii. this Answer, including, but :ot limited v;o: a. Ssvid Ifriehsi, Ph.i . !b. L:.t Alan Polar.! •v. iDr.. Vaul Gaidar: 0AS7 d« Ur. C. Paces e. iDr. Osttel, liAid it. Dr. E. 2. .fcDcr/ssil g. Dr. K. S. Kh:-.r:a h. Alvin .Alv’ . i. Marilvn 2 incarhut Any and ail rev ... ns who hove indrviduai repr*ss e n t r \\\ rot limite-.:?. 4. • the fed hewing; tarTd.tfic. *•• r*-a r teote1 d the it. Lifv.1 1er fc:: : anburies, assesses and/or relat .n . lr:o! co.vl conditions which résultée .al and fixza Plaintiff-e-exposure to Agent Grange, and/or phenoxy herbicides, their constituents, csoarv’ary by-products, wastes, residuals r d ro:vtc:rànF:.-.-'*.s. b. Any and ell hospital parrs;:-*- --I -where Plaintiffs have been confined for treatverd: relating tv> '-heir e^rposure to pefendants’ n w v im jtjs i VVietnam. if t '- .r a n i c. Any and all persons with kncwlndga of the sconanic losses, psydiologicai and/or intangible damages sustained by your Plaintiffs as a result of their injuries and diseases resulting from their exposure to Defendants’ products .in Vietnam. d. Any and all persons with kneviedgo cf the past, present rnd/cr fuf.ure economic lessen your Plaintiffs hr.ne or will sustain in the future rs a result r; f-heir loss of wage enmings and/or wages earning capacity resulting from th~ injuries and diseases ma''o the basis < 1 t h i s ?.av/sr:'-. v;hbch were caused -t v Prair.-t: ffs exocuure to Defendants' o-xduct.'-* in .ietnsm. 12403 r^. PLAINTIF?'.S GOVERNMENT CAUSATION WITNESSES D. Diane Courtney fr EPA» Washington, D. A* üfeth- factual C. Gen er al Events csrert t e s t i mo n y is scìngi '. Any factual knowl- dgn el the Listory oí herbicida sprayir.g ín U.5. and e.broad; inc ludinj , but nst !.í:.i.hcd to , (1 ) in d u : exposuras and exp losio . -; (2 ) regí rtrat: 2,4-D, 2 , A ,5-T t;A.;h tho Dspartmen oí i. culturo ar.d any other g-nvuvnaent ugenci any and/c r all oí the De f ende. 't b ; o c¿ ?re— IS ü I: and ..«-,.. of the u i r.t c ry o f «- • / - -r r-r CtlU £i1ro r.d ; j•>r ::ying in -he U .3. and .¡trl'Li cid but not limited to, (1 ) T U‘•/“>« inducir. r 1 i a ry ■ " 2 .7 A 3 e a t Or a n ge end r. e r p lì v ■ in victncm; (2 ) changes in Llic I orbi-' i gusto • ...'un r'u.-ireßeats of fcsrbicidas vit ' U. S. government and its agencias includi nr. hr.oviedge cf F173.A. FLA, EPA» and OCHA.; and .ó r.- ' know", edge cl industrial «and ether ione . c::c sV.re s t ~ 7. . 1 - .0 .. '1,4,5 - Y in the U .S . and abroad' Lappicimental Answer cf Plaintiffs’ to «•f*p•*]*•r» Interrogate ;:y No. 1 9 s,Ciac bed t r: a d incorporated herei a for ali. pu rs re: events ~.c occurrences which these ation • itiicsseu Euy be expected to c*¿v û £ UW», «pf\ i ti♦«^ ti . .. :."” rtnat i c n they Easy have regard;. ts outline-’ in said Answe r . u bp ec' Seo Anuo. r sr.ont of Expo s'?re to Z , h -J>, 2,4,5 -T and factual Laouledge ir. support dioxins and i h e rc o f . D. xpe ::t T est ime nv 1) Testimony sc it.ht in witr. car acity. ?*> ‘ / f!;■h ie :t Matts V.' c 4-.Ï). " A S-v Ttr-i) :s and dioxii.s; Agent Ora: »; >A i 7 (alno Whit* • -■-*¡0y and related chlotophenoi.j and ii man risk’ assessment, regarding exposure, .ncluding, but not limited to, one or more of the following subject areas: a) Chemistry/Biochemistry b) Manufacture and/or Product!' n c) Toxicity d) Modes of Human Exposure c) Fate in the Environment An LmaIs) r) :ltat 1 >. ^. 3 ) of Art /State cf Medical and Scientif 1 L ':er a are Plant Physiology/Studies .nimai Physiology/St .’ .dies i ’ill ftfcudiaB Epidemiology/Biostatistics 1) 2) 3) h‘ (Hu. ar :, Plants, Plants, animals, humans Cancer Epidemiology Reproductive Epidemiology A d v e m e Health Effects 2) Yes, witness wi.l . be asked opinions about both published and/or on-going studies. 4} Yes, witness will be asked opinions about any studies or research witness has personally perf ormed or actually participated in. 5) Yes, witness will be asked opinions about other governmental studies. 6 ) Yes, witness is expected to rev lev/ the. following documents prior to giving testimony: See, EP A , Res earch and Development, Health Assessment Document on Dioxins for the 0ff ices of Air Quality, Planning 'ana "Standards ",*“^1p?epared by the Environmental Criteria and Assessment Office, Cincinnati, Ohio 45248 ( July 1982 12406 ■f ' ( surribiE^rrAi a n s w e r t o i nterrogat o r y n o . 19 Plain-tint's not'-: preliminarily tfiat tlie extant. Older on producing fact v-utnesses states that fact -/itnesses are not due until March 2, 1984, However, Plaintiffs may call one or more of the following persons (c those fresn various categories listed below) at time of trial to testify a: to factual knowledge they nay have, including: 1. Ranch Hand Personnel: These persons will testify to t air iarowledgc of the Ranch Rand Operation, Ranch Handers' -.gposure to Agent Orange, ar.d/or knowledge relating to the sore l.:?, tenting, and effects of Agent Grange on humans. Mi-sbers o:: tl'.n U. G. Armed forces: These parsons may .ertify to the circumstances and conditions surrounding the sp ayiug of Agent Orange. 3. Persons pro sent in Vietnam during the exposure period 1 question 1961--1972,. including, but not limited to, mil fary and paramilitary personnel of the U. G., New Zealand a i Australia, who have JaiowLedge of the spraying operatio? 3 of. the herbicides, the exposure, of the Plaintiffs' class, :he hazards accompanying any such exposure, the Plaintiffs themselves, and the Defendant company representatives present in Vietnam to oversee the deliveries and spray, ic operations of the lierbicides they manufactured. 4. Persons together with their demonstrative and docuaentcry evidence who gave testimony (which will form the substance of their testimony herein) at the EPA Cancellation Hearincs of 2,4,5-T (1979-1980) •’nde?; 7IFRA, including but not limited to: a. >-b. - c. d. e. f. g. h. i. j“ Dr. Roy AlbertDr. K. Diane Courtney Robert K. Baughman, Ph.D. Dr. 01av Axelson Dr. Renate Kimbrough Dr. Dawn G. Goodman Dr, F irk T . Kite'in Dr. Donald Thomas Dr. Rainer Hrentzel'-Boyme Dr. '•lattheS« MeseIcon, Harvard -9- 12407 (' k. Major Alvin Young l . Lr. Rodney Eovey m. Kenneth V. Themsin n. David T. Buzzelli o. Dr. Michael Gross p. Dr. Renee Stringham r. Dr. Van Miller S_ Any current or previous employee, contractor, subcontrictor, in-house or private consultant cf each of the Defends os or any ether person who has knowledge of the manuf acturirg processes, chemistry, occupational exposure ant!/or to: Icity of 2,/--D and/or 2,4,5-T or related chlorcphenols; including, but mot liirlted to, laborers;, operators; supervisors; contract adr.iiniistrotors; reality control personnel; engineers .process, chemical, mechanical and/or safety). 5. ¿tef current or previous or.ploves, contractor, subcontractor, its-house or private consultant of each cf the Defendants or am-- other person who has knowledge of the possible meaas of yr.-vhi. .it; protection from tho hazards of dioxins" cavposure; iiicduii. . but not 1imitec. to, laborarc, operators, supervisor.:... •*ra;?xacf. administrators, quality control parsonr.oi, engineers (process.- chemical, mschani^l and/or safety) . 7. Ar.y current or previous employee, contractor, subcontractor, XTr-house or private consultant of each of the Defendants or any other person who h o knowledge cf the means to warn those who might be exposed to use of the herbicides in <-uestion, particularly Agent Grange, including, but not limited "o, laborers, operators, supervisors, contract administrators, quality control personnel, engineers {process, chemical, mechanical and/or safety). 8. Any current or previous employee, contractor, subcontractor, in-house or private consultant of each of the Defendants or any other person who has factual knowledge of any other manufacturing processes which could reduce the risks of exposure to Agent Orange and/or other phenoxy herbicides being contaminated with dioxins arid further reduce the risk and hazard to human health of any such'exposure. 9. Any current or previous employee, contractor, subcontractor, inr-bou.se or private consultant of each of the Defendants or any other person who has factual knowledge of conspiratorial conduct of tho Defendants, individually and/or duolicative efforts (acts which are parallel in native) which tended to or did in fact result in misleading the public and the United States government from gaining krcwledgo cf tlie dangers attendant iron exposure to Agent Orange end. other phenoxy herbicides. -.10- 10. Any current or previous employee, contractor, subcontractor, in-house or private consultant of each of the Defendant;.; or any oL icr pstson who has factual knew ledge of how diox.v.s work upon plants, animals, and/or humans. 11. Any current or previous employee, contractor, subcontractor, im-!icnise or private consultant of each of the Defendants or any other person who has factual knowledge of any statistics concerning the effects of dioxins upon plants, animal's, and/or Ih'tijbnnrMtii-^im 12. Any current or previous employee, contractor, sufccontactor, in-house or private r .-.nsultant of each of the Defendants or any ocher person ..nciudirig, but not limited to, members of EPA and other governmental agencies, wiio has factual knowledge of the following Incidents: a. Love Canal b. Times Beach, Missouri c. Sevesco, Italv d. BASF (1953, 1j 54 - Badisd'o in Germany) e. Production mishap:.: and/or explosions since 19213 at any of the plants of .any cf tiie ’ Defendants manufacturing, TCP, 2,4-D, 2,4,5-T phenol, chlorine, acetic acid, benzene, sodium lTydroxi.de.. potassium hydroxide, and/or Agent Orange, including mishaps in the packaging, and transporting of tiie Defendants' product.; to tiie U. 5. Armed Forces bases for eventual shipment to Vietnam. f. Spraying of Vietnam from 1961-1972. 13. Any current or previous employee, contractor, subcontractor, in-house or private consultant of each of the Defendants or any other person who has factual knowledge of any surveys, tests, epidemiological studies of any kind relating to the effects of exposure to Agent Orange, 2,4-D, 2,4,5-T or any constituent thereof including the econdary by-product known as dioxins. 14. Any person with factual knowledge of how decisions are made within tiie United States government, particularly the decision to use and to continue to use phenoxy herbicides in Vietnam, particularly Agent Orange; any person with factual knowledge government procurement contracts and the invitation to bidders, particularly those persons who negotiated the government contracts for all phenoxy herbicides (agents white, blue, purple, pink, green, orange T. and 11} with the individual defendants repre­ sentatives between 1961-1372. -11- 12409 ( ■k 15. Any person wiri factual knowledge through a m surveys, tests, epidemiological studies or otherwise undertaken by.,any state government, any private public or foreign corporation, the U. S, Congress or the government of any nation concerning the chemical compounds, 2 ,5-D, 2,4,5-T, dioxins, or related chlorouhenols relating to the creation of dioxins, the detection of dioxins, the dangers of dioxins’ exposure, and/cr the toxicity, carcinogenicity, fetotoxicity, teratogenicity, acute arc/or chronic effects on plants, animals and the human population. 16. Any and all parsons listed in The Chemical Scythe by Alastair Bay, as having factual knowledge regarding 2,4,5-T, 2,4-D, and its contaminant dioxins. 17. Ail worker compensation carriers for the Defendants and docu­ mentation of all occupational exposures filed since 1925 which evidence industrial injuries or diseases at the TCP, 2,4,5-T, 2.4- D- Phenol, packaging, and/or transporation plants of the Defendants. 13. Any and all cat rent or prior workers compensation claimants of the Defendants who claimed relevant occupational exposures and/or relevant occupational injuries and/or diseases and/or symptoms the relevant plants listed in Answer to No. 19. (sub 17) above. 19. Any ¿nd all members of the U. S. House of Representatives Committee or. Oversights Review of the EPA actions (1983) and/c any person together with their dccurxintary and demonstrative evidevice giving testimony at said hearing (which will form the substance of their testimony heroin) on the failure of the fill to tab. prompt ami effective action to ban the production of 2.4- D, 2,4,5-T, and its contaminant dioxins. 20. Ary and ail persons having knowledge of relevant facts regarding the financial status of the Defendants and their ability to respond in punitive damages, including, but not limited to, their past, present, and future profits and earnings in the United States and abroad since 1925 through and including the present frar the sale of tine products made the basis of this lawsuit, i.e., 2.4- D, 2,4,5-T, phenoxy herbicides and the relevant herbicide market. 21. Any and all persons having knowledge of relevant facts regarding the ownership interests cf the Defendants and their ability to respond in punitive damages, including,■but not limited to, defendants’ domestic and foreign subsidiaries, joint venturers, licensing agreements, and/or other public or private corporations in the U. Z. and abroad, in which these defendants own a sub­ stantial financial interest since 1925 through and inciudin.: the present. 12410 I \ «r- r IS. Any person with factual knowledge through any survt a, tests, epidksniological studies or otherwise undertaken by ry state goviarnroent, any private public or foreign ociporat ^ . the U. S. Congress or the government of any nation concern:' n the chemical compounds, 2,5-D, 2,4,5-T, dioxins, or related chi nhenols relating to the creation of dioxins, the detectior dioxins,.the dangers of dioxins' exposure, and/or the toxicity. > rcinogenicity fetotoxicity, teratogenicity, acute and/or chronic c fects on plants, animals and the human population. M. Any and all persons listed in The Chemical Sc.-the b; Alastair Hey, as having factual knowledge regarding 2,4,5-T, "2.4-0, and its ccntuninant dioxins. 17. All worker compensation carriers for the Defendants ind docunsantation of all occupational exposures filed since 1925 which (evidence industrial, injuries cr diseases ¿:t the TCP, 2,4,5-7, 2lT4-D, Phenol, packaging, and/or tronsporaticn plat u of the Dsfe. 'ants. 13. Any and all current or prior workers•cesraeneation claimants of the Defendants who claimed relevant occupational exposures and/or relevant occupational injuries and/or diseases ar.d/> r syraptans af the relevant plants listed in .'.nswav to Mo. 19 (sub .17} above. 15. Any and all members of the TJ. S. Rouse c? Representative's Camrnittee on Oversights Review of the EPA actions {1933) and/or any person together with their documentary and demonstrative evidence giving testimony at said hearing (which will form .the substance of their testimony heroin} on the failure of the EPA to take prompt and effective action to ban the production of 2.4- D, 2,4,5-T, and its contaminant dioxins. 20. Any and all persons having knowledge of relevant facts regarding the financial status cf the Defendants and their ability to respond in punitive damages, including, but not limited to, their past, present, and future profits and earnings in the United State and abroad since 1925 through and including the present iron the sale of the products made the basis of this lawsuit, i.e., 2.4- D, 2,4,5-T, phenoxy herbicides and the relevant herbicide roar.i-.et. 21. Any and all persons having huav/leace of relevant facts regarding the ownership interests of the Defendants and their ability to respond in punitive damages, including, but not limited to, defendants' domestic and foreign subsidiaries, joint venturers, licensin''' agreements, and/or other public or private corporation', in the n. S. and abroad, in which these defendants own sub­ stantial fin-uncial interest since 1925 through and including the present. -12- 12411 f ( 22. Any and all persons listed by Plaintiffs' in both^cri'inal and ¿mended! witness lists, as expert witness (medical, sc entific or cau^sation) , government wiuness, government causati witness, defendants' tanployees and/or related personnel and/or any witnesses .minted by all defendants, may be called at time of trial to present factual information as to any issue involved n this ca: 2. 23- &sy and all members cf the scientific and/or medical immunity wham have knowledge of relevant facts, including infer .'cion am any of die previously listed subjects in this Answer, including, tot not limited to: a. David Kriebel, Ph.D. lb-. Dr. Alan Poland c_ Dr. Paul Goldmann, BAS? dL Dr. C. Roppe e. Dr. Oettol, BASF f. Dr. E. McDonnell g. Dr. K. D. Khiera h. Alvin Ain1. i. Marilyn Fingerhut 24. Any and all persons wise have factual knowledge conce. ing the individual representative Plaintiff's damages, indue ng, b u : not limited to, tl o fcHexing: a. Any and all medical persons who have examined, observed, treated and/or tested the Plaintiffs' for injuries, diseases and/or related physical and emotional renditions v.' .ch resulted from Plaintiffs1 exposure to Agent Orange, and/or poenoxy herbicides, their constituents,- secondary ly-products, wastes, residuals and contaminants. b. Any aid all hospital personnel where Plaintiffs have been confined for treatment relating to their exposure to Defendant"* products in Vietnam. c. Any and all persons with knowledge of the economic losses, psychological and/or intangible damages sustained by your Plaintiffs as a result of their injuries and .diseases resulting from their exposure to Defendants' products in Vietnam. d. Any and all persons with knowledge of the past, present and/or future- economic losses your Plaintiffs have or will sustain in the future as a result of their loss of wage earnings and/or wages earning capacity resulting from, the injuries and discuses made the basis of this lawsuit which v;ere caused by Plaintiffs exposure to Defendants’ products in Vietnam. -13- £ J > Z l s í [ r o i n * u S*w¿ in*-..ucoj^Aac \ iMjcas-'U i A3U.lhv BSÎ'Sr hO iim u ü - U.O Ajoiiijr-qr-i :i-: vaJ'oOîV.ij-,¡liij: ujiu| uno ■}»)■.' i.'IUVU1U0JIA’ J^ U.-IIUP V W &»' ?L A iN T IF ? 'S GO V 7?.R ITM EH T C.A U 0 A T I O IT W I T ITE S S E S Th: 1 Tj .7. ù. Center for li sease Sa Z et y and Health , 2k. ;_3a fee teal. ano c:: r V*» GeneTal EverXÍ Any facti::■1 knarIedge of the history of C Z1. d P s p v a y i in U.S. and abv a a o -, iZ - x u . but « ■Z?tZ limited to, Cl) inoustr 1i xpe b . a ec and ex p i o cions; (2) regi c <' t7 £ tz _;i o r: - ' i - D - ■- ^ .5-T v ith the Department -• - ^Z-"s.* _ 7 .*«"y* r*. < ir ■:I a n y r t h o r g o v e r n m e n t a g a n c i o s 11 V and 4 - a 1 1 he Do fondants; c 1951 ÍZ Z b* PV;..1 0'6 ' ': " ” n i- b l:z r : j.‘ . .ilo ’j. d i . ": ■ rt *A•• VJi i. k r . o v .- le d g e ;. • p r a y i n g b Zb. - . . ' *' ■ ’:Z‘ *J V , e t no t in t a :• lim i re d A g •¿ u t fra n g e c^ n e r (2 ) . r e n u i r - : - : u c r .r .c ~ V. 1 o a to : I lZ o f th e U . 1 . ^ b i z * i w i ’ clc:»' s z: c f h i y t o ry and c , Z D D. and. o t .h r X ch a n te s o a l ro a 1 ; in h e r b ic id e s . "7:1 v. h e v; i H b 'i-t ' C* ZIC ..w. b agencies _nc ltd leg s edge o i ..:ERA, F!A, EPA, and OSH /i* and 7“» - 7* /a I^c o i indurti* i a 1 and otha r ■*.".;u:àzi • • — r* cQ fine >ó - D , 1 d ,5-T it. the IT ep. Arevrar and Scopieuenta 1 Answer cf Plaintiffs’ to Oaf and ant r : Interrogatory lie i-aretr a::.' incorporated herein for all pur­ poses re: events or occurrences which fees* causation witnesses may be expected to give any feet uni in fern:at ion they nay have re gar t'r.; 3coi ects outlined in said Answer. 5-T an ITAnaan 1x.:r Asosr: vaant of Expo eraro. to 2,4~D, 2 d it fit t end any far tirai knowledge in sunpor ::hor ■ V •V «* Expert 1 est imo ir. 1> Tostir.’ .^ny i.? sc uglifc in witter-,.;' personal and offre capacity. Z) Subject Matter ,4-r , 2 A .o — i TGDD 3 end die:::, ns ; i g e n t 0 : no White lue. Pink, G r e e n : a n a P u r i / r.i S it'S I I-: í*V ;íu’ ¿ " a a 3,7..-g y - i'.von..,;.v;;. .u^ a 7r¿püb :JnjrIS'iî /£ xp ‘¿0 FFF/- "j j - -y3 ~t :::: r."f IF.:-;7 ;;• -x’ -o "yzx vk ,;F:; ; V . " if *:.Lt ui1 w ^3-. _■' ;■.i\’ ’ ....Xj.jXi'> t .'.... .iV.u ■;p s :■ r T»*n -- . • ...op;: '■ ■.:>3^ 7 s::: ÏP * '.-r - ; .:r.;■:• 14 ••-v-- i; •-.-ï ’s w .JW ypoq :. .. '.ii.: *?A." '7’ A f ■? 3 ■W ‘ X y : ■■/ L .1 .**'--1.•4 .A . 1 ■ . - ¿ D..v;:y.::ip 71137.7 lr ..tí?O " ..... .T.iU r; zv.-. .i . "S'.1-:, "" .1 7 I— . J'3û "p : 3 «p :t\ *r. , 1, ' t -■ í7 U ” ■l-' ? *“ ' /_v B •.o :y. pr: » .».. j,- r ““ .-1 .: y .;; • ü..j af n? - ;;pr ; ■■ : ■■., c'.'.'.iU” ■: op- ; . y :x •3C ‘*¿V.J .... :" ;v . 'pf'/î. J ;> .1 r -3 MS : 5 :';::'.-p r. - ; 3 7..1 ilj JLi :iw: r;o” :;¿iv.7 r ; •'Jvïo" ■;'[ Í; *1 es . T.»V ;: ■.r:v.vt 1-i.■■■ *.-r-r *• :í -j : r : ; 1 • ?JO :o d :;3 SF \ -, » w .. 'T ■ *. s 0 . t . .. .... 0 . w- < J>0 J ;; T , ü D 1i d C ^ ^ V U :: \ .1'' t: s -. : ' " t ;; ¿ *• W :>.V. 3 1’ * — -tu.»¿í5/£?'^•■'‘--i-S •'uí-*.-- ‘ ÿy.; *&,!'! it**'i* ■*” *3a>''••**í' •'i 3r\ÿ':. r - . V [Research and g^'cÿf? Research ana D^y a 1 opment^%glox iris‘,-; i R C U S t r¿a l:£E|n^ _____ C i ac innat i Ohia:¿( .-K^Víj^SíafeSí^^í taen t s i •* ;:át-£*cS1édv»^$É' -- ¿ > . ‘■■••'••v-í- i.*«' •-. .- '-'•v--^:V.v£S>J i-*»i-' r'c’J'~vSÎÂf; i’!•:ÿ~r~t‘•ÍVÁ 'ÉjMít'. -1v>: ■-„ ■•■-•--•, ■. :t v -■- - j- ••.- •■•• -i- <-»- •’2'S:? -•-. ^=r*---= Tf 3LTPLEMENTAT. ANSWER To IKTERROrATDRY No ■ 19 Plaintiffs notn pre.liininar.13y Hint. the extant order or* prod-wing fact witnesses states that fact witnesses are ncv. due until March 2, 1984. However, Plaintiffs may call cne or more of the following persons (or those ¿ran various categories listed beim) time of trial to testify as to factual knowledge they rray have, including: 1. Bench Hand Personnel: These persons will testify to their taro.ledge c h a Ranch Hard operation, Ranch Handers' exposure to Agent 'range, cri/cr kr.a;iedg3 relating to the spraying, testing, and effects of Agent Orange on humans. 2. Ibarters c.f the V, s. fumed forces: These persons may testify to the circuast-anceo anc conditions surroundirjg tha spraying of Agent Grange. 3. Persons present in Viet •’ .an erring the exposure period in question iSCl-l?'/t, including, tut not limited to, military and paramilitary v rsonnol of the it S., New Zealand and Australia, who have knowledge of the rpraying operations of the herbicides, the exposure of ±:-. Plaintiffs' class, the hazards accrrpanyir.g any such, exposure, the Plaintiffs' thsmselver, and the Defendant ccspany representatives present in Vietnam to oversee the dr.liveries aid spraying operations of the herbicides they manufactured. 4 Per.:.3ons to.-ether ••ntr. 'heir demonstrative and documentary evidence vix gave testimony 'which will form the substance of their testi irony herein) at the EPA Cancellation Hearings of 2,4,5‘-T: {li'‘;?“-1980) under F3PBA, including but not limit--, ta: a. b. c. d. e. f. g* 4 J . • Dr. Roy Albert: Dr. ¡4. Diane Cbuxtnsv Robert. K. Bauchman, Fh.D. Dr. Oiav Areison Dr. Ren.ite Id-Through Dr. Dawn G. (V.'odnv’n Kirk T. Kitchin Ujl■ Ronald Tbcraas Or. Rainer Frentzel-Eevrae L::. Matthew Merelson, Hex 12417 _0_ 10. Any current, or previous employee, contractor, subcontractor, in-housc. or private consultant of each of the Defendant i or any other parson who lias factual knowledge of how cl:o:o is work upon plants, animals, and/or humans. 11. Any current or previous erp: oyee, cor.tractor, cuboontr; itor, 11 11 Cl in it i i i,ii iii i,t>iUI i i'i M i I i mi l*i i ii i 11 ! 'I any other person v.vo has knowledge of the possible means of prcpljiactic protection fran the hazards of dioxins1 exposure; including, but net limited to, laborers, operators, supervisors, contract adrr nistraters, quality control personnel, engineers (process, chemical, mechanicf.il and/cr safety). 7. k ' current or previous employee, contractor, subcontractor, it -house or private consultant of each of the Defendants or any other perron who has knowledge of the means to warn these who. might be exposed to use of the herbicides in question, perrticrlirl’- Agent Orange, including, but not limited to, ‘.ct*T7mrn, c.j,->»r:erei or to be rendered in the future to Plaintiffs as a result of their injuries and disease resulting iron their exposure to Defendants' products in Vietnam. f., Eagr and ail persons witli ituowledge of the physical disfig ¿.remenh (past and present), physical and mental impairment {past and present), physical pain (past and present) and mental anguish (past an present) which Plaintiffs have sustained as a result of their exposure to Defendants* products in Vietnam and which in reasonable probability Plaidstiffs will continue to sustain for an indefinite time into the future far beyond tiie date of this trial. Respectfully submitted, Thermic !v. Henderson, Esquire Allison Pettiette. Esquire i hereby certify that a true and correct copy of the foregoing Ellison Pettiette 12 A i Z Z l ’Z l K/öiUO -i.»AO(! i'swöswy 89 "SS . MC; tlfcUUJ.r 7 Àïoieior:••• .Jiciu»¡:iihíjiaij3 i>:msni¡'i; uo A*:i¡. h r SüjCï; dujujO i PLAINTIFF'S GOVERNMENT CAUSATION WITNESSES Donald Earne3 A. ____ E P A , Hashingt on , D .d . B. Beth C. General .actual and expert j___________________ testimony is sought. Events Pre-1961: Any factual knowledge of the history of h e rb ic ide spraying in U.S. and abroad; including, but not limited to, (1) industr exposures and explosions; (H)■registration 2,4-D, 2,4,5--T with the Department of Agri culture and any other government agencies any and/or all of the Defendants; 1951-present: Any factual know le dge of the history o herb iti.de spraying ir. the U.S. and abr.. a d ; i n c l u d i n g , but not limit ed to, (1) U.S. military use of Agent Orange and other pro he rbicides in Vietnam; (2) changes in t'. a gistraticr. requirements of herbicides wit; U.S. government and its agencies including kn owledge of 77.FRA, FDA,EPA, and OSLIA; end any knowledge of i nd ust ri al and other kune exposures to 2,4-h, 2,4,5-T in the U.S. an abroad; See Answer and Supplemental Ans we r of Plaintiffs' to D e f e n d a n t s ’ In te rrogatory No. 19 attached hereto and incorporated herein for all p ur ­ poses re: '•'.vents or oc cu rrences which the. causation witnesses ma y be expected to giv any factual information they may have regar the subjects outlined in said Answer. Human disk Assessment of Exposure to 2,4-D, 2,4 ,5-T ar. dioxins and any factual know led ge ir suppor­ ti: e r e o f .. Eu 'er:: Testimony 1} T est ir ->ny is sc u g h .: in witness' a a c it y . 2.) Subject Matter ,4-"\ 2 personal and offir f'-T, TCnr,'a nml dioxin a ; I/I I (aio o w h i t a , Blue, Pink, P G r a u n , a ud P u 12723 and related c h l o r o p h e n o l s ana human risk a s s e s s m e n t r e g a r d i n g exposure, including, but not limited to, one or more of the f o ll ow ing s u b 1'oct areas: a) Cham .stry, B i o c h e m i s t r y b) Manufacture c) Toxicity d) Modes e) Fate in the E n v i r o n m e n t Animals') f) .State of A r t / S t a t e Literature of H u m a n E x p o s u r e (Humans, of M e d i c a l and Plants, Scienti Plant Ph Animal P k v s i c 1 o g y / S t u d 1a s H u m a n St I) r-\ J ^, g) an d /o r P r od u c t i o n ;\c ’ m’iolt-gy /'Br 1) 3) Plants, Caa c e E ■ Re v-" - clue Adverse H e al t h **. ■ Eff ¡cts 3) Yes, w i t n e s s wi l l be aske.cj o p i n i o ns about both p u b l i s h e d and/ o: on--going st u d i e s . 4) Yes, witter w i l l be asked op in ion s about or r e s e a r ch w i t n e s s has p e r s o n a l l y or a c t u a l l y part 'oipeted in. any Studie p e r f o rm ed 5) Yes, wi. ie.ee w i l l tv asked o p i n i o n s g o v e r n m e n t a l studies. other 6) Yes, w i t n e s s is e x p e ct e d to re v ie w the f o l l ow in g d o c u m e n t s prior to giving testimony:: Coe , ETA, Ree car eh about and Developinent,_Hoal<* h A c s e s o m e n t D o c u m e n t on P 1 b x i s s o r t 'ne O-fj; f i e vs_ o £ A i r 0 u . J . j L t v , P l a n n i n g ' and *titan'ar?c ,__ pfesared ‘by the Envir-'n-enou-.l C r i t e r i a and As sec cm Office, '.ncinnati, Ohio 45243 { July 1 EPA , Re;;scrch and Development, 11 nltl; and E n vi r o nm ent al Efloots P a 1e for; Tot ?enta , and Hexaclilorodi b.e'.izo-p-dioxins for the Offi ce of Solid Waste and Em e r ­ gency Response, by the En .•ironmeV.tal Criteria and Asses sm ent C.'fice, Cincin Ohio 45248 (June 1983). EPA, Research and Development, A abient Water Quality Criteria for 2,3 ,8 TODD, pre pared for Office of Wate Regu i.atio .s and Standards, by the Er .ronnonta Criteria and A s ses sm ent fice, Cincin Ohio 45240 (July 1933). E?A, Research and Development, jicrins. Indust ial Environmental Research Cincinnati, Ohio (1978). copy of t h e document!" *s attach ed . 12425 SUPPLEMSWrAL ANSWER 'Ll. IlJTEffl&i&'iUy No. ID Plaintiffs note preliminarily that the extant Order on ting fact witnesses states that fact witnesses are not due until Marcl 984. However, Plaintiffs rosy call cne or more of the foliating person: those from various categories listed below) at time of trial to testif3 ;o factual knowledge they may have, including: 1. Ranch Hand Personnel: These persons will testify t ;mewledge of the Ranch Kara Operation, Ranch Hander to Agent Orange, and/or Irncwledge relating to the s testing, and effects of Agent Grange on ’-.-mans. iir cposure Lng, 2. Members of hie ti S. Anned Forces: These persons m to the circumstances an:’ . conditions surrounding the of Agent Orange. octify aying 3. Persons present in Vietnam during ‘the exposure peri' question 1961-1372, including, but rot limited to, itand paramilitary personnel of the U. 13., New Zealand Australia, who have knowledge of the spraying ccaret, tiie herbicides, the exposure of tire Plaintiffs' clas: hazards accompanying any such exposure, the Plainbif -ihsmselves, and the Defendant company representative: present in Vietnara to oversee the deliveries and spr; operation:, of the herbicides they manufactured. die' Pc’.-sons t- ■"ether wit.i tlieir demonstrative and documsi evidence who gave testimony (which will f o m the .cut: of their testimony herein) at the ERA Cancellation Hr of 2,4,fj—T (1379-lSOG] under F3FRA, including but not to: .ncjs 4. ■.ary \ 3 Of ■,g mi ted a. - b. - c* Dr. Roy Albert: Dr. 1. Diane Courtney Rober K. Baughman, Ph.D. dm Dr. Oiav Axelson br. Reuate Kimbrough Dr. Darn G. Goodman Dr. Kirk T. Kinchin 1JL• Dr. Ronald Thcnas i. Dr. Rainer Frentcel-rayira Dr. Mattliew Mecelr.cn, Harvard 1242S -9- r x * -*IL. k. Major Alvin Young l. Dr. Rodney Bovoy m. Kenneth V. Themein n. David T. Buzzelii o. Dr. Michael Gross p. Dr. Renee Stringham r. Dr. Van Mii'er 5. Any current or previous employee, contractor, sub in-house or private consultant of each of the Defi airy other person who has knowledge of the manufac processes, chemistry, occupational exposure and/o: 2,4-D and/or 2..4,5-T cr related chlorophenols; i: not limited to, Laborers;, operators; supervisors; administrators; quality control personnel; engines chemical, mechanical and/or safety) . actor, as or 1 icity of ing, but erect .process, 6. Any current or previous employee, 'contractcr, sub; in-house or private consultant of each of the Daf«. any other parson who lias iincwiedgo of the possibL prcphiactie protection from the hazards of dioxin.including, but net limited tc, laborers,, perator: contract administrate:, s q u a l i t y control personne (process, chemical, mechanical ar.d/cr safety) . ractor, its or ns of ensure; parvisers, 7. Any currant or previous employee, contractor, suber in-house or private consultant of each of the Defe: any ether person who has luiowledge of tho means to •who might re exposed to use of the herbicides in qi particularly Agent Orange, including, tut not limit laborers, operators, supervisors, contract adminisi quality control personnel, engir-eers (process, chc meciiai',;.cal and/or safety-. -actor, ts or e those ion,' to, ->rs, 8. Any current or previous employee, contractor, subcc in-house or private consultant of each of the Defer any other person who has factual knowledge of any c manufacturing processes which could reduce the risk to Agent Orange ar.d/or other phenoxy herbicides bei with dioxins and further reduce the risk and hazard health of any such exposure. 9. Any current or previous employee, contractor, subcc-. in-house or private consultant of each of the Defeat other person vino has factual laicwledge of cons; .-irate of tiie Defendants, individually and/or duplicative ; whi.ch are parallel in nature) which tended to or die result in misleading the public and the United Dtatr fre.n gaining knowledge of the dangers’attendant frex Agent Orange and other phenoxy herbicides. •actor, .'cs yc ;r >f exposure contaminated human ¿1C CO j~ j ,ts or any al conduct arts (acts o fact Tovemmont posure to 12427 -1.0- 10. Any current or previous employee, contractor, subcontractor, in-house or private consultant of each of the Defendants or any other person v/ho has factual knowledge of how dioxins work upon plants, arumais, and/or humans. 11. Any current or previous employee, contractor, subcontract .or, in-house or private consultant of each of the Deft-■•dents or cur other person who has factual knowledge of any statis ics concerning the effects of dioxins upon plants, animal’ s, nd/or humans. 12. Any current or previous employee, contractor, subcontacfor, in-house or private consul tar. of each of the Defendant.f or arc/ other person including, but i. t limited to, nembers of .IPA a d other governmental agencies; who has factual knowledge of the ’ foHaving incidents: a. lavs. Canal b. Tinies Beach, Mic:aouri c. Sevesco, Italy cl. BASF (1953, 1.): 1- - Endischo in Germany) e. Production r.rLshans and/or e:c?lcsicns since 1921 at any of tile pic .as of any c:i the Defendants manufacturing, TC"': 2,4~D, 2,4,5--? phenol, chlorine,, acetic acid, benseno, sodium hydroxide, .potassium hydroxide, and/or Agent Orange, including mishaps in the padcaging, and 'transporting of the Defendants’ products to the U. S. Armed Forces rases for eventual shipment to Vietnam. f. Spraying of Vietnam front 1961-1972. 11. Any current c-r previous employee, contractor, subcontractor, in--hotre cr private consultant of each of the Defendants or any other person rho has factual Icnorledge of any surveys, tests, epidemiological studies of any hind relating to the effects of exposure to Agent Grange, 2,4-D, 2,4,5-T or any constituent thereof -:ncluding the secondary by-product known as dioxins. 14. Any person with factual knowledge of her decisions are made within the United States government, particularly the decision to use and to continue to use phenoxy herbicides in Vietnam, carrticularly Agent Grange? any parson with, factual knowledge of goverrraent procurement contracts and th-;. invitation to bidder.':, particularly those persons who negotiated tine government ccntjracts for ail phenoxy herbicio':.: (agents white, blue, •nirp-ln, pinlc, green, orange I and II;. with the individual defendants repre­ sentatives between .1961-1972. 12428 -ii- 22. Any and all persons listed by Plaintiffs' in both original and amended witness lists, as expert witness (medical, scientific or causation) , government witness, government causation witness, defendants1 employees and/or related personr l and/or any witnesse. listed by all Defendants, may L.a called at time of trial to present factual information as to any issue involved in this case. 23. Any and all members of the scientific and/cr medical community who leave kiÆwledga of relevant fact?, including information cn any of the previously listed subjects in this Answer, including but not limited to: a. David Kriebsl, Ph.D. b. Dr. Alan Poland c. Dr. Paul GoldiruC:, BASF d. Dr. C. h-.ppe e. Dr. Gettel, BASF f. Dr. E. 2. McDcnnell g. Dr. K. 0. Khiera h. Alvin Ale i. Marilyn Finger-hut 24. Any and all person.“ wb _■ have factual Icnowledge.concerning trie individual representative Plaintiff:s damages, including, but not limited to, die following: a. Any and ail medical persons who have examined, observed, treated ard/or tested the Plaintiffs' for injuries, diseases and/or related physical and emotional conditions vliich resulted from Plaintiffs-' aseposure to Agent Orange, and/or phenoxy herbicides, their constituents, secondary try-products., wastes, residuals and ooriiaminants. b. Any and air hospital personnel where Plaintiffs have been confined for treatment relating to their exposure to Defendants products in Vietnam. c. Any and all persons with Ixcvledge of the economic losses, psychological and/cr intangible damages sustained by your Plaintiffs as a result of their injuries and diseases resulting from their exposure tc Defendants' products in Vietnam. d. krr and all persons with Icnowledge cf the past, present and/or future eccncnac losses your Plaintiffs have or will sustain in the future ::n a result of their loss of wage earnings and/or wages earning capacity resulting from the injuries and diseases made the basis cf this: lawsuit which were caused by Plaintiffs exposure to Defendants' products in Vietnam. 12429 -13- e. f. Any and ail persons with Knowledge of past, prand/or future reasonable and necessary cos'.s o doctors, hospitals, nursery care, medical jui drugs, and any rther related medical serv. .¡s or to La rendered in the future to Plaint: _fs result of their injuries and disease resulting their exposure to Defendants' products in Viet Any and ail persons with knowledge of the pays, disfigurement (past and present), physical and impairment (past and present), physical pain present) and mental anguish (past and present) Plaintiffs have sustained as a result of their to Defendants' produces in Vietnam and which i: reasonable probability Plaintiffs will continue sustain for an indefinite tine into the fucurc beyond the date of this trial. Respectfully su red t el and in jsure ted, CTeonas iWw.- (Render .itt:o n, Esquire Allison Pettiefct- Esquire CERTIFICATE CF SERVICE I hereby certify that a true and correct copy of the re sing Supplement to Plaintiff :s Interrogatories were mailed Federal E ess to Mr. William Krchley, Kellc :iff. ' Drye & Warren, Mr. Gene locks, Pla: Management Ccnsnittea Agent Orange Office, with copi«. .3 to persona ,.y serve tiie remaining Defendants at the Tuesday depositions and Ms. Nanc Petrilln, ■J.S. District Clark, U.S. Courthouse, 225 O.cman Plaza, Brooklyn New York 11201 this 20th day of February, 1904. i n Allison Peif.iette 12430 -14- ■ •paaa*VBB\^j V.T^^ S**1ai«-’ ‘JuttaJ J v S ri'rî’; ¡usinai îr'-.vimninenia! rîrv ‘¡¡tvtronm . ¡un Pm -ijctiuf» );rn lo rv a q o n r .v . ¡ tiA û li O H <-'S< Si rttíS*’ií:tt4 -¡•■a*. a « D i o x i n . \ ,.0 P LAINTIFF*S G0VEHNM3N"’ CAUSATION WITNESSES Umberto Saffiotti National Car-car Institute, Washington, D.C. B. Both factual and expert testirony is sought, C. General Event.; Pro-1961: Any factual knowledge of the history of herbicide spraying in U.S. and abroad; including, but not U n i t e d to, (1) industrial exposures and explosions; (2) registration of 2.4- D, 2,4,5-7 with the Department of Agri­ culture end a n y 'other government agencies by any and/cr all of the Defendants; 19C 1-y ..asent: ¿..ny factual knowledge of the history of herbicide spraying in the U.S. and abro.*-: i; including, bud cot limited t o ; •(!) U.S. military uc i of Agent Orange and ether whenherbicides in Vietnam; (2). changes in the ru_ gi3t-ration requirements of herbicides with the U.S. government and its agencies including knowledge of FTFRA, F D A ,E P A , and OSHA; and (3) any knowledge - f industrial and other human exposures t: ■ 2,4-D, 2,4,5-T in the U.S. end abroad; t See Answer and Supplemental ¿.newer of Plaintiffs' to Defendants' Interrogatory No. 19 attached hereto end incorporated herein for all pur­ poses re: events or occurrences which these causation witnesses may be expected to give any factual information they may have regarding the subjects outlined in S 3 i d Answer. r>-%» Human Risk Assessment of Exposure to 2,4-D, 2,4,5-7 and dioxins and any factual knowledge in support thereof D. Expert Testimony in witnes s ’ personal and official 1) Testimony is sought capacity. 2) Subject ’ .-latter , 2.4- D, 2,4,f--7, T C D D ’s and dioxins; Agent Or any I/II (also White, Blue, Pink, Green, an. Purple 12132 I ' ' .-V. • • and related chlorophenolr and huaan risk assessment regarding exposure, including, but not U n i t e d to, one cr more of the following subject areas; a) Chemistry/Biochemistry b) M a nufacture and/or Productioii c.', Toxicity d) Modes of human Exposure e) Fate in the Environment Animals) f) State of Art/State of Medical and Sclenti Literature 1; 2) 3; ) 1) 3) 3) Platts, Ilar.t P h y s i o l o g y / S t u d i e s animal P h y s i o l o g y / S t u d i e s ilu a n Li::;* los E p i d am i o 1 c g y /B i o ut a t i st i c s 2j h) (Humans, Plants, .anivais, humans Cancer Epidemiology Reproductive Epidemiology Adverse Health Effects / Yes, witness will be ashed opinions about both published and/or on-going s t u d i e s . ') Yes, witness will be asked opinions-'about any studio. or research witneaa has pornr-nally performed or actually participated in. 5} Yes, witness will be asked opinions about other governmental studi ’. .. 6) Yes, w i t n e s s is e x p e ct e d to r e v i e w the fol lo wi n g d o c u m e n t s prior to giving t es ti mon y See, EPA, R esearch and Development, -Health Lssessmerit Document- 'on 'DiOxins for the 0 f1 ices- of Air Quality , Planning ‘ar.d ^'iTag.d'Hrdr., pfeparecT'by the Environmental Criteria and Assassin Office, Cincinnati, Chic 45248 ( jv.ly 1 12133 to ' :>' ’ . •'.. .- ;•• . . ’'* ^T"V v " ■ '.Vi.;■■■■ : -I-■ ■■-, -' •¡•Tv'- .., yi ... . ifi. 4 EPA, Research and Development, Health and Environmental EfCects Profile for; Tet Pent a« and .liexach *orodibeuzo—p-dioxins for the Office of Solid Waste and Eme r ­ gency Response, by the Environmental Criteria and Assessment Office, Cincin C?iio 45248- (June. 1983). i ■■ :V: % ■•. • .i EPA, Research and D e velopment, Ambient Water Quality Criteria for 2,3,7,C TCRD,. pre­ pared for Office of Water-Regulations and Standards, by the Environmental Criteria and Assessment Office, Cinein: Ohio 45248 (July 1983). EPA, Research and Development, Dioxiis, Industrial Environmental Research C i n c i n n a t i , Ohio ;i973). A copy of.th-rse dccuacnts is attached. ■. ;' : •A. ; -U\ i. y 41 •V' i • .14 : :;•.>? • - .y. ■■■}?' • -V.vA r ■.z.vr: ■ ’ \ <7 .. ■.; . .. ;vvr. 12434 ifi! .-A? ''jV “**''. *r> ( ¿fa ■/lil •■VJ SUPPLEMENTAL ANSWER TO INTERROGATORY KO. 19 , Plaintiffs note preliminarily th-.t the extant Order cn producing fact witnesses states diat fact witnesses are not due until Mavch 2, 1984. However, Plaintiffs may call one or more of the following parsons (or there from various categories listed !xiw) at time of .trial to testify as to factual Icncwladge they may have, including: 1. Ranch Hand Personnel: Tiieta persons will testify to their knowledge of the Ranch Hand Operation, Ranch Handers' exposure to Agent Orange, and/or knowledge relating to the spraying, testing, and effects of Agent Orange on humans. 2. Member.: cf the U* 5. Armed Forces: These persons may testify to the circumstances and conditions currour.c.:n.g idle spraying of Agent Orancs. 3. Persons pro rent in Vietnam during the exposure period in question 1561-1372, including, but rr..t limited to, military and paramilitary personnel of the U. S., New Zealand and Australia, who have jnowledcc cf the spraying operations of the herbicides, the exposure of tiie Plaintiffs' class, the hazards accompanying any such exposure, the Plaintiffs' themselves, and the Defendant company representatives present in Vi etnam tc oversea the deliveries and spraying operations of the herbicides they manufactured. P ersons together with their demonstrative arid documentary evidence who gave testimony (which will form the substance cf their testimony herein) at the EPA Cancellation Hearings ° . 2,4,5-T (1379-1980) under FTFRA, including but not limits to . - *u • • ’ *4 A .■'> • h ‘v ns#* U-'. * /f i- ’V . _ C. ■J■-'” ">. <* d. e. .$85 '. f. Sv»Uw- gh. i. j- ''tir Dr. Roy Albert: Dr-. K„ Diana Courtney Robert K. Baughman, Fh.D. Dr. Olav Axeison Dr. Renate Kimbrough Dr. Dawn G. Goodman Dr. Kirk T. Kitchin Dr. Ronald Thomas Dr. Rainer ? renteal-Eevma Dr. Matthew Mese-lson.. Harvard - •V •' • . - - x&t' m m - h f -9- 1 2 -', f (o 7^ k. Major Alvin Young 3.. Dr. Rodney 3ovey ra. Kenneth V. Therein n. David T. iiuzzelli o. Dr. Michael Gross p. Dr. Renee Stringiiarn r. Dr. Van Miller 5. Any current cr previous employee, contractor, subcontractor, in-house cr private consultant of each of the Defendants or any other person who has knowledge of the manufacturing processes, chemisury, occupational expo.sure and/or toxicity of . 2,4-D and/or 2,4,5-T or related chlorcphsnols? including, but not limited to, laborers?, operators? supervisors; contract administrators; quality control personnel; engineers (process, clionicai, mechanical and/or safety}. 6. Any current cr previous employeef contractor, subcontractor, in-house or private consultant cf each of the Defendants or any other person who ass knowledge cf tie possib* . means of yrcplgiackic crctecai'vr; from the hazards of ■'.rucLn’ exposure; includin':, brt rot liraited to, laborers, operators, supervisors, contract administrators, quality control personnel, engineers (process, clerical, mechanical and/or safety). 7. Any curr ent or previous eaolcyee, contractor, subcontractor, in-house or private consultant cf each of the Defendants cr any other.' person who Ires knowledge of the naans to warn those wiio might he szeposed to use cf the herbicides in question, partiad-rrly Agent Orange, including, but not liin.ited to, laborers, operators, supervisors, contract administrators, quality control personnel, engineers (process, chenical, mechanical and/or safety'-}. 8. Any currant or previ-.us employe:':, contractor, subcontractor, in--house or private consultant cf each of the Defendants or any other person who has factual. Iincwledge of any otlier manufacturing processes which could reduce the risks of exposure to Agent Orange and/or other phenoxy herbicides being contaminated with dioxins and further reduce the risk and hazard to human health of any such exposure., 9. Any current or previous employee, contractor, subcontractor, in-house or private consultant of each of the Defendants or any other person who has .factual knowledge of conspiratorial conduct of the Defendants, individually and/or duplicative efforts (acts which r~n parallel in nature) which tended to or did in fact result in misleading the public and the United States government frem grimr.g know]edge of the dangers attrrdant fresa exposure t o Agent orange and other phenoxy herbicides. -10- 'rS 15. ■■je, r. k’V/íf' Any person with factual knowledge through any surveys, tec epidemiological studies or otherwise undertaken by any state government, any private public or foreign co. poration, the U. S. Congress or the gt /emmenb of anv nation concerning the chemical eompoundo, 2,5-D, 2,4,5-T, dioxins, or related chloronhenols :, relating tc the creation of dioxins, the detection of dioxins, the dangers of dioxins' exposure, and/or the toxicity, carcinc.genicitv, fefcotoxicity, teratogenicity, acute and/or chronic effects on ■■¡t ,, f 1 .. 10. .'ny current or previous srployae, contractor , subcontractor, in-housa or private consultant of each of the Defendants or . any ether person who has factual knowledge of how dioxins work t^on plants, animals, ¿nd/or humano, 11. Any current or previous amloyeo, contractor, subcontractor, in-house or private cor.rud.tant of cadi of the Defendants or any other person who lias factual knowledge of any statistic.-: concerning the affects of dioxins upon plants, animals, and/or humans..... ~ 12. Any current or previous f~ ~loyea, contractor, subcontactor, in-house or private consultant o'- each of the Defendants or any other person including, but not -.inited tc, members of SPA and o f ’er government?' agencies who factual knowledge of the a. Love Canal b. Times Beach, Missouri >,... c. Sevesco, Italy 'd. BASF (1953, .1954 - Badir- nhe An Genrsr- ; - . . o. Production mishaps and/or explosions since 1925 at any of the plants of any of the Defendants manufacturing, TCP, 2,4-0, 2,4,5-'? phenol, chlorine, acetic cid, ben2ene, sodium lydrosdde, potassium hydrcxi.de, ard/or Agent Orange, including mishaps in the packaging, and trar -porting of the Defendants' products to tlvs U. n. Armed Force; bases'for eventual-ellipment to Vietnam. f. Spraying of Vietnam from 19Q-1972. 13. 14. Any current or previous erployce, contractor, subcontractor, in-house or private consultant of each of the Defendants or any other person who has factual knowledge of any surveys, tests, epideuiological studies of any kind relating to the effects of exposure to Agent Orange, 2,4-D, 2,4,5-T or any constituent thereof including the seccudary by-product known as dioxins Any person with factual knowledge cf how decisions are made within the United States government, particularly the decision to use and to continue to use phenoxy herbicides ir Vietnam, -•If-iiigarl■> &/-- ----■■ ‘■1 7 12437 I i~ „ L ••C-; / ^ -~«tJ ; -jn*r ■•' rffi»v % p ;■ j -W. ■ > 4 ù X £ ^ ' im r ’ ' ■<** .¡¿ S ^ ‘T '. ’!$»*, V > i Ü ••/ i 1 j* v«p*v -r^ v . i i -Jt 12433 V :.u6 relatad chlorophnnols n.nd ’matan y ar.socsment rcgaráing e-pocare, inclrá b'i': not iiuited do, one ov r,sore of tu o1 ?. T.-iin g a u b \o c t a " o.a .o: d h en i a t r "/Bloc h ciri r;t r y i¡ar.::_'act:urri sná/or 1Jr o d “ i o n .-..' /v ionicitv ■'i) i' •¿es v) :a¿£ ir tbo .íuvirosaciit (Humane Animo. Is) .-tunan F.xrsc :i:rú . :cto nte of Medioal and Lt.-acrcsure -•/ Blant ”'-.yciology/otad ir.s Ar.ir:nl Payaiolcfiy / Sfcuóies dan-a.: d'rvdic-a J} * ■o.* ■?*•'.'.‘'ir. {•b.-.'.O.i ?.? x O■ 2T -• .*>- .> r. animáis - hir a-:ai ••*'. *¡in” Ipicasi.-Lology : ide.'..-.io 1 •p *•» h .•J... f. í.-j--* op.Vaioao a..-:-ub i; fea! -~ d /■•••r en go:‘::g e taclias r.v• v *■ o c*¡• -A o :i ..e ::Ii Ejioctíi l:ac! opAnisas about a w id n eco fea.s p e r s o n a l l ; p *}.> pe ;ti c.i o ó ir¿. 1.j.1 be ¿.10 feed opinic-nr n i - --.t c 1 s11:d i e . . *’ w. ‘i í*-TTT- C:Z r i:;., ya .■ pr 0d do ::ev:;aw ida fe 11 te y i- ir. ías'-.isor-': ;o e , r.I \ j ferjs r.r efe an J j- ev e 1 o peía n i:¿ 11 ■:.r.r.o ns ao at Do c a-m e nt -on-'Tixos:in s O f :;ic-ca- q::: A-ir’ Qv.á-lítv-, ’P .1snn: "sV-nuilñ'bttc - p r eparad by tfen Enviar nueriutíl Criteria and. Office, i’-'acina v.ti , Ofeio 4524 ¡’ ti :,r./.7.j'.n:i':’r3 gcveiviiìkht ga. g .-a '.'Iun w ::t ;;s s ?fs -..1ari *_ia_£;qo r* 4. Cantar 3. doth l.ro C. Cc::y...l : for Dis .».ns •: Contro.'. an'! (CDC) A t l a n t a , GA :t: tcat:.!-'.»ny io sought. ir.1!: h a ;uledg '. of th e history o r ■iC rpraying in 0 . B . and ab:, oad ; :..nc„u'...Innr; b u a o . t limited to, (1 ; il(■ •u t snd e : : p l o s i c n s (!■; regio.::; j.C X o .5-.' riti: t!i© Hep 3. ..nr :.C a J A C -►# *''•J» .1 .’ .r.y or he:: gcvernncnt a ? a.::?:icc all cf tha Dafendanr■ £■. . o r, r ?:1:o h 1 o t . ;*V v .7 rj .: '* i. • ..... -siO. .... jwlo . '.. ’J ; . i : g i ; ' .; ‘V C - - S . .:. : ■ :.fc:;oa-d ; opr r.y ,.. T‘ i ..i'_iiu.;.-.;ii5: b-t not lini "t.oh V *» ? : • « . r \ ' ' ’ . . 0 0 A 7. snd othe r ph-no i.g:at C .1 -i Acida." It \2) 'oI:m g os in i:h;. 'jv. '■* c ’ . Cu.m, rs :■. ' ur-cu c13 c ? *\ erbiai-ies v,- _.. c . g •v n r : neat :.n*l its age::uies ilici -.i.o --‘-‘L "• :’UA, FDA *£P/. ; and C3K.A S C.1» S. ;-.uy hr.owladgc :1 lilduSt ICJ. ti1- end ntiier hur.an :;■j■.rrrr . sc i .A*-or : : . , h n '*i. in the U. - a :ac •loro u ^ • . -i p !L eim.entrh •' i . ; i p, v ■-» ri —**| “ a s <2a r ?: ; rr t t ; : < J l: Arerei; Ih-.t-orrogatc iucorp tod<• herein :;c r all pur« ^ ^ r> f* »• ■•i r » f* !' rt e / e v e n t j or oc cf-r-r.t:7r.n T47.ti-asses ".ty bo e:ipectad tc give any ta .tua ‘ in '1cruaticn th ny :aay have regardi r.’ui U j; or ■'zj.?.n c l: ,iii ì;c.id Answer. » t .:;.:.i » •;r- - ,, U ■?**:Y C f Sr • re to 1 .i--D , .1.4 S-T and , >; v} *. tV. ..•;; ‘i'.v uny r cutnal un owledge in crppor-v. -* no art To S t i c . ; r%-*•:CS:-u~ i-Y r.3 sought ia .’it ne su * oar cnr *■ C 7 . ■N and off:.e it C• :r Ó - hi, .-.. - - .; CC: .i's c i i o : A,'ouu i ;a •■;o «'hit a » lina, .. i.nli, G r e e n , .-v« 1 , ? u : : p . / ,s -r V i4 X enr ,;h c n i cv c 1 o puent , üe.-iÂtii i-.:-. Profila fo ï Totr Ünvire ruer.'' P e n t e , a n d üc:;a ::lorod ib e n : o - p - d i e x i n s for the Office, ci Joiid Waste end Suerg c viey Rsspcr.se, b y the Environi-.-cr.tal Irileric and ¡rsessiaant Office viacinr;: O7._o 4 S 2 40 '.Tare 19Gin . ; * ; C a 1 . *■ * . e < * ■r » ••- U» .» « .W w : : . \ U!V ' - . . V " •'•> .V•■rch •» oi' u»J .ï ¡.2ïî" ,d DeveLr rincnt, Ai.';ï T î « -. •V. -» , Q A ■.i i î: C r i r o r i a for 2 .3,7 U i p '-'■î; ' for O f fi c e of «Jai ar UeG'.il .1 :.la-.-ciard-î, b y ï:!îc E:iviv i.V2,*»to .à. Usü 0 f - -•- 9 C.;i o 4 5 ."4e U u _ y 1 9 G 3 : - n I,■: L'i'.î p.'^eut:, Dioxine ; e ::t a .1 P.esear •:h .i’.*' A c .■>p y o •i f i i r*i * .9 s» <•i. 4 i.iT-xu-i cotad a n s h v . t o iwrawSGarroay i;o. 10 Plrintiff ; n : ' i a p r o l : m ;." 7 ten,. t-jr*o cactani C-rdor on prccucing rrec rvasres state-: that fret vLtnassss arc r 2 .: tea u.rfil ite:te 2 , IOC4. Idverar, Plaintiffs .ray call one or rere : f . ten following persons (or those from various categories listed ] y ~ .h : x s '. at trJ.tr..; or trial to osctify as to ff Jtual knrv/l&3ge they 1. ty have.. 5..alt-liny. Ranch iiarid Pomona -mu ’Thooo ;.-arsons wi.Il testify tc titer kncvdedge cl tee l •m.h Karr; Operation, itench Harders* e'-ipssnr:: to Agent Orange, r,wo: Inowlodge rel .ting to the spraying, testing, .ml off-rote of Ayanh (ranga on l.raans. 2.. ftsofoers tf tea R. Innsd For.cos: these perrons way testify to teo ntect-teteacc-.- ec.5..con 1 itl.anr snrr -nding the spraying of Agent invagn. Par.-.-ono yrem:.t i.. " r m u m .or.r.g te.. ci:> asur*' perio.. :•a quasti-M llcl-... 1 .. incivd;' ,g, -.„c-.': iicLtca to.. rtemtai ■ and. pa; ’ .ary rerro: m.l of tie U. 'few tealem. or.I Aitenralin: 1... Inn: i m k y ; of teo spraying operations or. the imbioiic ; .mpcrvre cf ten litentiffs5 class, ten hnoardo mm.yvotenc any sud. oteocnra, tea Plaintiffs? teemselves, mo. .la rteenimt errpony rmrerantatives ¿.•resent it: 7int:rr: tc oversea tire ■callv’ e.ries and spraying operations -1 . ie i miterides -'-hoy rmr:lcr.tiered. Drrsovr vomte: : cite ter:.:/ darrmirtrahive and dccnmsntarv trvidante ••rlo gave tai/lrv (which v*i'l form -¡/he subsrai^e of tie:..: t_teJ.r.o:v - herein) at ten ■'..V, Cancellation Heaxiro o {1171teffO) rafter Ftete . *ncludi:ig but not ii.dtea j..■ ‘ , . , . C •. 1 , a. r.?:o.. tev* Dr. n. Diene Oe^rtr.rv m Pecart !'.. Pmtensn, Iltet d., Dr, tew tecel.r:.n O. , or. m a m Iterbrrvgn D.r. 7t.c ¡"coir' i 0 . Dr,. tel; t1. ;*_-y.:ihi.: h. Dr, Ronale thrmar i. Dr. Frir.rr Dr l/ml-reyn.e * j* Dr.. 17.7'i.m 17 miser. r.arv:v:t 1 . . •• • IO > 1. * i\» i'lCLJ*CU /viVCS) -010.-" 5. 1. D r . ' f t o d r .s y l o v o y a . K e n n e th V . a, D e v x d ff . T h e r a e iii B u r r e ll:, u . U r. p. D r. M ic h a e l G ro s s B e n c e S tr in g i^ -iii .:, C r. Van M ille r A r *y c u r r e n t c r ir .- d e u c e or p r e v ia --u a r*y o t h e r p a rs o n oho In s d '< c r .i '.s t r 7/ . f rs c o n c e s , n u t l i m i t 2d ^ ;. C. c r 'p r o l h v p r o e s h e ..' m l o r an y o th e r v a le te d e r r .v n v . ; n -; L a e g r e t-r :ic n :rt ;rh 1: 1 .r e d c o n tra c t : lr» i i: t v re ;. ' • p r o c e c ■, c/:r::'- o l r»:vi o r . l c o r .. v . . w . . . : c l any ra e a a - Ip la b o r e r s ..- c o o — . '. q u a lity - p .'o r r ' o a v o f e v b c o rtra rtc r, o f d ie th e p c s s ib in o f c r rc s s n e o f d ic r h v r e x p o s u re ; -p a ra to rs ; s u p e r v is o r t; p e r s o n n e l, e n g in e e r s s a fe ty ). .a :.n t.c a t o v . s u b c o n tr a c .:o r , ; w d e fe n d a n ts l c :: ir e ro d o f i d le th e re a m h e r tir ile s r in g , ; v .g c '- a v e r s , p e r s o n n e l, (p ro c e s s , D e fe n d a n ts ;a .v :w la d g a h a ;.:;.': • 'r . r . v p e , c o n tro l ..l h at c o n tra c t e n g in e e r s • r c e .lr s c to r . '.f o r . . ' o d e lu d in g , s u p e r v is o r s ; c r .v x e X r. g a iv a 'a - n s a n d /o r t c x i c i t y e tc h o f s; _t r p 2s , s c r r n e n 'ila o b u r l i e r la b o r e r s , - p u '.iit y ’ . v-e: ; c r o .'i. to , i i ¿ -h o u s e r r p a r c ic tl« -: th e .1 s t ; -h r. h a t r e d s A n y cv.-.:.: o f w hv r i e l o f -e r s e r n e l; ! r .....l e f a a : i i e i u d i r ; .t r D e fe n d a n ts th .r • • .± lo : : o p lia n o .'..o ; y c r .. s u ltr o t o r q o ld r e tic e tl.r v o f c u ih ty i , r ? .y l o r p ra te r. i f s u h c c n .tr r .c to r , each e p o ra to ru ; n iio l o r - '/o r Any c m . _ : . . o v i . : : : in -h o u s e olv tr a c to r . h c w la d g a .1c h a r e r a ; . a iii» in 5 .s tr r ;.h c r s ; o f ^ c c u p r tio n a i e x p o s u re 2 , -'-*U a n d , o r d d i r : c fe a a ic a l, o p l-:/o c , p r i o r .h e c r n c u i t r . - v t b ut c o n ta c t •...•*y i n s e r s to w a rn c r th o s e h i q u e s tio n , lit i t e d ro t to , a d n in is tr a to r s , y ro o rrs , c h e r d c a l. r a o h a r u n o l a n d /' c s h i r t y ) . 3. A n y c u re no o r in -h o r .r e c r any e th e r ih n u fn r b to 7-~e. aha ? jy o th e r ^ o v e r. o f o a .n tr a ...c r , s u b e o a tr■r t o r , each. o f D e fe n d a n ts tie fo rtra l h ic v lL e c r e f a la a -.; :i.o h h ~ a c lr e e ■: f t p c o .r a e n d .'; : . . t i e r or a re a r : c " h a .o : / h r . I--: : e rr* s • f o u rre rf in -h o u s e c is t / has O r - * ..g o or as c m e r it h i: p e v s e r. r l o h i ca.tr....; e r r . h e e lth 9. p ...v ; r r iv a to -y r p ro v ir u s t iio c r o t .is h e rb :' .id e a : .* io ’.c s r r or o th e r o f o o .in g h rs o rd to c r e rrs , u o n tc u x lr s u e d h v x v in . a r p lc .- r r ': . r a n tr a -: h e r , o r i.v u iv r . c - - . . c a l f . r u t -.d ir 1 any s tr r l •*•.': e a r b . c f J ir r .lr lp e ,.f th e s u b c o n tra c to r, D e fe n d a n ts c o n n n ir c f .o r i." .'- . o r snp-r c a n d rd . c f th e o^erlc.rtn r . l '/ " d u p . l i c a t i v a e f f o r t s (.rots whir '-. p s r a lls 1 i: ir/r.:' . lei fovcisf to o r d id in fo n t resi.. f •Is ls o l r ;; ' ,.' 1 I t 'r i l e d .S tates govern se n t c i i .' . a i'.c’c ... ..cl; . of optss r t t r r o o n t i .'t n exrc .s.r:: t ; her n t C oo.r e ond ot!’ •;'«• e.. : ' ' ::rb; :i; .os. £■:■■■• - . v 12444 Iü. ilry •narrent or prate eu » ci.picyen, canhrr-Utov, subcontract- r, irHicusa or private co -subo r»t of cooli of fis Defendants or ony ocrer por sen who ir -5 incineri Ki.,r;ledgo of how diclino work upon oleres, arJ-meJ-s, encl/or rosne;"3. 11. tey crurent or prévenu:> sr:playee, contractor, subcontractor, iiv-bousa cu privato consultent of each of die Defendants or any otter pareen elio ¡.on factual dev.edge of any statistico concerning file effects of devins upon plants, sternal's, and/or humans, 12, any currant cr previe-: ; f l u y e s , contractor, ¡rte-ccntachor, irt-house or private c^nrraltsr.t of cadi of the Defendants or ¿;..y ether perse.. inchrlteg, :nv re': lirait on ..or 'nemters of EPA a 1 other gcvonursental n-jonnioo, tex ten frutve. . lunvledge of the following teoiidantau a- Lore Co.nl b. Mires Bertel; 1-ltefcV A c. lav- — .0 , "only e- P recau tio n u l s t e r s m l1/ :: : naie- rie. • ‘.lu re 1525 e t any o f th ? p iv o ts o f er.y o f to e tote .te ite r 0 .. .te n d r i n g , 1CP, ':Mir 2M ivo 'C, M l .ri.,.;, ..ode /...id.. ¡macana, sodium :ute:n.teda, ontoreoV-v. liter :lcic, end/ur : rout Drange, ineiiidirg nishrpu ;te the roroeging.. :yñ tevisportiio; of tire Defendants' prete.M s to ••„; ;• te, lo Aisne-' ‘orces hasss for eventual ehipnent to Viatnrv;.. t. rte.T.yiug "■7 5"M. ,:ra or,. I M l - i f . M .2 . Anv tornarte or previous sirteoyco, rond-actor, sutcontrcrtor.. in M e s a or* privet» a.advent of etch of tee Défendants or any of m :w:scu who : .; futeudL kcod-sdç* of a: y surveys, tests, car V cMloMo-'l ri udir : rf " * tete M l M g •a the »ff■'r;t-3 of Vope.. •ut.; La o/j-d-h A-v. ,.ya; .A'O-O, t,-. ;.r oi.y ecu .tituen:: r’ .iarccf Molul.Lr the suero tea • Ir-'-prochtct Icrowr. as dictesis. 1/ Ary era. .. with fr.-Jim.. •■uic.jlsd-oe * f hcv decisions are iraca \,dtein the U M ted Clot'eu rovantnant, prte/icndarly '-ha decisi' uo uso o.:c •‘•o continue ■te use -heneo ' ■ te:,h i d las iu Vietnam, p?::tio?J.a.-lv teent ":r.r a-— carro. 'tete. f- etua.l knowledge gevate.u ret pr-.-cuvAV /v h co. ? 0 0 ; arm '•he te/olation tr bilde: ■jerlicularly Mo,. : pn \ .-1:; / ' ? n y '' 'ôter’ l o gc'vot' Tir-rt ron' for elf. phone:?/ hate-lu.:ou [ Ml ar. s nh:.':.:, blu •, purp>ie, pink, -.•••.lar., orarne If.. ; ill;• rite in .teMM >&1 tetec.vtent:; repr-•• • mb- lunar tetuoen .1G 1:2145 Any person with f«actual l:nowiedc?a through any surveys ; tests, spidcmoic-gics 1 studioc m: c-lvrcra 3 under: :rlcen by any state ycvorn.’ .2nt, era/ pii sto public or foreign corporation, Lbs ü. S, 'iOi'gresr. or toe gov. orront of '.ny ns tier. concerning the charaical cccçcunâs, 2,5’“D, .V-.-f'*'!’.- dirdrra;, or related alùorc phenols relating to tlm creation of c"::.oxir.s> •he detection c: dioxins, the dangers of dioxins} cpcoure.. and/or die toxicity, corcincgcnicitv ; fetotoraicityc taarafc-.gcjnicitry.. acute and. or chronic effects on. plants, aniicals and tin human population » 15. Any arrl ail purons listed in The d.jgnicsl. Scythe by Alastair Eay, as baring factual îr-Twlcdga regarding 2,1,.r -1. 2-ID, : ,v..l its UDnter.f.:'ar± dira::!:ran 1?. AL:. workc ccnp.n: :nfi.. o r e . r s for tiro Defendants era.i cracurcuntaticc: .f ¿1.1 ••coupe tioral <•measures filed since 192!; ciie; ericcn .• industriel. inÿnr.cs cr diseases at the ïCF, ?..f,.f •'?, 2,4-D. fir a.:-? . uaararaçc vs, ¡x.'>:r c m rape rat'on slants cf die Défendrais.. 0 . _.r r.ra.-:r.Sct:ion ci..ixncU;tc of VIif~•/'ZL\ \'WO i.. rararâ sieve ct vupnlionnl exposroran rs.d/..-: '■■■ m- ,-v;".b” .•¡- ~ ! s--r. ;vxl/or ::,yinrl ■ "A"? relevant •- • ‘Id .sub ill .-.ioAra. '•he cel.. ; ;c . ■. . v -v v.. 1 Any and li'3 . J.V of Any v.l i.y.\ ■ . . 1. f. . . Ct :; ; prasentatives dcviTtl-tea : t . . of 'm : A rations (1383! and/or cyht ■iogc±-'ri y ç.-rs.c 1 v.*i; •id. . ch encan 1-• 7 and dame:-strut is: ......iy. y.-.. - ■ .vine foe 'which vri11 !c-rs: 'he evict: v a g:. ticon;. . /“WTCbu-! .. 'Æ' c : t k .t ; ■■'* r-C*'’*1 irarein; m the failure of the Did be take y;c:.cpi r.nd. -eff rclive eclien to ban (die production of ') M . t ^ /. tw”*-. .» ^.. /. i its .contaninanl ci- sir c : tv arid all. persons h ./ii •; :x-r-.viedge: 0: f relevant facts regarding tic. finnccl.al stats.s Of 'tiio Dcfcnc entra red their ability *rreapend in pUT-ltiVO .. nf. ...>. grc, including , but not liiiu.ted tc, -ra-i: pact, present, end .brtrrrra profits and earnings in the United State:. *'i’ 1trough -and including the present firasn 'die and slccad sinn cale of ihe prelects ranis the irnsic ci this lawsuit, i.c., 2.4-D, 2,4,1 •1'.. rlvrar.. ? hcraoicilec and ti e relevant herbicic market. Any "cd all pert one havr no lvra/ic..is or relevant facts regarding '•he rvercoip inter \sir. -Nf lira Defer, arris and their ability to respond in punitive damage.. jLrc.li,'riug, !v,t net liraited to. defendants1 daraccfi- am" feesip.\ si bciciiaries, joint venturers, license <7.g?:-'sracnt:j,. end/c :: other -ublic or private corporation-, in the . U. usd a h r , : - m which t.csse defendants own a sub­ stantial freer::iai if- us.. In no 1125 ierrrough and inci;;ding wra sresent. 12446 ■! 1 persorr' '..usted Ly Pía:.stiffs’ -'ll both crioinal and ‘-'■y ¿■•.rudcd tnaus :vs cscjXirt .'itnom n<;U:nl, ti.C:u; cr causation).. ge a-...me..': ritnoss,. yovu.mn.nt enusatic i witness, deiendant-d awplGyscs: and/or rn.lr.trñ personnel ;nd/or any witnesses listed by all Defenderte, m m be exJ.l x.l at fciir.u of trial to present factual i:dentation as to noy intro involved 1 i this casa. 23. Any anil all rumens of tito scientific and/or medical ■. omunity who hí.-’s bncv/lacga of relevant facts, including inforr otion on XTy o the jrevú usuy listel subjects in this f.mv: ., irxludinc, hot not ..':..it::.'i b f..r David j ., . .j . b. Lr. hi.TjI- . c. Dr. Paul 1-C.-V d. n— x * ...< ■ -rv: e. Dr. * r ... ■!? Hr. Moibsro:-; . ■.u-. c. Dr. ..1 ---c. *, h. Alulu -lii,: • ::. .s rhai '■L* Mr.ti.y1* 2A, Any o:' r.V oerrom \ir m u . lovcuul iumledye ccncerr ng 'ha ■ndivid'ul u y uso..'.ni: .o 12.ai hifi;o durugn , including.- Id: no': Ir-P.i 'rrl ; y. tho d o: :u;;; a. Any ano ñl. rmilrul. parser:: o', o huive examinod/ observed, treat: 1 end/.::: tasted ♦•'is 1laiivtiffs ' f-:: injurie.".. disease" and/or minted rluuicc.. and evxt.lonol conditions vi oh resulto fren ilaiotiffn erge-suro to P r u t Orange r and or fneno:"/ ñxdr.u: dos, uisir :onm ihueros, u m n d e r y by err.ducts, waster•suiárais si so ;.aa¿. ruta. i:, tsy m u all hespir u. n n o n o I vúr- a Plaintiffs have buen confined ir hroatuont relating -te. .their cc. ;ho of this, trial. rte3f.2Ctf-.il..y; subr:i.ttud; 1 1 t ^--.--.-hifefcferii'Q lucsics W. licrderscr. Esqif.ro Aliinon Pattiette- liruirr ■"'■1C-: 1 barely rer.J.fy rat t hrir: :_,v'. oup_ of the foregoing irpplrsaeno to .Isi.. riff *s lot-. .nyafnr: o tore tailed Federal Express to . ¿or. orllirnr K’reMo;;. K e l l ! t :y; h. r’s .ran, Mr. Gene Lodes# Plaintiffs' Mma'''arsr.i Cca\:it rt. Lgrsnt Leery.; ufiiro.- w'.iV1 . copies to personally serve the rdraining tsicv.l.o; p; r.r. via v --.-sdry 1 rosrhv.'rr; and Ms. Nancy Pctrilla :j.:t. Pistri:; ■ .11 iltV 1 .,;. y VJr *. - rac- h..as..;, hrcoklyn.. New Yob: this rOri; cl-..y of rebLun*y., lit ’ j tt.:~ r.;\. y - l i a l u - d l lili :.on lattiett a 12448 L'^UfiíJ S u í . cí; n v jfo n jn ;:.« . t ; í \ \ “ ;;e*ior* :tr.íivt.xonicnt.T. joor.'Kocv ir.cjr.ny;»0!: ú526íJ r- a ;jncv ftesoarc.t & üsvt!ku>nti: ;t 7“;a% a V L ’. u í o x ] t:¡5 ':jA V “. ‘V ■ ■ ..--'V 'X.tsí i . .rrt*. ■■ 'V. ■S-j wS .^ ¡ iO vCJ X f"-X "í ..,,:# ' W ' " ! T /' > 5M "U;U >-*r\ V-. j. -w ^ .*.*&*1"^^" X \ *■■>*•¿^♦•*4^ t**s. r S3, ■ •■*! .-■■i'1 J: 'í J • v-r UNITED STATES DISTRICT C O U R T EA STERN DISTRICT OF NEW YO RK "AGENT ORANGE" MDL N O . 381 ; P R O D U C T LIABILITY LITIGATION -X 0 O VI ^t •//•J' a .. ' D E FE N D A N T S LIST OF FA C T WITNESSES SUBMITTED P U R SU A N T TO THE SCHEDULING O RDER FO R THE COM PLETION OF DISCOVERY '"V I iI !^ B U D D , L A R N E R , K EN T, G RO SS, PICILLO & R O SEN BA U M , P .C . 33 W ashington S tr e e t N ew ark , N ew J e r s e y 07102 (201) 6 2 2 -7 4 0 0 \ UNITED STATES DISTRICT CO URT EASTERN DISTRICT OF NEW YORK ---------------------------------------------------------------------------X In R e "AGENT ORANGE" MDL NO . 381 PRODUCT LIABILITY LITIGATION ■X DEFEN DA NTS LIST OF FA C T WITNESSES SUBMITTED PU R SU A N T TO THE SCHEDULING ORDER FO R THE COMPLETION OF DISCOVERY B U D D , L A R N ER , KENT, GROSS, PICILLO & ROSENBAUM , P .C . 33 W ashington S tr e e t N ew ark , N ew J e r se y 07102 (201) 622 -7 4 0 0 12451 DEFENDANTS LIST OF FACT WITNESSES SUBMITTED PURSUANT TO THE SCHEDULING ORDER FOR THE COMPLETION OF DISCOVERY On behalf of all defen d an ts, and pursuant to th e Scheduling O rder For The Com pletion Of D iscovery d ated January 10, 1984, counsel for Thompson C hem ical Company hereby subm its th e following list of p o ten tial w itnesses to be called a t tria l, a tta c h e d h e re to as Schedule A. These w itnesses shall be called to te stify as to th e issue of th e governm ent c o n tra ct defense. F urtherm ore, a tta c h e d h ereto as Schedule B, defendants hereby submit a list of w itnesses presently scheduled to be deposed a t a fu tu re d ate. Therefore, defendants reserve the rig h t, a fte r th ese w itnesses are deposed to determ ine w hether or not these individuals shall be called upon a t tria l. Each individual defen d an t also reserves th e rig h t to subm it an additional list of w itnesses on th eir own b eh alf which they may choose to call upon to te stify . D ated February 29, 1984 R espectfully subm itted, BUDD, LARNER, KENT, GROSS, PICILLO & ROSENBAUM, P.C . Newark, New Jerse y 07102 (201) 622-7400 A ttorneys fo r D efendant Thompson C hem ical Company RIVKIN, LEFF, SHERMAN & RADLER 100 G arden C ity Plaza G arden C ity, New York 11530 A ttorneys for D efendant The Dow C hem ical Company 12152- 'Tir»TA7XTT U V XV I T 41UÌJ 1 Ar T T O n T t M T C A , V J . 4^111AJ . . 405 Lexington Avenue New York, New York 10174 (212)682-4567 A ttorneys for D efendant Monsanto Company ARTHUR, DRY & KALISH, P.C . 1230 Avenue of th e A m ericas New York, New York 10020 (212) 841-9300 A ttorneys for D efendant Uniroyal, Incorporated KELLEY, DRYE & WARREN 101 Park Avenue New York, New York 10178 (212)808-7800 A ttorneys for D efendant H ercules Incorporated SHEA & GOULD 330 Madison Avenue New York, New York 10017 A ttorneys for D efendant Uniroyal, Incorporated CLARK, GAGLIARDI <5c MILLER 99 C ourt S tre e t White Plains, New York 10601 (914) 946-8900 A ttorneys for D efendant T H A griculture <5c N utrition Company, Inc. Schedule A A n d r e w W. Anderson 1311 Thomas Run Road Belaire, Maryland 21014 Richard R. Bates 2810 Pheasant Lane Clarksburg, Maryland Gordon A. Anderson 102 Hickory Lane Naugatuck, Connecticut Frank L. Bauer 600 Grant Street Pittsburgh, Pennsylvania Robert J. Anderson 3624 North 36th Road Arlington, Virginia 22207 *Russell H. Betts Robert L. Andreoli 25 Eighth Avenue Iron River, Michigan *Weldon Bills John Angel Box 78 Yellville, Arkansas Peter S. Bing, M.D. 7900 W. Pico Boulevard Los Angeles, California Kenneth Arndt, M.D. 330 Brookline Avenue Boston, Massachusetts Donald J. Birmingham 19811 Wedgewood Drive Gross Point Woods, Michigan Louis B. Arnoldi 512 North Overlook Drive Alexandria, Virginia Warren R. Bontoyan 3910 Meeting House Road Perry Hall, Maryland 21228 John C. Atkinson 1222 Merchant Lane McLean, Virginia 22101 Rodney William Bovey Dept, of Range Science Texas A & M University College Station, Texas Dr. Joseph D. Avellino 2219 South Broad Street Philadelphia, Pennsylvania 19148 Carl Gwin Baker 19408 Charline Manor Road Olney, Maryland John D. Baldeschwieler 619 South Hill Avenue Pasadena, California William F. Barthel Route 2 Mount Vernon, Iowa 77343 Lester Boyer Edgewood Church Road Frederick, Maryland Harold Brown 101530 Third Street, N.W. Washington, D. C. Ma j o r William Andr e w Buckingham,Jr Department of Political Science U. S. Air Force Academy Colorado *At the present time, addresses on these witnesses are unavailable; however, they will be supplied as soon as possible. 1 2 ■'54 Schedule A - Page 2 John L. Buckley P. 0. Box 263 Whitnes Point, N e w York George W. Connell Route 2, Box 626 Warrenton, Virginia Levi T. Burcham 4701 Crestwood Way Sacramento, California Katherine D. Courtney, Ph.D. Environmental Biology Division E P A Environmental Research Center Research Triangle Park, N.C. 27711 Dr. Edward James Burger, Jr. 2233 Wisconsin Avenue, Suite 324 Washington, D. C. 20007 Jack E. Burton 204 Vivian Lane San Antonio, Texas Charles E. Bushey 374 South Peoria Circle Aurora, Colorado 80012 Dohrman H. Byers 12060 Lawnview Avenue Cincinnati, Ohio Theodore Carroll Byerly 6J Ridge Road Greenbelt, Maryland John F. Callahan, Sr. 2612 Green Road Baldwin, Maryland David M. Cawthorne P. 0. Box 293 Forest Hill, Maryland Milton K. Christensen 1089 Clubhouse Boulevard New Smyrna Beach, Florida Joseph F. Coates 3738 Kanawaha St., N.W. Washington, D.C. Nicholas H. Cox 2516 East Cass St. Joliet, Illinois Robert E. Cox 203 East Belerest Rd. Bel Air, Maryland W i l l i a m J. Crawford 524 Margaret Dr. Fairborn, Ohio W i l l i a m Murlin Creasy 3910 Molly Rd. Pine Bluff, Arkansas 71603 Eugene Cutright 1474 Maplewood Dr. Macon, Georgia 31210 Roswell G. Daniels 226 West Edgewood St. Morton, Illinois 61550 Robert A. Darrow 7613 Baltimore-National Pike Frederick, Maryland 21701 Thomas R. Dashiell 304 Thomas Ave. Frederick, Maryland 21701 Delmore, BG Fred J. 1600 S. Eads Arlington, Va. *George.Collins * Joseph Amadeo DiPaolo 6605 Melody Lane Bethesda, Maryland 20034 *At the present time, addresses on these witnesses are unavailable; however, they will be supplied as soon as possible. Schedule A - Page 3 Will i a m W. Dorrell 8600 Pine Cliff Drive Frederick, Maryland *Dr. Hans Falk Paul Doty 4 Kirkland Place Cambridge, Mass. William A. Fenner 2713 Roffin Road Hopewell, Virginia 23860 Francis Gene Douglas 3101 South 54th St. Kansas City, Kansas David Firestone HFF 426 200 C. Street S.W. Washington, D.C. 20204 Henry N. Doyla 5303 Augusta St. Bethesda, MD. Lee A. DuBridge 1730 Hornet Rd. Pasadena, California Robert H. Duguid 107 South Lyndbrook Rd. Bel Air, Maryland Sigmund R. Eckhaus 4208 Colonial Rd. Pikesville, Maryland Fred I. Edwards 5206 Worthington Drive Bethesda, Maryland Dr. Kenneth Endicott . 11317 Broad Green Drive P o t o m a c , Maryland William B. Ennis, Jr. 1131 S.W. 74 Terrace Plantation, Fla. 33317 Graydon C a s p e r .Essman 11 Holcomb Drive Williamsburg, Virginia Henry Fischbach. 5627 Bradley Blvd. Alexandria,. Virginia Lawrence Fishbein 3203 Misty Lane Littlerock, Arkansas 72207 Oscar G. Fitzhugh . 4208 Dresden St. Kensington, Maryland John Stewart Foster 2737 Sinton Place Pepper Pike, 44124 *John Frawley Herbert G. Fredericks 2414 Diana Road Baltimore, Maryland Seymour L. Friess 6522 Lone Oak Court Bethesda, Maryland Verne C. Fryklund, Jr. 6805 Broyhill St. McLean, Virginia 22101 Donald W. Falconer 115 Kline Blvd. Frederick, Maryland 21701 Donald W.. Fuhlhage Rural Route 1 Tonganoxie, Kansas * At the present time, addresses on these witnesses are unavailable; however, they will be supplied as soon as possible. 12 C5 6 Schedule A - Page 4 James Gardner 1616 Arlington Drive Salt Lake City, Utah 84103 Benjamin Harris 11323 Gienarm Road Glenarm, Maryland ' Major Robert M. Gastineau,. M.D. 2381 Rexford Drive Pittsburgh, Pennsylvania 15241 E. Ross Hart 1160 Chain Bridge Road McLean, Virginia 22101 *Perry Gehring Wayland J. Hayes 2317 Gold Club Lane Nashville, Tennesse John H. Gerety, Jr. North Entrance Friendhsip Inn P.O. Box 1885 Klamath Falls, Oregon Harry W. Hays 3900 Watson Place, N.W., Apt. Building A Washington, D.C. 20016 *Thomas Gervason Albert E. Hayward. 5716 Jefferson Blvd. Braddock Heights, Maryland 21714 William Godel 711 Ledo Park Dr. Newport Beach, Ca. 2G Robert J. Heaston 8231 Stonewall Drive Vienna, Virginia 22180 92660 ♦John Gordon James A. Hebbeler 821 Park Court Pal m Harbor, Florida ♦Harry Heimann Nathan Gordon 4990 Sentinel Drive Apartment 301 Bethesda, Maryland 20816 Dr. Herschel E. Griffin 11274 Pabellón Court San Diego, California 92124 Brunildo Antonio Herrero 616 Lake Hollingsworth Drive Lakeland, Florida ♦David Henry Groth Garnett Higginbotham Division of Food and Color Additi\ FDA 200 C Street, S.W. Washington, D.C. 20204 General Paul Donal Harkins 65104 Northport Drive Daillas, Texas 75230 Donald F. Hornig 16 Longfellow Park Cambridge, Mass. ♦At the present time, addresses however, they will be supplied these witnesses, are unavailable; soon as possible. Schedule A - Page 5 Richard G. Horton 208 East Ring Factory Road Bel Air, M a r yland 21014 Philip Charles Kearney Building 050 BARC-West Beltsville, Maryland Will i a m Horwitz 9830 Cherry Tree Lane Silver Spring, Maryland 20901 Surgeon M. Keeny, Jr. 3600 Albermarle St., N.W., Washington, D.C. Riley D. Housewright 147 Fairview Avenue Frederick, Maryland Dr. Marcus M. Key University of Texas Health Science Center, at Houston P.0. Box 20186 Houston, Texas 77025 Harry Otto Huss Route 1 Box 352 Uhrichsville, Ohio 44683 Kent R. Irish 1604 Rock Creek Drive Frederick, Maryland Keith H. Jacobson 740 Beall Avenue Rockville, Maryland Dr. Bernard J. Jandorf 6017 Baywood Avenue Baltimore, Maryland 21209 Marc Jeffries 2108 Hyden Ct. Fallston, Maryland 21067 * Dr. Henry A. Kissinger 435 East 52nd St. N e w York, New York Michael Klein 1800 South East St. Lucie Blvd. Building 10-306 Stuart, Florida Dayton L. Klingman 2028 Forest Hill Drive Silver Spring, Maryland 20903 Albert Christian Kolbye 4802 Fort Summer Drive Bethesda, Maryland Wesley Rudolph Koster Dr. William Jurgelski 105 Northlake Dr., Apt. 215A Office of Health Hazard Assessment Orange City, Florida 32763 National Institute of Environmental Health Science Wil l i a m George Kratz Research Triangle Park, N.C. 27709 935 North Capitol Many, Louisiana 71449 *A b r a m Saul Kaplan George M. Lawton 1388 Almond Ave. Livermore, California Ronald Joseph Kassel 222 East Belcrest Road Bel Air, Maryland * At the present time, addresses on these witnesses are unavailable; however, they will be supplied as soon as possible. IO/ \ o .)Ö Schedule A - Page 6 John S. Leary, Jr. 2002 Sea Cove Court Nassau Bay, Texas Ian Alastair Mitchell, M.D. 110 Parmele Blvd. ; Wrightsville Beach, N.C. Douglas H.K. Lee 421 Wood Duck Drive Sarasota, Florida Francis W. Morthland 5602 Garrett Rd. Durham, North Carolina Jane Lewis 5125 Temple Hills Road Temple Hills, Maryland 20748 Donald W. Norberg 9153 East Stanford Ave. Englewood, Colorado 80111 Dr. Douglas Lindsey 1501 North Campbell St. Tuscon, Arizona Dr. Harold T. Magnuson 12305 Fernando Drive San Diego, Cal. 92128 Gordon J. MacDonald 20 Occom Ridge Hanover, New Hampshire Dr. Arthur H. M c C reesh 1317 Saratoga Drive Bel Air, Maryland 21014 Harold Noble MacFarland 2320 Harrah Manner Drive Pittsburgh, Pennsylvania 15238 William D. McElroy 9651 Black Gold Road LaJolla, Cal. 92037 Dr. Arthur H. McCreesh 1317 Saratoga Drive Bel Air, Maryland 21014 Robert S. McNamara 2419 Tracy Place Washington, D.C. Harold Joseph Magnuson, M.D. 12305 Fernando Drive San Diego, California 92128 Vincent McRae 12000 Old Georgetown Rd. Rockville, Maryland Walter W. Melvin 413 Bobolink Court Fort Collins, Colorado 80526 John F. O'Leary Route 1, Box 213 Queenstown, Maryland 21658 Edward A. Metcalf 906 Wellington Rd. Baltimore, Maryland 21212 Peter G. Olenchuk 6801 Baron Rd. McLean, Virginia 22101 Lester L. Miller 437 Blueridge Drive York, Pennsylvania Normand E. Olivier 31 Mosher St. South Dartmouth, Mass. Charles E. Minarik P.O. Box 682 West Harwich, Mass. Boris J. Osheroff 13102 Camellia Drive Silver Spring, M a r y l a nd 20906 12459 Schedule A - Page 7 Arthur Joseph Pallotta 601 Abbott Lane Falls Church, Virginia M a j . Gen. Jacquard H. Rothschild 2323 N. Central Ave. Phoenix, Az. 85004 Laverne A. Parks 322 E. Garden Green Port Hueneme, Cal. 93041 Dr. Jack Phillip Ruina 28 Hawthorne St. Cambridge, Mass. 02138 *Vernon Perone Umberto Saffiotti 5114 Wissioming Road Bethesda, Maryland Lawrence M. Petrucelli 5600 Cedar Parkway Chevy Chase, Maryland Samuel Sass 17 North Read Street Bel Air, Maryland 21014 Alan P. Poland 2918 Nottingham Way Madison, Wisconsin Bernard Schwetz 1101 30th Street, N.W. Suite 205 Washington, D.C. 20007 Paul Aaron Possick 46 Winding Way Woodcliff Lake, N.J. Robert A. Shade 199 Rooster Drive Eagle, Indiana Melvin M. Rabstein 4401 Gulf of Mexico Drive Long Boat Key, Florida Eberhardt Rechtin 1665 Cataluna Palos Verdes Estates, Cal. Kennard A. Reynard 2496 Cedarwood Drive Adrian, Michigan Merl Ringenberg 612 Rock Spring Road Bel Air, Maryland Ralph T. Ross Room 330A Administration Building U.S. Department of Agriculture Washington, D.C. Warren C . Shaw 1907 Edgewater Parkway Silver Springs, Maryland Carleton G. Shead 1406 Flying W. Trail Helotes, Texas 78023 *John R. Shoemaker Seymour D. Silver 2920 Strathmore Ave. Baltimore, Maryland Dr. Van Murray Sim 1615 Toll Gate Road Bel Air, Maryland *At the present time, addresses on these witnesses are unavailable; however, they will be supplied as soon as possible. 12'iBO Schedule A - Page 8 Dr. Thomas C. Simmons 2706 Bynum Hill Circle f Charles H. Townes 1988 San Antonio Ave. Berkeley, California Anthony N. Sinclitico 1800 Willann Road Baltimore, Maryland 21237 John L. Traub 610 West Baker Ave. Abingdon, Maryland Marshall Steinberg 927 Jaysmith Street Great Falls, Virginia ♦Thomas A. Treglia *Dr. Jesse L. Steinfeld John Wilder Tukey 115 Arreton Rd. Princeton, N.J. ♦Herbert E. Stokinger W i l l i a m Martin Upholt 525 East Indian Drive Silver Springs, Maryland William W.. Stone 434 Sanahelena Drive Solana Beach, California Cyrus Robert Vance One Battery Park Plaza New York City Marshall Stubbs 2001 Columbia Turnpike Arlington, Virginia ♦Wayne E. Vandeventer Walter Edward Sultan 1203 Springwoods Terrace Fallston, Maryland 21047 Filiberto Vargas 6165 East I Lift Ave. Apartment 308 B Denver, Colorado 80222 D a 1 A i >• . T l L .J - M a >*tt 1 J Tl . CiJ.HwA William H. Summerson 5108 Brittany Drive South St^ Petersburg, Florida Steve S. Szabo 20 Milrose Lane Monsey, New York ^ Henry L. Verhulst 5917 Walton Rd. Bethesda, Maryland Frank J. Vocci 6009 Winthrope Ave. Baltimore, Maryland 21206 General Maxwell D. Taylor 2500 Massachusetts Ave. N.W. Washington, D.C. D orothy M. Ward 345 Homeland South Way Baltimore, Maryland 21212 *At the present time, addresses on these witnesses are unavailable however, they will be supplied as soon as possible. rS * p ■" Schedule A - Page 9 Paul C. Warnke Cummings, Burlington, Rubier, Acheson & Shaw Washington, D.C. John T . Weimer 1500 South Vie w Rd. Bel Air, Maryland 21014 Frank H. Westheimer 3 Berkeley St. Cambridge, Mass. 02138 William Childs Westmoreland Box 1059 Charleston, S.C. 29402 Jerome B. Wiesner 61 Shattuck Rd. Watertown, Mass. Jerome Wilkenfeld 5757 Owensmouth Ave. Woodland Hills, California Donald Whittam 10308 Brookmoor Drive Silver Spring, Maryland 20901 James H. Wills 9706 Bellevue Dr. Bethesda, Maryland Herbert F. York 6110 Camino De LaCosta LaJolla, California Dr. Mitchell Zavon Occidental Chemical Corp. P.O. Box 728 Niagara Falls, N e w York 14302 Walter Leo Zielinski, Jr. 12705 Darnestown Rd. Gaithersburgh, Maryland 20878 /—vc SCHEDULE B DEPOSITIONS SCHEDULED AFTER FEBRUARY 29, 1984: /—N 1. Donald Barnes 2. General Stanzwick 3. Julius Johnson 4. Harold Kinney 5. Debdas Mukerjee 6. Elmer Wheeler 12'83 UN ITED STATES DISTRICT CO URT EA STER N DISTRICT OF NEW YORK In R e "AGENT ORANGE" PR O D U C T LIABILITY LITIGATION MDL N O . 381 D E FE N D A N T S LIST OF FA C T WITNESSES SUBMITTED PU R SU A N T TO THE SCHEDULING O RDER FO R THE COMPLETION OF DISCOERY B U D D , L A R N E R , KENT, GROSS, PICILLO & RO SENBA UM , P .C . 33 W ashington S tr e e r t N ew ark , N ew J e r se y 07102 (2 0 1 )6 2 2 -7 4 0 0 A tto r n e y s fo r D e fe n d a n t T hom pson C h e m ic a l C om pany UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK In re "AGENT ORANGE" Product Liability Litigation DEFENDANT DIAMOND SHAMROCK CHEMICALS COMPANY'S PRELIMINARY LISTING OF FACT WITNESSES___ Pursuant to the Special Master's Final Amended R e c o m m e n d e d S c h e d u l i n g Order, a p p r o v e d by the C o u r t on J a n u a r y 10, 1984, defendant Diamond Shamrock Chemicals Company Shamrock") sets witnesses who forth may below its preliminary give live t e s t i m o n y listing at trial D i a m o n d S h a m r o c k ' s c l a i m s a n d defenses. ("Diamond of fact in s u p p o r t of T h i s l i s t i n g do e s n ot a d d r e s s d e p o s i t i o n t e s t i m o n y t h a t m a y be u s e d at trial, which will be identified as part of preparation of the pretrial order. In a c c o r d a n c e Pretrial with the S c h e d u l i n g O r d e r No. 9, Diamond Order Shamrock and t h e reserves supplement and am e n d this preliminary listing. Magistrate's the right to Name and Present Address Description of General Nature of Testimony Dr. Donald J. Birmingham 19811 Wedgewood Drive Gross Point Woods, Michigan Testimony concerning research and i n v e s t i g a t i o n of c h l o r a c n e by 0.S. Public Health Service in the i950's and 1960's, i n c l u d i n g v i s i t s to Dia m o n d Shamrock's former N e w a r k plant. Robert L. Chonoles Diamond Shamrock Chemicals Company Berry Avenue at Route 17 North Carlstadt, New Jersey 07072 Testimony concerning manufacturing o p e r a t i o n s at D i a m o n d S h a m r o c k ' s f o r m e r N e w a r k plant, inc l u d i n g : the r e m o v a l of d i o x i n f r o m tric h l o r o p h e n o l ; a n d the U.S. P u b l i c Health Service study of the Newark workers in 1968-69. Sigmund R. Eckhaus 4208 Colonial Road Pikesville, Maryland Testimony concerning United States' program for the construction of an Agent Orange manufacturing facil­ ity, a n d c o m m u n i c a t i o n s w i t h p r o ­ d u c e r s of A g e n t O r a n g e in c o n n e c ­ tion with that program. Dr. Marcus M. Key University of Texas Health Science Center P.O. Box 20186 Houston, Texas 77025 Testimony concerning research and i n v e s t i g a t i o n of c h l o r a c n e by U.S. Public Health Service in the 1960's i n c l u d i n g v i s i t to D i a m o n d S h a m ­ rock's former N e w a r k plant. Jane Lewis 5125 Temple Hills Road Temple Hills, Maryland 20748 T e s t i m o n y c o n c e r n i n g the p r o c u r e ­ ment and production of Agent Orange pursuant to the Defense Production Act , i n c l u d i n g d i r e c t i v e s and p r i o r i t y r a t i n g s i s s u e d by t h e United States. Dr. Alan P. Poland 2918 Nottingham Way Madison, Wisconsin Testimony concerning medical study of the workers at Diamond Shamock's former Newa r k plant in 196869, and research and investigation of trichlorophenol, 2,4,5-T and dioxin at. National Communicable Disease Center in the 1 9 6 0 's. Dr. Paul A. Possick 46 Winding Way Woodcliff Lake, New Jersey Testimony concerning medical study of the w o r k e r s at D i a m o n d S h a m ­ rock's former N e w a r k plant in 196869. -2- Name and £]Z:■■ - ' /V/, - ■’ / )■», v;>;; ts * 0’® r ^ ‘;v' DISTRICT COORT EASTEMi; DI STRI CT OP NEW YORK :ìliPiÆ i'i' -vïÿâbiNSi^ .-:.- ^ ^ ':-® MDL NO. ••. > 7«-%/\ -.V^ c Æ>.'..'‘■V:r.;'.'''".■■/r-i-../'-*;,';'~ AGENT ORANGE" ;• ; :i'; "AGEN • - •' ^ X ^ ^ P r o d i ^ t Liability Litigation -v--^v'Z.‘ Ä x>: . D E F E N D A N T DIAMOND SHAMROCK' S .OBJECTIONS, TO .P L A I N T I F F S ' P R ELIMINARY.LIS T _OF : 7 ^ POTENTIAL DEPONENTS PRESENTLY OR FORMERLY' .i•.:,•-■••.;•v ’* . . . . . . .. * " ’” *. r . • _ » ^ " ;\•(•1■ • ‘ /:\''••'•’ ;: •';i"••'•':f,.v - ^ -• V ‘v7>: -.y; "’.jjÀi-v.*:’*’ •' 5*t«V. J L ^ . ì i 'i S l ’AÀÌN'fcÀ«-- >•.•.l-V'.'. ö...■vi.'.S i'* ’!;., M S Ä «J.• ' ‘ •'•I.' ;: ':i ' '••:> *-„ k” r<. ' "•■’1 ' •,"’■,. . •" ..«.'■-■'.•■»>:• ,•? ; 4■./;•• -> '•< >•' ^.V.y v ' ;;Sr ^ x »V 7; ! S . . ? . ^ * ' . V ' *83 :C -y . A s s is ta n t S c i e n t i s t - J u ly , 1982 to January, 1983 P ro je c t Associ ate - June, 1980 to June, 1982 U n iv e r s it y o f Wisconsin Dept, o f Pathology Madison, Wisconsin project.?; in v o lv in g over uuui u m ated m u ltifa c e te d 120 rhesus monkeys exposed to low le v e ls o f to x in s ( h a lo genated arom atic hydrocarbons) and in te g r a te d the c l i n i c a l data and observation s with the residue analyses o f tis s u e s and f l u i d s o b tained by gas chromatography (GC) and con­ firm ed by mass spectrometry (MS). Supervised the c l i n i c a l and reproductive e v a lu a tio n s as well as the care o f lab o rato ry animals. Developed d a ta management and word processing systems u t i l ­ i z in g o n - s i t e computers and t i e - i n s to a Sperry Univac 1100 to s o r t , c o l l a t e and s t a t i s t i c a l l y e v a lu a te data. Conducted gross necropsies and m icroscopic e v a lu a tio n s and prepared necropsy rep o rts. Research A s s is ta n t - 1976-1980 U n iv e r s it y o f Wisconsin Dept, o f Pathology Madison, Wisconsin Conducted radioimmunoassays f o r serum progesterone and e s t r a ­ d io l f o r use in e v a lu a tin g the rep ro d u ctive parameters in rhesus monkeys. Performed c l i n i c a l assessments on la b . hematology and c l i n i c a l chem istries. animals in c lu d in g Supervised and evaluated data and prepared r e p o rts f o r con­ t r a c t u r a i work. Separated c e l l u l a r fr a c tio n s o f tis s u e homogenates by u l t r a ­ c e n t r i f u g a t i o n and assayed homogenates and r e s u l t a n t f r a c ­ t io n s f o r content o f various components. Provided animal husbandry f o r rhesus monkey and r a t c o lo n ie s . Supervised u n i t members on protocols f o r e x p e rim e n ta tio n and proper methods o f conducting basic l a b o r a t o r y analyses. Pre-D o cto ral Fellow - 1974-1976 U n iv e r s it y o f Wisconsin Dept, o f Pathology Madison, Wisconsin Stocked and organized a la b o ra to ry f o r the c l i n i c a l d u c tiv e analyses o f la b o ra to ry animals. and r e p r o ­ Prepared protocols f o r long-term feeding studies in the la b o r a to r y animals in c lu d in g those f o r gross, c l i n i c a l and reproductive assessments. Developed radioimmunoassay procedures f o r serum proges­ terone and e s t r a d i o l . Conducted metabolism and d i s t r i b u t i o n studies in r a ts and rhesus monkeys using r a d io la b e le d isomers o f halogenated arom atic hydrocarbons and o th e r chemicals. Laboratory A s s is ta n t - 1970-1972 Humboldt S tate U n iv e r s it y Student Health Center A r e a ta , C a l i f o r n i a Duties included a s s is t in g in r o u tin e c l i n i c a l la b o r a to r y p r a c tic e s involved in u r i n a l y s i s , gonococcal s cre en in g , VDRLs, h e te ro p h ile s f o r mononucleosis, t h r o a t c u ltu re s and pregnancy t e s t s . AWARDS/HONORS: N ational Sea Grant Graduate Student o f the Year - 1976. PROFESSIONAL SOCIETIES: American Society f o r P rim a to lo g is ts M i d - A t l a n t i c C h a p te r, S o ciety o f Toxicology SEMINARS/MEETINGS: P a r t i c i p a n t - Fed eration o f American S o c ie tie s f o r E x p e ri­ mental Biology (FASEB), A t l a n t i c C i t y , NJ, A p r i l , 1976. Topic: " E ffe c ts o f p o ly c h lo r in a te d biphenyls on re p ro ­ duction in the p rim a te " . P a r t i c ip a n t - American A s so ciatio n o f P a th o lo g is ts and B a c t e r io l o g i s t s , Boston, MA, March, 1976. Topic: "The A s so ciatio n o f T ran s p la c e n ta l and Mammary Movement o f PCBs w ith In fa n t M o r b id it y and M o r t a l i t y " . I n v i t e d Speaker - 9th Annual Sea Grant A s so ciatio n M eeting , Los A ngeles, CA, November, 1976. Topic: "Toxicology o f PCBs in the A dult and I n f a n t Rhesus Monkey". P a r t i c ip a n t - FASEB, Chicago, I L , A p r i l , 1977. Topic: " E ffe c ts o f p o ly c h lo r in a te d biphenyls in nonhuman prim ates". P a r t i c i p a n t - American Chemical S o c ie ty , 11th Great Lakes Regional M eeting, Stevens P o in t , WI, June, 1977. Topic: "Responses of i n f a n t primates to i n t e r u t e r i n e and neonatal exposure to p o ly c h lo r in a te d b ip h e n y ls ". I n v i t e d Speaker - Community Meeting on PCBs, U n iv e r s it y o f Wisconsin, P a rk s id e , March, 1977. - 3 - 12485 P a r t i c ip a n t - In te r n a tio n a l Symposium on Pathobiology of .Environmental P o ll u t a n t s , S t o r r s , CT, June, 1977. Topics: "Pathology o r rhesus macaques (Macaca m u la tta ) exposed to t e tr a c h lo r o d ib e n z o -£ -d io x in (TCDD)" and "Exposure o f p o ly ­ c h lo rin a te d biphenyl (PCB) to i n f a n t rhesus macaques (Macaca m u la tt a ) " . I n v it e d Speaker - Community Meeting on PCBs, Door County, WI, September, 1977. I n v ite d Speaker - 45th Annual Convention o f A s sociation o f Midwest Fish and W i l d l i f e Agencies, Milwaukee, W I, J u l y , 1978. Topic: "Consequences o f d i e t a r y PCB consumption in rhesus monkeys". I n v i t e d Consultant - Symposium on PBB L i t i g a t i o n , Traverse C i t y , M I, J u l y , 1978. Topic: "PBB t o x i c i t y in the rhesus monkey". In v i t e d Speaker - Smerkee's Conservation C lu b , Sheboygan, WI, F eb ru ary, 1979. Topic: "PCBs and t h e i r e f f e c t s on rhesus monkeys". P a r t i c ip a n t - FASEB, D a ll a s , TX, A p r i l , 1979. Topic: "Residual e f f e c t s o f p o ly c h lo r in a te d biphenyls on a d u lt nonhuman primates and t h e i r o f f s p r in g " . Expert Witness - S ta te o f North C a r o li n a , H a lif a x County; testim ony on t o x i c i t y o f PCBs, June, 1979. P a r t i c i p a n t - Sea Grant Symposium on Toxic M a te r ia ls and t h e i r E f f e c t s on Marine Resources, Madison, W I, J u l y , 1979. PUBLICATIONS: B a r s o t t i , D. A. and Van M i l l e r , J. P . : Reproductive assessments o f rhesus monkeys housed in c lim a te c o n tr o lle d co n d itio n s . Amer. J. P r i m a t o l . , submitted 1983. B a r s o t t i , D. A .: Long term rep ro d u ctive assessment o f rhesus monkeys exposed to c h lo rin a te d biphenyls (A ro c lo r 1248). Fd. Cosmet. T o x i c o l . , submitted 1983. B a r s o t t i , D. A. and Van M i l l e r , J. P. : Accumulation o f a commercial p o ly ­ c h lo rin a te d biphenyl m ix tu re (A ro c lo r 1010) in a d u lt rhesus monkeys and t h e i r nursing o f f s p r in g . Toxicology. In press. Bowman, R. E . , Heironimus, M. P. and B a r s o t t i , D. A . : Locomotor h y p e ra c t­ i v i t y in PCB-exposed rhesus monkeys. N e u r o to x ic o l. 2 : 2 5 1 -2 5 8 , 1981. B a r s o t t i , D. A. _, Abrahamson , L. J. , M a r la r , R. J. and A l l e n , J. R. : The e f f e c t o f clim ate c o n tr o lle d housing on the re p ro d u c tiv e p o t e n t ia l o f the rhesus monkey. J. Reprod. F e r t i l . 5 9 : 1 5 - 2 0 , 1980. - d - I24SG B a r s o t t i , D. A. and A l l e n , J. R . : nursing rhesus monkey i n f a n t s . (A b stract). Health im p lic a tio n s o f A ro c lo r 1016 on T o x ic o l. A p pl. Pharmacol. 5 2 :1 3 5 , 1980 A l l e n , J. R. , B a r s o t t i , D. A. and C arstens, L. A . : Residual e f f e c t s o f p o ly ­ c h lo r in a te d biphenyls on a d u lt nonhuman primates and t h e i r o f f s p r i n g . J. T o x ic o l. Environ. H lth . 6 : 5 5 - 6 6 , 1980. A l l e n , J. R . , B a r s o t t i , D. A. and Van M i l l e r , J. P .: T o x ic o lo g ic a l e f f e c t s o f A r o c lo r 1016 on nonhuman prim ates. EPA Report # 6 8 -0 2 :2 4 6 4 , 1980. B a r s o t t i , D. A . , Abrahamson, L. J. and A l l e n , J. R. : Hormonal a l t e r a t i o n s in female rhesus monkeys fed d ie t s c o n tain in g 2 , 3 , 7 ,8 -t e t r a c h l o r o d i b e n z o ­ l-d io x in . B u l l . Environ. Contam. T o x ic o l. 2 1 : 4 6 3 -4 6 9 , 1979. B a r s o t t i , D. A . , C a rstens, L. A. and A l l e n , J. R . : Residual e f f e c t s o f p o ly­ c h lo r in a te d biphenyls on a d u lt nonhuman primates and t h e i r o f f s p r i n g . Fed. Proc. 3 8 :1 1 1 9 , 1979 ( A b s t r a c t ) . A l l e n , J. R . , B a r s o t t i , D. A. and Lambrecht, L. K . : Reproductive e f f e c t s o f halogenated arom atic hydrocarbons on nonhuman p rim a tes . New York Academy o f Sciences, 3 2 0 :4 1 9 -4 2 7 , 1979. A l l e n , J. R . , B a r s o t t i , D. A. and Van M i l l e r , J. P . : Pathology o f rhesus macaqques (Macaca m u la tta ) exposed to t e t r a c h lo r o d ib e n z o - £ - d io x in (TCDD). I n t e r n a t i o n a l Symposium on Pathology o f Environmental P o l l u t a n t s , National Research C o u n c il, 3 4 6 -3 5 5 , 1979. A l l e n , J. R . , Van M i l l e r , J. P. and B a r s o t t i , D. A . : T o x ic o lo g ic a l responses o f nonhuman primates to 1 , 2 , 4 , 6 ,7 ,8 -h e x a c h lo r o d ib e n z o -£ -d io x in (HCDD). T o x ic o l. Appl. Pharmacol. 4 7 :1 7 9 , 1979 ( A b s t r a c t ) . C a rs te n s , L. A . , B a r s o t t i , D. A. and A l l e n , J. R . : Exposure o f p o l y c h lo r i n ­ ated biphenyl (PCB) to i n f a n t rhesus macaques (Macaca m u l a t t a ) . In te r­ n a tio n a l Symposium on Pathobiology o f Environmental P o l l u t a n t s , .N atio nal Research C o u n c il, 3 3 9 -3 4 5 , 1979. S c h a n tz, S. L . , B a r s o t t i , D. A. and A l l e n , J . R . : T o x ic o lo g ic a l e f f e c t s pro­ duced in nonhuman primates c h r o n ic a lly exposed to f i f t y p a rts per t r i l l i o n 2 , 3 , 7 , 8 - t e t r a c h l o r o d i b e n z o - p - d io x in (TCDD). T o x ic o l. Appl. Pharmacol. 4 6 : 1 8 0 , 1979 ( A b s t r a c t ) . A l l e n , J. R. , Lambrecht, L. K. and B a r s o t t i , D. A . : Some general e f f e c t s o f polybrom inated biphenyls in nonhuman p rim a tes . J. Am. Vet. Med. Assoc. 173 1 1 :1 4 8 5 -1 4 8 9 , 1978. Lambrecht, L. K. , B a r s o t t i , D. A. and A l l e n , J. R. : Responses o f nonhuman primates to a polybrominated m ix tu re . E nviron. Health Perspec. 2 3 :1 3 9 147, 1978. A l l e n , J. R. , B a r s o t t i , D. A . , Van M i l l e r , J. P . , Abrahamson, L. J. and ■ L a l i c h , J. J . : Morphological changes in monkeys consuming a d i e t c o n ta in ­ ing low l e v e l s o f 2 , 3 , 7 , 8 - t e t r a c h l o r o d i b e n z o - £ - d i o x i n . Fd. Cosmet. , T o x i c o l . 1 5 : 4 0 1 -4 1 0 , 1977. «4 1 * ' t v * -* -V O -J A l l e n , J. R. and B a r s o t t i , D. A . : Responses o f in f a n t primates to i n t e r u t e r i n e and neonatal exposure o f p o ly c h lo rin a te d biphenyls. American Chemical So­ c i e t y , Proceedings o f 11th Great Lakes Regional Meeting, June, 1977 (Ab­ s tra c t). A l l e n , J. R . , B a r s o t t i , D. A. and Van M i l l e r , J. P . : Reproductive dysfunc­ t io n in nonhuman primates exposed to d io x in s . T o x ico l. Appl. Pharmacol. 4 1 :1 7 9 , 1977 ( A b s tr a c t). Norback, D. H. and B a r s o t t i , D. A . : E ffe c ts o f p o ly c h lo rin a te d biphenyls in nonhuman primates. Fed. Proc. 3 6 5 :3 9 6 , 1977 ( A b s tr a c t). B a r s o t t i , D. A . , M a r la r , R. J. and A l l e n , J. R . : Reproductive dysfunctions in rhesus monkeys exposed to low le v e ls o f p o ly c h lo rin a te d biphenyls (A r o c lo r 1248). Fd. Cosmet. T o x ic o l. 1 4 : 9 9 -1 0 3 , 1976. B a r s o t t i , D. A. and A l l e n , J. R . : The ass ociation o f tra n s p la c e n ta l and mammary movement o f PCBs w ith i n f a n t m o rb id ity and m o r t a l i t y . Amer. J. Path. 8 2:21 a, 1976 ( A b s t r a c t ) . A l l e n , J. R. and B a r s o t t i , D. A . : The e f f e c t s o f tra n s p la c e n ta l and mammary movement o f PCBs on in f a n t rhesus monkeys. Toxicology 6 :3 3 1 -3 4 0 , 1976. A l l e n , J. R . , B a r s o t t i , D. A. and C a rstens, L. A . : Residual e f f e c t s of sho rt te rm , low le v e l exposure o f nonhuman primates to p o ly c h lo rin a te d biphenyls. T o x ic o l. Appl. Pharmacol. 3 0 :4 4 0 -4 5 1 , 1974. - 6 .- 12488 Dr. R o nald Corderio, M.D., in Philadelphia, Pennsylvania. is an internist practicing His c u r r iculum vitae will be supplied. Dr. Corderio will testify that he is currently engaged in the private practice of medicine as an internist. He will testify that he personally: has examined and/or treated over five hundred V i e t n a m veterans for complaints related to Agent Orange. He will testify as to the type of interview he has conducted with each veteran, have performed, the type of tests that each veteran should and the clinical significance of positive or negative findings on each of those tests. He will also discuss how toxins, can cause changes each and specifically Agent Orange, in of the tests and what such changes portend for the individual. Dr. Corderio will next discuss some of the available medical literature in both animals and humans to further validate his own work. Dr. Corderio will then outline in detail the results obtained from his own extensive investigation into Agent O range toxicity based upon his examination of more than five hundred veterans, and will present those conclusions which he feels are reasonably appropriate based upon an analysis of his investigative work. W i t h this material as background, Dr. C o r d e r i o will then proceed to present the test results w h i c h have been o b t ained for each c ourt-approved representative v eteran plaintiff. He will interpret each of the test results in terms of those individual plaintiffs. Finally, he will testify on generic causation and specific p roximate causation in relation to each representative veteran plaintiff. He will also testify as to prognosis for each r e p r e s entative veteran plaintiff. ARTHUR W. GALSTON, Ph.D. Dr. Galston is Eaton Professor of Botany, Department of Biology, at Yale University. His Curriculum Vitae will be supplied. Dr. Galston is a plant physiologist and has personally observed the effect of the spraying of Agent Orange on the Vietnam ecosystem, i.e. the devastation of the Vietnamese countryside. Dr. Galston has been in Vietnam on four occasions between 1971 and 1982, and will describe those observations while in Vietnam, with such pictorial evidence as is available. Dr. Galston will testify to the potential and actual effects of phenoxy herbicides and their contaminants, both in Vietnam and elsewhere, including the United States and Sweden, and other places. The testimony will include the chemistry and the mechanisms of action of such chemicals on plant life. In addition, Dr. Galston will testify to the fate of Agent Orange and other phenoxy herbicides and their contaminants, especially TCDD, in the environment generally and in Vietnam in particular. Dr. Galston will testify to the persistence of such chemicals on plants, in water, and in soil, such that exposure to the phenoxy herbicides and their contaminants, especially TCDD, by the veterans in sprayed areas in Vietnam is presumed. The bases or grounds for Dr. Galston's testimony as to any facts and opinions expressed are a review of the scientific literature and his personal research and experience. Dr. John Garofalo is a immunologist practicing in Philadelphia, Pennsylvania. His cu r r i c u l u m vitae will be supplied. Dr. Garofalo w ill testify to the performance of certain tests on the v eteran plaintiffs and their wives and children and to the i n t e r p retation of those test results. Specifically, he will be conducting pheno t y p i n g assay tests for, among others, B - l y m p h o c y t e s , K cells, T - l y m p h o c y t e s , T-helper c e l l s , T-cytotoxic c e l l s , and T - s u p pressor c e l l s . The purpose of these tests is to d etermine antigen levels, antibody levels, and the presence of a viral defenses and immune surveillance systems, and to identify various types of cells that m a y be indicators of a n d / o r precursors of malignancy. Not only wil l the tests determine the p r e sence of such f a c t o r s , but they will also include functional assays of each. 12492 LENNART HARDELL M.D. Dr. Hardell is employed by the University Hospital in its Department of Oncology in Umea, Sweden, where he specializes in internal medicine and oncology. His work includes diagnosis, treatment, and evaluation of possible causes of cancer, and education of medical students. Dr. Hardell will testify to several epidemiological studies which he and colleagues have conducted in Sweden. This research includes investigations concerning the relationship between the risk for different types of cancer and exposure to phenoxy herbicides and chlorophenols. The research has been published in the medical and scientific literature. These studies utilized the case-control study as the vehicle for investigation. Certain methodological aspects, such as selection of cases, selection of controls, assessment of exposure, and statistical methods, were considered; and then utilization was based upon thoroughly considered aspects of bias, all of which were well controlled. Specifically, these studies, four in number, involved soft tissue sarcomas, malignant lymphomas, and colon cancer. Highly statistically significant risks of soft tissue sarcomas and malignant lymphoma were found, whereas no association was found for colon cancer. In point of fact, the negative finding for colon cancer strongly supports the statistical significance of the increased risk demonstrated for soft tissue sarcomas and malignant lymphomas, i.e. a presumed causal relationship between exposure to phenoxy herbicides and human cancer particularly of soft tissue sarcoma and malignant lymphoma. Dr. Hardell has also seen in his clinical practice basal cell carcinoma of persons previously exposed to phenoxy herbicides, with no other known confounding variables. With respect to those cases with soft tissue sarcoma, malignant lymphoma, and basal cell carcinomas, Dr. Hardell will testify that the presumed exposure to Agent Orange caused, in significant part, such neoplastic processes. The bases for Dr. Hardell’s testimony as to various facts and opinion include: educational background; professional training and experience; review of the applicable medical and scientific literature; personal research; and a review of the pertinent medical data of the relevant representative plaintiffs. -2- 12434 MAUREEN C. HATCH, Ph.D. Dr. Hatch is Assistant Professor of Epidemiology at Columbia University, School of Public Health, in New York City. Her Curriculum Vitae will be supplied. The subject matter about which Dr. Hatch will testify is reproductive toxicology and its specific applicability to miscarriages and congenital malformations (birth defects) in the wives and children of Vietnam veterans. Dr. Hatch will testify at length to the data collected in Vietnam regarding untoward pregnancy outcomes. Dr. Hatch is one of two investigators who are to publish that portion of the International Symposium held in Ho Chi Minh City in January, 1983 having to do with reproductive toxicology as a result of exposure to Agent Orange and other phenoxy herbicide spraying in Vietnam. The results of these data demonstrate a statistically significant increase in certain congenital malformations, e.g. cleft palate, limb deformaties, and anencephaly, as a result of paternal mediated reproductive effects. The exposure of the fathers was to the spraying of Agent Orange in Vietnam. The mothers were not exposed. These human data are coupled with positive, consistent animal data. For example, such studies where males were exposed indicate the following; the male gonads, are a target site of 2,3,7,8-TCDD action; at the endocrinological level, there has been demonstrated a major effect, i.e., AHH receptor in male gonads; which very nicely provides a mechanistic linkage; and finally, abnormal biochemical and morphologic characteristics of the sperm have been likewise demonstrated. ALASTAIR W.M. HAY, Ph.D. Dr. Hay is a lecturer on Chemical Pathology, Department of Chemical Pathology, Old Medical School, University of Leeds, Leeds, England. His partial Curriculum Vitae is attached. Dr. Hay will testify to a broad spectrum of matters related to Agent Orange, phenoxy herbicides, and their contaminants, including dioxins, especially 2,3,7,8-TCDD. Dr. Hay will discuss in detail his knowledge of the various phenoxy herbicides and their contaminants, including but not limited to the various aspects of: chemistry; biochemistry; manufacture and/or production; fate in the environment, animals, and humans; modes of exposure, i.e. absorption, ingestion and inhalation, specifically by the veterans who served in Vietnam; toxicity; and the state of the medical and scientific literature at various times since at least 1957 forward. The medical and scientific literature, attendance and participation in various symposia, review of various documents of certain defendants, personal research, and experience form the bases of whatever facts and opinions to which Dr. Hay will testify. Dr. Hay's testimony regarding the medical and scientific literature will include an exposition of the definitions and explanations, and their applicability to the troops exposed in Vietnam, of the phenoxy herbicides and their contaminants, in the following areas: plant physiology; toxicology; neuro-toxicology, both neurological and psychological; epidemiology; immunology; mutagenicity; teratology; reproductive toxicology; and carcinogenicity. 12 m More specifically, the phenoxy herbicides, including Agent Orange, 2,4-D and 2,4,5-T, and their contaminants, including dioxins, especially TCDD are highly toxic, neuro-toxic, immuno-suppressive, teratogenic, potentially mutagenic, and certainly carcinogenic. As a carcinogen, e.g. TCDD, it has no safe level and indeed any single exposure may prove to result in human cancer many years later; said in another way, there is no "no effect" level that can be established. Dr. Hay will testify to examples of the grounds which support the above, including: knowledge of spraying Agent Orange, especially its effect on the Vietnamese countryside; the purpose and historical tracing of the animal studies; historical tracing of the human data, including the various industrial incidents since 1949; references to specific documents, such as the EPA Dioxin document (presently in Draft form); various cancer epidemiology; pertinent teratology epidemiology; various studies of the Vietnamese, especially in area of reproductive toxicology; and those reports of the symptoms and diagnoses of the U.S. Vietnam veterans. 12497 -2- Name: Alastair Watt Macintyre HAY D.O.B.: 21 April 1947 Marital Status: Married Children: 1 son Place of Birth: Glasgow, Nationality: British Degrees: B.Sc.(Hons), Ph.D., (Tom) Scotland Chemistry IIA - London 1969 Biochemistry, London 1973 Home Address: School House, Arthington Lane, Arthington, Leeds LS21 1PE England. Work Address: Department of Chemical Pathology, Old Medical School, University of Leeds, Leeds LS2 9NL England. Place of Secondary Education: Gifford Technical High School, Bulowayo, Zimbabwe (formerly Rhodesia) Present Appointment: University lecturer in Chemical Pathology since April 1979 (University of Leeds) Leeds, England. Former Appointments : Research Fellow - Zoological Soc September 1972 - November 1977 of London Research Fellow - University of Leeds, Department of Animal Physiology and Nutrition December 1977 - March 1979 PUBLICATIONS Books "(i.) Alastair Hay. The Chemical Scythe: Lessons of 2,4,5-T and Dioxin. Plenum Press. 265pp. August 1982 (ii) Sean Murphy, Alastair Hay and Steven Rose. No Fire: No Thunder. The threat of chemical and biological warfare. Pluto Press. (To be published in January 1984). 135pp. Scientific Papers Some 50 scientific papers including: (i) Hay, A.W.M., Mawer, E.B., Hassan, A.G., Crawford, M.A., & Stevens, P.A. The role of essential fatty acids in vitamin D dependent calcium absorption in the intestine. Proc. of 5th Vitamin D Workshop. Williamsburg USA now in Vitamin D, Chemical, Biochemical and Clinical Endocrinology of Calcium • 12498 2 Metabolism. Walter de Gruyter. Berlin. 1982 pp309-311. (ii) Hay, Alastair. Vitamin D: Sunlight and precursors. Nature. 2 9 7 , 364 (1982) (iii) Hay, A. Herbicides, Trichlorophenols and soft tissue sarcomas. Lancet I, 1240, (1982). (iv) Hay, A. It kills weeds, but what about people? Scientist. 94., No. 1314. ppl58-161 (1982). (v) Hay,A ., Murphy, S., Robinson, J.P., and S. Rose. The poison cloud hanging over Europe. New Scientist. 9_3, No. 1296 pp630 635 (1982) . (vi) Hay, Alastair. Nature, 294, (vii) Hay, A. Experimental Toxicology and cytogenetics: an overview. In "Herbicides and War" to be published by Stockholm International Peace Research Institute. (1984) A. Westing, Ed. (viii) Hay, A. The Mutagenic properties of 2,3,7,8-Tetrachlorodibenzo-p-dioxin in "Chlorinated Dioxins and Dibenzofurans in the Total Environment. Vol II" Edit, by Keith, L.H. et al to be published in 1984. New New Pathways for clorinated dioxins. 514-515 (1981). Other Publications I have written some 90 odd articles for the News, News and Views and books review section of the scientific journal Nature since 1976. 12499 Dr. Herbert Kaye, P h . D . , is a p s y c h ologist in the D e p a r t ­ m e n t of Psychology at the State University of N e w York at Stoneybrook, Long Island and a visiting Associate P r o f e s s o r in the D e ­ partment of Psychiatry at N e w York Un i v e r s i t y M e d i c a l Center. His curriculum vitae will be supplied. Dr. Kaye will testify concerning the significance of a battery of q u a n titative neurophysiological tests called neurometries will which be performed on the veteran, wif e and children plaintiffs. The procedures w e r e developed in part by Dr. Kaye in c o njunction wi t h medical a n d psychological researchers from this and other c o u n ­ tries. He will testify that neurometries, extensively, on wh i c h he has w r i t t e n is a sophisticated battery of electrical tests in use for about fifty years, which are highly e fficient in determing cortical EEG and evoked responses. Dr. Kay will explain the mo d e l used in the computeriza­ tion against w h i c h the test results are compared and will explain . how deviations from normal produce certain effects. Dr. Kaye w ill also discuss the m e c h a n i s m by which toxins produce these alt e r e d responses, and w hat effect those altered re­ sponses have u p o n the individual veterans at present, and the p r o g ­ nosis for any additional changes or d e t erioration in the future based upon an assumed bioaccumulation of the toxic m aterials in the system. In doing so, he will rely on his experience in diagnosing many Vie t n a m veter a n s exposed to Agent Orange. £ r. n 0 RONALD H. KERMAN, Ph.D. Dr. Kerman is Associate Professor, and Chief, Cellular Immunology, Clinical Immunology Laboratories, the University of Texas Medical School at Houston. His Curriculum Vitae is attached. Dr. Kerman will testify that 2,3,7,8-TCDD in particular causes, among others, immuno-suppressive effects, as reported in the literature regarding the various animal species studies. Specifically, TCDD has been demonstrated to suppress T-cell mediated immunity in such species. This effect likewise has been demonstrated in humans by Bekesi, specifically an alteration of mature T-cells. Dr. Kerman will testify that the special scientific discipline involved is immuno-toxicology which has been defined as "the undesirable effects of an inappropriate response of the immune system". The bases for the facts and opinions to which Dr. Kerman will testify include a review of the applicable medical and scientific literature, his educational and professional background, and his work in connection with the Texas Agent 0range Study. Dr. Kerman will discuss the following in his testimony: the immune system, with its organic, cellular, and humoral components - most especially with regard to the latter, T-helper cells, B-cells, plasma cells and immunoglobulin production; immune response, both beneficial and harmful; the various experimental studies, particularly those demonstrating atrophy of the thymus, weight loss, depletion of lymphoid organs, lymphopenia, cutaneous type delayed hypersensitivity (skin thickness) and altered bacterial immuni ty. 12501 Dr . Kerman will testify that on the basis of the above a person exposed to TCDD might have increased predisposition to increased infection and neoplasm (cancer). CURRICULUM VITAE Ronald H. K erm an, Ph.D . DATE OF BIRTH: June 10, 1943 PLACE OF BIRTH: Chicago, Illinois NATIONALITY: U.S. C itizen SEX: Male EDUCATION: 1965 1967 1969 U niversity of Illinois, B.S. (with Honors) U niversity of Illinois, M.S. University o f Illinois, Ph.D. in Immunology HONORS: 1965 1967-1969 1967 1969-1971 1970 Bachelor of Science with G eneral Honors in the College R ecipient of Public Health Service P red o cto ral Traineeship Phi Sigma N ational Biological Honorary R ecipient o f Public Health Service P ostdoctoral Traineeship Society of Sigma Xi RESEARCH AND PROFESSIONAL EXPERIENCE: 1983- 1981- 1977- 1977-1980 1974-1977 1973-1977 1972-1973 1969-1971 A ssociate Professor D epartm ent o f Pathology, and C hief, C ellular Im­ munology, Clinical Immunology L aboratories, The Uni­ versity of Texas Medical School a t Houston A ssociate Professor D epartm ent o f Surgery, and Head, H istocom patibility and Immune Evaluation L aboratories, Division of Organ Transplantation, The University o f Texas Medical School a t Houston Member, Program in Immunology, G raduate School o f Bio­ m edical Sciences, The U niversity of Texas H ealth Science C enter a t Houston A ssistant Professor D epartm ent of Surgery, and Head, H istocom patibility and Immune Evaluation Laboratories, Division o f Organ Transplantation, The University of Texas M edical School a t Houston A ssistant Professor D epartm ent of Surgery, Loyola U niversity S tritch School of M edicine, Maywood, Illinois R esearch Immunologist Chief, Immunobiology R esearch Laboratory, R esearch Service, V. A. Hospital, Hines, Illinois A ssistant Professor D epartm ent of Microbiology, Jefferso n M edical College Postdoctoral Fellow, (Immunology) Children's H ospital o f Philadelphia and The U niversity of Pennsylvania School of Medicine Curriculum Vitae Ronald H. Kerman, Ph.D. 2 PROFESSIONAL SOCIETIES: The RESEARCH INTERESTS: Immunologic response to allotransplantation and malignancy Evaluation of im m unocom petency T ransplantation Society (Editorial Board, T rans­ plantation and M ember, Symposium C om m ittee) A m erican A ssociation of Immunologists A m erican A ssociation for C ancer R esearch New York Academy of Sciences A m erican Society of Transplant Physicians (Member, and Vice C hairm an, S cien tific Studies C om m ittee) Society fo r E xperim ental Biology and Medicine Intern atio n al Society fo r H eart T ransplantation A m erican Association for the A dvancem ent of Science A m erican Society for H istocom patibility and Imm unogenetics (Chairm an, Finance and Audit C om m ittee, and M ember, Laboratory A ccreditation C om m ittee) RESEARCH SUPPORT: 1974-1978 1976-1979 1976- 1980 1977- 1978 19771977- 1983-1984 OTHER ACTIVITIES: C o-principal Investigator: Bronchogenic Carcinom a: Immu­ nologic P rofile, Radio and Im m unotherapy - V.A. M edical R esearch G rant No. MRIS-8121-08. $213,000 C o-principal Investigator: Im m unotherapy Adjuvant to R adiotherapy of Head and Neck C ancer - V.A. Medical R esearch G rant No. MRIS-8121-06. $73,814 C o-principal Investigator: F actors Influencing Immuno­ com pétence in Human Transplantation - V.A. Medical R esearch G rant No. MRIS-3068. $68,770 Principal Investigator: Functional and Surface R eceptor D ifferences of Human T-lym phocyte Subpopulations G eneral R esearch Support Funds, The U niversity of Texas Medical School a t Houston. $5,000 Principal Investigator: The Role of HLA Typing in R enal T ransplantation, ESRD Program , No. 450068. $377,400 (last year) Principal Investigator: Immune Monitoring for the Diagnosis of R enal A llograft R ejection, ESRD Program , No. 450068. $544,800 (last year) Principal Investigator: Immune Evaluation of V eterans Exposed to Agent Orange. Texas V eterans Agent Orange A ssistance Program , IAC(83-84)1266. $93,352 Special C onsultant in Immunology to the Epidemiology and D isease C ontrol Study Section, NIH C onsultant in Immunology and H istocom patibility T esting to the D epartm ent of Laboratory M edicine, M.D. Anderson H ospital and Tum or In stitu te E ditorial Board, T ransplantation Review of m anuscripts for the journal Human Immunology Review of m anuscripts for the journal T ransplantation Review of m anuscripts for the journal H eart T ransplantation Book review er for Journal of A m erican M edical A ssociation L ite ra tu re R eview er for The A m erican A ssociation of C linical H istocom patibility T esting — AACHTion News 12504 Curriculum Vitae Ronald H. Kerman, Ph.D. 3 G rant R eview er for the Kidney Foundation of Canada G rant R eview er in T ransplantation Immunology fo r T he March of Dimes - B irth D efects Foundation O utside Review er of R esearch Proposals in Immunology fo r th e R esearch and D evelopm ent C om m ittee, The V et­ erans A dm inistration R esearch Service Invited P articip a n t (as a testin g laboratory) in The Third A m erican HLA Workshop Invited P a rticip an t (as a testin g laboratory) in The Eighth In tern atio n al H istocom patibility Workshop "R elevance of DR typing to renal allo g ra ft survival" Invited P articip a n t (as a testin g laboratory) in The In te r­ national Transfusion and T ransplantation Workshop Invited P a rticip a n t (as a te stin g laboratory) for the N inth In tern atio n al H istocom patibility Workshop Invited P rese n ter a t an NIH Workshop, "The B iological R elevance of Imm une Suppression as Induced by G enetic, T herapeutic and Environm ental Factors" Invited P a rticip a n t (as a testin g laboratory) in the In te r­ national C ollaborative T ransplant Study Laboratory Inspector for C linical Laboratory A ccreditation in H istocom patibility for The A m erican Society fo r His­ tocom patibility and Im m unogenetics and The C ollege of A m erican Pathologists C hairm an, Finance and Audit C om m ittee for The A m erican Society for H istocom patibility and Im m unogenetics Member, Symposium and A ffiliations C om m ittee, T he T ransplantation Society Member and V ice-C hairm an, S cien tific Studies C o m m ittee, A m erican Society of T ransplant Physicians M ember, Acquired Imm une D eficiency Syndrome (AIDS) Working Group for th e Houston Area C hairm an, Organizing C o m m ittee and H ost for The F ourth In tern atio n al Imm une M onitoring Symposium: Im ­ munological Evaluation and M onitoring of the T ransplant R ecipient (1983) M ember, Organizing C o m m ittee for the Intern atio n al Sym­ posium on R elev an t Im m unological F acto rs in C linical Kidney T ransplantation, H eidelberg, West Germ any, 1985 Member, UTM3H Admissions Interview C om m ittee' Member, UTMSH Admissions C om m ittee Member, M edical Review Board, Organ T ran sp lan tatio n C en ter, UTMSH Member, C om m ittee on S ubject Selection for The U niversity of Texas System Agent Orange Study Member, S teering C o m m ittee, Program in Immunology, UT-GS3S Chairm an, By-Law s C o m m ittee, Program in Immunology, UT-GSBS Course D irector, "M ethods in C ellular Immunology," a P ro­ gram in Immunology C ourse, UT-GSBS 12505 BIBLIOGRAPHY R onald H . Kerm an, P h.D . P u b lication s 1. Kerman, R ., Segre, D. and Myers, W.L.: A ltered response to pneum ococcal polysaccharide in offspring of immunologically paralyzed mice. Science 156:1514, 1967. 2. Kerman, R., Segre, D. and Myers, W.L.: The role of immune and n atu ral specific antibodies in immunologic paralysis and immunity of mice to pneum ococcal polysac­ charide Type m . J . Immunol. 104:655, 1970. 3. Kerman, R. and Segre, D.: A nti-pneum ococcal polysaccharide Type EH hem olytic plaques in mice: C ellular response in immunity and immunologic paralysis. J. Immunol. 104:1262, 1970. 4. Kerman, R. and H arris, T.N.: R esistance to denaturation by periodate of a dialyzable histocom patibility antigen. Proc. Soc. Exp. Biol. Med. 141^:179-183, 1972. 5. Kerman, R.H., H arris, T.N. and H arris, S.: P rep aratio n of a dialyzable histocom pati­ bility antigen from balb/c mice. Proc. N atl. Acad. Sci. 6^:223-227, 1972. 6. Sm ith, R.A., Kerman, R ., Ezdinli, E. and Stefani, S.: A modified assay for th e detection of human adult activ e ro se tte forming cells. J . Immunol. Meth. 8:175-184, 1975. 7. Kerman, R. and Stefani, S.: Immunological evaluation of p atien ts with solid tum ors before and a fte r radiotherapy. In Crispen, R.G. (ed.): Neoplasm Immunity: Mecha­ nisms, pp. 109-120. U niversity of Illinois Press, 1976. 8. S tefani, S., Kerman, R. and A bbate, J .: Immune evaluation of lung cancer p a tien ts undergoing radiation therapy. C ancer 37:2792-2796, 1976. 9. Stefani, S., Kerman, R. and A bbate, J.: Serial studies of im m unocom petence of patien ts undergoing radiotherapy for malignancies of the head and neck. Am. J. Roentgenol. 126:880-886, 1976. 10. Kerman, R.H. and Geis, W.P.: T otal and activ e T -cell kinetics in renal allo g raft recipients. Surgery 79:398-407, 1976. U. Kerman, R., Sm ith, R., S tefan i, S. and Ezdinli, E.: A ctive T -ro se tte form ing cells in the peripheral blood of cancer p atien ts. C ancer Res. 36:3274-3278, 1976. 12. Kerman, R., Smith, R., Ezdinli, E. and S tefani, S.: U nification and technical aspects of to ta l T, active T and B lym phocyte ro se tte assays. Immunol. Comm. 5(7-8):685694,1976. 13. Dodson, M.G., Kerman, R.H ., Lange, C .F., S tefan i, S. and O'Leary, J.A .: cells in pregnancy. O bstet. Gynecol. 49:299-302, 1977. T and B 12506 Bibliography Ronald H. Kerman, Ph.D. 14. 15. 2 Kerman, R.H. and S téfani, S.: PHA stim ulation of lym phocytes from p atien ts with lung cancer. Oncology 34:10-12, 1977. Kerman, R.H. and Stefani, S.: Radio and im m unotherapy of lung cancer: A 11 m m n n t T r*r T> Ä J \_ X T - ___ 1 » _ . Tw+ ___ _ r e p o r i. ill v^nspen, K .U . iN 80pi5LSni i iiim U n ii.y ~ o O ilu lU H iO r r>\ r» /*\ pp. 29-35. Franklin In stitu te Press, 1977. 16. Stefani, S. and Kerman, R.H.: Lym phocyte response to PHA before and a fte r radiation therapy in p atients with carcinom as of the head and neck. J . Laryngol. O tol. 91:605-609, 1977. 17. Kerman, R.H., Ing, T.S., Hano, J.E . and Geis, W.P.: Prognostic significance of th e activ e T-RFC in renal allograft survival. Surgery 82:607-612, 1977. 18. M arshack, M., Toto, P. and Kerman, R.H.: Delayed hypersensitivity in the h am ster cheek pouch. J . Immunol. Meth. 15:325-330, 1977. 19. M arshack, M., Toto, P. and Kerman, R.H.: Im m unotherapy of chem ically-induced tum ors in the ham ster cheek pouch with dinitrochlorobenezene. J . D ental Res. 57:625-630, 1978. 20. Stefani, S. and Kerman, R.: Prognostic significance of pre-therapy delayed hypersen­ sitivity and T -cell levels in p atien ts with lung cancer. In Nieburgs, H.E. (ed.): Proceedings of the Third International Symposium on the D etection and Prevention of C ancer, Vol. 1, P a rt II, pp. 785-797. M arcel Dekker, Inc., 1978. 21 . Geis, W.P., Iw atsuki, S., Molnar, Z., Giacchino, J.L ., Kerman, R.H., Ing, T.S. and Hano, J.E .: Im m unoblastic pseudo-lymphoma in renal allo g raft recipients. Arch. Surg. 113:461-466, 1978. 22 . Dodson, M., K legerm an, M., Kerman, R.H., Lange, C., Tessier, J . and O 'Leary, J.: B echet syndrome: With immunologic evaluation. O bstet. Gynecol. 5D.621-625, 1978. 23. Dodson, M.G., K legerm an, M.E., Menon, M., K erm an, R.H., Lange, C .F. and O 'Leary, J.A .: E stablishm ent and c h aracterizatio n of a squamous cell carcinom a of th e vulva in tissue culture and immunological evaluation of the host. Am. J. O bstet. Gynecol. 131:606-619, 1978. 24. Kerman, R.H. and Geis, W.P.: T-RFC m onitoring of CMI events in renal allo g ra ft recipients. Transpl. Proc. 10(3):633-635, 1978. 25. Kerman, R.H., Ing, T.S., Hano, J.E . and Geis, W.P.: P redictive value of activ e T-RFC in renal allograft survival. Transpl. Proc. JJD(3):637—638, 1978. 26. Kerman, R.H. and Stefani, S.S.: E ffe c t of BCG im m unotherapy on the activ e T and to ta l T-RFC in p atien ts with lung cancer. C ancer Immunol. Im m unother. 4:41-47, 1978. 27. Kahan, B.D., Kerman, R.H. and McConnell, R.: Com bination of immunological and radionuclide techniques to diagnose allo g raft rejectio n . Surgical Forum . 29:364-366, 1978. 12507 Bibliography Ronald H. Kerman, Ph.D. 3 28. S téfani, S. and Kerman, R.H.: Prognostic value of th e immunologic profile in inoperable lung cancer p atien ts tre a te d by radiation. In Muggia, F. and R ozencw eig, M. (eds.): Lung C ancer (Progess in C ancer R esearch and Therapy), Vol. 11, pp. 465470. Raven Press, Inc., New York, 1979. 29. K erm an, R.H.; Identification of human T and B lym phocytes. In N atelson, S., Pesce, A .J. and D ietz, A.A.: C linical Im m unochem istry: C hem ical and C ellular Bases and A pplications in D isease, pp. 12-20. A m erican A ssociation for C linical C hem istry, 1979. 30. Kahan, B.D., Floyd, M., Oka, T ., Van Buren, C.T. and Kerman, R.H.: Im m unological techniques in clinical renal tran sp lan tatio n . I. Cross-M atch Methods, Jap . J . T rans­ p lant. 14:1-13, 1979. 31. Kahan, B.D., Floyd, M., Oka, T., Van Buren, C.T. and Kerman, R.H.: Imm unological techniques in clinical renal tran sp lan tatio n . II. Imm unological M onitoring P o st­ allografting. Jap . J . T ransplant. 14:14-25, 1979. 32. K erm an, R.H., Floyd, M., Conner, W., M cConnell, R., McConnell, B .J., Van Buren, C.T. and Kahan, B.D.: Combined im m unological and radionuclide techniques to m onitor ren al a llo g raft rejectio n . Transpi. Proc. JL1:1229-1231, 1979. 33. G eis, W.P., Giacchino, J.L ., Buckingham, J.M ., Bansal, V.K., Iwatsuki, S., Kerman, R.H ., Ing, T.S. and Hano, J.E .: Does suppression of T-RFC determ ine in vivo immunosuppressive e ffe c t of ATG? Transpl. Proc. 1_1:1433-1434, 1979. 34. Kerman, R.H., Floyd, M., Van Buren, C.T. and Kahan, B.D.: Improved a llo g raft survival of strong immune responder-high risk recip ien ts with adjuvant ATG therapy. T ransplantation 30:450-454, 1980. 35. Kerman, R. and Kahan, B.D.: C linical histocom patibility testin g in renal tran sp lan ta­ tion: P o te n tia l keys to alloimmune sp ecificity and re a ctiv ity . In R eisfeld, R. and F errone, S. (eds.): C urrent Trends in H istocom patibility, Vol. 2, pp. 201-226. Plenum Press, 1981. 36. K erm an, R.H. and Kahan, B.D.: A ssessm ent of immune p aram eters of tran sp lan t recip ien ts on immunosuppressive therapy. In Dean, J . and Padarathsingh, M. (eds.): Biological R elevance of Immune Suppression as Induced by G enetic T herapeutic and Environm ental F a c to rs, pp. 82-97. Van N ostrand Reinhold Co., New York, 1981. 37. Kerman, R.H ., Floyd, M., Van Buren, C.T. and Kahan, B.D.: Prolonged a llo g raft survival of strong p retran sp lan t immune responders tre a te d with ATG. Transpl. f r o c . 13:332-335, 1981. 38. Kerman, R.H ., Floyd, M., Van Buren, C.T. and Kahan, B.D.: C orrelation of non­ specific immune monitoring with rejectio n or im paired function of renal allo g rafts. T ransplantation 32:16-23, 1981. 39. K erm an, R.H ., Floyd, M., Van Buren, C.T., and Kahan, B.D.: Prediction of cadaveric a llo g raft survival based on p retran sp lan t nonspecific im m unocom pétence. Transpl. Proc. 13:1533-1535, 1981. 12508 Bibliography Ronald H. Kerman, Ph.D. 4 40. Kerman, R.H., Floyd, M., Van Buren, C.T. and Kahan, B.D.: Serial m easurem ent of nonspecific immune param eters of chronically hemodialyzed renal failure p a tie n ts. J . Clin. Immunol. 1:163-168, 1981. 41. Kerman, R.H.: New developm ents in transplantation immunology. Bulletin 33(6):281-286, 1981. 42. Kerman, R.H.: E ffe ct of blood transfusion on renal allo g raft survival: Imm unological considerations. Am. J. Kidney Diseases 2:125-127, 1981. 43. Kerman, R.H. and Kahan, B.D.: Imm unological evaluation of transplant rejectio n : P re and postoperative indices d etectin g immune responsiveness. In Hayry, P. (ed.): P resen t and Future Trends in Clinical Transplantation. Ann. Clin. Res. 13:244-263, 1981. 44. Kerman, R.H., Van Buren, C., Payne, W., Flechner, S., Agostino, G., Conley, S., Brew er, E. and Kahan, B.D.: Influence of blood transfusions on immune responsive­ ness. Transpi. Proc. 14:335-337, 1982. 45. Kahan, B.D., Van Buren, C.T., Lin, S.N., Ono, Y., Agostino, G., LeGrue, S., Boileau, M., Payne, W. and Kerman, R.H.: Immunopharmacologic monitoring of Cyclo­ sporin A -trea te d recipients of cadaveric kidney allo g rafts. Transplantation 34:36-45, 1982. 46. Ono, Y., Kerman, R.H. and Kahan, B.D.: N atural cell-m ediated cy to to x icity and suppressor activ ity for n atu ral cell-m ediated cytotoxicity in long-term renal tra n s­ plant p atien ts. T ransplantation 34:103-107, 1982. 47. Van Buren, C.T., Kerman, R.H., Agostino, G., Payne, W., Flechner, S. and Kahan, B.D.: The cellular ta rg e t of Cyclosporin A action in man. Surgery 92:167-174, 1982. 48. Kahan, B.D., Kerman, R.H., Agostino, G., Friedm an, A. and LeGrue, S.J.: The action of Cyclosporin A on human lym phocytes. In White, D.J.G. (ed.): Cyclosporin A, pp. 281-293. Elsevier - Biomedical Press, A m sterdam , 1982. 49. Agostino, G .J., Kahan, B.D. and Kerman, R.H.: Suppression of mixed leu co cy te culture using leucocytes from norm al individuals, urem ic individuals and allo g ra ft recipients. T ransplantation 34:367-371, 1982. 50. Kerman, R.H., Conklin, R., Cahall, D., Van Buren, C.T. and Kahan, B.D.: CMV and renal allo g raft survival. In Eisenstein, T. and Friedm an, H. (eds.): Host D efenses to Intracellular Pathogens, pp. 517-519. Plenum Press, Inc., New York, 1983. 51. E ttenger, R.B., Kerman, R., Jordan, S.C., Warshaw, B.L., Harris, R. and Fine, R.: Sensitization following donor-specific transfusions for living re la ted renal transplan­ tation. Transpl. Proc. 15:943-945, 1983. 52. Van Buren, C.T., Kerman, R.H., Agostino, G., Flechner, S., Payne, W., and Kahan, B.D.: E ffect of cyclosporine on im m unoregulatory cells of renal allo g raft recip ien ts. Transpl. Proc. 15:527-530, 1983. 1 1 IC L - Ü 1 IU C L 12509 Bibliography Ronald H. Kerman, Ph.D. 5 53. Kerman, R.H., Van Buren, C.T., Payne, W., Flechner, S. and Kahan, B.D.: Monitoring T cell subsets and immune events in renal a llo g raft recipients. Transpl. P roc. 15:1170-1172, 1983. 54. Flechner, S., Kerman, R ., Van Buren, C.T., Payne, W., and Kahan, B.D.: The use of cyclosporine and prednisone fo r high MLC haploidentical living related renal tran s­ plants. Transpl. P roc. 15:442-445, 1983. 55. Agostino, G., Kahan, B.D. and K erm an, R.: D etection of nonspecific suppressor cells from normal individuals, urem ic p atien ts and allo g raft recipients. Transpl. Proc. 15:724-728, 1983. 56. Kerman, R.H., Agostino, G., Van Buren, C.T., Payne, W., Flechner, S., Conley, S., B rew er, S. and Kahan, B.D.: E ffe c t of blood transfusions on g ra ft survival and immune responsiveness. Transpl. P roc. 15:1022-1025, 1983. 57. K erm an, R.H., Van Buren, C., Payne, W., Flechner, S., Agostino, G., Conley, S., B rew er, 8. and Kahan, B.D.: The influence of p retran sp lan t blood transfusions from random donors on immune p aram eters affectin g cadaveric allograft survival. Trans­ plantation 36:50-54, 1983. 58. K erm an, R.H., F lechner, S., Van Buren, C.T., Payne, W., and Kahan, B.D.: Cyclo­ sporine improves allograft survival in im m unologically high-risk renal allograft recipients. Transpl. P roc. 15:1909-1911, 1983. 59. K erm an, R.H., Van Buren, C .T., Payne, W., F lechner, S., and Kahan, B.D.: Immune m onitoring of renal a llo g raft recipients tre a te d with cyclosporine or azathioprine using donor-specific and nonspecific assays as well as monoclonal T cell reagents. Transpl. Proc. 15:1971-1973, 1983. 60. Kerman, R.H., Payne, W., Van Buren, C.T., Flechner, S., and Kahan, B.D.: D etection of host presensitization to donor alloantigens utilizing a comprehensive immune crossm atch. Transpl. P roc. 15:1815-1816, 1983. 61. Flechner, S.M., Payne, W.D., Van Buren, C., K erm an, R., and Kahan, B.D.: The e ffe c t of cyclosporine on early g ra ft function. T ransplantation 36:268-272, 1983. 62. V erani, R .R., B ergm an, D., and Kerman, R.H.: G lom erulopathy in acu te and chronic rejection: U ltra stru c tu ra l ch arac te ristic s and relationship to g ra ft survival. Am. J . N ephrol. 3:253-256, 1983. 631. K erm an, R.H.: E ditorial: Influence of HLA A, B and DR antigen m atching in transfused cadaver renal tran sp lan t p atien ts. Cleveland Clinic Q uarterly 50:216-217, 1983. 64. K erm an, R.H., Flechner, S., Van Buren, C.T., Payne, W. and Kahan, B.D.: Immuno­ logical monitoring of renal a llo g raft recipients tre a te d with cyclosporine. Transpl. P roc. 16:2302-2305, 1983. 12510 Bibliography Ronald H. Kerman, Ph.D. 6 65. Van Buren, C., K erm an, R., Agostino, G., Flechner, S., Payne, W.D., and Kahan, B.: E ffe c t of cyclosporine on im m unoregulatory cells of renal allo g raft recipients. Transpi. Proc. 16:2293-2297, 1983. 66. Kahan. B.D.. Van Buren. C.. Flechner. S._ Pavne. W.D.. and Kerman. R.: Cvcloannrinp immunosuppression m itigates immunologic risk fa c to rs in renal allotransplantation. Transpl. Proc. 16:2469-2478, 1983. 67. Flechner, S.M., Van Buren, C., Kerman, R.H., and Kahan, B.D.: The nephrotoxicity of cyclosporine in renal transplan tatio n . Transpl. Proc. 16:2689-2694, 1983. 68. Flechner, S.M., Van Buren, C.T., Kerman, R., and Kahan, B.D.: The e ffe c t of conversion from cyclosporine to azathioprine immunosuppression for in trac ta b le nephrotoxicity. Transpl. Proc., 1983 (In press). 69. Flechner, S.M., Kerman, R.H., Van Buren, C., and Kahan, B.D.: Successful tra n s­ plantation of cyclosporine tre a te d haploidentical living re la ted renal recipients w ithout blood transfusions. T ransplantation, 1984 (In press). 70. Kerman, R.H., Van Buren, C.T., Flechner, S.M., and Kahan, B.D.: C orrelation of visual, 5 1 c r-re le a se , and flow cy tom etry crossm atch results to g ra ft survival. Transpl. Proc., 1984 (In press). 71. Rogers, A .J., Kerman, R.H., and Kahan, B.D.: The pharm acokinetic and immunobiological activ ity of cyclosporine in man. Transpl. Proc., 1984 (In press). 72. Van Buren, C.T., Flechner, S.M., Kerman, R.H., Vaughn, W., and Kahan, B.D.: Cyclosporine improves outcom e in high risk cadaveric renal allograft recipients. Transpl. Proc. 1984 (In press). 73. Kerman, R.H., M anner, C., Ford, K., and Hoots, K.: Com prehensive immune evaluation of 78 hem ophiliacs. Ann. N. Y. Acad. Sc. 1984 (In press). Bibliography Ronald H. Kerman, Ph.D. 7 A b stra cts and P r e se n ta tio n s 1. Kerman, R ., C lark, J . and Wheelock, E.F.: M ononuclear in filtra te into an air pouch: A new in vitro cell m ediated immune assay. Fed, Proc, 32:973, A tlantic C ity, New Jersey , April 1973. 2. Wheelock, E .F ., K erm an, R.H ., C lark, J . and Toy, S.: Cell m ediated im m unity in dorm ant friend virus infections. Proc. Am. Assoc. C ancer Res. JL4:68, A tlan tic C ity, New Jerse y , April 1973. 3. S tefani, S., K erm an, R. and A bbate, J.: S erial studies of im m unocom petence in head and neck cancer p a tie n ts undergoing radiotherapy. A bstract, A m erican Radium Society M eeting, San Juan, P u erto Rico, May 1975. 4. Kerman, R ., S tefan i, S. and Geis, W.P.: T o tal and activ e T -cell dynamics in renal allograft recip ien ts. A bstracts of the A m erican Society T ransplant Surgeons, Chicago, Illinois, May 1976. 5. Kerman, R., S tefan i, S., Sm ith, R., Ezdinli, E. and. Geis, W.P.: Im m unological evaluation of p a tie n ts with solid tum ors and hem atological m alignancies. P resen ted a t the 1975 C ancer Symposium, Neoplasm Imm unity: Mechanism, Chicago, Illinois, Septem ber 1975. 6. S tefani, S., K erm an, R. and A bbate, J.: Im m unological evaluation of p a tie n ts with bronchogenic carcinom a. P resen ted at the A m erican Society of T herapeutic Radi­ ology, San Francisco, C alifornia, O ctober 1975. 7. S tefani, S. and K erm an, R.: D eterm ination and prognostic value of immunocompe­ ten ce in p a tie n ts with lung cancer tre a te d by radiotherapy. A bstracts of th e Third In ternational Symposium on D etection and P revention of C ancer, New York, April 1976. 8. Geis, W.P., Vaz, A.L. and Kerman, R.H.: Steroid sparing e ffe c t of ATG in high risk renal allo g raft survival. P resented a t th e A m erican Society of T ransplant Surgeons M eeting, Chicago, Illinois, May 1976. 9. Kerman, R .H ., and Geis, W.P.: Prognostic significance of the activ e T -cell in renal allograft survival. P resented a t th e A m erican Society T ransplant Surgeons M eeting, Chicago, Illinois, May 1976. 10. S tefani, S. and K erm an, R.: BCG and radiotherapy, in bronchogenic carcinom a: Prelim inary re p o rt. P resented a t the A m erican Society of T h erap eu tic Radiology, ..Atlanta, G eorgia, O ctober 1976. 11. K erm an, R. and Geis, W.P.: T-RFC m onitoring of CMI events in renal a llo g raft recipients. P resen ted a t the Sixth In tern atio n al Congress of th e T ransplantation Society Special Session Imm unological M onitoring of T ransplant R ecipient, New York, August 1976. 12. Kerman, R. and S tefan i, S.: Radio and im m unotherapy of lung cancer: A prelim inary re p o rt. P resen ted a t the 1977 Chicago Symposium: Im m unotherapy of Solid Tum ors, Chicago Illinois, F ebruary 24-25, 1977. 12512 Bibliography Ronald H. Kerman, Ph.D. 8 13. S tefani, S. and Kerman, R.H.: R elevance of immunologic analysis for p atien ts with inoperable lung cancer tre a te d by radiotherapy. P resen ted a t an NCI sponsored Symposium "The Second C onference on Lung C ancer T reatm en t," a t Airlie House, Virginia, May 22-24, 1977. 14. Kerman, R.H ., Ing, T.S., Hano, J.E . and Geis, W.P.: Prognostic significance of activ e T -R F C in renal allograft survival. A b stracts of F irst In tern atio n al Symposium on Im m unological Monitoring of th e T ransplant R ecip ien t. London, O ntario, June 8-10, 1977. 15. Kerman, R.H. and Geis, W.P.: T -R F C m onitoring of CMI events in renal allo g raft recipients. A bstracts of F irst In tern atio n al Symposium on Imm unological M onitoring of the Transplant R ecipient. London, O ntario, Ju n e 8-10, 1977. 16. Ezdinli, E., Simonson, K., Icli, F . and Kerman, R.: E ffe cts of single vs. m ultiple agent therapy on cell-m ediated im m unity. P roc. A m er. Assoc. Clin. Oncol. 18:355, D enver, Colorado, May 1977. 17. Geis, W.P., Iwatsuki, S., Molnar, Z., G iacchino, J.L ., Kerman, R .H ., Ing, T.S. and Hano, J.E .: Im m unoblastic pseudo-lymphoma in renal a llo g raft recip ien ts. P resen ted a t the W estern Surgical A ssociation, Las Vegas, N evada, November 15, 1977. 18. Kerman, R .H ., R oesler, H. and Kahan, B.D.: Specific stim ulation of activ e T -R o se tte form ing cells by 3M KC1 solubilized antigen. Fed. P ro c., 1978. Presented a t the FASEB-AAI M eeting, A tlanta, G eorgia, June 1978. 19. Kerman, R.H., Floyd, M., C onner, W., McConnell, B .J., McConnell, R. and Kahan, B . D.: C orrelation of activ e T -R F C and spontaneous blastogenesis with decreased renal allo g raft function. A b stracts of the A m erican Association for C linical H istocom patibility Testing, B oston, M assachusetts, June 1978. 20. Kerman, R.H ., R oesler, H. and Kahan, B.D.: Increased activ e T-RFC with in vitro stim ulation by soluble donor antigen. A b stracts of the Amer. Assoc, of Clin. Histocom p.. T esting, Boston, M assachusetts, Ju n e 1978. 21. K erm an, R.H ., Floyd, M., C onner, W., McConnell, R ., McConnell, B .J., Van Buren, C. T . and Kahan, B.D.: Combined immunological and radionuclide techniques to m onitor renal allo g raft rejection. P resen ted a t th e VII In tern atio n al Congress of The T ransplantation Society, Rome, Italy , Septem ber 1978. 22. Kerman, R.H.: Invited speaker to a special workshop "Immunological M onitoring of the T ransplant P atients", VII In tern atio n al Congress of The T ransplantation Society, ■ _Rome, Italy , Septem ber 1978. 23. Kahan, B.D., Kerman, R. and McConnell, R.: Com bination of immunological and radionuclide techniques diagnoses allo g raft rejectio n . P resen ted a t the A m erican College of Surgeons, San F rancisco, C alifornia, O ctober 1978. 24. Michelson, J ., McConell, Kerman, R. and Kahan, B.: Association of acu te rejection episodes in renal transplant p a tien ts with scored results of com puter analyzed data. P resented a t th e Southw est S ociety of N uclear M edicine M eeting, March 16, 1979, San Antonio, Texas. ■ 12513 Bibliography Ronald H. Kerman, Ph.D. 9 25. Kerman, R.H., M acek, C. and Kahan, B.D.: Increase in 3 d ifferen t E -ro se tte m arkers on human T cells following PHA activ atio n . Fed. Proc. 38 (No. 3, P a rt n):1282. P resented a t the Annual M eeting of The Am erican A ssociation of Im m unologists, D allas, Texas, April 1979. 26. Kerman, R.H.: Immunological considerations in renal tran sp lan tatio n . C linical Oncology Grand Rounds, M.D. Anderson H ospital and Tumor In stitu te , S eptem ber 1979. 27. Kerman, R.H. and Kahan, B.D.: A ssessm ent of immune p aram eters of tran sp lan t recipients on immunosuppressive therapy. P resented a t an NIH Workshop on "The Biological R elevance of Immune Suppression as Induced by G enetic T herapy and Environm ental F actors," W illiamsburg, Virginia, November 1979. 28. Invited p articipant in a working cadre for the NIH to develop a "Consensus On Immunotoxicology" for the N ational Toxicology Program , N ovem ber 1979, R esearch Triangle Park, N.C., NIEHS, NIH. 29. Kerman, R.H.: H istocom patibility testin g in transplantation. Rounds, S t. Luke's Hospital, Jan u ary 1980. 30. Van Buren, C.T., Kerman, R.H. V anB uren, D. and Kahan, B.D.: C orrelation of immune responsiveness with n u tritio n al indices in chronic ren al failu re p a tie n ts. P resented a t the American Society for P a re n te ra l and E n teral N utrition, Annual M eeting, Chicago, Illinois, Jan u ary - February 1980. 31. Kerman, R.H.: Immune m onitoring of renal allo g raft recip ien ts. Rounds, U niversity of Miami School of Medicine, March 1980. 32. Kerman, R.H.: P re - and postoperative immune monitoring of allo g raft recip ien ts. M edical Grand Rounds, Division of Dialysis and T ransplantation, C hildren's H ospital of Los Angeles, April 1980. 33. Kerman, R.H. and Semchuk, R.: D elineation of a rad io resistan t T cell subpopulation. Fed. Proc. 39(3):945. P resented a t th e Annual M eeting of The A m erican A ssociation of Imm unologists, Anaheim, C alifornia, April 1980. 34. Kerman, R.H.: E ffe c t of heat on the ability of human T cells to express the activ e T and to ta l T receptors. Fed. P roc. 39(3):1137. P resented a t the Annual M eeting of The A m erican Association of Im m unologists, April 1980, Anaheim, C alifornia. 3-5. K erm an, R ., Peddada, L. and Kahan, B.D.: C orrelation of hyperacute rejection with .LDA and CDA vs. 51C r-labeled donor T and B cell ta rg e ts. P resen ted a t The A m erican Association for C linical H istocom patibility T esting, S t. Louis, Missouri, April 1980. 36. K erm an, R ., Floyd, M., Van Buren, C.T. and Kahan, B.D.: Improved allo g raft survival of strong responder-high risk cadaver recipients with adjuvant immunosuppressive therapy. P resented a t the Annual M eeting of The A m erican A ssociation for C linical H istocom patibility Testing, April 1980. Pathology Grand Surgical Grand 12514 Bibliography Ronald H. Kerman, Ph.D. 10 37. Kerman, R., Conklin, R., C ahall, D. and Kahan, B.D.: Association of cytom egalovirus and renal allograft survival. P resen ted a t the m eeting of the A m erican A ssociation for C linical H istocom patibility T esting, S t. Louis, Missouri, April 1980. 38. Kerman, R., Floyd, M., Van Buren, C.T. and Kahan, B.D.: D elineation of donor specific and nonspecific p retran sp lan t im m unocom pétence as a p red icto r for LRD allo g raft survival. P resen ted a t th e M eeting of The A m erican Association of C linical H istocom patibility T esting, S t. Louis, Missouri, April 1980. 39. Kerman, R.H., Floyd, M., Van Buren, C.T. and Kahan, B.D.: Improved allo g raft survival of strong immune responder-high risk recipients with adjuvant immuno­ suppressive therapy. P resen ted a t the annual m eeting of The A m erican Society of T ransplant Surgeons, C hicago, Illinois, May 1980. 40. Kerman, R.H., Floyd, M., Van Buren, C.T. and Kahan, B.D.: C orrelation of nonspecific immune m onitoring of renal allograft recipients with rejectio n and im paired renal function. P resen ted a t th e Annual M eeting of The A m erican Society of Transplant Surgeons, Chicago, Illinois, May 1980. 41. Kerman, R ., Floyd, M., Van Buren, C.T. and Kahan, B.D.: Prolonged allo g raft survival of strong p retran sp lan t immune responders tre a te d with ATG. P resen ted a t the VUIth International Congress of The T ransplantation Society, Boston, M assachu­ s e tts, June 1980. 42. Kerman, R., Floyd, M., Van Buren, C.T. and Kahan, B.D.: P rediction of renal allograft survival based on p retran sp lan t non-specific im m unocom pétence. P resented a t The Second Internatio n al Symposium on Immunological Monitoring of the Trans­ plant R ecipient, Leiden, The N etherlands, Septem ber 1980. 43. Kerman, R.H., Floyd, M., Van Buren, C.T., McConnell, B .J., McConnell, R. and Kahan, B.D.: D elineation of renal a llo g raft rejection and im paired renal function by serial m easurem ent of non-specific immune param eters. P resented a t The Second International Symposium on Imm unological Monitoring of th e T ransplant R ecipient, Leiden, The N etherlands, S eptem ber 1980. 44. Kerman, R.H. and Kahan, B.D.: Increased expression of the activ e T-RFC re c ep to r as a m easure of allosensitization following in v itro stim ulation of recip ien t lympho­ cytes by soluble donor HLA antigens.- P resen ted a t The Second International Symposium on Imm unological M onitoring of the Transplant R ecipient, Leiden, The N etherlands, S eptem ber 1980. 45. Kerman, R.H., Floyd, M., Van Buren, C.T. and Kahan, B.D.: C orrelation of HLA A,B •. and DR typing to cadaveric and living related renal allo g raft survival. P resented at The Second International Symposium on Imm unological M onitoring of th e Transplant. R ecipient, Leiden, The N etherlands, S eptem ber 1980. 46. Floyd, M., Kerman, R., Woo, J ., Van Buren, C.T. and Kahan, B.D.: R elationships of beta-2-m icroglobulin m etabolism , immune re a ctiv ity and renal allo g raft rejection. P resented a t The Second In tern atio n al Symposium on Imm unological M onitoring of the T ransplant R ecipient, Leiden, T he N etherlands, Septem ber 1980. •4'n b? i Bibliography Ronald H. Kerman, Ph.D. 1 47. Kerman, R.H.: Immune m onitoring of renal allo g raft recip ien ts. Rounds, U niversity of Chicago, Ju n e 1981. Surgical Grand 48. Kerman, R .H ., Van Buren, C.T., LeGrue, S .J. and Kahan, B.D.: Im m unopharm acological m onitoring of cadaveric renal allo g raft recip ien ts receiving Cyclosporin A. P resented a t the Annual M eeting of the American S ociety of Transplant Surgeons, Chicago, Illinois, June 1981. 49. Kerman, R .H ., Conklin, R., C ahall, D., Van Buren, C .T. and Kahan, B.D.: CMV and renal allo g raft rejectio n . P resen ted a t a Symposium on H ost D efenses to In tra ­ cellular Pathogens, Franklin P laza H otel, Philadelphia, Pennsylvania, Ju n e 1981. 50. Schoenberg, L .P ., Kahan, B.D. and Kerman, R.H.: The use of Cyclosporin A as immunosuppressive m edication in renal tran sp lan tatio n . P resen ted a t The N ational Kidney Foundation, Inc., W ashington, D.C., N ovem ber 1981. Amer. J . Kidney Diseases, Program for C linical Dialysis and T ransplantation Forum , p. 29. 51. E tten g er, R ., Kerman, R., A rn e tt, J ., Jo rd an , S., Warshaw, B., H arris, R., Wassner, S. and Fine, R.: Sensitization following donor-specific transfusions for liv e-related renal transplantation. A m erican Society of Nephrology, W ashington, D.C., Novem ber 1981. 52. F lechner, S., Boileau, M., Payne, W., Van Buren, C., K erm an, R. and Kahan, B.: The use of Cyclosporin A in strong immune responder, high risk renal tran sp lan t re c i­ pients. A m erican Urological A ssociation, Kansas C ity, Kansas, 1982. 53. Kerman, R., Van Buren, C., Payne, W., Flechner, S., Agostino, G., Conley, S., B rew er, E. and Kahan, B.: Influence of blood transfusions on immune responsiveness. P resented a t The Transfusion and T ransplantation C onference, Los Angeles, C ali­ fornia, January - February 1982. 54. Agostino, G., Kahan, B.D. and Kerman, R.H.: Suppression of mixed leu co cy te culture using m ononuclear leukocytes from norm als, urém ies and a llo g raft recip ien ts. P re ­ sented a t the Annual M eeting of The A m erican Association of Im m unologists, FASEB, New O rleans, Louisiana, April 1982. 55. Agostino, G .J., Kahan, B.D. and Kerman, R.H .: M easurem ent of suppressor cell statu s in p o te n tia l allo g raft recip ien ts. P resen ted a t th e Annual M eeting of The Am erican A ssociation of C linical H istocom patibility T esting, San Francisco, C ali­ fornia, April 1982. 56. K erm an, R.H.: Invited p resen ter at two workshops on 1) Imm une monitoring of • ..a llo g r a f t recip ien ts and 2) The e ffe c t of transfused blood and blood products on urem ic hosts. P resen ted a t the Annual M eeting of The N orth A m erican T ransplant C oordinators O rganization, San Antonio, Texas, May 1982. 57. Kerman, R.H., Van Buren, C., Flechner, S., Agostino, G., Conley, S., B rew er, E. and Kahan, B.D.: The influence of p retran sp lan t blood transfusions from random donors on immune param eters affectin g cadaveric allo g raft survival. P resen ted a t The Annual M eeting of The American Society of T ransplant Surgeons, Chicago, Illinois, Ju n e 1982. 12518 Bibliography Ronald H. Kerman, Ph.D. 12 58. Agostino, G., Kahan, B.D. and Kerman, R.H.: Suppression of mixed leucocyte cu ltu re using leucocytes from norm al individuals, urem ic individuals, and allograft recip ien ts. P resen ted a t The Annual M eeting of The A m erican Society of T ransplant Surgeons, Chicago, Illinois, June 1982. 59. K erm an, R.H.: Invited p re sen te r a t a workshop on "Human T lym phocyte subpopula­ tions: T heir role in rejectio n and immunosuppression." P resen ted a t the In tern atio n al Congress of T he T ransplantation Society, B righton, England, August 1982. 60. Kerman, R.H.: Invited p re sen te r a t a workshop on "M echanisms responsible for blood transfusion effects." P resen ted a t The In tern atio n al Congress of The T ran sp lan tatio n Society, B righton, England, August 1982. 61. E tten g e r, R.B., Kerman, R ., Jo rd an , S.C ., Warshaw, B.L., H arris, R. and Fine, R .: S ensitization a fte r donor-specific transfusions for liv e-related renal tran sp lan tatio n . P resen ted a t The In tern atio n al Congress of The T ransplantation Society, B righton, England, August 1982. 62. Van B uren, C.T., Kerman, R.H ., Agostino, G., Flechner, S. Payne, W. and Kahan, B.D.: E ffe c t of cyclosporine on im m unoregulatorv cells of renal allo g raft recip ien ts. P resen ted a t The Intern atio n al Congress of The T ransplantation Society, B righton, England, August 1982. 63. Kerman, R.H ., Van Buren, C .T., Payne, W., F lech n er,.S . and Kahan, B.D .: M onitoring T cell subsets and immune events in renal a llo g raft recip ien ts. P resen ted a t The In ternational Congress of The T ransplantation Society, B righton, England, August 1982. 64. Flechner, S., Kerman, R., Van Buren, C.T., Payne, W. and Kahan, B.D.: The use of cyclosporine and prednisone fo r high MLC haploidentical living related renal tra n s ­ plants. P resented a t The In tern atio n al Congress of The T ransplantation S ociety, Brighton, England, August 1982. 65. A gostino, G., Kahan, B.D. and Kerman, R.: D etection of nonspecific suppressor cells from norm al individuals, urem ic p atien ts and a llo g raft recip ien ts. P resen ted a t The In tern atio n al Congress of The T ransplantation Society, B righton, England, August 1982. 66. Kerman, R .H ., Agostino, G., Van Buren, C.T., Payne, W., F lechner, S., Conley, S., B rew er, E. and Kahan, B.D.: E ffe ct of blood transfusions on g ra ft survival and immune responsiveness. P resented a t The In tern atio n al Congress of The T ransplantation Society, B righton, England, August 1982. 67. Kahan, B.D., Kerman, R., Payne, W.D., F lechner, S. and Van Buren, C.T.: Imm unopharm acologic studies of cyclosporine-treated renal allo g raft recipients. F ifth T rip a rtite M eeting, Society of U niversity Surgeons, Salzburg, A ustria, S eptem ber 1982. Bibliography Ronald H. Kerman, Ph.D. 13 68. Kerman, R.H., F lechner, S., Van Buren, C.T., Payne, W., and Kahan, B.D.: Cyclo­ sporine improves a llo g raft survival in immunologically high-risk renal allo g ra ft recipients. P resented a t th e Third In tern atio n al Imm unological Monitoring Sym­ posium, K eyB iscayne, Florida, N ovem ber 1982= 69. K erm an, R.H., Van Buren, C.T., Payne, W., F lechner, S., and Kahan, B.D.: D etection of host presensitization to donor alloantigens utilizing a com prehensive im m une crossm atch. P resen ted a t the Third In tern atio n al Imm unological Monitoring Sym­ posium, K eyB iscayne, Florida, N ovem ber 1982. 70. Kerman, R.H ., Payne, W., Van Buren, C.T., F lechner, S., and Kahan, B.D.: Imm une m onitoring of renal allo g ra ft recip ien ts tre a te d with cyclosporine or azathioprine using donor-specific and nonspecific assays as well as monoclonal T cell reag en ts. P resented a t th e Third In tern atio n al Imm unological Monitoring Symposium, Key B iscayne, Florida, N ovem ber 1982. 71. Kerman, R.H.: Invited plenary speaker a t the F irst Annual M eeting of The Am erican Society of T ransplant Physicians, "O ptim izing immunosuppression: Mode of action of cyclosporine." Chicago, D ecem ber 1982. 72. Kerman, R.H., Van Buren, C.T., Payne, W., F lechner, S., and Kahan, B.D.: Cyclo­ sporine improves a llo g raft survival in im m unologically high-risk renal a llo g raft recipients. P resented a t The Annual M eeting, N ational Kidney Foundation, C linical Dialysis and T ransplant Forum , Chicago, D ecem ber 1982. 73. Kerman, R.H.: Role of immune evaluation in clinical m edicine. Clinical Immunology Grand Rounds, T he C hildren's M emorial H ospital, Chicago, Illinois, D ecem ber 1982. 74. Kerman, R.H.: Immunologic e ffe c ts of toxic m aterials. P resented a t Toxicology C linical U pdate, U niversity of Texas M edical B ranch, G alveston, Texas, Jan u ary 1983. 75. Kerman, R.H.: C yclosporine im proves allo g raft survival in immunologically high risk renal a llo g raft recip ien ts. P resen ted a t Pathology Grand Rounds, U niversity of Pittsburgh School of M edicine, F ebruary 1983. 76. Kerman, R.H.: Imm une evaluation of renal failure p atien ts and allo g raft recip ien ts. P resented a t Surgical Grand Rounds, S t. Louis U niversity M edical C en ter, S t. Louis, Missouri, March 1983. 77. Kerman, R.H.: Im m unological evaluation of hem ophiliacs. P resented a t a Symposium on C urrent Problem s in the M anagem ent of H em ophiliac C om plications, H ouston, • T exas, April 1983. 78. Flechner, S., K erm an, R.H., Van Buren, C.T., Payne, W., and Kahan, B.D.: Successful transp lan tatio n of high mixed lym phocyte cu ltu re haplo-identical living re la te d donors using cyclosporine and prednisone. P resen ted a t the Annual A m erican U rological A ssociation, Las Vegas, N evada, April 1983. 79. K erm an, R.H., F lechner, S., Van Buren, C.T., Payne, W., and Kahan, B.D.: Imm unolo­ gical m onitoring of renal allo g raft recipients tre a te d with cyclosporine. P resen ted a t The F irst In tern atio n al Congress on C yclosporine, Houston, T exas, May 1983. 12518 Bibliography Ronald H. Kerman, Ph.D. 14 80. Van Buren, C., Kerman, R., Agostino, G., Flechner, S., Payne, W.D., and Kahan, B.: E ffe c t of cyclosporine on im m unoregulatory cells of renal allo g raft recipients. P resen ted a t The F irst Intern atio n al Congress on Cyclosporine, Houston, Texas, May 1983. 81. Kahan, B.D., Van Buren, C., Flechner, S., Payne, W.D., and Kerman, R.: Improved outcom e of 150 renal allografts in immunologically high risk recipients tre a te d with cyclosporine. P resented a t The F irst In tern atio n al Congress on Cyclosporine, Houston, Texas, May 1983. 82. Flechner, S.M., Van Buren, C., Kerman, R.H., and Kahan, B.D.: The nephrotoxicity of cyclosporine in renal transplan tatio n . P resented a t The F irst In tern atio n al Congress on Cyclosporine, Houston, Texas, May 1983. 83. Flechner, S.M., Van Buren, C.T., Kerman, R., and Kahan, B.D.: The e ffe c t of conversion from cyclosporine to azathioprine immunosuppression for in trac ta b le nephrotoxicity. P resented a t The F irst In tern atio n al Congress on Cyclosporine, Houston, Texas, May 1983. 84. Kerman, R.H., Flechner, S., Van Buren, C.T., Payne, W., and Kahan, B.D.: Cyclo­ sporine immunosuppression overcom es immunologic risk facto rs for recipients of cadaveric renal allografts. P resen ted a t the Annual M eeting of The A m erican Society of Transplant Physicians, Chicago, Illinois, June 1983. 85. Flechner, S.M., Kerman, R.H., Van Buren, C.T., and Kahan, B.D.: The high risk haploidentical living related recipient: T ransplantation w ithout blood transfusions and steroid withdraw al using cyclosporine. P resented a t the Annual M eeting of The A m erican Society of T ransplant Physicians, Chicago, Illinois, June 1983. 86. Kerman, R.H.: R elationship of im m unocom pétence of hem ophiliac p atien ts and acquired immune deficiency syndrome (AIDS). P resented a t the Gulf C oast Hemo­ philia C hapter M eeting, Houston, Texas, O ctober 1983. 87. Kerman, R., Van Buren, C.T., Flechner, S., and Kahan, B.D.: C orrelation of visual, 5 1 c r-re le a se and flow cytom etry crossm atch results to g ra ft survival. P resen ted a t The Fourth International Symposium: Immune M onitoring of The T ransplant R e­ cipient, Houston, Texas, Novem ber 1983. 88. Rogers, A .J., Kerman, R.H., and Kahan, B.D.: The pharm acokinetic and immunobiological activ ity of cyclosporine in man. P resen ted a t T he F ourth Intern atio n al Symposium: Immune M onitoring of The T ransplant R ecipient, Houston, Texas, N ovem ber 1983. 89. K erm an, R.H., Manner, C., Ford, K., and H oots, K.: Com prehensive immune evaluation of 78 hem ophiliacs. P resented a t th e New York Academy of Sciences Symposium on Acquired Immune D eficiency Syndrome, New York, New York, Novem­ ber 1983. 90. Kerman, R., Van Buren, C.T., Flechner, S.M., and Kahan, B.D.: DRW6 and- DR3 phenotypes correlating with immune response. P resen ted a t the Annual M eeting of The American A ssociation for C linical H istocom patibility T esting, Chicago, Illinois,' N ovem ber 1983. 12519 Bibliography Ronald H. Kerman, Ph.D. 91. 15 Van Buren, C .T., Flechner, S.M., Kerman, R .H ., Vaughn, W., and Kahan, B.D.: Cyclosporine im proves outcom e in high risk cadaveric renal allo g raft recip ien ts. P resented a t the F irst M eeting of The European Society for Organ T ransplantation, Zurich, Sw itzerland, November 1883. 92. Kerman, R.H.: Cyclosporine immunosuppression fo r renal transplantation. P resen ted to Sandoz P harm aceuticals, Inc., E ast H anover, New Jerse y , D ecem ber 1983. 93. Kerman, R.H.: New horizons in tran sp lan tatio n : Influence of cyclosporine on renal transplantation. Invited presenter a t the W estern Dialysis and T ransplantation Society, P ark C ity, U tah, Jan u ary 1984. 94. S terling, R .P ., B radley, B.B., Khalil, K.G., K erm an, R.H., and Conklin, R.H.: Com pari­ son of biopsy proven pneumocystis pneumonia in acquired immune deficiency syndrome (AIDS) p atien ts versus renal allo g raft p atien ts. P resen ted a t The Society for T horacic Surgeons, San A ntonio, Texas, Jan u ary 1984. 95. Rogers, A .J., Kerman, R.H., and Kahan, B.D.: C orrelation of im m unopharm acokinetic profiles of cyclosporine-treated allo g raft recipients and rejection. P resented a t The Society for U niversity Surgeons - R esidents' M eeting, Chicago, Illinois, February 1984. 12520 MARVIN S. LEGATOR, Ph.D. Dr. Legator is Professor of Environmental Toxicology, University of Texas Medical School at Galveston. His Curriculum Vitae will be supplied. The subject matter of Dr. Legator's testimony will include: the teratogenic and carcinogenic effects of TCDD, as well as its mutagenic potential; the multi-system effects of TCDD at extremely low concentrations; the demonstrable effects, both gross and more subtle, of TCDD on animals; the extrapolition of the animal studies to humans, that is, the inherent, intended predictive aspects of the animal data to man; and finally to his work as a geneticist with respect to reproductive toxicology, i.e. male (Vietnam Veterans) - mediated birth defects and certain untoward pregnancy outcomes. Dr. Legator will testify to the extreme toxicity of dioxins, particularly 2,3,7,8 -TCDD. Specifically, his testimony will indicate that TCDD is a complete carcinogen based upon certain animal studies, and that as a carcinogen, there is no safe level and does not have therefore a so-called no effect level. With respect to that, Dr. Legator will describe the extra­ ordinary precautions which are taken, and the fears of the researchers, in connection with the laboratory use of TCDD. In addition, Dr. Legator will testify to the reproductive toxicological effects, i.e. birth defects, and miscarriages of the children and wives of the exposed Vietnam veterans. The animal data in this regard are positive and consistent and provide a mechanistic linkage which confirms the Vietnamese epidemiological study of Hatch and others. Specifically, therefore Dr. Legator will testify that the miscarriage of Mrs. Dan G. Jordan and the congenital malformations of the children of Dan G. Jordan, as well as those of Kerry Ryan, daughter of Michael F. Ryan, were caused by the presumed exposure of representative plaintiffs Jordan and Ryan to phenoxy herbicides and dioxins - specifically 2,3,7,8-TCDD — while serving in Vietnam. The bases or grounds for such facts and opinions include Dr. Legator's: educational and professional experience; personal researches; review of the applicable medical and scientific literature; and a review of the medical records and/or data of the Jordan and Ryan families. -2- ALAN SCOTT LEVIN, M.D. Dr. Levin is engaged in the practice of medicine in San Francisco, His Curriculum Vitae is attached. Dr. Levin will testify that phenoxy herbicides and their contaminants, including dioxins, most especially 2,3,7,8 -TCDD, cause an assortment of immunological responses, i.e. immuno-toxicity, which predispose persons exposed by absorption and/or ingestion and/or inhalation - to such chemicals to a whole host of adverse health effects, such as: chloracne or other skin rashes; various neuro-toxic effects; reproductive effects; and neoplasm. In connection with the carcinogenic effect, Dr. Levin will state there is no safe level for this or any other carcinogen, and that a single exposure several years earlier can result in human cancer many years later. The bases for such facts and opinions expressed herein by Dr. Levin include: review of the medical and scientific literature, including both animal and human data; his personal researches; his clinical experiences; and his personal knowledge of the defoliation of Vietnam by such phenoxy herbicides and dioxins, with such chemicals in the presence of the veterans and their presumed exposure thereby; and review of all pertinent medical data of the representative plaintiffs. Dr. Levin will discuss the following in his testimony: the immune system, with its organic, cellular, and humoral components - most especially with regard to the latter, T-helper cells, B-cells, plasma cells and immuno­ globulin production; immune response, both beneficial and harmful; the various experimental studies, particularly those demonstrating atrophy of the thymus, weight loss, depletion of lymphoid organs, lymphopenia, cutaneous type delayed hypersensitivity (skin thickness) and altered bacterial immunity. In addition, Dr. Levin will discuss the following and their significance: immunology as molecular biology; chemical-induced immune disregulation; T-cells (lymphocytes from thymus) acting as immune modulators, (for which again there is no "no effect" level); immune surveillance; the similarity of the immune, neurologic, and endocrine systems and their significance in the area of immuno-toxicity; the relationship of immune disregulation caused by chemicals and carcinogenicity. Dr. Levin will then testify to the causal relationship of the various Agent Orange/dioxin related adverse health effects of the representative plaintiffs, including: chloracne; neuro-toxic effects, both neurological and psychological; reproductive toxic effects, both miscarriages and birth defects; and such neoplastic processes as soft tissue sarcoma, as here a rhabdomyosarcoma, lymphocytic lymphoma and basal cell carcinoma. -2- V\ ^ ' C • CURRICULUM VITAE Alan Scott Levin, M.D, .Born: January 12, 1938= Chicago, Illinois. High School: Austin, Chicago, Illinois College: University of Illinois, Champaign-Urbana, Illinois 1956-1960 B.S. Chemistry in L.A. with Honors. Graduate School: University of Illinois (Chicago Medical Center) M.S. in Biochemistry, 1963. Masters Thesis: Metabolism of Serum Albumin in Rats with Cirrhosis of the Liver, 1963. Medical School: University of Illinois (Chicago Medical Center) M.D. 1964 Alpha Omega Alpha Honor Medical Society, 1963 Internship: Children's Hospital Medical Center, Boston, Mass. Fellowships: Traineeship Grant, Harvard Medical School 1964 Research Assistant, Children's Hospital Boston, 1965. USPHS Hematology Training Grant, University of California San Francisco, Medical Center 1969-1971 (Pediatric and General Immunology). American Cancer Society Faculty Research Award, 1971-1974 Specialty Board Certifications: Military: Marital Status: 1. Certified Diplomnte American Board of Allergy and Immunology, 1975. 2. Certified Diplomate American Board of Pathology-Clinic Pathology, 1977. 3. Fellow in the American College of Emergency Physicians 4. Fellow College of American Pathologists. 5. Fellow American Society -of Clinical Pathologists. 6. Member American Academy of Allergy. 7. Member American Association of Clinical Chemists. USN attached to USMC as Flight Surgeon 1966-1968 Viet Nam Campaign ribbons and unit citation, Navy and Marine Corps Commendation, First through Fourth Air Medals Bronze Star Medal with Combat "V", Silver Star Medal, Honorable Discharge November 1969. Married to V e r a S. B y e r s , No c h i l d r e n . Ph.D., M.D. fL P ~yl1 2ht \r J> .V i f Acad ernie Appointments : Adjunct Instructor in Pediatrics University of California San Francisco Medical Center 1971 - 1972 Assistant Professor of Immunology in Dermatology University of California San Francisco Medical Center 1972 - 1978 Adjunct Associate Professor of Immunology University of California San Francisco Medical Center 1978 Director of Laboratory of Immunology University of California and Kaiser Foundation Research Institute Joint Program Project San Francisco, California 1971 - 1974 Director of Division of Immunology Western Laboratories 2945 Webster Street Oakland, California 1974 - 1977 Medical Director MML/Solano Laboratories 2920 Telegraph Avenue Berkeley, California 1977 - 1979 N Medical Director Levin Clinical Laboratories, Inc. 326 6 th Stree-t San Francisco, California 1979 - 1981 Private Practice of Medicine 450 Sutter, Suite 1138 San Francisco, California, 94108 1981 - Member, Medical Quality Review Committee, ^4 Board of Medical Quality Assurance State of California 1982 *i r*. * * o £ X &O&O I ALAN SCOTT LEVIN, M.D. BIBLIOGRAPHY (Abstracts not included) 1. Levin, A.S., and Jeffay, H.: Metabolism of serum albumin in rats with cirrhosis of the liver. J. Lab & Clin. Med. 63: 776-783, 1964. 2. Klemperer, M.R., Gotoff, S.P., Alper, C.A., Levin, A.S., and Rosen, F.S.: Estimation of serum beta 1-C globulin concentration: Its relation to the serum hemolytic complement titre. Pediatrics 36: 766-769, 1965. 3. Alper, C.A., Levin, A.S., and Rosen, F.S.: Beta-IC-globulin: Metabolism in Glomerulonephritis. Science 153 (3732): 180-182, 1966. 4. Vyas, G.N., Levin, A.S., Fudenberg, H.H.: Intrauterine isoimmunization caused by transplacental passage of maternal IGA. Nature 225: 275-276, 1970 5. Levin, A.S., Pipkins, M.O., and Fudenberg, H.H.: A rapid.radioimmunoassay for measuring nanogram levels of antigens. Vox. Sang. 18:459-466, 1970. 6. Levin, A.S., Spitler, L.E., Stites, D.P., and Fudenberg, H.H.: A gene­ tically determined cellular immunologic deficiency: Clinical and laboratory responses to therapy with transfer factor. Proc. Natl. Acad. Sci.L'SA 67: 321-328, October, 1970. 7. Stites, D.P., Levin, A.S., Austin, N.E., and Fudenberg, H.H.: Immuno­ biology of Human Lymphoid Cell Lines. Immunoglobulin biosyncheseis in cultures from Hypogamma-globulinemias and Paraproteinemia. J. Immunol, 107: 1376-1381, November, 1971 8. Levin, A.S., Fudenberg, H.H., Hopper, J.E., Nisonoff, A., and Wilson, S.K.: Immunofluorescent evidence for control of synthesis cf variable regions of light and heavy chains of IgG and IgM by^the same gene. Proc. Natl. Acad. Sci. USA 63: 169-171, 1971 9. Fudenberg, H.H., Wang, A.C., Pink, J.R.L., and Levin, A.S.: Studies of an Unusual Biclonal Gammopnthy. Ann. N.Y. Acad. Sci. 190:501-506, 1971. 10..Levin, A.S., Fudenberg, H.H., Pete, L.D., and Sharp, G.C.: IgG levels in Cerebrospinal Fluid of Patients with Central Nervous System Lupus. Clin. Immunol, and J. Inmunonath. 1: 1-5, 1972 11. Spitler, L.E., Levin, A.S., Huber, I!., and Fudenberg, H.H.: Prediction of Results of Transfer Factor Therapy in the Wiskott-Aldrich Syndrome by Monocyte IgG Receptors. In Proceedings of the Sixth Leukocvte Culture Conference. Academic Press, Inc., New York and London, P.795-803, 1972. ( 12. Spitler, L.E., Levin, A.S., Stites, D.P., Fudenberg, H.H., Pirofsky, C.S., August:, E.R., Stiehm, W.H., Hitzig, H. , and Gatti, R.A. : The WiskottAldrich Syndrome Results of Transfer Factor Therapy. J. Clir.. Invest. 51: 3216- 3224, 1972 13. Spath, P., Garraty, G., Levin, A.S., Petz, L.D., Fudenberg, H.H.: Immunhematologische Veränderungen bei Cephalosporin-therapie. Verhandlungen der Duetschen Gesselschaft fur innere Medizin, Vol. 78, 914-916, 1972. 14. Fudenberg, H.H., Spitler, L.E., and Levin, A.S.: Treatment of Immune Deficiency Disorders. Amer. J. Pathol. 69:529-536, 1972 15. Stites, D.P., Levin, A.S., Lauer, B., Costom, B.H., Fudenberg, H.H.: Selective "Dysgammaglobulinemia" with elevated serum IgA and chronic salmonellosis. Amer. J. Med. 54:260, 1973 16. Spitler, L.E., Levin, A.S., and Fudenberg, H.H.: Agammaglobulinemia and Lymphopenia without infection: A demonstration of immunologic unknowns. Amer. J. Med. 54: 371-377, 1973. 17. Raubitschek, A.S., Levin, A.S., Stites, D.P., Shaw, E.B., and Fudenberg, H.H.: Normal Granulocyte Infusion Therapy for Aspergillosis in a Patient with Chronic Granulomatous Disease. Pediatrics 51-230-233, February 1973 18. Wybran,'J., Levin, A.S., Spitler, L.E., and Fudenberg, H.H.: Rosette Forming Cells, Immunological Diseases and Transfer Factor. New England Journal o: Med. 228:710-713, 1973. 19. Spitler, L.E., Levin, A.S., and Fudenberg, H.H.: Human Lymphocyte Transfer Factor in "Methods in Cancer Research", H. Busch (ed.) Acad. Press. Ill 5th Ave., New York, N.Y., 59-106, 1973. 2 0 . Levin, A.S., Spitler, L.E., and Fudenberg, H.H.': Transfer Factor Therapy in Immune Deficiency States. Ann. Rev. Med, (invited Review) 2_4: 1973 21. Levin, A.S., Spitler, L.E., and Fudenberg, H.H.: Immune Deficiency States. Introduction to Clinical Allergy (cd.: B. Feingold) Charles Thomas, Springfield, Illinois, Chapter 19, 346-359, 1973. 2 2 . Spitler, L.E., Levin, A.S., and Fudenberg, H.H.: The Wiskott-Aldrich Syndrome. In the Science and Practice of Clinical Medicine. J.M. Dictschy, L.E. Early, H.H. Fudenberg, A. Renold, C.A. Sanders, and J.P. Sanford (ed.) New York, 1974. 23. Spitler, L.E., Levin, A.S., Fudenberg, H.H.: Transfer Factor. Clinical Immunology Volume M. (ed. R.A. Good £. Bach), 2: 153-175 , Academic Press, N.Y. 1974. 24. Fudenberg, H.H., Levin, A.S., Spitler, L.E., Wybran, J.E., and Byers, V.S Therapeutic Uses of Transfer Factor. Hosnital Practice 9:95-104 1974 \ 25. Levin, A.S., Transfer Factor Therapy: Current Status. So. Med. Journal (invited editorial) 68^ 1465-1466, 1975 26. Fudenberg, H.H., Byers, V.S., Levin, A.S., and Hackett, A.J.: Additional evidence for viral etiology of certain human tumors in A.A. Gottlieb, M.D., Fundamental Aspects of Neoplasia. New York: SpringerVerlag, 1974 27. Fudenberg, H.H., Byers, V.S., and Levin, A.S., : Immunologic Evidence for a Viral Etiology of Certain Malignant Tumors, in Perspectives in Virology (Gustav Stern Symposium), New York, February 4-5, 1974. 28. Levin, A.S., Byers, V.S., Fudenberg, H.H., and Wybran, J .: Immunologic Parameters for monitoring immunotherapy with tumor-specific transfer factor. Trans. Assoc. Amer, Phys.,_87, 153-158, 1974 29. ■Fudenberg, H.K., Byers, V.S., Levin, A.S., and Hackett, A.J.: Immunologic Evidence for a Viral Etiology of Certain Human Malignant Tumors. Ann. N.Y. Acad. Sci. (In Press, 1975) 30. Wybran, J., Levin, A.S., Fudenberg, H.H., and Goldstein, A.L.: Thymosin: Effects on Normal Human Blood T Cells. Ann. N.Y. Acad. Sci. 249:301-307, 1975 31. Carter, J.B., Ponce, B., Byers, V.S., Barr, G.D., Fudenberg, H.H. and Levin, A.S.: Standardization of tissue culture conditions for spontan­ eous thymidine-2l4c incorporation by unstimulated lym.phocytes : Circadian rhythm in Human Lymphocytes. J. of Allergy and Clinical Immunology 56, 191-196, 1975. 32. Byers, V.S., Levin, A.S., Hackett, A.J., and Fudenberg, H.H.: Tumor specific cell mediated immunity in household contacts of cancer patients. J. of Clin. Invest. 55-500-517, 1975. 33. Levin, A.S., Byers, V.S., Fudenberg, H.H., Hacket^ A.J., Johnston, J.O., and J.E. Wybran: Osteogenic sarcoma: Immunologic' parameters before and during therapy with tumor specific transfer factor. J. Clin. Invest 55: 487-499, 1975. 34. Levin, A.S., Spitler, L.E., and Fudenberg, H.H.,;' Transfer Factor 1. ■Methods of Therapy, (end Int. Coni, on Immunodeficiency in Man. St. Petersburg, Fla. 1973), in BIRTH DEFECTS: Original Article Series (Editors: D. Bergsma and R.A. Good), Sinaucr, Assoc., Inc., N.Y., 1975. 35. Spitler, L.E., Levin, A.S., and Fudenberg, H.H.: Transfer Factor II. Results of Therapy. (2nd Int. Conf. on Immunodeficiency Disease in Man, St. Petersburg, Fla., 1973), in BIRTH DEFECTS:. Original Article Series (Editors: D. Bergsma and R.A. Cood) , Sinauer Assoc., Inc., N.Y., 1975. I 36. Fisher, J., Byers, V.S., Shafrin, M., and Levin, A.S.: Relationship of Cu and Zn levels to metastatic events in human bone sarcomas. Cancer, 37, 356-364, 1976. 37. Spitler, L.E., Levin, A.S., and Fudenberg, H.K.: The Wiskott-Aldrich Syndrome: Immunological Studies in Patients and Family Members Cellular Immunology, 19, 201-218, 1975. 38. Byers, V.S., Levin, A.S., Hackett, A.J., and- Johnston, J.W.: Quantitativ Iramunofluorescent Studies on the Tumor Antigen Bearing Cell in Giant Cell Tumor of Bone and Osteogenic Sarcoma, Cancer Research, 35:2520 2531, 1975. 39. Jones, L.W., Levin, A.S., and Fudenberg, H.H.: Glomerular Antigen Comple Associated with Transitional Cell Carcinoma. Surgery, Gynecology and Obstetrics 140:896-898, 1975 40. Kaplan, M.A., Byers, V.S., Levin, A.S., German, D., Fudenberg, H.H., and LeCam, L.: Circadian Rhythm in Human Lymphocyte Function. J. Allergy and Clinical Immunology: 58 I, 180-189, 1976. 41. Spitler, L.E., Levin, A.S., and Wybran, J.: Adjuvant Immunotherapy for Malignant Melanoma with BCG and Transfer Factor. Cellular Immunology 21, 1 - 19, 1976. 42. Levin, A.S., Byers, V.S., Hackett, A.J., Johnston, J.O., and LeCam, L.M. Tumor Specific Transfer Factor Therapy in Osteogenic Sarcoma, Immunotherapy in Cancer, Proceedings of ITR-C'nicago, 1975. 43. Byers, V.S., Levin, A.S., Hackett, A.J., Johnston, J.O., and LeCam, L.M. Tumor Specific Transfer Factor Therapy in Osteogenic Sarcoma, A Two-Year Followup Study, Annals of New York Academy of Science, 277, 621-627, 1976 44. Byers, V.S. and Levin, A.S., Tumor Immunology, in Basic and Clinical Immunology: Eds. Caldwell, J., Fudenberg, H.H., .-^tites, D.P. and Wang, A.S., Lange Books, 1976. 45. 'Levin, A.S., Byers, V.S., LeCam, L.M., and Johnston, J.O., An Unusual Metastasis in an Osteogenic Sarcoma Patient on Tumor Specific Transfer Factor Therapy, Transfer Factor, 537-542, Academic Press, 1976. 46. "'Byers, V.S., LeCam, L.M., Hackett, A.J., Johnston, J.O. and Levin, A.S.: Familial Incidence of Breast Carcinoma Immunity - A Statistical Survey. Cancer Immunology and Immunotherapy. 2, 163-172, 1977 47. Byers, .S., and Levin, A.S.: Tumor Antigen Density on Osteogenic Sarcoma Cells in Vitro. Cancer Research. 37, 3173-3183, 1977. 12330 Chun. Shi-Han, ico c , C.R., Giblett, E .E ., Levin, A.S.: Adenosine Deaminase Défi Lenc : Another Family with a "Silent" .Ada Allele and in Two Hetcrozygotes. American Journal of Human Norasl Ada Act 642-644, 1977.’ ’ Genetics. Vol 49. Marmor, M.D., Nelson, J.W., Levin, A.S.,: Copper Metabolism in American Retinitis Pigmentosa Patients: British Journal of Opthalmology. Vol. 62. 163-171, 1973. 50. Byers, V.S.,. LeCam, L., Levin, A.S., Johnston, J.O., and Hackett, A.J.: Osteogenic Sarcoma: Immunotherapy of Clinically Disease Free Patients with Transfer Factor: Long-Term Follow-up. Cancer Immunology and Immunotherapy - 6_. 243-251, 1979. 51. Byers, V.S., Levin, A.S.: Poison Oak III: Genetic Restriction in T Cell Mediated reactivity-Journal of Clinical Investieation.-Submitted. 52. Newman, B.R., Byers, V.S., German, D., and Levin, A.S.: Variability of Lymphocyte Function by Serum Factors. Journal of Clinical Laboratory Immunology 2, 151-154, 1979. 53. McGovern, J.J.,Jr., Lazaroni, J.L., Saifer, Phyllis, Levin, A.S., Rapp, D.J., Gardner, R.W.: Clinical Evaluation of the Major Plasma and Cellular Measures of Immunity. Journal of Orthomolecular Psychiatry. Vol. 12, No. 1. , 1933. 54 . Eyers, V.S., Baldwin. R . L e v i n , A.S., Embleton, M.J , and Price, M.R.. Monoclonal Antibodies: Their Use in the Diagnosis and Treatment of Cancer - In probability Models and Cancer, pp. 15-3^. L . LeCam and J, Neyman (Eds.) North-Holland, 1932. 55. Binder, R.L., Callaway, E., Levin, A.S., Stites, D.P.: Relationship between Creatine Phosp'nokinase and Immunoglobulins in Unmedicated Caucasian Schizophrenics. Biological Psvchiatrv. In Press. 1983. 56 McGovern, J.J.,Jr., Rapp, D.J., Levin, A.S.: Immune Response During Double-Blind Testing. PhOmol Provokes Abnormal J .'A,M.A . Submitted 1983. 31 ( ALAN SCOTT LEVIN, M.D. BIBLIOGRAPHY (Abstracts Only) 1. 2 Alper, C.A., Levin, A.S., and Rosen, F.S.: Turnover of an I complement component. J. Clin. Invest. May 1965. labeled 4 Levin, A.S., Petz, L.D., Fudenberg, H.H.: Immunoglobulins and C Levels in Normal and CNS-SLE ’Cerebrospinal fluids using new micro radio immuno­ assays. Abstract presented ASCR Western Regional Meetings. 3. Levin, A.S., Stites, D.P., Spitler, L.E. , Sa'nud, M. A. and Fudenberg, H.H. : Induction of "delayed hypersensitivity" in Wiskott-Aldrich pacient by transfer factor. Clin. Res. 18:426, April, 1970. 4. Vyas, G.N., Levin, A.S., and Fudenberg, H.H.: Isoimmunization to human IgA in pregnancy. Clin. Res. 18:157, April 1970. 5. 4 Levin, A.S., Petz, L., and Fudenberg, H.H.: IgG and C levels in CSF of patients with active CNS-SLE. Clin. Res. 19:137, June 1971 6. Levin, A.S., Fudenberg, H.H. , Hopper, J.. , and Nisonoff, A.: Immunohistologic investigations of a Biclonal Camopathy: Detection of identical antigen in variable regions of IgG and IgM producing cells. Presented at ASH Meeting, San Juan, P.R. Blood XXXVI (6), 831, 1970. 7. Spitler, L.W., Levin, A.S., Stites, D.P., and Fudenberg, H.H.: Current status of transfer factor therapy in Wiskott-Aldrich Syndrome. Presented at ASCI Western Regional Meetings, Carmel, Jan. 1971 Clin. Res. XIX (j) 162, 1971 8. Levin, A.S., W’einer, R.S., Fudenberg, H.H., Spath, and Petz, L.: Granulocytopenia caused by anticephalothin antiboMies. Clin. Res. XIX (2) 424, 1971 9. Levin, A.S,Spitler, L.E., Stites, D.P., and Fudenberg, H.H.: Molecular intervention in genetically determined cellular immune deficiency disorder J. Clin. Invest^ 50:59a, 1971 10. Spitler, L.E., Levin, A.S., Fudenberg, H.H., Huber, H.: Abnormal monocyte IgG receptors in the Wiskott-Aldrich Syndrome. Sixth Annual Leukocyte Culture Conference. Academic Press, 1972. 11. Spitler, L.E., Levin, A.S., Stites, D.P., Pirofskv, Fudenberg, H.H.: Transfer Factor Therapy in Mucocutaneous Candidiasis. Sixth .Annual Leukocyte Culture Conference. Academic Press, 1972 12. Wybran, J., Spitler, L.E., Levin, A.S., and Fudenberg, H.H.: The Rosette Forming Cell as an Indicator of Successful Transfer Factor Therapy in Immuno Deficiencies. Clin, Res. XX (3), 1972 i p K '12 1*% J. Levin, A.S., Spicier, L.E., Wybran, J., and Fudenberg, H.H.: Treatment of Osteogenic Sarcoma with Tumor Specific Transfer Factor. Clin. Res. XX (3), 56S, 1972. 14 . Spider, L.E., Levin, A.S., and Fudenberg, H.H.: Immunologic Evaluation of Patients with Micocutaneous Candidiasis and Results of Transfer Factor Therapy. Clin. Res. XX (3), 519, .1972. 15. Spitler, L.E., Levin, A.S., Blois, M.S., Epstein, W., Fudenberg, H.H., Hellstrom, 1., and Hellstrom, K.E.: Lymphocyte Responses to Tumor Specific Antigens in Patients with Malignant Melanoma and Results of Transfer Factor Therapy. J. Clin. Invest. 16. Wybran, J., Levin, A.S., Spitler, L.E. , and Fudenberg, H.H.: Tne Human Rosette Forming Cell, Transfer Factor and Prognosis of Cancer. Clin. Res. XX, (3) 635, 1972. 17. Fcnes, D.U., Mogerman, S.N., Spitler, L.E., Stites, D.P., Shinefield, H.R., Fudenberg, H.H., and Levin, A.S.: Graft Versus Host (GVH) in A Di George Patient: Probable Accelerated Induction of T Cell Competence. Clin. Res. XXI (2) 309. 18. Mogerman, S.N., Levin, A.S., Spitler, L.W.,'Stites, D.P., Fudenberg, H.H. and Shinefield, H.R.: Transfer Factor Therapy in X-Linked Recessive Severe Combined Dual System Immune Deficiency Disorder (SCID). Clin. Res. XXI (2) 310. 19. Carter, J.B., Pence, 3.E., Stites, D.P., Levin, A.S., German, D.F., and Fudenberg, H.H.: Spontaneous Thymidine' - 2--*-'4 C Incorporation by Unstimulaced Normal Human Peripheral Lymphocytes In_ Vitro: Tissue Culture Conditions and Quantitative Measurements. 20. Carter, J.B., Ponce, B.E., Stites, D.P., Levin, A.S., German, D.E., and Fudenberg, H.H.: Circadian Cycle of Spontaneous Thymidine-2*-^ C Incorporation by Unstimulated Normal Human Peripheral Lymphocytes In Vitro. ----------------------- 21. .v A. X Fones, D.W. , Levin, A.S., Mogerman, S.M., Spitler, L. E., Stites, D.P., Shinefield, H.R., and Fudenberg, H.H.: Graft Versus Hose Followed by Host Versus Graft: Evidence for Accelerated Induction of T-Cell Competence. s' 22: Levin, A. S',v •Spitler, L.E’., Wybran, J., Byers, V.S., and Fudenberg, H.H.: Treatment of Osteogenic Sarcoma (OS) with Tumor Specific DiaLysable. Transfer Factor (TF). Clinical Research. 1973 23. Levin, A.S., Byers, V.S., Fudenberg, H.H., and Wybran, J.E.: Immunologic Parameters for Monitoring Immunotherapy with Tumor Specific Transfer Factor. Clin. Res. 1974. 24. Gardner, R.D., Byers , V.S., Levin, A.S., and Fudenberg, H.H Frozen Human Lynphoc ytes: Dissociation between Tumor Specif ic Cytotoxicity and Mix ed Leukocyte Reactivity (MLC Reactivity) 25. Byers, V.S., Levin, A.S., and Fudenberg, H.H.: Detection of Tumor Specific Immunity in Normal Household Contacts of Tumor Bearing Patients. Clin. Res. 1974. 26. Levin, A.S., Byers, V.S., Johnston, J.O., Hackett, A.J.,and Fudenberg, H.H.: Host-Tumor Relationships in Giant Cell•Sarcoma of Bone (GCS): Measurement by Quantitative Immunofluorescence. Clin. Res. 1974 27. Fudenberg, H.H., Byers, V.S., Levin, A.S., and Hackett, A.J.: for Viral Etiology of Human Hypernophroma and Osteosarcoma. Perspectives in Virology. In Press, 1974 28. Levin, A.S., Byers, V.S., LeCam, L., and Johnston, J.O.: Evidence for Regression in Osteogenic Sarcoma Induced by Tumor Specific Transfer Factor. 2nd International Workshop on Transfer Factor. Frederick, MD., 1975. 29. Hackett, A., Springer, L., Levin, A.S., and Fink, M.: Transmission and Scanning Electron Microscopic Studies on Osteo Sarcoma Before and After Transfer Factor Therapy. Cancer Research 16:193, 1975 30. Levin, A.S., LeCam, L.M., Hackett, A.J. and Johnston, J.O.: Osteosarcoma (O.S.): 5 Year Followup of Epidemiology and Tumor Specific Transfer Factor Therapy (TSTF). Clin. Res. 1976 31. Levin, A.S., LeCam, L.M., and Agraz, J.M.: Dip-Stick Method of Quanti­ tative Immunofluorescence. Clin. Res, 1976-, 32. Newman, B.R., Byers, V.S., Levin, A.S., and Jerman, D.: Circadian Influences on T. Lymphocyte Function Mediated by Serum Factors. Clin. Res. 1976 33. Levin, A.S., Kassel, S.D., and Flam, M., A New Diagnostic Index: Collagen Disease vs. Malignancy vs. Infectious Disease. J.A.M.A. 237, 1916, 1977. 34. Levin, A.S., and Baldwin, R.W. : Solid Phase Fl’uoroimmunoassay to Detect Serum Immune Complexes. 6th International Congress on Immunofluorescence, Vienna, Austria. 1973 Evidence 3-5, Levin, A.S., McCovern, J.J.,Jr., Miller, J.B., LeCam, L.L., and Lazaroni, J.: Non-Anaphylac tic Food Allergies Mediated by Immune Complexes: Ann. Allergy, Abstract in Press. 1981 12534 Dr. Peter Orris is an internist practicing in Chicago, Illinois. His c u r r iculum v i t a e wil l be supplied. Dr. Orris will testify as to the clinical aspects of the diseases in the r epresentative p laintiff veterans. His testimony will be b a s e d u pon a medical records review and an analysis of various; test results that wil l h ave bee n performed upon the repre­ sentative plaintiffs. Dr. Orris will also testify on generic c ausation and specific prox i m a t e causation in relation to each r epresentative veteran, plaintiff. He wil l also testify as to prognosis for each representative vet e r a n plaintiff 12535 Marvin A. Schneiderman, Ph.D., of Bethesda, Maryland, is a statistician and epid e m i o l o g i s t who is the former Chief of Statistics and E p i d e miology and the former Director for Science Policy of the National Cancer Institute and is currently a consultant. His c u r r iculum v i t a e is attached. Dr. Schneiderman will models, statistics, testify concerning mathematical and epid e m i o l o g y in the area of cancer. He will first discuss the e p i d e m i o l o g y of dioxins and their contaminants to human cancer insofar as it relates to soft tissue sarcomas, and p a r t i cularly the E P A peer review.group conclusions in regard thereto, stomach cancers and lymphomas. In that regard, he will discuss the r e l a t i o n s h i p of exposure to the time the disease appears, the s o-called latency period. He will also discuss the m u l t i p lication of base rates in the p r o d uction of such cancer. Next, Dr. Sch n e i d e r m a n will present a multi- s t a g e model of cancer induction. He will discuss age relationships and the stage of cancer devel o p m e n t as they are affected by dioxins and their contaiminants or other materials. certain pertinent animal d ata and discuss human experience. He will also present it as a pred i c t o r for He will also testify that TCDD is more toxic than many other carcinogens, including being more carcinogenic by a factor of 4 or 5 than benzene, for example. He will also explain the concept of risk assessment and how judgments as to such are capable of being m ade w ith regard to humans. This will include discussion of a m a t h e matical model for associ a t i o n of the multi-f a c e t e d pres e n t a t i o n of symptoms and signs in the same 1 iC/ veteran to exposure to A g e n t Orange as a causative factor. He will also discuss the population incidences of these rare cancers, presenting a comparison of the onset ages for them in the general population wit h the ages of onset for the cancers observed in the Vi e t n a m veterans. He will also discuss the relationship of cancer induction to immune deficiencies or deficits. He will place special emphasis upon lymphomas and soft tissue sarcomas and explain how the ex­ perience with transplant patients validates his opinions in this regard. Finally, he will discuss the question of a threshold in the induction of cancer. This will include testimony to the effect that there is no "safe" dose for a carcinogen and that a single exposure may cause cancer. He will also discuss the disease-producing behavior of gener a l i z e d carcinogens, i.e., the chance of a single carcinogen leading to cancer at multiple sites. E? 0 *9 £► 1 i n i/-•a bringing a W i trial. In LeCam, L., and . V J i J . n j . v C i UniverNeyman, J., eds. B i o l o g y and P r o b l e m s of Health. Vol. 4, pp. 855-866 sity of C a l i f o r n i a Press, Berkeley. (1967) S c h n e i d e r m a n , M.A. N o n - o b j e c t i v e art and o b j e c t i v e evaluation of cancer c h e motherapy. In Brodsky, I., and Kahn, S.B., eds. C a n c e r Chemotherapy. N e w York, Gruñe and Stratton. Pp. 67-76 (1967) Spurr, C.L., Carbone, P.P., and S c h neiderman, M.A. C o m parative e v a l u a t i o n of c y c l o p h o s p h a m i d e and vinca a lkaloids in lymphomas. P r o c e e d i n g s of the 57th Annual Mee t i n g of the A m e r i c a n A s s o c i a t i o n of C a n c e r R e s earch 7:67 (1966) Myers, M.H., S c h n e i d e r m a n , M . A . , and Armitage, P. Bo u n daries for closed (wedge) s e q u e n t i a l t-test plans. Biometrika 5 3 : 4 31-437 (1966) S c h n e i d e r m a n , M.A. E x p e r i m e n t a l d e s i g n cons i d e r a t i o n s in m u l t i ­ c l i n i c trials. In R a d o u c o - T h o m a s , C., exec. ed. Interna­ tional E n c y c l o p e d i a of P h a r m a c o l o g y and Therapeutics. P e r g a m o n Press, Oxford. Vol. 2, pp. 617-636 (1966) S c h n e i d e r m a n , M.A. The value of c o n t r o l l e d trials. In Hayward, J.L., and Bulbrook, R.D., eds. C l i n i c a l E v a l u a t i o n in B r e a s t Cancer. London, A c a d e m i c Press. Pp. 249-259 (1966) Cutler, S.J., G r eenhouse, S . W . ,.C o r n f i e l d , J., and S c h neiderman, M.A. T h e role of h y p o thesis testing in c l i nical trials. J. Chron. Dis. 1 9 : 8 57-882 (1966) Bourg e o i s , L.D., Hart, L.J., Herman, L.G., Schneiderman, M.A., and Young, V.M. E f f e c t on v arying p r e i n c u b a t i o n and d i f f u ­ sion times and an t i b i o t i c disc s u s c e p t i b i l i t y testing. In Day, R.A., ed. A n t i m i c r o b i a l A g ents and C h e m o t h e r a p y — 1965. W a v e r l y Press, Baltimore. Pp. 283-288 (1966) S c t m e i d e r m a n , M.A., on whom: Why? and Krant, M.J. W h a t shall we m e a s ure Canc e r Chemother. Rep. 50:107-112 (1966) Dawson, J.M., Hall, T.C., S c hneiderman, M.A., Shnider, B.I., Owens, A.H., Andrews, J.R., Baxter, D.H., Brenner, S . , Hunter, C., Levene, M.B., Sheehan, F.R., and White, G. The o b j e c t i v e e v a l u a t i o n of change in tumor size in lung cancer p a t i e n t s with n o n - m e a s u r a b l e disease. C a n c e r 19:415-420 (1966) SCHNEIDERMAN, page 13 Sch neiderman, M.A. L o o k i n g backward: Is it worth the crick in the neck? Or: P i t f a l l s in using r e t rospective data. A J R 9 6 : 2 30-235 (1966) Bull, B.S., Schneiderraan, M.A., and Brecher, with the Cou l t e r counter. Am. J. Clin. (1965) G. P l a t elet counts Pathol. 45:678-688 S c h n e i d e r m a n , M.A. How can we find an opt i m a l dose? A p p l . Pharmacol. 7, Supp. 2:44-53 (1965) Sch neiderman, M.A. J. O r a l Ther. Toxicol. The op t i m a l dose and the ranking of drugs. Pharmacol. 2 :118-119 (1965) Carbone, P.P., Krant, M.J., Miller, S.P., Hall, T . C . , Shnider, Colsky, J., Horton, J., Hofley, H., Miller, J.M., Frei, E.J., III, and Schnei d e r m a n , M.A. The feasi b i l i ty of ■using r a n d o m i z a t i o n schemes early in the clinical trials of new c h e m o t h e r a p e u t i c agents: H y d r o x y u r e a (NSC-32065). Clin. Pharmacol. Ther. 6:17-24 (1965) Sch n e i d e r m a n , M.A. ma's strudel" The proper size of a c l i n i c a l trial: method. J. N e w Drugs 4:3-11 (1964) 3. "Grand­ Schnei d e r m a n , M.A. D e f e n s i v e design of c l i n i c a l trials. In Sternberg, T.H., and Newcomer, V.D., eds. The E va l u a t i o n of T h e r a p e u t i c Agen t s and Cos m e t i c s . McGraw-Hill, New York. Pp. 66-73 (1964) Sch neiderman, M.A., Myers, M.H., Sathe, Y.S., and Koffsky, P. Toxicity, the therapeutic index, and the ranking of drugs. S c i e n c e 1 4 4 : 1 2 1 2 - 1 2 1 4 (1964) Schnei d e r m a n , M.A. Is it really bad? A p r o p o s a l for the to x i ­ c i t y - t e s t i n g of drugs. J. Soc. C o s m e t i c Chem. 14:227232 (1963) Sch n e i d e r m a n , M.A., and Armi t a g e , B i o m e t r i k a 49:359-366 (1962) P. Closed sequential t-tests. Brecher, G., Jakobek, E.F., Sc h n e i d e r m a n , M.A., Williams, G.Z., and Schmidt, P.J. Siz e d i s t r i b u t i o n of erythrocytes. Ann. N.Y. Acad. Sci. 99 : 2 4 2 - 2 6 1 (1962) Sch n e i d e r m a n , M . A . , and Armitage, P. A f a mily of closed s e q u e n ­ tial procedures. B i o m e t r i k a 49:41-56 (1962) Schnei d e r m a n , M.A. J. Chron. Dis. The clinical e x c u r s i o n 51:283-295 (1962) into 5 - f l u o r o u r a c i l . SCHNEIDERMAN, page 14 Schnei d e r m a n , M.A. C o n t r o l l e d c l i n i c a l trials: Monday's count­ d own for T u e s d a y ' s launching. J. N e w D r u g s 1 :250-255 (1961) Schneiderman, M.A. S t a t i s t i c a l p r o b l e m s in the screening search for an t i c a n c e r drugs by the N a t i o n a l C a n c e r I n s t i t ute of the U n i t e d States. In Q u a n t i t a t i v e M e t h o d s in P h a r m a c o l ­ ogy. N o r t h H olland P u b l i s h i n g Co., Amsterdam. Pp. 232247 (1961) Zubrod, C.G., S c h n e i d e r m a n , M.A., Frei, E . , III, Brindley, G., Gold, G.L., Shnider, B . , Oviedo, R . , Gorman, J., Jones, R . , Jr., Jonsson, G., Colsky, J., Chalmers, T., Ferguson, B., D éderick, M . , Holland, J., Selawry, O., R e g e l s o n W . , Lasagna, L . , and Owens, A.H. A p p r a i s a l of met h o d s for the study of c h e m o t h e r a p y of cancer in man: Comparative thera p e u t i c trial of n i t r o g e n mus t a r d and triethylene t h i o p h o s p h o r a m i d e . J. Chron. Dis. 11:7-33 (1960) Leiter, J., Wodensky, I., Bourke, A.R., and Schneiderman, M.A. S c r e e n i n g data from the C a n c e r C h e m o t h e r a p y N a t i o n a l S e r vice C e nter screening laboratories, III. Cancer Res. 19:488575 (1959) Leiter, J., and Schnei d e r m a n , M.A. Scre e n i n g data from the C a ncer C h e m o t h e r a p y N a t i o n a l Service Center screening laboratories. Canc e r Res. 19:31-279 (1959) Schne i d e r m a n , M.A. M a t h e m a t i c a l m o d e l s in the r e g u l a t i on of g r a n u l o c y t e production. In Stohlman, F., Jr., ed. Kinetics of C e l l u l a r P r o l i f eration. G r u ñ e and Stratton, N ew York. Pp. 259-264 (1959) Brindley, C.O., Markoff, E . , and S c h neiderman, M.A. Direct o b s e r v a t i o n s of lesi o n size and number as a m e t h o d of following the g r o w t h of human tumors. C a n c e r 12:139-146 (1959) Freireich, E.J., Schmidt, P.J., Schneiderman, M . A . , v E. , III. A c o m p a r a t i v e study of the effe c t of of fresh and p r e s e r v e d whole blood on b l e e d i n g with acute leukemia. N. Eng. J. Med. 2 6 0 :6-11 Armitage, P., and Schneid e r m a n , in mas s scre e n i n g program. 908 (1958) Frei, M.A. Ann. and Frei, transfusion in patients (1959) S t a t i s t i c a l p r o b l ems N.Y. Acad. Sci. 76:896- E. , III, Holland, J.F., Schnei d e r m a n , M . A . , Pinkel, D., Selkirk, G. , Freireich, E.J., Silver, R.T., Gold, G.L., and Regelson, W.A. A c o m p a r a t i v e study of two regimens of c o m b i n a t i o n c h e m o t h e r a p y .in acute leukemia. Blood 13: 1126-1148 (1958) . . tri X /v o o .i. SCHNEIDERMAN, page 15 Schneid e r m a n , M.A. E p i d e m i o l o g y of carc i n o m a of the.breast. Med. Ann. Dist. C o l u m b i a 27:275-280 (1958) Silver, R.T., Beal, G.A., Schneiderman, M.A., and McCullough, N.B. The role of the m a t u r e ne u t r o p h i l in b a cterial infections in acute leukemia. Blood 1 2 : 8 14-821 (1957) Stohlman, F., Jr., Brecher, G., Schneiderman, M.A., and Cronkite, I The h a e m o l y t i c effect of ionizing radiation and its r e l a t i o n ­ ship to the h e m o r r h a g i c phase of radiation injury. Blood 12: 1 0 6 1 - 1 0 8 5 (1957) Brecher, G . , S c h n e i d e r m a n , M . A . , and Williams, of an e l e c t r o n i c red blood cell counter. Pathol. 2 6 : 1 4 3 9 - 1 4 4 9 (1956) G.Z. E va l u a t i o n Am. J. Clin. Olivier, L . , and S c h n e i d e r m a n , M.A. A method for estimating the d e n s i t y of a q u a t i c snail populations. Exp. Parasitol. 5:10 9 - 1 1 7 (1956) Stohlman, F . , Jr., and Schneiderman, M.A. A p p l i c a t i o n of the c r ^ tech n i q u e to the study of e x p e r imental hemolysis in the dog. J. Lab. Clin. Med. 47:72-37 (1956) Cutler, S.J., Sc h n e i d e r m a n , M.A., and Greenhouse, S.W. s t a t i s t i c a l c o n s i d e r a t i o n s in the study of cancer Am. J. P u b l i c H e a l t h 4 4 : 1 159-1166 (1954) Some in industry. Prehn, R.T., Main, J.M., and Schneiderman, M.A. Factors in f l u ­ encing tumor d i s t r i b u t i o n among the mam m a r y glands of the mouse. JNCI 1 4 : 8 95-904 (1954) Olivier, L., and S c h n e i d e r m a n , M.A. A c q u i r e d resistance to s c h i s t o s o m a M a n s o n i infection in laboratory animals. Am. J. Trop. Med. H y g . 2:298-306 (1953) Brecher, G., Sc h n e i d e r m a n , M.A., and Cronkite, ibility and c o n s t a n c y of p l a t e l e t counts. Pathol. 23:15-26 (1953) E.P. The r e p r o d u c ­ Am. J. Clin. Heston, W.E., and S c h n e i d e r m a n , M.A. Analysis of d o s e - r e s p o n s e in r e l ation to m e c h a n i s m of p u l m o n a r y tumor induction in mice. S c i e n c e 1 1 7 : 1 0 9 - 1 1 1 (1953) Plum, C.M., C l e m m e s e n , J., and Schneiderman, M.A. In vitro study of bone m a r r o w v. e r y t h r o p o i e s i s of bone marrow from cases of p e r n i c i o u s anemia and leukosis. Acta Med. Scand. 1 4 3 : 2 3 7 - 2 4 8 (1952) 12 SCHNEIDERMAN, page 16 S c h n e i d e r m a n , M . A . , Mantel, N., and Brecher, G. T h e effect of r ejection p r o c e d u r e s on the a c c u r a c y of blood counts. • u* v_.xj.ii* ira Lnuj.. 4»-U ♦J ! Schneiderman, M.A., and Brecher, G. The relative freq uency of sparse cell e l e m e n t s — an a p p l i c a t i o n to reti c u locyte blood counts. B i o m e t r i c s 6 : 3 9 0 - 3 9 4 (1950) Brecher, G., and Schneiderman, M.A. the c o u n t i n g of reticulocytes. 20:1074-1083 (1950) A time saving device Am. J. Clin. Pathol. Williamson, C.R., and Schnei d e r m a n , M.A. survey films for heart d i s e a s e case 30:7-14 (1950) for The use of mass x-ray finding. Mass. H e a l t h J. D i 1 J-* J 1 1__________ I J c i i c n o iijje r y e iQ , "p n i _ t'n .u ., is an environmental scientist and toxicologist who is the Chief Toxicologist for the Environmental Defense Fund and a R e s e a r c h Scientist in the R e p r o ductive Toxicology L a b o ratory of the National Institutes of H e alth in Bethesda, Maryland. vitae is attached. Dr. S i l b ergeld will models for TCDD toxicity. model, Her curriculum testify as to the scientific She will e mphasize the receptor its role in physiology, how to dete c t receptors and how to link receptors to function. She will discuss how receptors recognize TCDD by virtue of structural "fine-tuning". She will testify as to the existence of receptors in humans and in their various organs, together w i t h the implications of their presence for TCDD potency. She will also discuss the extrapolations w h i c h are possible bet w e e n animals and humans. She will further testify as to the mec h a n i s m s of toxicity including the sensitivity of the r e p r o ductive system, endocrine and gonadal, Finally, to the r e c e p t o r - m e d i a t e d both effects of TCDD. she will discuss the consequences of receptor inter­ action with TCDD insofar as that interaction produces results involving RNA-DNA, AHH induction, and heme synthesis regulation, among others. In the field of neurotoxicity, she will discuss the experimental and clinical studies with p a r t i c u l a r emphasis upon dose-response mechanisms, acute versus chronic exposures and early versus long latency effects. She will also discuss the 12554 biochemical and m o r p h o l o g i c a l effects of TCDD, the e l e c tro­ physiology involved and the effects of TCDD on such things as cognition, mood, and affect. She will also e m p h a s i z e the basic mechanisms of toxicity on b o t h the central and peripheral nervous systems, specifically dealing w i t h the role of altered porphyrin synthesis on the nervous system. will be discussed: First, Three aspects of this problem the effects of decreased cellular energy supply on neuronal a c t ivity and viability; second, the effects of decr e a s e d heme systhesis on the integrity of myelin; and third, the n e uroactive pr o p e r t i e s of certain porp h y rin precursors. 12555 CURRICULUM VITAE N a m e : _ -Ellen Kovner Silbergeld Date and Place of B i r t h : July 29, 1945. Washington, DC Education: 1967 - A.B. 1972 - Ph.D. Vassar College Johns Hopkins University Chronology of E m p l o y m e n t : 1967 1968- 70 1969- 71 1972-75 1975 1975-79 1979-81 1982 Instructor, California International Summer Program, Uppsala Sweden Secretary and Program Officer. National Academy of Sciences. National Research Council, Washington. DC "Nader's Raiders", Center for the Study of Responsive Law. Washington, DC Postdoctoral Fellow in Environmental Medicine and Neurosciences, Johns Hopkins University. Baltimore. Maryland Assistant Professor. Department of Environmental Medicine, School of Hygiene and Public Health, Johns Hopkins University Staff Fellow and Head. Unit on Behavioral Neuropharmacology. Experimental Therapeutics Branch. NINCDS.NIH Chief, Section on Neurotoxicology, NINCDS.NIH Chief Toxics Scientist, Environmental Defense Fund, Washington, DC Guest Scientist, Reproductive Toxicology Section. Pregnancy Research Branch. NICHD.NIH Other Professional A p p o i n t m e n t s : Consultant. NSF Energy Program. 1974-1975 Member. Nutrition Foundation National Committee on Food Additives and Hyperkinesis. 1975-1980 Member. USDHEW-FDA Committee to Coordinate Toxicology and Related Programs. 1977-1981 Member, US Delegation of the Joint US-USSR Health Agreement on Environmental Health. 1977-78 Member, Society for Neuroscience Committee on Social Issues. 1978 Member. OECD Chemicals Program Ad Hoc Expert Review Committees on Reproductive Toxicity and Neurotoxicity. 1982 - 12556 Member, Member. Member. Member. Member. Member. US Delegation to OECD Expert Meetings on Existing Chemicals, 1983 Hazardous Waste Task Force and Hazardous Waste Facilities Siting Board. State of Maryland, 1983 Govenor's Blue Ribbon Panel on Binghamton. NY. State Office Building. 1982 Executive Committee. Science Advisory Board. US EPA, 1983 Board on Toxicology and Environmental Health Hazards. National Academy of Sciences. 1983 Public Policy Committee. American Society for Neurochemistry, 1983 - Professional Society M e m b e r s h i p s : American Public Health Association Society for Occupational and Environmental Health Society for Neuroscience Association of Women in Science American Association for the Advancement of Science International Brain Research Organization American Society for Neurochemistry American Society for Pharmacology and Experimental Therapeutics Engineering Society of Baltimore Other Activities Secretary-Treasurer, Society for Occupational & Environ­ mental Health. 1983Editorial Board: Neurobehavioral Toxicology. 1979American Journal of Industrial Medicine. 1980Neurotoxicology, 1981Environmental Research, 1983Hazardous Waste. 1983 Participant. NIH Consensus conferences, 1979 and 1982 Expert consultant on lead poisoning. U.S. Secret Service. 1979-81 Chairperson. Society for Occupational and Environmental Health Special Committee on El Paso Lead Poisoning. 1977-1979 Preceptor, NIGMS Pharmacology-Toxicology Research Associateship Program. 1977-1981 Graduate board examiner. University of Pittsburgh and University of Toronto Lecturer, continuing medical education courses in environ­ mental medicine (Johns Hopkins) and occupational medicine (NIOSH) 2 \n E l e c t e d c o u n c i l l o r . NIMH-NINCDS A s s e m b l y o f S c i e n t i s t s . 1979-1981 E l e c t e d r e p r e s e n t a t i v e . NINCDS EEO C o m m i t t e e . 1 9 7 7 - 1 9 8 0 C o - ^ o r g a n i z e r , Women i n N e u r o s c i e n c e M e m b e r . S o l o w e y L e c t u r e s h i p s e l e c t i o n c o m m i t t e e , NIH , 1 AOA 1 no 1 J.7 0 U -1 7 0 1 E n v i r o n m e n t a l H e a l t h C o n s u l t a n t , O i l . C h e m i c a l and A to m ic W o rk ers U n i o n . AFL-CIO. W a s h i n g t o n . D . C . . 1 9 7 0 R e v i e w e r . EPA d o c u m e n t s o n l e a d , m a n g a n e s e . m e r c u r y , d i o x i n , r i s k a s s e s s m e n t , and e x p o s u r e . 1 9 8 1 Ad H o c M e m b e r , O c c u p a t i o n a l S a f e t y a n d H e a l t h S t u d y S e c t i o n . NIOSH, 1 9 8 3 M e m b e r , NIMH C o m m i t t e e o n F r o n t i e r s o f N e u r o s c i e n c e . 1 9 8 3 G r a n ts r e v i e w e r . N a t i o n a l F o u n d a t i o n - March o f D im es; N a tio n a l S c ie n c e F o u n d ation : N u t r it io n F ou n d ation : T h r a s h e r F o u n d a t i o n ; H e r e d i t a r y D i s e a s e s F o u n d a t i o n . NIH M an u scrip t r e v ie w e r . L i f e S c i e n c e s . B io c h e m ic a l P h a rm a co lo g y . E n v iro n m en ta l J o u rn a l P h arm acology. S c i e n c e . N e u r o to x ic o lo g y . N eu rob eh avioral T o x ico lo g y T e r a to lo g y . P h arm acology B io c h e m ic a l B e h a v io r . P r o c s . S o c i e t y E xp erim en tal B i o l o g i c a l M e d ic in e . E xp erim ental N e u r o lo g y , etc. Honors and Aw ards: G r a d u a t e d summa cum l a u d e , 1 9 6 7 e l e c t e d t o P h i B e ta Kappa. 1967 u n d erg ra d u a te academ ic s c h o la r s h ip . 1963-1965 Woodrow W i l s o n N a t i o n a l F o u n d a t i o n F e l l o w , 1 9 6 7 - 1 9 6 8 L ev erh u lm e and F u l b r i g h t F e l l o w s h i p s to U n i v e r s i t y o f London, 1967 N a t io n a l S c i e n c e F o u n d a tio n G raduate T r a i n e e s h ip . 1 9 6 8 -1 9 7 2 P u b l i c H e a l t h S e r v i c e R e s e a r c h F e l l o w s h i p t o Woods H o l e , 1970 R o c k e fe lle r F oun dation p r e d o c to r a l r e se a r c h f e llo w s h ip . 1971-1972 NIH p o s t d o c t o r a l f e l l o w s h i p i n e n v i r o n m e n t a l h e a l t h s c ie n c e s , 1972-1972 J o s e p h P. K ennedy, J r . F e l l o w s h i p i n n e u r o s c i e n c e s . 1974-1975 P h a rm a ceu tica l M anufacturers A s s o c ia t io n F oun dation R esearch S t a r t e r Award. 1 9 7 4 -1 9 7 5 N a t i o n a l Academy o f S c i e n c e s E x ch a n g e F e l l o w t o Y u g o s l a v i a , 1976 G eorge M ille r l e c t u r e s h ip in en v iro n m en ta l s t u d ie s . U n i v e r s i t y o f I l l i n o i s , 1984 P ro fessio n a l In terests: N eu rop h arm acology & T o x ic o lo g y E n viron m en tal R isk A ssessm en t 3 12558 BIBLIOGRAPHY ELLEN KOVNER SILBERGELD A. S C I E N T I F I C PUBLICATIONS 1. Silb ergeld . E.K .: D ieldrin: E ffe c ts of chronic su b le th a l e x p o s u r e on a d a p t a t i o n t o t h e r m a l s t r e s s i n a f r e s h w a t e r fish. Environ. S c i. Technol. 7 :8 4 6 -8 4 9 , 1973. 2. S i l b e r g e l d . E. K . : and G o l d b e r g , A . M . : A lead-induced behavior d iso rd er. L i f e S c i . 1J_(9) : 1 2 7 5 - 1 2 8 3 , 1 9 7 3 . 3. S i l b e r g e l d , E. K . : Blood g lu c o se : A se n s itiv e indicator of environm ental s t r e s s in f i s h . B u l l . E n v ir o n . Contam. T o x ico l l l ( l ) : 2 0 - 2 5 . 1974. 4. S i l b e r g e l d , E. K . , F a l e s . J . Evidence for a p reju n c tio n a l function. Nature 2 4 7 :49-50. 5. S i l b e r g e l d . E. K . , F a l e s , J . T. and G o l d b e r g , A . M . : L e a d : The e f f e c t s o f i n o r g a n i c l e a d o n t h e n e u r o m u s c u l a r junction. Neuropharmacology 13.:146-157, 1974. 6. S i l b e r g e l d , E . K. a n d G o l d b e r g . A . M . : Lead behavioral dysfunction: An a n i m a l m o d e l o f Exp. N e u r o l . 4 2 : 1 4 6 - 1 5 7 , 1 974. 7. S i l b e r g e l d . E . K. a n d G o l d b e r g . lead induced behavior d is o r d e r . 7:227-232. 1974. 8. S i l b e r g e l d , E . K. a n d G o l d b e r g . A . M . : Pharm acological neurochem ical i n v e s t i g a t i o n s of lead induced hyperactivity. Neuropharmacology 1.4:431-444, 1975. 9. M o r r i s o n . J . H . . O l t o n . D. S . . G o l d b e r g , A. M. a n d S i l b e r g e l d , E. K . : A l t e r a c t i o n s in consummatory b e h a v io r o f m i c e p r o d u c e d by d i e t a r y e x p o s u r e t o i n o r g a n i c l e a d . D e v . P s y c h o b i o l . 8.( 5 ) : 3 8 9 - 3 9 6 . 1 9 7 5 . 10. S i lb e r g e ld . E.K.: N e u r o c h e m i c a l and p h a r m a c o l o g i c a l s tu d ie s of cen tra l nervous system lead to x ic o lo g y . In. C a r n o w , B. W. ( e d . ) : H e a l t h E f f e c t s o f O c c u p a t i o n a l Lead a n d A r s e n i c E x p o s u r e . USDHEW. PHS, CDC, NI OSH. W a s h i n g t o n . D . C . . pp. 7 4 - 8 5 . 1976. T. and G o l d b e r g . A . M . : e f f e c t on n e u r o m u s c u la r 1974. Lead: induced hyperactivity. A .M .: H yperactivity: A Environ. H ealth Persp. and 4 1 C- O 53 11. S i l b e r g e l d . E . K. a n d C h i s o l m . J . J . , J r . : Lead poisoning: A ltered u rin a ry catecholam ine m e ta b o lite s as i n d i c a t o r s o f i n t o x i c a t i o n i n m i c e and c h i l d r e n . Science 192.1153-155, 1976. 12. F i t z g e r a l d , R. S . . G a r f i n k e l , F . , S i l b e r g e l d . E . K. a n d L o scu to ff, S.C .: F a c t o r s i n t h e i n t e r p r e t a t i o n o f mouth o c c lu s i o n p r e ssu re during measurements of chem osensitivity. Chest 7 0 (1 ):1 4 5 -1 4 9 . 1976. 13. S i l b e r g e l d . E . K. a n d G o l d b e r g . A. M . : H yperactivity. In G o l d b e r g , A.M. and H a n i n . I . (eds): B iology of C holinergic F unction. R a v e n P r e s s . Ne w Y o r k . p p . 6 1 9 - 6 4 5 . 1976. 14. S i l b e r g e l d . E. K . : In teraction s of s y n a p t o s o m a l u p t a k e o f do p a m in e and 2 0 ( 2 ) :309-318, 1977. 15. C a r r o l l . P . T . , S i l b e r g e l d , E . K. a n d G o l d b e r g , A . M . : A l t e r a t i o n o f c e n t r a l c h o l i n e r g i c f u n c t i o n by c h r o n i c l e a d aceta te exposure. Biochem. Pharmacol. 2 ^ :3 9 7 -4 0 2 . 1977. 16. S i l b e r g e l d , E . K. a n d P f e i f f e r . R. F . : D ifferential e f f e c t s o f t h r e e dopamine a g o n i s t s : Apomorphine. b r o m o c r i p t i n e and l e r g o t r i l e . J . Neurochem. 28:1323-1326. 1977. 17. S i l b e r g e l d . E. K .: Na+ r e g u l a t e s r e l e a s e seq u estered in synaptosomal m itochondria. B i o p h y s . R e s . Comm. 77. ( 2 ) : 4 6 4 - 4 6 9 , 1 9 7 7 . 18. Silbergeld. Subcellular Comm. Che m. l e a d and choline. c a l c i u m on t h e Life Sci. o f Ca++ Biochem. E . K . . A d l e r , H. S . a n d C o s t a . J . L . : lo c a liz a t io n of lead in synaptosom es. P a th o l. Pharmacol. 1 7 :7 1 5 -7 2 5 . 1977. Res. 19. G o l d b e r g . A. M. a n d S i l b e r g e l d . E . K . : Animal m odels o f h y p e r a c t i v i t y In. H a n i n . I . a n d U s d i n , E . ( e d s . ) : Animal M o d e l s o f P s y c h i a t r y a n d N e u r o l o g y . P e r g a m o n P r e s s , Ne w York. pp. 3 7 1 -3 8 4 . 1977. 20. S i l b e r g e l d . E . K . . A d l e r . H. S . . K e n n e d y . S . a n d C a i n e . D. B.: t h e r o l e s o f p r e s y n a p t i c f u n c t i o n and h e p a t i c dr u g m e t a b o l i s m i n t h e h y p o t h e r m i c a c t i o n s o f some n o v e l dopam inergic a g o n is ts . J . Pharm. Pharmacol. 29:632-635. 1977. 5 12560 21. S i l b e r g e l d . E. K . : Neuropharm acology of h y p e r k i n e s is . In V a l z e l l i . L . a n d E s s m a n . W. B . ( e d s . ) : Cu r r e n t D ev elo p m en ts in P sy c h o p h a r m a c o lo a v . v o l . 4, pp. 1 8 1 -2 1 4 . 1977. 22. S i l b e r g e l d . E . K. a n d A d l e r . H. S . : S u b c e l l u l a r mechanisms of lead n eu ro to x icity . Brain Res. 14 8 (2 ):4 5 1 -5 6 7 . 1978. 23. S i l b e r g e l d , E . K . . C a r r o l l . P . T . a n d G o l d b e r g . A. M . : N eu rotoxicity of lead: A review of experim ental s tu d ie s . P r o c . I n t e r n a t i o n a l C o n f e r e n c e on Heavy M e t a l s i n th e E n v iro n m en t. U n i v e r s i t y o f T o ro n to P r e s s . T o r o n to . Canada, pp. 2 1 3 - 2 2 8 . 1 9 78. 24. S i l b e r g e l d . E . K. a n d C o s t a . J . L . : synaptosomal calcium m e t a b o l i s m s t u d i e s by e l e c t r o n m ic r o p r o b e a n a l y s i s . Exp. N e u r o l. 63_:277-292. 1979. 25. C a i n e . D . B . . K e b a b i a n , J . . S i l b e r g e l d . E . K. a n d E v a r t s . E.: Advances in the neuropharm acology o f P arkinsonism . A n n . I n t . M e d . 90. ( 2 ) : 2 1 9 - 2 2 9 . 1 9 7 9 . 26. S i l b e r g e l d , E. K. and W a l t e r s . J . R . : Synaptosomal uptake and r e l e a s e o f d o p a m in e i n s u b s t a n t i a n i g r a : e f f e c t s of GABA a n d s u b s t a n c e P . N e u r o s c i . L e t t . ¿ 2 _ : 1 1 9 - 1 2 6 , 1 9 7 9 . 27. W a l s h , M. J . and S i l b e r g e l d , fo r pharm acology r e s e a r c h . 1 0 :4 3 3 -4 3 6 . 1979. 28. H r u s k a . R . E . . K e n n e d y . S . , and Q u a n t i t a t i v e a s p e c t s o f normal S c ie n c e s 25/.171-179. 1979. E.K.: Rat Pharmacol. rotation Biochem. m onitoring a Behavior S i lb e r g e ld . E.K.: locom otion in r a ts . Life 29. H r u s k a , R . E . and S i l b e r g e l d . E . K . : Abnormal l o c o m o t i o n r a ts a fte r b i l a t e r i a l i n t r a s t r i a t a l in j e c t io n of k a in ic acid. L i f e S c ie n c e s 25.:181-193 , 1979. 30. S i l b e r g e l d . E . K . . H r u s k a . R . E . . W e i r . R . . and K ennedy, S. W. : D o p a m i n e r g i c and s e r o t o n e r g i c e f f e c t s o f e r g o t drugs. I n : F u x e , K. a n d C a i n e , D . B . . e d s . D o p a m i n e r g i c E r g o t D e r i v a t i v e s and M o to r F u n c t i o n . P e r g a m o n . O x f o r d , 223-235. 1979. i l . L a f f e r m a n , J . A . . and S i l b e r g e l d , E . K . : Erythrosin B i n h i b i t s dopamine t r a n s p o r t in r a t cau d ate s y n a p to s o m e s . S c ien ce 2 0 5 :410-412. 1979. 6 in pp. 32. S i l b e r g e l d . E . K . . M i l l e r , L . P . . K en n ed y, S . . and Eng. N . : L e a d , GABA a n d s e i z u r e s : e f f e c t s of subencephalopathic l e a d e x p o s u r e on s e i z u r e s e n s i t i v i t y and GABAergic function. E n v i r o n . R e s . .19.: 3 7 1 - 3 8 2 . 1 9 7 9 . 33 . S i l b e r g e l d . E. K. and H r u s k a . R . E . : on s e r o t o n e r g i c f u n c t i o n : behavior Eur. J . Pharm acol. 5 8 : 1 - 1 0 . 1979. 34. S i l b e r g e l d . E. K. and H r u s k a . R . E . : E ff e c t s of k ain ic acid on b e h a v i o r a l and b i o c h e m i c a l a s p e c t s o f c h o l i n e r g i c function. In: C h a s e , T . N . . W e x l e r , N . S . . and B a r b e a u , A . , e d s . . A d v a n c e s i n N e u r o l o g y , V o l . 23 ( H u n t i n g t o n ' s D i s e a s e ) . Raven. N . Y . . pp. 6 3 3 -6 4 4 , 1979. 35. S i l b e r g e l d . E. K. and H r u s k a . R . E . : L i s u r i d e a n d LSD: D o p a m i n e r g i c and s e r o t o n e r g i c i n t e r a c t i o n s i n t h e " s e r o to n in syndrome". Psychopharm acology £ 5 :2 3 3 -2 3 7 , E f f e c t s of e r g o t d cuy and n e u r o c h e m i s t r y . 1979. 36. S i l b e r g e l d . E. K. and H r u s k a . R . E . : Tremor: Role of s t r i a t a l c h o l i n e r g i c n e u r o n s and t h e e f f e c t o f in tr a str ia ta l kainic acid. N eurosci. L etters 15:235-242. 1979 . 37. S i l b e r g e l d , E. K. and G o l d b e r g , A . M . : Problems in experim ental s tu d ie s of lead p o iso n in g . In Singhal, and Tho mas . J . A . ( e d s . ) : Lead T o x i c i t y . B a l t i m o r e : and S c h w a r t z e n b e r g . pp. 1 9 - 4 2 . 1 9 8 0 . R. D. Urban 38. H r u s k a , R. E. and S i l b e r g e l d , E . K . : Estrogen treatm ent enhances dopamine r e c e p t o r s e n s i t i v i t y in th e r a t striatum . Eur. J. Pharm acol. £ 2 : 3 9 7 - 4 0 0 , 1980. 39. S i l b e r g e l d . E . K . , G o l d s t e i n . G. W. . and W o l i n s k y . J . : E le c tr o n probe m ic r o a n a ly s is of i s o l a t e d brain c a p i l l a r i e s poisoned w ith lead. Brain Res. 1 8 9 :369-376, 1980. 40. S i l b e r g e l d , E . K . , H r u s k a . R . E . . M i l l e r , L . P . , and Eng. E f f e c t s o f l e a d i n. v i v o a n d i n. v i t r o o n G A B A e r g i c neurochem istry. J . N e u r o c h e m . 34.: 1 7 1 2 - 1 7 1 8 , 1 9 8 0 . 41. H r u s k a , R. E. and S i l b e r g e l d . E . K . : Increased recepton s e n s it iv i t y a fte r estrogen treatm ent r o t a t i o n m odel. S cien ce 2 0 8 :1466-1468. 1980. 42. dopamine u sin g the N .: rat H r u s k a , R. E. and S i l b e r g e l d . E . K . : C o r tic a l neurochemical changes a fte r i n t r a s t r i a t a l i n j e c t io n of k a in ic acid . Brain Res. 1 91:572-576. 1980. 7 12562 43. H r u s k a . R . E . and S i l b e r g e l d . E . K . : E ffect of d e r i v a t i v e s on p o s t - d e c a p i t a t i o n c o n v u l s i o n s . P s y c h o p h a r m . 4.: 5 7 - 6 2 . 1 9 8 0 . AA u Urne lrUa 0 4 V » 4 J • | T.n^mer ir\A C i 1 K û r c t û l t? ir 414 U U U H ypophysectom y p r e v e n t s t h e s t r i a t a l dopamine r e c e p t o r s u p e r s e n s i t i v i t y p r o d u c e d by c h r o n i c h a l o p e r i d o l treatm ent. E u r . J . P h a r m a c o l . 6J5 : 4 5 5 - 4 5 6 ( 1 9 8 0 ) . 45. S i l b e r g e l d . E. K. and H r u s k a . R . E . : Neurochemical i n v e s t i g a t i o n s of low l e v e l lead exposure. In: N eedlem an, H . L . . e d . . Low L e v e l L e a d E x p o s u r e : The C l i n i c a l I m p l i c a t i o n s o f C u r r e n t R e s e a r c h . Raven. N . Y . . pp. 135-157,1980. 46. H r u s k a . R . E . and S i l b e r g e l d . E . K . : Inhibition [ H ] s p ? r o p e r i d o l b i n d i n g b y i n. v itr o addition ethanol. J. Neurochem. 35.:750-752, 1980. 47. S ilb e r g e ld , E.K., s y n th e s is in lead 2 2 :6 8 0 -6 8 4 . 1980. 48. H r u s k a . R. E . . L u d m e r , L . M . , a n d S i l b e r g e l d . E . K . : C h a r a c t e r i z a t i o n o f t h e s t r i a t a l dopamine r e c e p t o r s u p e r s e n s i t i v i t y p r o d u c e d by e s t r o g e n t r e a t m e n t o f m a le rats. N e u r o p h a r m a c o l . 19.: 9 2 3 - 9 2 6 . 1 9 8 0 . 49. S i l b e r g e l d , E. K . : D etection of n eu rotoxicity using n eu ro ch em ica l methods In: R. M. G r y d e r a n d V . H. F r a n k o s , ( e d s . ) . The E f f e c t s o f F o o d s and D ru g s on t h e D e v e l o p m e n t and F u n c t i o n o f t h e N e r v o u s S y s t e m : Methods f o r P r e d i c t i n g T o x i c i t y . FDA ( N o . 8 0 - 1 0 7 6 ) , W a s h i n g t o n . D . C . , p p . 9 9 - 1 0 5 . 1980. 50. S i l b e r g e l d . E. K . : E rythrosin B is a s p e c if ic in h ib ito r of h i g h a f f i n i t y 3H - o u a b a i n b i n d i n g a n d i o n t r a n s p o r t i n r a t brain. N e u r o p h a r m a c o l . 20.: 8 7 - 9 0 . 1 9 8 1 . 51. S i l b e r g e l d . E. parkinsonism . 52. G o u d s m i t . J . . R o h w e r , R. G . . S i l b e r g e l d , E . K . . a n d G a d j u s e k . D. C . : H y p e r se n sitiv ity of cen tral seroton in r e c e p t o r a c t i v a t i o n i n s c r a p i e - i n f e c t e d h a m s t e r s and t h e e f f e c t s o f s e r o t o n e r g i c d r u g s on s c r a p i e symptoms. Brain Res. 220: 372-377, 1981. U U 4 4 1 II* M 4 ergot Commun. I of of and Lamon. J . M . : Role of a l t e r e d neurotoxicity. J . O c c u p . Me d . K . . and C a i n e , D. Pharmacol. T h er. B.: 12.: heme Animal m odels o f 159-166, 1981. 8 12563 53. H r u s k a , R. E . , a n d S i l b e r g e l d , E . n e u r o t r a n s m i t t e r b i n d i n g by e r g o t N eurosci. R e s . 6.: 1 - 1 1 . 1 9 8 1 . K.: I n h i b i t i o n of derivatives. J. 54. S i l b e r g e l d . E. K=. Lamon, J . M . . B r a d l e y . D . . H r u s k a , R . E . . P i t m a n . K . , H e s s . R. A . , a n d F r y k h o l m . B. C . : Heavy m e t a l n e u r o t o x i c i t y ; p o r p h y r in o p a th ic mechanisms. Procs. I n t e r n a t . S y mp . o n H e a v y M e t a l s . WHO-EEC-EPA. A m s t e r d a m , pp. 5 6 1 - 5 6 4 . 1981. 55. C h is o lm . J . J . , and S i l b e r g e l d . E . K . : Increased excretion of h o m ovan illic acid in ch ild r e n w ith increased lead absorption. P r o c s . I n t e r n a t . S y mp . o n H e a v y M e t a l s . WHO- EEC- EPA. A m s t e r d a m , p p . 5 6 5 - 5 6 8 , 1 9 8 1 . 56. W e i r , R. L . . H r u s k a , R. E . . a n d S i l b e r g e l d , E . K . : Binding o f a n t i p a r k i n s o n i a n e r g o t d e r i v a t i v e s t o t h e dopamine recep to r. Psychopharm acol. 75.: 1 1 9 - 1 2 3 , 1 9 8 1 . 57. S ilb e r g e ld . E.K.: N e u r o c h e m i c a l and i o n i c m ec h a n is m s o f lead n e u r o to x ic ity . In: ( V e r n a d a k i s , A . , a n d P r a s a d . K. N . , ( e d s . ) . Mechanisms of A c t io n of n e u r o t o x ic S u b s t a n c e s . R a v e n . Ne w Y o r k , p p . 1 - 2 4 . 1 9 8 2 . 58. H r u s k a , R. E . . P i t m a n . K. T . . S i l b e r g e l d , E . K . . a n d L u d me r , L. M . : P r o l a c t i n in c r e a s e s the d e n s it y of s t r i a t a l ■dopamine r e c e p t o r s i n n o r m a l and h y p o p h y s e c t o m i z e d m a l e rats. L ife S c i . 10: 547-553. 1982. 59. H r u s k a , R. E . , L u d m e r . L . M . . P i t m a n , K. T . . D e R y c k . M . . and S i l b e r g e l d . E. K . : E f f e c t s o f e s t r o g e n on s t r i a t a l d o p a m i n e r e c e p t o r f u n c t i o n i n m a l e and f e m a l e r a t s . P h a r m a c o l. Biochera. B e h a v . 16: 2 8 5 - 2 9 1 , 1982. 60. S i l b e r g e l d , E. K . , an d A n d e r s o n . S . M . : A r t i f i c i a l food c o l o r s and c h i l d h o o d b e h a v i o r a l d i s o r d e r s . B u l l . N. Y. A c a d . Me d . 58.: 3 7 5 - 2 9 5 , 1 9 8 2 . 61. M o r r i s . S . J . , S i l b e r g e l d . E . K . , B r o w n . R. R . , a n d H a y n e s . D. N . : E r y t h r o s i n B (USFD&C R e d 3 ) i n h i b i t s c a l c i u m t r a n s p o r t and AT Pa se a c t i v i t y o f m u s c l e s a r c o p l a s m i c reticulum . B i o c h e m . B i o p h y s . R e s . Commun. 1 0 4 : 1 3 0 6 - 1 3 1 1 , 1982. 62. S ilb e r g e ld , E.K.: Current s ta tu s and a p p l i e d . Trends in N eu ro sci. of n eu ro to x ico lo g y , 8.:291-294, 1982. basic 9 12564 63. S i l b e r g e l d , E . K . , A n d e r s o n . S . M . . and M o r r i s . S . J . : I n t e r a c t i o n s o f e r y t h r o s i n B ( U . S . F . D & C Re d 3 ) w i t h c o r t i c a l membranes. L i f e S c i . 3.1:957-969. 1982. rat 64. S i l b e r g e l d . E . K . . H r u s k a , R. E . . B r a d l e y . D . . L a m o n . J . M . , and F r y k h o l m , B. C . : N eu rotoxic a sp ects of porphyrinopathies: l e a d and s u c c i n y l a c e t o n e . Environ. R e s . . 22:459-471. 1982. 65. S i l b e r g e l d . E. K.: E x p e r i m e n t a l and e n v i r o n m e n t a l neurotoxins: c o r r e l a t i o n o f b e h a v i o r a l and b i o c h e m i c a l effects. I n L e v y . M. a n d S p i e g e l s t e i n . A. ( e d s . ) B e h a v i o r a l M o d e l s and t h e A n a l y s i s o f Dr ug A c t i o n E l s e v i e r - N o r t h H o l l a n d . A m s t e r d a m , pp 2 9 7 - 3 1 5 . 1 9 8 2 . 66. DeRyck. M . . H ru sk a. R . E . , and S i l b e r g e l d , E . K . : Estrogen and h a l o p e r i d o l - i n d u c e d v e r s u s h a n d l i n g - r e l a t e d c a t a l e p s y i n male r a t s . Pharmacol. Biochem. Behav. 1 7 :1 0 2 7 -1 0 3 5 . 1982. 67. S i l b e r g e l d . E. K . . L a f f e r m a n . J . . and F i n k e l . T . : In v i t r o testin g for n eu rotoxicity. In: K o l b e r . A . . Wo n g , T . K . , G r a n t. L . D . . D e w o sk in , R . S . . and H ughes. T . J . ( e d s ) . In V i t r o T o x i c i t y T e s t i n g o f E n v i r o n m e n t a l A g e n t s . Ne w Y o r k , P l e n u m , pp 4 7 3 - 4 8 6 . 1 9 8 2 . 68. S i l b e r g e l d . E . K . , and Lamon. J . M . : E ffe c ts of a ltered p o r p h y r i n s y n t h e s i s on b r a i n n e u r o c h e m i s t r y . Neurobehav. T o x i c o l . T e r a t o l . 4.: 6 3 5 ~ 6 4 2 * 1 9 8 2 . 69. H r u s k a , R. E . , W e i r , R. L . . P i t m a n . K. T . . a n d S i l b e r g e l d , E. K . : E r g o t d e r i v a t i v e s a r e p o t e n t d r u g s a t CNS a m i n e r g i c receptors: c o r r e l a t i o n s t o b e h a v i o r and a g i n g . In: A g n o l i . A . . T r a b u c c h i . M . . and S p a n o . P. F. ( e d s ) . A g i n g B r a i n a n d E r g o t A l k a l o i d s . Ne w Y o r k . R a v e n , p p 2 1 5 - 2 2 6 . 1983 . 70. S i lb e r g e ld , E.K.: Experim ental s tu d ie s of lead neurotoxicity: I m p lic a tio n s fo r mechanisms, d o s e - r e s p o n s e , and r e v e r s i b i l i t y . I n R u t t e r . M. , a n d R u s s e l l - J o n e s , R. ( e d s ) Le a d V e r s u s H e a l t h . L o n d o n , J o h n W i l e y , pp 1 9 1 - 2 1 6 , 1983 . 71. S i lb e r g e ld . E.K.: E f f e c t s o f l e a d on r e p r o d u c t i o n : review of experim ental s tu d ie s . In R u t t e r , M . . and R u s s e l l - J o n e s . R. ( e d s ) L e a d V e r s u s H e a l t h . L o n d o n . W i l e y , pp 2 1 7 - 2 2 7 . 1 9 8 3 . a John 10 --------- 12565 72. S ilb erg eld . E.K.: In d ir ec tly actin g neurotoxins. P s y c h i a t . S c a n d . 67. S u p p l . 3 0 3 , 1 6 - 2 5 , 1 9 8 3 . Acta 73. M a ttiso n . D. R. . Takizawa, K . . S i l b e r g e l d , E.K.. N i g h t i n g a l e , M . S . , J e r i n a , D . . and Y a g i , H . : G e n e t i c s o f o v a r i a n b e n z o ( a ) p y r e n e , m e t a b o l i s m , o o c y t e d e s t r u c t i o n , and impaired f e r t i l i t y . I n R y d s t r o m , J . . M o n t e l u i s , J . , and B e n g t s s o n , M. ( e d s ) E x t r a h e p a t i c D r u g M e t a b o l i s m a n d C h e m i c a l C a r c i n o g e n e s i s . A m s t e r d a m . E l s e v i e r , pp 3 3 7 - 3 5 0 . 74. S ilb e r g e ld . E.K.: L o c a liz a tio n of lead: im p lica tio n s for mechanisms of n e u r o t o x i c i t y . N e u r o to x ic o l. £:193-200, 1983. 11 - if* -t n w..‘ n> b I N PRESS: S ilb e r g e ld . E.K.: Behavioral te r a to lo g y of lead. In Yanai. J. (ed) B eh avioral T e r a t o lo g y . E ls e v ie r /N o r th H olland. S ilb e r g e ld , E.K.: N eu rotoxicity of lead. Blum, J . ( e d s ) N e u r o t o x i c o l o g y . D e k k e r . In Manzo. L. and F o w l e r . B . F . , and S i l b e r g e l d , E . K . : M e ch a n ism s o f m e t a l toxicity. In N r i a g u . J . . and H o r n i g . D. F . ( e d s ) C h a n g in g G e o c h e m i c a l C y c l e s o f M e t a l s a n d I m p l i c a t i o n s f o r Human H ea lth . B e r lin . Springer V erlag. M a t t i s o n . D . R . , and S i l b e r g e l d . E . K . : O c c u p a t i o n a l r i s k s t o reproduction. I n O s o f s k y . H. ( e d ) A d v a n c e s i n G y n e c o l o g y and O b s t e t r i c s . B a l t i m o r e . W i l l i a m s & W i l k i n s . S i l b e r g e l d . E. K. : M it o c h o n d r ia l mechanisms o f lea d neurotoxicity. I n N a r a h a s h i . T. ( e d ) C e l l u l a r and M o le c u la r Mechanisms of E n v iro n m en ta l N e u r o t o x i n s . Raven P r e s s . NY. i n p r e s s . S ilb e r g e ld . E.K.: PCBs. In K uiper, R e v ie w o f o c c u p a t i o n a l h e a l t h s t u d i e s on H. ( e d ) P C B s . M a r c e l D e k k e r . i n p r e s s . S i l b e r g e l d . E . K . : E f f e c t s o f PCBs i n O c c u p a t i o n a l Populations. I n V i s s e r . R. ( e d ) P C B s . A m s t e r d a m , E lsevier. M a t t i s o n . D . R . , and S i l b e r g e l d . E . K . : R e p r o d u c t i v e t o x i c i t y o f TCDD. I n L o w r a n c e , W. ( e d ) D i o x i n s . R o c k e f e l l e r U n iversity Press. I N PREPARATION: S i l b e r g e l d , E . K . , and M a t t i s o n , D . R . : E f f e c t s o f t h r e e p o l y c y c l i c a r o m a t i c h y d r o c a r b o n s on f e r t i l i t y i n f e m a l e m ice: A l i f e t i m e stu d y of th e e f f e c t s of s i n g l e - d o s e treatm ent. Silbergeld. E.K.: A Textbook in N eu rotoxicology. 12 12567 B. ABSTRACTS 1. Silbergeld. functions: presynaptic E. K . : E f f e c t s o f l e a d on n e u r o m u s c u la r In v i t r o e v i d e n c e f o r s i t e o f a c t i o n a t t h e level. Fed. P r o c . 32.:275, 1973. 2. S i l b e r g e l d , E . K. a n d G o l d b e r g , anim al model o f h y p e r a c t i v i t y . 3. S i l b e r g e l d , E . K. a n d G o l d b e r g , A. M . : c h o lin e r g ic -a m in e r g ic in t e r a c t i o n s in lead induced hyperactivity. P h a r m a c o lo g is t 16.:335. 1974. 4. G o l d b e r g , A. M. a n d S i l b e r g e l d , E . K . : a s p e c ts of lead induced h y p e r a c t i v i t y . Neurochem. p.185. 1974. 5. S i l b e r g e l d . E . K . , C a r r o l l . P . T . a n d G o l d b e r g . A. M. : Monoamines i n l e a d - i n d u c e d h y p e r a c t i v i t y . Pharm acologist 13:203, 1975. 6. G o l d b e r g . A. M . . C a r r o l l . P . T . a n d S i l b e r g e l d . E . K. : C holinergic aspects of h y p e r a c tiv ity . F ifth Internatl. M eeting for Soc. Neurochem., 1975. 7. P f e i f f e r . R. . a n d S i l b e r g e l d . E . K . : D ifferential b e h a v i o r a l and n e u r o c h e m i c a l e f f e c t s o f . t h r e e d o p a m i n e r g i c agonists. N e u r o s c i . A b s t . I_I:720. 1976. 8. S i l b e r g e l d . E . K. a n d M i l l e r . L . P . : Lead i n t o x i c a t i o n : c h a n g e s i n s e i z u r e t h r e s h o l d and g a m m a - a m i n o b u t y r i c a c i d function. N e u r o l o g y 4.(27) : 405, 1 977. 9. A d l e r . H. S . a n d S i l b e r g e l d . E . K . : Intrasynaptosom al i n t e r a c t i o n s o f l e a d and c a l c i u m i n d o p a m i n e r g i c neurotransm ission. P h a r m a c o l o g i s t 19.(2) : 4 0 , 1 9 7 7 . 10. S i l b e r g e l d . E . K. a n d W a l t e r s , J . R . : D o p a m i n e u p t a k e and r e le a s e in su b sta n tia nigra: E f f e c t s of gamma-aminobutyric a c i d and s u b s t a n c e P . P h a r m a c o l o g i s t 19.(2) : 5 4 4 . 1 9 7 7 . 11. S i l b e r g e l d . E . K . . M i l l e r . L. P . . K e n n e d y , S . a n d . E n g . Lead and s e i z u r e s : R ole of gamma-aminobutyric a c id . N eu rosci. Abst. I l l :1039. 1977. 12. A d l e r . H. S . C o s t a , J . L . a n d S i l b e r g e l d . E . K . : m icroan alysis in neurochem istry: L ocalization of A. M . : Lead p o i s o n i n g : an P h a r m a c o lo g ist 15.:143, 1973. Neurochem ical T r a n s . Amer. S o c . N .: X-ray an 13 l ^ elemental neurotoxin and manipulations of mitochondrial Ca++. Neurosci. Abst. ITI:1235. 1977. Silbergeld. E. K.. Eng. N.. systemic apomorphine on in rats with striatal kainic 4. 267. 1978. 13 Baring. M. D . , Walters, J . R .. . T?-P -F O f l t nf and L a k o s k i , J IX LI ■ U i . i. L. WJL firing rates of dopamine cells acid lesions. Neurosci. Abst. 14. Hruska, R. E. and Silbergeld. E. .: Ergot drugs inhibit spiroperidol and serotonin receptor binding. Soc. Neurosci. Abst. 4.: 425, 1978. 15. Silbergeld, E. K., Hruska. R. E., Walters. J. R., Kennedy. S.. Eng. N.. and deSantis, S.: Effects of intrastriatal kainic acid on motor behavior in rats. Soc. Neurosci. Abst. 4: 49. 1978. 16. Kennedy, S., Hruska. R. E., and Silbergeld, E. K.: Serotonergic-dopaminergic effects of ergot drugs. Soc. Neurosci. Abst. 4.: 426, 1978. 17. Silbergeld, E. . Hruska, R. E., Lamon. J. M . . Frykholm. B. F.. and Hess. R. A.: Neurotoxic mechanisms in porphyria and lead intoxication: Possible role of a-aminolevulinic acid. Clin. Res. 27:307A. 1979. 18. Lamon. J. M . , Silbergeld. E. K.. Frykholm, B. F.. and Hruska. R. E.: Extra-erythropoietic heme metabolism in lead intoxication. Clin. Res. 27: 299A, 1979. 19. Silbergeld. E. K.. Hruska. R. E.. Lamon. J. M . . Frykholm. B. F., and Hess. R.A.: The effects of lead (Pb) on hepatic heme synthesis and drug metabolism. Pharmacologist 21.: 209. 1979. 20. Silbergeld, E. K . , Hruska. R. E.. and Lafferman, J. A.: Actions of lead (Pb) on GABAergic neurotransmission: Discrepancies between in vivo and in vitro effects. Soc. Neurosci. Abst. 5.: 416, 1979. 21. Lafferman. J. and Silbergeld, E. K.: Erythrosin B (Food, Drug and Cosmetic Red No. 3) inhibits dopamine uptake in rat caudate s y n a p tosomes: a kinetic study. Soc. Neurosci. Abst. 5. 562. 1979. 22. Hruska. R. E. and Silbergeld, E. K . : Increased dopamine receptor sensitivity after estrogen treatment. Soc. Neurosci. Abst. 5.: 73 (1979), No. 236. 14 12569 23. Silbergeld. E. K . . Hruska. R. E.. Schwarcz. R.: GABA in the basal ganglia: effects of selective lesions. Brain Res. Bull., 4: 696, 1979. 24. Weir. R. L., Hruska. R. E. and Silbergeld. E. K . : of dopamine agonists on 3H-spiroperidol receptor binding. Soc. Neurosci. Abst. 5: 81, 1979. 25. Hruska, R. E.. Ludmer. L. M . , and Silbergeld, E. K.: Prolactin increases the number of striatal dopamine receptors. Pharmacologist 22:220 (1980), No. 338. 26. Silbergeld, E. K.: Erythrosin B: ouabain-like actions of an artificial food dye in rat brain tissue. Pharmacol. 22.: 198, 1980. 27. Hruska, R. E., Ludmer. L. M . . and Silbergeld. E. K.: The striatal dopamine receptor supersensitivity produced by estrogen may be mediated through prolactin. Soc. Neurosci. Abst. 6: 441. 1980. 28. Chisolm. J. J., and Silbergeld. E. K . : Increased excretion of homovanillic acid (HVA) in urine by young children with increased lead absorption. Neurosci. Abst. vol. 6^508. 1980. 29. Silbergeld, E. K.. and Anderson, S. M . : Erythrosin B: specific inhibitor of high affinity [3H]-ouabain binding and ion transport in rat brain. Neurosci. Abst. vol. 6.:56, 1980. 30. Silbergeld. E. K . . Anderson. S. M . . DeRyck. M . . C h ro n w a l l , B., and Morris, S. J.: Neurotoxicity of an artificial food color (erythrosin B): methods for rapid testing. Abstr. 8th Meeting Internat. Soc. N e u r o c h e m . . p. 238, 1981. 31. Ptiman. K. T.. Hruska, R. E.. Ludmer. L. M . , and silbergeld. E. K . : Prolactin increases the density of striatal dopamine receptors in normal and hypophyse.ctomized male rats. Soc. Neurosci. Abstr. 7: 217, 1981. 32. DeRyck. M . . Hruska. R. E.. and Silbergeld, E. K.: Estrogen potentiates haloperidol-induced catalepsy/akinesia in male rats. Soc. Neurosci. Abstr. 7: 217. 1981. 33. Silbergeld, E.K.: The biochemical basis of lead neurotoxicity. Abstr. Ann. Mtg. A A A S , Toronto. 1981. Effects 15 12570 34. Hruska, R. E.. Pitman. K. T., Ludmer. L. M . . DeRyck, M . . and Silbergeld. E. K . : Comparison of the biochemical and behavioral effects of estrogen in male and female rats. So-Cr Neurosci. Abstr. 7: 218, 1981. 35. Silbergeld, E. K . , Morris, S. J., and Anderson. S. M . : Erythrosin B and N a ,K - A T P a s e : receptor-like interactions with brain synaptic membranes. Soc. Neurosci. Abstr. 7: 105. 1981. 36. Silbergeld. E. K . : Basic and applied neurochemistry of hazards. Abstr. Annual Meet. A A A S . Washington. D.C., p. 63. 1982. 37. Silbergeld. E. K.: Neurotoxic implications of altered heme synthesis in lead poisoning. Neu r o t o x i c o l . 3/.119-120, 1983 . 38. Silbergeld. E. K . , Nightingale. M. S.. and Mattison, D. R . : Effect of oocyte destruction by polycyclic aromatic hydrocarbons (PAH) on fertility of DBA/2N (D2), C57BL/6N (B6), and (D2 x B6) FI mice. Soc. Gynecol. Invest. A b s t r . . p. 51. 1983. 39. Silbergeld. E.K., Nightingale, M.S.. Godlove. K . . Malley, J . . and Mattison, D.R.: Reproductive toxicity of polycyclic aromatic hydrocarbons (PAHs) in female mice. Pharmacol.. 21:655. 1983. 40. Mattison. D.R., Takizawa. K . . Silbergeld. E.K., Nightingale. M.S., Jerina, D., and Yagi, H . : Genetics of ovarian benzo(a)pyrene metabolism, oocyte destruction, and impaired fertility in inbred DBA/2N and C57BL/6N mice and D2xB6 FI heterozygote mice. Abstr. Internat. Conf. Extrahepatic Metabolism of PAHs and Carcinogenesis. 1983. 41. Mattison, D.R., and Silbergeld, E.K.: Occupational exposures and pregnancy, Abstr. 15th Ann. Cong. Col. Soc. Obstet. Gynecol., Bucarananja, Columbia, 1983. 42. Mattison. D.R.. Nightingale. M.S.. Shiromizu. K . . Takizarva K . . Silbergeld, E.K., Kay. H.H., and Swartz. W.J.: Ovarian toxicity. Abstr. 15th Ann. Cong. Col. Soc.. Obstet. Gynecol. Bucaramanga, Colombia, 1983. 43. Swartz, W . . Silbergeld. E.K.. Malley. K . , and Mattison. D.R.: The effects of benzo(aJpyrene on urine ovarian function and fertility. Abstr. Amer. Assoc. Anat., in press. 1984. 16 ----- 12571 OTHER PUBLICATIONS REVIEWS Silbergeld. E.K.: "Lead in M a n and the Environment" for Trends in Pharmacological Sciences. 1981 Silbergeld. E.K.: "Hazardous Waste in American" Quarterly Review of Biology, in press Silbergeld. E.K.: in Neurosciences, for "Nutrition and Brain Function" for Trends in press OTHER Silbergeld. E.K.: "US Lead Program Vital" Chem. News. February. 1983. page 4 (editorial) Clin. Silbergeld. E.K.: "Where do we go from here?", in Legator. M.S. (ed) Community Health STudies: A Guide for C i t i z e n s . Johns Hopkins Press. Baltimore. MD. in press Silbergeld. E.K.: "Health Effects" in Environmetal Defense Fund. Dumpsite Cleanups: A Guide to the Superfund P r o g r a m . Washington, DC. 1983 Silbergeld. E.K.. and Highland. Science, 2 1 6 :462. 1982 J.: "Ghost Dumps" (letter) Silbergeld. E.K.: "Cancer Policy: Has the Dust Settled?" Environmental Forum. 2.:25-29, 1983 Hall. K.L., and Silbergeld. E.K.: "Reappraising Epidemiology" Harvard Environmental Law Review. 7:441-44.8, 1983 17 12572 Dr. Raymond Singer, P h . D . , is a neurotoxicologist and neuropsychologist practicing at Occupational H e a l t h Consulting, Inc., of N e w York, N e w York. Dr. Singer's cur r i c u l u m vitae is attached. Dr. Singer will p repare reports concerning each of the veteran plaintiffs. These reports will be based upon personal interviews and revi e w of a p propriate himself and/or by others. a thorough test findings p erformed by The personal i nterview will consist of account of the v e t e r a n 's b a c k ground and current and historic symptoms. It will also detail the educational and o c c u p a ­ tional background of each veteran. Various n e uropsychologic tests will be given and d iscussed w ith p a r t icular reference to whether:: any deficits or changes noted are due to the results of any toxic chemical exposures. N e u r o p h y s i o l o g i c tests will also be given or reviewed and interpreted, with p a r t icular emphasis placed upon nerve conduction velocity findings, and the results will be set out and discussed, wit h p a r t icular reference to wh e t h e r the findings are related to toxic chemical exposures. Dr. To the exte n t warranted, Singer will relate any findings to A g e n t O r a n g e exposure. Dr. Singer will also testify to the effects of toxic chemical exposures as they have been studied in a number of resear c h efforts in both animals and humans. He will discuss the findings reported in v arious populations exp o s e d to toxic chemicals 12573 and particularly to TCDD through the mech a n i s m of industrial ac­ cidents. He will also discuss the findings concerning demyelination of the fatty sheaths surrounding the nerves and the "dying-hack" neuropathy w h i c h has b e e n associated wit h toxic chemical exposures. Dr. Singer w i l l also discuss the results of his own wor k in relation to occupational exposures to TCDD, and w i l l explain how his results are consistent w i t h those obtai n e d from tests p e r ­ formed on the veterans here, and h o w those results are consistent w i t h causation by phenoxy herbicides and their c o n t a m i n a n t s . 12574 RESUME Name: Raymond M. Singer Born: August 20, Address: 1950; Philadelphia, 415 East 85th Street, N e w York, NY 10028 (212) 744-1728 Pennsylvania #10H EDUCATION AND DEGREES Ph.D. M.S. B.A. Washington State U n i v ersity Washington State University University of Rochester 1978 1975 1972 Psychology Psychology Psychology PROFESSIONAL ORGANIZATIONS Certified Psychologist, N e w York State Board of Psychology Member, American Psychological Association Member, National Academy of Neuropsychologists Member, Society for Occupational and Enviromental Health Member, American Public Health Association Associate Member, College of Toxicology PROFESSIONAL EXPERIENCE 1983 1983 1982 1982 1982 1981 - 1982 1979 - 1981 1978 - 1979 1978 1979 Adjunct Instructor, Mount Sinai School of Medicine Department of Comm u n i t y Medicine, N e w York City Consultant, N e w York State Department of Social Services, Offi c e of D i s a bility Determinations President, Occupational Health Consulting, Inc. Clinical Psychologist, Private Practice, N e w York City Reviewer, The A m e rican Journal of Industrial Medicine Fellow, Mount Sinai School of Medicine, Department Community Medicine, Enviromental Sciences Laboratories, N e w York City NIH Post-Doctoral Fellow in Environmental Epidemiology, Mount Sinai Medical School of Medicine, N e w York City NIH Post-Doctoral Fellow in Biological Psychiatry, Millhauser Laboratories, N e w York University Medical Center, N e w York City Clinical Psychology Intern, Park East Psychological Associates, N e w York City 22^7"" Dr. Raymond Singer 1972 - 1978 December 5, 1983 Teaching and Research Assistant, Department of Psychology, Was h i n g t o n State University, Pullman, Washington PUBLICATION AND PAPERS Singer, Raymond. Peripheral nervous system assessment in the evaluation of toxic chemical exposure. Paper to be presented at the 12th Annual Meeting of the International Neuropsychological Society, Houston, February, 1984. Singer, Raymond. Neural indicators of p henoxy herbicide exposure. Paper presented at the 1983 Annual Meeting of The Society for Occupational and Environmental Health, Washington (D.C.), December, 1983. Singer, R . , Valciukas, J . , and Lilis, R. Lead exposure and nerve conduction velocity: The differential time course of sensory and motor nerve effects. Neurotoxicology, 4, 2, 193-202, 1983. Presented at the' XI Triennial World Congress of Pathology, Jerusalem (Israel), September, 1981. Singer, R . , Moses, M . , Valciukas, J., Lilis, R . , and Selikoff, I.J. Nerve conduction veloc i t y studies of workers employed in the manufacture of p henoxy herbicides. Environmental Research, 29, 297-311, 1982. Presented at the XX International Congress of Occupational Health, Cairo (Egypt), September, 1981. Valciukas, J. and Singer, R. The embedded figures test in epidemiological studies of environmental neurotoxic agents. Environmental Research, 28:183-198, 1982. Lilis, R . , Valciukas, J . , Singer, R . , et al. A s s e ssment of Lead Health Hazards in an Autobody Shop at an A u t o mobile Assembly Plant. Report to the National Institute of Environmental Health Sciences, June, 1981. Valciukas, J., Lilis, R . , Singer, R . , et al. Lead exposure and behavioral changes: Comparisons of three occupational groups with different levels of lead absorption. A m e rican Journal of Industrial Medicine, 1:421-462, 1980. Singer, R. The Neuropsychological E v a l uation of Patients Affected by Occupational Neurotoxic Agents. Invited address, New York State Psychological Association Convention, N e w York City, May, 1980. 12576 Dr. Raymond Singer December 5, 1983 Valciukas, J . , Lilis, R . , Singer, R . , et al. Neurobehavioral studies of painters. Presented at the International Symposium on Occupational Health Hazards Encountered in Surface Coating, Handling of Paints in the Construction Industry, Stockholm (Sweden), October, 1979. Manuscript submitted, Archives of Environmental Health. Singer, R. The role of the psychologist in the prevention of myopia. Paper presented at the annual meeting of the American Psychological Association, N e w York, N e w York, September, 1979. Singer, R. The Camphill approach to the education of the retarded person. Symposium presented at the annual meeting of the American Psychological Association, New York, New York, September, 1979. Singer, R. The behavioral etiology of myopia. Paper presented at the annual meeting of the Eastern Psychological Association, Philadelphia, Pennsylvania, May, 1979. Singer, R. The relationship between visual refractive error and interests, values, personality, academic performance, and reading. Doctoral dissertation, Washington State University, 1978. Singer, R . , Young, F., and Rokeach, M. Values as predictors of visual refractive error (in B a r r o w E s k i m o s ) . Paper presented at the Western Psychological A s sociation Convention, Seattle, Washington, April, 1977. Singer, R. Can myopia be prevented? Invited address - Presented to the Washington State University Chapter of Sigma XI, February, 1976. Singer, R. The association of personality and myopia. Papers presented at the Western Psychological Association Convention, Sacramento, California, April, 1975. Young, F., Singer, R., and Foster, D. The psychological diff erentiation of male myopes and non-myopes. American Journal of Optometry, October, 52, 10, 679-686, 1975. 12577 THEODOR D. STERLING, Ph.D. Dr. Sterling is Professor in the Facility of Interdisciplinary Studies and Department of Computing Science, Simon Fraser University, Vancouver, British Columbia, Canada. His Curriculum Vitae is attached. Dr. Sterling is a mathematician, statistician, and epidemiologist; as well, Dr. Sterling is intimately familiar with existing data and analyses concerning the effects of phenoxy herbicides and impurities, e.g. 2,3,7,8-TCDD> contained therein. Dr. Sterling has devoted much of his teaching and research to the collection and analysis of data and their use for scientific inference. Dr. Sterling will testify that there exists a considerable body of medical and scientific evidence which demonstrates that the preparations of 2,4,5-T and 2,4-D are toxic, teratogenic, and carcinogenic. Further, there is no credible scientific evidence of a no effect level; said another way, as a carcinogen, there is no safe level and therefore a single exposure years ago may be responsible for human cancer which develops today. In addition, Dr. Sterling will testify that there is ample evidence that exposure to 2,4,5-T is teratogenic in humans when the mother is exposed, and convincing evidence is now extant that the outcome of pregnancy is influenced by exposure to the father alone. Most especially, Dr. Sterling will testify of the incidence of subjective symptoms and/or medical records documenting such symptoms. These symptoms are those which have been compiled by the National Center for Health Statistics, and will be compared, to the extent available, to those symptoms of the Vietnam veterans, particularly those of the representative plaintiffs. The purpose will be to ascertain the incidence of such symptoms in the general population so as to analyze statistically the symptoms of the plaintiffs. The product of such overall incidence will be calculated to examine the possibility or likelihood of such a constellation of Agent Orange/dioxin related symptom complex to occur in a random fashion. The bases or grounds for the facts and opinions of Dr. Sterling's testimony are: educational and professional background; publications regarding the subject phenoxy herbicides; review of the applicable medical and scientific literature; attendance and participation in various symposia dealing with the scientific issues in question; training as a mathematician, statistician, and epidemiologist; and training and experience in the computer sciences. -2 - CURRICULUM VITAE Theodor D.Sterling EDUCATION B. A. (CUM LAUDE) , 1949. M.A., 1952* University of Chicago; Ph.D., 1955, Tulane University. PROFESSIONAL AFFILIATIONS Present: Professor, The Faculty of Interdisciplinary Studies and Department of Computing Science, Simon Fraser University. Previous: Visiting Professor, Department of Statistics, Princeton University, (78). Chairman, Department of Computing Science, Simon Fraser University, (72-77). Professor in the Department of Applied Mathematics and Computer Science, Washington University, St. Louis, Missouri (66-72). Also Joint appointment as Professor in the Department of Sociology (66-68), and Visiting Professor in Computers and Humanities, Hebrew Union College, Cincinnati, Ohio (68-70). Professor of Biostatistics and Director of the Computing Center, College of Medicine, University of Cincinnati, Ohio (58-66). Previously instructed in the Department of Statistics, Michigan State University and Department of Mathematics, University of Alabama. PROFESSIONAL ACTIVITIES ACM Committee on Scientific Freedom and Human Rights; President of the Computer Science Association cf Canada (75-80); Chairman, Ombudsman Committee, Canadian Information Processing Society (73-80); Chairman, President of Biological Information Processing Organization (64-65); Chairman, CIPS Special Interest Groups, Humanization of Information Systems (73-80) ; Chairman, SIGCAS Committee of Information and Public Policy (72- ) ; President of Missouri Chapter, American Association of Workers for the Blind (70-72) ; Member of the Panel for Biology, Management, and Social Sciences of the Mathematics Association of America (62-67) ; Chairman, Committee on Professional Activities of the Blind of the Association for Computing Machinery (63-71); Chairman, Ad Hoc Committee on Accreditation, Association for Computing Machinery (66-67); Committee on Radiation Dosimetry, American Association of Physicists in Medicine (66-69); National Lecturer for Association for Computing Machinery (72-3, 75-6). EDITORIAL ACTIVITIES: Associate Editor - Canadian Journal of Statistics (73-78) ; Editorial Board - International Journal of Biomedical Computing (69- ); Computers and Applied Mathematics (73- ), Humanist in Canada (73- )- 12580 GOVERNMENT AND OTHER SERVICES: (Consultant/adviser, now and previous): (In Canada) Canadian Standards Board; Environment Canada, The Royal Commission (B.C.); Consumers Association of Canada; Society for Professional and Environmental Control. (In U.S.) NIH: PHS; EPA; FTC; SRA; 0,S. National Academy of Science, National Research Council; American Lung Association; Natural Resource Board (Wisconsin); Environmental Defense Fund, MECCA (Minnesota); Citizens. Against Toxic Sprays (Oregon) . (In Kuwait) - Ministry of HealthPROFESSICNAL SOCIETIES: Can. Inf. Proc. See.; Can. Comp. Sci. Assoc.; Assoc. Comp. Machinery; Amer. Math. Assoc.; MathSoc. ; Inst. Math. Stat.; Amer. Stat. Assoc.; Biometric Soc.; N.Y. Acad. Sci.; Amer. Assoc. Phys- Med.; Assoc. Res. Opthamology. HONORS AND AWARDS: Assoc. for Advancement of Science; Fellow, Fellow, Amer. Assoc.; Amer. College of Epidemiology; Fellow, Amer- Stat. Fellow, Car. Com. of Scientists and Scholars; Sigma Xi; Pi in National Science; Nu Epsilon, Mo rrison Cressy Award University Res earch Professor ( 1 9 8 0 - 1981) 12581 BIBLIOGRAPHY Theodor D. Sterling Book s A Guide to PL/1 and Structured ? rog ramni in g . doit, Rinehart ana Winston, February, 1969. Second edition - 1976. Third Eaition 1 980. Essentials cf PL/1. Holt, Fiinenart and Winston, January, 1573. Visual Prosthesis - The Interdisciplinary Academic Press, March, 1971. Dialogue. (Editor), Computing and Computer Science with 1 9 70 . dacmi1lan , January, Computing ana Computer January, 1970. Introduction Ju n e , 1966. to Science Statistical PL/1. with Data Fortran Processing. IV. Macmillan, Prentice-Hall, Advances in Biomedical Computing Applications (Editor), of The New York Academy of Science, Vol 123, 1966. Annals Computers and the Life Sciences. Columbia Press, December, 1965. In preparation: People are Trouble: Concepts The Human Side of a C o m p u t e r i z e d Society. of Machine Computation. 12582 Articles 1984 The Economics and Politics of Building Illness: The NAS/NRC Report on Indoor Pollutants. International Journal of Health Services 14(1): 43-5 3. Second Thoughts: On Filtering Information About Occupation, Smoking and Disease. Journal of Chronic Diseases. (In press) Computers and Society. Encyclopedia. (In press) In Adriana Davies, (ed.) The Canadian Investigations on the Effect of Regulating Smoking on Levels of Indoor Pollution and on the Perception of Health and Comfort of Office Workers. Proceedings of workshop on Effects and Exposure Levels, Geneva, Switzerland, ¡larch 1 5-1 7 , 1983. (In press) The Emerging Key Role of White-Collar Computer workers Vis A Vis Organized Labor. Technology and People. (In press) What is the Most Advanced Technology on Earth Today and for What is it Used? In Gallup, G. and Ncrirack, C.T. (cas.) . America Wants to Know: Ihe Experts' Answer Ro o k , New York. A £ w Publishers, Inc. (in h ress) 19 Q }._M ' C J)'auorescent The Impact or Different Ventilation An Experimental Study. Lighting Types on building Illness: Canadian Journal or Public Health. (E. Sterling, senior author) Septemter/Cctober. Unemployment Follows from the Chan g e s in T e l e c o m m u n i c a t i o n s . T e l e c o m m u n i c a t i o n s Workers Union T r a n s m i t t e r IV (3): 9. Air Quality in Puolic Buildings ASHRAE T r a n s a c t i o n s 89(2). with Health Related Complaints. Perceived vs Actual 7l/i ^ ^ 1*.U» HU ± 1 10 nuwAXiio f C o m p a r a t i v e otuay. in i-niazze, l . or. W. (eds.), Methods and Issues in O c c u p a t i o n a l and Environmental E p i d e m i o l o g y . Ann Arbor Science Publishers, Inc., Ann Arbor, Michigan, pp. 165-176. 1 932 Unionization of Professionals in Data Processing: An A s s e s s m e n t of Recent Trends. C o m m u n i c a t i o n s of the ACM 25(11): 807-816. Health Effects of Chlorophenol Wood Preservatives. Journal of Health Services 12(d): 559-571 . I n t e rnational Job D i s c r i m i n a t i o n Based on E x p osure C o n s i d e r a t i o n s and Smoking. In Lee, J. and Rom, w . (eds.) Legal and Ethical Dilemmas in Occupational Health. Ann Arbor Science Publishers, Ann Arbor, Michigan, pp. 379-387. The Case tor Entirely Removing the Gas Range from Indoors. P r o c e e d i n g s of International Sym p o s i u m on Indoor Air Pollution, Amherst, Mass., Oct. 13-16, 1931. Indoor byp r o d u c t Levels of Tobacco Smoke: the Literature. JAPCA, "arch 32: 250-259. A Critical What is Ahead tor Canadian D atasystems in Lab o u r / M a n a g a m e n t Id (5): 90-99. C r i t i q u e V. The Health Effects of 2,4,5-T. Science, Twisted C o n s u merism. Center for Interest. Washington, D.C. 93-49. Data Review or Processing?. In Harnik, P. voodoo Science in the Public 1981 Does Smoking Kill Workers or Working Kill Smokers? R e p rinted in Feinberq, H.G. (Chairman) L i t i g a t i o n and Settling O c c u p a t i o n a l Disease Claims. New York Law Journal, New York. October. H u manizing Computer I nformation Systems. Reprinted in Murray Gruber (ed.) Management Systems in the Human Services. Temple Univ e r s i t y Press. Philadelphia, PA. 287-299. Setting the Stages for Labour Unrest in the Industry. CIP5 Review, July/Oct. Voi. 5(4): 36-37. Canadian DP nt .tC<ü 85 What EFT Will Hear, to the Consumer. CIPS Reviw, 5(3) nay/June. Vol. 16-17« Ve n t i l a t o r y F u n ction Changes Over a workshift. I n oustrial Medicine. 36 : 1 52-135 . (H. Diniich, senior Br. J. author.) ot Uni o n i z a t i o n and its I m p l i c a t i o n s . Proceedings of the Second Annual Of f i c e A u t o m a t i o n Conference, March 23-25, 1981, Houston, Texas. P o s sible Risks to Human Lunas from Magnetometric Exp e r i m e n t s . Journal of Applied Physics, Vol. 52 2575-2577. Dust Cle a r a n c e (3, Part II) Use of Gas Ranges tor Cookinc and Heating in Uroan Dwellings. Journal of the Air Pollution Control Association, February, Vol. 31 (2) 1 62 -165. E n g ineers Throa ter; Domination V o l . 3(1): fc-b. or 0? Jobs. TIPS Review, Jan./Feb. 19 80 Paoiation: A Et fects Health ot Ionizing of Lou -level (eds.) , Health Rom , W .II. and In Archer, W.E. Dialogue. Arbor Science I m p l i c a t i o n s Of New T e c h nologies. Ann Energy Publishers, I nc . , A r.n Arbor, Mien. Pages 150-164. The Stressing Design Rather Than Performance standards to Ensure Protection of Information: Comments. In iloffman, W. (ud.), Computers ana Privacy in the Next Decade. Academic Press, Inc. 1 0 2 -1 C 7 . Smoking, American Meeting, Occupation and R e s p i r â t or y Disease. Report to the Lung Association, Occupational Health Task force April 9, 1980, C l e a r w a t e r , Florida. The Social Impacts of Elec t r o n i c Fund Transfers, Post, Special Report, March 8 , 1960, si 1• The Financial The Health Effects of L o w - D o s e Radiation on Atomic workers: A Cas e Study of Employ er--Dir ected Research .' In ternational Journal of Health Services, January, 10(1): 37-46. C o v e r - u p at Hanfora: The Effects of Low-Dose in Canada, Spring (No. 52) XII, No. 1: 5-d. Radiation. Humanist The C o m puter Ombudsm an, A Possible Model of A c c o u n t a u i l i t y Among P r o f e s s i o n a l s , Tra n s a c t i o n s of Society, 17(2): 31-35. 12586 1979 Statistical Problems in Multi-Variate (Etiological) Canadian Journal ot Statistics, 7 (2): 205-21 5. The Mutual Relationship Between Smoking, Occupation P r o c e edings of the XIX International Congress on Health. Supplement to vol. 30. Consumer Empirical 283-285. Difficultie s with Computerized Investigation. C o m m u n i c a t i o n s or Surveys. and Disease. O c c u pational Transactions: An the ACM, May, 22(5): Carbon Monoxide Levels in Kitchens ana Homes with Gas Cookers. J. Air Pollution Control Association, iiarch, 29 (3): 238-241. What Consumers 11 (12) : 64-67. say About C o m p u t e r Errors, Canarian Datasystems, What Happens When Magor Errors Are Discovered Long After An Important Report Has Eeen Published?, I n v i t e d talk to the Annual Meeting of the American S t a t i s t i c Association, Washington, D.C., A u g u s t , 1979. 1978 Computers in Developing Nations: A C a u t i o n a r y Tale. Personal Computing. February, 27-jl. Smoking Archives Reprinted in Patterns fcy Occupation, Industry, sex, and Race. of Environmental Health. November, 33(6): 313-317. Processing Errors Among the Public: Their Frequency ana Crigin. Proceedings of the Session '73 C a n a d i a n Computer Conference, CIPS, Edmonton, Alberta. May. Does Smoking Kill Journal ot healtn Workers or forking Kill Smokers, Services, 6(3): '437-452 .. Follow up: New Evidence Australia, 65: 384-387. Frequency of C o m puter Charge or Dank Accounts, C o ncerning Smoking ana International Health, Med. J. Related Errors Among Holders of Credit, CIPS REVIEW, June, 5: 17. High Level Language P r o g r amming. In Belzer, J., Holzman, A.G., ana Kent, A. Encyclopedia of Computer Science and Technology, Marcel Dekker, 9: 257-283. H umanizing Info rma Li or. Systems. In aelzer, J., riolzman, A.G. ana Kent, A. E n c y c l o p e d i a of Computer Science and T echnology, Pa r c e l DekJcer, S : 361-37 1 . Natural Language C o mpilers and Interpreters in hadiation Treatment Planning or Nous Pardons Anglais 'Setter Than Jede Anaere Sprache. In V. hosenaw (?.a) , Computers in Hadiation Therapy: Proceedings of the Sixth International C o n g r e s s on the Use of C o m p u t e r s in Radiation Therapy, University oi Goettingen, G oettingen, F R G . 1 9 77 Com p u t e r s in lev eloping Nations: a Cauti o n a r y C o m m u n i c a t i o n s of the ACM. December, 20 (1 2): 971 -972. New Evidence Conc e r n i n g Smoking Australia, October, 2: 53B-S42. Fold, Spindle and Mutilate. and Health. Medical Humanist Exposure to Pollutants in E n v i r o n m e n t a l Research, February, 2 , 4 , 0 -T .... Teratogenic Acres U .S .A . , 7/7. in Canada, Tale. Journal ¡-¡arch. 40/15-20. Enclosed " L i v i n g ’' vol 13: 1-13. Em D r o y o t o x i c , of Fetogenic, Spaces. Mutogenic, Smoke Gets in lour L'yes. iiuaanist in Canada. U2 : 2-b. 1 97d Humanizing I n f o r mation Systems. Datamation. Smoking Characteristics by Type of Medicine, November, 1b (11): 7 4 3 - 7 5 4 . Do *e Need A Computer Ombud s m a n ? 62-64. . Decern b e r . Employment. Canadian J. Occup. Datasystems, August, Programming. In Ralston, A., and Meek, C.L. (Editors), Encyclopedia of Computer Science, P e t r c c e l l i - C h a r t e r , Ne« ïork, pp. 1127-1166. Statements, of Computer Ralston, A., and Meek, C.L. (Editors), E n c y c l o p e d i a Science, P e t r o c e l i i - C h a r t e r , New '/ork, pp. 326-1 329 . A Single-Track INFOR, February, Universal Curriculum 14: 1, 40-62. for Com p u t i n g Science. Kan Against Himself B iological Dangers from the Herbic i d e s . Humanist in Canada, February, IV (3): 2-7. Use of Addit i o n a l C o m ments on the C r i tical Assessment of the Evidence Bearing on smoking as the C a u s e or Lung Cancer. American Journal of Public Health. February, Vol 6b (2) : 161-164. R e l a t i o n of Place of Birth and M i g r a t i o n in Cancer Mortality in the D.S. - A study of Ohio R e s i d e n t s (1959-1967), reprinted in the 1976 Year Book of Cancer. iy 7b H umanizing Computerized I nformation T h e i r Implications. Science, December, Systems: Vol 190: Guidelines 1168-1172. ana A C r i tical the Cause September, Reassessment of the Evide n c e Bearing on Smoking as of Lung Cancer. American Journal of Public Health. Vol 65 (9) : 9 39-953 . A C r i tical Fertility. Review of Reports on the Effect of Smoking Journal of Sex Research. August, Vcl 11(3) on Sex and 201-217. Lung Cancer Among black ani white Migrants In the U.S. Et i o l o o i c a l C o n s i d e r a t i o n s . Journal -ji the National Medical Association, J a ic n , Vol 17(1) : IJ - 1 1 1 , 1Od . (7 . F . M a nc u so , s e riio.r author.) 19 79 Relation of Place of firth anu Migration in Cancer Mortality in the ’J . s . A r t u d y of Ohio ,- e s i tents 9 3 3 - 19 b 7) . Journal oi Chronic Diseases. Vol 2 7 : 0 5 9 -4 7 /1 . (7 . f. K ancuso, senior author.) Guide l i n e s ior h'u n.an iz i no Ccmr-uti;-r lie:. Infer nation Systems: Report from Stanley House. C o m m u n i c a t i o n s oi the ACM. November, Vol 17 (11): 609-613. (Reprinted m AEDS Journal, Vol 10 (1), Fall 1S 76: 1-10. T e a c h i n g S imulators of Ideal T e a ching ACM. June, Vol fc (2 ) : 45-56. Machines. S1GSCE Bulletin, University pp. 6-7. Aft ,.1 is . to the Pedagogic 16: 207-208. Language. Approach. A Proposal tor a New Curri c u l u m Simon Fraser University, Eurnaoy, 3.C. May, Ideal Teaching Communications Machines — of tne ACM. A Solution April, Vol 12589 The ’ Jse of an Information System to "liuaanizs" Procedures in a Rehabilitation Hospital. International Journal of -io-Eedicai Computing. Vol 5: ¿1-5 7 . Information for Public Policy. Conputsrs m i 2 . (Invited editorial). Society. Vcl £(i): The Simon Eraser One-Track. Universal Curriculum for Computing Science. SIGSCL Bulletin, ACM. February, vol 6 (1) : 28-32. I9 7 3 The Statistician vis-a-vis Issues of Public Health. The American Statistician. December, Vcl 27(5): 212-217. Extending the General Fieli Equation to fit the Dose Distributions of a Variety of Therapy Units. Sritish Journal cf Radiology. Vol 4 6: *83-990. (J. .einxam, senior author.) Air Pollution and Smokinq. Environment. Voi 15(b): 3-5, 25-26. Dynamic l/icplay or naci ct her a oy Plans Dsin Films, ¡iaaiology . June, Voi 107: 639-691. Humanists and tne Ccni.u ter Community. Humanist 25: h. Coirputer-Procucea in Computing and the humanization of Medici r.tj. Journal or riomedical Computing. t u t o r i a l , July, Canada. vol I nterr.aticnai Vol 4(3): 159. 197 j Difficulties ci Searuring the effects of Air Pollution vs the Effects of Smoking. Presented at the 139th Meeting cf the American Association for tne Advancement of Science, „acesler 1 972. A Versatile System for Three-Dimensional Radiation Dose Computation ana Display, 3T P . Computer Programs in 3 iomedi cine. Voi 2: 1 78-1 92 . (J. weinkam, senior author.) Fitting the Cenerai Field L'gu t i on to t r.-? jio mens Gai:;matron 3. Technical Report on Research Agreement No. 1051/CF for the In tern aticnal Atomic Energy Agency, Vienna , Austria. The Incidence of Lung Cancer in the U.S. Since 1955 in -elation to the Etiology or the Disease. American Journal or Public Heaitn. February: 152-158. 12590 i y 7i A critical Assessment of the Evidence on the Cigarette Smoxina Lung Cancer Relationship. Presented at the 138th Meeting of the American Association for the Advancement of Science, Symposium on Smoking and health Now. Philadelphia, December, 1971. ^ Difficulty of Evaluating the Toxicity and Teratogenicity of 2,4,5,-T from Existing Animal Experiments. Science. December, V ol 174: 1358-1359. Some Thoughts on Treatment Strategy. Computers in Radiotherapy (proceedings of the uth International Conference on Computers in Radiotherapy, Glasgow, September 1970). Edited by A. S. Glicksman, ;i. Cohen, and J. K. Cunningham. Puolishea as Special Report No. 5 (1971) by the British Institute of Radiology, London . Three-Dimensional Treatment Plan Display Films. Computers in Radiology, op. 12-14. on Computer-Produced A Review of the Claim that Excess 'lorbiaity and Disability Can Be Ascribed to Smoking. Journal of the American Statistical Association. Vol t-b (334) : 251 -257 . A Critical Reassessment of the Evidence Bearing on Smoking as the Cause or Lung Cancer. Special Report on the Washington ’ university Project on the Review of Crucial Data Searing on the E mox in u and Health Issue, St. Louis. Robot Data Screening, An Intelligent (?) Data Search Technique. AGARD Conference Proceedings No. 94 on Artificial Intelligence, 2-1-d-r, Tecnnitdi Editing and Reproduction Limited, Loncon. Comment on Smoking Dogs. Letter to the Environmental health, vol. 22: 631-032. Editor. Archives ot 19 70 Problems in Determining if a Commonly-Used Herbicide (2,4,5-T) Has an Effect on Human Health. Proceedings of the Sixth Berkeley Symposium on Mathematical statistics and Probability, field at the Statistical Laboratory, University of California. University ot California Press, pp. 479-494. Experience with a "Universal" introductory Course in Computer Science. Proceedings of SIGCSE Technical Symposium on Academic Education in Computer Science, NovenDer 10, 1970. Houston, Texas. SIGCSE Bulletin, Vol 2(3), Association tor Computing Machinery, New York. 12591 Robot Lata icreeiunq, An Automatic Search Technique, Rio-Medical Computing. Voi 1: 61 -74. (From the Proceedings of the Conference on Statistical Computation, University of Wisconsin, April, 1 969 .) u a1 Prosthesis Report on Prog ress in the .• ü * « i .h t New OutiooK for the 31 i nd . Feoru j I'y , Voi 64: 41-4 6. The 19 69 Automatic Data Screening: A Practical Solution to the Multivariate Problem in Clinical Data. Annals of cue hew York Academy or Sciences. Vol 161: 6 32-ouO. A Comment on "Air Pollution -- The Industrial viewpoint” . Journal of Occupational Medicine. July, Vol 11: 3»1-je3. Robot Lata screening -- A Ubiquitous Automatic s e ar c h Technique, statistical A. in nil ton , C • n . and Helder, J. (“d •) t . 319-333. Computa tier., Academic Pre ss, Mew Y or S Computer Interlace, Incut Metnocs, a 5.- Presentation of Results. R ole or Compii ti. re m ra lictherapy , In t rn a tional A to ic Inert y Agency, Vienna. Pape r Vo. 16, p p . 136-141. Opti mi ration as a joint Result of Planning ana Implementation. Role or Ccapu ter s in nadi ot.no rap y , in tec national Atomic Energy Agency, Vienna, pp. 163-167. Display Devices tor Computer Translatai Irailie. ?rocaeai n as Conference on New Processes for amila Ma nu rac tu r e , 196c, Center ter sensory hies Evaluation ana Development, nassaenusets Institute of Technology. February, pp. 14-20. 19 67 Automation of Radiation Treatment Planning, VI: A General Fie la equation to Calculate Percent Deptn Dose m the Irradiated volume of a Cobalt 60 Beam. British Journal or Radiology. Voi 40 : 46 3-UbB . Urban hospital Morbidity and Air Pollution: Second Archives of Environmental Health, vol 16: 362-374. Report. 12592 A New Direction in Rehabilitation Through Advanced Instrumentation and Computation. Journal of the American Medical Association. Vol 200(7): 625-629. .ihe Use of Computers in Therapeutic Radiology, Summary Report of an International Conference heia in Cam d ridge, England, June 19 16 (Editor) . r n t i s h Institute of Radiology, London. final Narrative. Report, Training of the a n n a for Professional Computer Work. Department of Health, Education, and Welfare, HD-1 5-5-67-C.. . 1 966 Robot Data Screening: A Solution to Multivariate Type Proclems in the biological ana Social Sciences. Communicatons of the ACM. Vol 9(7): 529-532. A Biologically-Oriented York Academy of Sciences. senior editor.) Computer Language. Armais of the hew Vol 128(3): 755-755. (S. V. Pollack, Cancer Therapy - Computation ana Visualization Distributions ir. External Beam Therapy. Journal Diseases. Voi 15: 523-539. of Dose or Chronic Use of the Computer Communications of the ACM. statistics. Teach Introductory to Vol 9 : 274-27b . Computers : No Longer a Big Bargain Comuuters ana Automation. Vol 1 5 : 1-4. author .) tor Uneducated (3.V. Pollack, U s e rs . 3 1 n i G r. The Selection, Training, and Placement of Blind Computer Programmers. Report or the Association for Computing Machinery . Is Medical Diagnosis a General Computer Proolem? Journal of American Medical Association. Vol 196(3): 281-266. the Lefogging the Issue: California has discovered that laws can's control auto exhaust fumes. Barron's, May 2, pp. 5, 14-15. Urban Morbidity and Air Pollution: A first Report. Environmental Health. Vol 13: 150-170. Archives of The Blind as Computer Programmers. 7(1): 7-1 u . Record. Vol Role of Statistics in the World of Computers. Annals of the York Academy of science. Vol 12 8 (3): 1108-1115. New Rehabilitation The Role o t tne 31 i na in Data Processing. Presented at Third Annual Conlerence on Computer Personnel Research Group, held at '¿ashin cton University, 1965. Reprinted in Com outers and Automation. Voi 15: if-27. Proceedings on the P raille Research ana Development Conference, Aids, Evaluation and Development. Massachusetts Sensory Institute t Tocnnoiccy, üovsnbnr, 19i>6. 1 9 65 Automation cf Radiation Treatment Planning, v : Calculation un a Visualisation of the Total Treatment Volume, British Journal pi r.&Gicloqy . Vol 5B : y 0 1-- î1 2 . Roaot Data Processing Techniques tor Multivariate Epidemiolccical Predictions. Annals o t the Mew York nca c e.my ot Science, vox 12 6(2): 77 9-79'». The Role of the Blind in Data Processing. Procedures oi Third Annual Computer Person n oi Hesaarcn Conlerence, June 1'-b5. (11. H . Gotterer, e c..; Computers in Personnel Research Group, Silver Spring, Da.; pp . a 1- 3 5 . Computation ot 1.a dia tion Dosajes. In Stacy, R. ¿no Gasman, (td .) , Computers in •'»ioracd ica 1 Research. Academic Press, York, Voi 1 (Chapter Id). "a tn em a tics Toward on Ur.de re r<.c ua te une r.esoarenerr: in the riuias oi oioloqy Proceedings. Vci id(1): 5-9. Proc r .lin Medicine. : g r t B., hew F u t u r r. r.«ratior» Careers tor the: Elina in Electronic Data Processing. Electronic Data Processing. Occupational Outlook quarterly, voi ?(!): 1-à . Lmployire;nt Potential tor the Elina in Computer Hc-iatr-u Fields. The International Journal for Rancation of the Blind. October, pp . 1- 5. The t i m e the Blind. in ¿DP. ACM Commi tree on Professional Activities ot 1 ?11u Mathematical Analysis of Lead Burdens. Archives of Bnvironmental Health. 8: uu-51. Design and Operation oi a Medical Computing Center. Annals the ew York Academy of Science. Vol 115 ( 2 ) : 5 9 1 -599 . Saengsr , senior author) . of (F . Planning- Radiation Treatment on the Computer. York Academy ol Science. Vol 115(2): 976-997. Professional Computer Work for ACM. V cl 7 (4) : 226-211 . Computer Wcr?; R e habilitation. Epidemiology Environmental Lead Burdens. the Blind. as a Profession Vol it: 20-21. for the Annals of the New C o m m u n i c a t i o n s of the Blind. Journal of of Disease Assoc i a t e d with Lead. Archi v e s health. Vol 8: 133-248. 'latnomatical Analysis Archives of Envir o n m e n t a l Health. Vol 8: 44-51 ot of Automation of Radiation T r e a t m e n t Planning, IV: Derivation ot a Mathematical Expression for the Per Cent Depth Dose Surface ot Cobalt 60 Beams and Visualisation of Multiple Field Dose D i s tributions. British journal of Radiology. Vol 37(439): 544-550. Locating Placenta Praevia. Procedures or the Rochester Confe r e n c e on Data Acquisition ana Processing in Biology and Medicine, New York, 1963. Pergamon Press, New foric, pp. 103-111. 19 6 3 Do Malignancies Result : rcn Diagnostic and Therap e u t i c Radiation? Genetics ¿{¡a the . . ‘pi ac-rdo ioyy of Chronic Disease, U.5. Dept, of h e a l t n , Education rind Welfare, 'pp. 2oS-i7l . MEDCOMP, Part 1, Statistical Systems. University of Cincinnati, Ohio. Medical Computin': Center, Boron, Cadmium, Chromium, and riicxel in the Blood ana Urine. Archives ot Environmental Health. Vol 6: 236-295. (H. Imbus, senior author.) Potential Hazard ot Exposure to Lead. Archives ot E n v i r o n m e n t a l Health. Voi fc: 255: 272. (R . Kehoe, senior autnor.) Carcinogenic Effects of T1JI Compared with X-Irraoiation - a Review. Health Physics. Vol 9: 1371-1:64. (6. Saer.ger, senior author.) A u tomation ct Radiation T r e a t m e n t Planning, III: A Simplified System ot Digitizing isodoses and Direct Print-Out of Dose Distribution. British Journal of Radiology. Vol 36: 522-527. I n t r a v e n o u s M e t h o tre xate (Amethopterin) Therapy in the Treatment of Acute Leukemia. Pediatrics. vol 31 : 834-339 . (J. Perrin, senior author.) Autonation cf Radiation T r e a t m e n t Planning, Kon-Convergent Field Dose Distributions. Radiology. Vol 36(427) : 63-67. II: Calculation or British Journal ot Rotot Treatment Planning. Procedures ct m e h o c nester Con ter e nee on Data Acquisition ana Processing in Biology and Medicine, hey Y o l k , 1 6 6 2 . Peroamon Tress, New York, p p . 2 3 3 - 3 1 9 Robot Data York, [■a t a Screening . Procee d i n g s ot ln e Hoc n e s t.e Acquisition ana Processing in Biology and Medicine, 1962. Perca.ton Tress, New jerk , p p . 31-2^2. hew 17 6 2 O c c u p ational Exposure to Organic Environmental Health. Vol 5: Lean Compounds. Archives oi 532-636. (R. OeTrivixie, senior a u t h o r .) New Developments in Chronic Risks ana Eligibility. American Journal. Vci 2o : 6 3 3 - 0 4 6 . Kaaiatiou trini- r-1 o 1 c •:y . Cancer, Comparative Ctuoies environmental ;-tai:h. senior author.) of 0Ì Disease Spidemiciog y : Competing industrial hygiene Association vc 1 1 u t j. Certain Lead ALxyls. 5 : 515-32 , a :3 -6 Ì c . Archives ot (E . ci n g ham, 19M A Practical Procedure Planning. British Journal for Automating ot Haciioioqy. Voi Epidemiclogical Methods ana Community Environmental health. Vol 3: 267-275. Competing Causes ot Deatn in Coal Air (J. radiation Treatment ad : 7 ¿6-7 33. Pollution. Archives or Phair, senior author.) :ar '«orders, lettering Report. 1 9 60 C e s i u m -137 Retention and Distribution in x-Irraaiateu Rats. U.S. Army Medical .research Laboratory, fort Knox, Kentucky. Report No. 504. (G. Keriakes, senior author.) Seasonal Variations in the Birth ot the Mentally American Journal of Public Heiltn. Vol 50: 555-^65. Deficient? 12596 The Lean Content of the Atmosphere. Presented a t the b 3r a Annual (J. Cholax, senior 1 960 , Cincinnati. h e e t inc of A P C A , May author.) A cc e p t i rig About What is so E ecu liar Ps yc nolc gicai Reports, vol 7: 3fa3-3 faa . the U 11 Hypo tn es is? f or Neoplasia Following Therapeutic Irradiation 839-904 Conditions in Child ho od. Radiology. Vol 74: Saenoer, senior author.) Bî n lqn (t • 1959 L*-/ 0 1 u £ Fuolic Decisions ana Their PossiDle Effects on inferences Drawn from Tests of Sign ificance - or Vice-Versa. Journal of the American fatatisticai Association. Vol 54 : or Pulmonary Function in Children, I and 11 . Journal sen ior author.) Vol 30 (s) : 514 -5a 3 . (I . L . Herns te in , a 11 er a y . Tables of Pulmonary Function Values in Children Ages o to 14. Kreger Printing Co., Cincinnati, Ohio. (I. L. Rernstein, senior a u t h o r .) The A nor r-x iger. ic Action of Doxtro-Arapn at amine Gulfate upon fees m o nest on.st- s or Pilfering otrenutn. Journal of Comparative ana Physiological Psychology. vol 52: 179-182. (P. Siegel, senior author.) Sources of Contextuel Constraint Upon ■■•oris in Journal of Experimental Psychology. Voi 57: 171-lhU. senior author.) Sen te nets . (H . Adorn, 19 57 Effect or Irrelevant Drive on Extinction F s yc no 1o r;ic a i Reports. Vo 1 1 : fa1 5 - 1a . of bar-Pressing. A Central surveillance System deasurement Model, Frcyrct “ r c!. : ;a r. Z 34 o , 7.91"-, diversity or d ionium. A General Survey of Statistical Decision Michigan Z915, University of o i cmqan. Part I, II. Theory. Project Bio-Statistician/Mathemat icianThis witness will be identified in the near future. At that time a curriculum vitae will be supplied. This witness will describe the m a t h e matical/statistical model which will be used in the presentation of the figures to which the witness w i l l testify. The theory subserving the testi­ mony is that the m u l t i - f a c e t e d presentation of symptoms and signs and test results in the same vet e r a n makes a random compo­ sition of such an array extremely unlikely in view of the relative in-frequency of each facet of the array. As such, this testimony will be used in the generic and specific proximate causation areas. 12598 66SS1 AGENT ORANGE TESTIMONY DAY 8 MOYER V DOW UNITED STATES DISTRICT COURT EASTERN DISTRICT OF N E W YORK In re MDL 381 (All Cases) Agent Orange SPECIAL MASTER'S RECOMMENDATION RE APPLICATION OF P H Y S ICIAN/PATIENT PRIVILEGE TO MEDICAL AND WORKERS' COMPENSATION RECORDS OF DOW EMPLOYEES Product Liability Litigation X Plaintiffs, V ietnam veterans and members of their families claim that they suffered injuries as a result of the veterans' exposure to herbicides manufactured by the defendant chemical companies and supplied by them to the United States government for use in the Vietnam War. The case has been certified as a class action for all liability and compensatory damage issues pursuant to Rule 23(b)(3) of the Federal Rules of Civil Procedure and for determination of punitive damage issues pursuant to Rule 23(b) 1 (B). Liability L i t i g a t i o n , P.T.O. See In re "Agent Orange" Product 72, --- F. Supp.--- (E.D.N.Y. Dec. 16, 1983), writ of mandamus d e n i e d , No. Cir. January 9, 1984). 83-3065, Slip Op. (2d Pursuant to the discovery rules of the Federal Rules of Civil Procedure, plaintiffs are seeking from defendant-Dow Chemical Company ("Dow") the medical and workers' compensation records of its employees who have made claims against Dow arisincr out of allecred industrial exposure to Dhenoxv herbicides from 1953 to 1970. Dow argues that these records are privileged b y reason of a Michigan statute which prohibits physicians from disclosing information acquired in attending any patient. Dow further bolsters its argument b y reference to Michigan Public Health Code §333.5611 which requires employers to file written reports of occupational disease claims made by employees and which expressly denotes such reports and exempt from disclosure. §333.5611. "non-public" See MCL, Public Health Code Both sides have extensively briefed the issues including which law should apply to a resolution of this dispute. After careful consideration, it is the Special Master's recommendation that Dow produce, under an appropriate protective order, the requested records to the plaintiffs, with the names, addresses and information identifying individual employees redacted. The following memorandum sets forth the reasons for the Special Master's conclusion. Introduction Rule 26(b) of the Federal Rules of Civil Procedure provides for the discovery of any matter, not privileged, is relevant to the subject matter of the litigation. court always has discretion to limit discovery, Civ. - 2 While the see Fed. P. Rule 26(c); Apicella v. McNeil Laboratories, which R. I n c . , 66 - 12718 FED 78, 82 (E.D.N.Y. 1-----R r p l P v a n t +"n --------------------------------------------------ww privileged, 1975), generally, t*hW p c—n h iJ PWnwl -w tmt t wa wf w t ow -r. it is discoverable. if the item being sought r\-f t h e w - 1 i -t-i a a f i p n - . - .w - .- 3 s - .w - . w - ,- . anH n n+- s— .s- —w w Relevancy for discovery purposes is treated mor e flexibly than under the Federal Rules of Evidence, Rul e 4 0 1 V and includes anything that appears "reasonably calculated to lead to the discovery of admissible evidence". Fed. R. Civ. P. Rule 26(b)(1). Clearly, the records sought b y plaintiffs here are relevant for discovery purposes, and m a y themselves constitute admissible evidence. Plaintiffs seek those medical and workers' compensation records of Dow employees who claimed to have suffered injuries by reason of industrial exposure to phenoxy herbicides from 1953 to 1970. Such records m a y show that phenoxy herbicides cause certain types of injuries; concerning the product they may also show what Dow knew it manufactured for the government, which may help plaintiffs to refute defendants' contract defense.**/ However, government if such records are *Rule 401 of the Federal Rules of Evidence defines relevant evidence as "evidence having any tendency to make the existence of any fact that is of consequence to the determination of the action more p r o b a b l e ... than it would be without the e v i d e n c e " . **The government contract defense has b een described by Judge Pratt as having three elements. To prevail on the defense, a defendant must show: 1) that the government made the specifications for "Agent Orange", 2) that the product manufactured by a defendant complied with these specifications in all material respects and 3) that the government knew as much as or more than the defendant about the hazards to people that accompanied use of the p r o d u c t . In re "Agent Orange" Product Liability L i t i g a t i o n , 534 F.Supp.1046, 1055 (E.D.N.Y. 1982) -3- 12719 privileged they are outside the scope of Rule 26 and are not ^ m A« a v Vk 1 «A » u io u u v c ta u ic . 4 « «■ xiiu& , medical and workers' Aa exit? -a M MM« 4 x ^ tDu c X« yA m 4 «■ xs> • tla > > «• w u e uiitri. I 1A * x / v j w « * /a » A « m w \ 1 a « « a a cui^A uyee compensation records are protected from disclosure by reason of the physician/patient privilege. I. Rule 501 of the Federal Rules of Evidence Rule 501 of the Federal Rules of Evidence deals with the subject of privilege and provides that: Except as otherwise required by the Constitution of the United States or p r o v i d e d by Act of Congress or in rules prescribed by the Supreme Court pursuant to statutory authority, the privilege of a witness, person, government. State or political subdivision thereof shall be governed by the principles of the common law as they m a y be interpreted by the courts of the United States in the light of reason and experience. However, in civil actions and proceedings, with respect to an element of a claim or defense as to which State law supplies the rule of decision, the privilege of a witness, person, government, State or political subdivision thereof shall be determined in accordance with State law. The Rule, especially its second sentence, attempts to establish a relationship between federal courts and state law-making bodies. Saltzburg, Federal Rules of Evidence Manual, (3d ed. 1982); See Berger, "Privilege, Presumptions and Competency of Witnesses in Federal Court: Choice-of-Laws Rule", However, 42 B r o oklyn L.Rev. commentators to the Rule, it have not always agreed on what at 229 A Federal 417, 436 (1976). as well as courts applying it means. See Saltzburg, Federal Rules of Evidence Manual at 229. -4 - 12720 One approach to construing Rule 501 calls for a federal court sitting in diversity to apply the forum state's law on privilege. 546; S e e , e . g . , Samuelson v. S u s e n , 576 F.2d Super Tire Engineering Co. v. Bandag, 439, 440 (E.D.Pa. 1983). I n c . , 562 F.Supp. This result is hardly startling since, under the principles of E r i e , state law would normally be expected to supply the rule of decision in a dive r s i ty case. See Pollitt v. Mobay Chemical C o . , 95 F.R.D. 1982); 2 Weinstein's Evidence §501[02] s u p r a , at 448. 101, at 501-21; 104 (S.D.Ohio Berger, If the privilege rules of more than the one state were involved, e . g . , where the communication sought to be protected was made in a state other than the forum, the federal court would look to the choice-of-law rules of the forum state to determine which state's substantive law would be used for resolution of the privilege question. See Klaxon Co. v. Stentor Elect. Mfg. C o ., 313 U.S. 61 S.Ct. 487, see, e . g . , Mazzella v. Philadelphia Newspapers, F.Supp. 523 (E.D.N.Y. 1020 (1941); I n c . , 479 1979). At least one commentator, however, has argued that Rule 501 directs the federal courts to apply a federal choice-of-law rule in cases where state law supplies the rule of decision and more than one state's privilege law is implicated. Berger, "Privilege, Witnesses in Federal Court: Presumptions and Co m p etency of A Federal Choice-of-Laws Rule", 42 -5 - 12721 Brooklyn L. Rev. 417 (1976). Cf^ Mitsui & Co. Puerto Rico Water Resources Authority,- (U.S.A.) Inc, v. 79 F .R .D . 72 (D .P .R . 1978)(District court in Puerto Rico applied an interest analysis test to dete r m i n e whether the Puerto Rico accountant-client priv i l e g e should be used to protect information sought in depositions of accountants which does not recognize the p r i v i l e g e ) . v. McNeil Laboratories, In Apicella, I n c . , 66 F.R.D. in New York, See also, 78 (E.D.N.Y. Apicella 1975). a products liability case based on diversity jurisdiction, the court refused to permit disclosure of a newsman's sources even though the forum state did not recognize the privilege. The court balanced relevancy of and need for the material sought against the state's policy regarding p r o t ection of news sources and federal constitutional interests. It hel d that even though the forum state had no privilege for newsmen, the parties' request for the journalist's sources should be denied in view of other factors weighing in favor of protection of those sources, such as the adverse effect disclosure would have on First Amendment rights, the ability of the journalist to obtain information from his sources in the future and the fact that the parties had not demonstrated need for the material. diversity case, Although Apicella was a the court did not slavishly follow the state - 6 - 12722 law which, it wo u l d appear, would hav e resulted in disclosure; instead it fashioned a balance test to determine whether the material w o u l d be protected from disclosure by a privilege. U t i l i z i n g a balance test in this case, that Dow's employee medical and workers' are not p r o t e c t e d from disclosure. it seems clear compensation records The need for the requested material far outweighs any interest in absolutely protecting these records from disclosure, especially where the names, addresses and other identifying information concerning individual employees are redacted. E ven under the first approach, however, this result would hold because, it is submitted, federal common law will govern the instant privilege question, and under federal common law, as will be shown below, no physician-patient privilege exists. A l t h o u g h jurisdiction in this case is founded upon diversity, the recent learned and provocative opinion on choice of law of the newly-assigned trial judge, Chief Judge Jack B. Weinstein, suggests that, rather than applying its own law, each state w o u l d look to federal common law or national consensus law to supply the rule of decision at least with respect to the product liability, and punitive damage issues. Conflicts of Law, P.T.O. government contract defense See Preliminary Memorandum on 87, dated January 12, 1984 at 5,6 ("PTO 87"). -7- 12723 In its very detailed analysis, the Court distinguished between federal law applying by its own force, for example, when jurisdiction is founded upon the existence of a federal question, and federal substantive law applying because a state chooses to apply it. See PTO 87 at 8-10. As an example of the latter, the Court noted that in deciding what state policy and law ought to be, a state often looks at federal law; drawing upon federal decisions, statutes and executive orders, a state might incorporate federal substantive law into its own substantive law. Id. at 9. In examining the question of what law should apply in this multidistrict litigation. Judge Weinstein looked at the choice-of-law rules of the states in which the transferor courts sit. See PTO 87 at 2-3, citing Klaxon v. Stentor Electric Mfg. C o . , 313 U.S. 487, 61 S.Ct. Dusen v. Barrack, 612; 84 S.Ct. concluded that, 376 U.S. 1020 (1941) 805 (1964). and Van He regardless of which choice-of-law m e thodology was used, each state, "because of its inability to identify and select any other state's law to be applied, as the rule of decision, would seek to divine what the national rule of decision with respect to product liability law w o u l d be so that such law would appropriately reflect the national and international characteristics of this case". -s - PTO 87 at 33. 19 7 24 The D o w employee records which plaintiffs have requested relate to the products liability and the government contract defense issues, see supra at 3. As to both, Judge Weinstein has t e ntatively determined federal common law or national consensus law applies. C f . In re "Agent Orange" Product Liability L i t i g a t i o n , No. 83-3065, Slip Op. n.2, (The Second Circuit noted that (2d Cir. January 9, 1984). although there is no federal question here> at 1091 it has not yet been determined what law might apply to which issues and implied that federal law might apply to certain issues, government contract defense). such as the Pursuant to Rule 501, then, purposes of resolving the instant privilege problem, that, for it appears since state law does not supply the rule of decision with respect to those issues, the court should look to federal common law to determine whether Dow employee medical and workers' compensation records are protected from disclosure by a physician-patient privilege. F.R.D. 568, 571 (N.D.Ga. See Scott v. M c D o n a l d , 70 1976). II. The Balance T e s t . At common law no physician-patient privilege existed. However, Rule 501 directs federal courts to apply "the principles of common law as they may be i n t e r p r e t e d . . -in light of reason and e x p e r i e n c e " . F.R.E. -9 - Rule 501 (emphasis added). 12725 Rather than attempting to set one rule by which privilege questions should be determined in all cases, Rule 501 permits a more flexible, case-by-case approach. Education of the City of N e w York, See Lora v. Board of 74 F.R.D. 1977) where Judge Weinstein recognized that, privileges on a case-by-case basis, 565, 578 (E.D.N.Y. in developing "'reason and experience' dictate a balancing of the public and private interests involved". Id. See a l s o , United States v. King, 105 (E.D.N.Y. 73 F.R.D. 103, 1976). In L o r a , this court formulated a balance test to determine whether a psychiatrist-patient privilege would apply to diagnostic and referral records used by the Board of Education in its procedures for p lacing children in schools for emotionally disturbed children. The "most constant" factor in the balancing equation is the "need for full development of the facts in federal litigation in order that the paramount interest in fair administration of justice be s e r v e d " . Board of E d u c a t i o n , 74 F.R.D. at 578. Lora v. The court also identified other public interest factors such as the public's interest in civil rights cases generally and in particular the public's interest in the effects on society of discriminaton in remedial schools. Id. at 579. - 10 - 12726 Private interests, such as an individual's "justifiable privilege expectations", must be considered too. See Lora v. Board of Education, 74 F.R.D. at 579. court isolated four factors designed to narrow, possible, potential In Lora this as much as intrusion into the privacy of the students whose records were being sought: "First, is the identification of the individuals required for effective use of the data? Second, is the invasion of privacy and risk of psychological harm being limited to the narrowest possible extent? Third, will the data be supplied only to qualified personnel under strict controls over confidentiality? necessary or simply desirable?" Finally, of decision, Fourth, is the data Id. even though state law m a y not supply the rule a federal court may look at state law to determine what the state's law is with respect to the privilege in question. See, e .g ., Lora v. Board of Education, 576; United States v. King, 73 F.R.D. at 105: 74 F.R.D. at "A strong p o l i c y of comity between the state and federal sovereignties impels federal courts to recognize state privileges where this can be accomplished at no substantial cost to federal substantive and procedural p o l i c y " . Recommendation As indicated above, the Special Master recommends that Dow's employee medical and workers' -11- compensation records which 12727 arise out of alleged claims of industrial exposure to phenoxy herbicides from 1953 to 1970 be produced to plaintiffs with the names, addresses and other such identifying information redacted. "'The public...has a right to every man's evidence' except for those persons protected b y a constitutional, common-law, U.S. 665, or statutory privilege." 688, 92 S .C t . 2646 (1972) physician-patient privilege exists Branzburg v. Hayes, (citation omitted). 408 As no in federal common law, one should be reluctant to recommend this court to adopt one in this case. 1983), See In re D o e , 97 F.R.D. 640, affirmed 711 F.2d 1187 (2d Cir. 645-46 (S.D.N.Y. 1983) where the court ordered production of a psychiatrist's patients' because, after an in camera examination, records it found that the records contained only information which would be found in records of a non-psychiatrist physician, and, there being no physician-patient privilege in federal common law, were not protected from disclosure. In addition, such records the physician-patient privilege has been often criticized by leading authorities. (Cleary 2d.ed. 1972). See McCormick, Evidence, §105 at 228 It is worth noting, too, that the Advisory Committee to the Federal Rules of Evidence included rules defining nine specific privileges -12- in the original Article 12728 V of the Federal Rules of Evidence, however, rejected the physician—patient privilege, the Committee adopting, instead, narrow privilege for psychiatrist-patient communications. a See, Salzburg, Federal Rules of Evidence Manual, Rule 501 at 231 (3d Ed. 1982). See a l s o , In re Doe, 97 F.R.D. at 644-46. As was stated in Lora v. Board of Education, 74 F.R.D. at 578, the most constant factor in the balancing test is "the need for full development of the facts in federal litigation". Also, as in L o r a , there are other public interest factors in this case weighing in favor of disclosure of Dow employee medical and workers' compensation records. The need to have all relevant information before the court is heightened here where the public has a particular interest in the resolution of claims which involve United States servicemen alleging serious injuries as a result of a product manufactured in the United States by every major chemical manufacturer and used by the government during a war which has not yet ceased to provoke controversy. Dow argues that the medical and w o r k e r s ' compensation records of present and former Dow workers should not be produced just because their employer has been sued in federal court. Dow maintains that Dow employees, having no interest or involvement in this litigation, invasion of their p r i v a c y " . stand nothing to gain but "an Memorandum of Dow Chemical -13- 12723 Company, dated December 30, 1983, at 7-8. However, D o w also indicates in its papers its willingness to supply the information sought by plaintiffs. Id. at 6-7. having Dow extract the data, however, the records themselves be provided. Rather than it seems preferable that Dow's e m p l o y e e s ’ privacy will be protected by blocking out the names, addresses and any other identifying information on the individual records and files. See E.E.O.C. v. U n i v ersity of Notre Dame Du L a c , 715 F.2d 331, 338 (7th Cir. 1983). See a l s o , Marrese v. American Aca d e m y of Orthopaedic S u r g e o n s , 52 U.S.L.W. January 3, 19 8 4 ) (en b a n c ) . Further, 2399 (7th Cir. the material should be disclosed under a protective order which will limit the use of the records solely for purposes of this lawsuit. While the general purpose of the physician-patient privilege is to encourage a patient in need of medical assistance to communicate freely with his or her doctor, this policy will not be impaired in the instant case where the records to be produced retain their confidentiality, inasmuch as all identifying information will be redacted. Plaintiffs have shown a compelling need for this data. The information contained in these records m a y be of great importance in determining whether, when and to what 14- extent D o w knew that its product might cause harm to human health. Accordingly, it is m y recommendation that these records, redacted as indicated, be produced forthwith, under the terms of a protective order as described above. Dated: N e w York, N e w York January 31, 1984 Respectfully submitted, :i b e r Master -1 5 - . •9 ^ ^ 1 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK X IN RE MDL N o. 381 (A ll C ases) "AGENT ORANGE" PRODUCT L IA B IL IT Y LITIGATION X rrr p j| r~' r\i r ì trr \/'c. — ¥ il.V.. ; I-' MEMORANDUM OF DEFENDANT MONSANTO COMPANY IN SUPPORT OF IT S MOTION FOR A PROTECTIVE ORDER 12600 T o w n l e y & CHRYSLER BUILDING 405 U LEXINGTON NEW p d i k e AVENUE Y O R K , N . Y. 1 0 1 7 4 TELEPHONE ( 212 ) 6 8 2 - 4567 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK ----------------------------------- x IN RE MDL No. 381 (All Cases) "AGENT ORANGE" PRODUCT LIABILITY LITIGATION ------------------------------ X MEMORANDUM OF DEFENDANT MONSANTO COMPANY IN SUPPORT OF ITS MOTION __________ FOR A P R O T E C T IVE ORDER__________ Defendant Monsanto Company ("Monsanto") memorandum in support of its motion, P. 26(c), submits this pursuant to Fed. R. Civ. for an order barring plaintiffs from deposing the twenty present or former Monsanto employees named in plaintiffs' most recent "preliminary list" of so-called "priority witnesses," dated February 13, 1984. With trial only eleven weeks away, to permit these twenty additional depositions would be to impose on Monsanto a heavy and unjustifiable burden — unjustifiable because plaintiffs have had two years to take the depositions they now so belatedly request. This Court should not allow plaintiffs' deliberate delay to prejudice Monsanto. Relevant Procedural History To put plaintiffs' light, eleventh-hour request in its proper a concise account of the course of discovery in this case is required. In Pretrial Order No. 26 the Court ordered 12601 first-wave discovery on the then undefined government contract defense. See 506 F. Supp. 762, 797, 799 (E.D.N.Y. January, 1981 plaintiffs served interrogatories on defendants. In February, 1980). In 1981 Monsanto, pursuant to Fed. R. Civ. P. 33(c), produced documents responsive to those interrogatories which pertained to the government contract defense as interpreted by defendants. In Pretrial Order No. 33 the Court explicitly defined the elements of the government contract defense. 1046, 1055 (E.D.N.Y. 1982). See 534 F. Supp The Court's definition made relevant the issue of each defendant's knowledge of the human health hazards, if any, that accompanied the use of Agent Orange — issue that remains the focus of plaintiffs' liability. See, e .g ., Pretrial Order No. 1276 (E.D.N.Y. an theory of defendants' 51, 565 F. Supp. 1263, 1983) ("Plaintiffs undoubtedly will strongly emphasize a negligent failure to warn as a basis for liability."). The Court also ordered "intensive discovery" on the now defined government contract defense. 534 F. Supp. at 1058. On July 9, 1982 Monsanto served supplemental answers to plaintiffs' interrogatories. See Exhibit A hereto. In addition to producing documents relevant to the government contract defense, Monsanto identified — relevant job title — by name, address, and 76 present or former Monsanto employees with relevant knowledge. Thus for over nineteen months plaintiffs have known the identities and whereabouts of 76 persons from Monsanto with knowledge about the critical issues -2- 12602 in this case, e . g . , the formation of dioxin in the 2,4,5-T production process; the identification, detection, and measurement of dioxin; the toxicity of dioxin; and the means of avoiding or minimizing the presence of dioxin in 2,4,5-T. What have plaintiffs done with this information? During the nine-month period preceding the Court's announcement on May 12, 1983 adjourning the trial scheduled for June 27, plaintiffs deposed only six of the 76 persons identified by Monsanto. During the five-month period after the adjournment, plaintiffs deposed no one presently or formerly employed by Monsanto. In September, 1983 Special Master Schreiber established a deposition schedule for the rest of the year pursuant to which plaintiffs, during three of every four weeks, would each week take the depositions of three of each defendant's present or former employees. During each such three-week period, defendants would not be permitted to depose anyone. The Special Master clearly stated the purpose of this schedule: "to give the plaintiffs catch up time." Hearing on September 7, 1983 at 6470-74, 6476-78, See T r . of 6483-84 (Exhibit B hereto). The Court affirmed this schedule, noting that "plaintiffs' failure thus far to undertake a regular program of depositions makes appropriate the program directed by the special master." 1983). Pretrial Order No. 59 at 3 (September 15, This program, pursuant to which plaintiffs were -3- 12603 permitted to take 27 Monsanto depositions by year's end, was slated to begin October 3, 1983. See Pretrial Order No. 59 at 7; T r . of Hearing on September 15, 1983 at 6561. Plaintiffs' counsel, however, who had known about the "catch up" deposition program since early September, delayed three weeks in sending counsel for Monsanto a witness list. See letter dated September 27, 1983 from David J. Dean to John Sabetta (Exhibit C hereto). That list contained the names of seven present and thirteen former employees. After witnesses were located and arrangements made, the deposition program finally began on October 17, 1983. In October, six Monsanto depositions were taken. In November six were taken; two more had been scheduled but were adjourned by Special. Master Schreiber at the request of plaintiffs' counsel and over Monsanto's objection. two depositions were taken. In December In January three were taken; thus far in February one has been taken, and one witness has been re-deposed. Thus during the four and a half months since the Court-approved deposition "catch up" program began, plaintiffs have deposed eighteen Monsanto witnesses. On February 9, 1984 plaintiffs submitted a deposition witness list containing 203 names, 98 of which were purported present or former employees of defendants, Monsanto. including seven from See Plaintiffs' Response to Paragraph No. 7 of the 12604 -4 - Magistrate's Pretrial Order No. 1 (Exhibit D hereto), at 3. In their submission plaintiffs assured the Court that the number of depositions they actually planned to take would "of necessity be but a fraction" — less than a quarter — less than half, perhaps even of the number listed. In this regard plaintiffs undertook to submit a second list of "priority witnesses" from the first list. Plaintiffs' I d . at 1-2. counsel reiterated these assurances at the hearing before Magistrate Scheindlin on February 9. See T r . at 9200 ("But I am sure that these [lists] will be pared down. know ours will."), I 9211, 9215 (Exhibit E hereto). Plaintiffs' "priority list" was received by counsel for Monsanto on February 15. The list contains 111 names, 60 of which are purported present or former employees of defendants. See letter dated February 13, 1984 from Schlegel & Trafelet, Ltd. to Hon. Shira Scheindlin (Exhibit F hereto). The extent of plaintiffs' prioritization of each defendant's employees is as follows: Number on First List Diamond Dow Hercules Monsanto T-H Thompson Uniroyal Number on "Priority" List 14 40 9 7 22 6 0 6 15 5 22* 6 6 0 * Of these 22 names, one, Louis Schwartz, was never a Monsanto employee, and another, L.C. Weger (identified incorrectly by plaintiffs as E. Weger), is deceased. 12605 -5- With respect to Monsanto employees, plainly not prioritized — plaintiffs have they have multiplied, more than tripling the number of depositions they seek to take. During the past two years of discovery in this case, plaintiffs have taken 28 Monsanto depositions. They now propose to take 22 more during the month of March. ARGUMENT THIS COURT SHOULD REJECT PLAINTIFFS' BELATED REQUEST FOR TWENTY MORE MONSANTO DEPOSITIONS AS UNJUSTIFIABLE AND HIGHLY PREJUDICIAL The original complaint in this case was filed over five years ago. There has been intensive discovery during the past two years. The Court has made plain its firm intention that the trial will begin May 7, eleven weeks away. this litigation is so big, so complex, Because and so important, there is much to do before trial and little time in which to do it. Plaintiffs want to force Monsanto to spend a good deal of this precious time preparing for and defending twenty depositions they could have taken many months ago. the twenty names on plaintiffs' Eleven of "priority list" were specifically identified by Monsanto over nineteen months ago as persons having knowledge relevant to the core issues of liability in this case. All names on the list have been identified in relevant documents produced by Monsanto as long as three years ago. 12806 -6- Plaintiffs have deposed twenty-five present or former Monsanto employees during the past two years. That they have not deposed a greater number is not an accident but rather a litigation decision. Plaintiffs' counsel have often proclaimed their readiness for trial without need for any further discovery of defendants. See, e.g., Ex. B at 6468. Plaintiffs' deliberate inattention to deposition discovery of defendants did, however, concern Special Master Schreiber. As a result he required plaintiffs to take depositions and prohibited defendants from taking depositions during 75% of the last three months of 1983. Master, The Special in announcing this deposition "catch up" program, and the Court, in approving it, were careful to consider whether it would prejudice defendants' preparation for trial. Because the program was slated to end well in advance of the then unfixed trial date, both concluded that no such prejudice would result. See Ex. B at 6473-74, 6478, 6483-84; Pretrial Order No. 59 at 5. Plaintiffs in large part availed themselves of this unusual opportunity to "catch u p " . At the beginning of the three-month period they had taken only eight Monsanto depositions; during that period they took fourteen more. Since the beginning of 1984, however, plaintiffs have shown little interest or initiative in taking more Monsanto depositions, with the notable exception of Dr. R. Emmet Kelly, whom they 12807 -7- regard as very important and have been permitted to depose on three separate occasions. Otherwise, they have apparently again decided to concentrate their trial preparation efforts elsewhere. On February 9 plaintiffs served a deposition witness list containing the names of seven purported present or former Monsanto employees. Monsanto objected only to the deposition of two of the seven on the ground that plaintiffs had already deposed them. See letter dated February 15, 1984 from John C. Sabetta to Stephen J. Schlegel (Exhibit G hereto). When plaintiffs last week served their so-called "priority list" of deposition witnesses, the number of Monsanto employees they wish to depose suddenly tripled. Moreover, because only one name appears on both lists, the first list has turned out to be a sham. In light of plaintiffs' repeated assurances to this Court — counsel's both in writing and at the hearing before Magistrate Scheindlin on February 9 — that they would pare down and prioritize their deposition requests, the conclusion is inescapable that their conduct with regard to Monsanto has worked a fraud on Monsanto and on the Court. Indeed, plaintiffs' new list is a creature of litigation tactics, not legitimate need. It is difficult to imagine a stratagem more disruptive of Monsanto's preparation for trial than an eleventh-hour odyssey of nationwide deposition defense. If plaintiffs really thought they needed 12S08 -8- twenty more Monsanto depositions, they would have taken them during the past two years. They chose not to take them. That was a litigation decision, an exercise of their counsel's discretion. Now they want to take them. This is a litigation ploy that the Court should not enforce. Judge Weinstein on prior occasions has, in light of the rapidly approaching trial, drastically reduced the number of depositions requested by the parties. For example, last November defendants requested 61 depositions of government causation experts. The Court, citing the "enormous amount of work" to be done in the time remaining before trial, the number to ten. limited See T r . of Hearing on November 21, 1983 at 65-67, 72-75, 77-78 (Exhibit H hereto). Similarly, last week plaintiffs proposed to take the depositions of scores of government contract officers. Judge Weinstein reserved decision on whether to allow any such depositions and made it clear that he would in any event permit only a few. Hearing on February 15, 1983 at 39-40, See T r . of 45 (Exhibit I hereto). The Court recognizes there is no time on the eve of trial for a large number of depositions — have been taken months ago. all of which could The "catch up" program has ended, and there is no time for another. Moreover, based on our preliminary review, many of the twenty Monsanto witnesses plaintiffs now seek to depose have knowledge that, if relevant, is at best merely cumulative of that of the twenty-five Monsanto witnesses whom plaintiffs have already deposed. -9- In 12SG9 such circumstances, the Court should recognize plaintiffs' omnibus request for twenty more Monsanto depositions as the mere device that it is. Because plaintiffs' deliberately belated request is completely unjustifiable and very prejudicial to Monsanto's preparation for the now imminent trial, its entirety. it should be denied in At the very least, plaintiffs should be required to explain to the Court's satisfaction, for each of the twenty Monsanto witnesses, why he was not noticed for deposition last year or before, what information plaintiffs expect to obtain from him, and why they have not been able to obtain that information from their extensive discovery of Monsanto over the past three years. CONCLUSION For the reasons stated above, Monsanto's motion for a protective order should be granted. Dated: New York, New York February 21, 1984 Respectfully submitted, TOWNLEY & UPDIKE Attorneys for the Defendant Monsanto Company 405 Lexington Avenue New York, New York 10174 (212) 682-4567 12610 10- Bound Fil £ UNITED STATES D I S T R I C T COURT EASTERN DI ST R I C T OF NEW YORK ----------------------------- x I N RE MDL N o . "AGENT ORANGE" 381 : PRODUCT L I A B I L I T Y LI TIG AT ION ----------------------------------------------------------------------x SUPPLEMENTAL ANSWERS OF DEFENDANT MONSANTO COMPANY TO P L A I N T I F F S ' INTERROGATORIES TO DEFENDANTS _______________( F I R S T WAVE)________________ To w n l e y CHRYSLER •405 & U p d ik e Bu ild in g LEXINGTON NEW a v e n u e Y O R K , N . Y. 1 0 1 7 4 TClC P h O m E <2i2> 662- 4567 12611 UNITED STATES D I S T R I C T COURT EASTERN D I S T R I C T OF NEW YORK ---------------------------------------------------- -x I N RE MDL N o . "AGENT ORANGE" 381 : SUPPLEMENTAL ANSWERS OF DEFENDANT MONSANTO COMPANY PRODUCT L I A B I L I T Y LI TIG AT ION : TO P L A I N T I F F S ' INTERROGATORIES TO DEFENDANTS ( F I R S T WAVE) ---------------------------------------------------------------------- x M o n s a n t o Company P retria l to P la in tiffs' dated the O rder No. 1981 the names o f m an agerial or The p ertin en t and 13 (2) co n ta in in g sch ed u les a n in e-d ig it of the Each number. to In M onsanto than listed job title and of M onsanto to the one to in terrogatory. docum ent the is lists who h e l d 1, be 1971, liv in g ; the id en tified by nature some sch ed u les names the of response to together w ith , p rio r January to (1) docum ents o v erla p p in g annexed h e r e to , of January docum ent one h eld p rovid es o r more o f of in co n sist to some title s W ave)," em p loyees p rio r the a lp h a b etica lly , or 1981 Answ ers (F irst are b e lie v e d a d d itio n a l id en tified 11, w ith P la in tiffs' answ ers such M onsanto an A p p e n d ix em p loyees are relev a n t more to p o sitio n s Because February M onsanto resp o n siv e in terro g a to ries, resp o n siv e to ries of in fo rm a tio n in terro g a to ries. answ ers in fo rm a tio n , accordance In terro g a to ries" ), and p a s t su p erv iso ry in D efendants su p p lem en tal present possess to (" P la in tiffs' su p p lem en tal In terro g a to ries. of and M o n s a n t o 's " In terrogatories January, fo llo w in g 33 ("M onsanto"), of are a ll in terro g a ­ for 1, each, h is 1971 and, if he is not p resen tly em p loyed by M onsanto, The d o c u m e n ts id en tified h is la st known address. a cco rd in g to and c o p y i n g U p d ik e, the at 13 the sch ed u les o ffices upon r e a s o n a b le of and h erein have been are a v a ila b le M on san to's segregated for in sp ectio n attorn eys, T ow nley & n o tice. .oc!13 tC'O. - 2- ANSWERS INTERROGATORY NUMBER 2 P rovide a ta b le of D e f e n d a n t Company s e t t i n g Interrogatory A. organ ization forth T h e name an d resp o n sib le p ro d u ctio n and s a l e for to the U n ited in clu d in g V ietnam d u rin g S u p p lem en tal Answer t o See attached Interrogatory rela ted to in Interrogatory 2B(i) or (i) G overnm ent in for d iv isio n in of the the d esig n , Governm ent o f in 1960 the S ou th east A sia through 1971. 2A 1 and 3. telep h on e em p loyed b y , under each D efendant w ith number, wh o w a s any of the the A sia id en tified in clu d in g , in M otions docum ents or w ith A gen t Orange in clu d in g V ietnam during not lim ited fa m ilia r w ith the referred Su m m a r y J u d g m e n t to -3- th erein . for, the U n ited h erb icid e but for or fo llo w in g : the of and resp o n sib le and c o n t r a c t sa le title c o n tr a c t w ith N eg o tia tio n s 1971, D efendants' and t h e use p erio d address, fa m ilia r Southeast through persons for S ch ed u les person p a rticip a ted 1960 the S tates Interrogatory The name, every in each 2B B. use of o r w h ich p a r t i c i p a t e d known a s A g e n t O ran ge oth erw ise answ ering fo llo w in g : lo ca tio n h erb icid e of the 2A defendant d u ties the of the to p erio d a ll m atters in for th is stated case S tates Supplemental Answer to Interrogatory 2B(i) R ob ert Baynard John Bush Jam es C onnaughton D on ald F is c h e r G. H. G riffin P. N. H offm an W illiam J. M cC arville Dan M i d d l e t o n R o b e r t Rumer C ecil H. M ilt Sm id C. Interrogatory P. Zorsch 2B(ii) (ii) the D esign subject S u p p lem en ta l R u ssell of the Answ er to of the governm ent Agent O range h e r b i c i d e w h ich was contract. Interrogatory 2B(ii) D on ald Cayard Tom G r e e n m a n F red M atthew s D o n a ld Mayer William J. M cC a rv ille Dan M i d d l e t o n Robert Rumer C ecil H. D. Sharp B. R u ssell -cola -4- Interrogatory 2B(iil) (iii) The p r o d u c t i o n w h ich was t h e S u p p lem en tal subject Answ er t o of the of the A gent Orange h e r b ic id e governm ent c o n tr a c t. Interrogatory 2B(iii) R ick A tk in so n P h ilip B. B ald erson Edmun d B a u e r Tom B o c h J o h n Boehm Carl Bohl D on ald Cayard Jam es C onnaughton Eugene C u tw rig h t Eugene D otson F r e d Edmonds D on ald H. F isch er M axw ell G allow ay Tom G r e e n m a n R o b e r t M. Paul H eisler Frank J. F. J. P eter Hal H am lett H elm er H o lza p fel H ow ell K irtley W illiam A. Kuhn A rthur L eisy 12616 -5- Darwin E. Lewis C h a rle s F. Lueeke F red M atthew s D o n a ld Mayer W illiam J. M cC arville Dan M id d le t o n John M u llen d ore Roy Payne Homer P a y t o n J. T. Pebw orth D a rrell R ainey V e r n o n L. Rhodes R o b e r t Rumer C ecil H. H erbert Carl R u ssell Sachs Schumacher R ob ert Sido R o n a l d R. S m ith R ob ert Soden Jam es S p rin ggate Ed S t e w a r t F r a n k E. Take, H en ry F. T rail W illiam H. E. U d ell W ebb, Jr. R o b e r t Webber Jr. Toby W hite H ill W illia m s R ob ert Yoder C. Interrogatory P. Zorsch 2B(iv) (iv) The state tim e when D e f e n d a n t s p erio d of U n ited S tates h erb icid e of the Governm ent w ith respect m an u factu rin g, to art to and t e c h n o l o g y were under su p p ly the the the c o n tr a c t w ith the A gen t Orange form u lation , m ethod o r p r o c e s s d u rin g d esig n , and p r o d u c t i o n of the A gent O range h e r b i c i d e . S u p p lem en tal See 2B(ii), Answer (iii) and risk s of d io x in and p r o d u c t i o n th e m ethods S u p p lem en tal to In terrogatories Numbers (vii). The d esig n costs A nsw ers 2B(iv) 2B(v) (v) the Interrogatory S u p p lem en tal Interrogatory the to of d io x in of co n ta m in a tio n the control P. to red u ction G. Interrogatory Arvan R ick A tk in so n P h ilip Carl B. B ald erson Bohl Owen E. D olin -7- w ith A gen t Orange h e r b i c i d e , thereof. Answ er a ssociated 2B(v) or e lim in a tio n and J a c k D. E arly P e t e r H ow ell R. Emmet K e l l y D a r w in E. L ew is W illiam M cC a rv ille J. John M u llen d ore Roy P ayn e V e r n o n L. Rhodes F red erick L. Rupel C ecil H. D. B. Sharp A. J. S p ezia le J. A. Stephans William R u ssell U d ell E lm er W h eeler Interrogatory 2B(vi) (vi) w ith W arning t o regard S u p p lem en tal to the Answer t o m atters to the d io x in m ethods for, U n ited stated Interrogatory M onsanto p r e s e n t l y resp o n sib le the knows p a rticip a ted in U n ited in the of no or was w arnings co n ta m in a tio n a sso cia ted w ith Agent com m unicated w ith governm ent (v). familiar regard H owever, item who w a s w ith co n tro l. p reced in g rep resen ta tiv e governm ent d io x in G overnm ent, 2B(vi) S tates of S tates R. to w ith the Orange, risk s or of the Emmet K e l l y rep resen ta tiv es co n cern in g h e a lth 12619 -8- if an effects to workers John M u llen d ore co n cern in g exposed d io x in Interrogatory 2B(vii) content (vii) S u p p lem en tal 2,4,5-T com m unicated w it h the u tilize d to of and i t s precursors, governm ent r e p r e s e n ta tiv e s c h lo rin a te d p h en ols. The m a n u fa c tu r in g p r o c e s s or u t i l i z e d Answ er t o in the and p ro d u ctio n Interrogatory of proposed to be A gent Orange. 2B(vii) R ick A tk in so n P h ilip D. E. B. B ald erson B aldus Ed mund B a u e r Tom R. Boch J o h n Boe hm Carl Bohl D on ald Cayard Jam es C onnaughton Eugene C u tw right Owen E . D olin Eugene D otson F r e d Edmonds H. M axw ell G allow ay Jack G arrett Tom G r e e n m a n R o b e r t M. L. P. H am lett H arich 1 -9- r nri a H. C. Heineman Paul H eiB ler Frank J . H elm er P e t e r H ow ell D arw in E. C h arles L ew is F. Luecke ,D. L y n c h Fred M atthew s D o n a ld Mayer W illiam J. M cC a rv ille Dan M i d d l e t o n John M u llen d ore R. L. N u ll Roy P a y n e H om e r P a y t o n J. T. Pebw orth Wa yne P h i l l i p s Vernon L. J a m e s N. Rhodes Roark R o b e r t Ru me r F red erick C ecil H. H erbert L. Rupel R u ssell Sachs V. N. Schrodt D. B. Sharp 12621 -1 0 - Ronald R. Smith A. J. S p ezia le J. A. Stephans Ed S t e w a r t Frank E. Take, M a r r in e A. W illiam H. E. Jr. T erpstra U d ell We bb, Jr. R o b e r t W ebber Toby W hite R ob ert Yoder INTERROGATORY NUMBER 3 Id en tify retired every so state person, b y name and and su p p ly scientific, th is defendant or reta in ed by known t o any stu d ied , ev a lu a ted , com m unicated found or of ch em ical " D ioxin") the or in co n ta in in g and o t h e r h erb icid es by or other defendants who h a s d ir ec tly to or such not co n ta in in g were so exposure, d esig n , m anufacture 2 , 4 , 5-Trichloro- lim ited D ibenzo effects from as have been in d irectly w hatever resu ltin g 2 ,3 ,7 ,8-Tetrachlor reta in ed and to fo rm u la tio n , but each defendant refera b le the o th erw ise, of th is phenoxy h e r b ic id e s phenoxy A lip h a tic s o rgan ic of and i f known a d d r e s s or o r human b e i n g s in d irectly , and p r o d u c tio n la st known b y reported any f i n d i n g s upon a n im a ls d irectly or the known a d d r e s s , medical, known t o or la st to the sy n th etic p -d io x in (TCDD o r P o ly ch lo rin a ted Dibenzo-p-dioxins (PCDDs) and Polychlorinated Dibenzo furans (PCDFs) including the ultimate users of those expected to be exposed to same. Supplemental Answer to Interrogatory 3 See attached Schedule 7. INTERROGATORY NUMBER 4 (FIRST) Provide a table or organization as to the United States Government showing: Interrogatory 4A (First) A. The division or units of such division of the United States Government with whom Defendants contracted to supply the Agent Orange herbicide to be used in Southeast Asia including Vietnam during the period 1960 through 1971. Supplemental Answer to Interrogatory 4A (First) See attached Schedule 1. Interrogatory 4B (First) B. The name, address, telephone number, title and duties of every person employed by, under contract with or otherwise related to said division or units of the United States Government w ith whom the Defendants, agents, servants, or any of their or employees dealt in connection with the negotiations and contract for the supply of the Agent Orange herbicide, including the design and production of such herbicide. 12623 -1 2 - Supplemental Answer to Interrogatory 4B (First) See attached Schedule 1. Interrogatory 4C (First) C. The name, address, telephone number, title and duties of every person employed by said division and units whom Defendants claim were knowledgeable with respect to the following: Interrogatory 4C(i) (i) (First) The state of the art and technology at the time the Defendants were under contract with the United States Government to supply the Agent Orange herbicide with respect to the design and method of process of production including manufacturing process of the Agent Orange herbicide. Supplemental Answer to Interrogatory 4C(i) (First) See attached Schedule 3. Interrogatory 4C(ii) (ii) (First) The risks of dioxin contamination associated with the design and production of the Agent Orange herbicide, the methods of dioxin control, reduction or elimination and the costs thereof. Supplemental Answer to Interrogatory 4C(ii) (First) See attached Schedule 4. i? -13- rj à Interrogatory 4C(iii) (First) (iii) Warning to the U n i t e d States Government, if any, wit h regard to the matters stated in the preceding item (ii). Supplemental Answer to Interrogatory 4C(iii) (First) Monsanto is presently unable to identify any such person. Interrogatory 4C(iv) (iv) (First) The process utilized or p r o posed to be utilized by defendant to manufacture Agent Orange. Supplemental Answer to Interrogatory 4C(iv) (First) See attached Schedule 3. INTERROGATORY NUMBER 4 (SECOND) Identify all documents, title, their location and the name, address and telphone number of the custodian in possession or control of, or known to the Defendants which relate to the items 1 through 3 s u p r a , including: Interrogatory 4A A. (Second) Any and all research, analyses, procedures relative to the manufacture, promotion, tests, advertising, testing sale, and marketing of phenoxy herbicides such as 2 , 4 , 5-Trichlorophenoxy Aliphatics containing but not limited to the synthetic organic chemical 2 , 3 , 7 , 8-Tetracholor Dibenzo p-dioxin (TCDD or "Dioxin") and other herbicides containing Polychlorinated Dibeno-p-dioxins Dibenzo furans (PCDFs), (PCDDs) and Polychlorinated hereinafter simply "Phenoxy herbicides." »; ip, -14- Supplemental Answer to Interrogatory 4A (Second) See attached Schedule 6. Interrogatory 4B (Second) B. Analysis, experiments, studies, experiments, results of such including b u t n o t limited to the recommendations concerning the results of experiments relative to the formulation, promotion, production, manufacture, sale, marketing, and advertising of phenoxy herbicides. Supplemental Answer to Interrogatory 4B (Second) See attached Schedule 6. Interrogatory 4C (Second) C. Anyone acting by or on behalf of this defendant or known to be acting by or on behalf of any of the other defendants relative to the research, evaluation, sale, testing, analysis, and recommendations relative to the manufacture, distribution, advertising, and promotion of phenoxy herbicides. Supplemental Answer to Interrogatory 4C (Second) See attached Schedule 6. Interrogatory 4D (Second) D. Effects of exposure of whatever nature and under whate v e r circumstances or conditions to phenoxy herbicides. Supplemental Answer to Interrogatory 4D (Second) See attached Schedule 7. •? O 3 J8. -15- W 28 Interrogatory 4E (Second) E. The dates, places and times of measuring and testing exposure in animals (identify by animal) of phenoxy herbicides. Supplemental Answer to Interrogatory 4E (Second) See attached Schedule 8. Interrogatory 4F (Second) F. The dates, times, places, and results of exposure to humans in whatever form of phenoxy herbicides. Supplemental Answer to Interrogatory 4F (Second) See attached Schedule 9. Interrogatory 4G (Second) G. Any studies conducted by this defendant or known by this defendant to have been conducted by any of the other defendants or by anyone or by any independent organization retained by this defendant or known by this defendant to have been retained by other defendants with respect to the effects, if any, upon the employees of this defendant or the employees of other defendants known to this defendant or their spouses and children who were in any manner, with or exposed to the manufacture, shape, or form associated production and shipment of phenoxy herbicides. Supplemental Answer to Interrogatory 4G (Second) See attached Schedule 10. -i J r : fC ' -16- r>o ^ vO é Interrogatory 4H (Second) H. manufacturing, A n y and all accidents in the production and shipping, and distribution of phenoxy herbicides including the results of any inquiry by this defendant or known by this defendant to have been made by other defendants or any inquiry by any public or private agency relative to such accident or accidents. Supplemental Answer to Interrogatory 4H (Second) See attached Schedule 11. Interrogatory 41 I. (Second) Identify and set forth the process utilized for the manfacture of phenoxy herbicides. Supplemental Answer to Interrogatory 41 (Second) See attached Schedule 3. Interrogatory 4J (Second) J. If the process in response to the above was changed from time to time, identify and set forth each and every process and the dates of changes, if any, Supplemental Answer to Interrogatory 4J (Second) to date. See attached Schedule 3. Interrogatory 4K (Second) K. The existence of Dioxin in the manufacture and production of phenoxy herbicides. Supplemental Answer to Interrogatory 4K (Second) See attached Schedule 4. 12628 -17- Interrogatory 4L (Second) L. Warranties, representations, and assurances, made b y this defendant or known b y this defendant to have been made b y other defendants to the United States Government in respect of phenoxy herbicides. Supplemental Answer to Interrogatory 4L (Second) See attached Schedule 2. Interrogatory 4M (Second) M. The company's knowledge of the existence of Dioxin in the production, marketing, manufacture, distribution, sale, and promotion of phenoxy herbicides. Supplemental Answer to Interrogatory 4M (Second) See attached Schedule 4. Interrogatory 4N N. (Second) Warranties, representations, assurances, and/or promises made by this defendant or known to this defendant to have been made by other defendants to the United States Government relative to the existence or non-existence of Dioxin in phenoxy herbicides. Supplemental Answer to Interrogatory 4N (Second) Monsanto has no such documents. Interrogatory 40 (Second) O. Negotiations between this defendant or known by this defendant to have been undertaken by or on behalf of the 12829 -18- other defendants between this and/or the other defendants and the United States Government wit h respect to the existence of Dioxin in the manfacture, sale, advertising, production, and distribution, marketing, promotion, on [sic] phenoxy herbicides. Supplemental Answer to Interrogatory 40 (Second) See attached Schedule 2. Interrogatory 4P (Second) P. The manufacturing process from beginning to end in the production of phenoxy herbicides. Supplemental Answer to Interrogatory 4P (Second) See attached Schedule 3. Interrogatory 4Q (Second) Q. indirectly, report, All documents which refer or relate, to any action, investigation, analysis, directly or study, or statements by or on behalf of the company or received by the company or known by this company in respect of the other defendants relating to incidents of medical signs, symptoms, and conditions claimed, suggested, or suspected of being related to exposure in any form to phenoxy herbicides from in or about 1945 to date including but not limited to activities of any treatment organization, study organization and its groups. Supplemental Answer to Interrogatory 4Q (Second) See attached Schedule 7. 12630 -19- Interrogatory 4R (Second) R. indirectly, local, All documents which refer or relate, directly or to claims filed against this defendant in any State or Federal Court, agency, board, or any other entity established to hea r such claims for medical conditions claimed to have resulted or be connected directly or indirectly to the formulation, design, production and manufacture of phenoxy herbicides. Supplemental Answer to Interrogatory 4R (Second) See attached Schedule 13. Interrogatory 4S S. (Second) All documents relative to studies of the effects of phenoxy herbicides when used in Southeast Asia including Vietnam including the dates, times, and places and amounts of use and conditions i n c i u u m y our not limited to meteorological conditions for use and any and all instructions, suggestions, indications, directions, and contraindications relative to the use of phenoxy herbicides in Southeast Asia from 1960 to 1971. Supplemental Answer to Interrogatory 4S (Second) See attached Schedule 12. Interrogatory 4T (Second) T. A n y and all such documents relating to any private organizations, conferences, foundations, which have conducted any studies, experiments, evaluations, or analyses 12631 -20- either independently or by and on behalf of the answering defendant or k n o w n to have been conducted by or on behalf of the other defendants with respect to the effects, if any, of exposure to phe n o x y herbicides on animals and humans and the conclusions and recommendations drawn therefrom and the actions, if any, taken in respect thereto by this defendant or known by this defendant to have b e e n taken by other defendants. Supplemental Answer to Interrogatory 4T (Second) See attached Schedule 5. Interrogatory 4U (Second) U. The funding by this defendant or known by this defendant to have been funded by any or all of the other defendants of any organizations commissioned, encouraged, suffered, and/or directed to undertake studies relative to the medical, genetic, and systematic effects and any other medical effects upon animals and humans exposed by whatever means under whatever conditions and circumstances to phenoxy herbicides. Supplemental Answer to Interrogatory 4U (Second) See attached Schedule 5. INTERROGATORY NUMBER 5 Provide an idex to and summary of each of said documents and provide and indicate their means of identification such as file number, case, etc. Supplemental Answer to Interrogatory 5 See attached Schedules. 12032 -21- INTERROGATORY NUMBER 6 Identify the name, title, address and telephone number of those persons employed b y or under contract with, or otherwise related to the Defendants, who were authors of said documents and those persons who are familiar with such documents. Supplemental Answer to Interrogatory 6 See attached Schedules. Dated: New York, New York July 9, 1982 405 Lexington Avenue N e w York, N e w York 10174 (212) 582-4567 TO: SEE ATTACHED SERVICE LIST 12G33 - 22- APPENDIX P.G. ARVAN Director of Marketing,- Agricultural Division 420 North Maple Greenwich, CT 06348 RICK ATKINSON Process Research Chemist Monsanto PHILIP B. BALDERSON Chemist, Nitro Monsanto D.E. BALDUS Research Chemist, Agricultural Division Monsanto EDMUND BAUER General Manager, Agricultural Division Monsanto ROBERT BAYNARD Product Supervisor, N e w York 231 Jeffrey Lane Newtown Square, PA 19073 TOM R. BOCH Production Supervisor, Nitro Monsanto 12634 JOHN BOE H M Engineer, W.G. Krummrich Monsanto CARL BOHL Industrial Hygienist Monsanto JOHN BUSH Manager and Director of Governmental Marketing, Washington, D.C. 2232 North Military Road Arlington, VA 22207 DONALD CAYARD Manager of Guest Operations, Agricultural Products Company Monsanto JAMES CONNAUGHTON Manufacturing Superintendent, Nitro and Krummrich Agricultural Division 9905 Roundstone Trace Louisville, KY 40223 EUGENE CUTWRIGHT Guest Manufacturing Superintendent, Nitro 1474 Maplewood Dr. Macon, GA 31210 OWEN E. DOLIN Research Supervisor, Nitro 1 -2- i\y Monsanto EUGENE DOTSON Operations Supervisor, Nitro Foote Mineral Company Gover Road Kingsmountain, NC 28086 JACK D. EARLY Director of Technical Services, Agricultural Division and EnviroChem, Washington, D.C. 8024 Lakenheath Way Potomac, MD 20854 FRED EDMONDS Foreman, W.G. Krummrich Monsanto DONALD FISCHER Manager of Proprietary Pesticides, Chemicals Director of Agricultural Monsanto H. MAXWELL GALLOWAY Engineer, Technical Services Department Monsanto JACK GARRETT Manager, Industrial Hygiene & Pollution Abatement Monsanto TOM GREENMAN Superintendent, Technical Services Department Monsanto ?L P " 1 Ü R ¿V O -3- G.H. GRIFFIN Legal Department, St. Louis Monsanto ROBERT M. HAMLETT Manufacturing Supervisor, W.G. Kruitunrich 24 Queensbrook St. Louis, MO 63132 L.P. HARICH Production Supervisor, Nitro Monsanto H.C. HEINEMAN Production Superintendent, W.G. Krummrich Monsanto PAUL HEISLER General Manufacturing Superintendent, W.G. Krummrich Monsanto FRANK J. HELMER Engineering Services and Process Engineering Superintendent, Nitro Monsanto P.N. HOFFMAN Product Manager for Agricultural Chemicals, Division Agricultural 1202 Lakeshore Dr. North Barrington, IL 60010 -4- •f r , \ ..4. 3? F.J. HOLZAPFEL Director of Engineering, Queeny 12124 St. Clement St. Louis, MO 63131 PETER HOWELL Engineer, Nitro Monsanto R. Emmet KELLY Director, Medical Department 665 S. Skinker St. Louis, MO 63105 HAL KIRTLEY Shipping Superintendent, Nitro 835 Hughes Drive St. Albans, WV 25177 WILLIAM A. KUHN Superintendent, W.G. Krummrich 11915 Paradise Lane St. Louis, MO 63131 ARTHUR LEISY Guest Superintendent, W.G. Krummrich 3609 Tibet Drive Gulf Breeze, FL 32561 12338 -5- DARWIN E . LEWIS E n g in e e r in g S u p e r v iso r S u p e r in te n d e n t and A s s i s t a n t T e c h n ic a l S e r v ic e s 3235 B a in b u rr y C t. S t . L o u i s , MO 6 3 1 2 9 CHARLES F . LUECKE A s s is ta n t D ir e c to r o f M a n u fa c tu r in g , A g r ic u ltu r a l D iv isio n M on san to D . LYNCH S e n io r R e s e a r c h C h em ist and R e s e a r c h S p e c i a l i s t in p r o c e s s d e v e l o p m e n t a n d i m p r o v e m e n t , Q u e e n y a n d W. G. K r u m m r ic h M on san to FRED MATTHEWS P r o d u c t io n and O p e r a tin g S u p er v iso r, W. G. K r u m m r ic h M on san to DONALD MAYER P r o d u c tio n C o o r d in a to r , W. G. K r u m m r ic h M on san to WILLIAM J . McCARVILLE D ir e c to r o f Product S a le s, A g r ic u ltu r a l D ivision M on san to DAN MIDDLETON P r o d u c tio n S u p e r v is o r , W. G. K r u m m r ic h M on san to 12339 -6- JOHN MULLENDORE E n g in e e r in g and T e c h n ic a l K ru n u n rich 1020 G rove E v a n s t o n , IL S e r v ic e s S u p e r in te n d e n t, W.C. 60201 R . L . NULL T e c h n ic a l S e r v i c e s D e p a r tm e n t E n g in e e r , A rea M a in te n a n c e S u p e r v is o r and T e c h n ic a l P r o d u c t io n S u p e r in t e n d e n t , N it r o M on san to ROY PAYNE H ead O p e r a to r and B u ild in g Forem an, N itr o M on san to HOMER PAYTON D ir e c t o r o f M a n u fa c tu r in g , S t. L o u is 1 7 5 3 H a g g i n G r o v e Way C a r m i c h a e l , CA 9 5 6 0 8 J . T . PEBWORTH O p e ra tin g S u p e r v is o r , N itr o . E t h y l A s i a P a c i f i c Com pany 1 S c i e n c e C e n t r e Rd. 0 6 - 0 5 U n it y H ouse S in g a p o r e , 2260 WAYNE P H I L L I P S P r o c e s s C h em ist and M a n u fa c tu r in g S u p er v iso r, N itr o M on san to < -¿L -7- ,r> DARRELL RAINEY F o r e m a n , W. G. K r u m m r i c h 1 0 7 0 G eo r g ia A venue E n g l e w o o d , FL 33533 VERNON L . RHODES P r o d u c tio n S u p e r v is o r , N itr o M on san to JAMES N . ROARK C h ie f A n a ly tic a l C h em ist, N itr o M on san to ROBERT RUMER V ic e -P r e sid e n t 2 6 2 0 Q u a il H i l l P i t t s b u r g h , PA and G e n e r a l M anager, A g r ic u ltu r a l D iv isio n 15241 FREDERICK L . RUPEL S u p er v iso r o f P rod u ct Q u a lity , S t. L o u is W. G. K r u m m r ic h M on san to CECIL H. D ir e c to r RUSSELL o f P rod u ct Q u a lity 46 W in g fie ld S t . L o u i s , MO 6 3 1 2 2 HERBERT SACHS M a n u fa c tu r in g S u p e r in te n d e n t, 4322 S ton e C rest S t . J o s e p h , MO 6 4 5 0 5 for* -e - 41 V.N. SCHRODT Senior Research Engineer Monsanto CARL SCHUMACHER O p e ra tio n S u p e r v is o r , A d m in is tr a tiv e S e r v ic e s S c h e d u lin g P la n n in g , A g r ic u ltu r a l D iv is io n and P r o d u c t io n M on san to D . B . SHARP R esearch D ir e c to r , S t. L o u is S t. L o u is M on san to ROBERT SIDO L a b e llin g M anager, M on san to MILT SMID M a t e r ia ls H a n d lin g K r u m m r ic h and P a c k a g in g E n g in e e r in g S p e c ia list, W. G. M on san to RONALD R . SMITH H ead O p e r a t o r , N i t r o M on san to ROBERT SODEN P la n t M anager, W. G. K r u m m r ic h M on san to 1 <*>.-T» X A* -9- A.J. SPEZIALE Director of Research, Agricultural Division 311 Northumberland Redwood City, CA 94061 JAMES SPRINGGATE P la n t M anager, N it r o 13060 E. S u n se t D r iv e L o s A l t o s H i l l s , CA 9 4 0 2 2 J . A . STEPHANS D ir e c to r o f R esearch M on san to ED STEWART S e n io r E n g in e e r , W. G. K r u m m r ic h M on san to FRANK E . TAKE, J R . M a n u fa c tu r in g S u p e r in te n d e n t, N itr o 480 H illb r o o k D r. B a l l w i n , MO 6 3 0 1 1 MARRINE A . TERPSTRA R e s e a r c h G roup L e a d e r , 515 A ndrew s S t . L o u i s , MO S t. L o u is 63122 123 -10- HENRY F . TRAIL E n g in e e r in g M anager, S t. L o u is Box 239, Watson Hill Freedom, NH 03836 WILLIAM UDELL R e s e a r c h C h em ist, A g r ic u ltu r a l D iv isio n M on san to H . E . WEBB, J R . S a fe ty D ir e c to r , N itr o 1 1 4 1 N ew H o p e R o a d S p r i n g H i l l , FL 33512 ROBERT WEBBER A s s is ta n t D ir e c to r of E n g in e e r in g , A g r ic u ltu r a l D iv isio n D ep artm en t, N itro M on san to ELMER WHEELER I n d u str ia l H y g ie n is t, S t. L o u is 110 C ool S p r in g s D r. C a m d e n , SC 29020 TOBY WHITE P la n t E n g in e e r , T e c h n ic a l S e r v ic e s 5 0 1 5 Tow n C e n t r e D r . S t . L o u i s , M0 63128 •C/u 4 -11- H IL L WILLIAMS E n g in e e r in g , Q ueeny M on san to ROBERT YODER S e n io r E n g in e e r , S t. L o u is M on san to C . P . ZORSCH P rod u ct S u p e r v iso r , A g r ic u ltu r a l D iv isio n R t. 2 B ox 30 P a c i f i c , MO 6 3 0 6 9 -12- V E R IFIC A T IO N STATE OF MISSOURI ) ) LO U IS) COUNTY OF S T . J. R. B le y , Jr., he is an a s s i s t a n t a c o r p o r a tio n ; _ s s . : b e in g d u ly sw orn, secreta ry th a t he has read A n sw ers o f D e fe n d a n t M on san to r o g a to r ie s to th e co n ten ts D efen d an ts th ereo f; th a t of deposes th e fo re g o in g Com pany t o is in fo r m e d and b e l i e v e s a u th o r iz e d in fo r m e d tru e; Com pany h a s p e r s o n a l fo r e g o in g S u p p le m e n ta l e m p lo y e e s deponent and t h a t S u p p le m e n ta l to and th e th e b est A n sw ers are in th e th a t 7 ^ , b efo re day o f J u ly , no o f f ic e r a ll A n sw ers h a v e been fo r e g o in g M on san to 1982 VIRGINIA SGHRGEDER HOTARY PUBLIC. STATE OF MISSOURI MY COMMISSION EXPIRES 8/29/RB w ith S u p p le m e n ta l or su ch m a tte r s; a sse m b le d S u p p le m e n ta l A n sw ers o f d e p o n e n t's R. e m p lo y e e by Com pany, who h a v e k n o w le d g e tru e. me t h i s In ter­ fa m ilia r of J. Sw orn t o is fo r e g o in g k n o w le d g e counsel o f th a t P lain tiffs' w ith o u t p e r so n a l A n sw ers, th e S u p p le m e n ta l deponent i s sta ted th at Com pany, and m a tters M on san to th at ( F i r s t W ave) th e of says d e f e n d a n t M on san to k n o w le d g e o f and and Bley, Jr th o se are 1 UNITED STATES DISTRICT COURT ftft ftg f tT f*rn T ftx n er u r u cno icrtri U i 3 Ir\1 l v /r lun P* A V ft D V iursis 2 X 3 4 In r e : : "AGENT ORANGE" : MDL No. 381 5 Product L i a b i l i t y L i t i g a t i o n : 6 X 7 Uni t ed S t a t e s Courthouse U n i o n d a l e , Long I s l a n d New York 8 9 September 7, 1983 1:30 o ' c l o c k P.M. 10 11 12 13 U B E F O R E : 15 HONORABLE SOL SCHREIBER, S p e c i a l Master 16 17 18 19 20 21 22 HENRY SHAPIRO HARRY RAPAPORT OffTcTal Court Re por t e r s 23 24 25 .26 47 6401 1 2 A P P E A R A N C E S : 3 4 5 6 YANNACONE & YANNACONE, ESCS. Post O f f i c e Drawer 109 P a t c h o g u e , New York 11772 BY: VICTOR J. YANNACONE, ESQ. 7 8 9 10 11 P laintiffs' Management Committee: IRVING LIKE, ESQ. 12 13 14 15 16 17 ASHCRAFT & GEREL, ESOS. 2000 L S t r e e t , M. W. Washi ngton, 0. C. 20038 18 BY: ROBERT A. TAYLOR, J R . , ESQ. 19 20 21 22 23 24 25 c o n t i nued__ 6402 1 2 3 A P P E A R A N C E S : (continued) 4 ó RIVKIN, LEFF, SHERMAN & RADLER, ESQS. A t t o r n e y s f o r De f e n da n t Dow Chemical 100 Garden C i t y Pl aza Garden C i t y , New York 11530 7 BY: 5 3 LEONARD RIVKIN, ESQ. MARJORIE MINTZER, ESQ. STANLEY PIERCE, ESQ. 9 ROBIN STALBOV, ESQ. 10 lì 12 13 14 CADWALADER, WICKERSHAM & TAFT, ESQS. A t t o r n e y s f o r De f e n dan t Diamond Shamrock One Hall S t r e e t New York, New York 10005 15 BY: 16 KENDELL B. ALCORN, JR. , ESQ. MICHAEL M. GORDON, ESQ. JEANNE P. BOLGER, ESQ. 17 18 19 20 21 22 23 TOHNLEY & UPDIKE, ESQS. A t t o r n e y s f o r De f endant Monsanto Company 405 Le x i n g t o n Avenue New York, New York 10017 BY: PHILIP PAKULA, ESQ. JOHN C. SABETTA, ESQ. JAMES E. TYRRELL, ESQ. 24 25 c o n t i nued. . . EASTERN nTSTOTCT POTTO-T í t a n o T c n e 6403 1 2 A P P E A R A N C E S : (continued) 3 4 7 CLARK, SAGLIARDI & MILLER, ESQS. A t t o r n e y s f o r De f endant T. H. A g r i c u l t u r e & Nutrition Co., I«c. The Inns o f Court 99 Court S t r e e t White P l a i n s , New York 10607 a BY: 5 6 MORTON SILBERMAN, ESQ. JOHN J . BURKE, ESQ. 9 io n 12 13 u 13 KELLEY, DRYE & WARREN, ESQS. A t t o r n e y s f o r De f endant H e r c u l e s , 101 Park Avenue New York, New York 10178 BY: Inc. PATRICIA TUOHEY, ESQ. 16 17 18 19 20 21 ARTHUR, DRY & KALISH, P.C. A t t o r n e y s f o r De f endant UniRoyal 1230 Avenue o f t h e Americas New York, New York 10020 BY: THOMAS A. BECK, ESQ. MARILYN NEIMAN, ESQ. 22 23 24 25 continued — id Ö 'J 6404 1 2 A P P E A R A N C E S : (continued) 3 4 5 SHEA, GOULD, ESQS. A t t o r n e y s f o r Def endant UniRoyal 330 Madison Avenue New York, New York 10017 6 7 BY: RICHARD GOLDSTEIN, ESO. 3 9 10 12 BUDD, LARNER, KENT, GROSS, PICILLO 4 ROSENBAUM, ESQS. A t t o r n e y s f o r De fendant Thompson Chemi cal s 33 Washington S t r e e t Newark, New J e r s e y 0 7 102 13 BY: 11 EDWIN R. MATTHEWS, ESQ. DAVID GROSS, ESQ. _ 14 15 15 19 UNITED STATES OF AMERICA C i v i l D i v i s i o n , Department o f J u s t i c e 521 12th S t r e e t , Northwest Rnom 822 Washi ngton, D. C. 20530 20 BY: 17 18 ARVIN MASKIN, ESQ. 21 22 continued. . . 23 24 25 Ea s t e r n district c o u r t -r e p o r t * « 6505 1 2 3 A P P E A R A N C E S : (continued) 4 5 ALSO PRESENT: ó 7 JOY BEANE, ESQ. A s s i s t a n t to S p e c i a l Master a 9 i 10 11 12 oOo 13 14 13 16 17 18 19 20 21 22 23 24 23 V V D £. 6468 1 2 3 4 5 6 7 8 9 10 11 12 13 14 time t o c ompl et e i t . There were a number o f problems t h a t have a r i s e n and t h e r e were some a d d i t i o n a l documents and c ouns e l saw f i t In good f a i t h t o c o n t i n u e the d i s c o v e r y . However, I do b e l i e v e t h a t I t 1s n e c e s s a r y to g i v e t he p l a i n t i f f s some o p p o r t u n i t y to conduct some d e p o s i t i o n d i s c o v e r y . And I r e c o g ni z e d t h a t e a r l i e r In the p r o c e e d i n g s p l a i n t i f f s have I n d i c a t e d t h a t they were ready to go to t r i a l and t h a t t hey did not need any o t h e r d i s c o v e r y on the government c o n t r a c t d e f e n s e , but with t he summary judgments and wi th the enl argement o f the c a s e taken I n t o account t h e I s s u e of general c a u s a t i o n , I did not view the e a r l i e r s t a t e me n t s 15 by the p l a i n t i f f s t h a t they had completed 16 d i s c o v e r y as meaning t h a t they coul d not 17 18 c o n t i nu e to make t h a t d i s c o v e r y now. My guess i s t h a t t hey must have conducted 19 t o dat e maybe f i v e or ten d e p o s i t i o n s o f a l l 20 de f e ndant s on government c o n t r a c t d e f e n s e and, 21 f r a n k l y , w h i l e I r e c o g n i z e couns el f o r t he 22 d e f e n s e c o n t i n u a l l y r a i s e t h a t I s s u e , I f i nd I t 23 hol ds no m e r i t t h a t we have wai ved. 24 I t shoul d be a l s o noted t h a t a number o f 25 Ea s t e r n district c o u r t reporters UNITED STATES DISTRICT COURT 223 CADMAN PLAZA EAST ± ¿ 0 «. 6478 1 2 HR. RIVKIN: I have no problem wi th t h a t . 3 The o t h e r problem I have, f o r c l a r i f i c a t i o n , 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 s i r , 1s you are s a y i n g we cannot conduct d e p o s i t i o n s o t h e r than a f f i r m a t i v e l y more than one week a month? SPECIAL MASTER: Yes. MR. RIVKIN: Is t h e r e a reason f o r t hat ? SPECIAL MASTER: Yes. The reason 1s you conducted f i f t e e n months of depositions. MR. RIVKIN: Not one week on l i a b i l i t y or causation. SPECIAL MASTER: You w i l l g e t I n t o 1 t . At t h i s s t a g e I want to g i v e the p l a i n t i f f s catch up t i me . Ue have oirly’ been t a k i n g d e f e n d a n t s ' d e p o s i t i o n s o f government w i t n e s s e s . MR. RIVKIN: I am throwing t h e s e out not n e c e s s a r i l y - SPECIAL MASTER: I n c i d e n t a l l y , I d o n ' t 20 what the d i s c o v e r y 1s on mi suse and c a u s a t i o n y e t 21 as f a r as t he d e f e n d a n t s , because I have gi ven 22 them a d d i t i o n a l time t o prepare t h e i r b r i e f s 23 on t h a t . 24 MR. PAKULA: Th a t ' s mi s us e . 25 e a s t e r n district c o u r t reporters UNITED STATES DISTRICT COURT TiS C A D M A N Pf A7A t*rr 12S54 6483 1 2 1t. SPECIAL MASTER: Not any l o n g e r . 3 4 a l r e a d y p a s t September 1 s t now. was the new h o r i z o n , so to speak. I t 1s September 1 s t We were going 5 t o t ake anot her approach. 6 MR. RIVKIN: Then I take i t you w i l l 7 e n t e r t a i n document r e q u e s t s from the Government? 8 SPECIAL MASTER: By a l l means. 9 I would p r e f e r to g e t t h a t as soon as p o s s i b l e . 10 But not onl y on the I s s u e o f c a u s a t i o n . 11 MR. RIVKIN : L i a b i l i t y also? 12 SPECIAL MASTER: The I s s u e o f mi s u s e . 13 MR. RIVKIN: Very d e f i n i t e l y , y e s , s i r . MR. PAKULA: A question, sir. 14 15 SPECIAL MASTER: Yes. 16 MR. PAKULA: On the f o u r t h week, what are 17 the l i m i t s , 1f any, on how many d e p o s i t i o n s 18 the de f e ndant s can take on each o f t h o s e weeks? 19 You may have s a i d t h a t . 20 21 22 23 24 SPECIAL MASTER: No, I d i d n ' t . But I would thi nk somewhere in the area o f t h r e e or four. MR. PAKULA: Three or four d e p o s i t i o n s ? SPECIAL MASTER: Yes. 25 Eastern district court reporters UNITED STATES DISTRICT COURT p- r. £484 1 2 MR. PAKULA: 3 SPECIAL MASTER: 4 MS. MINTZER: 5 SPECIAL MASTER: Yes. 6 7 8 A week? MR. RIVKIN: Yes. A week? There are t we l v e to f i f t e e n , s i r , goi ng - SPECIAL MASTER: Ye s. I want the plaintiffs 9 to have a l i t t l e c a t c h up t i me . You have had 10 160 d e p o s i t i o n s . We are not goi ng to t r i a l 11 12 13 14 15 16 17 18 19 1n October or November. MR. SILBERMAN: What 1s the f i r s t date of depositions? SPECIAL MASTER: September 22nd. MR. SILBERMAN: T h a t ' s a Thursday? SPECIAL MASTER: No, 1t 1s n o t . MR. SILBERMAN: Then you have the wrong da t e . SPECIAL MASTER: The 2 6 t h , I'm s o r r y . MR. SILBERMAN: All r i g h t . SPECIAL MASTER: Now, one f u r t h e r a d d i t i o n . 20 I f couns el cannot agree on w i t n e s s e s f o r the 21 f i r s t few we e k s , I e x p e c t to meet wi t h them ne xt 22 23 week and r e s o l v e the d i s p u t e s . MS. MINTZER: S p e c i a l Mast er, may I ask 24 a q u e s t i o n on PSAC w i t n e s s e s ? Where w i l l 25 they 12656 e a s t e r n district c o u r t reporters UNITED STATES DISTRICT COURT 223 CAD MAN PLAZA EAST DAVIO JOHN OEAN ( t it ) 24S -M U ANTHONY J. FALANOA m<) 741-4411 (212)343-4114 JOSEPH COVELLO COUNSELLORS AT LAW NORMAN ROSE JOSEPH M. Re y n o ld s ONE OLD COUNTRY ROAD • CARLE PLACE, NEW YORK 11514 MONROE FMK September 27, 1983 BY HAND Townly & Updike, E s q s . 405 Lexington Avenue New York, New York Re: Attention: Agent Orange Product Liability Litigation MDL # 3 8 1 John Sabetta, Esq. Dear John: The following is a partial list of those past and present Monsanto employees whom w e now wish to depose: Past: Present: Unknown: Robert Rumer Vernon L. Rhodes James Springgate A. J. Speziale D. B. Sharp Jack D. Early Frank E. Take, Jr. J. A. Stephans J. L. Sims Elmer Wheeler Owen E. Dolin John Mason Peter G. Arvan George Kempson Paul N. Hoffman J. C. Strum R. Emmett Kelly, M.D Eugene Outright L. E. Dotson L. T. Webber With professional respect, we remain, Very truly y o u r s , DEAN, FALANGA & ROSE DAVID J. DEAN D J D :at 12857 UNITED STATES DI S T RI CT COURT EASTERN DI S T RI C T OF NEW YORK In re * "AGENT ORANGE" Product L iability L itigation * * * MDL N o . * Judge 381 Jack B. W einstein P L A I N T I F F S ' RESPONSE TO PARAGRAPH NO. 7 OF THE MAGISTRATE'S PRETRIAL ORDER NO. 1___________________________________ The undersigned, Management Committee, the P lain tiffs No. 7 of the Stephen J. subm its the may w i s h to M agistrate's be Schlegel, me m b e r of nam es of w itnesses follow ing deposed P retrial in conform ity Order No. the P lain tiffs' with which Paragraph 1. PRELIMINARY STATEMENT The u n d e r s i g n e d on T u e s d a y , of February com piling zations have who not m ately the 200 to 7, The 1984. have deposed not been list which and/or P retrial follow s issues. deposed It O rd er No. is departments previously on c a u s a t i o n at contains the 1 result and organi­ a ll o r who approxi­ w itnesses. P lain tiffs su p p le m e n t M agistrate's of w itnesses prospective Although able the nam es either been received this w ish, list in conform ity with the with additional w itnesses Order, as to be they 1 becom e they of known, b elieve the total deposition P lain tiffs that also discovery num ber show n discovery wish w ill to only hereafter. should not exceed advise of The the M agistrate necessity be but undersigned one-half and a that fraction estim ates perhaps will that not exceed any more than one-quarter of the total number of witnesses listed. We request 7 to 10 days additional time to provide the Magistrate with a list of priority witnesses from this number. The Magistrate should know that the first nine witnesses listed are shown in conformity with the Court's prior wishes regarding the names of up to ten Government causation witnesses the Plaintiffs wish to depose. It is not anticipated that any reduction in the number of those witnesses' depositions will be effectuated. Plaintiffs acknowledge that by their calculations there are approxi­ mately sixty normal working days available for the purpose of taking depositions between the time of this submission and the commencement of trial. They also submit to this Court that they have previously demonstrated their ability to engage in a multiple-track deposition schedule. They represent to this Court that they continue to be able to appear at multiple depositions in a variety of locales on the same day and in successive days and that they have the ability to complete the discovery they need to be ready for trial on May 7, 1984. The names of witnesses are as follows: Debdas Mukerjee, EPA - D.C. Philip J. Landrigan, CDC, NIOSH Janet Springer, - D.C. EPA Vernon N. Houk, CDC - Atl. James Mason, CDC - Atl. Dr. Diane Courtney, EPA - D.C. Peter Infante, NIOSH - D.C. Umberto Saffiotti, Donald Barnes, NCI - D.C. EPA - D.C. MONSANTO WITNESSES I. II. III. R i c h m o n d , Virginia: Contracting officers Edward E. Adams Jesse Gershberg W. B. Bells George Kline William Blumenauer Frank Lemak John Blish Francis 0. Panneton George Collins L. Val K. Gaertner R. D. Thompson Monsanto inspectors P. Seitz St. Louis region: Ten Eyck Roy Meyers R. D. Fisher N. Wirz Me McCalley R. Wright Monsanto employees: Robert E. Baynard IV. S. S. Daniels T o m K . Smi th W. J. McCarvelle John S. Sullivan Lapin 0. Scott Charles Zorsch Miscellaneous witnesses Johnston Chemical Laboratories, Des Moines, Iowa Dr. Oettel 12G60 -3- UNIROYAL, INC. WITNESSES I. Government witnesses - Defense General Supply Center - Richmond, Virginia: William Fenner H. G. Fredericks William Kidd II. Defense Contract Administration Service Office: F. H. Placet (Process inspector) A. Matasauage - Industrial Specialist M. Dojny - Quality Assurance Rep. (Chemical inspector) A. W. Glenn - Preservation Packing Specialist J. F. O'Connor - Transportation officer Harold A. Llo y - Administration Contracting officer W. Maloney - Transportation officer Wayne Vandervendor - Specialist for Technical Orange Orange Herbicides. - 4- 12G61 H E R C U L E S ' WITNESSES I. Hercules' employees: J. G. Copeland II. III. C . L . Dunn A. E. Sidwell J. R. Fisher A. L. Treisback Thomas R. Hunt H. E. Wilder Rafael H. Huston R. T. Yates Defense Personnel Supply Center - Contracting officers: Government witnesses Thomas P. Dalby Donald Elmore Jacob L. Bolton W. Schuback Ellis Cash L. A. J. R. Mallet J. G. Charlton J. M. Kirgis E. D. Baumgartner L. K. Woolfolk P. R. Little J. E. Pallard L. E. Faist Pardee Miscellaneous witnesses: Dr. L. L. Danielsson, NACA Otis Fancher, G. Holsing, Industrial Biotests Laboratories Hazelton Laboratories J. Klingman, NACA -5- 12562 HERCULES’ WITNESSES - CONT. III. Miscellaneous witnesses: Paul Mayfield, NACA Charles E. Minarick, U.S. Army - Chemicals Biologies William Lee Popham - U.S.D.A. Mitcher Zavon - University of Cincinnati IV. Depositions Duces Tecum of the Custodian of Records of the following facilities: NACA - National Agricultural Chemicals Association, Washington, D.C. Bionetics Research Laboratories, Methesda, Maryland Hazleton Laboratories, Falls Church, Industrial Biotests Laboratories, Virginia Illinois Jacksonville Arkansas Laboratories V - 6- fO ^ 1 o Q -J T-H AGRICULTURE & NUTRITION CO. WITNESSES I. Government witnesses: Edward E. Adams, St. Louis, Missouri A. A. Block, Kansas City, Missouri James E. Bowers, St. Louis, Missouri Charles Dilley, Kansas City, Missouri A. A. Pello, L. W. Kansas City, Missouri Stenzel, Kansas City, Missouri Frank W. Kleman, St. Louis, Missouri Joseph W. Fowler, Kansas City, Missouri A. Y. Kistner, Kansas City, Missouri K. M. LeFever, Kansas City, Missouri Employees : R. E. Ballinger John Ferris Gary Linderman Bob Brooks Bob Greer Sam Long George Carmack Jack Hallen Bob Mayer Dale Carpenter John Hughes Bob Perry L. S. DeAtley Bill Kates Harold Page Mr. Damaunas Dr. Charles Lewis Chet Roberts Bill Schirley Bill Sulzen T o m Terlly Art Wilson « e> f> - 7- jf THOMPSON- ' CHEMICAL COMPANY _________WITNESSES Employees : John Mayer Leo Crivello D. Halleck Cecil McGill James Reagan F. Vargas II. Government witnesses: Director Commander, DCSR - St. Louis, Missouri Director of Procurement and Production - Defense General Supply Center - Richmond, Virginia III. Miscellaneous witnesses: Kosciusko Medical Clinic - St. Louis, Missouri Dr. Earnest Velasco Dr. A. J. Reichas Dr. Raymond Simpson' American Mutual Liability Insurance Company St. Louis, Missouri Custodian of Records - Division of Worker's Compensation Dept, of Labor and Industrial Relations Jefferson City, Missouri - Local office, St. Louis, MO. Mr. Jack Randall n.r* o rr ù -8- ■u D DIAMOND-SHAMROCK WITNESSES I. Diamond-Shamrock employees: J. 0. King Lex Creamer Howard E. Edison S. B. Honour David J. Ponter Cy Perkins J. J. Lusardi Melvin Hochberg R. F. Lindeman John J. Brennan Peter Celli W i l l i a m Goodloe Harry E. Klepp Milt o n Rosenfeld II. Government witnesses: M. Isele, DCAS - contracting officer J. K. Murphy, Chief - Contracts branch E. R. Sabala, DCAS - contracting officer R. J. I. Schlesinger - Transportation officer Wolin, DCAS - Cleveland, Ohio -9- 12368 DIAMOND-SHAMROCK WITNESSES - CONT. II. Government witnesses (Cont.) Inspector, DCASRO - Contracting officer Schenectady Army Depot Petroleum Division Schenectady, New York Chief DSASD - Newark 240 Route 22 Springfield, N e w Jersey 07081 Commander, DCASR Contracting officer 1367 E. 6th Cleveland, Ohio -10tL° J /OP uQ O P» DOW WITNESSES I. Dow employees: George E. Lynn R. C. Hoff Paul Orrefice W. J. McCoy Ray Holmes K. C. Barrons R. D. Wilcox Joseph Temple Ross Mulholland Earl Farnham Larry G. Silverstein W'ade VanValkenberg H. R. Hoyle Roy Van Horn Julius Johnson Fred Chase V. K. Rowe Harold DeLong Patricia C. A. Highhill Keeler G. Goergen J. L. Spalding Chester Otis Dr. Keith Barrons, 142 W. Bay Cove Holmes Beach, FL S. E. Sadek F. H. Riley K. Y. Hanson, Ocala, FL retired retired R. N. Smiley Sam Birkman L. B. Grant John Barber C. 0. Hutchenrenther F. C. Amstutz D. E. Pletcher W. L. Corbin D. D. Irish J. C. Tucker ' 1 2 0 6 8 J. W. Harris E. C. Staehling K. Y. Hansen DOW WITNESSES fCONT.) II. Government witnesses: Inspection Commander, DSACR Detroit, Michigan George C. Slagle, Jr. - Contract Administrator August Barbarine J. L. Brinser, Middleton, PA Welton Bills - Defense General Supply Center John Boyce - Defense General Supply Center Brigadier General John D. Hines Edward R. Killam R. G. Knott - DSACR Inspector C. E. Raub - Middletown, Hon. Richard M. Nixon John Baldeschweiler PA - Former President of the United States (continuation of deposition) The aforesaid list is submitted in accordance with the terms of the Magistrate's Pretrial Order No. 1 and is subject to the r e p r e ­ sentations and requests contained in the preamble first above written. Respectfully, -12- 9164 UNITED STATES D I S TRICT COURT EASTERN D I S TRICT OF N E W Y ORK x In re: : "AGENT ORANGE" : PRODUCT LIAB I L I T Y L I T I GATION M D L No.381 : x United States Courthouse Brooklyn, New York February 9, 1934 3:00 o'clock p.m. B e f o r e : H ONORABLE SHIRA S C H E I N D L I N , M a g i strate HENRY SHAPIRO JOSEPH B A R B E L L A SHELDON SILVERMAN O F F ICIAL COURT REPORTERS 12870 EASTERN DISTRICT COURT REPORTERS UNITED STATES DISTRICT COURT 225 CADMAN PLAZA EAST BROOKLYN. NEW YORK 11201 91G 5" 1 2 PLAINTIFFS' MAN A G E M E N T C OMMITTEE 3 DAVID DEAN, ESQ. STEPHEN J. SCHLEGEL, ESQ. 4 5 6 7 8 9 R I V K I N , LEFF, SHERMAN & RADLER, Attorneys for Dow Chemical 100 Garden City Plaza G a rden City, New York 11530 BY: MARJORIE MINTZER, Of Counsel ESQS. ESQ. 10 11 12 13 14 15 CADWALADER, W I C K ERSHAM & TAFT, ESQS. Attorneys for Defendant D iamond Shamrock 1 Wall Street N e w York, N e w York 10005 BY: 16 17 18 MICHAEL M. GORDON,' ESQ. GRANT HERING, ESQ. JOSEPH S C H I A V O N E , ESQ. Of Counsel EDWARD J. J1ASEK, ESQ. Counsel for Di a m o n d Shamrock 19 21 TOWNLEY & UPDIKE, ESOS. Attorneys for Defendant Monsanto Comoany 405 Lexington Avenue New York, New York 10017 22 BY: 20 23 24 25 PHILIP PAKULA, ESO. JOHN C. SABETTA, ESQ. JAMES E. TYRRELL, ESQ. EDV7ARD FERGUSON, ESQ. Of Counsel 12^71 9160 1 A P P E A R A N C E S : 2 3 5 SHEA, GOULD, E S Q S . A ttorneys for UniRoyal 330 Mad i s o n Avenue N e w York, New York 6 BY: 4 MEGAN LESS E R LEVINE, Of Counsel ESQ. 7 8 9 10 BUDD, LARNER, KENT, GROSS, PICILLO & ROSENBAUM, A ttorneys for Defendant Thompson Chemicals 33 Washington Street Newark, N e w Jersey 07102 ESQS. 11 BY: 12 13 EDWIN R. MATTHEWS, ESQ. DAVID GROSS, ESQ. WIL L I A M J. MARCONI, ESQ. SUSAL O L N E Y , ESO. Of Counsel 14 15 16 UNITED STATES DEPARTMENT OF JUSTICE Civil Division 17 BY: GRETCHIN WITT, ESQ. Special Attorney 18 19 A l s o present: 20 21 JOY BEAN, ESQ. Assi s t a n t to Special Mast e r 22 23 24 25 1 o *10 JL Ctu I 9xÜv 1 2 A P P E A R A N C E S : 3 4 5 6 7 8 CLARK, GAGLIARDI & HILLER, ESOS. Attorneys for D e f e n d a n t T.H. Agriculture & N u t r i t i o n C o . , Inc. The Inns of Court 99 Co u r t Street White Plains, N e w York 10607 BY: JOHN J. BURKE, Of Counsel ESQ. 9 10 11 12 13 14 KELLEY, D RYE & WARREN, ESOS. Attorneys for D e f e n d a n t Hercules, 101 Park Avenue N e w York, N e w York 10178 BY: 15 Inc. W I L L IA M A. KROHLEY, ESQ. PATRI C I A TUQHEY, ESQ. Of Counsel 16 17 18 19 20 21 ARTHUR, DRY & K A L I S H , P.C. Attorneys for Defe n d a n t UniRoyal 1230 Aven u e of the A m e ricas N e w York, N e w York 10020 BY: THOMAS A. BECK, MARILYN NEIMAN, Of Counsel ESO. ESO. 22 23 24 25 12G73 9200 1 2 MR. DEAN: can we just go into it a little further. 3 THE COURT: 4 MR. DEAN: 5 Wh i l e we are on the topic, ground. Sure. Y o u r Honor has outlined one hopeful A n d that's five days. THE COURT: F r o m the day after they are served 6 7 w i t h a notice, MR. DEAN: yes. But I am still troubled by -- and wh e n 8 9 I see the u n limited n a ture of the p r o p o s e d deposition, and, y o u r Honor — 10 THE COURT: On both sides. 11 MR. DEAN: Y o u r Honor understands and considers 12 if this is done and w e are here -- that w e m a y not 13 be all o w e d and then w e w o u l d have to apply for other 14 names. Other names, y o u know, that w o u l d be an 15 inevitable result of a request. But I am sure that 16 these w i l l be pared down. I k n o w ours will. And I 17 must, be forthright w i t h your Honor and tell y o u that 18 there are m o r e names here than we are going to call. 19 We are just fearful of not us i n g the one or two that -20 THE COURT: We could get a duplicate set of books 21 if y o u w i l l give me the real list. 22 MR. DEAN: There isn't any real list. Every one 23 of the names that we have submitted are v a l i d names. 24 But w h a t we are saying -25 EASTERN DISTRICT COURT REPORTERS UNITED STATES DISTRICT COURT 22G74 9211 1 the treating physicians. 2 y o u say that y o u have the right to add to these. 3 We expect they m a y have to do so. 4 physician -- this is the list that we have. 5 taken them all. 6 7 8 9 10 11 We wer e ver y clear. We heard But the treating We have We m a y pair that one down, but the rest are absolutely — THE COURT: I am glad y o u brought me back. I hadn't known in the past that there had been a preferred and not preferred list. I like the idea. I suggested the same thing. I w o u l d ask that the plaintiff do that w ithout any fear or ris k of notice or preclusion. But just to give the notice of who the must do list 12 is and then -13 MR. SCHLEGEL: We have our own preamble to that. 14 It's w i t h i n seven to ten days. 15 THE COURT: Great. W i t h i n seven to ten days. 16 Is that acceptable to the defendants. 17 MR. SCHLEGEL: We refer to it as a priority list. 18 THE COURT: Great. The second list, you will 19 get them. 20 MR. SCHLEGEL: Yes. 21 THE COURT: Great. 22 MS. MINTZER: A n d the cutoff date as of n o w for 23 the deposition of the defendant's w itnesses is 24 M a r c h 30th. * 2 ^7'' 25 e a s t e r n district c o u r t reporters UNITED STATES DISTRICT COURT 9214 1 counsel w i l l in fact on five day's notice present any 2 one of these people w h o is available to go to two or 3 three tracks just on the one defendant. 4 THE COURT: 5 MR. 6 THE COURT: 7 MR. 8 THE COURT: 9 Sure. SCHLEGEL: I can take 90 in M a r c h alone. Wel l — SCHLEGEL: I can It's not a boast. take 90 in M a r c h alone. 10 Well, 11 priority list? 12 h a v i n g -MR. 13 do that. I think that is a reality. is there any p o ssibility to get us that But if you could, SCHLEGEL: m e e t i n g on the 15th. 15 THE COURT: 16 MS. MINTZER: That's the m o s t we can ask. If we could have it before the 17 meeting, 18 can't argue about a list of 35, 19 a m e a n i n g f u l list -- 21 22 23 24 25 and since w e are I am going to have it for the 14 then we can deal w i t h it at the meeting. THE COURT: 20 He m a y have to No. I and apparently it is Y o u k n o w it's 35. Y o u can find out w h o they are w h e n he comes in w i t h the priority list. Then y o u can do it on the spot. X2: 78 the b i g list to w o r k with. MR. SCHLEGEL: Y o u wi l l have I think y o u have one thing that is apparent as to wha t we did and w h a t they did. e a s t e r n district c o u r t reporters UNITED STATES DISTRICT COURT They 921b 9 1 are giving an essential list, but they are telling 2 y o u that I've got the right to take 200 more. 3 giving 200 more and even m a y b e a couple of more as 4 an inclusion and saying I wan t to cut it down to a 5 quarter or to a half of that. 6 of approach. 7 THE COURT: Okay. I am It's just a difference I appreciate that, Mr. Schlegel. 8 A n d I hope that y o u are w r o n g about the defendants. 9 Is there any thought y o u are going to have 200 10 m o r e or are y o u talking about a small addition where 11 needed? 12 MR. SCHLEGEL: 13 MR. KROHLEY: 14 top to bottom. 15 on it. I am just suggesting -I haven't reviewed this list from I am familiar w i t h mos t of the names I think one thing y o u have to bear in m i n d 16 is that we were really begi n n i n g to try six cases. 17 Six cases w h i c h have just been identified not that 18 long ago. 19 20 and scientific issues. 23 24 Ordinarily y o u have use to do w h a t w e are trying to do in a period of months. THE C O U R T : 21 22 We are getting into compl i c a t e d m edical MR. KROHLEY: I k now t h a t . W e are serious and I am agraid that the — THE COURT: m a k e additions. But my question is, I said y ou could Dow expects them to be fast or just 25 EASTERN DISTRICT COURT REPORTERS UNITED STATES DISTRICT COURT 225 CADMAN PLAZA EAST 12377 f-?- *ltiet . S c H i.r .O F .i. & T r a p e l e t . Lt d . A ttorneys a t - Law i f r ’ O n e N o r t h La S a u l e S t r e e t C h i c a o o . I l l i n o i s G O G 02 STEPHEN J . SCIILCUBL ÜCAN M. T r a k k l k t S u i t e n iH X ) (3 IÜ ) 708*1001 I v a » R. A z m i s S t e v e n P. P o i . icn J a m e s A. R o m a n y a k February 13, 1984 Honorable Shira Schneindlin Magistrate & Special Master United States District Court Eastern District of New York 225 Cadman Plaza East Brooklyn, New York 11201 Re: In re "Agent Oran g e ” Product Liability Litigation - MDL No. 381 Dear Magistrate Scheindlin: In conformity with the representation made by the Plaintiffs to you at the hearing he d on February 9, 1984, we are tendering the.following as our preliminary list of our priority witnesses. Plaintiffs wish to depose: Debdas Mukerjee, EPA - D.C. Philip J. Landrigan, CDC, NIOSH Janet Springer, EPA - D.C. Vernon N. Houk, CDC - Atl. James Mason, CDC - Atl. Dr. Diane Courtney, EPA - D.C. Peter Infante, NICSH, D.C. Umberto Saffiotti, NCI - D.C. Donald Barnes, EPA - D.C. 12678 DIAMOND-SHAMROCK WITNESSES I. Diamond-Shamrock employees : David J. Porter S. B. Honour J. 0. King Melvin Hochberg Howard E. Edison Lex Creamer II. (Would like to depose, but unable to locate) Government witnesses : M. Isele, DCAS - Contracting officer J. K. Murphy, Chief - Contracts branch E. R. DCAS - Contracing officer Sabala, I. Wolin, DCAS - Cleveland, Ohio DCASR - Commander Contracting officer 1367 E. 6th Cleveland, Ohio 12G79 -2- D O W CHEMICAL COMPANY I . Em ployees: George E. Lynn Julius Johnson H. R. Hoyle Ross Mulholland Larry G. Silverstein Ray Holmes R. D. Wilcox V. K. G. Rowe Goergen Paul Orrefice Sam Birkman John Barber Joseph G. Temple, Jr. Etcyl H. Blair David L. Rooke -3- 12680 HERCULES' WITNESSES I. First priority list : C . L . Dunn T. Eagon A. E. Sidwell A. L. Triesback H. E. Wilder II. Second priority list : J. G. Copeland Rafael H. Huston Charles E. Minarick, U.S. Army - Biochemical Custodian of Records of NACA - National Agriculture Chemicals Association, Washington, D.C. Custodian of Records of Bionetics Research Laboratories, Bethesda, Maryland III. Third priority list : Otis Fancher, Industrial Biotests Laboratories Custodian of Records of Industrial Biotests Laboratories, Illinois R. T. Yates Custodian of Records of Hazleton Laboratories, Falls Church, Virginia 2S81 HERCULES’ WITNESSES IV. cont. Defense Personnel Supple Center - Contra c t i n g officers: Government witnesses Donald Elmore Thomas P. Dalby Jacob L. Bolton Ellis Cash IC.'? Q O L j MONSANTO WITNESSES Charles Luecke John Mullendore Carl Bohl Phillip Balderson Homer Payton Frederick L. Rupel Ronald R. Smith R. L. Payne T o m K. Smith Richard Wallace, M.D. Nel Putzel Louis Schwartz Robert R. Rumer U. L. Sims R. L. Null Toby White Howard Minkler E. Weger Nick Machacrola Paul Ekberg Jim Starrett Bruce Ely (Recall) MONSANTO WITNESSES II. cont. Contracting officers - R i c h m o n d . Virginia : John Blish George Collins Jesse Gershberg III. Monsanto inspectors - S t . L o u i s .region : Ten Eyck R. D. Fisher M. McCallev Roy Meyers N. Wirz R. Wright 1223 -7- 4 THOMPSON CHEMICAL COMPANY WITNESSES Employees : John Mayer L e o Crivello D. Halleek Cecil McGill James Reagan F. Vargas II. Government witnesses : DCSR, Director Commander - St. Louis, III. Missouri Miscellaneous witnesses: Dr. Earnest Velasco Kosciusko Medical Clinic St. Louis, Missouri American Mutual Liability Insurance Company St. Louis, Missouri UNIROYAL, INC. WITNESSES I. Defense Contract Administration Service O f f i c e : F. F. Placet (Process inspector) A. Matasauage - Industrial Specialist M. Dojny - Quality Assurance Rep. (Chemical inspector) A. W. Glenn - Preservation Packing Specialist Harold A. Lloy - Administration Contracting officer Wayne Vandervendor - Specialist for Technical Orange Herbicides 12G86 -9- T-H AGRICULTURE & NUTRITION CO. WITNESSES T-H Agriculture & Nutrition Co. e m p l o y e e s : L. S. DeAtley Bill Sulzen Art Wilson Dr. Charles Lewis Bob Mayer Jack Hallen Government w i t n e s s e s : Edward E. Adams A. A. - St. Louis, Missouri Block - Kansis City, Missouri James E. Bowers - St. Louis, Missouri Charles Dilley - Kansas City, Missouri Frank W. Kleman - St. Louis, Missouri Joseph W. Fowler - Kansis City, Missouri Respectfully submitted, On behalf of the Plaintiffs' Management Committee f ^ "* Q IfcOO J Wendall B. Alcorn. Jr.. Esq. ** Cadwalader, W i c k e r s h a m & Tafc One Wall Street New York. New York 10005 Thomas Beck, Esq. ** Arthur. Dry & Kalish, P.C. 1230 Avenue of the Americas New York, New York 10020 Judith !.. Spanier, Esq. Shea & Gould 330 Madison Avenue N ew York, New York 10017 Howard Lester, Esq. ** Lester, Schwab, Katz & Dwy^r 120 Broadway New York, New York 10271 Michael V. Corrigan, F.sq. ** Simpson, Thatcher & Bartlett One Battery Park Plaza New York, New York 10004 ** Morton B. Silberman, Esq. ** Clark, Gagliardi & Miller 99 Court Street White Plains, New York 10601 William A. Krohley, Esq. ** Kelley. Drye & Warren 101 Park Avenue New York. New York 10178 David R. Cross, Esq. ** Budd, L a m e r , Kent, Gross, Picillo & Rosenthal 33 Washington Street Newark, N e w Jersey 17102 Mr. Robert Heinemann ** Clerk of the United States District Court 225 Cadman Plaza East Brooklyn, New York 11201 *** - Hand Delivered ** - Delivery by Federal Express Herbert L. Fenster, Esq. McKenna, Conner & Cunes 1575 Eye Street, N.W. Washington, D.C. 20005 ★* John M. Fitzpatrick, Esq. Stillworth, Paxson, Kalish & Levy 2600 Fidelity Building Philadelphia, Pa. 19109 ★* Deli v e r e d regular mail to everyone else. Paul V. Esposito, Esq. Lewis, Overbeck & Furman 135 S. LaSalle Street Suite 1060 Chicago. Illinois 60603 88 t A G E N T ORANGE S E RVICE LIST Judge Jack B. Weinstein ** United States District Court Eastern District of New York 225 Cadman Plaza East Brooklyn, New York 11201 Neil Peterson, Esq. ** Gene Locks, Esq. Creitzer & Locks 1500 Walnut St., 21st FI. Philadelphia, Pa. 19102 Honorable Shira Schneidlin ** Magistrate - Special Master United States District Court 225 Cadman Plaza East. Rm. 235 Brooklyn, New York 11201 Phillip E. Brown, Esq. Hoberg. Finger, B r o v m . Cox & Molligan, P.C. Central Tower 703 Market Street San Francisco, Calif. 94103 Honorable Sol Schreiber Milberg. Weiss. Bershad & Specthrie One Penn Plaza New York, New York 10019 John O ’Quinn, Esq. O'Quinn, Hagans & Wettman 3200 Texas Commerce Tower Houston, Texas 77002 Stephen J. Schlegel. Esq. Schlegel & Trafelet, Ltd. One N. LaSalle St., Ste. 3900 Chicago. Illinois 60602 Plaintiffs' Management Commit: c/o Jan Levien, Esq. ** 26 Court S t . , Suite 905 Brooklyn, N e w York 11242 Thomas W. Henderson, Esq. ** Henderson & Goldberg Frick Building, Rpi- 1601 Pittsburgh, Pa. 15219 Irving Like, Esq. ** Reilly, Like & Schneider 200 West Main Street Babylon, N e w York 11702 David Dean, 1 Old Carle Clerk of the Panel ** Judicial Panel on M u l t i ­ district Litigation 1120 Vermont Avenue, N.W. Suite 1002 Washington, D.C. 20005 J. Dean, Esq. ** Falanga & Rose Country Road Place, New York 11514 Benton Musslewhite, Esq. ** 609 Fannin - Suite 517 Houston, Texas 77002 Newton B. Schwartz, P.C. Houston Bar Center Bldg. 723 Main, Suite 325 Houston, Texas 77002 Stanley M. Chesley, Esq. Waite, Schneider. Bayless & Chesley Co., L.P.A. 1318 Central Trust Tower Fourth & Vine Streets Cincinnati, Ohio 45202 A r v i n Maskin, Esq. ** United States Attorney United States Dept, of Justice Safeway Bldg. - Room 904D Washington, D.C. 20530 Leonard Rivkin, Esq. ** Rivkin, Leff, Sherman & Radler 100 Garden City Plaza Garden City. New York 11530 John C. Sabetta, Esq. ** T ownlcy i Updike 405 L e xington Avenue New York. New York 10017 12389 To w n l e y & U p d ik e m. m cM O C M C «. j n . J O H N J . L E IO H T O N jo h n hoch C h r y s l e r B uilding n e id EDW ARD M. M Ä H E * A N D R E W L. H U O H C S t e l e p h o n e (£ 1 2 ) S S 2 - 4 S S 7 4 0 5 LEXINGTON AVENUE MHIL»R D. MHUL iviC n a n w «A S A n fifc » R IC H A R D m . LUTZ J O H N RAUL R E IN E R R M tU » ft. O L IC K M AHR O. O E R A O M T Y JO H N 0. CA NO N' M A R IE V. D R tS C O L L R IC H A R D C. R U LLEN . J A . R O B E R T C. MANOONE W ILLIAM O C M ANNI&CH J A M Q & B W IR E R C N N C T H J . Mc C U L L O C H D O U O L A S C . rA lN H O N S T ELUQT R A S R O F f R E R C Z C . C H N IC H J O H N C. »A B ETTA J A M E S R. L E A O E R r N C O C R lC R O. » E N R O N J E N O M E N. C O L E M A N R E N N E T H M. H A RT J A M E S E. T Y R R E L L . J * . NEW YORK. N. Y. 10174 C A B LE : TU CA RRO TEL EX : W UO I2 -7 B IB RCA *25077 T E L E C O P IE R (zi*)es7-3oei February 15, 1984 cdw aro w . sc h a ll CO UN SEL BY COURIER Stephen J. Schlegel, Esq. Schlegel & Trafelet, Ltd. One North LaSalle Street Suite 3900 Chicago, Illinois 60602 RE: “Agent Orange" Product Liability Litigation Dear Mr. Schlegel: I write to state the objections of defendant Monsanto Company ("Monsanto") to Plaintiffs' Response to Paragraph No. 7 of the Magistrate's Pretrial Order No. 1, which was served at the hearing before Magistrate Scheindlin on February 9, 1984. Monsanto recognizes that plaintiffs have requested additional time in which to submit a prioritized list of potential deposition witnesses. See Plaintiffs' Response at 1-2. Accordingly, Monsanto reserves its right to make further objections, if appropriate, when such a list is submitted. Monsanto objects to the depositions of William J. McCarville and Charles P. Zorsch on the ground that both have already been deposed by plaintiffs in this litigation. McCarville was deposed on February 11, 1983; Zorsch, on May 3, 1983. Plaintiffs have demonstrated no special need for redeposing them on the eve of trial. Nor have plaintiffs offered any explanation for their long delay — about a year and about nine and a half months, respectively — in noticing the redepositions of Messrs. McCarville and Zorsch. Because the defense of these unjustified redepositions would prejudice 12390 Tow n let & U p d ik e M o n s a n t o ’s prepa r a t i o n for t h e rapidly approaching trial, plaintiffs' inexcusable de l a y should not be condoned b y the Court. W i t h respect to the deposition of Lapin O. Scott, Monsanto has thus far not found any information in its files on such an individual. Thus at this time it appears that no such p erson was ever an employee of Monsanto. Sincerely, TOWNLEY & U P DIKE Attorneys for Defendant Monsanto Company 405 Lexington Aven u e N e w York, N e w Y o r k 10174 (212) 682-4567 cc (by courier): attached service list Hon. Shira Schleindlin SERVICE LIST Michael M. Gordon, Esg. Cadvalader, Wickersham & Taft One Wall Street New York, New York 10005 Stephen J. Schlegel, Esg. Schlegel & Trafelet, Ltd. One North LaSalle Street Suite 3900 Chicago, Illinois 60602 Leonard L. Rivkin, Esg. Rivkin, Leff, Sherman & Radler 100 Garden City Plaza Garden City, New York 11530 Benton Musselwhite, Esg. Law Offices of Benton Musselwhite, Inc. Suite 517 609 Fannin Houston, Texas 77002 William Krohley, Esg. Kelley Drye & Warren 101 Park Avenue New York, New York 10178 Howard Lester, Esg. Lester Schwab Katz & Dwyer 120 Broadway New York, New York 10005 * Thomas W. Henderson, Esg. Baskin & Sears Frick Building, 10th Floor Pittsburgh, Pennsylvania 15219 Paul V. Esposito, Esg. Lewis, Overbeck & Furman 135 South LaSalle Street Suite 1060 Chicago, Illinois 60303 Victor J. Yannacone, Jr., Esg., Yannacone & Yannacone Post Office Drawer #109 Patchogue, New York 11772 David R. Gross, Esg. Budd, Lamer, Kent, Gross, PiciIlo & Rosenbaum 33 Washington Street Newark, New Jersey 07102 David J. Dean, Esg. Dean, Falanga, Sinrod & Rose One Old Country Road Carle Place, New York 11514 Judge Morton B. Silberman Clark, Gagliardi & Miller 99 Court Street White Plains, New York 10601 Thomas Beck, Esg. Arthur, Dry & Kalish 1230 Avenue of the Americas New York, New York 10020 Richard M. Goldstein, Esg. Shea 6 Gould 330 Madison Avenue New York, New York 10017 L. Kenneth Sheridan, Esg. Executive Assistant D.S. Attorney United States Attorney's Office 225 Cadman Plaza East Brooklyn, New York 11201 Irving Like, Esg., Reilly, Like and Schneider 200 West Main Street Babylon, New York 11772 Arvin Maskin, Esg. Trial Attorney, Torts Branch, Civil Div., U.S. Department of Justice Safeway Building Washington, D.C. 20530 Clerk of Panel Judicial Panel on -inn q o Multidistrict Litigation I & o o & 1120 Vermont Avenue, N.W. Suite 1002 Washington, D.C. 20005 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF N E W YORK X IN RE: : "AGENT ORANGE" : PRODUCT LIABILITY LITIGATION : MDL NO.381 •X United States Courhouse Brooklyn, N e w York N o v ember 21, 1:00 P.M. B e f o r e 1983 : HONORABLE JACK B. WEINSTEIN, CHIEF U.S.D.J. s'Ki.l'ii:" 12393 1 A p p e a r a n c e s : 2 3 4 SOL SCHREIBER, THE SPECIAL MASTER 5 6 JOY BEANE, ESQ. A s sistant to Special M a s t e r 7 8 9 10 PLAINTIFFS' M A N A G E M E N T COMMITTEE 11 DAVID DEAN, ESQ. STEPHEN SCHLEGEL, ESQ. THOMAS W. HENDERSON, ESQ. N E W T O N B. SCHWARTZ, ESQ. NICHOLAS A L T I M A R I , ESQ. STANLEY CHESLEY, ESQ. IRVING LIKE, ESQ. BENT O N MUSSELWHITE, ESQ. AARON T W E R S K I , E S Q . 12 13 14 15 16 17 18 20 RIVKIN, LEFF, SHERMAN & RADLER, E S Q S . Attorneys for D o w Chemical 100 G a rden Cit y Plaza Garden City, N e w Y o r k 11530 21 BY : 19 22 LEONARD R I V K I N , E S Q . , of Cou n s e l MARJO R I E MINTZER, ESQ., of Counsel 23 24 25 eastern district c o u r t reporters UNITED STATES DISTRICT COURT 223 CADMAN PLAZA EAST BROOKLYN. N EW YORK 11201 I2C94 1 Appea r a n c e s (Continued) 2 3 4 5 CADWALADER, W I C K E R S H A M & TAFT, E S Q S . Attorneys for Dia m o n d Shamrock One W a l l Street N e w York, N e w Y o r k 10005 6 BY: 7 8 9 W E N D E L L B. ALCORN, JR., ESQ. of Counsel M I C H A E L M. GORDON, ESQ., of Cou n s e l JOHN M A R I A N I , ESQ., of C o u n s e l I I 10 11 12 14 BUDD, LARNER, KENT, GROSS, PICILLO & ROSENBAUM, Attorneys for D e fendant Thompson Chemicals 13 W a s h i n g t o n Street Newark, N e w J e r s e y 07102 15 BY: 13 16 DAVID GROSS, ESQ., of Counsel EDWIN R. MATTHEWS, of Cou n s e l ESC ESQ. 17 18 19 20 22 A R T H U R DRY & K A L I S H , ESQS. A ttorneys for Defe n d a n t UniRoyal 1230 A v e n u e of the Americas N e w York, N e w Y ork 10020 23 BY: 21 THOMAS A. BECK, ESQ., of C ounsel 24 25 EASTERN DISTRICT COURT REPORTERS UNITED STATES DISTRICT COURT 222 CADMAN PLAZA EAST BROOKLYN. NEW YORK 11201 12G 95 ” ~ 1 Appearances (continued) 2 3 4 ó TOWNLEY & UPDIKE, E S Q S . Attorneys for D efendant Monsanto Company 405 Lexington Avenue N e w York, N e w Yor k 10017 7 BY: 5 8 PHILIP PAKULA, ESQ., of C ounsel JAMES E. TYRRELL, ESQ., of Counsel 9 10 11 12 ROBERT T. BERENDT, ESQ. In House Counsel - Monsanto 13 14 15 i 16 19 CLARK, GAGLIARDI & MILLER, ESQS. Attorneys for Defe n d a n t T. H. A g riculture & N u t r i t i o n Company The Inns of Court 99 Court Street W h i t e Plains, N e w York 10607 20 BY: 17 18 21 22 MORT O N SILBERMAN, ESQ., of Counsel JOHN J. BURKE, ESQ., of Counsel LAWRENCE D' ALOISE, ESQ., of Counsel 23 24 25 EASTERN DISTRICT COURT REPORTERS UNITED STATES DISTRICT COURT 223 CADMAN PLAZA EAST BROOKLYN. NEW YORK 11201 1.2G96 1 A p pearances (Continued) 2 3 4 5 6 KELLEY, DRYE & WARREN, E S Q S . A t torneys for D e f e n d a n t Hercules, 101 Park Avnue N e w York, N e w Y o r k 10178 Inc. 7 BY: 8 9 10 W I L L I A M A. KROHLEY, E S Q . , of Counsel PATRICIA T O U H Y , ESQ., of Counsel WIL L I A M C. HECK, ESQ., of Counsel 11 12 13 15 UNIT E D STATES OF A M E R I C A Civil Division, D e p a r t m e n t of Justice 521 12th Street, N orthwest Washington, D. C. 20530 16 BY: 14 ARVIN MASKIN, ESQ. GRETCHEN WITT, ESQ. 17 18 19 20 A S H C R A F T & G E R E L , ESQS. 2000 L Street, N o r t h w e s t Washington, D. C. 20038 21 BY: 22 ROBERT A. TAYLOR, JR., ESQ. of Counsel 23 24 25 EASTERN DISTRICT COURT REPORTERS UNITED STATES DISTRICT COURT 223 CADMAN PLAZA EAST BROOKLYN. NEW YORK 11201 65 9 1 2 3 4 and over the rapids without destruction. MR. GROSS: I am over the rapids now. I am now over the waterfall. I w o u l d respectfully request the same certification 5 by this court to take to the Second Circuit as done 6 by Hercules. 7 THE COURT: Denied. 8 MR. T h a n k you. 9 THE COURT: 10 Dia m o n d Shamrock? 11 MR. GROSS: For the same reasons. ALCORN: Wendell Alcorn, I a m e m b e r of the 12 Cadwalader, W i c k e r s h a m & Taft representing Diamond 13 Shamrock Chemicals Company. 14 To my knowledge, 15 16 17 of the party the m o t i o n to change the name is unopposed. THE COURT: Nobody being he a r d in opposition, w o u l d y o u submit an order w i t h i n forty-eight hours? 18 MR. 19 THE COURT: 20 Item 4, appeal from the r e c o m m endation of the 21 ALCORN: Yes, your Honor. Granted. Special M a ster on Government causation witnesses. 22 MR. MASKIN: 23 of the Unit e d States. 24 25 Your Honor, Arvin M a s k i n on behalf The UnitedStates begins w i t h its recognition of one truth in this case; and that is, this trial EASTERN DISTRICT C O U R T REPORTERS UNITED STATES DISTRICT COURT 223 CADMAN PLAZA EAST «innri vxi utw YOftK 11201 is going 10 1 2 3 4 5 66 to go forward on My 7th. We w o u l d also add that the interests of acceleratinjg discovery of identifying all information for w h i c h there is a genuine n eed of m i n i m i z i n g discovery disputes and of accomodating the United States' legitimate interests in discovery are not m u t u a l l y exclusive. 6 7 The United States has demonstrated, the context of the deliberative process, at least in privilege 8 9 issues and state secrets privilege issues, that car e ­ fully considered procedures resolving privilege 10 disputes do wor k and our experience has been that they 11 w o rked in the past. 12 V irtually none of the 18 witness who have been 13 identified by the parties could be considered fact 14 witnesses. 15 THE COURT: W o u l d be considered what? 16 MR. MASKIN: Could be considered fact witnesses. 17 Each and every one of those witnesses are described 18 as "expert." 19 THE COURT: Let m e suggest this to you and get 20 your reaction to it. 21 We have to move ahead quickly. They are not going 22 to have a lot of time to depose these people. 23 I do not k n o w whe t h e r they are going to come 24 forward w i t h other lists, but I wo u l d suggest that each 25 EASTERN DISTRICT COURT REPORTERS UNITED STATES DISTRICT COURT 22i CADMAN PLAZA EAST BROOKLYN. NEW YORK 11201 12039 67 11 1 side have ten. 2 that they be limited to one or two days deposition as 3 to anything they want to take. 4 Fact, opinion, 5 wants the witness and the other -- most of the other 6 day for the o p p osing party and then just a little 7 rebuttal. 8 If they overlap, anything. that is fine. And Let's say two days. One day for the party who I u n d e r s t a n d your point. You cannot have these 9 experts constantly a nnoyed w i t h this, but let's see 10 if we keep it to a bar e minimum, n anything they want 12 day asking them about things they don't need, 13 up to them. 14 15 16 17 18 19 20 21 22 23 24 25 to. let them ask them If they want to waste their Then I w o u l d suggest, too, that's that if -- before the witness testifies or gives his deposition, that they tell the witness w h a t they are going to use in the way of documents so the witness doesn't'come in cold. That is i t . MR. MASKIN: M a y I respond? THE COURT: Yes. MR. MASKIN: Your Honor, the procedures that we suggested while at first glance seem cumbersome I envision that with respect to the same n u m b e r of people you have suggested, the information that we requested could be in our hands by this Friday. Government could EASTERN DISTRICT C O U R T REPORTERS UNITED STATES DISTRICT COURT 225 CADMAN PLAZA EAST BROOKLYN. NEW YORK 11201 12700 72 16 1 case, your Honor, and it's w o r k e d absolutely fine. 2 If there is a p r o b l e m that's asked at the time, 3 the Special Master can rule as to whether that question 4 makes any sense. 5 To set up 6 THE COURT: 7 makes sense or not. I do not need the M a ster to tell 8 me whether it makes sense. 9 10 Excuse me. I do not care whether it If you want to ask a question that does not make sense, m y ruling n o w is, ask it. 11 The witness will be entitled to say, I cannot 12 answer it or I will be delighted to answer that senseles 13 question. 14 That is all. I do not want you coming in here 15 m a king applications to the M a s t e r whe n we have five 16 months to prepare a c o mplicated trial. 17 You want ten witnesses? 18 MS. MINTZER: 19 The Special M a s t e r requ e s t e d an initial list Give them ten witnesses. Let me clarify that, please. 20 of fen witnesses, w h i c h is what we have provided. 21 is by no means our complete list. THE COURT: 22 23 24 25 list. I am telling you, That it is your complete You can take ten and they will take ten. I am not going to have the Government denuded of witnesses. If after four years you do not k n o w who EASTERN DISTRICT COURT REPORTERS U N I T E D S T A T E S D IS T R IC T C O U R T 223 C A D M A N P L A Z A E A S T BRO O KLYN. N E W YORK 11201 1 Z i ü 1 17 1 2 3 4 5 73 the best ten people are in the Government, then you are not prepared. MS. MINTZER: Your Honor, this is very, very important and please let me address that issue. For one thing, I believe today my office received 6 and all offices received the 7 that are actually going to be litigated, 8 will be litigated so up until this date we haven't 9 even known the particular med i c a l issues that will be 10 at issue. 11 12 names of the plaintiffs the cases that i Number two, and that's exceedingly important, the Government -- 13 THE COURT: 14 I myself think you may want to delay a little while 15 16 I understand. in putting in those names. (Continued on next page.) 17 18 19 20 21 22 23 24 25 EASTERN DISTRICT COURT REPORTERS UNITED STATES DISTRICT COURT 223 CADMAN PLAZA EAST BROOKLYN. NEW YORK 11201 12702 1 1 2 71 MS. MINTZER: We have already submitted ten, but the — 3 THE COURT: You can w i t h d r a w them. 4 MS. MINTZER: I u n d e r s t a n d that. 5 The other point that I w a n t to make, is very 6 important here, is the Government's papers admit that 7 the Government — Congress has expended vast suns of 8 mo n e y on causation 9 w i t h i n the G o v e rnment today on the very issues that 10 this Judge and the jury in this case will decide. 11 and energy and knowledge is amassed I think it is incredibly unfair to the jury and 12 to the Court not to have that testimony before the 13 Court. 14 15 16 17 18 19 THE COURT: You can have all the reports. are giving you every report that was made. Any report that is finished before the trial, you can have that, you have. MS. MINTZER: 21 THE COURT: 23 too. You can have ten experts free, plus all the experts 20 22 They I submit to your Honor that this — I am not going to be drowning in experts. MS. MINTZER: I u n d e rstand that, but at this point 24 in the litigation, when we are just b e g i n n i n g causation 25 discovery, when we don't kno w yet what issues we face — EASTERN DISTRICT C O U R T REPORTERS UNITED STATES DISTRICT COURT 223 CADMAN PLAZA EAST 1270-1 1 2 3 THE COURT: Hold off. Do not give them a full ten names. MS. MINTZER: May I request that y o u please not 4 be so firm on that number ten? 5 sense. 6 I just doesn't make It is an arbitrary number, your Honor. THE COURT: Yes. You are going to find that we 7 will be arbitrary time after time here because that 8 is the way it goes. 9 MS. MINTZER: There may well be ten different 10 injuries that are being focused upon here. 11 well be far more than that number of causation witnesses 12 13 14 15 16 17 18 19 20 21 22 23 24 25 There may required. THE COURT: If you need more, the Special Mastern. you will go to My inclination would be to give you ten each. If I were in your position, I w o u l d n ' t use my whole ten. MS. MINTZER: I am not sure that the — you might w a n t to rethink that. Can I just ask you one question? I am not clear on your ruling with regard to Page 34. THE COURT: Yes. MS. MINTZER: It is my understanding that the information that the Government is requesting on Page 34 you are suggesting that we do supply that, but EASTERN DISTRICT C O U R T r e p o r t e r s UNITED STATES DISTRICT COURT 22} CADMAN PLAZA EAST BROOKLYN. NEW YORK 11201 n X Ct *70 4 77 4 1 2 3 THE SPECIAL MASTER: Your Honor, if I may be he a r d for a moment? I have carefully studies the submissions of the 4 defendants. 5 reviewed those bot h by their comments and my own research 6 and I tend to suggest to your Honor, without being 7 impolite, 8 20, and the time is sufficient, w o u l d give the defendant 9 appropriate attack upon or — As you know, THE COURT: 11 THE SPECIAL MASTER: 15 or 20 for each? No, no. the plaintiffs have indicated that they only have eight. 13 THE COURT: 14 THE SPECIAL MASTER: 15 we can easily get it in. 16 MR. DEAN: 17 THE COURT: They may w ant — Even 15 or 20, your Honor, I give — Respectfully, m a y we — Excuse me. I just want to p o i n t out to you, 18 19 even ten is 30 witnesses. 20 depositions. 21 I that a number of somewhere between 15 and 10 12 they submitted 61 names. There are five months. 22 of the plaintiffs. 23 be tested. 24 doctors. 25 enormous amount of work. That's that 20 plus 30 solid days of You've got to depose all You p r o bably — that are going to You will probably have to depose their You are going to have to — there is an EASTERN DISTRICT COURT REPORTERS UNITED STATES DISTRICT COURT 225 CADMAN PLAZA EAST «ROOKLYN. NEW YORK 11201 1 THE SPECIAL MASTER: 2 not be one deposition team. 3 MR. DEAN: D i f f e r e n t teams. There will May I rise r e s p e ctfully to uphold the 4 desire of the Special Master, w h o m I have the highest 5 regard for and w h o mandates we have often followed. 6 Alwa y s followed, 7 8 9 h o w is that? We will certainly abide by your Honor's direction wit h him and we ask the defendants do the same. THE COURT: All right. I will rule, in view of 10 m y special respect for the Special Master, 11 ten on each side with the .Master having the authority 12 subject to an appeal to me to add an extra five on each 13 side. 14 15 16 MR. PAKULA: I tried to rise, I did rise but I didn't get a chance to speak before your Honor ruled. Right now we are looking at a list of 46 p roposed 17 named plaintiffs, w h i c h we just received, 18 say they will reduce at 19 I will rule THE COURT: which they some time in the future. We are going to have to get to that. 20 We must get to that and get to it fast because that 21 is step number one. 22 23 Until they give us those names, we are not going to be able to proceed. 24 I underst nd your problem. 25 MR. PAKULA: Second point, and I think Ms. Mintzer EASTERN DISTRICT C O U R T REPORTERS UNITED STATES DISTRICT COURT 223 CADMAN PLAZA EAST BROOKLYN. NEW YORK 11201 X & £ 0 K) UNITED STATES D I S TRICT COURT EASTERN D I S TRICT OF N E W Y O R K x In r e : : "AGENT ORANGE" : PRODUCT L IABILITY L I T I G A T I O N M D L No.381 : X United States Courthouse Brooklyn, New York February 15, 1984 2:00 o' clock p.m. B e f or e : HONORABLE J A C K B. WEINSTEIN, Chief U.S.D.J. HENRY SHAPIRO ILENE GINSBERG SHELDON SILVERMAN O F F ICIAL COURT REPORTERS EASTERN DISTRICT COURT REPORTERS UNITED STATES DISTRICT COURT 22J CADMAN PLAZA EAST BROOKLYN. NEW YORK 11201 •t 2 1 2 A P P E A R A N C E S : 3 4 Plaintiffs' 5 THOMAS H E N D E R S O N , ESO. • BENTON MUSSELWHITE, ESQ. GENE LOCKS, ESO. 6 Management Committee 7 8 9 10 11 12 RIVKIN, LEFF, SHERMAN & RADLER, Attorneys for Dow Chemical 100 Garden City Plaza Garden City, New York 11530 BY: 13 ESQS. MARJO R I E MINTZER, ESQ. STEVEN BROCK, ESQ. Of Counsel 14 15 16 17 18 19 CADWALADER, W I C K ERSHAM & TAFT, ESQS. Attorneys for Defendant Diamond Shamrock One Wall Street New York, New York 10005 BY: MICHAEL M. GORDON, ESQ. GRANT B. HERING, ESQ. 20 21 22 23 24 25 127 0 9 3 3 i 2 A P P E A R A N C E S : 3 4 5 6 TOWNLEY a UPDIKE, E S Q S . Attorneys for Defendant Monsanto Company 405 Lexington Avenue N e w York, New Y ork 10017 BY: 7 8 9 PHILIP PAKULA, ESQ. JAMES E. TYRRELL, ESQ. JOHN C. SABETTA, ESQ. JOSEPH S C H I A V O N E , ESQ. BRUCE G. SHEFFLER, ESQ. Of Counsel 10 11 12 13 14 15 CLARK, GAGLIARDI & MILLER, ESQS. Attorneys for Defendant T.H. Agriculture & Nutrition Co.,Inc. The Inns of Court 99 Court Street White Plains, New Yor k 10607 BY: 16 MORTON S I L E E R M A N , ESQ. JOHN J. BURKE, ESQ. Of Counsel 17 18 19 20 KELLEY, DRYE & WARREN, ESQS. Attorneys for Defendant Hercules, 101 Park Avenue N e w York, New York 10178 Inc. 21 BY: 22 23 24 25 W ILLIAM A. KROHLEY, ESQ. PATRICIA T U O H E Y , ESQ. WILLIAM HECK, ESQ. Of Counsel 12709 1 2 3 4 5 1 A P P E A R A N C E S r 4 : ARTHUR, DRY i KALISH, F.C. Attorneys for Defendant UniRoyal 1230 Avenue of the Americas New York, N e w York 10020 BY: 6 7 THOM A S A. BECK, M A R I L Y N NEIMAN, Of Counsel ESQ. ESQ. 8 9 10 11 BUDD, LARNER, KENT, GROSS, PICILLO & ROSENBAUM, ESQS. Attorneys for Defendant Thompson Chemicals 33 Wa s h i n g t o n Street Newark, New Jersey 07102 12 13 BY: 14 E D W I N R. MATTHEWS, DAVID GROSS, ESQ. SUSAN O L N E Y , ESQ. Of Counsel ESQ. 15 16 17 19 UNITED STATES OF AME R I C A Civil Division, Department of Justice 521 12th Street, Northwest Room 822 Washington, D.C. 20530 20 BY: 18 21 AR V I N MASKIN, ESQ. GRETCHIN LEAH WITT, Special Attorneys ESQ. 22 23 24 25 12710 5 1 2 Also present: 3 4 HONORABLE SHIRA SCHEINDLIN, Magistrate 5 SOL SCHREIBER, E S Q . , Special Master 6 JOY BEAN, Assistant to Special Master 7 8 NANCY PETRILLO, Clerk of Court 9 10 11 12 13 14 15 16 17 18 19 20 21 ■¡I &•. **■>■ | 3.9 1 But I take it that u l t i mately they are goino to 2 3 contest it if they don't concede it — 4 MR. MASKIN: Y our Honor, I am not sure — 5 THE COURT: (Continuing) — because if they 6 concede it, y o u may be able to, almost as a matter of 7 summary judgment, 8 them for any judgment the plaintiffs get against you. Tha t is the posture of the case, 9 10 11 12 13 14 15 16 17 18 19 have a third-party judgment against as I understand it. Now, party, if that is an open issue as to the third then it is an issue in the case. MR. KROHLEY: Apart from whe t h e r it is an open issue in the case or not and whether it needs to be decided again or not, to this, there is a practical d imension too. We spent four, four and a half years on the Government contract defense prior to trial in June. That — A t least that aspect of the case, of the first two elements, in terms and the third element was 20 d i scussed into at substantial length and hundreds of 21 depositions were taken. 22 23 24 25 If we now go back and try to go back to issues one and two in the Government contract defense and depose 40, 50, 60 additional witnesses in the time 12712 1 THE COURT: 2 3 40 rema i n i n g — to put it on the I am g o i n g back burner to in stru ct and c u t it the M a g istra te way, w a y d o w n . 4 A couple of w i t n e s s e s are all y o u are going to get. 5 I am not g o i n g to, a month and a hal f before trial, 6 a l l o w a whole b i g discovery. 7 e n e r g y left in all the plaintiffs' 8 in the country for that. 9 10 11 There is not enough and defendants' bars We have to be realistic. But the issue is between the defendants and the third-party plaintiffs. MR. GROSS: I think Mr. Maskin was about to say 12 that the Government may indeed not oppose or contest the 13 matter. 14 THE COURT: 15 Did you say that? 16 MR. MASKIN: 17 posture whatever, 18 us to take a position. 19 THE COURT: 20 21 22 23 24 25 I didn't hear him'say that. No. The Government again assumes no and n othing happened to day to require F r o m a tactical point of view, it w o u l d be a very serious concession. MR. KROHLEY: I don't see how this is an issue at all between the defendants and the Government. The G o v e rnment contract defense is the claim the plaintiffs are asserting against us. THE COURT: If the Government ordered something •f (T1 4 5 Jl 2 3 MR. MUSSELWHITE: Your Honor, question? Due to the time element — 4 basically, 5 officers and inspectors. 6 7 8 9 10 11 may I ask you a all we are asking for, from the Government, are the contracts, the They are not going to be long depositions. THE COURT: Y o u h a d better get it cut down. I will put it down for February 27th. MR. GROSS: May we have two weeks beyo n d that? THE COURT:- M a r c h 5th. MR. MUSSELWHITE: Can we go ahead and start taking some of these depositions? 12 13 14 THE C O U R T : No. You have got plenty of other things to do. You have not done so great on getting you r experts in. 15 MR. LOCKS: Gene Locks on behalf of the Plaintiffs. 16 I think I might have something to do w i t h that. 17 18 I agree wit h Mr. Gross. May we go to the 12th rather than the 5th? 19 You have got another hearing date scheduled on 20 the 12th. 21 THE COURT: You are speaking for the plaintiffs. 22 Y o u are the ones they want. 23 MR. LOCKS: Yes. THE COURT: March 12th. 24 eastern district court Government specifications reporters UNITED STATES DISTRICT COURT 223 CADMAN PLATA EAST 12? 14 CERTIFICATE OF SERVICE I HEREBY AFFIRM that I am an attorney duly admitted to practice in the State of N e w York and in the Eastern District of New York. I HEREBY CERTIFY that on February 21, 1984 I caused to be served a true and correct copy of the Notice of Motion and the Memorandum of Defendant Monsanto Company in Support of its Motion for a Protective Order on all counsel on the attached service list -- by hand on Mr. Dean and on all counsel in Manhattan, by courier on all others. 1 SERVICE LIST Stephen J. Schlegel, Esq. Schlegel & Trafelet, Ltd. One North LaSalle Street Suite 3900 Chicago, Illinois 60602 Michael M. Gordon, Esq. Cadwalader, Wickersham & Taft One Wall Street N e w York, N e w York 10005 Leonard L. Rivkin, Esq. Rivkin, Leff, Sherman & Radler 100 Garden City Plaza Garden City, New York 11530 Benton Musselwhite, Esq. Law Offices of Benton Musselwhite, Inc. Suite 517 609 Fannin Houston, Texas 77002 William Krohley, Esq. Kelley Drye & Warren 101 Park Avenue New York, N e w York 10178 Howard Lester, Esq. Lester Schwab Katz & Dwyer 120 Broadway New York, N e w York 10005 Paul V. Esposito, Lewis, Overbeck & 135 South LaSalle Suite 1060 Chicago, Illinois Esq. Furman Street 60303 David R. Gross, Esq. Budd, L a m e r , Kent, Gross, Picillo & Rosenbaum 33 Washington Street Newark, N e w Jersey 07102 Judge Morton B. Silberman Clark, Gagliardi & Miller 99 Court Street White Plains, N e w Yor k 10601 Thomas Beck, Esq. Arthur, D r y & Kalish 1230 Avenue of the Americas New York, N e w York 10020 Richard M. Goldstein, Esq. Shea & Gould 330 Madison Avenue New York, N e w York 10017 L. Kenneth Sheridan, Esq. Executive Assistant U.S. Attorney United States Attorney's Office 225 Cadman Plaza East Brooklyn, New York 11201 ' J Thomas W. Henderson, Esq. Baskin & Sears Frick Building, 10th Floor Pittsburgh, Pennsylvania 15219 Victor J. Yannacone, Jr., Esq. , Yannacone & Yannacone Post Office Drawer #109 Patchogue, N e w York 11772 David J. Dean, Esq. Dean, Falanga, Sinrod & Rose One Old Cou n t r y Road Carle Place, N e w York 11514 Irving Like, Esq., Reilly, Like and Schneider 200 West Mai n Street Babylon, N e w Y o r k 11772 Arvin Maskin, Esq. Trial Attorney, Torts Branch, Civil Div., U.S. Department of Justice Safeway Building Washington, D.C. 20530 Clerk of Panel Judicial Panel on Multidistrict Litigation 1120 Vermont Avenue, N.W. Suite 1002 Washington, D.C. 20005 I UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK x MDL No. JOi (All Cases) ' - In re: Agent Orange" SPECIAL MASTER'S FINAL AMENDED RECOMMENDATION RE: SCHEDULING ORDER FOR THE COMPLETION OF DISCOVERY AND THE PREPARATION OF A PRETRIAL ORDER AS APPROVED BY JUDGE WEINSTEIN Product Liability Litigation - - - - - - - - - - - - - - - - - x Pursuant to the direction of the Court, as set forth in its Pretrial Order #69, the Special Master met with opposing counsel to review their recommendations concerning the completion of discovery and the preparation of a pretrial order. On December 16, 1983, the Special Master's recommendation concerning these matters was sent to the Court with copies to counsel. Thereafter, on December 19, 1983, at a hearing before the Court, the recommendation was reviewed and substantially approved by the Court, and the Special Master was asked to meet again with counsel in an attempt to resolve a few remaining issues. This hearing took place immediately after the Court's hearing on December 19, 1983. A draft of the Special M a s t e r ’s amended scheduling order was thereafter circulated among the interested parties and a further review hearing was held on December 28, 1983. At this hearing, the views of counsel were further examined by the Special Master, and additional requested changes by plaintiffs', defendants' and government's counsel were reviewed. A number of these changes were accepted by the Special Master and are incorporated herein. The following is the amended scheduling order which is recommended for the Court's consideration: I. Interrogatories Served by Respective Parties A. Plaintiffs' Interrogatories The interrogatories served by the plaintiffs upon the defendants and reviewed by the Court at its hearing on December 12, 1983 are to be served in amended form upon the defendants not later than Thursday, December 22, 1983. Defendants will serve and file their responsive answers not later than Monday, January 16, 1984. Plaintiffs' interrogatories dealing with the Government Contract Defense, which were recently served upon the defendants will be reviewed by the Special Master at a hearing to be held on Thursday, December 29, 1983 at 2:00 p.m . , tinless prior meetings of counsel resolve the outstanding conflicts. The interrogatories agreed upon by counsel or approved by the Special Master will be served upon the defendants, in amended form, by Wednesday, January 4, 1984 and will be answered by the defendants not later than January 30, 1984 . 12733 B. Defendants' Interrogatories The interrogatories served by the defendants were reviewed by the Special Master and thereafter his recommendations were examined by the Judge at a hearing on December 12, 1983. The Special Master's recommendations were approved by the Court with a few modifications. These revised interrogatories are to be served upon the plaintiffs by December 22, 1983. Plaintiffs will serve and file their answers to these interrogatories not later than Monday, January 16, 1984. Any disputes concerning these amended interrogatories were resolved at the Special Master's hearing of December 29, 1983 II. Interrogatory Requests Served Upon United States Re Causation Documents____________________________ Defendants' documentary requests of December 1, 1983 entitled "Notice to Produce Documents re Causation Issue", and served upon the United States were reviewed by the Special Master at a hearing on December 20, 1983. At this hearing all disputed requests were resolved by the Special Master whose recommendations are contained in the transcript of the hearing. The Special Master advised counsel that if any of the recommendations were to be appealed they were to notify opposing counsel and set forth their objections in written form within a few days after the December 20th hearing; thereafter, the Special Master would hold a hearing to determine the 12734 -3- validity of such objections before submitting his recommendations to the Court. At the December 28, 1983 hearing before the Special Master counsel were requested to state their objections to the Special Master's rulings of December 20, 1983. No objections were raised and defendants were directed to serve an amended documentary request (re: causation issues) upon the government by January 4, 1984. The government was directed to produce documents as soon as they were assembled and not to wait for the final date of Jainuary 16, 1984 to make production. Ill. Depositions A. Plaintiffs' Depositions Plaintiffs' depositions of defendants’ present and/or prior employees will continue on a daily basis and end by March 30, 1984 unless good cause be shown for a short extension of this cut-off date. Plaintiffs' depositions of other non-party witnesses, except expert witnesses, discussed below, will be completed by the same date. Plaintiffs' depositions of government experts or persons knowledgeable on the issue of causation and liability will be taken between January 15, 1984 and March 12, 1984. plaintiffs' These depositions will be preceded by the serving upon the government and opposing counsel at least seven (7) days prior to the scheduled depositions a list of documents upon which these government witnesses will be | ni^ -4- J A deposed. In addition, both plaintiffs' and defendants' counsel, in seeking depositions of such government witnesses, must comply with Judge Weinstein's directions concerning preliminary notice and information to be given to the government. (See transcript of proceedings before Judge Weinstein of November 21, 1983, pp. 69 & 71.) This information must also be supplied at least seven (7) days prior to the scheduled depositions. B. Defendants' Depositions of Plaintiffs' Representative Parties and Non-Party Fact Witnesses_________________________ Prior to their taking depositions of plaintiffs' representative parties, defendants may serve on plaintiffs a limited number of interrogatories. These interrogatories should be served not later than December 22, 1983; responses due not later than January 11, 1984. plaintiffs' Depositions of the representative parties, their wives, children, relatives and legal representatives will begin on January 16, 1984 and will be completed by April 6, 1984, unless good cause be shown for a short extension of this date. The April 6, 1984 cut-off date also applies to non-party fact witnesses. The government is directed to locate and produce all service and medical records of the representative plaintiffs by January 6, 1984. In addition, all medical records of treating doctors and medical institutions which counsel for the representative plaintiffs have in their possession will be turned over to the defendants by January 6, 1984. «# >'•**'ri JL £ J o i Defendants' medical -5- f. ‘ i 4 Af*fC their wives. A 4 I W W f children and relatives will begin on January 17, 1984 and notice of the said examination will be given to plaintiffs' counsel at least ten (10) days prior to the examination date. In the event that plaintiffs object to the type or place of the said medical examination, these objections will be heard by the Special Master within 48 hours. Defendants will exert all efforts to complete these examinations by March 6, 1984 and will further advise all doctors or institutions conducting such examination that they must submit their reports in writing to the defendants' counsel not later than March 12, 1984. It is expected, however, that these reports will be delivered to counsel as soon as the examinations are completed. This same instruction (i.e., staggered delivery of reports) is applicable to plaintiffs' medical experts. C. Defendants' Depositions of Government Witnesses on All Issues Including Causation _________ These depositions will begin on January 15, 1984 and be completed by March 30, 1984 unless good cause be shown for a further short extension of this date. Prior to taking the depositions of government witnesses, defendants will deliver to counsel for the government and plaintiffs, copies of documents upon which the said witnesses will be deposed. -6 - Such documents must be r e c e i v e d by c o u n s e l at least the d ep o sitio n . D efendants w i l l counsel w ith the a d d ition al d iscu ssed IV. in paragraph P la in tiffs days p r io r to p rovid e governm ent's and i n f o r m a t i o n , as above. w ill sum m aries o f p l a i n t i f f s ' R u le 2 6 ( b ) ( 4 ) ( A ) ( i ) be d e liv e r e d plaintiffs other b eh alf not will later reports to resu lts, m ed ical exam ination s will fu rn ish the of will summary r e p o r t s to be c a lle d to t e s t i f y 1984. All sa id of on the ex p erts' reports conduct b e fo r e trial resu lts to thereof d ep o sition s 1984 or sum m aries in clu d in g m ed ical reports are based. rep resen tative p l a in t i f f s b e g i n on February 1, u n less reports In a d d i t i o n , counsel P roced u re or c o p ie s upon w h ic h t h e D efendants' to Procedure. w ritten 1984. defendants' by J anuary 2 3 , and/or 1984, th e doctors' b e accom panied by any d o c u m e n ts, plaintiffs reports pursuant pursuant to t h e R u l e 2 6 ( b ) ( 4 ( A ) ( i ) o f t h e plaintiffs, w ritten will doctors' th an January 16, d eliv er R u les of C i v i l 1984. of e x p e r t s who a r e e x p e c t e d of to the defen dants of th e F e d e r a l R u les o f C i v i l Federal will d eliv er trea tin g Such sum m aries or c o p i e s to (7) E xpert W itn esses A. of also n o tice III seven tests A ll that s h a l l be co m p le ted in tim e the defendants by January 23, of p l a i n t i f f s ’ expert w itn esses a nd b e c o m p l e t e d b y M a r c h 1 3 , good c a u s e b e shown f o r a short e x te n sio n of th is date. B. experts' D efendants w i l l testim on y pursuant a ltern a tiv ely , cop ies of to th eir subm it e i t h e r R ule 2 6 ( b ( 4 ) ( A ) ( i ) experts' -7- w ritten sum m aries o f th eir or reports not’ p “ 3g I later than March 13, 1384. All reports or summaries will be accompanied by any documents, including medical tests and/or results, upon which these reports are based. Defendants' experts will be deposed by plaintiffs' counsel between March 20, 1984, and April 15, 1984. C. If counsel cannot agree upon reasonable expenses to be paid for the appearance of opposing counsel's experts, the Special Master will recommend the appropriate fee to be paid. V. P retrial Order Counsel are directed to meet with the Special Master at a date to be set within the next few weeks but prior to February 1, 1984 in an attempt to agree upon a schedule for the completion and filing of a pretrial order not later than April 24, 1984. VI. Other Matters A. All fact witnesses who will give testimony in support of the claims of the respective parties will be listed by name, present address and a description of the general nature of the testimony. This information will be exchanged by the parties not later than February 29, 1984. In addition, counsel for the respective parties will have an additional ten (10) days thereafter to supplement their earlier lists. -8 - B. A scheduling order for in limine or pretrial evidentiary rulings, special interrogatories to the jury, preliminary and interim jury instructions and the dates for the submission of trial briefs will be recommended to the Court by the Special Master by February 1, 1984 after consultation with counsel. Dated: New York, New York January 10, 1984 Respectfully submitted. Special Master Dated: Brooklyn, New York January/¿" , 1984 -9- i 1 2 3 MR. GORDON: Well, access will be permitted according to the order. THE SPECIAL MASTER: Well, we can say that the 4 list will be made available to both parties under seal 5 of the Court. 6 7 8 9 10 11 So, the Government will supply a list to plaint.: defendants and to the Court, MR. PAKULA: under seal.. What wil l be filed that purports to be proof of -MR. DEAN: We w ill file -- no matter what is informally agreed today -- we will file affidavits of service w ith regard to everyone who m we have mailc 12 13 14 notices, including those on the Agent Orange registry THE SPECIAL MASTER: Y o u can say those on the Agent Orange registry but your affidavits of service 15 can only be appropriate to those not on the Agent 16 Orange registry because the Post Office will make the 17 mailing and stuff and supply the stamps. 18 MR. DEAN: And supply their own affidavits of 19 service. They agreed to do that? 20 THE SPECIAL MASTER: Yes, 21 MR. H E I N E M A N N : M a y I request the information' 22 as to what Post Office person received these tapes 23 since I am going to be the conduit? 24 THE SPECIAL MASTER: I think you ought to get 25 EASTERN DISTRICT COURT REPORTERS UNITED STATES DISTRICT COURT 223 CADMAN PLAZA EAST BROOKLYN. NEW YORK 330-7687 11201 > ^ v„ i -L ,h. « % I I cnose as quiciciy as possiDie. 2 Will you wr i t e to Mr. Heinemann by tomorrow? 3 MR. HEINEMANN: 4 Then we can do it immediately in case it happens suddenly. THE SPECIAL MASTER: 5 We now have -- unless anyon 6 has another m a tter to be taken up — the final order 7 of the business, w h i c h Mr. Pakula will address himself 8 to. 9 MR. PAKULA: 10 Dates and status of disclosure matters that 11 12 13 14 15 16 17 18 19 Thank you. are the subject of the order, scheduling order entered in this case. January 6th, the Government was to produce all service and medical records of representative plaintiff As of this morning, we do not have the following records: Danny Ford, we don't have his 201 file -- that is his service record. We don't have his military medical file. Michael Ryan -THE SPECIAL MASTER: Let's go one at a time. 20 Does the Govenrment know all of this information" 21 Is this the first time they are hearing it? 22 MR. PAKULA: This is the first time they are 23 hearing it and I think a convenient time on a day-to24 day proposition -25 EASTERN DISTRICT C O U R T REPORTERS U N IT E D S TA T E S D IS T R IC T C O U R T 223 C A D M A N P L A Z A EAST BRO O KLYN. N E W YORK 330-7687 11201 y ^ A L ^ 5 T* .Lin- 1 2 ¿ n a n we asK tne government to respond to each one? HR. PAKULA: 3 4 «AiitK: I am not suggesting we have an argument about who shot John. THE SPECIAL MASTER: You are just posting the 5 record. 6 MR. PAKULA: I feel you should have a status 7 report regularly. 8 I didn't raise it to stick a knife in them, 9 but 10 THE SPECIAL MASTER: Let's do all the service 11 and medical records and we will find out what is 12 happening. 13 MR. PAKULA: Michael Ryan. We don't have his 14 military medical file. 15 Mr. Ewault -- we don't have his military 16 medical file. 17 Next date 18 THE SPECIAL MASTER: L e t ’s stop here for a mome: 19 Can Government counsel illuminate for us where 20 we are? 21 MS. WITT: As to Danny Ford, the problem here - 22 I stood here and said we had not been able to find 23 any record and at that time Danny Ford was dropped 24 from the case and therefore we stopped looking for 25 him. EASTERN DISTRICT COURT REPORTERS UNITED STATES DISTRICT COURT 225 CADMAN PLAZA EAST BROOKLYN. NEW YORK 330-7687 11201 I j a u ^c 2 ictsL w e e s uney nave Degun to cry a n a locate his records again. 3 Hopefully they will be found quickly, but they 4 were having difficulty before in locating any records 5 pertaining to Mr. As to Mr. Ryan and Mr. Ewault, 6 7 records records, 10 11 12 13 14 the military I am not aware of the status of those My belief is that those files were contained 8 9 Ford. within the VA Claims Files and I may be m i s taken on that, but most of the veterans whose files we have found, their military medical records, have not been contained w i t h their military file and already forwarc on to VA, as is normally the case when somebody applies for VA benefits. I will have to go back and look at the records 15 16 but I thought those records were already contained -MR. PAKULA: I imagine that you can guess that 17 I have not looked at every page of these records and 18 we too will look and see if we -- we will check and 19 see if we were wrong. 20 THE SPECIAL MASTER: If it i s n ’t, y o u will let 21 counsel know immediately. 22 MR. PAKULA: Of course immediately. 23 THE SPECIAL MASTER: Ewault is the same. 24 MR. PAKULA: Schaeffer. That was January 11th 25 EASTERN DISTRICT C O U R T REPORTERS UNITED STATES DISTRICT COURT 225 CADMAN PLAZA EAST BROOKLYN. NEW YORK 330-7687 11201 I 3T1Q 2 plaintiffs were to answer defendant's limited 3 interrogatories re representative plaintiff and that 4 is the subject of objections by the defendant to the 5 answers that wer e served which will be heard at a 6 later time. 7 8 9 10 11 It §OC CflcLIlgSG tO •JcLriTJ.cLI'y January 16th, plaintiffs were to answer defends:, general interrogatories. Those answers have been received. 13 of a later hearing. 16 17 18 19 20 wao deposition date we talked about before. to the answers have been made. 15 wuiuii January 15th -- I'll skip that -- that's the 12 14 I^LU Objections That will be the subjt January 16th was also the last day for the Government to respond to defendant's document request re causation. As you can tell the documents are still rolling in and I think we resolved a lot of problems because of your ruling, but that is the status of that -- the> are coming in as they come in. January 16th, the plaintiffs w ere to produce 21 22 23 24 Rule 26(b) — y o u always straighten me out on this -- THE SPECIAL MASTER: (b)(4)(a)(1) -- because I have u sed it so long. MR. PAKULA: For their treating physicians and 25 EASTERN DISTRICT C O U R T REPORTERS UNITED STATES DISTRICT COURT 223 CADMAN PLAZA EAST BROOKLYN. NEW YORK 330-7687 11201 ^ -,u A fe * p 1 none have bee n received. 2 THE SPECIAL MASTER: I received a letter from 3 Mr. Musselwhite which I assume counsel -- which was 4 addressed to the Court and I am not sure -- would y ou 5 check, Mr. Dean, 6 has the M a g i strate on the mailing list because I am 7 not sure that the Magistrate received a copy. MR. DEAN: 8 to make s u r e 'that Mr. Musselwhite The Magistrate did not get 9 Mr. M u s s e l w h i t e ’s communication and we will remedy 10 that. THE SPECIAL MASTER: 11 12 That dealt wit h not only the medical expert but also experts. Frankly, 13 I was troubled not so muc h that the 14 deadline was not met but there was no indication of 15 a date. MR. DEAN: 16 Mr. Musselwhite told me a couple of 17 days ago he had written a letter and I have not seen 18 it. 19 20 21 22 23 24 25 THE SPECIAL MASTER: More important than that, when are the plaintiffs going-to select their experts. MR. DEAN: I know that plaintiffs have now some names of experts. I will tell you that I spoke to Mr. Henderson this morning and he alerted me that he assumed this was going to be discussed. EASTERN DISTRICT C O U R T REPORTERS UNITED STATES DISTRICT COURT 223 CADMAN PLAZA EAST BROOKLYN. NEW YORK 330-7687 11201 ^ ^ ^ A * 1 2 ' I said, thanks a lot. He w a nted me to convey to you the fact that I 3 k n o w his office has received -- had sent out many, many 4 man y requests for medical reports from the treating 5 physicians. 6 A number of those reports -- so the defendants 7 are not n o w prejudiced -- a number of those reports 8 are found within the medical records themselves and 9 I tell you, 10 reports -- 11 if there was a way to duplicate those (Continued on next page.) 12 13 14 15 16 17 18 19 20 21 22 23 24 25 EASTERN DISTRICT C O U R T REPORTERS UNITED STATES DISTRICT COURT 223 CADMAN PLAZA EAST BROOKLYN. NEW YORK 330-7687 11201 i-iV Ì I THE SPECIAL MASTER: But even assuming that the i t 2 key seems to me that it is your expert medical 3 witness -- 4 MR. DEAN: We are not talking about expert 5 witnes se s at all. Mr. Pakula was talking about 6 treating physicians. 7 THE SPECIAL MASTER: But they are also -- he 8 is also talking about expert medical. And Mr.-M us se 9 white's letter says he is sorry, we m issed all 10 deadli ne s but we are trying our best. 11 That's fine, but somebody has to be in a p o s i ­ 12 tion by Monday to ask w h e n is this going to be done. 13 The whole structure of discove ry depends on the 14 plaintiff's going first and making proper production. 15 Now, you know the judge's feeling that time is 16 short and people are doing their best, he u n d e r ­ 17 stands it and recognizes it and sympathizes w i t h it. 18 But you better get that done and you should be in a 19 position by Mond ay to say, Judge, you will get it 20 by Tuesday or Wednesday. And if you don't have a 21 date by then you will be jumping into the frying pa; 22 23 or into the fire, which ever is w o r s e . MR. PAKULA: You have covered the whole subject 24 And we don't have any 26(b) reports of any sort 25 whatsoever. Until we get that there are things that EASTERN DISTRICT COURT REPORTERS UNITED STATES DISTRICT COURT 223 CADMAN PLAZA E.AST BROOKLYN. NEW YORK 330-7687 11201 I 3 2 3 4 THE SPECIAL MASTER: I agree, counsel. j MR. PAKULA: Those are the only dates that have j passed. 5 So the only other thing that I wanted to mentic 6 and this is something that the defendants just workc 7 out yesterday or the day before -- yesterday, really 8 and that is that we are scheduling in New York our 9 medical examinations for the period March 1st thro 10 March 5th. 11 New York is the place and Albert Einstein is the 12 location. You probably don't know that yet, Mr. he- 13 THE SPECIAL MASTER: The hospital? 14 MR. PAKULA: 15 THE SPECIAL MASTER: 16 MR PAKULA: Yes. In the Bronx? And the dates are March 1st thr cup:'. 17 March 5th for the examinations, 18 other information as well, but I am conveying that 19 date to you now, Dave. 20 on it unless you want to. 21 THE SPECIAL MASTER: 22 I once represented them. 23 ' MR. PAKULA: he will provide I am.not asking you to comrm I t ’s a fine institution. At the soonest possible time I 24 would like to know if there is anybody that cannot 25 go there or cannot be there at that time. Because • j EASTERN DISTRICT C O U R T REPORTERS UNITED STATES DISTRICT COURT 225 CADMAN PLAZA EAST BROOKLYN. NEW YORK 330-768/ 11201 ; ^ _ [ 1 P X* 4 ! JL Kv u asI ! UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK x In re MDL No. 381 jj "AGENT ORANGE" | | Product Liability Litigation I* DEFENDANTS' INTERROGATORIES TO ELEVEN PROPOSED REPRESENTATIVE PLAINTIFFS. P L E A S E T A K E N O T I C E t h a t p u r s u a n t to the d i r e c t i o n s of Special Master Schreiber, : of the following you are hereby required to answer interrogatories representative plaintiffs derivatively through him and each for each of the eleven proposed for e a c h oth er person claiming as a r e s u l t of his e x p o s u r e to Ag e nt Orange in V i et n am under oath on or before January 11., 1984. These Interrogatories sha ll be d e e m e d s e r v e d on l y on b e h a l f of tho se d e f e n d a n t s w h o h a v e p r o p e r l y b e e n m a d e p a r t i e s hereto by service of the sum mo ns and complaint in accordance with the F e d e r a l R u l e s of C i v i l P r o c e d u r e and shall not be d e e m e d an appearance, a d m i s s i o n of s e r v i c e or c o n s e n t to j u r i s d i c t i o n by !, any defendant not so m a d e a party to this action. !■' j! T h e s e I n t e r r o g a t o r i e s a re c o n t i n u i n g interrogatories. ji |j If at any time after service of answers hereto plaintiff obtains !; ji or becomes aware of additional information pertaining to any of \:j i ! the I n t e r r o g a t o r i e s , plaintiff shall i m m e d i a t e l y serve supplemental sworn written answers setting forth such additional information. f A v v I. GENERAT, State your name, social security number, military service n u m b e r , and e a c h a d d r e s s at w h i c h y o u have ever li ve d (excluding time during active military service), starting w i t h your current address, and give the dates you lived at each address. I d e n t i f y e a c h e d u c a t i o n a l i n s t i t u t i o n you att e nd ed , the d a t e s of y o u r a t t e n d a n c e , and d e s c r i b e any p h y s i c a l or m e n t a l e x a m i n a t i o n you r e c e i v e d at or in c o n n e c t i o n w i t h your attendance at each institution, stating with respect to each such examination: a) the date of the examination; b) the hospital given; and c) the n a m e a nd examination. or institution where such examination was address of the person conducting the If you have ever applied for life, health or accident insur­ ance, state with respect to each such application: a) the date of the application; b) the kind of c) the name and address of the insurance company to which the application was made; d) w h e t h e r s u c h a p p l i c a t i o n wa s a c c e p t e d and if not, w h y not; and e) whether a medical examination was given in connection w i t h the a p p l i c a t i o n , and, if so, i d e n t i f y the p e r s o n conducting the examination and the medical institution w h er e the ex amination was given. insurance applied for; If you have ever made a claim for benefits for any medical condition (including worker's compensation, veteran's bene­ fits, state or federal disability or insurance or union or third party medical plans) state with respect to each such claim: a) the type of c l a i m benefits, etc.); (worker's compensation, ve teran's >*V -2- i#* «I si -i*« b) the date of the cla im ; c) the cla im number or d) t h e e n t i t y t o whom t h e n a m g and address; e) the m ed ica l f) the d isp o sitio n other con d ition of id en tifica tio n cla im for w as m ade, w h ich th e of the claim ; in c lu d in g the was made; and cla im cla im . I f you h a v e e v e r f i l e d or o t h e r w i s e commenced a l e g a l a c t io r in c o n n e c tio n w ith any m e d ic a l c o n d itio n (o th er than t h is a c tio n ) s t a t e as to each such a c tio n : a) t h e d a t e t h a t a c t i o n w as f i l e d or o t h e r w is e comm enced t h e c o u r t or a d m i n i s t r a t i v e body, t h e f u l l t i t l e o f tht a c t i o n , t h e i n d e x or o t h e r i d e n t i f y i n g nu m b er, and the id e n tit y of a l l p a r tie s to the actio n ; b) a d e s c r ip t io n o f th e m e d ic a l c o n d itio n in c o n n e c tio r w i t h w h i c h t h e a c t i o n w a s f i l e d , and how you b e l i e v e th a t m ed ical c o n d itio n occurred; c) a d e s c r ip t io n of the outcom e of th e a c tio n , p r e s e n t s t a t u s i f i t i s s t i l l p e n d i n g ; and d) t h e d a t e s and am ou n ts o f any p a y m e n ts , e i t h e r r e s u l t o f a judgm ent or s e t t le m e n t , w h ich you r e c e i v e d or w h ic h you a r e s c h e d u le d t o r e c e i v e . II. or of itt as i have EMPLOYMENT HISTORY Id e n tify and d e s c r i b e e a c h jo b you have h e ld , w hether e m p lo y e d by o t h e r s or s e l f - e m p l o y e d , and s t a t e a s t o e a c h : a) t h e name and a d d r e s s o f y o u r your w o rk p la ce, the n atu re o f title ; b) your c) th e d a te th e job began te r m in a tio n o f the job; d) t h e d a t e and p l a c e o f e a c h p h y s i c a l or m e n ta l e x a m in a ­ t io n th a t you underw ent in c o n n e c tio n w ith su ch job , id en tify in g t h e name and a d d r e s s of each m ed ica l p r a c t i t i o n e r c o n d u c t i n g t h e e x a m i n a t i o n and t h e nam e d u ties and em p lo y er, the a d d r e ss of t h e b u s i n e s s and y o u r j o t r e sp o n sib ilitie s; and and ended and the reasons . -3- n! for and a d d r e s s o f any m e d ic a l ex a m in a tio n was conducted. 7. in stitu tio n at ~~ J a) a description of the injury, medical condition or acci­ dent; b) the dates of the injury, and c) the treatment received, including the treating physi­ cian's name and address and all hospitalizations, oper­ ations and medication received. III. medical condition or accident; FAMILY MEDICAL HISTORY S t a t e t h e nam es and a d d r e s s e s o f y o u r s p o u s e , c h i l d r e n , b r o th e r s, s is t e r s , p a ren ts, grandparents, au n ts, u n cles, c o u s i n s , n i e c e s , n e p h e w s and g r a n d c h i l d r e n , and w i t h r e s p e c t to each: a) i f any o f them a r e d e c e a s e d , s t a t e h i s th e tim e o f d e a th and th e tim e , p la c e death; b) i d e n t i f y each i l l n e s s , d i s e a s e , d i s a b i l i t y , or m ed ica l c o n d i t i o n e v e r had by e a c h d u r in g h i s or h e r l i f e t i m e w h ich r e q u ire d p r o f e s s i o n a l m ed ica l a t t e n t io n ; c) identify any birth or genetic wh i c h they had; and d) w i t h r e s p e c t to e a c h r e la ti ve , i d e n t i f y ea ch m e d i c a l practitioner and medical institution that treated them, and set forth the diagnosis. IV. 9. such W i t h r e s p e c t to e a c h job i d e n t i f i e d in r e s p o n s e to Interr n o i f n r v Hn. f M r h nn-fhp medi/'al ^ • *i. r »i»H. »o. .n H f v - -i _ /o b in^urv.r v m * v * condition or accident that you experienced, and state sepa­ rately as to each: mf ~ 8. w h ich VETERAN'S MEDICAL HISTORY State: a) defects the date of your birth; -4 - or or h er a g e and c a u s e at of miscarriages 10. 11. b) the name and address of the hospital or other facility w h e r e y o u w e r e born, a n d the n a m e a nd a d d r e s s of each attending physician or other medical practitioner; and c) each birth defect that you had and each medical co mpli­ c a t i o n c o n n e c t e d w i t h yo u r b i r t h (e.g.> p r e m a t u r e birth, b r e e c h birth, ja undice, fetal a l c o h o l i s m ) , and each medical complication or health problem that your m o t h e r had in c o n n e c t i o n w i t h her p r e g n a n c y or your birth (e.g.. toxemia, long period of labor). Identify each injury, illness, disability or other physical or mental condition which you have ever had, whether tempo­ rary or permanent, and state separately as to each: a) e a c h m e d i c a l p r a c t i t i o n e r and/or m e d i c a l i n s t i t u t i o n seen or v i s i t e d by y o u for the p u r p o s e s of c o n s u l t a ­ tion, diagnosis, prognosis, x-rays, treatment or other care, specifying the dates of all hospitalizations; b) t h e d i a g n o s i s or p r o g n o s i s m a d e b y e a c h practitioner and medical institution; and c) t h e n a t u r e a n d e x t e n t of t h e c a r e a n d t r e a t m e n t r e c e i v e d in ea c h m e d i c a l i n s t i t u t i o n and f r o m each medical practitioner. medical W i t h resp ect to e a c h injury, illness, d i s a b i l i t y , or other physical or mental condition identified in response to In­ terrogatory 10, identify each such condition that you claiir or b e l i e v e w a s c a u s e d by or a r o s e out of e x p o s u r e to Ag e n t Orange, 2,4-D, 2,4,5-T, dioxin or some combination thereof, and state separately as to each: a) a description of each symptom; b) whether you contend that such injury, illness disabili­ ty or other physical or mental condition was caused by e x p o s u r e to A g e n t O r a n g e , 2,4,5-T, 2,4-D, dioxin, or some combination thereof; c) the date and m a n n e r i n w h i c h e a c h s u c h s y m p t o m first manifested itself or was made known to you; and d) the bas is for yo u r c l a i m or b e l i e f that the c on d i t i o n was caused by or arose out of exposure to Agent Orange, 2,4-D, 2,4,5-T, d i o x i n or s o m e c o m b i n a t i o n thereof, i n c l u d i n g the n a m e an d a d d r e s s of e a c h p e r s o n whc f u r n i s h e d i n f o r m a t i o n c o n t r i b u t i n g to said c l a i m or belief, and the substance of that information. -5- II 1 i; I •12. i j ! ' i i i i 13. | I 1 Identify each drug or medication ever used or taken by you, i n c l u d i n g , but no t l i m i t e d to, illegal, r e c r e a t i o n a l and over-the counter drugs, and for each drug or medication, set forth the following w i t h respect to each: a) the bra nd n a m e , g e n e r i c name, or " s t r e e t n a m e " of the drug; b) the dates of use; c) the amount used during each period of use; d) the n a m e a n d a d d r e s s p r e s c r i b e d t h e drug; e) a description of f) whether you have ever received any medical treatment or counseling in connection with your use of such drugs. if any, ever had, state the dates during which you had that condition; b) d e s c r i b e a n y d i a g n o s i s or m e d i c a l ceived for the condition, and state: | I | i ii) iii) iv) who reasons for your use of the drug; and a) i) I i the p h y s i c i a n , I d e n t i f y each s k i n c o n d i t i o n that y ou h a v e with respect to each such condition: i 14. of and t r e a t m e n t you the n a m e and a d d r e s s of the p e r s o n r e n d e r i n g the diagnosis or treatment; the name and address of the medical institution(s) at w h i c h you were diagnosed or treated; the dates of the diagnosis or treatment; and the effect of the treatment. If yo u ha ve ev e r tobacco product: smoked cigarettes or otherwise used a fe.a.. cigars, ciga­ a) i d e n t i f y e a c h type of p r o d u c t rettes, chewing tobacco); b) i d e n t i f y the t i m e p e r i o d d u r i n g w h i c h y o u used that tobacco product; c) i d e n t i f y the a m o u n t used on a d a i l y b a s i s (e.g., packs of cigarettes/day); and d) st a t e w h e t h e r an y p h y s i c i a n or o t h e r h e a l t h care p r o f e s s i o n a l h as ever a d v i s e d y ou to s t o p or reduce your use of cigarettes or other tobacco products, and, -6 - 3 ft ^ if if 4 ; wJ if so, s t a t e the n a m e and a d d r e s s of the p h y s i c i a n or o t h e r h e a l t h care p r o f e s s i o n a l a n d the date of the advice. 15. 16. If you have ever consumed or drunk alcohol, state separately w i t h r e s p e c t to e a c h type of a l c o h o l (e.g.. liquor, beer, wine, etc.) consumed: a) at what age consumption began; b) the amount and frequency of such consumption; c) if consumption ceased at any time, the reasons for such cessation and the reasons for any resumption; and d) wheth er you were ever hospitalized or institutionalized f o r a l c o h o l use, or a d v i s e d to l i m i t or stop alc oh ol use, and, if so, state the name(s) of ea c h such h o s p i ­ tal or institution or medical practitioner who treated or advised you. If a n y i n s e c t i c i d e s (e . g . . C h l o r d a n e , L i n d a n e , DDT), r o d e n t i c i d e s (e.g.. rat poison), i n s e c t r e p e l l e n t s (e.g.. DEET) or other pest control compounds we r e ever used by you or o t h e r s a r o u n d y o u r livin g or w o r k i n g q u a r t e rs , st a te as to each: a) the brand n a m e or generic name of the chemical; b) a d e s c r i p t i o n of the c h e m i c a l color, smell); c) a d e s c r i p t i o n of the c o n t a i n e r for the c h e m i c a l (e.g.. shape, color, markings) d) the dates of use: e) the metho d of application; f) the place it was applied; g) the frequency of application; and h) w h e t h e r y o u e x p e r i e n c e d any a d v e r s e r e a c t i o n to the compound and, if so, describe the reaction. V I. 17. (e.g.. p o wd er , liquid, M ILITA R Y SERVICE S t a t e w i t h r e s p e c t to y o u r m i l i t a r y s e r v i c e : -7 - Jt r- fi i . ' ai)o a) th e b ra n ch o f t h e arm ed s e r v i c e s in w h ic h you serv ed ? b) the in clu siv e dates of your c) the in clu siv e dates of service d) t h e name o f e a c h m i l i t a r y u n i t t o w h ic h you w e r e a s s i g n e d w h i l e s e r v i n g in or n ea r V ietn am ? and th e d a te s d u rin g w h ich you w ere a s s ig n e d to each such unit? e) th e name and l o c a t i o n o f e a c h p l a c e or a r e a a t w h ic h you w e r e p h y s i c a l l y p r e s e n t in or n e a r V ietn a m and t h e d a t e s d u rin g w h ic h you w e r e p r e s e n t a t ea ch su ch p la c e or area? f) your im m ed iate su p e r io r i n or n e a r V ie tn a m ? and g) the type of d isch arge you service? in o fficer's or n ear V ietnam ? name and rank w h ile received . w ith resp ect to each illn e s s , in ju ry , wound, or o th e r m e d i c a l o r p s y c h o l o g i c a l c o n d i t i o n e x p e r i e n c e d by y o u d u r i n g y o u r m i l i t a r y s e r v i c e in or n ear V ietn a m , s t a t e : a) the d a te o f your i l l n e s s , in ju ry , m e d ic a l or p s y c h o l o g i c a l c o n d itio n ; or other b) a d e s c r i p t i o n o f t h e i l l n e s s , i n j u r y , w ound, or m e d ic a l or p s y c h o l o g i c a l c o n d i t i o n , i n c lu d in g s c r i p t i o n o f a l l sym ptom s? other a de­ c) the cau se m e d ic a l or other d) t h e n a m e a n d r a n k o f t h e p e r s o n t o whom y o u f i r s t r e p o r t e d t h e i l l n e s s , i n j u r y , w ound, or o th e r m e d ic a l or p s y c h o l o g i c a l c o n d i t i o n ( i f a n y o n e ); e) the date th a t you f i r s t rep o rted th e i l l n e s s , in ju ry , wound, or o th e r p s y c h o lo g ic a l or m e d ic a l c o n d itio n ? f) t h e nam e, rank and l o c a t i o n o f e a c h p h y s i c i a n or o t h e r h e a l t h c a r e p r o f e s s i o n a l who t r e a t e d y o u r i l l n e s s , i n j u r y , w ound, or o t h e r p s y c h o l o g i c a l or m e d ic a l c o n d i ­ t i o n , i n c l u d i n g t h e d a t e s and p l a c e s o f t r e a t m e n t , and a d e s c r i p t i o n o f t h e t r e a t m e n t you r e c e i v e d ; and g) t h e name and l o c a t i o n o f e a c h h o s p i t a l or o t h e r h e a l t h care f a c ilit y w h ic h t r e a t e d y o u r p s y c h o l o g i c a l or m ed ica l c o n d itio n , the d a tes of treatm en t, and a d e s c r ip t io n o f th e tre a tm e n t th a t you r e c e iv e d . of the ill n e s s , in ju ry , p sy c h o lo g ic a l con d ition ? -8 - wound, wound, or «P C; 19. 20. 21. Describe any other medication taken by you during your military service (e.g., Dapsone, Chloroquine, Primaquine, Binoctal), stating as to each: -\ a; the brand name or generic name of the medication; b) the form of the m e d i c a t i o n injection, etc.); c) the color, taken; d) the reasons for taking the medication; e) the name and rank of the person(s) who gave you the medication; f) the dates you took the medication; g) the amount of the medication taken (e.g.. pills/day) and h) whether you experienced any adverse reaction to th« medication and, if so, describe the reaction. shape, (e.g., pill/ capsule, and size of any pill or capsule State whether you ever received any training, instructions warnings or health and safety information concerning herbi­ cides during your military service, and identify as to each a) the dates you received the foregoing; b) the location where received; c) the name and rank of the person(s) received; d) the substance of any oral information received; and e) the title, date, author or source, and content of an: written material received. from who it was Set forth with respect to each time you claim to have beer exposed to herbicides: a) the date of the alleged herbicide exposure; b) the time of day of the alleged exposure; -9 - I*,w,£#■» ■¿v <3 c) the closest geographical or political reference point (e.g., hill, to w n , l a n d i n g zone) to the p l a c e yot believe you were exposed; d) a d e s c r i p t i o n of the t e r r a i n at the p l a c e of allégée exposure; e) a d e s c r i p t i o n of h o w t h e h e r b i c i d e w a s be i n g a p p l i e d (e.g., h e l i c o p t e r , a i r c r a f t , hand, f) a description of your activities at the time of allégée exposure; g) the manner you believe your body was physically exposec to the h e r b i c i d e (e.g.. s k i n contact, i n h a l a t i o n , i n ­ g e s t i o n or s w a l l o w i n g ) , and, if you b e l i e v e you were exposed by contact on your skin, identify the areas o: skin that came in contact with the herbicide; h) the n a m e and rank of o t h e r p e o p l e p r e s e n t at the tim< of alleged exposure; and i) w i t h r e s pe ct to an y d e c e a s e d p r o p o s e d r ep re se n ta ti v e plaintiff, state how such plaintiff will demonstrate any of the information requested in subparts a) throug] h) of this interrogatory, identifying any persons wit: s u c h i n f o r m a t i o n w h o w i l l t e s t i f y as to s u c h p l a i n ­ tiff's exposure to herbicides. ONLY IF YOU CONTEND THAT ANY OF YOUR CHILDREN HAS A BIRTH DEFEC'. C A U S E D B Y Y O U R E X P O S U R E TO A G E N T ORANGE, 2,4-D, 2,4,5-T, DIOXIr OR SOME COMBINATION THEREOF, A N S W E R THE FOLLOWING INTERROGATO­ RIES. 22. I d e n t i f y the c h i l d r e n th a t y o u have fathe re d, inclu di ng n a m e , dat e and p l a c e of b i r t h of each such child, a nd the n a m e and address of each child's mother. 23. Identify each of your children w h o m you contend has birth o: genetic defects allegedly caused by your exposure to Agent Orange, 2,4-D, 2,4,5-T, dioxin or some combination thereof and identify; a) th e b i r t h or g e n e t i c d e f e c t s w h i c h y o u c o n t e n d we re c a u s e d by y o u r e x p o s u r e to A g e n t Ora ng e, 2,4-D, 2,4,5T, dioxin, or s o m e c o m b i n a t i o n th er eo f, and s t a t e the b a s i s for y o u r b e l i e f , i n c l u d i n g o p i n i o n s of anj physicians; b) any other birth or genetic defects which the child has; -1 0 - ¿Vi * 4 ii C 24. 25. 26. c) each medical practitioner and medical institution seen or v i s i t e d by th e c h i l d or in w h i c h the c h i l d wa s c o n f i n e d for p u r p o s e s of c o n s u l t a t i o n , di a gn os i s, p r o g n o s i s , t r e a t m e n t or other care, an d the dates, p u r p o s e s and r e s u l t s of such c o n s u l a t i o n , di a gn os i s, prognosis, treatment or other care; and d) the identity of the mother of each child. I d e n t i f y each and e v e r y c h i l d of each m o t h e r i d e n t i f i e d in response to Interrogatory 22 and state as to each: a) the child's na m e , a d d r e s s , date of b i r t h and p l a c e of birth, i n c l u d i n g the n a m e and a d d r e s s of the h o s p i t a l or other place where delivery occurred? and b) the physician(s) w h o tre a t e d the pregnancy and/or delivered the child. mother during W i t h respect to each mother identified in response to Inter­ r o g a t o r y 23(d), i d e n t i f y her brothers, sister s, p ar e nt s, g r a n d p a r e n t s , aunts, unc le s, cousins, niec es , n e p h e w s , and grandchildren, and: a) if any of t h e m are de c e a s e d , state his or her age at the t i m e of d e a t h an d the time, place, and c a u s e of death; b) identify each illness, disease, disability, or medical c o n d i t i o n ever had by ea c h du ring his or her l i f e t i m e whic h required professional medical attention; c) identify each medical practitioner and medical institu­ tion that treated them, and set forth the diagnosis of each, stating the same as to each relative. W i t h respect to each pregnancy, for each mother in response to Interrogatory 23(d), state: identified a) w h e t h e r the m o t h e r w a s e x p o s e d to or c o n t r a c t e d any vi r a l or b a c t e r i a l i n f e c t i o n or d i s e a s e d u r i n g or s h o r t l y b e f o r e the p r e g n a n c y fe.a.. G e r m a n m e a s l e s , flu, £i£.) a n d if so, i d e n t i f y t h e i n f e c t i o n or illness, the p e r i o d d u r i n g w h i c h it oc cu rr e d, a nd any medication or treatment given therefor; b) whether the mother incurred any injury during pregnan­ cy, and, if so, d e s c r i b e the injury, the t r e a t m e n t -îi- V F* & Ó r\ âfe » © y received, any examining or treating physicians, institutions at w h i c h treatment occurred; and any c) w h e t h e r the m o t h e r or f a t h e r ever h a d any v e n e r e a l di se a se , and, if so, d e s c r i b e the d i s e a s e , the t r e a t ­ m e n t received, an y e x a m i n i n g or t r e a t i n g p h y s i c i a n s , and any institutions at wh ic h treatment occurred; d) whether diagnostic procedures, including, but not limited to, abdominal x-ray or pelvimetry, amniocentesis, and/or ultrasound were used, and, if so, set f o r t h the d a t e of the p r o c e d u r e , d e s c r i b e the procedure, the examining or treating physician and any institutions at w h i c h the procedure occurred; and e) w h e t h e r any m e d i c a l p r o b l e m s or c o m p l i c a t i o n s a r o s e d u r i n g p r e g n a n c y (e.g.. t o x e m i a ) , and, if so, d e s c r i b e t h e p r o b l e m s or c o m p l i c a t i o n s a n d t h e t r e a t m e n t received. 27. An sw er Interrogatories 6, 7, 12, 14, 15, and 16 with respect to ea ch m o t h e r i d e n t i f i e d in r e s p o n s e to I n t e r r o g a t o r y 23(d). 28. For ea c h m o t h e r i d e n t i f i e d in r e s p o n s e to I n t e r r o g a t o r y 22 identify each and every pregnancy not resulting in a live birth, and state with respect to each: a) w h e t h e r there was a mi s c a r r i a g e and/or spontaneous a b o rt io n , and, if so, s t a t e the date a nd d e s c r i b e the reason for the miscarriage and/or spontaneous abortion and identify any examining or treating physicians, and any institutions at whi ch it occurred; b) if the r e s p o n s e to a) a b o v e is a f f i r m a t i v e , state w h e t h e r you c ontend that such m i s c a r r i a g e and s p o n t a n e o u s a b o r t i o n w a s c a u s e d by y o u r e x p o s u r e to Agent Orange, 2,4-D, 2,4,5-T, dioxin, or some combination thereof; c) whether there was a .voluntary or therapeutic abortion, and, if so, s t a t e the d a t e and d e s c r i b e the reaso n for the voluntary or therapeutic abortion, and identify any examining or treating physicians, and any institutions at whic h the abortion occurred; and d) if the r e s p o n s e to c) a b o v e is a f f i r m a t i v e , s ta te whether you contend that such voluntary or therapeutic abortion was caused or necessitated by your exposure to Agent Orange, tion thereof. Dated: 2,4-D, 2,4,5-T, dioxin, or some combina New York, New York December 23, 1983 CADWALADER, WICKERSHAM & TAFT * • «» w v « w j ■» •> v * v ^ w • «• Diamond Shamrock Chemicals Company One W all Street New York, New York 10005 (212) 908-7000 TOWNLEY & UPDIKE Attorneys for Defendant Monsanto Company 405 Lexington Avenue New York,. New York 10174 (212) 682-4567 RIVKIN, LEFF, SHERMAN & RADLER Attorneys for Defendant The Dow Chemical Company 100 Garden City Plaza Garden City, New York 11530 (516) 746-7500 CLARK, GAGLIARDI & MILLER Attorneys for Defendant T H Agriculture & Nutrition Company, Inc. The Inns of Court 99 Court Street White Plains, New York 10601 (914) 946-8900 -13- ARTHUR, DRY & KALISH Attorneys for Defendant Uniroyal, Inc. 1230 Avenue of the Americas New York, New York 10020 (212) 841-9300 BUDD, LARNER, KENT, GROSS, PICILLO & ROSENBAUM Attorneys for Defendant Thompson Chemicals Company 33 Washington Street Newark, New Jersey (201) 622-7400 -14- 12763 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK __ ___________ ____ — In r e ________ _ _ _ ____ "AGENT ORANGE" Product L ia b ility : L itig a tio n : MDL N o . 381 ANSWERS OF DAVID GENE LAMBIOTTE TO DEFENDANT'S INTERROGATORIES TO PROPOSED REPRESENTATIVE P L A I N T I F F S P L A I N T I F F ' S MANAGEMENT COMMITTEE P h i l l i p E. Brown, Esq. H o b e r g , F i n g e r , B r o w n , Cox it Mol 1 i g a n 7 0 3 M arket S t r e e t (1 8 th F lo o r ) San F r a n c i s c o , C a l i f o r n i a 94103 T h o m a s W. H e n d e r s o n , E s q . B a s k i n it S e a r s F r ic k B u ild in g (10th F I .) P i t t s b u r g h , PA . 15219 S t a n l e y M. C h e s l e y , E s q . W aite, S ch n eid er, B a y le ss and C h e s l e y Co. L . P . A . 1 5 1 3 C e n t r a l T r u s t Tower F o u r t h and V i n e S t r e e t s C i n c i n n a t i , O hio 45202 B en ton M u s s e lw h it e , Esq. John 0 . O 'Q u in n , E sq. 6 0 9 F ann in ( S u i t e 517) H ouston, T exas 77002 D avid J . Dean, E sq . D e a n , F a l a n g a it R o s e One O ld C o u n t r y Road C a r l e P l a c e , New Y o r k S te p h e n J. S c h l e g e l , Esq. S c h l e g e l it T r a - f e l e t , L t d . One N o r t h L a S a l l e S t r e e t S u ite 3900 C h icago, I l l i n o i s 60602 11514 N e w t o n B. S c h w a r t z , E s q . H o u s to n Bar C e n t e r B u i l d i n g 7 2 3 M ain ( S u i t e 3 2 5 ) H ouston, Texas 77002 Gene L o c k s , E sq . N e il P e ter so n Esq. G r e i t z e r Sc L o c k s , E s q s . 1 5 0 0 W alnut S t r e e t P h i l a d e l p h i a , PA 19102 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK In re "AGENT ORANGE" M D L No. __________ GENERAL I. 1. 381 S t a t e your name, s o c i a l s e c u r i t y num ber, m i l i t a r y s e r v i c e number, and each a d d r e s s a t w h ich you h a v e e v e r liv ed (e x c lu d in g tim e d u rin g a c t i v e m ilit a r y s e r v i c e ) , s t a r t in g w ith your c u r r en t a d d r e ss, and g i v e t h e d a t e s you liv ed at each ad d ress. D a v id Gene L a m b i o t t e 223-68-8395 4 4 W e s to v e r Road N ew port News, V i r g i n i a 1983 , 551 Logan P l a c e Newport N e w s,' V i r g i ni a 1980-1983 Y o rk , M aine 1978-1980 220 P a ïen Ave. N ew port News, V i r g i n i a 1975 304 H u rley Ave. N ew p ort News, V i r g i n i a 1974 R iver D rive A partm ents N ew p ort News, V i r g i n i a 1973 4 4 W e s to v e r Road N ew p ort News, V i r g i n i a 1947-1969 2. Id en tify each e d u c a t io n a l i n s t i t u t i o n you atten d ed , the dates of your a tte n d a n c e , and d e s c r i b e a n y p h y s i c a l or m ental e x a m in a tio n you r e c e iv e d a t or in c o n n e c tio n w ith your a tten d a n ce a t each i n s t i t u t i o n , s t a t i n g w ith r e sp e c t t o each such e x a m in a tio n . a) b) . c) the date of the ex a m in a tio n ; th e h o sp ita l or was g i v e n ; and in stitu tio n the name a n d a d d r e s s exam in ation . of where the person such ex a m in a tio n con d u ctin g the ■ a d escrip tio n ( e .g ., shape, d) the date e) the m ethod of f ) the p la ce it 9> the frequ en cy h) w h eth er you e x p e r ie n c e d any a d v e r s e r e a c t io n compound an d , i f s o , d e s c r i b e t h e r e a c t i o n . f of of the c o lo r , co n ta in er m ark in gs) for the chem ical use; a p p lica tio n ; was of a p p lied ; a p p lication ; and to the 16. Y es. P l a i n t i f f has used i n s e c t i c i d e s t o co n tro l f l i e s , f l e a s , e t c . A partm ent c o m p le x e s u s e i n s e c t i c i d e s to c o n tr o l i n s e c t s how ever, p l a i n t i f f i s n ot aware of neme brands of the products they used. P la in tiff ord in ary store b r a n d p o w d er f o r f l e a s and s p r a y for w ith no r e a c t i o n from su ch u s e . VI. 17. S tate w ith respect MILITARY SERVICE to your m ilita ry the armed serv ice: a) th e branch served; b) the in clu siv e dates of your c) the in c lu s iv e Vi e t n a m ; dates of serv ice d) t h e name o f e a c h m i l i t a r y u n i t t D w h ic h you were a s s ig n e d w h ile se r v in g in or near V ietn am ; and t h e d a t e s d u r in g w h ic h you were a s s ig n e d t o each such u n it s ; e) t h e name and l o c a t i o n o f e a c h p l a c e o r a r e a a t w h ich you w ere p h y s i c a l l y p r e s e n t in or n e a r V ie tn a m and t h e d a t e s d u r i n g w h ic h you were p r e s e n t a t each such p la c e or area; f ) your im m ed iate s u p e r io r o f f i c e r ' s w h i l e i n o r n e a r V ie tn a m ; and 9> the type of of ants, a lso the used ants d isch arge serv ices in w h ich you serv ice; in or near name and ra n k you r e c e i v e d . -jr L- . i '± 18. 17 a. Army b. December 1966 c. May - 1967 d. S ta tio n ed e. d eliv erin g f. P la in tiff d e liv e r ed g. H on orab le. - A p ril on Septem ber 1968. 1968. Cam Rahn su p p lies to Bay and vari ous went wi t h areas on the names of d o e s n o t remember a n y s p e c i f i c t h e s u p p l i e s and l e f t . convoys m ain i and. p la ces, W ith respect t o each i l l n e s s , in ju ry , wou nd o r other m ed ical or p s y c h o lo g ic a l c o n d itio n ex p erien ced by you d u r in g y o u r m i l i t a r y s e r v i c e in o r n e a r V ietnam , s t a t e : a) th e d a te of your o th e r m ed ic a l or i l l n e s s , i n j u r y , wound, or p sy c h o lo g ic a l co n d itio n ; b) a d escrip tio n o th e r m ed ical a d escrip tio n c) t h e c a u s e o-f t h e i l l n e s s , i n j u r y , w o u n d , m ed ical or p s y c h o lo g ic a l c o n d i t i o n ; d> t h e n a m e a n d r a n k o-f t h e p e r s o n t o whom y o u - f i r s t r e p o r t e d t h e i l l n e s s , i n j u r y , wound, or o t h e r m e d ic a l or p s y c h o lo g ic a l c o n d itio n ( i f anyone): e) th e d a te t h a t you f i r s t r e p o r te d wound, or o th e r p s y c h o lo g ic a l' or f) t h e nam e, ran k and l o c a t i o n o f e a c h p h y s i c i a n or o t h e r h e a l t h c a r e p r o f e s s i o n a l who t r e a t e d y o u r i l l n e s s , i n j u r y , wound, o r o t h e r p s y c h o l o g i c a l o r m e d i c a l c o n d i t i o n , i n c l u d i n g t h e d a t e s and p l a c e s o f t r e a t m e n t , and a d e s c r i p t i o n o f t h e t r e a t m e n t y o u r e c e i v e d ; and g> t h e name and l o c a t i o n o f e a c h h o s p i t a l or o t h e r h e a l t h c a r e f a c i l i t y w h ich t r e a t e d your p s y c h o lo ­ g i c a l or m ed ical c o n d i t i o n , t h e d a t e s of tr e a tm e n t, and a d e s c r i p t i o n o f t h e t r e a t m e n t t h a t you r e c e i v e d . o-f t h e i l l n e s s , i n j u r y , w o u n d , o r or p s y c h o lo g ic a l c o n d itio n , in c lu d in g o-f a l l s y m p t o m s ; or other the illn e s s , in ju ry , m ed ical c o n d i t i o n ; •?) r* V* 11 he IB. The o n l y i n j u r y p l a i n t i f f r e c i e v e d was i n t h e w a r e h o u se w here he was w ork in g. P l a i n t i - f f was s i t t i n g a t a d e sk d o in g p a p e r w ork when a l i e u t e n a n t who had n o t b e e n c l e a r e d t o do so began to u se a -fo rk lift,, h e l o s t c o n t r o l o f i t and the fo rk lift pinned p la in tiff to the w all and in ju red p l a i n t i f f ' s s h i n from w h ich p l a i n t i f f h a s a s c a r . 19. D escrib e an y o t h e r m e d i c a t i o n t a k e n by you d u rin g your m i l i t a r y s e r v i c e ( e . g . , D apsone, C h loroq u in e, P rim aq u in e, B in o c ta l), s ta tin g as to each: a) the b) brand name o r g en eric name o f the m ed ica tio n ; t h e form o f t h e m e d ic a t io n in jectio n , e tc .); (e .g ., p ill, c) the co lo r, taken; of d) the e) t h e name and ra n k o f you th e m ed ic a tio n ; f > the dates g> the and amount h) w hether you e x p e r ie n c e d any a d v e r se m e d ic a tio n and, i f s o , d e s c r i b e th e / shape, reasons for and sir e ta k in g the you to o k of the the the any p i l l ca p su le, or cap su le m ed ication ; p erson (s) who g a v e m ed ica tio n ; m ed ica tio n taken (e .g ., p ills/d a y ); rea ctio n to rea ctio n . 19. The o n l y m e d i c a t i o n p l a i n t i f f had was f o r p l a i n t i f f d o e s n o t r e c a l l what m e d ic in e i t was. 20. the a headache, S tate w hether you ever receiv ed any tra in in g , in stru ctio n s, w arn in gs o r h e a l t h and s a f e t y i n f o r m a t i o n c o n cern in g h e r b ic id e s d u rin g your m ilit a r y serv ice, and i d e n t i f y as t o each: a) the dates you r e c e iv e d b) the lo ca tio n c) the name and r a n k the foregoin g; where r e c e iv e d ; of the 12 person (s) fro m who r: ry _L<4 i ( O it was received; d> the and e) th e t i t l e , d a te , author o-f a n y w r i t t e n m a t e r i a l 20. 21. Set been substance of any oral in-form ation or s o u r c e , receiv ed . receiv ed ; and c o n t e n t No. -forth w ith r e s p e c t t o exposed to h e r b ic ie s : each tim e you c la i m h erb icid e exposure; to have a) the date o-f t h e a lleg ed b) the tim e of of c) th e c l o s e s t g e o g r a p h ica l or p o l i t i c a l r e fe r e n c e p o in t ( e . g . , h i l l , tow n, la n d in g zone) t o th e p l a c e you b e l i e v e you w ere ex p o sed ; d) a d escrip tio n exposure; e) a d e s c r i p t i o n o f how t h e h e r b i c i d e was b e i n g a p p lie d ( e . g . , h e l i c o p t e r , a i r c r a f t , hand, e t c . ) ; f) a d e s c r ip tio n of your a lle g e d exposure; g) t h e manner you b e l i e v e y o u r b od y was p h y s i c a l l y exposed to th e h e r b ic id e ( e .g ., sk in c o n ta c t, in h a l a t i o n , i n g e s t i o n or s w a llo w in g ), and, i f you b e l i e v e you w e r e e x p o s e d by c o n t a c t on y o u r s k i n , i d e n t i f y t h e a r e a s o f s k i n t h a t came i n c o n ta c t w ith th e h e r b ic id e ; h) t h e name and r a n k o f o t h e r p e o p l e t i m e o f a l l e g e d e x p o s u r e ; and i) w ith r e s p e c t t o any d e c e a se d proposed r e p r e ­ s e n t a t i v e p l a i n t i f f , s t a t e how s u c h p l a i n t i f f w ill dem onstrate any o f th e in form ation r e q u e s t e d i n s u b p a r t s a) t h r o u g h h ) o f t h i s in t e r r o g a t o r y , i d e n t i f y i n g any p e r so n s w ith such i n f o r m a t i o n who w i l l t e s t i f y a s t o s u c h p l a i n t i f f ' s exposure to h e r b icid e s. day of the the a lleg ed terra in exposure; at the a ctiv ities at p lace the of tim e present at a lleg ed of the L&'£ i'( 21. Cam R a h n w a s d e f o l i a t e d , p l a i n t i f f l i v e d the so il th ere, a l s o t h e a r e a s on t h e m a in la n d Cam R ah n w e r e d e f o l i a t e d and t h e c o n v o y s w ent t h e n o r th and t o t h e s o u t h , so m etim es o v e r n ig h t and worked in across -from to areas to runs. ONLY I F YOU CONTEND THAT ANY OF YOUR CHILDREN HAS A BIRTH DEFECT CAUSED BY YOUR EXPOSURE TO AGENT ORANGE, 2 ,4 -D , 2 ,4 ,5 -T , DI O XI N OR SOME COMBINATION THEREOF, ANSWER THE FOLLOWING INTERROGATORIES. Id en tify t h e c h i l d r e n t h a t you have f a t h e r e d , in clu d in g nam e, d a t e and p l a c e o f b i r t h o f e a c h s u c h c h i l d , and t h e name and a d d r e s s o f e a c h c h i l d ' s m o t h e r . 2 2 . Not a p p lica b le. I d e n t i f y e a c h o f y o u r c h i l d r e n whom y o u c o n t e n d h a s b i r t h or g e n e t i c d e f e c t s a l l e g e d l y c a u se d by your e x p o s u r e to Agent O range, 2 .4 -D , 2 ,4 ,5 -T , d io x in or some other c o m b i n a t i o n t h e r e o f , and i d e n t i f y : a) t h e b i r t h or g e n e t i c d e f e c t s w h ich you c o n te n d were ca u sed by your e x p o su r e t o Agent O range, 2 ,4 -D , 2 , 4 , 5 - T , d i o x i n , o r som e c o m b i n a t i o n t h e r e o f , and s t a t e th e b a s i s fo r your b e l i e f , in c lu d in g o p in io n s o f any p h y s i c ia n s ; b) any o th er has; c) e a c h m e d i c a l p r a c t i t i o n e r and m e d i c a l i n s t i t u t i o n s e e n or v i s i t e d by t h e c h i l d or in w h ich t h e c h i l d was c o n f in e d f o r p u r p o se s o f c o n s u l t a t i o n , d i a g n o s i s , p r o g n o s i s , t r e a t m e n t o r o t h e r c a r e , and t h e d a t e s , p u r p o s e s and r e s u l t s o f su c h c o n s u l t a t i o n , d i a g n o s i s , p r o g n o s i s , t r e a t m e n t o r o t h e r c a r e ; and d) the 2 3 . Not b irth id en tity of a p p lica b le. or the gen etic m other d efects of each w h ich ch ild . the ch ild 24. Id en tify each in r e sp o n s e t o and e v e r y c h i l d o f e a c h m o th er id en tified I n t e r r o g a t o r y 2 2 and s t a t e a s t o e a c h : a) t h e c h i l d ' s name, a d d r e s s , d a t e o f b i r t h and p l a c e o f b i r t h , i n c l u d i n g t h e name and a d d r e s s o f t h e h o s p i t a l o r o t h e r p l a c e w h er e d e l i v e r y o c c u r r e d ; and b) th e p h y sicia n (s) pregnancy and/or 2 4 . Not who t r e a t e d t h e m o t h e r d e liv e r e d the c h ild . du rin g a p p lica b le. W ith respect t o each m other i d e n t i f i e d in respcn& ft- t o Interrogatory 23(d), id en tify her brothers, siste rs, parents, grandparents, aunts, u n cles, co u sin s, n ie c e s , n e p h e w s , and g r a n d c h i d r e n , and: 1 a) i f any o f them a r e age at t h e tim e of c a u se of death; b) id en tify each illn e ss, d isea se, d isa b ility , m e d ic a l c o n d i t i o n e v e r had by e a c h d u r i n g h i s o r h e r l i f e t i m e w hich r e q u i r e d p r o f e s s i o n a l m e d ic a l a tten tio n ; c) i d e n t i f y e a c h m e d ic a l p r a c t i t i o n e r and m e d ic a l in stitu tio n that t r e a t e d them , and s e t forth d i a g n o s i s o f e a c h , s t a t i n g t h e same a s t o ea ch r e la tiv e. 2 5 . Not 26. deceased, s ta te h is d e a t h and t h e t i m e , or her p l a c e and or the a p p lica b le. W ith respect to each id e n tif ie d in response to pregnancy, for each m other Interrogatory 23(d ), sta te : a) w h eth e r t h e m other was e x p o s e d t o or c o n t r a c t e d a n y v i r a l or b a c t e r i a l i n f e c t i o n or d i s e a s e d u r in g or s h o r t l y b e f o r e t h e p r e g n a n c y ( e . g . , G erm an m e a s l e s , f l u , e t c . ) and i f s o , i d e n t i f y t h e i n f e c t i o n o r i l l n e s s , t h e p e r io d d u r in g w h ich i t o c c u r r e d , and any m ed ic a tio n or trea tm en t g iv e n t h e r e f o r ; b) w hether the m other incurred any i n j u r y durin g ■l.?7 73 pregnancy, and, i f so , d e s c r ib e th e in ju r y , th e t r e a t m e n t r e c e i v e d , any ex a m in in g or t r e a t i n g p h y s i c i a n s , and any i n s t i t u t i o n s a t w h ich t r e a t ­ m ent o c c u r r e d ; c) w h e th e r t h e m other or f a t h e r e v e r had any v e n e r a i d is e a s e , and, i f so , d e s c r ib e th e d is e a s e , th e t r e a t m e n t r e c e i v e d , any e x a m in in g or t r e a t i n g p h y s i c i a n s , and any i n s t i t u t i o n s a t w h ich treatm ent occurred; d) w hether d ia g n o s tic p ro ced u res, in c lu d in g , but not l i m i t e d t o , abdom inal x - r a y s or p e l v im e t r y , a m n io c e n t e s is , and/or u ltr a s o u n d were u sed , and, i f so, s e t fo r th the date of the procedure, d esc rib e t h e p r o c e d u r e , th e ex am in in g or t r e a t i n g p h y s ic ia n and a n y i n s t i t u t i o n s a t w h ich t h e p r o c e d u r e o c c u r r e d ; and e) w h eth er any m ed ical p rob lem s or c o m p lic a t io n s a r o s e d u r in g p reg n a n cy ( e . g . , t o x e m ia ) , and, i f s o , d e s c r i b e t h e p r o b le m s o r c o m p l i c a t i o n s and t h e treatm ent receiv ed . 26. 27. a p p lica b le. 6 Answer I n t e r r o g a t o r i e s , respect to each m other Interrogatory 23(d ). 27. 28. Not Not 7, 12, 14, id en tified 15, and 16 w it h in response to a p p lica b le. For e a c h m other i d e n t i f i e d in r e s p o n s e t o Interrogatory i d e n t i f y e a c h and e v e r y p r e g n a n c y n o t r e s u l t i n g i n a l i v e b i r t h , and s t a t e w it h r e s p e c t t o e a c h : 22 a) w h e th e r t h e r e was a m i s c a r r i a g e a n d /o r sp on tan eou s a b o r tio n , and, i f s o , s t a t e th e d a t e and d e s c r i b e t h e r e a s o n f o r t h e m i s c a r r i a g e a n d /o r s p o n t a n e o u s a b o r t i o n and i d e n t i f y any exam in in g or t r e a t i n g p h y s i c ia n s , and any i n s t i t u t i o n s a t w h ich i t o c c u r r e d ; b) i f t h e r e s p o n s e t o a) above i s a f f i r m a t i v e , s t a t e w h e th e r you c o n te n d t h a t su ch m i s c a r r i a g e and s p o n t a n e o u s a b o r t io n was c a u s e d by your e x p o s u r e 16 t o Agent O range, 2 ,4 - D , com b in ation th e r e o f ; 2 ,4 ,5 -T , d io x in , or some c) w h eth e r t h e r e was a v o l u n t a r y or t h e r a p e u t i c a b o r t i o n , a n d , i f s o , s t a t e t h e d a t e and d e s c r i b e t h e r e a s o n -fo r t h e v o l u n t a r y o r t h e r a p e u t i c a b o r t i o n , and i d e n t i f y a n y e x a m in in g or t r e a t i n g p h y s i c i a n s , and a n y i n s t i t u t i o n s a t w h ich t h e a b o r t i o n o c c u r r e d ; and d) i f th e r e sp o n se to c) above i s a f fir m a t iv e , s t a t e w hether 'you contend that such volu n tary or t h e r a p e u t i c a b o r t io n was c a u se d or n e c e s s i t a t e d by your e x p o su re t o Agent O range, 2 ,4 -D , 2 ,4 ,5 - T , d i o x i n , or som e c o m b in a t io n t h e r e o f , 28. Dated: Not a p p lica b le. Carle Place, N e w York January 14, 1984 PLAINTIFFS' MANAGEMENT COMMITTEE DAVID J. DEAN, ESQ. DEAN, FALANGA & ROSE, ESQS. One Old Cou n t r y Road Carle Place, N e w York 1151 (516) 248-9888 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK In re "AGENT ORANGE" Product Liability Litigation : MDL No. 381 ANSWERS OF DANNY GENE JORDAN TO DEFENDANT’S INTERROGATORIES TO PROPOSED REPRESENTATIVE PLAINTIFFS PLAINTIFF’S MANAGEMENT COMMITTEE: Phillip E. Brown, Esq. Hoberg, Finger, Brown, Cox S< Mol 1igan 703 Market Street (13th Floor) San Francisco, California 94103 Thomas W. Henderson, Esq. Baskin ?•< Sears Frick Building (10th FI.) Pittsburgh, PA. 15219 Stanley M. Chesiey, Esq. Waite, Schneider. Bayless and Chesiey Co. L.P.A. 1513 Central Trust Tower Fourth and Vine Streets Cincinnati, Ohio 45202 Benton Mussel white, Esq. John 0. 0 ’Quinn, Esq. ¿09 Fannin (Suite 517) Houston, Tex as 77002 David J. Dean, Esq. Dean, F a 1ang a ?< Rose One Old Country Road Carle Place, New York Stephen J. Schlegel, Esq. Schlegel S< Trafelet, Ltd. One North LaSalle Street Suite 3900 Chicago, Illinois 60602 11514 Newton B. Schwartz, Esq. Houston Bar Center Building 723 Main (Suite 325) Houston, Texas 77002 Gene Locks, Esq. Neil Peterson Esq. Greitzer 2< Locks, Esqs. 1500 Walnut Street Philadelphia, PA 19102 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK In re "AGENT ORANGE" M D L No. 381 Product Liability Litigation I. 1. GENERAL State your name, social security number, military service number, and each address at which you have ever lived (excluding time during active military service), starting with your current address, and give the dates you lived at each address. Danny Gene Jordan SSN 443-70-2511 MSN US54665959 7212 Sir Gawain, Austin, Texas 321 William Cannon, Austin, Texas 6049A Karen Circle, Fort Worth, Texas 1204 Scotland, Azle, Texas 3809 Delaware, Fort Worth, Texas 6215 Lloydhill, Fort Worth, Texas SpringbrooK, Fort Worth, Texas 215 Folk Street, Mangum, Oklahoma 404 Alpha, Mangum, Oklahoma U.S. Army Georgia Street, Mangum, Oklahoma Lincoln Street, Mangum, Oklahoma 1705 1/2 E. Broad, Lake Charles, LA Gueydan, Louisiana 1705 1/2 E. Broad, Lake Charles, La Big Lake. Texas Glendive, Montana Newtown, North Dakota Dickinson, North Dakota Bismarck, North Dakota Mi note, nORTH Dakota Chickasota, Oklahoma Mangum, Oklahoma 1/80 to present 8/78 to 1/B0 6/75 to 8/78 1/75 to 6/75 4/73 to 1/75 9/72 to 4/73 5/71 to 9/72 1/70 to 5/71 . 2/69 to 1 /70 6/67 to 2/69 11 /65 to 6/67 8/65 to 11/65 9/60 to 8/65 9/59 to 1/60 5/57 to 9/59 1/57 to 5/57 5/55 to 1/57 10/54 to 5/55 8/54 to 10/54 5/54 to 8/54 1/54 to 5/54 12/53 to 1/54 9/53 to 12/53 Identify each educational institution you attended, the dates of your attendance, and describe any physical or mental examination you received at or in connection with your attendance at each institution, stating with respect to each such examination. a) the date of the examination; b) the hospital or institution where was given; and c) the name and address of the person conducting ex ami nati on. University of Texas. Auston, Texas No physical or mental exam given such examination the 9/78 to 12/78 lexas Wesleyan university. Fort Worth, TX No physical or mental exam required / w> U> r\ W «■- / *7 A Altus Jr. College, Altus, Oklahoma Physical by Dr. Pierson a description of the medical condition in connection with which the action was filed, and how you believe that medical condition occurred; c> a description of the outcome of the action, or of its present status if it is still pending; and d) the dates and amounts of any payments, either as a result of a judgment or settlement, which you have received or which you are scheduled to receive. See answer to 4-A. II. 6. Identi-fy employed No lawsuit actually -filed. EMPLOYMENT HISTORY and describe each job you have held, whether by others or self-employed, and state as to each: aT1 the name and address of your employer, the address of your workplace, the nature of the business and your job title; b> your duties and responsibilities; c) the date the job began and ended and the reasons for termination of the job; and d) the date and place of each physical and mental examination that you underwent in connection with such job, identifying the name and address of each medical practitioner conducting the examination and the name and address of any medical institution at which such examinations was conducted. A. Part-time janitor employed by others Central Elementary School, Lake Charles, La. Helping sweep and mop cafeteria in exchange for free lunches. during school terms from 1957 to 1960 graduated to high school unknown. B. Newspaper Delivery Boy - employed by others ^ 30 Lake Charles American Press Daily Newspaper Del ivery Boy 4 Delivery o-f papers 7 days a week, collections, etc. Fall 1957 to 1959 - moved Unknown C. School Student Aide - employed by others St. Josephs Catholic School Gueydan, Louisiana Cleaning classrooms and mowing church grounds 10/59 to 5/61 - moved away Unknown D. Summer jobs in High School - construction worker employed by others Richard Construction Co., Lake Charles, La.; residential and commercial construction; part-time 1abcrer 'job site cleanup Summers o-f 1963 and 1964; returned to school N/A E. Seismograph Worker - employed by others Western Drilling Co.; Oil Exploration Big Lake, Texas; Jug Lineman Laying seismophones along blast sites and driving water truck. Summer of 1961; returned to school Unknown F. Seismograph Driller's Helper - Employed by others Fhillips Petroleum Co. Bart1esvi11e, Oklahoma; hermi t , Texas and Jal, New Mexico; Petrikeyn Ex loration, Driller's helper To help the driller in punching test holes for seismic exploration. Summer of 1962; returned to school Unknown G. Fast Food Worker - employed by others Slick’s Drive-In, Mangum, Oklahoma Slick Avery property Soda fountain and short order cook July 1965 to October 1965; better job N/A H. Grocery Employee - employed by others United Supermarket, Mangum, Oklahoma Wade Ridley, Manager, Grocery Sales, Clerk Checking, stocking, sacking, ordering and building sales displays. ^ ¿Of October, 1969 to June, 1967; Drafted into army Unknown I. Police O-f-ficer - employed by others City of Mangum, Oklahoma; Mangum Police Station. Law Enforcement; patrolman Car patrol; enforcement of the law June, 1969 to August, 1969; enrolled in college Unknown J. Work study employee - employed by others Altus Jr. College, Altus, Oklahoma, education,' student aide Helping in computer lab grading papers, etc. During school sessions from 1969 to May, 1971; Graduated N/A K. Laborer, summer - employed by others City of Mangum, Oklahoma Street Department Road and street maintenance; laborer Drove dump trucks and ran tractors with mowers on City right-of-way. Part-time Fall 1969 to Spring, 1970; Fall, 1971; moved Unknown L. Gas Station Attendant - employed by others Bill's Shamrock Station, Mangum, Oklahoma; service station; Bill Van Vacter, Owner; cashier attendant Pumping gas, repairing flats, etc. February, 1971 to May 1971; moved No exam M. Retail sales - employed by others k>Mart Sporting Goods, Fort Worth, Texas Bruce Watson District Manager, Stockboy, Assistant Manager and Manager Buying, selling, merchandising sporting goods; hiring, and firing personnel; accounting, inventory, etc. September, 1971, to June, 1974; resigned Unknown N. Retail Grocery; employed by others Safeway Grocery Co. , Lake Worth, Texas Groceries; night Stocker Ordering and restocking grocery supply September, 1974, to October, 1974; better job Unknown P. Warehouse and delivery; employed by others Moody Printing Company, Main Street, Fort Worth, Texas; Ed Moody prop.; warehouse man Inventory control paper warehouse -for printing company January - June, 1975; injury, then fired Unknown Q. Convenience Store Clerk; employed by others McClouds Food Stores, Fort Worth, Texas; Manager trainee Stocking, checking in convenience store August-September 1975; health problems Unknown R. Warehouse Work; employed by others Wap 1es/F'l at ter, Inc., Fort Worth, Texas wholesale groceries; order puller Filling orders, loading trucks October - November, 1975; health Unknown 7. With respect to each job identified in response to Interrogatory No. 6, identify each on-the-job injury, medical condition or accident that you experienced, and state separately as to each; a) a description of the injury, medical condition or acci dent; b) the dates of the injury, medical condition or accident; c) the treatment received, including the treating physician's name and address and all hospital­ izations, operations and medication received. See answer to Interrogatory No. 4 supra. yt 7 -fS to. FAMILY MEDICAL HISTORY III. 8. State the names and addresses of your spouse, children, brothers, sisters, parents, grandparents, aunts, uncles, cousins, nieces, nephews and grandchi1dren, and with respect to each: a) if any o-f them are deceased, state his or her age at the time o-f death and the time, place and cause o-f death; b) identify each illness, disease, disability, medical condition ever had by each during his or her lifetime which required professional medical attent ion. c) identify any birth or genetic miscarriages which they had; and d) with respect to each relative, identify each medical practitioner and medical institution that treated them, and set forth the diagnosis. defects or or Spouse - Donna Frances Hukill Jordan 7212 Sir Gawain, Austin, Texas a. Living b. c. d. Normal childhood diseases; none other known Had one spontaneous abortion Obstetricians involved with the birth of two sons: Chad - 09 was Dr. Kingery, but he did not deliver. Dr. Funell delivered baby by Caesarean section at Mercy Hospital in Oklahoma City, Okla. Michael -09 was Dr. Darwin Fielder the baby at All deli vered Hospi tal, Ft. Worth, Texas. who Saints Son - Chad Alan Jordan 7212 Sir Gawain, Austin, Texas a. Li vi ng b. Sronchitis; Various birth defects c. Medical problems involving missing wrist bones, absence of thumb on either hand with an extra digit on the left hand. d. Scottish Rite Hospital for Children, Dr. Aston and l. the date of use; c .< the amount used during each period of use; d) the name and address of the physician, if any, who prescribed the drug; e) a description of reasons for your use of the drug; and f) whether you have ever received any medical treatment or counseling in connection with your use of such drugs. D. Plaintiff is not aware of all drugs taken during childhood, but has listed the following as those taken in his adult life: 1. b. c. d. e. f. a n 12. (Not aware of name) October or November, 1967 Not aware of amount Female Major located at the Ft. Polk army hospital Had double pneumonia with 107 degree temperature No 12 cr t-j n cl -+. ro cr c i n cl ro i> n u No Dexadrene Not aware of dates; seldom used depending upon patrol assignment in 1968 Amount - 2 tabs per day Issued by Army Medic Drug used -for alertness on patrol no Iodine tablets Placed in cantene each time it was -filled 1 tablet Issued by Army Medic Water purification no Vali urn 4X daily 1 tablet; 5 mg. Issued by Dr. Van Zant and Dr. Bernel1 Muscle relaxant yes cl n era) + a n cr u •+> m (Not aware o-f name) Taken 1 time weekly 1 orange tablet Issued by the Army Medic This is an anti-malarial drug no -*111 cl n cr o Dapsone Daily used 1968 1 small tablet Issued by the Army Medic This is an anti-malarial drug no u a n tr \i ■+. (ti a Mari juana Not aware of dates; used approximately fifteen times in a one year period <1968) Joints Not applicable Recreati on e. - Fercodan As needed, probably took 35 tablets over a 6 or 7 month period 1 tablet Issued by Doctors' VanZant and Bernel1 This drug is a pain killer a,.- r\ w 9. Rob a::son b. 4 X daily-for 3 months c. i tablet d. Issued by DrsJ VanZant and Bernell e. Muscle relaxer f . . No 10. El evil b. 1 or 2 tablets daily for 6 or 7 months c. see (b) d. Issued by Drs' VanZant and Bernell e. To aid in giving up the Valium f . No 11. b. c. d. e. f. 13. Antibiotics the date of u 35 Ï e) the method of appii cati on ; f) the place it was appiie d ; 9> the frequency of application; h> whether you e xperienced any adverse reaction to the compound and, if so, describe the reaction. (e.g., powder, liquid, and To his knowledge, he was never exposed to the listed insecticides prior to Vietnam. Since Vietnam, he has used the various foggers (Raid, Holiday) a couple of times in his home. Never directly handled on the job. Knows specifically, he did not use those listed. VI. 17. MILITARY SERVICE State with respect to your military service: a) the branch of the armed services in which you served; Army h 16 the inclusive dates of your service; June 1967 through February 1969 the inclusive dates o-f service in or near Vi etnam; February 1968 through February 1969 the name o-f each military unit to which you were assigned while serving in or near Vietnam; and the dates during which you were assigned to each such units; Delta Company 1/5 First Air Cavalry (February 1968 through October 1968) Echo Company 1/5 First Air Calvary (October 1968 through February 1969) the name and location o-f each place or area at which you were physically present in or near Vietnam and the dates during which you were present at each such place or area; Quang Tri Province (February, 1968 through November 1963) and Tua Thien Province (same dates). I-Ccrps Located at the -following landing zones (L2); Hue, Red Beach, LZ Jane, LZ STud, LZ Wharton, LZ Butcher, khe Sahn VAlley, LZ Peanuts, LZ Barbara, Con Tien, Cua Viet, Dong Ha, A Shau Valley, Lang Vei, and An Khe base camp. These were areas they worked out o-f as base camps. This is not a conclusive list. Also, -from November 1968 through February 1969, with III Corps in Tail Ninh Province and Quan Loi Province. These included the -following areas "Katum Special Forces (SF) camp, Chien Lien (SF); War Zone C & D. the Iron Triangle region, Hobo Wood and Vietnam/Cambodia border. your immediate superior officer's name and rank while in or near Vietnam; and Delta Company - Sgt. E5 John Willis (Platoon Sergeant) Echo Company - Staff Sergeant Timothy Meador (Platoon Sergent) Dan had 6 or 7 different commanding officers, but is unable to remember particular names of each. the type of discharge you received. Honorable rf, Ufe* 1 fy¡J t With respect to each illness, injury, wound or other medical or psychological condition experienced by you during your military service in or near Vietnam, state: a) the date o-f your illness, injury, wound, or other medical or psychological condition; b< a description o-f the illness, injury, wound, or other medical or psychological condition, including a description o-f all symptoms; c) the cause o-f the illness, injury, wound, or other medical or psychological condición; d) the name and rank o-f the person to whom you -first reported the illness, injury, wound, or other medical or psychological condition (if anyone): e) the date that you -first reported the illness, injury, wound, or other psychological or medical condition; -f) the name, rank and location o-f each physician or other health care professional who treated your illness, injury, wound, or other psychological or medical condition, including the dates and places o-f treatment, and a description o-f the treatment you received; and g) the name and location of each hospital or otherhealth care facility which treated your psycholo­ gical or medical condition, the dates of treatment, and a description of the treatment that you received. a. b. c. d. e. f. g. 1967 Pneumonia Does not know Doesn't recall Approximately October or November, 1967 Fort Polk physician Fort Polk Army Base; Does not recall the treatment for this illness due to high temperature. He was delirious but does remember alcohol and ice dips. cr a> IS. November, 1968 (Was nit pulled from field) Shrapnel wound to left shoulder ie 12830 n cl ■*> u ci ii u a n + . ij to cr ii Q. n u + e« er m c. d. e. f. g. 19. Enemy -fire Army company medic November, 1968 Army company medic treated Flaintiff, by giving him a tetanus shot, cleaning wound and using butterfly bandages with field dressing, k'atum Special Forces Camp October, 1968 (Was not pulled from field) Pneumonia, flu like illness Cause unknown, but whole company had it Army company medic October, 1968 Army company medic diagnosed, but they treated for it. LZ Barbara with Echo Company were never July, August of 1968 (taken from field) Heat Stroke Weather conditions Army company medic July or August 1968 Battalion Aid Unit doctored him; He was given a glucose and saline solution (several IVJs of each) LZ Jane with Delta Company April or Hay of 1968 ( Was not pulled from field) Dysentary Not known, but was located in heavily defoliated area at time. The whole company had this for approximately 2 weeks. Army company medic thought it was dysentary, but this was not actually diagnosed. April or Hay 1968 Army company medic Delta Company LZ Jane Describe any other medication taken by you during your military service (e.g., Dapsone, Chloroquine, Primaquine, Binoctal), stating as to each: a) the brand name or generi c name of the medication; b) the form of the medication (e.g., pill, capsule, injection, etc.); c) the color, shape, and size of any pill or capsule taken ; 19 * p ;(\* ■A. VÌVA d) the reasons for taking the medication; e) the name and rank of the person(s) who gave you the medication; f) the dates you took the medication; 9> the amount of the medication taken (e.g and h) whether you experienced any adverse reaction to the medication and, if so, describe the reaction. pills/day); See Question 12 1 through 6 items for the answers to a) through g ). h. The dey.adrene made him nervous and edgy. He also experienced some chest pains. This drug was taken as needed for patrol duty. The iodine which they put in the water for purification purposes seemed to make everyone nauseous. He is not sure if this was due to iodine or the water. State whether you ever received any training, instructions, warnings or health and safety information concerning herbicides during your military service, and identify as to each: a) the dates you received the foregoing; b> the location where received; c) the name and rank of the person(s) from who it was received; d) the substance of any oral information received; and e) the title, date, author or source, and content of any written material received. Plaintiff never received any information concerning herbicides They were told that the planes were spraying the foliage to hinder the enemy. the identity of the mother of each child. Chad Allan Jordan a. Missing thumbs, missing wristbones b. None c. Dr. Senevey, Dr. Aston, Texas Scottish Rite Hospital for Crippled Children in Ft. Worth, Texas. Diagnosis was bilateral terminal radial hemimelia with Bilateral duplication of index fingers and absence of both thumbs. Had various surgeries on May, 1974, July 1975, and June 1976 (list may be inconclusive) d. Donna Frances Hukill Jordan Michael Ryan Jordan a. Missing thumb, club hands, missing wristbones, missing bone in forearm b. None c. Dr. Senevey, Dr. Aston, Texas Scottish Rite Hospital for Crippled Children in Ft. Worth, Texas. Diagnosis was Bilateral radial club hands, Left hand has four digits (absence of left thumb) and short humerus and forearm. Had various surgeries on February 1975, July 1975 and June 1976. Surgeries continuing. d. Donna Frances Hukill Jordan 24. Identify each and every child of each mother identified in response to Interrogatory 22 and state as to each: a) the child's name, address, date of birth and place of birth, including the name and address of the hospital or other place where delivery occurred; and b) the physician(s) who treated the mother during pregnancy and/or delivered the child. Chad Allan Jordan 7212 Sir Gawain Austin, Texas Born January 7, 1971 Mercy Hospital in Oklahoma City, Oklahoma 12805 Mi chael Ryan Jor dan 7212 Sir Gawain Austin, Texas Born November 17, 1972 All Saints Hospital in Fort Worth, Texas b. Dr. Dr. Funel1 delivered Chad, Dr. Fielder delivered Michael Kingery was DB With respect to each mother identified in response to Interrogatory 23(d), identify her brothers, sisters, parents, grandparents, aunts, uncles, cousins, nieces, nephews, and grandchi1dren, and: a) if any of them are deceased, state his or her age at the time of death and the time, place and cause of death; b) identify each illness, disease, disability, medical condition ever had by each during his or her lifetime which required professional medical attenti on; c) identify each medical practitioner and medical institution that treated them, and set forth diagnosis of each, stating the same as to each relati ve. or the Mother - Vada Hukill Mangum, Oklahoma a. Living b. In good health; had chronic bronchitis between 1957 and 1961; Also had one miscarriage in 1954 c. Doctors' names unavailable, but both instances were treated at Gardenia Hospital, Gardenia, California. Father - F. Gerald Hukill Mangum, Oklahoma a. Living b. In good health; did have cyst cut from back (1956) and one cut from thigh (1957); Vitamin B deficiency noted in 1983 c. Doctors' names unavailable, but operations for cysts done ; at Gardenia Hospital, Gardenia, California. Vitamin B definciency noted by Dr. Troung Thach in Mangum, Oklahoma Brother - Jerry Hukill Stillwater, Oklahoma ■ 12806 a. b. c. Living Good health, no other details known Unknown Maternal Uncle - Chester N. Anderson Commerce City, Colorado a. Living b. Disability - has a vascular and circulatory problems in legs c. Unknown Maternal Grandmother - Ada Anderson Mangum, Oklahoma a. Living b. c. Has high blood pressure Dr. Thach in Mangum, Oklahoma Dr. Lenaburg in Mangum, Oklahoma Maternal Grandfather - Chester H. Anderson a. b. c. Deceased; 1958; Age 54; Heart attack Unknown Dr. White at Bethina Hospital in Wichita Falls, Texas Maternal cousins - Larry Anderson Denver, Colorado Gary Anderson Denver, Colorado Donnie Anderson (Deceased; Dallas, Texas, murdered, early 20’s) Joleyn Anderson, Commerce City, TX Angel Anderson, Commerce City, TX Denise Anderson, Commerce City, TX Melody Anderson, Ft. Worth, TX Chester Anderson, Ft. Worth, TX a. Living , exception to Donnie b. Unknown c. Unknown 1977, Paternal Grandmother - Audrey Hukill Mangum, Oklahoma a. Deceased, 1970; 70; Cerebral hemmorage b. High blood pressure, ulcers, intestinal blockage c. Dr. Laniberg, Mangum, Oklahoma Paternal Grandfather - Francis Letcher Hukill Mangum, Oklahoma a. Deceased, 1983; Age 87; Pneumonia b. Unknown c. Mangum City Hospital Paternal Uncle -Dr. Viron Hukel1 Conway, Arkansas a. Living f np A b. c. Wounded severly in World War II; No other details known Unknown U U U 3 X I u y u u u a i_i.. i, _ i i r~i ix r%cr x x Kansas City, Missouri a. b. c. 26. Living Unknown Unknown With respect to each preganancy, -for each mother identified in response to Interrogatory 23(d), state: a) whether the mother was exposed to or contracted any viral or bacterial infection or disease during or shortly before the pregnancy (e.g., German measles, flu, etc.) and if so, identify the infection or illness, the period during which it occurred, and any medication or treatment given therefor; b) whether the mother incurred any injury during pregnancy, and, if so, describe the injury, the treatment received, any examining or treating physicians, and any institutions at which treat­ ment occurred; c) whether the mother or father ever had any venerai disease, and, if so, describe the disease, the treatment received, any examining or treating physicians, and any institutions at which treatment occurred; d) whether diagnostic procedures, including, but not limited to, abdominal x-rays or pelvimetry, amniocentesis, and/or ultrasound were used, and, if so, set forth the date of the procedure, describe the procedure, the examining or treating physician and any institutions at which the procedure occurred; and e) whether any medical problems or complications arose during pregnancy (e.g., toxemia), and, if so, describe the problems or complications and the treatment received. a. Contracted Belles Palsy (a neuroligical disorder) but other than this did not contract virus and exposed to any. None No. Did receive x—rays in the ninth month of both b. c. d. 12808 26 e. pregnancies. Dr. Kingery ordered the and Dr. Fielder for Michael, No ray -for Chad í J '•4 O'- Answer Interrogator!es 6, 7, 12, 14, 15, and 16 with respect to each mother identified in response to Interrogatory 23(d). . . . See attached handwritten sheet No on the job injuries a. Birthcontrol (does not remember name) b. October 1967 through 196? c. 1 pill one time daily d. Dr. Kingery, Mangum, Oklahoma e. Birth contral reasons f • hO a. b. c. d. e. f. Medication given during Bell's Palsy January 1971 through March 1971 Once daily, she did not take due to pregnancy Dr. Thomas Parker, Oklahoma City, Oklahoma Helped condition No a. b. c. d. e. f. Librium June, 1972 Once daily, she only took 2 or 3 Dr.: Fielder in Fort Worth, Texas Nervous condition No 27 12809 c. d. cigarettes Eighteen years of age to present, none during pregnancy 1 pack daily No 15. a. b. c. d. Eighteen years Infrequently - once a month NA NO 16. She used various foggers (Raid, Holiday) in the house approxi matel y 2 or 3 times a year. Never exposed due to the -fact that they totally clear the house of -fumes before entering. 14. 28. a. b. For each mother identified in response to Interrogatory 22 identify each and every pregnancy not resulting in a live birth, and state with respect to each: a) whether there was a miscarriage and/or spontaneous abortion, and, if so, state the date and describe the reason for the miscarriage and/or spontaneous abortion and identify any examining or treating physicians, and any institutions at which it occurred; b) if the response to a) above is affirmative, state whether you contend that such miscarriage and spontaneous abortion was caused by your exposure to Agent Orange, 2,4-D, 2,4,5-T, dioxin, or some combination thereof; c) whether there was a voluntary or therapeutic abortion, and, if so, state the date and describe the reason for the voluntary or therapeutic abortion, and identify any examining or treating physicians, and any institutions at which the abortion occurred; and d) 12810 if the response to c) above is affirmative, state whether you contend that such voluntary or therapeutic abortion was caused or necessitated by your exposure to Agent Orange, 2,4-D, 2,4,5-T, a. a n b. Spontaneous abortion Occurred around January 1972 Dr. Rhodes treated at White Settlement Austiopathic Hospital, White Settlement, Texas Ves, due to toxins No NA Dated: Carle Place, N e w York January 14, 1984 PLAINTIFFS' MANAGEMENT COMMITTEE DAVID J. DEAN, ESQ. DEAN, FALANGA & ROSE, E£ One Old Country Road Carle Place, New York 11 (516) 248-9888 12811 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK. In re "AGENT ORANGE" Product Liability Litigation : MDL No. 381 ANSWERS OF MICHAEL FRANCIS RYAN TO DEFENDANT'S INTERROGATORIES TO PROPOSED REPRESENTATIVE PLAINTIFFS PLAINTIFF'S MANAGEMENT COMMITTEE: Phillip E. Brown, Esq. Hoberg, Finger, Brown, Co:-: S< Mol 1igan 703 Market Street (18th Floor) San Francisco, California 94103 Thomas W. Henderson, Esq. Baskin ?•< Sears Frick Building (10th FI.) Pittsburgh, F‘A. 15219 Stanley M. Chesley, Esq. Waite, Schneider, Bayless and Chesley Co. L.P.A. 1513 Central Trust Tower Fourth and Vine Streets Cincinnati, Ohio 45202 Benton Mussel white, Esq. & John 0. 0'Quinn, Esq. 609 Fannin (Suite 517) Houston, Texas 77002 David J. Dean, Esq. Dean, Falanga h Rose One Old Country Road Carle Place, New York Stephen J. Schlegel, Esq. Schlegel S< Tra-felet, Ltd. One North LaSalle Street Suite 3900 Chicago, Illinois 60602 11514 Newton B. Schwarts, Esq. Houston Bar Center Building 723 Main (Suite 325) Houston, Texas 77002 Gene Locks, Esq. Neil Peterson Esq. Greitzer ?< Locks, Esqs. 1500 Walnut Street Philadelphia, PA 19102 12812 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF FEW YORK In Re "Agent Orange" Product Liability Litigation I. . MDL NO. 281 GENERAL State your name, social security number, military service number, and each address at which you have ever lived (excluding time during active military service), starting with your current address, and give the dates you lived at each address. Michael Francis Ryan 133-34-2420 US 51579873 73 University Heights Drive Stony Brook, New York 1971 - Present 41 Juniper Road Kings Park, New York 5805 Avenue "0" Brooklyn, New York U.S. Army 1970 - 1971 1967 - 1970 1965 - 1967 3320 Avenue "L" Brooklyn, New York Identi-fy each educational institution you attended, the dates o-f your attendance, and describe any physical or mental examination you received at or in connection with your attendance at each institution, stating with respect to each such examination. a) the date o-f the examination; b) the hospital or institution where was given; and c) the name and address o-f the person conducting examination. □ur Lady Help o-f Christians 1951-1959 Brooklyn, New York such examination the 12813 1 Brooklyn Preparatory 1959 - 1961 Midwood High School 1961 - 1964 St. John’s University Brooklyn, New York 1964 - 1965 Service 1965-1967 Suffolk Community College Suffolk County 1972 or 1973 Doesn’t recall any examinations If you have ever applied for life, health or accident insurance, state with respect to each such application: a) the date of the application; b) the kind of insurance applied for; c) the name and address of the insurance which the application was made; company to d) whether such application was accepted and if not, not; and why e) whether a medical examination was given in connection with the application, and, if so, identify the person conducting the examination and the medical institution where the examination was given. INTERROGATORY DELETED If you have ever made a claim for benefits for any medical condition (including worker’s compensation, veteran’s benefits, state or federal disability or insurance or union or third party medical plans) state with respect to each such claim: a) the type of claim (worker’s compensation, veteran’s benefits, etc.); b) the date of the claim; 12814 c) the claim number of other identification of the claim d) the entity to whom the claim was made, including the name and address; e> the medical condition for which the claim was and f) the disposition of claim. 2/13/72 Suffolk County Police Department Sprained Thumb Insurance; Royal Globe 3/10/73 Concussion Insurance: made; Royal Globe 4/12/73 Punture Wound Right Wrist Contusion to rib cage Insurance: Royal Glote 5/19/73 Sprained ring finger Insurance: Royal Globe 12/19/73> Two chipped teeth, all teeth loosened swollen jaw Insurance: Royal Globe 1/17/77 Neck Sprain Insurance: Suffolk County 6/12/77 Abrasions on hand, arms and smoke inhalation Insurance: Suffolk County 9/22/78 Sprained left elbow, wrist and knee Insurance: Suffolk County 11/26/S1 Hematoma right wrist and elbow Insurance: Suffolk County If you have ever filed or otherwise commenced a legal action in connection with any medical condition (other than this action) state as to each such action; a) the date that action was filed or otherwise commenced, the court or administrative body, the full title of the action, the index or other 4 H o n + i i ■v / i - n n ■ •ta r» i i m h we. r y. ' in H f h i dsntity cf il 1 n a r - 4- • to the action; b) a description of the medical condition in connection with which the action was filed, and how you believe that medical condition occurred; c) a description of the outcome of the action, or of its present status if it is still pending; and d) the dates and amounts of any payments, either as a result of a judgment or settlement, which you have received or which you are scheduled to receive. NONE II. 6. EMPLOYMENT HISTORY Identify and describe each job you have held, whether employed by others or self-employed, and state as to each: a) the name and address of your employer, the address of your workplace, the nature of the.business and your job title; b> your duties and responsibilities; c> the date the job began and ended and the reasons for termination of the job; and d) the date and place of each physical and mental examination that you underwent in connection with such job, identifying the name and address of each medical practitioner conducting the examination and the name and address of any medical institution at which such examinations was conducted. 10/70 to present Suffolk County Police Department Physical examintion prior to hiring 10/70 - 2/70 New York City Police Physician examination prior to hiring 2/70 - 8/67 IBM Physical examination prior to hiring B/67 - 10/65 U.S. Army 12816 4 10/65 - 6/65 Service Bureau Corp. IBM Subsidiary 7. With respect to each job identified in response to Interrogatory No. 6, identify each on-the-job injury, medical condition or accident that you experienced, and state separately as to each: a) a description of the injury, medical condition or acci dent: b) the dates of the injury, medical condition or acci dent; c) the treatment received, including the treating physician's name and acdress and all hospital­ isations, operations and medication received. See Answer to Interrogator-, #5 supra. III. 8. FAMILY MEDICAL HISTORY State the names and addresses of your spouse, children, brothers, sisters, parents, grandparents, aunts, uncles, cousins, nieces, nephews and grandchi1dren, and with respect to each: a) if any of them are deceased, state his or her age at the time of death and the time, place and cause of death; b> identify each illness, disease, disability, medical condition ever had by each during his or her lifetime which required professional medical attenti on. c) identify any birth or genetic miscarriages which they had; and d) with respect to each relative, identify each medical practitioner and medical institution that treated them, and set forth the diagnosis. defects or or SPOUSE: Maureen Ann, 73 University Heights Dr., Stony Brook, NY 12317 t'--i '">/6S ■ 6/£>5 ..fSe ov-vc-r -bunpan I ■ 7, rli r' ••• With respect tc each job', identified in response to Interrogatory No. />, identify each on-the-job injury, medical condition or accident, that you experienced, and state separately as to each: a) a description of the inj.ury, medical condition or ac <:ident; b) the dates of the injury, medical condition or accident; c) the trestment received, including the treating phys_i ci arc s name and acdress and all hospital­ izations, operations and medication received. e i if*; v •••i..-( •_* > 1 l cr;' IJ(. 8. l >g a t o r y' 5 supr a , i-AMILY MEDICAL HISTORY State the names and addresses of your spouse, children, brothers, sisters, parents, grandparents, aunts, uncles, cousins, nie.es. necnews and grandchi1dren, and with respect to each-. -) K *"■' of thc-m are deceased, state his or her age at the time >vf drath and the time, place and cause of death; b> id-ent ify g-«,;h illness, disease, disability, medical coruii >"ion ever had by each during his or .'h'er.-.,li f '-'J!-.:ch required professional medical a 1 1 t h e name and a d d r e s s p r e s c r i b e d th e drug; e) a description drug; and f) w hether you have ever r e c e i v e d any m edical t r e a t m e n t or c o u n s e l i n g in c o n n e c t i o n w it h your u s e of such drugs. of each period o-f t h e reasons of use; physician, for your use if of any, who the P lain tiff ton sils. doctors. canal; he was p r e s c r i b e d a n t i b i o t i c s f o r rem oval of his He cannot recall the exact an tib iotics or P lain tiff was p r e s c r i b e d p e r c o d a n f o r a root does not r e c a l l the d octor. "Catodot" - "Periactin" NY i n a b o u t P lain tiff does not recall prescribing doctor - Dr. R o b e r t D i n a p o l i , P o r t J e f e r s o n S t a t i o n , 1983 f o r p l a i n t i f f s m ig r a in e h e a d a c h e s T y l e n o l c o d e i n e - Dr. Robert D in a p o li p r e s c r ib e d t y le n o l codeine w i t h in th e p a st few weeks t o be taken as w ell as the p e r ia c tin for the p l a i n t i f f ' s m igraine headaches. f ) - None 13. I d e n t i f y each s k in c o n d i t i o n t h a t you w ith r e s p e c t t o each such c o n d it io n : a) state the b) describe received dates during which you have had ever that t h e name and a d d r e s s o f rendering the d iagn osis the person or t r e a t m e n t ; ii) t h e name and a d d r e s s o f i n s t i t u t i o n ( s ) a t which d ia g n o se d or tr e a t e d ; th e m edical you were iii) the dates iv) and the first of the effect of suffered diagnosis the or you treatm ent; treatm ent. from a s e v e r e a and condtion; any d i a g n o s i s or m ed ic a l t r e a t m e n t f o r t h e c o n d i t i o n , and s t a t e : i ) P lain tiff had, rash in the groin, 12822 neck and persisted scars. -facial u n til at area in 1966, th is l e a s t 1971, leaving P l a i n t i f f ' s s k i n c o n d i t i o n was b e l i e v e d in 1 9 66-1967. T h i s c o n d i t i o n was l a t e r a s c h l o r a c n e b y D r . S u s a n B a u m, N J . P lain tiff condition. 14. If you tobacco was not have ever product: treated smoked by same skin very large, rash deep t o be j u n g l e diagnosed in rot 1983 a physician cigarettes or for th is otherw ise a) i d e n t i f y each type of product c i g a r e t t e s , chewing t o b a c c o ) ; (e.g., b) id e n tify the that tobacco tim e p eriod product; c) id e n tify the ( e .g ., packs amount u s e d on a d a i l y b a s i s o f c i g a r e t t e s / d a y ) ; and d) s t a t e w hether any p h y s i c i a n or o th e r h ea lh c a r e p r o f e s s i o n a l h a s e v e r a d v i s e d you t o s t o p or r e d u c e your u s e o f c i g a r e t t e s or o th er to b a cco p ro d u cts, and, i f so , s t a t e the name and a d d r e s s o f t h e p h y s i c i a n o r o t h e r h e a l t h c a r e p r o f e s s i o n a l and t h e d a t e o f t h e advi ce. during skin used a cigars, which you used C ig a r e t t e s - 1 - 1 /2 pack/day s i n c e 1965, with th e e x c e p t i o n o f a p p r o x i m a t e l y 5 y e a r s d u r in g which p l a i n t i f f q u i t o n h i s own a c c o r d . P lain tiff 15. was never advised to quit. If you have ever consumed or drunk separately with r e sp ec t to each ty p e of liq u o r , b e e r , w ine, e t c . ) consumed: a) at what age b) the c) i f consum ption ceased at any tim e , f o r s u c h c e s s a t i o n and t h e r e a s o n s r e s u m p t i o n ; and amount consumption and frequency 10 alcohol, alcohol state (e.g., began; of such consumption; the for reasons any 12823 d) w h e t h e r y o u w e r e e v e r h o s p i t a l i s e d or i n s t i t u t i o n a l i s e d -for a l c o h o l u s e , o r a d v i s e d t o l i m i t or s t o p a l c o h o l u s e , and, i f s o , s t a t e t h e n a m e (s ) of e a c h s u c h h o s p i t a l or i n s t i t u t i o n o r m e d i c a l p r a c t i t i o n e r who t r e a t e d or a d v i s e d you. a) A pproxim ately b) P lain tiff d r a n k - f or consumed during t h i s per week. c) P lain tiff P lain tiff d) No age 18. a p p r o x i m a t e ly two years and p e r i o d one t o two s i x - p a c k s of beer qu it d r in k in g in 1966. c a n n o t d r i n k now. If any i n s e c t i c i d e s (e.g., Chlordane, Lindane, DDT), rodenticides (e.g ., rat poison), insect rep ellen ts (e.g ., DEET) or o t h e r p e s t c o n t r o l compounds were e v e r u se d by you or o t h e r s around your l i v i n g or working quarters, s t a t e as to each: a) the brand name o r b) a d e s c r ip t io n of c o l o r , s m e l ); c) a description ( e . g . , shape, d) the date e) the method of f) the place it g) the frequency h) w h ether you e x p e r ie n c e d any a d v e r s e r e a c t i o n compound and, i f s o , d e s c r i b e t h e r e a c t i o n . 1 P lain tiff of never with the of t h e color, name o f the chemical (e.g., container m arkings) for chem ical; powder, the liquid, chemical use; application; was a p p l i e d ; of used VI. State generic respect to application; any and to the in secticid es. MILITARY SERVI CE your m ilitary service: 12824 a) th e branch served * b) the inclusive dates o-f y o u r c) the in c lu s iv e Vi e t n a m ; dates o-f d) t h e n a m e o-f e a c h m i l i t a r y u n i t t o w h i c h y o u were a s s ig n e d w h ile s e r v i n g in or near V ie tn a m ; and t h e d a t e s d u r i n g w h ic h you were a s s ig n e d t o each such u n i t s ; e) t h e name a n d at which you near Vietnam were p r e s e n t -f) your im m ed ia te s u p e r i o r o-f-ficer ' s w h i l e i n o r n e a r V i e t n a m ; and g) the e r Qi ) ) c) d) e) ■f) g) 18. type o-f the armed services in which you service; service in or near l o c a t i o n o-f e a c h p l a c e o r a r e a w ere p h y s i c a l l y p r e s e n t in or and t h e d a t e s d u r i n g w h ich you at each such p la c e or area; o-f d i s c h a r g e you name a n d rank received. U . S . Army 11/65 - 8/67 Vietnam - 8/67 1 1 th Armored C a l v a r y R egim ent 3 r d S q u a d r o n , H e a d q u a r t e r s Co. L o n g B i n h , Xu a n L o c 1st Sergeant Snipes H onorable D i s c h a r g e (good c o n d u ct medal) L o n g B i n h , Xu a n L o c F'lainti-f-f can o n l y r e c a l l - f i r s t S e r g e a n t S t r i p e s Honorable 8/66 With respect to each i l l n e s s , injury, wound o r other medical or p sy ch o lo g ica l condition experienced by you d u r in g your m i l i t a r y s e r v i c e in or n ear Vietnam , s t a t e : a) t h e d a t e o-f y o u r o th er m edical or b) a description oth er m edical a description c) t h e c a u s e o-f t h e i l l n e s s , i n j u r y , w o u n d , medical or p s y c h o l o g ic a l c o n d it io n ; d) the name a n d i l l n e s s , i n j u r y , wound, o r psychological condition; o-f t h e i l l n e s s , i n j u r y , w o u n d , o r or p s y c h o lo g ic a l c o n d it io n , in c lu d in g o-f a l l s y m p t o m s ; rank o-f the 12 person to or whom y o u other •* -first 1 2 8 2 5 r e p o r t e d t h e i l l n e s s , i n j u r y , wound, c or p s y c h o l o g i c a l c o n d i t i o n ( i f anyone) other medical e) th e d a te t h a t you -fir st rep orted wound, or o t h e r p s y c h o l o g i c a l or the i l l n e s s , injury, medical c o n d it io n ; f ) t h e n a m e , r a n k a n d l o c a t i o n o-f e a c h p h y s i c i a n o r o t h e r h e a l t h c a r e pr o - f e s s i o n a l wh o t r e a t e d y o u r i l l n e s s , i n j u r y , wound, or o t h e r p s y c h o l o g i c a l or m e d i c a l c o n d i t i o n , i n c l u d i n g t h e d a t e s and p l a c e s o-f t r e a t m e n t , a n d a d e s c r i p t i o n o-f t h e t r e a t m e n t you r e c e i v e d ; and g) t h e n a m e a n d l o c a t i o n o-f e a c h h o s p i t a l o r o t h e r h e a l t h c a r e - f a c i l i t y which t r e a t e d your p s y c h o l o ­ g i c a l o r m e d i c a l c o n d i t i o n , t h e d a t e s o-f t r e a t m e n t , a n d a d e s c r i p t i o n o-f t h e t r e a t m e n t t h a t y o u r e c e i v e d . In 1966 Flainti-f-f was h ô p ita l ice d in the 91st EVAC hospital i n Lon g B i n h f o r 10 d a y s f o r u p p e r respiratory d i s t r e s s , se v e r e w eight lo s s , f a tig u e , m igraine headaches and a s k i n r a s h . P l a i n t i f f d o e s n o t r e c a l 1 t h e na me o f reported h i s m edical c o n d itio n s to . t h e a b o v e - l i s t e d p r o b lem s in 1966. P lain tiff has been t r e a t e d for Robert D i n a p o l i , Port J e f f e r s o n 19. the person P lain tiff m igraine Station, he f i r s t reported headaches NY. b y Dr . D escribe any o t h e r m e d i c a t i o n t a k e n by you during your m i l i t a r y s e r v i c e ( e . g . , Dapsone, C h lo r o q u in e , Frim aqu ine, B i n o c t a l ) , s t a t i n g a s t o each: a) the b) brand name o r na me o f the th e form o f t h e m e d ic a tio n i nj e c t i o n , e t c . ) ; (e.g., p ill, c) the color, taken ; d) the e) t h e name and r a n k o f you t h e m e d ic a t io n ; f ) the dates you took 9> the and amount of the shape, reasons for generic and sice of taking the m edication; the the any p i l l person(s) m edication; capsule, or capsule wh o g a v e m edication; m edication 13 taken (e.g., p ills/d ay); 12826 h) w h e t h e r y o u e x p e r i e n c e d any a d v e r s e m ed ication and, i f so, d e s c r ib e th e P lain tiff including did not take m alaria p i l l s . any drugs reaction to reaction. w hile in the Vietnam, State whether you ever received any training, instructions, warnings or h e a l t h and s a f e t y in-form ation c o n c e r n in g h e r b i c i d e s d u rin g your m i l i t a r y service, a nd id e n tif y as to each: a) the dates you received b) the location c) t h e name a n d r a n k i t was r e c e i v e d ; d) the and e) the t i t l e , d a te, author o f any w r i t t e n m a t e r i a l where substance of the foregoing; received; of the person(s) any oral from inform ation who received; or s o u r c e , received. and content each tim e you c la i m herbicide exposure; None. Set been forth with resp ect to exposed to h e r b ic ie s : to a) the date of the alleged b) the tim e of day of c) t h e c l o s e s t g e o g r a p h i c a l or p o l i t i c a l r e f e r e n c e p o in t ( e . g . , h i l l , town, la n d in g zone) t o th e p l a c e you b e l i e v e you were exp osed ; d> a description exposure; e) a d e s c r i p t i o n o f how t h e h e r b i c i d e was b e i n g a p p lie d ( e . g . , h e l i c o p t e r , a i r c r a f t , hand, e t c . ) ; f) a d e s c r ip t io n of your alleged exposure; activities the your g) manner you of the the alleged terrain believe have exposure;- at the at place the of tim e alleged of 12827 14 body was physically exposed t o th e h e r b ic id e ( e . g . , sk in co n ta ct, i n h a l a t i o n , i n g e s t i o n or s w a llo w in g ), and, i f you b e l i e v e yo u w e r e e x p o s e d by c o n t a c t on your s k i n , i d e n t i f y t h e a r e a s o f s k i n t h a t came i n contact with the herb icid e; h) t h e name an d r a n k o f o t h e r p e o p l e t i m e o f a l l e g e d e x p o s u r e ; and present at the i) w ith r e s p e c t t o any d e c e a s e d p r o p o se d r e p r e ­ s e n t a t i v e p l a i n t i f f , s t a t e how s u c h p l a i n t i f f w i l l d e m o n s tr a t e any of t h e in f o r m a t io n r e q u e s t e d i n s u b p a r t s a) t h r o u g h h) o f t h i s i n t e r r o g a t o r y , i d e n t i f y i n g any p e r s o n s w i t h such i n f o r m a t i o n wh o w i l l t e s t i f y a s t o s u c h p l a i n t i f f ' s exposure to h erb icid es. To t h e b e s t o f p l a i n t i f f ' s r e c o l l e c t i o n he b e l i e v e s t h a t he was p h y s ic a lly exposed to herbicides through skin c o n t a c t , i n h a l a t i o n , i n g e s t i o n and s w a l l o w i n g . P lain tiff believes he wa s e x p o s e d t o h e r b i c i d e s i n Long Bin h and a d d i t io n a l a r e a s which he cannot r e c a l l a t t h i s tim e. ONLY I F YOU CONTEND THAT ANY OF YOUR CHILDREN HAS A BIRTH DEFECT CAUSED BY YOUR EXPOSURE TO AGENT ORANGE, 2,4-D, 2,4,5-T , DI OXI N OR SOME COMBINATION THEREOF, ANSWER THE FOLLOWING INTERROGATORIES. Identify t h e c h i l d r e n t h a t you h ave f a t h e r e d , including na me , d a t e an d p l a c e o f b i r t h o f e a c h s u c h c h i l d , and t h e name a n d a d d r e s s o f e a c h c h i l d ' s m o t h e r . K e r r y Ann R y a n 1/24/71 Community H o s p i t a l B r o o k l y n , New Y o r k M i c h a e l F r a n c i s Ryan 6/26/83 U n iversity H ospital S t o n y B r o o k , NY Mother - M a u r e e n Ryan 73 U n i v e r s i t y H eig h ts S t o n y B r o o k , New Y o r k Drive I d e n t i f y e a c h o f y o u r c h i l d r e n whom y o u c o n t e n d h a s b i r t h or g e n e t i c d e f e c t s a l l e g e d l y ca u sed by your e x p o s u r e to Agent Orange, 2.4-D , 2,4,5-T , dioxin or some other 15 12828 combination thereof, and identify: a) t h e b i r t h or g e n e t i c d e f e c t s which you c o n te n d were c a u s e d by your e x p o s u r e t o Agent Orange, 2 , 4 - D , 2 , 4 , 5 - T , d i o x i n , o r some c o m b i n a t i o n t h e r e o f , and s t a t e th e b a s is fo r your b e l i e f , in clu d in g o p in io n s of any p h y sic ia n s; b> any o t h e r has; c) e a c h m e d i c a l p r a c t i t i o n e r and m e d ic a l i n s t i t u t i o n s e e n or v i s i t e d by t h e c h i l d or in which t h e c h i l d was c o n f i n e d f o r p u r p o s e s of c o n s u l t a t i o n , d i a g n o s i s , p r o g n o s i s , t r e a t m e n t o r o t h e r c a r e , and t h e d a t e s , p u r p o s e s and r e s u l t s o f su ch c o n s u l t a t i o n , d i a g n o s i s , p r o g n o s i s , t r e a t m e n t o r o t h e r c a r e ; and d) the a) birth identity Kerry These of was born include: or genetic the with mother defects of each approxim ately which the child child. 22 b i r t h defects. - 4 d e f o r m e d f i n g e r s on h e r r i g h t hand - m i s s i n g thumb on r i g h t hand - 2 / 3 of u ln a bone m is s in g - l e f t hand i s m i s s i n g m u s c l e s and n e r v e s - h y p e r p l a s i a of sacrum -n e u r o g en ic bladder -duodinal a tr e sia - h o l e in heart -o cc u lt spinobifida -d ou b le reproductive organs ( i.e . uterus', cervixes, v a g i n a s , u n d e t e r m i n e d amount o f ovaries) - m i s s i n g anus -p yloric stenosis 2 2 2 b) due t o her o p e r a t io n s , Kerry s u f f e r e d b rain damage, blindness, scoliosis, " h y p h o s i s ", speech, h e a r i n g and in tellecu tal impediments. She is also permanently confined to a w heelchair. c) 24. Maureen Ann Ry a n Identify each in r e sp o n se to a) and e v e r y c h i l d o f e a c h mother identified I n t e r r o g a t o r y 2 2 and s t a t e a s t o e a c h : t h e c h i l d ' s name, a d d r e s s , d a t e o f b i r t h and p l a c e o f b i r t h , i n c l u d i n g t h e name and a d d r e s s o f t h e h o s p i t a l o r o t h e r p l a c e w h e r e d e l i v e r y o c c u r r e d : and 12829 16 b) the physician(s) pregnancy and/or who t r e a t e d t h e m o t h e r d eliv ered the ch ild . during K e r r y Ann R y a n , 7 3 U n i v e r s i t y H e i g h t s D r i v e , S t o n y B r o o k , NY, 1/24/71. Community H o s p i t a l , Brooklyn, NY. Dr. W i l t o n F r i t z , B r o o k l y n NY. M ichael Brook, Baker 5. F r a n c i s Ryan, 73 U n iv e r s it y H eights D r iv e , Stony NY. U n iversity H ospital, S t o n y B r o o k , NY. Dr. With respect t o each mother i d e n t i f i e d in response to Interrogatory 23(d), identify her brothers, sisters, parents, grandparents, aunts, uncles, cousins, n ieces, n e p h e w s , and g r a n d c h i d r e n , and: 1 a) i f any o f them a r e age at th e tim e of cau se of death; deceased, d e a t h and sta te his the tim e, or her p l a c e and b) identify each illn ess, disease, d isab ility, m e d i c a l c o n d i t i o n e v e r had by e a c h d u r i n g h i s or her l i f e t i m e which r e q u ir e d p r o f e s s i o n a l m edical attention; c) i d e n t i f y e a c h m e d i c a l p r a c t i t i o n e r and m e d i c a l in stitu tion that t r e a t e d them, and s e t forth d i a g n o s i s o f e a c h , s t a t i n g t h e same a s t o e a c h r e la t i ve. Maureen PARENTS: or the Ann Ry a n D an iel O'Connor, Died I r e l a n d a n d New Y o r k . 1961, Helen living, O'Connor, S till PATERNAL GRANDPARENTS: John natural causes. O'Connor, Josephine causes. Died O'Connor, Pancreatic Bronx Died in in cancer, NY. 1970's, 1970's, natural BROTHERS AND S I S T E R S : Helen Calahan, still p la in tiff's knowledge. H o w e l l NJ. Carol G allagher, livin g, healthy to 3 children, no s till : living, 17 4 the best of m iscarriages, children, no m iscarriages, Lakewood, NJ. Lorraine R eilly, b o r n w i t h a t u r n e d - f o o t (NY O r t h o p e d i c H o s p i t a l ) , 3 c h i l d r e n , o n e m i s c a r r i a g e , New R o c h e l l e , NY. Bernadette M iesner, B a r d o n i a , NY. 2 children, Gayle Stapleton, 2 children, m i s c a r r i a g e s , B a r d o n i a , NY. Daniel John O'Connor, O'Connor, Brian O'Connor, no children, unm arried, no currently lives in no c h i l d r e n , unm arried, no c h i l d r e n , With respect to each i d e n t i f i e d in r e s p o n s e t o preganancy, Interrogatory m iscarriages, pregnant, no V irginia. Bronx, Bronx, NY. NY. -for each mother 23(d), sta te: a) w h ether t h e m other was e x p o s e d t o or c o n t r a c t e d any v i r a l or b a c t e r i a l i n f e c t i o n or d i s e a s e d u r in g or s h o r t l y b e f o r e t h e p r e g n a n c y ( e . g . , Ge r ma n m e a s l e s , ■f l u, e t c . ) a n d i f s o , i d e n t i f y t h e i n f e c t i o n o r i l l n e s s , t h e p e r i o d d u r i n g w h ich i t o c c u r r e d , and any m e d ic a tio n or t r e a t m e n t g iv e n t h e r e f o r ; b) w h ether t h e m other i n c u r r e d any i n j u r y d u r in g pregnancy, and, i f so , d e s c r ib e th e in ju ry , th e t r e a t m e n t r e c e i v e d , any e x a m in in g or t r e a t i n g p h y s i c i a n s , and any i n s t i t u t i o n s a t which t r e a t ­ ment o c c u r r e d ; c) w h e t h e r t h e m o th e r or f a t h e r e v e r had any v e n e r a i d i s e a s e , and, i f so , d e s c r i b e t h e d i s e a s e , t h e t r e a t m e n t r e c e i v e d , any e x a m i n i n g or t r e a t i n g p h y s i c i a n s , and any i n s t i t u t i o n s a t which treatment occurred; d) whether d i a g n o s t i c p ro ced u res, in c lu d in g , but not l i m i t e d t o , abdom inal x - r a y s or p e l v im e t r y , a m n io c e n t e s is , a n d /o r u ltr a s o u n d were u sed , and, i f so, se t forth the date of the procedure, d escrib e t h e p r o c e d u r e , t h e e x a m in in g or t r e a t i n g p h y s i c i a n and a n y i n s t i t u t i o n s a t w h i c h t h e p r o c e d u r e o c c u r r e d ; and e) whether any m ed ic a l p ro b lem s or c o m p l i c a t i o n s a r o s e during pregn an cy ( e . g . , t o x e m i a ) , and, i f so , d e s c r i b e t h e p r o b l e m s or c o m p l i c a t i o n s and t h e treatment r e ce iv ed . 18 .28 31 PI a i n t i f f ' s w ife ca r ry in g Kerry. Maureen had a normal pregnancy Neither P lain tiff or P lain tiff's wife c o m p l i c a t i o n s e v e r had v e n e r e a l d i s e a s e . 7. 6 Answer I n t e r r o g a t o r i e s . respect to each mother Interrogatory 23(d). Maureen worked A $< P F o o d Service K ings for Store, Bureau Park the 7, 12, 14, identified H ospital, with no 15, and 16 w i t h in response to N follow ing: 1962-1964, Corp., while New R o c h e l l e 1965-1971/72, K ings Park, NV NY NY In 19B2 M a u r e e n Ryan s u f f e r e d a s e v e r e a s t h m a t i c a t t a c k . She has been h o s p ita liz e d seven or eight tim es at U n iversity H ospital, S t o n y B r o o k , NY f o r h e r r e s p i r a t o r y condition. She is now on disab ility for a severe asthm atic condition d i a g n o s e d by Dr. Michael Sampson, U n i v e r s i t y H o s p it a l, S ton y Brook. To th e b e s t of P l a i n t i f f ' s knowledge, Maureen Ryan has taken the follo w in g m edications: A l l u p e n t - 2 s p r a y s , 4 t i m e s a day Theodur - 2000 mg/day S t e r o i ds Bennet p o s i t i v e p r e s s u r e b r e a t h in g machine 4 t i m e s a day. Her trea tin g physician i s H o s p i t a l , S t o n y B r o o k , NY Maureen Ryan f i v e drinks in M ichael d o e s n o t smoke and her l i f e t i m e . has Sampson, U niversity drunk approxm ately P lain tiff's wife has been exposed to in secticid es b e g i n n i n g a p p r o x i m a t e l y i n 1979 or 1980 a t t h e K in g s Park H ospital. The i n s e c t i c i d e w a s u s e d b y t h e h o s p i t a l . She does n o t know t h e b r a n d name b u t r e c a l l s i t being used approxim ately o n c e a month in t h e hospital. 8. For each mother live birth, iden tified in response to Interrogatory a 22 i d e n t i f y e a c h a n d e v e r y p r e g n a n c y n o t r e s u l t i n g i n and state with respect 19 to each: 1 ^ ^ 3 2 a) whether t h e r e was a m i s c a r r i a g e a n d /o r s p o n ta n e o u s a b o r t i o n , and, i f s o , s t a t e t h e d a t e a n d d e s c r i b e t h e r e a s o n - f or t h e m i s c a r r i a g e a n d / o r s p o n t a n e o u s a b o r t i o n and i d e n t i f y any exam in in g or t r e a t i n g p h y s i c i a n s , and a n y i n s t i t u t i o n s a t w h i c h i t o c c u r r e d ; b) i f t h e r e s p o n s e t o a) a b o v e i s a f f i r m a t i v e , s t a t e w h e t h e r y o u c o n t e n d t h a t s u c h m i s c a r r i a g e and s p o n t a n e o u s a b o r t i o n was c a u s e d by your e x p o s u r e t o A g e n t O r a n g e , 2 , 4 - D , 2 , 4 , 5 - T , d i o x i n , o r some com bination th e r e o f; c) w h e th e r t h e r e was a v o l u n t a r y or t h e r a p e u t i c a b o r t i o n , a n d , i f s o , s t a t e t h e d a t e and d e s c r i b e th e reason fo r th e v o lu n ta ry or t h e r a p e u tic a b o r t i o n , and i d e n t i f y any e x a m i n i n g or t r e a t i n g p h y s i c i a n s , and a n y i n s t i t u t i o n s a t w h ic h t h e a b o r t i o n o c c u r r e d ; and d) i f th e resp o n se to c) above i s a ffir m a t iv e , s t a t e whether you contend that such voluntary or t h e r a p e u t i c a b o r t i o n was c a u s e d o r n e c e s s i t a t e d by your e x p o s u r e t o Agent Orange, 2 ,4 - D , 2 , 4 , 5 - T , d i o x i n , or some c o m b in a t io n t h e r e o f . a) P lain tiff had Kerry in 1971. Dated: one m iscarriage before the birth of Carle Place, N e w York J anuary 14, 1984 PLAINTIFFS' MANAGEMENT COMMITTEE DAVID J. DEAN, ESQ. DEAN, FALANGA & ROSE, ESC One Old Country Road Carle Place, N e w York 115 (516) 248-9888 20 12833 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK x In r e "AGENT ORANGE" Product L iab ility : L itigation : MDL N o . 3B1 ANSWERS OF DANNY LEE FORD TO DEFENDANT’ S INTERROGATORIES TO PROPOSED REPRESENTATI VE P L A I N T I F F S - P L A I N T I F F ’ S MANAGEMENT COMMITTEE: P h i l l i p E. Brown, Esq. H o b e r g , F i n g e r , B r o w n , Cox i< Mol 1 i g a n 703 Market S t r e e t <18th F l o o r ) San F r a n c i s c o , C a l i f o r n i a 94103 T h o m a s W. H e n d e r s o n , E s q . B a s k i n !< S e a r s F rick B u ild in g (10th F I .) P i t t s b u r g h , PA. 15219 S t a n l e y M. C h e s l e y , E s q . Waite, S c h n e id e r , B a y le s s a n d C h e s l e y Co. L . P . A . 1513 C e n t r a l T r u s t Tower F o u r t h and V in e S t r e e t s C i n c i n n a t i , Ohio 45202 Benton M u sselw h ite, Esq. John 0. 0 ’ Quinn, Esq. 609 Fannin ( S u i t e 517) Houston, Texas 77002 David J . Dean, Esq. Dean, F a la n g a & Rose On e O l d C o u n t r y R o a d C a r l e P l a c e , New Y o r k !< Stephen J. S c h l e g e l , Esq. S c h le g e l & T ra-felet, Ltd. On e N o r t h L a S a l l e S t r e e t S u ite 3900 Chicago, I l l i n o i s 60602 11514 N e w to n B. S c h w a r t z , E s q . H ouston Bar Center B u i l d i n g 7 2 3 Main ( S u i t e 3 2 5 ) Houston, Texas 77002 Gene L o c k s , E sq. N eil P e te r so n Esq. G reitzer & Locks, Esqs. 1500 Walnut S t r e e t P h i l a d e l p h i a , PA 19102 12834 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK X In re "AGENT ORANGE" M D L No. 381 Product Liability Litigation. X I. 1. GENERAL S t a t e your name, s o c i a l s e c u r i t y number, m i l i t a r y s e r v i c e number, and each a d d r e s s at which you have ev er lived (excluding tim e during a c t iv e m ilit a r y s e r v ic e ) , s ta r t in g w ith your c u r r e n t a d d r e s s , and g i v e t h e d a t e s you lived at each ad d ress. Danny Lee Ford 365-52-1794 US 54976275 3507 St. Anthony R'd. Temperance, MI . 4 B 4 1 2 19 7 4 - P r e s e n t ; 6507 S e c o r Rd . Toledo, OH. 43613 1973-1974; 13478 South C o u n t y L i n e Hwy. Ottawa Lake, MI 49267 1953-73; 5024 T r e l l i s Way, S y l v a n i a , OH 1948-1953 Identify e a c h e d u c a t i o n a l i n s t i t u t i o n you attended, the dates of your a tte n d a n c e , and d e s c r i b e any p h y s i c a l or mental exam in ation you r e c e iv e d at or in c o n n ectio n with your a tte n d a n c e at each i n s t i t u t i o n , s t a t i n g w ith r e s p e c t t o each such exam ination . a) the b) th e h o s p ita l or was g i v e n ; and c) date of the exam ination; in stitu tion the name an d a d d r e s s exam ination. W hiteford A gricultural High of where the School, 3. Interrogatory 4. If you have e v e r made a c l a i m medical condition (including veteran’s b enefits, sta te or such person a. b. exam ination conducting c.r the none deleted. 1 for b enefits for any worker’ s com pensation, I £ ~ federal d isab ility or 35 insurance or union or t h ir d p a r ty w ith r e sp e c t t o each such claim : a) t h e t y p e o-f c l a i m b en efits, etc. ) ; b) the c) the claim claim d) the the date o-f the (w orker's m edical plans) compensation, veteran’s claim ; number o-f o t h e r e n t i t y t o whom t h e name a nd a d d r e s s ; e) the and m edical f) the d isp osition claim condition of iden tification for was which made, the of injury - Feb. claim 1973, claim - removal 1976 - Flower I960 -Toledo 1980 - chemotherapy, 19B1 - Toledo H ospital 1981 biopsy A pril, of plate H ospital H ospital - January, 1982 - Ma y , - made; State of and screws crushed biopsy stress right bone g r a f t big and radiation Ohio allow ed r e s e c t i o n of sm all bowel in su ra n ce c a r r ie r Aetna 1974 was claim . Carbon m o n oxid e p o i s o n i n g , a p p r o x , 1975 Sem i-truck a c c i d e n t - November 5 , 1979 abdominal c o n t u s io n s - c la im a llo w e d . May 1983 C orporation the including V e t e r a n s B e n e f i t s - m a l a r i a - 10/1 d i s a b i l i t y , B u r e a u o f Workmans C o m p e n s a t i o n Back state - right claim allow ed laceration le f t claim allow ed - knee, AMC Jeep leg toe surgery therapy fracture leg righ t leg j 1983 surgery righ t leg. 2 Flower H ospital 12836 Summer, 1983 R adiation Insurance - 1967 5. - - Drs. - right i removed date unknown - f emur 1966 rod - right at Iowa 1970 - compound righ t 1972 Appendectomy -fracture and 1983 - th is tim e Agent - Schafer D evilb iss - Gary B a r r i c k l o w - Bell tib ia I-f you h a v e e v e r - f i l e d or o t h e r w i s e commenced a action in c o n n e c tio n w ith any medical c o n d itio n than t h i s a c t io n ) s t a t e a s t o each such a c tio n : legal (other a) t h e d a t e t h a t a c t i o n was f i l e d or o t h e r w i s e commenced, t h e c o u r t or a d m i n i s t r a t i v e body, t h e f u l l t i t l e o f t h e a c t i o n , t h e in d e x or o t h e r i d e n t i f y i n g number, and t h e i d e n t i t y o f a l l p a r t i e s to the action; b) a d e s c r i p t io n of th e m edical c o n d itio n in c o n n e c tio n w i t h w h i c h t h e a c t i o n w a s f i l e d , a n d how y o u b e l i e v e t h a t m edical c o n d it io n o ccurred; c) a d e s c r i p t i o n of t h e outcome of th e a c t io n , or i t s p r e s e n t s t a t u s i f i t i s s t i l l p e n d in g ; and d) Compan- - f e mur B ankers Li-fe, Des Moine, B u i l d i n g , T o l e d o , DH - Horvath Flower H o s p it a l - -fall of c a r r i e r unknown a t t h i s t i m e . T onsillectom y Fractured chemotherapy of t h e d a t e s and a m o u n t s o f any p a y m e n t s , e it h e r as r e s u l t of a judgm ent or s e t t l e m e n t , which you have r e c e i v e d or which you a r e sc h e d u le d t o r e c e i v e . Out of co u r t s e tt le m e n t in c o n n ectio n with a c c id e n t in 1970 - * 1 5 ,0 0 0 awarded in 1972. a m otorcycle/auto Workers c o m p e n s a t i o n s u i t - Danny Ford v s . Jeep 1982 No. 8 1 - 2 8 7 2 - l o s t c a s e i n v o l v i n g s e m i - t r u c k Chatham, O n t a r i o Canada. Corporation a ccid en t in 12837 EMPLOYMENT HISTORY II. Identify and d e s c r i b e e a c h j o b you have held, whether employed by o t h e r s or s e l f - e m p l o y e d , and s t a t e as to each: a) t h e name and a d d r e s s o f y o u r e m p l o y e r , t h e a d d r e s s o f y o u r w o r k p l a c e , t h e n a t u r e o f t h e b u s i n e s s and your job t i t l e ; b) your duties and r e s p o n s ib i1i t i e s ; c) the for d) t h e d a t e and p l a c e o f e a c h p h y s i c a l and m e n t a l exam ination th a t you underwent in c o n n ectio n w i t h s u c h j o b , i d e n t i f y i n g t h e name a nd a d d r e s s of each m edical p r a c t i t i o n e r conducting th e e x a m i n a t i o n and t h e name and a d d r e s s o f a n y m e d i c a l i n s t i t u t i o n a t w h ic h s u c h e x a m i n a t i o n s was c o n d u c t e d . date th e job began ter m in a tio n of t h e Stubn itz, d iv is io n of MI . W elder, went i n t o and en ded j o b ; and Hoover B all service. J o - J o ’ s F i z z a r i a , Monroe S t . , d e l iv e r y m a n - went t o work a t Aamco Transm ission in s ta lle r - doesn’t and Bearing reasons 1966-1967 T oledo, O h io ,1966 Stib nitz. Monroe S t . , Toledo, remember when. Landmark farm bureau d o e s n ’ t remember d a t e s the - Berkey, or pay. Ohio - Ohio - Adrain, - transm ission deliverym an - E d d y ’ s g a s a n d o i l S y l v a n i a - P e t e r s b u r g Rd . S y l v a n i a , O h i o 43560 truck driver 1969-1973 $135. W e e k l y w e n t t o AMC J e e p ]2 AMC J e e p C o r p o r a t i o n , p r e ss operator, in s p e c to r , sem i-truck d r i v e r - $ 6 1 5 . 0 0 w e e k l y — p h y s i c a l J a n u a r y , 197 3 - Dr. B erb er, 9 4 0 N. C o v e B l v d . T o l e d o , O h i o accident; b) the dates of acci dent ; c) the treatm ent re ce iv ed , including the tre a tin g p h y s i c i a n ' s name and a d d r e s s and a l l h o s p i t a l ­ i s a t i o n s , o p e r a t i o n s and m e d i c a t i o n r e c e i v e d . See answer to the question Dr. Robert Cooke Farafon -forte Dr. St. Dr. Randall Dr. Ernst OH 4 3 5 6 0 B. condition Sylvania Sun-forest H osp ital, Secor Stern-feld Flower Rd. Court, Chatham, Stern-feld, III. m edical or #4. H ollsnd- Finken, Joseph's Ernst injury, Rd. , Sylvania, Toledo, Ontario, Toledo, H ospital OH 4 3 5 6 0 Ohio 43612 Canada Ohio 4 3613 Harroun Rd. Syslania, FAMILY MEDICAL HISTORY State t h e n a m e s a n d a d d r e s s e s o-f y o u r s p o u s e , children, brothers, s i s t e r s , p a ren ts, grandparents, aunts, uncles, cousin s, n ieces, nephews and g ra n d ch i1dren, and with r e sp ec t to each: a) i -f a n y o-f t h e m a r e d e c e a s e d , a t t h e t i m e o-f d e a t h a n d t h e o-f d e a t h ; state tim e, h i s or h e r a g e p l a c e and c a u s e b) id e n t if y each illn ess, disease, d isab ility, m e d ic a l c o n d i t i o n e v e r had by e a c h d u r i n g h i s or her l i f e t i m e which re q u ire d p r o f e s s io n a l m edical attention . c> identify any birth or genetic m i s c a r r i a g e s w h i c h t h e y had; and d) w ith r e s p e c t t o each r e l a t i v e , i d e n t i f y each medical p r a c t i t i o n e r and m edical i n s t i t u t i o n t h a t t r e a t e d them , and s e t f o r t h t h e d i a g n o s i s . W ife C hristina Margaret Crawfis Ford 3507 defects St. or or Anthony .12839 Rd. Temperance. MI 4 8 1 8 3 . M i t r a l v a l v e insu-f f i e n c y - Dr. T h o ma s Abound Sector R d . , T o l e d o OH. Breast tumor benign Dr. Abraham S t e i n b e r g , P h i l l i p s A v e . , T o l e d o , O h io . Father Raymond Ford, 13478 South County Line H w y., Ottowa L a k e , MI 4 9 2 6 7 - N o n e Mother Ml - b a c k Rose F ord, 13478 South County L in e Hwy., Ottowa Lake, s u r g e r y - D r . R o b t C o o k e - h y s t e r e c t o m y D r . Wm. Me w b o r n Brother - Terry Ford, 6507 S ecto r R d ., Toledo, h a n d - F l o w e r H o s p i t a l , T o n s i l l e c t o m y - D r . Wm. Brother D r . Wm. - Randy F o r d , Mewborn Rt#2 Ottowa Lake, MI 4 9 2 6 7 Aunt M ildred B a r r i c k l o w Wo o d r o w St. h y s t e r e c t o m y Dr. Randal Fi nken S u n - f o r e s t Aunt Buelah Southard Uncle Morgan Ford Uncle Garland Uncle Arthur died January 26, Tecumseh, Ford Ford 2969 MI 3 0 0 Eastbrook deceased OH 4 3 6 1 3 Mewborn - Cut on tonsillectom y Sylvania, OH 4 3 5 6 0 C t . T o l e d o , OH 4 3 6 1 2 1964 outer at home c a n c e r Dr. Toledo, OH n o n e June 1971 heart attack at h o me 61 yrs. Grand-father Ly ma n F o r d deceased 1953 stroke at Grandmother years Susie deceased 5-45 heart attack Grand-father years Earl Capron deceased 11-21-50 car Grandmother Esther Capron 5319 Aunt H elen P r i c e ad h esio n s Toledo Aunt could Ford 5319 Secor H ospital - Capron 13460 South 4814 Rd. at Bowser Lake, Toledo, 49267- County L in e Hwy, D r., OH. Uncle Ron C a p r o n N iece Mandy F o r d R t # 2 O t t o w a L a k e , 6 MI . Toledo, MI . none yrs. h o me 6 0 accident OH. Rd. T o l e d o , OH. 4 3 6 2 3 doesn't r e c a ll date Jerry Hoyt R t#2 Ottowa n o t r e c a l l D r . ' s name Uncle Earl MI . 4 9 2 6 7 Secor home 7 4 61 None abdominal Appendectomy Ottowa Lake. 32613 12840 Nephew Andy Ford Rt#2 Ottowa Lake, MI.49267 none IV. 9. State: a) the b) t h e name an d a d d r e s s o f t h e h o s p i t a l o r o t h e r ■ f a c i l i t y w h e r e y o u w e r e b o r n , and t h e name and a d d r e s s o-f e a c h a t t e n d i n g p h y s i c i a n o r o t h e r m e d i c a l p r a c t i t i o n e r ; and c) e a c h b i r t h d e f e c t t h a t y o u had and e a c h m e d i c a l c o m p l i c a t i o n c o n n e c te d w ith your b i r t h ( e . g . , premature b ir th , breech b ir th , ja u n d ice, f e t a l a l c o h o l i s m ) , and e a c h m e d ic a l c o m p l i c a t i o n or h e a l t h p r o b le m t h a t you mother had i n c o n n e c t i o n w ith her p r e g n a n cy of your b i r t h ( e . g . , t o x e m ia , long p e r io d of l a b o r ) . 8-23-48 Mewborn c. 10. VETERAN' S MEDICAL HISTORY date of your birth; Toledo H ospital N. Cove B l v d . S u n f o r e s t C t . T o l e d o , OH 4 3 6 1 2 Toledo, OH D r . Wm. none Identify each injury, illn ess, d isab ility or other physical or m ental c o n d i t i o n which you have ever had, whether tem porary or permanent, and s t a t e s e p a r a t e l y as to each: a) each m edical p r a c t i t io n e r and/or m edical i n s t i t u t i o n s e e n or v i s i t e d by you f o r t h e p u r p o s e s o f c o n s u l ­ t a t i o n , d i a g n o s i s , p r o g n o s i s , x - r a y s , t r e a t m e n t or other ca re, s p e c ify in g the dates of a ll h o s p it a l­ izations; b) t h e d i a g n o s i s o r p r o g n o s i s made b y e a c h m e d i c a l p r a c t i t i o n e r and m e d i c a l i n s t i t u t i o n ; and c) t h e n a t u r e and e x t e n t o f t h e c a r e and t r e a t m e n t r e c e i v e d i n e a c h m e d ic a l i n s t i t u t i o n and fro m each m edical p r a c t it io n e r . Tonsilectom y Fractured Dr. righ t Wm. 12841 Me w b o r n Femur F e b r u a r y 1966 Dr. Robt Cooke Toledo i H ospital -fourteen days open c r u tc h e s-o n e year-tem porary reduction Toledo H ospital Dr. Robert p h ysical therapy-T oledo c li n i c with Schneider Cooke removed temporary rod- rod received 1970 T o l e d o H o s p i t a l Dr. R o b e r t C o o k e c o m p o u n d - f r a c t u r e o-f righ t t i b i a - 14 days h ospitalisation, -fracture plated temporary 1972 appendectomy temporary Dr. Wm. Mewborn-ten 1974 removal o-f p l a t e - from r i g h t H o s p i t a l - a p p r o x i m a t e 3 d a y - s t a y Dr. — high tib iaRobert 1974 Dr. m edication Randal 1976 Flow er observation H o s p i t a l - Dr. and x - r a y s November 5 , observation 1979 Chatham, O n t a r i o S t . a n d s u t e r i n g o-f l e f t k n e e Transferred Sternfeld 1979 Finken Fred days-Toledo blood temporaryCooke pressure Hawkens— c r u sh e d O ffice v i s i t e le v a tio n of 12, day 1979 Dr. Clark Toledo H o s p ita l-o u tp a tie n t O.V. Toledo H ospital January 1980 Referred back tomagraphs, Gallium to possib le scan, Robert phlebitis, xero to in fection - 1 ami n o g r a m s sigvaris stockings radiographs possib le abscess Cooke by Dr. Toledo H osp ital Dr. Ernst November 10, le g - x-rays Clark tissu e Paul Cooke O utpatient b i o p s y - T o le d o Hospi t a l - F e b r u a r y R ob ert C o o k e-M a lig n a n t mass in r i g h t l e g Admitted toe- 1979-possible stay lower r ig h t t o Dr. Paul Dr. Paul C l a r 1- p o s s i b l e s o f t l e g , w a r m s o a k s - k e f 1 e x 5 0 0 mg December Paul big Joseph’s H ospitallaceration Flower H o s p ita l-D r . Ernst S tern feld -N o v . bowel o b s t r u c t i o n due t o t r u c k a c c i d e n t - 1 0 Robert Cooke-pain 27, 1979-referred Toledo — received by ambulance to Flower H ospital November 7, 1 9 7 9 - o b s e r v a t i o n - r e l e a s e d O ffice visit-D r. b o th 1egs-N ovem ber H ospital February 22, 22, 1980 for 1980- Dr. 1 2 8 4 2 further s u r g e r y Dr. R ob er t Cooke F eb. right leg -oncologist called started Six weeks R adiation chemotherapy-Dr. s therapy-3 Dr. Stanley cancer Stress Dr. Stephen Continued Flower Stephen Horvath leg-T oledo K iechel-casted chemotherapy chemotherapy Flower H ospital Follow up Chest x-ray Dr. S. adjustm ent to leg Dr. s Scha-fer August and H orvath right leg. negative, Jan. 1982 Dr. 1981 Ki e c h e l o-f-fice v i s i t s - D r . s Flower mental H ospital-x-rays H o sp ita l-A p ri1 19B l-biopsy K iechel Finished o-f-fice H ospital P sychologist, right r e s e c t io n of chemotherapy and S c h a f e r ' s treatm ents-F low er Zupnick, -fracture 27, 1980 r a d ic a l in-regim ine o-f bone Horvath gra-ft and Scha-fer H ospital Flower H o sp ita l-D r . S. K iechel-M ay 16, 1983-mass in lower thigh, extensive surgery on thigh, resection o-f retropertonealarea, v ein gra-ft, t u m o r s i n l e g and abdomen, r e s e c t i o n s m a ll bowel due t o t r u c k a c c i d e n t in 1979 Chemotherapy, D r.s Horvath and Scha-fer— 3 m o n th s 11. With r esp ect t o each injury, illn ess, d isab ility, o t h e r p h y s i c a l or mental c o n d i t i o n i d e n t i f i e d in r e s p o n s e to In terrogatory 10, i d e n t i f y each such c o n d i t i o n that you claim or believe was c a u s e d by or arose out of e x p o su r e t o Agent Orange, 2 , 4 - D , 2 , 4 , 5 - T , d i o x i n or some c o m b i n a t i o n t h e r e o f , and s t a t e s e p a r a t e l y a s t o e a c h : a) c) a description of each or symptom; t h e d a t e and manner i n w h i c h e a c h s u c h symptom f i r s t m a n i f e s t e d i t s e l f o r w a s made known t o y o u ; and Embryonal rhabdom yosarcom a February 22, 1980 o u t p a t ie n t 190 biopsy Intolerance 1974-1975 Rash 1969 in to alcohol thighs and buttocks J o in t pain 1974-1975 Me m o r y l o s s 1976 Headaches 1969-1970 Identify each drug or m e d ic a t io n e v e r used or taken by you, in c lu d in g , but not l i m i t e d t o , i l l e g a l , r e c r e a t i o n a l and over-the-counter drugs, and - f or each drug or m ed ication , s e t fo rth the fo llo w in g with r e sp ec t to each: a) t h e brand name, of t h e drug; b) the date of use; c) the amount used d) t h e name and a d d r e s s p r e s c r ib e d th e drug; e) a description d r u g ; and f ) w hether you have e v e r r e c e i v e d any m ed ical trea tm en t or c o u n s e ll i n g in c o n n e c tio n w ith your u se of such drugs. of fisp irin ,p eriod ically pain generic during name, each of reasons through or "street period the for of use; physician, if your use p resen t,for of 2 t i m e s d a i l y p r e s c r i b e d , Dr. Thomas R d . T o l e d o , OH 4 3 6 1 3 , h y p e r t e n s i o n K eflex 5 0 0 mg D r . Paul Clark 3930 S u n fo r e s t 43612-possible so ft tis s u e in fectio n 3 Dr. Parafon forte Stephen K iechel Secor Rd. Dr. Robert Cooke H o ll a n d OH 4 3 5 6 0 - b a c k i n j u r y any, who the headaches HCTZ Tylenol name" and Abound joint Sector Ct. Toledo, Toledo, OH 4 3 6 1 3 Sylvania, OH Sylvania, 1 2 3 4 4 A nti-m alarial M arijuana 13. drug occasionally in in Vietnam Vietnam I d e n t i f y each s k in c o n d it io n t h a t you w ith r e sp e c t t o each such co n d itio n : a) state the b) describe received dates any for during which you have ever had t h a t t h e name and a d d r e s s o f rendering the d ia g n o sis the person or tr e a tm e n t; ii) t h e name and a d d r e s s o f i n s t i t u t i o n ( s ) at which d i a g n o s e d or t r e a t e d ; the you iii) the dates iv) and the If you tobacco of the effect of diagnosis the smoked you medical were or treatment; 1969-present cigarettes or never seen otherw ise used a) i d e n t i f y each type of product c i g a r e t t e s , chewing t o b a c c o ) ; b) id en tify the that tobacco tim e period product; c) id en tify the ( e .g ., packs amount u s e d on a d a i l y b a s i s o f c i g a r e t t e s / d a y ) ; and d) s t a t e w h ether any p h y s i c i a n or o t h e r h e a l t h c a r e p r o f e s s i o n a l h a s e v e r a d v i s e d you t o s t o p or r e d u c e your u s e o f c i g a r e t t e s or other tob acco p rod u cts, and, i f so , s t a t e th e name a nd a d d r e s s o f t h e p h y s i c i a n o r o t h e r h e a l t h c a r e p r o f e s s i o n a l and t h e d a t e o f t h e advice. C igarettes o wn a c c o r d less than one and treatm ent. and b u t t o c k s - have ever product: had, condtion; d ia g n o s is or m edical treatm ent the condition,and sta te: i> Rash on thigh s p h y s i c i an 14. prescribed (e.g ., during pack d aily which for by a cigars, you u sed five years- quit on If you have ever consumed or drunk separately w ith r e sp e c t to each type o f l i q u o r , b e e r , w in e , e t c . ) consumed: what age a) at b) the c) i f consum ption c e a s e d a t any tim e , f o r su c h c e s s a t i o n and t h e r e a s o n s r e s u m p t i o n ; and d) whether you w ere e v e r h o s p i t a l i s e d or i n s t i t u t i o n a l i s e d f o r a lcoh ol u se, or a d v ised t o l i m i t or s t o p a l c o h o l u s e , and, i f s o , s t a t e t h e nameCs) o f e a c h s u c h h o s p i t a l o r i n s t i t u t i o n o r m e d i c a l p r a c t i t i o n e r wh o t r e a t e d o r a d v i s e d you. amount Beer less per week. consum ption alcoh ol, alcohol and state (e.g., began; frequency of such consumption; the for reasons any than 3 per week. D istilled sp irits Stopped due t o d i g e s t i v e d is tu r b a n c e s less than If any i n s e c t i c i d e s (e.g., Chlordane, Lindane, DDT), rodenticides (e .g ., rat poison), in sect r e p e llen ts (e .g ., DEED or o t h e r p e s t c o n t r o l compounds were e v e r u sed by you or o t h e r s around your l i v i n g or working quarters, s t a t e as to each: a) the b) a descrip tion of col o r , sm el1); c) a description ( e .g ., shape, d) the date e) the method of f) the place it g) the frequency h) w hether you e x p e r ie n c e d any a d v e r s e r e a c t i o n compound a n d , i f s o , d e s c r i b e t h e r e a c t i o n . None b r a n d name o r of generic the of the color, name o f the chemical (e.g., container markings) for chem ical; powder, the liquid, chemical use; application; was of applied; application; and to the MILITARY SERVICE VI. 17. State with respect your m ilitary service: the armed services a) the branch served: b> the inclusive dates o-f y o u r c> the in c lu siv e Vietnam; dates o-f s e - v i c e d) the name o-f each military unit to which you were assiQned while serving in or near Vietnam; and the dates during which you were assigned to each such units; e) t h e name a n d a t which you near Vietnam were p r e s e n t ■f) your im m ed ia te s u p e r i o r o-f-ficer's w h i l e i n o r n e a r V i e t n a m ; and g) the type o-f to o-f in which you service; in or near l o c a t i o n o-f e a c h p l a c e o r a r e a were p h y s i c a l l y p r e s e n t in or and t h e d a t e s d u r i n g w hich you a t each such p l a c e or area; discharge name and rank you r e c e i v e d . f ' Ar my ! 1-15-6B - 9 -1 8 -6 7 j S ep t. 1968 - S e p t . 1969 I C h a r lie B a t t e r y F i r s t B a tta lio n 92nd A r t i l l e r y I Sept. 1 9 6 8 C a m e r o n B a y . p a e i k u , K o n t u m , B a mb i T u i t , Dak ■ to Landing Zone Marylou, Firebase 13, Firebase I B l a c k h a w k , c a n ' t remember d a t e s I C ap t. Farmer Honorable 18. With respect to each i li n e s - , injury, wound o r other m edical or p sych o lo g ica l condition experienced by you d u r in g your m i l i t a r y s e r v i c e in or n e a r V ietnam , s t a t e : a) t h e d a t e o-f y o u r o th e r m ed ical or b) a description other m edical a description c) the cause i l l n e s s , i n j u r y , wound, or psychological con d itio n ; o-f t h e i l l n e s s , i n j u r y , w o u n d , o r or p sy ch o lo g ica l c o n d i t i o n , in c lu d in g o-f a l l s y m p t o m s ; o-f t h e illn ess, injury, wound, or other 12847 m edical or psychological condition; d) t h e n a m e a n d r a n k o f t h e p e r s o n t o whom y o u - f i r s t r e p o r t e d t h e i l l n e s s , i n j u r y , wound, or o t h e r m ed ic a l or p s y c h o l o g i c a l c o n d it io n ( i f a n y o n e): e) t h e d a t e t h a t you f i r s t rep o rted wound, or o t h e r p s y c h o l o g i c a l or f) t h e nam e, r a n k and l o c a t i o n o f e a c h p h y s i c i a n or o t h e r h e a l t h c a r e p r o f e s s i o n a l who t r e a t e d y o u r i l l n e s s , i n j u r y , w o u n d , or o t h e r p s y c h o l o g i c a l o r m e d ic a l c o n d i t i o n , i n c l u d i n g t h e d a t e s and p l a c e s o f t r e a t m e n t , and a d e s c r i p t i o n o f t h e t r e a t m e n t you r e c e i v e d ; and g) t h e name and l o c a t i o n o f e a c h h o s p i t a l o r o t h e r h e a l t h c a r e f a c i l i t y which t r e a t e d your p s y c h o l o ­ g i c a l or m e d ic a l c o n d i t i o n , t h e d a t e s o f t r e a t m e n t , and a d e s c r i p t i o n o f t h e t r e a t m e n t t h a t y o u r e c e i v e d . the i l l n e s s , injury, m edical c o n d itio n ; Schrapnel r ig h t lower leg , L.2. M arylou, don't d a t e t r e a t e d b y army m e d i c a l s t a t i o n o n p e r i m e t e r recall M a l a r i a c o n t r a c t e d i n Ko nt u m, sent to aide sta tio n and then to Cameron Bay and hospitalized. Don't recall date. 19. D escribe any o th e r m ed ica tio n ta k en by you during your m i l i t a r y s e r v i c e ( e . g . , Dapsone, C h l o r o q u i n e , P r i m a q u in e , B i n o c t a l ) , s t a t i n g as t o each: a) the b) brand name o r name o f the th e form of th e m edication i n j e c t i o n , e t c . ); (e.g., p ill, c) the co lo r, taken; of p ill d) the e) t h e name and rank o f you t h e m e d ic a tio n ; f) the dates g) the and amount h> w h e t h e r y o u e x p e r i e n c e d any a d v e r s e m e d ic a tio n and, i f so, d e sc rib e t h e shape, reasons for and size taking you took of generic the any capsule, or capsule the m ed ica tio n ; th e person (s) the m edication; who g a v e m edication; medication taken (e.g., p ills/d ay); reaction to reaction . the 12343 Some sort of a n ti-m a la r ia l drug. Took m edication for e n t ir e sta y , reaction. 20. Don't Did n o t recall type. have adverse State whether you ever received any training, instructions, warnings or h e a l t h and s a f e t y in -fo r m a tio n c o n c e r n in g h e r b i c i d e s during your m i l i t a r y service, and identi-fy as t o each: Cl ) the dates b) the location c) t h e name and r a n k i t was r e c e i v e d ; d> the and e) the t i t l e , date, author o-f a n y w r i t t e n m a t e r i a l you r e c e i v e d substance the -foregoing; where r e c e i v e d ; o-f t h e o-f a n y person (s) oral -from wh o in-formation or s o u r c e , received. received; and c o n t e n t No 21. Set been ■forth with r e sp ec t to exposed to h e r b icie s: each tim e you c la im herbicide exposure; to a) the date o-f t h e b) the tim e o-f d a y o f c) t h e c l o s e s t g e o g r a p h ic a l or p o l i t i c a l r e f e r e n c e p o in t ( e . g . , h i l l , town, la n d in g zone) t o th e p l a c e you b e l i e v e you were e x p o s e d ; d) a description exposure; e) a d e s c r i p t i o n o f how t h e h e r b i c i d e wa s b e i n g a p p l i e d ( e . g . , h e l i c o p t e r , a i r c r a f t , hand, e t c . ) ; f ) a d e s c r i p t i o n of your a lle g e d exposure; g> t h e manner you b e l i e v e your body was p h y s i c a l l y exposed to the h erb icid e ( e .g ., skin con tact, i n h a l a t i o n , i n g e s t i o n or s w a l lo w in g ) , and, i f yo u b e l i e v e you w e r e e x p o s e d by c o n t a c t on y o u r s k i n , i d e n t i f y t h e a r e a s o f s k i n t h a t came i n c o n ta ct with the h erb icid e; h> the alleged of name and ra nk the the of alleged terrain exposure; at the activities other 15 have people at place the of tim e present at alleged of the 12849 time o-f alleged exposure; i> and with r e s p e c t t o any d ecea sed proposed rep re­ s e n t a t i v e p l a i n t i f f , s t a t e how s u c h p l a i n t i f f w ill d em onstrate any of th e in fo r m a tio n r e q u e s t e d i n s u b p a r t s a ) t h r o u g h h> o f ^ i s i n t e r r o g a t o r y , i d e n t i f y i n g any p e r s o n s With such i n f o r m a t i o n who w i l l t e s t i f y a s t o s u c h p l a i n t i f f ' s exposure to h e r b icid e s. _ Exposed a t v a r i o u s t i m e s u n i t was a i r l i f t e d i n t o v a r i o u s areas sprayed with d e f o i l i a n t , drank water from rice paddies i n a r e a s w i t h d e a d and d y i n g foliage, chopped down d e a d and d y i n g f o l i a g e , went t o bathroom in dead and dying foliage. L .2. Marylou and other areas p r e v io u s ly m entioned in Q u estion 17. Fred Falana, Robert Wo r k e d a n d o f t e n dying f o i l a g e . Dated: Snodgrass, lived in Sgt. areas Br o w n sprayed with dead and/or Carle Place, N e w York January 14, 1984 H. 1 Si - J : P L A I N T I F F S ’ MANAGEMENT COMMITTEE BY:A ■ ______ DAVID J. DEAN, ESQ. DEAN”, F A L A N G A & ROSE, ESQS. One O l d Country Road r Carle Place, N e w York 11514 (516) 248-9888 , t . or. r .-r aD î-iT ^tur» -y ;.e 16 12.850 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK In re "AGENT ORANGE" Product L iab ility : L itigation : MDL N o . 3B1 ANSWERS OF S t e p h e n John Z a r d i s TO DEFENDANT' S INTERROGATORIES TO PROPOSED REPRESENTATIVE P L A I N T I F F S PLAINTIFF'S MANAGEMENT COMMITTEE: P h i l l i p E. Brown. Esq. H o t - e r g , F i n g e r , B r o w n , Cox S-. Mol 1 i g a n 7 0 3 Market S t r e e t ( 1 8 th F lo o r ) San F r a n c i s c o , C a l i f o r n i a 94103 T h o m a s W. H e n d e r s o n , E s q . B a s k i n S< S e a r s F rick B u ild in g (10th F I .) P i t t s b u r g h , PA. 15219 S t a n l e y M. C h e s l e y , E s q . W aite, Schneider, B e y le ss an d C h e s l e y Co. L . P . A . 1 5 1 3 C e n t r a l T r u s t Tower F o u r t h and V in e S t r e e t s C i n c i n n a t i , Ohio 45202 B enton Mussel w h it e , Esq. John 0. 0 ’ Quinn, Esq. 609 Fannin ( S u i t e 517) Houston, Texas 77002 David J. Dean, Esq. Dean, F alan ga & Rose One Old C o u n t r y Road C a r l e P l a c e , Ne w Y o r k Stephen J. S c h l e g e l , Esq. S c h l e g e l V. T r a f e l e t , L t d . One N o r t h L a S a l l e S t r e e t S u it e 3900 Chicago, I l l i n o i s 60602 11514 N e w t o n B. S c h w a r t s , E s q . H o u s to n Bar C e n t e r B u i l d i n g 7 2 3 Main ( S u i t e 3 2 5 ) Houston, Texas 77002 Gene L o c k s , Esq. N e il P e te r so n Esq. G r e i t s e r Sc L o c k s , E s q s . 1500 Walnut S t r e e t P h i l a d e l p h i a , PA 19102 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK I n Re "Agent Orange" Product L iability L itiagation I. 1. MDL N o . 381 GENERAL S t a t e your name, s o c i a l s e c u r i t y number, m i l i t a r y s e r v i c e number, and each a d d r e s s a t w h ich you have e v e r lived (exclu d in g tim e during a c t i v e m ilita r y s e r v ic e ) , s t a r t in g w it h your c u r r e n t a d d r e s s , and g i v e t h e d a t e s y o u lived at each address. S t e p h e n John Addresses: Zardis, 5 2 P i t m a n Road M a r b l e h e a d , MA PRESENT - S e p t e m b e r , IB M e r r i t t S t r e e t M a r b l e h e a d , MA S e p t . , 1981 - S e p t . , One C r o c k e r M arblehead, S e p t . , 1980 Park MA - Sept., 141 F r o n t S t r e e t M a r b l e h e a d , MA S e p t . , 1 9 7 9 - Ma y , 2. . 013-34 -SS09, RA 1 1 6 2 1 8 4 6 . 1981 141 F r o n t S t r e e t M a r b l e h e a d , MA F e b r u a r y , 1972 - 1981 35 Baker S t r e e t M a l d e n , MA J u n e , 1971 - J u n e , 1970 1979 ACTIVE SERVICE US Army June, 1970 - June, 1967 1976 June, 1971 35 Baker S t r e e t M a l d e n , MA June, 1967 - 1956 5 0 H o l d e n Road S t e r l i n g J u n c t i o n , MA M a y , 1 9 7 6 - Ma y , 1 9 7 5 G o r e N u r s i n g Home W o l l a s t o n , MA 1956 - 1954 Clintwood V illa g e Bldg. 3, A p t., 5 C l i n t o n , MA May, 1 9 7 5 - F e b . 1 9 7 2 Cook S t r e e t Charlestown, 1954 - 1948 MA Identify e a c h e d u c a t i o n a l i n s t i t u t i o n you attended, the dates of your a tte n d a n c e , and d e s c r i b e any p h y s i c a l or m ental exam ination you r e c e iv e d at or in co n n e c tio n w ith your atten d an ce at each i n s t i t u t i o n , s ta tin g w ith r e sp e c t t o each such e x a m in a tio n . a) b) c) the date the was of the exam ination; h o s p i t a l or g i v e n ; and institution the name and a d d r e s s exam ination. Salem S t a t e C o l l e t g e , F a ll S em ester, 1976 Salem where o-f t h e such person exam ination conducting the M assachusetts W orcester S t a te C o lle g e , W orchester, M assachu setts S p rin g , 1975; F a l l , 1974; S p rin g , 1974; F a l l , 1973 Salem S t a t e C o l l e g e , Salem , S p r in g , 1972; Fai 1 , ' 1 9 7 1 Eoston C o lle g e , C hestnut F a l l , 1965; S p rin g , 1967 4. M assachusetts H ill, M assachusetts I-f you have e v e r made a c l a i m - f or bene-fits -for any medical condition (including worker's comipensati o n , veteran’s bene-fits, s t a t e or -federal d isab ility or insurance or u n io n or t h i r d p a r ty m ed ic a l plans) state with r e s p e c t t o each such claim : a) t h e t y p e o-f c l a i m bene-fits, e tc . ) ; b) the c) the claim cl ai m d) the the date o-f t h e number (w orker's com pensation, veteran’s claim ; o-f other e n t i t y t o whom t h e name and a d d r e s s ; condition id en tification claim which made, the the including e) the and m edical f) the disposition A) Veteran’s B> July, C) C-26083311 D) V e t e r a n ’ s Admini s t r a t i on R e g i o n a l O f f i c e , Federal B u ild in g, Boston, M assachusetts o-f - for was o-f claim was ma d e ; claim . bene-fits 1970; Mar cK 7 , 1977 2 12333 I E) J u l y . 1970 — I n ju r y t o jaw a s a r e s u l t of com bat i n V ietn am and u r i n a r y t r a c t p r o b le m in c u r r e d w h ile in Vietnam. March 7 , 1 9 7 7 — c o m p e n s a t i o n f o r n e u r o l o g i c a l damage• F) A ll c l a i m s a p p roved 10 p e r c e n t jaw , 40 p e r c e n t u r in a r y t r a c t problem , 100 p e r c e n t n e u r o lo g ic a l problem. If you h a v e e v e r f i l e d or o t h e r w i s e commenced a action in c o n n e c t i o n w i t h any m e d ic a l c o n d i t i o n than t h i s a c t i o n ) s t a t e as t o each such a c t io n : legal (other a) t h e d a t e t h a t a c t i o n was f i l e d or o t h e r w i s e commenced, t h e c o u r t or a d m i n i s t r a t i v e body, t h e f u l l t i t l e o f t h e a c t i o n , t h e inde:; or o t h e r i d e n t i f y i n g num ber, and t h e i d e n t i t y o f a l l p a r t i e s to the action; b) a d e s c r i p t i o n of t h e medical c o n d itio n in c o n n e c tio n w i t h w h i c h t h e a c t i o n w a s f i l e d , a n d how y o u b e l i e v e th a t m edical c o n d itio n occurred; c) a d e s c r i p t i o n of t h e outcome of t h e a c t i o n , or i t s p r e s e n t s t a t u s i f i t i s s t i l l p e n d i n g ; and d) of t h e d a t e s and am ounts o f any p a y m e n t s , e ith e r as r e s u l t of a judgm ent or s e t t l e m e n t , which you have r e c e i v e d or which you a r e s c h e d u le d t o r e c e i v e . F l a i n t i f f h a s n e v e r f i l e d or commenced any o t h e r l e g a l a c t i o n w ith reg a rd t o any m ed ical c o n d i t i o n p l a i n t i f f h a s had o t h e r than t h i s l a w s u i t . a which 12854 II. 6. EMPLOYMENT HISTORY Identify and d e s c r i b e each jo b you have held, whether employed by o t h e r s or s e lf - e m p lo y e d , and s t a t e as to each: a) t h e name and a d d r e s s o f your e m p l o y e r , t h e a d d r e s s o f y o u r w o r k p l a c e , t h e n a t u r e o f t h e b u s i n e s s and your j o b t i t l e ; b> your duties and r e s p o n s i b i l i t i e s ; c) the for d) t h e d a t e a n d p l a c e o f e a c h p h y s i c a l and m e n t a l e x a m i n a t io n t h a t you underwent in c o n n e c t io n w i t h s u c h j o b , i d e n t i f y i n g t h e name and a d d r e s s of ea ch m edical p r a c t i t i o n e r c o n d u c tin g t h e e x a m i n a t i o n and t h e name and a d d r e s s o f a n y m e d i c a l i n s t i t u t i o n a t w h ich s u c h e x a m i n a t i o n s was c o n d u c t e d . d a te th e job began term in ation of the and e n d e d j o b ; and and the reasons Commonwealth o f M a s s a c h u s e t t s , D e p a r tm e n t of S o c i a l S e r v i c e s . 150 Causeway S t r e e t , P o s t o n , M a s s a c h u s e t t s , S o c i a l W o rk er, March, 1 9 7 9 t h r o u g h S e p t e m b e r , 1 9 7 8 . Term inated b eca u se of n e u r o lo g ic a l problem. Could not w a l k t o m ake home v i s i t s . P l a i n t i f f d i d not h a v e any p h y s i c a l o r m e n t a l e x a m i n a t i o n s p e r f o r m e d upon hi m. R ob ert F. Kennedy A c t i o n C o r p s . , A s s i s t a n t D i r e c t o r of R e s i d e n t i a l D ia g n o s t ic C enter, L a n ca ster, M assachusetts. C h ild Care Worker, Sep tem b er, 1970 t h r o u g h May, 1 9 7 6 . Home f o r e m o t i o n a l l y d i s t u r b e d children. P l a i n t i f f d id n o t h ave any p h y s i c a l or m en tal e x a m i n t i o n s p e r fo r m e d upon him. M ilit a r y S e r v ic e , p h y sic a l exam in ation at Boston Army B a s e , B o s t o n , M a s s a c h u s e t t s , 1 9 6 7 - 1 9 7 0 . Boston C o lle g e , Chestnut tim e s tu d e n t, 1965-1976. Revere K n ittin g M ills, M a s s a c h u s e t t s , Summer, warehouse fo r c lo th in g 7 With respect Interrogatory to No. each 6, H ill, M assachusetts, fu ll­ F e r r y S t r e e t , Malden, 1966. F i l l i n g orders in shipped to r e t a i l custom ers. job i d e n t i f ie d in response to id e n tify each on-the-job i nj u r ^ 2 8 5 5 m ed ica l c o n d i t i o n or a c c i d e n t s t a t e s e p a r a te ly as to each: of injury, you experienced, m edical condition a> a description acci dent ; b) the dates acci dent ; c) the treatm ent received , in clu d in g the tre a tin g p h y s i c i a n ' s name and a d d r e s s and a l l h o s p i t a l i r a t i o n s , o p e r a t i o n s and m e d i c a t i o n r e c e i v e d . o-f t h e the that injury, m edical condition and or or NONE III. 8. FAMILY MEDICAL HISTORY . State t h e n a m e s a n d a d d r e s s e s o-f y o u r s p o u s e , children, brothers, s is t e r s , parents, grandparents, aunts, uncles, cousins, n ieces, nephews and g r a n d c h i 1 d r e n , ■ and with resp ect to each: a) i-f at o-f a n y o-f t h e m a r e d e c e a s e d , t h e t i m e o-f d e a t h a n d t h e death; state tim e, h i s or h er age p l a c e and c a u s e b) identi-fy each illn ess, disease, d isab ility, m e d i c a l c o n d i t i o n e v e r had by e a c h d u r i n g h i s or her l i- f e t im e which r e q u ir e d p r o -fe s s io n a l m edical a t t e n t i on. c) identi-fy any birth m i s c a r r i a g e s which th ey d> w ith r e s p e c t t o each r e l a t i v e , id e n ti-fy each medical p r a c t i t i o n e r and m ed ic a l i n s t i t u t i o n t h a t t r e a t e d th e m , and s e t -forth t h e d i a g n o s i s . or genetic had; and de-fects or or P l a i n t i - f - f h a s n o s p o u s e , c h i l d r e n , n o s i s t e r s and no brothers. T o t h e b e s t o-f p l a i n t i f f ’ s r e c o l l e c t i o n , t h e r e h a v e b e e n no b i r t h d e f e c t s . B oth o f p l a i n t i f f ' s parents are s t i l l liv in g . They a r e a s f o l l o w s : FATHER: E m m a n u e l Z a r d i s , A g e 61 P o l y p s removed from t h r o a t , 1981 H a r v a r d Community H e a l t h P r o g r a m Cambridge, M a s sa c h u se tts a ~ j_& O D MOTHER: I r e n e Z a r d i s , Age 60 Cancer of b r e a s t , 1980 Mastectomy performed B r i g h a m a n d Wo me n ’ s H o s p i t a l Boston, M assachusetts MATERNAL GRANDMOTHER: C a th e r in e MacFarlane D e c e a s e d - Summer, 1 9 7 8 C o m p l i c a t i o n s -from d i a b e t e s E verett. M assachusetts MATERNAL GRANDFATHER: John M acFarlane D eceased - 1962 C a n c e r o-f C o l o n C helsea, M assachusetts PATERNAL GRANDMOTHER: Ma r y Z a r d i s D eceased - 1930 C om plication s at Q u e e n s . New Y o r k PATERNAL GRANDFATHER: John Z a r d is D eceased - 1943 Q u e e n s , New Y o r k FAMILY P H Y S I C I A N S : Dr. Dr. IV. childbirth Halpin (deceased) Finnegan VETERAN’ S MEDICAL HISTORY State: a) the date o-f y o u r birth; b) t h e n a m e a n d a d d r e s s o-f t h e h o s p i t a l o r o t h e r - f a c i l i t y w h e r e y o u w e r e b o r n , a n d t h e n a me a n d a d d r e s s o-f e a c h a t t e n d i n g p h y s i c i a n o r o t h e r m e d i c a l p r a c t i t i o n e r ; and c) e a c h b i r t h d e f e c t t h a t y o u had and e a c h m e d i c a l c o m p lic a tio n con n ected w ith your b ir th ( e . g . , premature b ir th , breech b ir th , jaundice, f e t a l a l c o h o l i s m ) , and e a c h m e d i c a l c o m p l i c a t i o n o r h e a l t h p r o b le m t h a t you m other had i n c o n n e c t i o n w ith her pregnancy of your b i r t h ( e . g . , to x em ia , long p e r io d of l a b o r ) . January 26, 194B C h e l s e a Memorial H o s p i t a l , P h y s i c i a n unknown No b i r t h de-fects or m edical Chelsea, M assachusetts com plications. Identify each injury, illn ess, d isab ility or other physical or m en ta l c o n d i t i o n which you h a v e ever had, w hether tem porary or perm anent, and s t a t e s e p a r a t e l y as to each: a) each m edical p r a c t i t i o n e r and/or medical i n s t i t u t i o n s e e n o r s ' i s i t e d b y y o u -for t h e p u r p o s e s o-f c o n s u l ­ t a t i o n , d i a g n o s i s , p r o g n o s i s , x - r a y s , t r e a t m e n t or o t h e r c a r e , s p e c i f y i n g t h e d a t e s o-f a l l h o s p i t a l i c a t i o n s ; b) th e d ia g n o s is or p r a c t i t i o n e r and c) t h e n a t u r e a n d e x t e n t o-f t h e c a r e a n d t r e a t m e n t r e c e i v e d i n e a c h m e d i c a l i n s t i t u t i o n a n d -from each medical p r a c t i t i o n e r . p r o g n o s i s made by e a c h m e d i c a l m e d i c a l i n s t i t u t i o n ; and November, 1959 — broken a n k le . Dr. H a l p i n . Treated a t L a w r e n c e M e m o r i a l H o s p i t a l , Med-ford, M a s s a c h u s e t t s . A n k l e s e t and c a s t made. August, 1960 — Chest x -ra y . Dr. H a l p i n . Treated at L a w r e n c e M e m o r i a l H o s p i t a l , Med-f ord, M a s s a c h u s e t t s . F e l l on c h e s t , had t r o u b l e b r e a t h i n g and p h y s i c i a n t o o k x - r a y which was n e g a t i v e . February 22, 1977 — Jamaica P la in V eteran s Adm inis­ t r a t i o n H o s p i t a l and West Roxbury V e t e r a n s A dm inistration H osp ital. E a c h p e r i o d o-f h o s p i t a l i z a t i o n s i n c e t h i s t i m e h a s b e e n - f or n e u r o l o g i c a l p r o b l e m s . The h o s p i t a l i z a t i o n a r e s o numerous t h a t p la in ti-f-f c a n n o t r e c a l l e a c h and e v e r y h o s p i t a l i z a t i o n , w hich d a t e s a r e s e t - f o r t h i n p i a i n t i - f - f ”s v a r i o u s h o s p i t a l records. In t h e R epublic o-f V i e t n a m , plainti-f-f had a -fever o-f 12858 unknown o r i g i n and w a s h o s p i t a l i z e d a t t h e l B 7 t h E v a c u a t i o n H o s p i t a l a n d t h e n M e d i v a c e d t o Cu Ch i 2 5 t h E v a c u a t i o n H o s p i t a l and s e e n a t Tay N in h H o s p i t a l . Agent Orange Exposure: R esulting in a se v e r e , progressive dem yelination disease, which has been diagnosed as m ultiple sclerosis, with peripheralneuropathy, marked lower e x tr e m ity and back rigid ity and sev ere s p a s t ic it y (requiring L l-Sl anterior rhizotom y), progressive lower e x t r e m it y w eak n ess, lo s s of movement and marked sensory ataxia, stiffness of lower extrem ities, r ig h t f o o t drop, i n t r a c t a b l e p a in syndrome of lower extrem ities, interm ittent numbness of the feet, paraplegia, s e v e r e s p a s t i c i t y and l i m i t a t i o n o f movement o f upper e x t r e m i t i e s , marked d e c r e a s e d s e n s a t i o n o f b o t h upper extrem ities, i n t e r m i t t e n t numbness of both hands, s i g n i f i c a n t impairment in strength, dexterity and p r o p r io c e p t io n in upper e x t r e m i t i e s , r e s u l t i n g in low l e v e l "quadraplegia", recurrent urinary tract infections, interm ittent renal failure, bladder d y sfu n ctio n with incontinence, bladder sphincter dysynergia (requiring TURF' and TURBN with sphincterotom y), interm ittent bowel in c o n tin e n c e , p r o la p s in g of rectum, enlargem en t of p r o s t a t e , sacral decubiti, left ischial ulcer (requiring left ischiectom y ulcer excision). sexual dysfunction, marked visual disturbances and deficit, severe diplopia, i n t e r n u c l e a r o p h t h a l m o p l e g i a and a t a x i a , m ark ed l e f t l a t e r a l nystagmus, l e f t g r e a te r than r i g h t , se v e r e l o s s of v is io n , decreased visual acuity, abdominal mass (requiring excision), chloracne, chronic urinary tr a c t infections, recurrent fever o f unknown o r i g i n , in a b ility to swallow , drastic weight loss, disanthenia, em otional overlay depression, leth a rg y , d ep ressiv e n e u r itis , lo s s of a p p e tite , speech in c o o r d in a tio n , chronic f a tig u e , p e r s is t e n t headaches and j o i n t and m u s c l e p a i n , ir r a s c ib i1ity , e r r a t ic behavior d i f f i c u l t i e s and i r r i t a b i 1 i t y . O Co iJ QO 11. With r e s p e c t to each injury, illn ess, d isab ility, or o th e r p h y s i c a l or mental c o n d i t i o n i d e n t i f i e d in r e s p o n s e to In ter r o g a to ry 10, i d e n t i f y each such c o n d itio n that you claim or believe was c a u s e d by or arose out of e x p o s u r e t o Agent Orange, 2 , 4 - B , 2 , 4 , 5 - T , d i o x i n or some c o m b i n a t i o n t h e r e o f , and s t a t e s e p a r a t e l y a s t o e a c h : a) a description of each symptom; c) t h e d a t e and manner i n w h ic h e a c h s u c h m a n i f e s t e d i t s e l f o r w a s made known t o See P la in tiff's answer Agent Orange E xp osu re. 12. to question symptom f i r s t yo u ; and number 10 supra Identify e a c h drug or m e d i c a t i o n e v e r u s e d or taken by yc"_., i n c l u d i n g , b u t n o t l i m i t e d t o , i l l e g a l , r e c r e a t i o n a l and over-the-counter drugs, and for each drug or m ed ica tio n , s e t fo r th the fo llo w in g with r e s p e c t to each: a' ’ t h e b r an d name, of th e drug; b> the date of use; c) the amount used d) t h e name and a d d r e s s p r e s c r i b e d t h e drug; e> a d escription d r u g ; and f) w hether you have ever r e c e i v e d any medical t r e a t m e n t or c o u n s e lin g in c o n n e c tio n with your u s e of such drugs. Pain m edication, Various See tim es m edical of generic name, during each period of use; the physician, if of reasons morphine, w hile for or your "street use of n a me " any, who the valium . hospitalised from 1977 onward. records. V a rio u s d o c t o r s a t Jamaica P l a in V e t e r a n 's A d m in is t r a tio n H o s p i t a l , J a m a i c a P l a i n , M a s s a c h u s e t t s , and West Roxbury' V e t e r a n ' s A d m i n i s t r a t i o n , West R o x b u r y , M a s s a c h u s e t t s . Prescription to of s ie e p No ease pain, for 9 m uscle sp asticity and loss re: 13. I d e n t i f y ea ch s k in c o n d i t i o n t h a t you w ith r e s p e c t t o each such c o n d itio n : have a) state had t h a t b) describe received the dates during which you ever t h e name and a d d r e s s o f rendering the d ia g n o sis th e person or tre a tm e n t; II) t h e name and a d d r e s s o f i n s t i t u t i o n (s ) at which d ia g n o s e d or t r e a t e d ; the you III) the dates I V) and the of the effect of diagnosis the and condtion; any d i a g n o s i s or m ed ic a l t r e a t m e n t f o r t h e c o n d i t i o n , and s t a t e : I) had, you m edical were or treatm ent; treatm ent. In 1 * t » 1 9 6 8 o r e a r l y 1 9 6 9 w h i l e i n V i e t n a m , p l a i n t i f f d e v e l o p e d a r a s h on h i s a r m s and chest. P l a i n t i f f was s e e n by a p h y s i c i a n a t t h e 1 8 7 t h A s s a u l t H e l i c o p t e r Company H o s p i t a l in Tay N in h . A w h ite o in tm e n t, which P l a i n t i f f b e l i e v e s t o be c o r t i s o n e was g i v e n by s a i d p h y s i c i a n , w h o b e l i e v e d P l a i n t i f f may h a v e b e e n s u f f e r i n g f r o m an a l l e r g y t o d i e s e l f u e l . The o i n t m e n t was i n e f f e c t i v e . The c o n d i t i o n , e x p e r i e n c i n g p e r i o d s o f e x a c e r v a t i o n and r e m i s s i o n , r e m a i n s . 14. If you have ever tobacco product: smoked cigarettes or otherw ise a) i d e n t i f y each typ e of product c i g a r e t t e s , chewing t o b a c c o ) ; (e.g., b) id en tify the that tobacco tim e period product; c) id en tify the ( e .g ., packs amount u s e d on a d a i l y b a s i s o f c i g a r e t t e s / d a y ); and d) s t a t e w h ether any p h y s i c ia n or o th e r h e a lh c a r e p r o f e s s i o n a l has ev er a d v is e d you t o s t o p or r e d u c e your u s e o f c i g a r e t t e s or o th e r t o b a c c o p r o d u c ts, and, i f s o , s t a t e t h e name a nd a d d r e s s o f t h e p h y s i c i a n o r o t h e r h e a l t h c a r e p r o f e s s i o n a l and t h e d a t e o f t h e advi ce during which cigars, you used used a C igarettes — January, 196B. Two p a c k s / d a y . December, 19B2. No. 15. I-f you have ever consumed or drunk separately w i t h r e s p e c t t o e a c h t y p e o-f l i q u o r , b e e r , w in e, e t c . ) consumed: what a) at b) the c) i-f c o n s u m p t i o n c e a s e d a t a n y t i m e , ■for s u c h c e s s a t i o n a n d t h e r e a s o n s r e s u m p t i o n ; and d> w h e t h e r y o u w e r e e v e r h o s p i t a l i s e d or i n s t i t u t i o n a l i s e d -for a l c o h o l u s e , o r a d v i s e d t o l i m i t o r s t o p a l c o h o l u s e , a n d , i-f s o , s t a t e t h e n a m e ( s ) o-f e a c h s u c h h o s p i t a l o r i n s t i t u t i o n o r m e d i c a l p r a c t i t i o n e r who t r e a t e d o r a d v i s e d you. 17 y e a r s age amount o-f consumption alcoh ol, alcohol and ■frequency state (e.g., began; o-f such consumption: the reasons -fob a n y age. Beer - in-frequent 1y . Co n s u mm e d v e r y l i t t l e a l c o h o l , perhaps a s i x pack/month w h ile in t h e s e r v i c e . Wine a n d o c c a s i o n a l l i q u o r n o w l e s s t h a n o n e ( 1 ) b o t t l e o-f wine/month. L e s s than t e n (10) c o c k t a i 1 s / m o n t h . Consumption c e a s e d hospi t a l i s e d . - f or e x t e n d e d periods w hile No. r; Q■hs; O tA**' i0 & 16. I-f any in secticid es (e.g., C hlordane, Lindane, DDT), r o d e n t i c i d e s ( e . g . , r a t p o i s o n ) , i n s e c t r e p e l 1e n t s < e . g . , DEET) or o th e r p e s t c o n t r o l compounds were e v e r used by you or o t h e r s around your l i v i n g or working quarters, s t a t e as to each: a) the b) a d e s c r i p t i o n o-f t h e col o r , sm el1); chemical ( e . g . , . powder, c) a description ( e .g ., shape, container m arkings) -for t h e d) the date e) the method o-f a p p l i c a t i o n ; -f ) the place it g) the -frequency h) w h e t h e r you. e x p e r i e n c e d a n y a d v e r s e r e a c t i o n c o m p o u n d a n d , i -f s o , d e s c r i b e t h e r e a c t i o n . None t o brand the name o r o-f generic o-f t h e color, with chem ical; liqu id, chemical use; best was o-f applied; application; o-f PI a i n t i - f - f ’ s VI. State n a m e o-f ' t h e respect to o-f t h e and to knowledge. MILITARY SERVI CE your armed m ilitary service: a) th e branch served; services in which b) the in clu sive dates o-f y o u r c) the in c lu siv e Vi e t n a m ; dates o-f s e r v i c e d) t h e n a m e o-f e a c h m i l i t a r y u n i t t o w h i c h were a s s ig n e d w h ile s e r v in g in or near V ietn am ; and t h e d a t e s d u r i n g w h ich you were a ssig n e d t o each such u n it s ; e) t h e name and a t w hich you near Vietnam were p resen t ■f) your im m ediate su p e r io r o-f-ficer's w h i l e i n or n e a r V ietn am ; and you service; in or near you l o c a t i o n o-f e a c h p l a c e o r a r e a were p h y s i c a l l y p r e s e n t in or and t h e d a t e s d u r i n g w h ich you at each such p la c e or area; name an d r a n k the g) the type o-f discharge you received United States Army. June 25, 1967 through June 26, 1970. April 4, 1968 through April 7, 1969. 3 6 2 n d A v i a t i o h S u p p o r t D e t a c h m e n t a t t a c h e d t o 2nd B r i g a d e 2 5 th In-fantry D i v i s i o n ; 1 s t A ir C avalry D i v i s i o n , 2 2 8 t h 2 2 9 t h C o m p a n i e s ; A e r o - S c o u t D e t a c h m e n t o-f t h e 1 1 t h Armored C a v a l r y a t Tay N inh; B - 3 2 Fi-fth S p e c i a l F o r c e s G r o u p ; A d v i s o r y T e a m 9 0 , M i l i t a r y A s s i s t a n c e Co mma nd, V i e t n a m 1 8 7 t h A s s a u l t H e l i c o p t e r C o m p a n y o-f F i r s t A v i a t i o n Brigade. U n i t p l a i n t i - f - f was a s s i g n e d t o was r e s p o n s i b l e ■for a i r s p a c e s e c u r i t y o r g r o u n d c o n t r o l o-f a i r c r a - f t t o i n s u r e p l a n e s and h e l i c o p t e r s d i d n o t -fly i n t o e a c h other. C l e a r a n c e - f or a i r s t r i k e s a n d s p r a y i n g m i s s i o n s , m e d i c a l e v a c u a t i o n s , i n s e r t i o n a n d e x t r a c t i o n o-f t r o o p s , t a c t i c a l and l o g i s t i c a l a i r - f l i g h t s . T a y N i n h P r o v i n c e , E a s t a n d W e s t , Da u T i e n g , T r a n g B a n g , Cu Ch i t o C a m b o d i a . P l a i n t i - f - f ws i n t h i s g e n e r a l a r e a t h e e n t i r e w h i l e h e was i n V ie tn a m . P l a i n t i - f - f was on t h e g r o u n d t h e e n t i r e p e r i o d o-f t i m e e x c e p t - for a c o u p l e o-f h o u r s p e r m o n t h w h e n b e i n g t r a n s p o r t e d -from o n e p l a c e to another. Major B e l l , were o th ers Major which Scully. F i e l d Grade 0-f-ficers. plainti-f-f cannot r e c a l l . There H onorable. 18. With respect to each i l l n e s s , injury, wound o r other m edical or p sy ch o lo g ica l co n d itio n experienced by you d u r in g your m i l i t a r y s e r v i c e in or near Vietnam, s t a t e ; a) t h e d a t e o-f y o u r o th er m edical or i l l n e s s , i n j u r y , wound, o r psychological condition; b) a description o th er medical a description c) t h e c a u s e o-f t h e i l l n e s s , i n j u r y , w o u n d , m edical or p s y c h o l o g i c a l c o n d i t i o n ; o-f t h e i l l n e s s , i n j u r y , w o u n d , o r or p s y c h o lo g ic a l c o n d itio n , in c lu d in g o-f a l l s y m p t o m s ; 13 or other ?4tj l ,2 b ^ d) t h e n a m e a n d r a n k o f t h e p e r s o n t o whom y o u f i r s t r e p o r t e d t h e i l l n e s s , i n j u r y , wound, or o t h e r m e d ic a l or p s y c h o l o g i c a l c o n d i t i o n ( i f a n y o n e ): e> th e d a te t h a t you f i r s t rep o rted wound, o r o t h e r p s y c h o l o g i c a l or f) t h e name, rank and l o c a t i o n o f e a c h p h y s i c i a n or ; o t h e r h e a l t h c a r e p r o f e s s i o n a l who t r e a t e d y o u r i l l n e s s , i n j u r y , wound, or o t h e r p s y c h o l o g i c a l or m e d ic a l c o n d i t i o n , i n c l u d i n g t h e d a t e s and p l a c e s o f t r e a t m e n t , and a d e s c r i p t i o n o f t h e t r e a t m e n t you r e c e i v e d ; and g) the i l l n e s s , injury, m edical c o n d it io n ; t h e name and l o c a t i o n o f e a c h h o s p i t a l or o t h e r h e a l t h c a r e f a c i l i t y w hich t r e a t e d your p s y c h o l o ­ g i c a l or m edical c o n d i t i o n , t h e d a t e s of t r e a t m e n t , and a d e s c r i p t i o n o f t h e t r e a t m e n t t h a t y o u r e c e i v e d . J u ly , 1968, in ju red jaw from r o c k e t e x p l o s i o n . U rinary t r a c t i n f e c t i o n s from A u g u st, 1868, onward. Pain e s p e c i a l l y when u r i n a t i n g , b u t a l m o s t c o n t i n u o u s . Sometime around Septem ber t h r o u g h November, 1 9 6 8 , P l a i n t i f f w a s m e d i v a c e d t o Cu Ch i f o r t h r o a t exam ination. P l a i n t i f f was u n a b le t o sw a llo w . P l a i n t i f f w a s t a k e n t o T a y N i n h B a s e Camp H o s p i t a l . P l a i n t i f f ws e v a l u a t e d p s y c h o l o g i c a l l y January, 1869, for f i t n e s s fo r duty in i n or a b o u t combat r o n e . Combat. T h r o a t , f e v e r o f unknown o r i g i n , and ja w i n j u r y — D o c t o r a t 1 8 7 t h A s s a u l t H e l i c o p t e r Company, who referred t o 25th In fa n try H o sp ita l. H ospitalired 4 t o 5 d a y s f o r f e v e r o f unknown o r i g i n and t h r o a t . Jaw — o u t - p a t i e n t , 1 8 7 t h A s s a u l t H e l i c o p t e r Company H ospital. P sy c h o lo g ic a l - o u t - p a t i e n t , 187th A s s a u lt H e l i c o p t e r Company H o s p i t a l . January, 1969, p s y c h o lo g ic a l. November, 196B, t h r o a t , f e v e r and jaw i n j u r y . September through o f unknown o r i g i n , Unknown. 1 8 7 t h A s s a u l t H e l i c o p t e r Company H o s p i t a l f o r a l l i n j u r i e s . The jaw and p s y c h o l o g i c a l e x a m i n a t i o n s w ere on an o u t ­ p a t i e n t b a s i s and p l a i n t i f f was r e t u r n e d t o d u t y t h a t same d a y . The s w a l l o w i n g d i f f i c u l t i e s and f e v e r o f unknown o r i g i n o c c u r r e d s i m u l t a n e o u s l y , and p l a i n t i f f was s e n t t o t h e 2 5 t h I n f a n t r y H o s p i t a l and h o s p i t a l i z e d for several days. 12385 1A J 19. D escribe any o t h e r m e d i c a t i o n t a k e n by you during your m i l i t a r y s e r v i c e ( e . g . , Dapsone, C hloroquine, Prim aquine, B in o c t a l) , s t a t in g as t o each: a) the brand name o r generic b) t h e - f orm o-f t h e m e d i c a t i o n i n j e c t i o n , e t c . ); (e.g., c) the color, taken; d) the reasons e) the you n a m e a n d r a n k o-f th e m edication; ■f) the dates g) the and amount h) w h ether you e x p e r ie n c e d any a d v e r s e m e d i c a t i o n a n d , i-f s o , d e s c r i b e t h e shape, - f or size o-f a n y p i l l taking the m edication; the the the m edication; p ill, and you. t o o k o-f n a m e o-f t h e person (s) capsule, or capsule who g a v e m edication; m edication taken (e.g., p ills/d ay); reaction to reaction. the PI a i n t i -f -f n e v e r t o o k a n y o-f t h e m e d i c a t i o n s d e s c r i b e d e x c e p t a s a l m o n - c o l o r e d ( p i n k ) h o r s e t a b l e t -for a n t i m a l a r i a w h i c h P l a i n t i - f - f t o o k a -few t i m e s u p o n - f i r s t a r r iv in g in Vietnam in A p r il, 1968. One S g t . F r e e m a n w a s m e d ic a t io n , which he sleeping quarters. i n c h a r g e o-f d i s p e r s i n g t h e u s u a l l y d i d by l e a v i n g i n t h e Plainti-f-f consumed a c o u p le Vietnam, th en sto p p e d . o-f p i l l s upon a r r i v a l in Di a r r h e a . 20. State whether you ever received any training, instru ction s, warnings or h e a l t h and s a -f e ty in -fo r m a tio n c o n c e rn in g h e r b i c i d e s during your m i l i t a r y service, and identi-fy as to each: a) the dates you r e c e iv e d b) the location c) t h e name and r a n k i t was r e c e i v e d ; where the -foregoing; received; o-f the person (s) -from w h o * <$0 15 d> the and substance of any oral e) th e t i t l e , d a te , author of any w r it t e n m aterial inform ation received; or s o u r c e , received. and c o n t e n t NONE 1. Set been forth w ith resp ect to exposed to h erb icies: each tim e you c l a i m a) the date of the alleged herbicide exposure; b) the tim e of day of alleged c) t h e c l o s e s t g e o g r a p h ic a l or p o l i t i c a l r e f e r e n c e p o in t ( e . g . , h i l l , town, lan d in g zone) t o th e p l a c e you b e l i e v e you were exposed; d) a d escription exposure; e) a d e s c r i p t i o n o f how t h e h e r b i c i d e was b e i n g a p p lie d ( e . g . , h e l i c o p t e r , a i r c r a f t , hand, e t c . ) ; f ) a d e s c r i p t i o n of your alleged exposure; g> t h e manner y o u b e l i e v e your body was p h y s i c a l l y exposed to th e h erb icid e ( e .g ., skin con tact, i n h a l a t i o n , i n g e s t i o n or s w a l l o w i n g ) , and, i f you b e l i e v e y o u w e r e e x p o s e d by c o n t a c t on y o u r s k i n , i d e n t i f y t h e a r e a s o f s k i n t h a t came i n contact w ith the herbicide; h) t h e name a n d r a n k o f o t h e r p e o p l e t i m e o f a l l e g e d e x p o s u r e ; and i ) w ith r e s p e c t t o any d eceased proposed r e p r e ­ s e n t a t i v e p l a i n t i f f , s t a t e ho w s u c h p l a i n t i f f w ill d em on strate any of th e inform ation r e q u e s t e d i n s u b p a r t s a) t h r o u g h h) o f t h i s i n t e r r o g a t o r y , i d e n t i f y i n g any p e r so n s w ith such i n f o r m a t i o n who w i l l t e s t i f y a s t o s u c h p l a i n t i f f ' s exposure to h erb icid es. of the the terrain to have exposure; at the activities at place the of tim e present at alleged of the Nu i B a D i n h , T r a n g B a n g , Da u T i e n g — t h i s i s t h e g e n e r a l a rea where p l a i n t i f f r e c a l l s being sprayed d i r e c t l y . On two o c c a s i o n s i n t h e e a r l y morning, p l a i n t i f f remembers being caught in a d r i f t of foggy, foul sm e llin g chemical sprayed by U n ite d S t a t e ' s p la n e s . The f i r s t o c c a s i o n , was e i t h e r J u n e o r J u l y o f 1 9 6 8 , and s h o r t l y a f t e r w a r d s , t h e 16 P lain tiff developed vom ited. The s e c o n d o c c a s i o n , t h e P l a i n t i f f a f e v e r o f unknown o r i g i n a week o r s o t h e r e a f t e r . On t w o o t h e r o c c a s i o n s , o n e w h e n a UC 1 2 3 g o t h i t w i t h g r o u n d f i r e a n d dumped i t s l o a d o f c h e m i c a l s , P l a i n t i f f was sp ra y ed d i r e c t l y . T h is o c c u r r e d around November, 196B. The o t h e r o c c a s i o n was a f l y b y 5 0 - 1 0 0 m e t e r s f r o m me. P l a i n t i f f was a g a i n s p r a y e d d i r e c t l y . All spraying P lain tiff Head, arms were was and by walking chest aircraft. on t h e were ground. exposed. O n l y t w e n t y - t w o men i n U n i t . P l a i n t i f f w o r k e d on g e n e r a t o r s by h i m s e l f . E x p o s e d w i t h E4 s o l d i e r on i n i t i a l s p r a y i n g a n d w i t h RVN r e g u l a r s s e c o n d t i m e . P l a i n t i f f was e x p o s e d by h i m s e l f on t h e n e x t tw o occasi ons. Dated: C a r l e P l a c e , New Y o r k J a nuary 14, 1984 PLAINTIFFS' MANAGEMENT COMMITTEE BY DAVID J . DEAN, ESQ. DEAN, FALANGA & ROSE, One O l d C o u n t r y Ro a d C a r l e P l a c e , New Y o r k (5U>) 2 4 0 - 9 3 3 9 ESQS. 11514 17 CO 12 UNITED STATES D I S T R I C T COURT EASTERN D I S T R I C T OF NEW YORK In r e "AGENT ORANGE" Product L iab ility : L itigation r MDL N o . 301 ANSWERS OF GEORGE W. EWALT, J R . TO DEFENDANT' S INTERROGATORIES TO PROPOSED REPRESENTATI VE P L A I N T I F F S P L A I N T I F F ' S MANAGEMENT COMMITTEE: P h i l l i p E. Brown, Esq. H o b e r g , F i n g e r , B r o w n , Cox & Mol 1 i g a n 703 Market S t r e e t (1 8 th F lo o r ) San F r a n c i s c o , C a l i f o r n i a 94103 T h o m a s W. H e n d e r s o n , E s q . B a s k i n !< S e a r s Frick B uilding (10th F I.) P i t t s b u r g h , PA. 15219 S t a n l e y M. C h e s l e y , E s q . W aite, S c h n e id e r , B a y le s s and C h e s l e y Co. L . P . A . 1 5 1 3 C e n t r a l T r u s t Tower F o u r t h and V i n e S t r e e t s C i n c i n n a t i , Ohio 45202 Benton Mussel w h it e , Esq. John 0. 0 ' Quinn, Esq. 609 Fannin ( S u i t e 517) Houston, Texas 77002 David J. Dean, Esq. D e a n , F a l a n g a t< R o s e One O l d C o u n t r y Ro a d C a r l e P l a c e , Ne w Y o r k & Stephen J. S c h l e g e l , Esq. S c h l e g e l ?< T r a f e l e t , L t d . One N o r t h L a S a l l e S t r e e t S u it e 3900 Chicago, I l l i n o i s ¿0602 11514 N e w to n B. S c h w a r t s , E s q . Houston Bar C e n te r B u il d i n g 7 2 3 Main ( S u i t e 3 2 5 ) Houston, Texas 77002 Gene Locks, Esq. N eil P eterson Esq. G reitser & Locks, Esqs. 1500 Walnut S t r e e t P h i l a d e l p h i a , PA 19102 12869 UNI TED STATES D I S T R I C T COURT EASTERN D I S T R I C T OF NEW YORK X In re "AGENT ORANGE" MDL No. 381 '.Vf Product L i a b i l i t y Litigation. X I. ]. - GENERAL S t a t e y o u r name, s o c i a l s e c u r i t y number, m i l i t a r y s e r v i c e nomc e**, «nd each a d o '■e = c a t w h i c h y o u h a v e e v e r lived (excluding tim e during a c tiv e m ilita r y s e r v ic e ) , s t a r t in g w ith your cu rren t a d d r e ss. and g i v e t h e d a t e s you lived at each a d d r e ss. J r . : = . = . fc 1 6 9 - 3 3 - 4 5 3 8 ; M . S . # U S 5 2 8 0 7 8 4 5 . e c - ç a W. Ew>j t . a c t A r d r e s i . e c : Ft e c e n i . at 4 331 Lau*“i s t ö r , P h i l a d e l p h i a , PA : - ovg=4 y e a r =. P - i o r t o t h a t 701 Summi t Avenue, Kr - sc e l p h i a . PA i 912 r .= y e s : s : 5300 block Ridge Avenue, F •: 1 c hi a .. 3 year: block Jamestown Street, F . rdclphi a, 1 yes*: 200 b ) ock W e n d o v e r Street, -:Lscsi phi a, 2 year: “21 Fenn Pi n e s Boulevard, C lifton u ■::chtz, FA appro :-1 msts I y 2 years; m ilitary service, 2 \ s ? -= : 731 Fenn Pines Foulevard 6 y e a r s ; 729 West Wood i. • • ¡ . . a , Clifton Heights. FA, 2 years; 1 3 4 R i d g e w a y A v e n u e , I-,r-.-coc. FA B or 9 yea~s; Greenway Avenue i n S h a r o n H ill F s " s . ' l vcinis. Born in ger aid Mercy H o s p i t a l , D a r b y , F’A sc camber 34. 1947. Identify e a c h e d u c a t i o n a l i n s t i t u t i o n you attended, the cates of your a tte n d a n c e , and d e s c r i b e any p h y s i c a l or mental e x a m in a tio n you r e c e i v e d at or in c o n n e c tio n w ith y o u 1- a t t e n d a n c e a t e a c h i n s t i t u t i o n , s t a t i n g w i t h r e s p e c t t o e a c h s u c h ex a n d n a t i o n . Grade Sch ool at S t . G abriel's, N o r w o o d , PA f r o m 1 s t t o 6 t h grade; 7 t h a n d 8 t h g r a d s B l e s s e d V i r g i n Mary i n D a r b y , PA; four years of h ig h sc h o o l a t Monsenior Bonner In . D r e x e l H ill, PA a f t e r s e r v i c e . n i g h t sc h o o l in a p p r o x im a t e ly 1978 or 1979 at C hestnut H ill C o lle g e . No r e c o l l e c t i o n ' : o f any sp ecific testin g, p h y s i c a l l y or m e n t a l l y , during^the above p eriod other than reg u la r s c h o la s t ic t e s t in g such as SAT's. Hs h a s n o p r e s e n t r e c a l l o f t h e d a t e s o f t h e S AT’ s . R outine ph.si c a ls , d a t e s unknown. . : a/ the date of the e x a n : n a t i on; • 4 ' 1 2 - 3 7 0 1 A. b) tf"iE h o s p i t a l o r was g : v e n ; and c) the name a n d e x ami ns'.; o n . inE titution address of where the such person exam ination conducting the If you have e v e r made a c l a i m - f or bene-fits -for any m edical condition (including worker's com pensation, veteran's bene-fits, s ta t e or -federal d isab ility or insurance o r u n i o n c-r t h : r d p a r t y m e d i c a l plans) state w ith r e s p e c t t o each such cla im : a ■ c =■. - -f: t s . t '* the c ' t^-e c l a i m n u m b e r d> the entity to whom the claim was made, including the name and address: e> she medical corrrii t.io~ for which the claimi was made: f■ ans t*-e di spc-ci to* date etc.: of the claim or other i d e n t i -fi c a t i o n o-f t h e claim of the claim. Claim -for V e t e r a n Adm:i r. i = t r a t i o n b e n e f i t s f o r left knee, f r a c t u r e d i n Ts n. a r w h i l e i n t h e s e r v i c e . F o r t H o o d , T e x a s i n 19o2. Thereafter. a c l a i m f o r p o e t - t r a u m a t i o s t r e s s . F'ric-r t o f i l i n g th e p o s t - t r a u m a t i c s t r e s s c la im -a n d subsequerrt to t h e f r a c t u r e d I-.nee c l a i m i . P lan tiff filed an Agent Orange claim . Claims have bee- n ma d e u n d e r G e o r g e W. Ew alt, no Jr. C e r t a i n h a d W o r k e r ' s Comip . c l a i m s w i t h t h e B e l l T e l e p h o n e Co. Ap p r o - : i m e . t e l y 6 t o E y e a r s a g o Mr. Ewalt broke a finger on the job. The claim was made w ith Bell Telephone, medical b i l l s were p a id . A p p roxim ately 4 o t 5 y e a r s a g o , a d d i t i o n a l 1 y, l e f t arm, e l b o w , s h o u l d e r s t r u c k by van. M e d i c a l b i l l s w e r e p a i d , No r e c o l l e c t i o n o f l o s t tim e for e it h e r . ) l » } •I'“' i f i w. If you have ever filed or otherw ise commenced a , , legal 12571 action in c o n n e c t i o n w i t h £n. - m e d i c a l than t h is a ctio n ) s t a t e as tc each such condition action: (other a) the date that action was -filed or otherwise commenced, trie court c* admi ni strati ve body, ^tht- -i■11 title cef the action, the index or other ident l -fyi nc number, and the identity o-f all parties to the action; b> s description o-f the medical condition in connection with which the act ion was -filed, and how you believe that medical condition occurred: •r ■ a. ce s c" l p t . on o s t \ s - o u t c o t .s o-f t h e a c t i o n , o r i t s p--e» i s t a t u s i -f i t . = s t i l l p e n d i n g ; arc- e> o-f the cates and amount s o- any payments, ei the-" as a res. It c-f s- judgment o** sett 1ement, which ye: ha-e re:.=■:'-s-d or which vc-u -:■■■•e scheduled to recei-s. Automobile accids-nt e-.c-pro; imstely 10 years ago, and cut o-f wor k -for some wee! s. jury to neck and uppe- tad . Emergene, treatment and !■-•?:= st Roxborough Memorial Hospital. th-erea-fter. -followed b . his -family ph.siciar-. r-r. Joan riurlock. The case was settled with carrier. In approx :mat el y l=6t-, had ar- accident while a passenger in car. Injur - to head end r,e: : . lost little -.■-.pensea, No recollection c- attorney’s name. II. Identi-fy em ployee each: EMPL-jVrtENT HISTORY . arid d e s c r i b e e a c h j o b y o u have held, o t h e r s or s e l -f-empl e y e d , and s t a t e by whether as to a) t h e n a m e a n d a d d r e s s o-f y c u r e m p l o y e r , t h e a d d - e s s o-f y o u r w o r k p l a c e , t h e n a t u r e o-f t h e b u s i n e s s a n d your job t i t l e ; b) your c) th e date the job began ■for t e r m i r . a t i o n o-f t h e d) the* d a t e arid p l a c e o-f e = : : h p h y s i c a l a n d m e n t a l e x am: n e t i or. t h a t y o u u n d e r w e n t i n c o n n e c t i o n duties and resp on sib ilities; and e n d e d j o b ; and and t h e reasons w i t h s u c h j o b , i d e n t i f y i n g t h e name and a d d r e s s of each m edical p r a c t i t io n e r con d u ctin g th e e x a m i n a t i o n a n d t h e n a m e a n d a d d r e s s o-f a n y m e d i c a l i n s t i t u t i o n a t which such e x a m in a tio n s was conducted . W hile in high school in approxim ately 1964 worked part-tim e f o r Ad a ms C a d i l l a c , 2 0 t h and Sansom Streets, P hiladelph ia. Washing and c l e a n i n g t h e a u t o m o b i l e s . He was term inated when h e g r a d u a t e d f r o m h i g h school and went into fu ll lin e employment. W hile in high school, George a l s o was a vend or f o r t h e N y l o n Brothers food c o n c e s s i o n s at th e stad ium s s e l l i n g hot dogs, candy bare, cokes, 7-Ups and root beer beverages. After high P ublishing o p e r a t e d an L e ft Curti o p p o r t u n i t -, / * in the sch o o l, accepted fu ll-tim e work Co. in June of 1965 t o January of a u to m a tic l a b e l i n g machine. Curtis 1966. He P u b l i s h i n g Co. for a b e t t e r 'employment an. S o r e n s o n I n d u s t r y . C o l w i n , PA. a n d w o r k e d : re shop a s mat a! man, (bringing m aterial to Th e c h e n d s : ,-.heo he w a s d r a f t e d i n t o v h e military. In 1968, returned to Sorenson Industries as a m achinist. fcr 3 o: 4 m o n t h s . He l e f t i n t e n d i n g t o go baci t o s c h o o l . “ h e r e-af Le*". e m p l o y e d b y W i n g s a n d Wn e e l s as a p a r t - t i m e d rive*- for a f r e i g h t company. In 1769. he became a f u l l - t i m e e m p lo y e e w i t h Postal E- f c' - vi ce f o r 1 y e a r i n Wayne. PA. as mai . mari d e l i v e r ì n o mai 1 . the U.S. a regular In ¡ 9 7 0 , becam e e m p lo y e d w i t h th e t e l e p h o n e compa.-y, B e l l c>f PA. He s t a g e d a.s spl i cer - h e l p e r , an d was t h e n p r o m o t e d a f t e r 13 m o n t h s t o l i n e m a n . Was a l i n e m a n u n t i l 1 9 5 3 . - A l t h o u g h h e w a s a. t i t l e d l i n e m a n u n t i l 1 9 8 3 , in 1981 t c 1 9 5 3 d u e t o h i s h e a l t h p r o b l e m s h e performed fu n c tio n of o f f i c e worker. He b e c a m e a f a c i l i t y a s s i g n e r in 1983 and i s p r e s e n t l v em p loyed a t B e l l T e l e p h o n e at that p o sitio n . P lantiff b e l i e v e s he i s p r e s e n t l y employed by Bell Avantic, alth o u g h has not yet r e c e iv e d f i r s t chect a f te r telephone com panies reorganization. Any physical exam inations during the period of employment with S o r e n s o n I n d u s t r i e s a n d ma ny o f t h e p a r t - t i m e j o b s b e f o r e were perform ed by f a m i l y d o c t o r , Dr. Marvin W e r lin sk y , A l d e n , PA. 7. With r e s p e c t t o e a c h jot- i d e n t i f i e d i n response to Interrogatory No. 6, id e n tify each o n -th e-jo b injury, medical c o n d i t i o n or a c c i d e n t t h a t you e x p e r i e n c e d , and s t a t e s e p a r a te ly as to each: 4 a) a description acci dent : of the injury, m edical b) t h e d a t e ; - c-f acci dent : the in.iurv, c) ¿he, trea tm en t r e c e iv e d , in c lu d in e th e t r e a t i n g p h y s i c i a n ' s nane and a d d r e s s and a l l h o s p i t a l ­ i e n t i o n s , e p e r a t i ons. a n d m e d i c a t i o n r e c e i v e d . m edical condition condition or or E a c h on t h e jot- i n j u r y r e c a l l e d h a s b e e n s t a t e d . U»-.j i s a t Sorer son* s . he d i d have a n o t j o b r e l a t e d injur-, A* none - , h e s l i c e d t h e t o p o-' h i s -f: n g e r . Treated at ? : : w*e-- e l a Me- • c ■ Ho: ;-i t a. l i n r=-.rbv, PA. family medical history Elate t h e n a m e s a n d a d d r e s s e s , o-f v o u r s p o u s e , children, t'cthei's. s is t e r s , parents, grandparents, aunts, uncles, cc.-cins, n ie c e s . nephews a.r-d grandchildren, and with >- a s p e c t t c - e a c h : a'* i-f a n y o-f t h e m a t t h e t i m e o-f o-f d e a t h : : are- d e c e a s e d , d e a t h and t h e state tim e, h i s or her age p l a c e ‘a n d c a u s e b) identi-fy each illn ess, disease, .d isab ility, m e d i c a l c o n d i t i o n e v e r had by e a c h d u r i n g h i s o r h e r l i - f e t i m e w h i c h r e q u i r e d p r o-f e s s i o n a l m e d i c a l a t t e n t i on. c) identi-fy any tirth m i s c a r r i a g e s which t h e y d) w ith r e s p e c t t o each r e l a t i v e , id en ti-fy each medical p r a c t i t i o n e r and m e d i c a l i n s t i t u t i o n t h a t t r e a t e d them , and s e t -forth t h e d i a g n o s i s . or genetic had; and de-fects or or R e s i d e s w i t h h u s b a n d w i f e ' s name i s S h i e l a S . E w a l t . One child, a daughter, 12, Tara C a t h e r in e , who al se­ r e s i d e s a t home w i t h h e r m o t h e r and - f a t h e r . PI a i n t i - f - f h a s n o b r o t h e r s , a n d h a s t w o s i s t e r s . S u s a n arc Maroaret Scanlon. M a r c a r e t i s t h e o l d e s t and m a r r ie d t o Peter F orlan o, S t a f f S a r g e n t , U . 5 . Ar my , s t a t i o n e d a t Ft. Dix. There- a r e n o o t h e r b r o t h e r s a n d s i s t e r s . . Parent George and E u n i c e , r e s i d e a t 733 P e n n P i n e s Boulevard. Father, grand-father and great grandfather we**e all extended career sc-ldiers. The h e a l t h of parents and s i s t e r s i s good. Grandparents: father's side: Ch a r 1 e y ’ E w a l t , b o r ri J a n u a r y 2 9 , 3 3 7 c , d i e d J u l y 1 8 , 1 9 6 8 , E r y e a r s o l d . F a . t h e - * s m o t h e r r s na me i s H a z e l F o r c e Ewa l t , b o r n J u r i s 1 , 1 3 5 8 . D i e d S e p t e m b e r 1 0 , 1 9 2 3 . K a. li A• n -I Ha d;-:c . • Mo t h e r ' s mo the.-- i s E u n i c e tr - r z r* H j v c - t t t- ► t :■■■r* £• - t h e r Cecemfc e r 17 or 26, -4 -r e.Wr €r 1 £ . . “7JV c/ 2 y e a r s Of f O t , J o h n H. — — »— i.n in S-- a n o f 2, Jul , K¿*1 C: :r-r e t 4— ■^ ~ passed iij ,-h Mother’s side; i' >t ff ' s fa tha-t ' s o► *a.r z : c th e- 1i » ed to be 9, -father * s gr a->df at,her 1; .ec to be 89 • and 1 FI : r1 1 iff ' s father's oranz*at her t a *d / brothers and and t-is-y ail lived be-.-ond 30. Fattier is frc-m s i tnrs ha !-.iria.i~ Cit y. K.cfjiuan. nis and Jncles: M other's sics. F 1 a i n t i f f r s mc- t ner h a d 7 b r o t h e r s a n d 5 s i s t e r s . . T.vcbrothers are deceassd. 1 »*=•= h i l l e d i n t h e K o r e a n War , the other had an i n d u s t r i a l a c c i d e n t s o m e t i m e in the 7 0 's. B e l i e v e s t h a t c-ne c-- h i s u n c l e s h a s d i a b e t e s , the rest of them a r e in good h e a l t h . Knows of no major illn eses, i f any. w ith th e e x c e p t i o n of one of h i s a u n ts on his m o t h e r ' s ; s i d e wh o h a s d e v e l o p e d l e u h e m i e . in the past year. H e r n a m e i s Ne"-e>*st J o h n s o n ar.d s h e l i v e s in Norwood, PA o n Amo s ] a n d F o a d . With r e f e r e n c e t o n i e c e s and n e p h e w s , h a s 3 n i e c e s and 1 n e p h e w . T h e i r names a r e M ichele Scanlon, 13, good health? Stephen Scanlon, approxim ately 7 or 8 y e a r s old, good health; Yolanda Forlano, a p p r o ; - : i m e t e l y 12 y e a r s o l d , gc- od h e a l t h e x c e p t for s c o l i o s i s l a s t y e a r and A l i c e F o r l a n o , approxim ately 1 0 y e a r s o l d . fJc- g r a n d c h i 3 c** er.-. IV. VETERAN' S MEE'ICAL HISTORY t X, 9. S t at e: a) the b; the c) da te­ n e me i 1i t y * ¿ 2 r e s e. m e d i c a l pr £ . a n d e a r r,i e c c o a l c on if ■i . c ; t : o n or protls*. that vou mother f r 1 i ob .*.s .-^ r ..a l-_ - t . d -, had : connect:on j a ho** - . r-i-, c i{i »•.=.r' -. l t * ! ■» a A . C . .» r. .e .-r ,»r u*y , a r.o othor Kr . -■-1rj C.i: i ■» . ■. C-1 r th ci •f£*'"t.r-r •»•. - • 10. il iries= , d iSr Ice-c:- y Gri-C.h 1njU'- y, ph-=:cal or men t=.’ conditi on yo. w k 5;*.s ' + "»£.O*1 "cif** or pe-mar.ent ar-c! sta t o s a: : a) or other eve'had. *r a t e 1 y as each medi cel pr act iti oner end/or med s e e r , o r v i s i t e d b y you. - for t h e p u r p o s e s o - c o n s u l ­ t a t i o n , d i a g n o s i s , p r o g n o s i s , r - r s y i . ‘t r e a t m e n t o r o t o e - c a r e , s p e c i f y i n g t h e d a t e s c-f a i l h o s e i t e l ications: i^ '■ 1 t) t h e d i a g n o s i s or p r a c t i t i o n e r and p r o g n o s i s m a d e by e a c h m e d i c a l m e d i c a l i n s t i t u t i o n : and c) t h e n a t u r e a n d e . : t e n t o-f t h e c a r e a n d t r e a t m e n t r e c e i v e d i n e a c h m e d i c a l : r. = t i t u t i or. . a^d - from each m edical p r a c t i t i o n e r . Other t h an t h e c o n d i t i o n s a s e n u m e r a t e d i n 11 infra, p lain tiff s u s t a i r. ec a b r o k e r l e f t w r i s t a t 1 0 y e a r s o f a g e . F i t z g e r a l d He s c i t a l ; Mercy length of d i s a b i l i t y g u e s s sc at 6 t o 8 weeks. Ri g h t e a r m a s t o i d o p e r a t i o n appr o:-: lm a t e l y 6 y e a r s o l d , F i t z g e r a l d M e r c v Ho s c i t e l . d i s a b i l i t y u n k n o w n . b e l i e v e s h e w a s i n t h e h o s p i t a l fQ£ JL> ? '\ it for I appro: . 1 month. At a g e 1 0 . b e c a u s e o f c o n t i n u i n g e a r a c h e s , and removed he wa s t r e a t e d w i t h r a d i a t i o n on r i g h t e a r skin t h a t h a d o r own o v e r t h e s c a r t i s s u e a n d n o p r o b l e m s -rays.-for the auto sin ce then. He h a d n o r m a l r o u t i n e ' - r e - s o-f h i s b a c k i n the V.fi. accident of h i a n e e I:. H o s p i t a l w h e n t h e y t r i e d a s p i n a l t a p , x - r a y s o-f h i s l e - f t knee. Apid: t j o n a 1 1 y , h e b r o k e l e - f t w r i s t i n t h e s u mme r o-f 1 9 3 3 when he - f e l l w h i l e p l a y i n g s o f t b a l l . He w a s x-rayed i n W i l k e s t a r r e M e d i c a l C e n t e - H o s p i t a l , W i l k e s B a r r e , PA a n d a t Rc- rbör o u g h M e m o r i a l H o s p i t a l i n P h i 1 a d e l p h i a . FI a n t i - f - f recalls the -first d o cto rs is Br. Paul Keenan, Norwood, FA; D*‘ . Patton, Alden, FA; Dr. Wor kl i n s '> v , A l d e n , PA; D r . J o a n H u r i o c k , P h i l a d e l p h i a , PA at F a x t O'* o-ugh M e d i c a l B u i l d i n g . The r i g h t ear problem at c --e-c: s c u s s e d w;.:s h a n d l e d c D r . McConnell in P i l g r i m c r ‘* v ‘ i i . FA. the cceratior»-as at Fitrgeral-r M~rc> Ho? p i t a l c-nd trea tm en t a l s : ’ in Darby, PA. Dr. Joan H u r l o c i i r more- or l e s s ar.d n = s b e e n PI s i n t i -f -f ?s f a m i l y doctor since- l a t e r£ 0 ' s o r s a ' l y r7 0 ! s . Dr. G sc'ge M. W ilson, al sur g e o n , Fa . b o r o u g h M e m o r i a l -ospita.l removed *•■= s k i n gr c - w t h s i ri - . he h e a d , right arm. le-ft legs, t s -C: a n d t h r o a t . F 2 «•.* r,*.: -f -f w a s r e f e r r e d to- D r . Wi 1 s o n D» Dr. i c e ! . R e c e n t 1 > h a ? c s e n s e e n b> R o n a l d D c d a r i o , M. D. fci s A g e n t O r a n g e p - - c o l errs, a n d h a s b e e n s e e n b y e n u m e r a b l e d o c t o r t ¿.± the- V'.A. Add: X i o n e ! 1 y , Pi a.i n t i -f f ad h i s t o n s i l s o u t a i a g e 4 o r sc at F : t c c-er a 1 d Me - c y H c-scital. Perhaps t : -i same p h y s i c : a" that did his e=- *. F’i a i n t i - f - f s t i l l h a s h l sa p p e n d ! O p t h a m o lo g is t , is Dr. C-oroco, F.o o o r o u g n Medical B u i l d i n g . Has b e e n s e e n by Dr. Barbara Rockett initially with t h e V.fi. , and her p r i v a t e practice at Philadelphia I n s titu te . 2 11. i With respect to each injury, illn ess, d isab ility, or o t h e r p h y s i c a l or m e n t a l c o n d i t i o n i d e n t i f i e d i n r e s p o n s e to Interrogatory 10, i d e n t i f y each such c o n d itio n that you claim or b elieve was c a u s e d by or arose out o-f ex p o su re t o Agent Orange, 2 , 4 - D . 2 , 4 , 5 - T , d i o x i n o r some c o m b i n a t i o n t h e r e o f , and s t a t e s e p a r a t e l y a s t o e a c h : See a.' #11 f o r A g e n t a description 0-ange poisoning o f e a c h symptom; problems, c) t h e d a t e and manner i n w h i c h e a c h s u c h symptom f i r s t m a n i f e s t e d i t s e l f or w a s made known t o y o u ; and I s en O r*rj 1 tCi c! se-vC-re stomach pains at base- camp in Phuc-Vinh requirino reassignment ir o n t combat arid treatment. Skin growths, including a basal cell carcinoma, shingles, chi or acne, elevated porp.'-.et in level. Numbness: in hands and -feet, pains in joints. pesine along the Lack. muscle pains concentrated in his legs, but all through oodv; muscle spasms all through Jr-ody: p: ne and needles sensations in scalp, pains that -feel as. if hot needles are being inserted in hie. body, revere rearti one to beer and alcohol; fatigue, chest pai ne, peripheral neuropathy, eyes are sensitive to I i Ç. i unnatural aging of nails; Nausea; Numbness on the la-ii side of his jèh. High blood pressure, nervousness, ds> :■essi on, other associ ated mental problems, greater sus espiib:1 1 1v i o di seas* s , illnesses, and ange-*. t s . :rromr: a , delated stress syndrome; c e d i n e in p 1 sir i. :■•:t h . ii f i ci.l i -, wi th memo- and l o~ :ent: at ; on . . an. :e t . ri oslie-es. that the symptoms -firs". became when he auffe-ed severe pains in the field, and was trc-a.eJ in the field f or toils and growths on h_ = r- k* »“. • Jd-.'tit v each drug or m e d i c a t i o n ever used or nal.en by y c . . ir-cl udi *i c. but not limited l O, i l l e g a l , rec-eat i ona.i arc! O'■£!"-the-: ountov cirugs. and f o r each drug or fTiirci cat i o n , set forth the following with respect to each: a’ the -brand name, generic name, or "street nans" of the drug; b' the date of use: c > the amount usee during each period o f use; d> the name and address of the physician, i f prescribed the drug; e) a description of reasons for your u s e o f drug; and f> whether you have ever received any medical treatment or counseling in connection w i t h your use of drugs. Marijuana, any, who the de.edrine pills,, tai.en in Vietnam, net before 9 12378 ; or a f t e r . Th e d e x e d r i n e w a s h a n d e d o u t b y t h e Army'. In a d d i t i o n . P l a i n t i f f h a d p r e s c r i b e d - f or h i m a t r a n q u i 3 i : er in the 7 0 's. It was prescribed by a physician w*- c s u t s t i l u t e d -for h i s - f a m i l y p h y s i c i a n , Dr. Hu*"l oc* . F or approxim ately one year during 1980 P l a i n t i f f wa s o n f j e r d i l p r e s c r i b e d b y V . A . p h y s i c i a n s . A d d i t i on a I drugs i nl c u d e d Tylenol ■for muscle pains, p en icillin ; \ : t a.-.i n B 1 2 -for s h i n g l e s . The V.A. also p r e s c r ib e d a high regim er of vitam in s in c lu d in g vitam in B a n d -f p i i c £■: : d . -. c o n d a t i o n tnat you h a v e s. . . c h c. o : d ■ ~ o n : I d e n t : -f . e wi t h r5s ; . *f . ; i 2 a s i a 4. <••• i n a t • d e s cr : hs f - . r e : e i . t d -'c; ) c:-:è: dur i r,g w r j c h ever >. c-u h a d t h a t had, and c o n d i i on; c i f or. o s i s o r m e d i c a l t r e a t m e n t i n a c o n d i t i cr , ano s t a t e : you .!1 11It? ... r r ' .-•■d a d d r e s s o f t h e p e r s o n !• a n d " - ~ V *. h c i e g n o e i s or t r e a t m e n t ; c i Ì / th e r,;:; a-id a d d “ e s s of C *1 \ & •> a t w h i c h a s - r. t r e r t e c i ; i ns t i l . ill! ivi di th e C; s' 1 D*f th e and this e-f - fe c t o-f the medical y Ou. w e r e d l sc-no =i s the or treatm ent treatm ent. The s h i n c o n d i t i o n s t a r t e d in Vietnam and h a s continued s p o ^ a d i c a l 1> t o t h e p r e s e n t t i m e . It included p u stu les, b oils, shingles. c h i or a c n e and other skin growths. Treatment includes lancing o-f t . he boils in Vietnam, continuing trestme-nt in t h e U nited States, removal o-f b oils, removal of cysts, a n d s u r g i c a l r e m o v a l o-f the growths a t Ro.: t o** o u g n M e m o r i a l H o s p i t a l u n d e r G e o r g e M. W i l s o n i n 1 9 7 5 o" 7 t - , 1 9 7 9 or 8 0 , and 1 9 8 1 . P lain tiff presently has s o m e g r o w t h s on h i s l e f t l e g which w ill require su rgical rem oval. In addition, Basal cell carcinom a on t h e r i g h t s i d e o f t h e P l a i n t i f f ' s h e a d was r e m o v e d b y D r . W i l s o n i n 1 9 7 5 or 1 9 7 6 . ! ► l 14. If you tobacco have ever product: smoked cigarettes 10 or otherw ise used ó) j denta f y e a c h t y p e of product c i o a r e t t e s , chewino tob acco': -!e.g., b > identify the time period during wh;c that tobacco product; c) i dent if y the- amount use:. c-n a d a i 1 y : e . g . . p a c 1;s of c i g ar et tes/dav': and cigare, <, d) state whether any physician c* other car e pr of es s ion a 1 has- s-y er ad-ised y E t OD c-r reduce your use of cigarette c c her t ci. a c c p c-c' u c t s . arid, i* so. r. --.'a c r c a c dr t.-s*.; o f i f ie ¡.J: - v Ei 1 *. ' i C»(* t •Cic-t c P-- c- era: on a; =■".0 c ;•<' o ac v c a par1, ar c a h a „•f a o a . . O n c e ri t h e 1 a t a ; a-: when ne oot out c-* the sa¡* ce a r c = . ear] , t- ;7=, resumed i-■i-i-k:no îrier =■ : ■: s . p ; : r e : i r n a t l e y ■ 5r»'ï amoi »•! as be-f or e. Dr. Coc-anc- n a s 5ÖV3 s e d h i m etc. síTiC-íi'to ci qe-eí í c e . le. I* i h* .*e ?•■. e?r consumed or druni eararaial, i - i t h r e s p e c t t c e a c h t y p e o-f l i q - . - o r , b e e r , wine, e t c . ) c o n s u m e s : alcohol. alcohol scale '"e.g., a.1 at what age consumption began; fc> the amount and -frequency o-f such con sump 1 1 o n ; c) i -f consumption ceased at any time, the reasons ■for such cessation and the ree.sons -for. an. resume i io n ; and d) w h e t h e r you were e v e r h o s p i t a l i c e d or i n s t i t u t i o n a l i z e d -for a l c o h o l u s e , o r a d v i s e d t o l i m i t o r s t o p a l c o h o l u s e , a n d , i -f s o , s t a t e t h e n a m e ( s ) o-f e a c h s u c h h o s p i t a l o r i n s t i t u t i o n o r m e d i c a l p r a c t i t i o n e r who t r e a t e d o r a d v i s e d you. F l a n t i f f consumed he could drink b e f o r e s e - v i c e in Vietnam. In V i e t n a m a. si;.-pack o-f beer. After Vietnam 11 12880 concump t : on o f b e e r c e n s e d produced s e v e r e headaches. on N a r d i 1 . t h e FI a n t i f f Advised t o t o b e c o m e i l l and discontinue when If an. i n s e c t i c i d e s (e.g., Chlordane, Lindane, DDT/, r o d e n t i c i des ( e . g . , rat p o is o n ), i n s e c t r e p e ll e n t s ( e . g . , DEET) cr o t h e r p e s t c o n t r o l compounds were e v e r u s e d by you o-o t h e r s around your l i v i n g or working quarters, s t a t e as t o each: a- the brand name- o r t 1 s - ..1r.2 c <•j p l : £.*i •:*- ii.-t container for the chemical ï L * •. i:'t •s' « «r->-. markings) - -:--:- cats r~>- i-si. e. • tr.-s m-fthod of r-pp-1’ic at i on ; ■* - t hi. r t -, e frequency of appli cation : and r.i ■'•T,r-1her you ex per ienced any adverse reaction to comp : the i n c l u s i ve tíates of your c : th e i n c l u s i ve Vi etna*!;: dates of service d' t he- name- c-f e a c h m i l i t a r y u n i t t o w h i c h were a s s i g n e d w h i l e s e r v i n g i n or near V i - t - a ’ : a r i d t h e d a t a s o r : n g wh i c h y o u T••« •*-;.t,,' s f.s c r i e d! t o e a c h s u Ch Uiii ^ S — the a r med s e r v i c e o i n which you s e r vi c e ; i n or near you 1 / z. the T i r , . . s,:.tí location of each c-i a c e or area-. a. w- i . vou were physically r''eEer*t- in or *.te-ar Vi e I n s m a n d the clr.lt; du'~: n g w h i c h >ou ‘-•-■■ e p:- eter i at east, eucv: pi act. or area.; ♦ ■(Tir.ee. i a t e suc-e r v i ec-r • c.".." while u- the t -pa /in Vietnam, c-f discharge u f f i c a r ' s name a n d r e - r. a* d \ oc r e c e v e d triced Eli-tee Arn.»-, 9.-'1A :'6± - 9 / 1 7 t-E. February IS. !'&“ to I-i, 1568. First Ir.-frantry Division, Cr-cp-mv E, 05' ’=+ Batcal ic-n, 26th In-f a.ntr First Brigade. For a ■few months he was attached to headouarters o-f that unit. He a r r i v e d i n V i e t N'arr. o n t h e 2 5 t h o f F e b r u a r y , 1 ? : " a t E-:e-r. H o e . FI 5 j n t : f-i ? e g r o u p s t a v e d a t t h e r e p l a c e m e n t d e c o t -for -5 or 5 d a v s t ri er- t h e y w e r e s p l i t i n t o i n d i v i d u a l u n i t s a n d G e o r g e ' s u n i t wee s e n t t o t h e F i r s t I n -fa n tr y D i v i s i o n at D i o - - . A- ^t e r a we e ! t o a w e e k a n d a. h a l f P l a n t i - f - f w a s s e n t t o h i s u n i t a t FTruc V i n h . He w a s " t h e r e - f or appro:-: i m a t e ! y 3 t o A weel e . T h e n h e j o i n e d h i s u n i t i n q u a n Lo: w h e - e he remained in o p e r a tio n sin th a t area, i.e ., the Iron Triangle, Loc N in h , a.nloc, L a i Kai , B o i L o i W o o d s , Ph.u L oi. song B ai, Nue Boi B i a ( E n g l i s h name B l a c k V irgin M ountain) in Tayninh Province, Phuc Wa.i. Thereafter Geci-ge l e - f t Qua.n L o i a n d w e n t t o K i o n t h a n b a c k tc the r epl acement center near De n Wa.i t h e n t o T o n Sen Nhut a: i - p o r t t o O a k l a n d , C a l i f o r n i a . Captain Pederson; th e r e a fte r Captain Smith; First L ie u te n a n t Sm ith. Th e E 5 s q u a d l e a d e r ’ s n a m e w a s S s ^ g e r . t J ^ B D: a. c . The brigade commander was Lieutenant Colonel 3 3 13. A] e - e.r-de?- M. Haig, Jr. Ho n e * ' al. 1 e discharge-. end tN eresU er Colonel Ho-f-fman. respect t o e a c h illness. injury, wound o r other medical z'~ psychological condition experienced pv you during vc-ur a : I-it ar y service m or near Vietnam, state: With i Kc c a t e o ' y o u r other m ed ical or i l l n e s s , i n j u r y , wo und, or psycho! og: ca l c o n d i t i o n ; the illn e s s p s . c !■c I o g i c i n j u r y , w o u n d , or c o n d i t i o n , ir.r 1 . y err c-f ■i t hfc i ] I r*e-s s . i n j u r ' , - , w o u n d , p e y c h o l o o i c a 1 c c n d i t : tins t ‘ fT.^rV' or ether t ht *>. -- and •'au,!- o-f t :■a- person to whom you -first r t-. r o6> - .* • j- = . s . n * r . ç i i 1 n e s s . i. 1 ; ; i g i •cal c o n d i a : . y. wound, or ( i •f a n y o n e ! : tnr-.t VO*. • f l : * S t ! ep-or t e d c ■ o t h a- ■ c a. -, c h c l o g i c a l o r o t h e 1* m e d i c a l th e i l l n e s s . injLT>, m e d i c a l c o r d : t : ori ; the r a - f c . r a n k a.r-d l o c a t i o n o-f e a c h p h y s i c i a n c** h e a l t h ca* e p r o - f e s s i c n a l w h o t r e a t e d vou** i l l n e s s , i n j u r y , w o u n d . O'* o t h e r p s y c h o l o g i c a l o r m e d i c a l c o n d i t i o n , i n c l u d i n g t h e d a t e s and p l a c e s o-f t r e a t m e n t , a n d a d e s c r i p t i o n o-f t h e t r e a t m e n t vc-u. r e c e : u ? o : a n d g • t Lie •-■ar-e a n d l o c a t i o n o-f e a c h h o s p i t a l o r o t h e r h e a l t h ca^e - f a c i l i t y which t r e a t e d your psycho! og i c a l o r m e d i c a l c o n d i t i o n , t h e d a t e s o-f t r e a t m e n t , a n d a d e s c r i p t i o n o-f t h e t r e a t m e n t t h a t y o u r e c e i v e d . The stomach problem a r o s e in a p p r o x im a te ly October o-f 1967 a n d t h e s h i n p r o b l e m s were- s e e n m o n s o o n s e a s o n i n V i e t n a m a r o u n d m i d - s u m m e r o-f 1 9 6 7 . W hile Planti-f-f was a t an L .F . p o s i t i o n o u t s i d e h i s p e r i m e t e r and h e was s t r u c k in the l i p b* a b u l l e t . T h is went unreported and no p u r p l e h e a r t was r e c e i v e d . F 1 a i n t i -f1 ' s stom ach and s k i n p r o b l e m s d e s c r i b e e . F I a: r,t i-f f w a s - f i r s t t r e a t e d wa = s e n t t c Fru. c V i n h . have been a t Auan L o i and then o O 14 19. D escribe s n v e t h e r medi c a t i on ta ker . b y y o u during your m i l i t a r y service- ( a . g . , Dapsone. C h loroq u in e, Primaquine, P in o c ta l), s ta tin g as to each: *) the brand ns-me or generic name o-f t h e b) the -form o* the medi cat i on i nject i ori. ct i . ) ; c ) thi color, taker; d'1 the reason? -for tal-ring the medication; ï■ the ne ms r“.r rani: of the person's' who gave t'Oi- \ :at i on : ■f • the dates .zv too! the - ; che medi c at i en ts.i en (e.g.. pills cay); • ie.g.. m edication; p ill, shape-, and size of any p i l l capsule, or capsule the medi cat ion; and r. whither . a- ■per i enced a n y a d v e r s e m e d i c a t io- s-r. if so. describe t h e reaction to reaction. the F l a i n t i f f ta:. *r o r a n g e p i l l w e e k l . a n d a w h i t e m j r = c f t e n bctii d ie * - p ■ the m edics. P l a i n t i f f h a d r.o a d v e r s e r e s i t i j,ri t e a i t'-e*- . Was t a k e n b v P l a i n t i f f d u r i n g t h a s n t i r e t : me h e ws s i n Vi a t r . ô i u 20. Sc a t e whether you ever received any training, instructions. wa-nings or h e a l t h and s a f e t y i n f o r m a t i o n c o n c e r n i n g h e r b i c i d e s , d u r i n g your ^ m il i t a r y service, and i d e n t i f y as tc each: a) the dates you r e c e i v e d b> the location c) t h e n a me a n d r a n k i t was r e c e i v e d : d> the and substance where of the foregoing; received; of the any oral person is) from inform ation who received; 123 15 e> th e t i t l e . d ? te , author of anv w r i t t e n m a t e r i a l or source, received. and c o n t e n t No 21. Set been a) ' b! c- -forth with r e s p e c t to exposed sc h e r b i c i es: t he - d a 4. e of the the c- ca>- o-f tire i i ■i the herbicide alleged you claim to have exposure; e:-. p c s u r e ; o-f the ie'-r c.in a.t the pi ace of a.l Ieged e) a cie =c -■i p: •. c a. deec •*1 1 1: rr o-f you'* activities at the time o-f alleged e co=-'.rs:. g) the n.a*irie- v o j believe your body was physically exposed tc the herbicide (e .q . , stin contact, inhalation, ingestion or swallowing), and, i f you. belie-, -r- you were exposed by contact c>r. your shin, identify the areas o-f shin that cams in contact with the herbiciti«; h) t h e n a m e a**d r a n k o-f o t h e r p e o p l e t i m e o-f a l l e g e d e x p o s u r e ; a n d i) w i t h r e s p e c t t o any d e c e a s e d p r o p o s e d r e p r e s e n t a t i v e p i a i n t i -f -f , s t a t e h o w s u c h p l a i n t i f f w i l l d e m o n s t r a t e a n y o-f t h e i n - f o r m a t i o n . .-J-.A-'. r e q u e s t e d i n s u b p a r t s a.) t h r o u g h h ) o-f t h i s i n t e r r o g a t o r y , i d e n t i f y i n g a n y p e r s o n s w i t h such ;K , i n f o r m a t i o n w h o w i l l t e s t i f y a s t c s u c h p l a i n t i f f ’ -s exposure to h erb icid es. ■ t alleged tim e the •_*ï :--Tï- ge on- ar-h j c ai or political refer e*-cs point • ’î .c . . hill, town, 3 ending zone) to the pi m: e •c-.- c -••ieve y ou we-r e exposed: a decor ir -- < each present at the 12335 \ 1Ô P lain tiff was s u b j e c t e d t o h e r b i c i d e e x p o s u r e t h e entire time he was i n V ie tn a m . S p e c i ■( i c c a t e s a n d t i m e s are p r e s e n t l y u n a v a i l a b l e , e-.cept as t o a s p r a y in g m i s s i o n which w a s c o n d u c t e - d a t F'huc V : n h , M a r c h 7 , 3= r ~ . Plaintiff was consistently and repes t e d i - . in perim eter areas that had cS'iousiv been recent I v d e t o n a t e d „ a nd he repeated! ; saw the Vs einemese civil i a n a r m y em ployees spray a.round mess Lai Is, barrac hs. t e n t s and h o o t c h e s . Additionally, "thunder ” bases- and t ■ Qh w c. y 13 we r e defoliated for 1C!1 meters on each s: ds-. In m id-1967, Pi ai nt i f f 's bat all ion went to Lai La:, h eli copter A i t er drop off in lav N: nh Province, his tattalion marched through jung I e t n des 1 3n ati on i-,i 1 ]t o p . P i a.i n t i -f -f r e c a . i l s thr". theaeareas hs«-:’ ci; v sut s.tartce c*i - f r e s h l y dying 1 Ttc was n o or e o a r i c u i a r l - c l o s e s * . geo-g** a p h i c a l or p :t:cr' r n-f c- •• s *>r e p c : n t o t h e r t h a - , t n s j u n g l e arid the Ks-e.r i 0 1 ; i s d a t PL.- c '.'3 rill a n d L-us." L e i a n d t h e Irc-n Triangle. Gec- e l s e a r s ■&! t o +¡01 i t . The tori* a i n i r. c 1 . r t! j L - n g I t . i OK- ■*' 1 s *. l a n d s ? p a e d : e s ; !i.- c h e l i r r .r.'!>sr p 1 ar. t a t i o n e . C £1 £->!*& was . :rhalat: o n . t nr c u l t s !. 3 n c o n t s c *. . rice ingestion and [‘.‘■ e peop-le- present irii udc-o Let 'voter, E 4 ; Staff Sergeant Ds so : Lieutenant Smith; Colonel Haig: Colonel Ho-f-fman; Captain Fede**sc-n: Captain Smith; enumerable otter soldier's names presently unknown.. ONLY I F YOU CONTEND THAT ANY OP YOUR CHILDREN HAS A BIRTH DEFECT CAUSED F ’r YOUR EXF n5UF:E TO AGENT ORANGE, 2,4-D , 2,4,5-T . DI OVI N OR SOME COMBINATION THEREOF, ANSWER THE ■FOLLOWING INTERROGATORIES. 22. Identify t h e c h i l d r e n t h a t you have -fathered, including name, d a t e and p l a c e o f b i r t h o f e a c h su c h c h i l d , and t h e n a m e a n d a d d r e s s o f e a c h c h i l d ' s m o t he**. Tara C a t h e r i n e E w a l t , 8 / 2 7 / 7 1 , Ro-.-boro.gh M e m or ial H o s p i t a l , P h i l a d e l p h i a . Mother S .h ie la E w a lt . All r e s i d e t o g e t h e r . t X0 fV W 1 I d e n t i f y e a c h o-f y o u r c h i l d r e n whom y o u c o n t e n d h a s b i r t h or c e ~ e t i c d e f e c t s a l l e g e d ! » ' c ? u i e d by your e x p o s u r e to Accent Or a n g e * . 2.4-D . 2 , 4 . 5-T, dioxin on some other c o m b i r . ai i o n the«* e o - f . a n d i d e n t f . : 1 a) the d :rth or genetic defects- which you contend were caused by you- e :posure to Agent Or ar.ge, 2,4-D, die in. or some combi rial i or. thereof, and state the basis -for you- belief, including opinions o-f cip; physicians; b ' S.r-■ Z-i h o •• b .i-ih : QC-r,ei i C d e f e c t s w h ic h t h e C h i l d =■ Ws C cica! pr :-ct:1 i c-•= arid modi Csi institution visited b the c :ld o r in wrier, the child f ift»1-C TO* 1 V.r p O r of consul tet ion. diagnosis, is. t- Si tmunt D * the*- irre. £•-■£ the dates, = and t s - •-c l . consul t s t : o n . di acr.usi =. .t: t c-» t* »Ti of each c n ld, Tr-i c-feie. nt ! r o w “; d e f e c t ? .• r c 1 ud;.- e a r p r o b l e m s r e q - . i r i n g a i r "-' - • • r i t e ’. . f o.** f i v e : r-r.ei e a - o p e ? a t i o n s , rasnes. pyl o*“i o s t e n o s i s a t b i r t h w h i c h " e o L ' i r t d close ¿•ttantion d u r in g - f i r s t t h r e e wee s of life. Temper e . i d a n c e d by p e r s o n a l i t y c h a n g e s r e q u i r i n g p = . chu! c i i c a l counseling. She was h ,p er-acti ve, and a l t h o u g h she- h a s t h e i n t e l l i g e n c e o f a - g i f t e d c h i l d . she doe? net wo-k close to her a b i l i t y . -'She is easily d i s t r e c t e d and has a r a s h or her a n k l e s , w r i s t s and h a n d s , l o c i s l i i e d r i e d sl-in which so m e tim e s breaks, open, f l a r e s up and b e c o m e s i n f e c t e d . The s k i n a r o u n d h e r a n k l e s is leathery. Whenever she becomes s i c k l y . which is o fte n , she com plains of j o in t pain. F’h v s i c i a n s include Dr. Cc-nsuelo S au l ka. Pennsylvania M edical C ollege. Henry Avenue, Philadelphia delivered Ta-a. The pediatrician was Dr. J e a n Gal w i n , w h o i s presently retired . Dr. Joan H u - l o c l , Dr. S a b i n a , West Park H ospital. 3500 b lo c k Conshohocken Avenue, P h i l a d e l p h i a . FA 1 9 1 3 1 . Her a l l e r g i s t i s D - . J e f f r e y G r e e n , C h i l d r e n ' s H ospital, P h ila d elp h ia . Present p e d ia tr ic ia n Dr. Carolyn V erier. C hildren's hospital. Dr. Paul Honig fo r skin problems at Children's. Latest skin doctor is Dr. Kol bl er.zer, Spruce Street, F'hi Iedel phi a. Dr. Cor or a teles cere of her e\ e problems - F>:o.'.borough Medical Center, piv'chc! ogi st is Dr . Annet te L vcic *"i. School house Lane, F'h: ] adc 1 phi a . Ht r•1 1 -f. t-; r 11 ¿-rii e •el'i c hi Id of ee ch mother lder t if res;-or, = e t **• Ini err c-gat l r\ I! and state as to each-: hd"o:r Qc't fc.‘ of birth and pi are t‘-f chi :-J' a , . . . X u o* t ; r . ir r 3ud: • l ‘i- r a--.-.' ar,d addr ess of tr.s ! 1 1 1 :t . : c iKe* r i jc. i i-'‘ e de ] i ver •. oc cu.rrcd: a the p no l- t e.-:1 e toe mother during del •_ er the child. : car*- m e t ho- i d e n t i f i e d in reI : d . ice - t : her brothers, c t s . urc 2 es, cousins .or b i : j dr e-o . a.od : :■ 1:,ti ■•ro;?- :.r n e p 'if? ^ = , c - .r ■Cj o i f a n y c-f the*- ere d e c e a s e d . s t a t e his or her age at the. i i me c.-f death end the time,- p i e c e end c a u.s C'f d e a t h : b) idw.nt i f y ea-rb. illness. disease, disability. medic.a.1 cone j1 1 on trier had bv each: during his or her 1 i -fet j me which required pr o-fes si onel medical ett enl i or,; c) identify each medical practitioner and medical institution that treated them, and set forth diagnosis o-f each, stating the same as to each relat i v e . Previously answered. or the See #S supra. <5 0 r' JL s-*' Wit!’, respect. to each p e g a n e n c >•. -for each motner lG'eiiti-fitd 3 r- ’*f rEpori s e to I r. p er- r oy a t o r y 2 3 < d / , d a t e : ivf i r l h e r t h ez mo X '. 1k. e r w i s e ■ . p o = e d t o or c o n t r a c t e d an v + v i r a l or t ’* Xa i l M e c t i c r o r d i s e a s e d u r i n g c s h o r 1 1 y b e t z i* p ‘l. h e p r e g n a n e > er . y • » G e r m a n m e e s l e = . f l u . e t L . . £• r, .*■ j f s o . ) Cj t- i”i u i t v t h e i r r f e c t i o n or : 1 3 n e s = . t he F‘e • 1 Od d u r i n g whi ch i t o c c u r r e d , an. - =■n V m e d : c a \ ; rt: , r t r (r c u fist-Ti 1 u: \fS r, t h e r e f o r ; «V .u • e>' K-J-eths r t h C" .. ,i j. ' * c.' “J •• a I r. - • - -; i' i- *. ■* - • i n c u r r e d a-r.y i n j u r y d u r i n g c: i z r i be t h e i n j u r y , t h e EO. . e a - * “ ■ r. g o r t r e a t i n g _ j. 'J ' ' • • - '-r|'- c* w wh . i c h t r e i c - r... J - A!■ - •- - . e • ha d a n y v e n c - •* a -* 4 Ci O , dCC. r r . z-e t r ;e d i E c - e s e , t h e t r i. a •: ve-r:t *-e wf i •ZC *. c*Tr>' £*. l n i n u or t r e a t i ng l~'~ = - ~ : f-' ir • £- " 7 a-. - i r - s t i t o p : o n e a.t w h i c h t • 11« n ■. - •J . —. . _ V- . - "i v l : £;• d: a i* r-s 1 1 c pr ‘- • c e d v r e s . i n c l u d i n g , b u t '■■rt j j Hi - t £■_- t 1*‘. c l Z 1:“ j Tif i - —r a . r C,r p e l v i m e t r y , e i - n j u c f r t s i i 5. a n d / o r ul t “ a so--nd w e r e u s e d , i * c - . i e :-. r eh * -i ■ -.*• *.nt; c 1 & o- t h e p r o c e d u r e , d e s c r i b e t ’’U pr C'Ce . * h e e a,’ . n ; r>g or t r e a t i n g p h y s i c ; a * a n d ar, v 1 n = t : u l : o n e a t wh i c h , t h e p r o c e d u r e o c c u r r e d : arc e■ whet he1- an. medical problems wi compl ¿"cat ione areas during p- eg " ar- » (e .g . . t o .emj a.•, and , it so, describe the pr obi eos c-*‘ cc-r-ij. Iicatior.s and the t >■ai tment received. Fos. e i t i l i t - the Women's Medical Coll see i n 1970 and 1971. D iagnosis not con-firmed. F i a : r . t i -f -f ' s d o n o t b e l i e v e t h a t t h e m o t h e r w a s e.-.posed t o or c o n t r a c t e d any v i r a l b a c t e r i a , i n - f e c t i o r . or d i s e a s e d u r i n g or s h o r t l y b e f o r e t h e p r e g n a n c y . Answer c- an earlv In terro g eio r : es 6 mi = c a-- r i a g e at , 1 1". 14, and 1 th a fjtO f. • ,'ri r e - s pt . e t le Interi c ic i e r y each mother 2~id). identified in response to Noi c»ppj i cebi e. 25. F o 1' e a c h m o t h e r i d e n t i -f i eci i n r e s p o n s e t o Interrogatory 22 i d e n t i f y e a c h and e v e r y p r e g n a n c y n o t r e s u l t i n g i n a l i v e L- . ' r t h, a n u : l i . l t ' w i t h r e s p e c t t o e a c h : ¿■ 'i w h e t h e r t h e r e wa r a mi s c a n - i a g e a n d / o r >_•{. e»ni r ri./uui. at*or l i o n . ar i d, i f s o . s t a t e t h e d a l e a n u dt.-i. c i i t - t h e r e a s o n f c*r t h e fiilr-. • .1 dip!- and.- or s p e n t oi ic-vus a b o r t i o n arid i d e n t i f v any. e a n i i n i rig or t r e a t i n g p h y s i c i a n s , and any i n s t i t u t i o n s a t w h ich i t o c c u r r e d ; b ) i f t h e r e s p o n s e t o a) s b o v E i s a f f i r m a t i v e , s t a t e whether you c o n t e n d t h a t such m i s c a r r i a g e and s p o n t a n e o u s a b o r t i o n was c a u s e d by y o u r e x p o s u r e t o A g e n t O r a n g e , 2 , 4 - D , 2 , 4 , 5 - T, d i o x i n , o r s o m e combi n a t i on t h e r e o f ; c) w h e th e r t h e r e was a v o l u n t a r y or t h e r a p e u t i c a b o r t i o n , and, i f s o , s t a t e t h e ’ d a t e and d e s c r i b e t h e r e a s o n f o r t h e v o l u n t a r y or t h e r a p e u t i c a b o r t i o n , and i d e n t i f y a n y e x a m i n i n g o r t r e a t i n g p h y s i c i a n s , and any i n s t i t u t i o n s a t w h i c h t h e a b o r t i o n o c c u r r e d ; and i f t he- r e s p o n s e t o c> a b o v e i s a f f i r m a t i v e , s t a t e whether you contend that such voluntary or t h e r a p e u t i c a b o r t i o n wa s c a u s e d o r n e c e s s i t a t e d b y y o u r e x p o s u r e t o A g e n t O r a n g e , 2 , 4 - D , 2 , 4 , 5 —T , d i o x i n , o r somie c o m b i n a t i o n t h e r e o f . Dated: 12390 Carle Place, N e w York January 14, 1984 PLAINTIFFS' MANAGEMENT COMMITTEE v'x- ■■ B DAVID J. DEAN, ESQ. DEAN, FALANGA & ROSE, ESQS. One Old Country Road Carle Place, New York 11514 / c i t\ «» . o n o D O Defendants' interrogatories to Plaintiffs dated December 22, 1983 and Plaintiffs' answers thereto dated January 16,1984 12891 Defendants' 1. Interrogatory Separately as to each person identified as required by Paragraph "1" of Pretrial Order No. 65, specify each illness or injury you contend was caused to him or her by exposure to Agent Orange and the date of onset of each such illness or injury. Plaintiffs' 1. Response See answers to interrogatories filed as to each plaintiff on January 16, 1984. Defendants' Interrogatory 2. Separately as to each p e r s o n .referred to in Interrogatory 1 and each illness or injury specified in your answer to that interrogatory: (a) specify each component, ingredient or impurity of Agent Orange you contend caused or contributed to each such illness or injury; Plaintiffs' 2. Response (a) 2,3,7,8 tetrachlorodibenzo-p-dioxin dichlorophenoxyacetic acid (2,4-D), trichlorophenoxyacetic acid and tetrachlorodibenzofuran (2,3,7,8-TCDF) and all other isomers of polychlorinated dibenzo-p-dioxin, appears to be the most hazardous. of which TCDD These chemical compositions are all hereinafter referred to as "material". -2- (TCDD), Defendants' 2. Interrogatory (b) State all facts as to the amount, manner, type and dates of exposures to Agent Orange, any component, ingredient or impurity of Agent Orange or any other substance you contend caused or contributed to each such illness or injury; Plaintiffs' 2. Response (b) Such facts as are known concerning his exposure by each plaintiff have been set forth in their answers to interrogatories filed as to each plaintiff on Jan u a r y 16, 1984 . -3- Defendants' Interrogatory 2. (c) State all facts as to the amounts and routes of absorption and manner and rates of elimination of Agent Orange or any component, ingredient or impurity of Agent Orange or of any other substance you contend caused or contributed to each such illness or injury; Plaintiffs' Response 2. (c) No plaintiff has sufficient knowledge as to the amount of material which be absorbed, manner of its absorption. or the routes and Suffice it to say that each plaintiff absorbed sufficient material to produce his illness or injury, or to produce the untoward side-effects his children. The plaintiffs it did in like-wise have no information as to how much material was eliminated from their systems or what amount still remains therein. QK I to-v O 0 t ^ -4- Defendants’ Interrogatory 2. (d) Fully describe each scientific theory upon which you base your contention that exposure to each component, ingredient or impurity of Agent Orange caused or contributed to each such illness or injury; Plaintiffs' 2. Response (d) These theories will be a matter of presentation in the expert witness statements to be filed by the plaintiffs on J anuary 23, 1984. -5- Defendants' 2. Interrogatory (e) State all facts as to the medical, military and occupational history of each such person. Plaintiffs' 2. Response (e) The pertinent facts are that each veteran plaintiff was p h y s ically present in South Viet N a m and was exposed to the material several methods. in some amount through any or all of The medical history of each person is available through the medical records of each plaintiff which are being produced as rapidly as they become available and which plaintiffs have authorized the defendants to obtain. knowledge of each veteran plaintiff, To the best of the no occupational history is relevant because there was no known exposure to the material by any verteran plaintiff other than in South Viet Nam. 1239? -6- Defendants' Interrogatory 3. Do you intend to support your claims as to the persons referred to in Interrogatory 1 with evidence that exposure to Agent Orange caused any illnesses or injuries other than those illnesses or injuries specified in your answer to Interrogatory 1? (a) Plaintiffs' If so: specify each such other illness or injury; Response 3. (a) Chloracne; hyperpigmentation; hyperkeratosis; weakness in low expremities; fatigability; fatigue; polyneuropathy; deficits; weight; loss of appetite; vomiting; nerasthenia; impairment of sight; anorexia; loss of loss of sexual drive; abdominal pain; sleep nausea; other gastrointestinal disorders; psychobehavioral disorders; myocardial other infarction; other cardiovascular disorders; pancreatic dysfunction; disorders; impairment impairment of taste; depression; violent behavior; atherosclerosis; easy other neurological orthostatic hypotension; diarrhea; asthenia; peripheral neurophathy; intolerance to cold; impairment of smell; disturbances; hirsutism; loss of strength; headaches; irritation to eyes; of hearing; porphyria cutanea tarda; kidney disorders; pulmonary pathologies; -7- liver damage; urinary tract other respiratory disorders; 12893 fat metabolism disorders; carbohydrate metabolism disorders; cholang i o c a r c i n o m a ; other liver cancers; kidney cancer; bladder cancer; stomach cancer; other pancreatic cancer; gastrointestinal cancers; leiomyosarcoma; colon cancer; lung cancer; liposarcoma; fibrosarcoma; rhabomyosarcoma; myofibrosarcoma; neurofibrosarcoma; fibrous histiocytoma; neurogenic sarcoma; fib?" sarcomatous mesothelioma; soft-tissue sarcomas; cancers; hepatoma; lymphoma; other skin cancers; cancer of tongue; mouth, leukemia; retroperitoneal angiosarcoma; other blood squamous cell carcinoma of skin; thyroid cancer; other glandular cancers; cancer of hard palate; chronic lympphocytic leukemia; other cancers of various brain cancers; ischemic heart disease; lung fibrosis; loss of lymphoid tissue; loss of thymus tissue; infections; sclerosis; testicular cancer; DNA disturbances; skin eruptions and cysts; impulses; hypertension; sensitivity to multiple RNA slowing of nerve elevated blood lipid levels; elevated levels; prediabetic and diabetic states; abnormal cell proliferations; organ enlargements; decreased cell proliferation; miscarriages; eosinophil; loss of body weight; immune system d i s t u r b a n c e e s ; brain cancer; disturbances; cholesterol other cellular atrophy; birth defects in offspring; increased white blood cell counts; elevation of decrease in IgM and IgD; decrease in B-cell T-cell capabilities; skin rash; scalp tumors; bleph a ro-conjunctivitis; porphyria. and aching muscles; This list is not meant to be total or exclusive. - 8 - 12399 Defendants' 3. Interrogatory (b) Fully describe each scientific theory upon which you base your contention that the occurrences of the injuries specified in answer to Interrogatory 3(a) support your claims as to the persons referred to in Interrogatory 1. Plaintiffs' 3. Response (b) See answer to 1(d) -9- 12900 Defendants' Interrogatory 4. Separately as to each illness or injury specified in your answers to Interrogatories 1 and 3(a): (a) State the m inimum amount of a single exposure to and the minimum amount of a single absorption of each component, ingredient or impurity of Agent Orange y o u contend causes or contributes to such illness or injury; Plaintiffs' 4. Response (a) This question cannot be answered because it contains an invalid assumption that the amount of the material which produced the harm in any given case was the result of a single exposure and a single absorption. Each plaintiff contends that the totality of the material and/or any part thereof to which he was exposed and which he absorbed was what caused the harm he experienced. - 10- 12301 Defendants' 4. Interrogatory (b) State the minimum amount and minimum number of multiple exposures to and the minimum amount and minimum number of multiple absorptions of each such component, ingredient or impurity you contend causes or conributes to such illness or injury; Plaintiffs' 4. Response (b) This question cannot be answered because it asks for data which has never been satisfactorily investigated, since there has been no true epidemiologic study in humans to determine whether there is a no-effect level for the material. Given the fact that the material appears to b io-accumulate in humans, minimum levels for exposure as to amount or times cannot be given with precision, true with absorptions. nor need they be. Obviously, The same is each plaintiff contends that the total exposure and/or any part thereof he had to the material in South Viet Nam was responsible for the har m caused him. 12302 -11- Defendants' Interrogatory 4. (c) State what you contend is the minimum time interval between exposure to each component, ingredient or impurity of Agent Orange and the onset of such illness or injury; Plaintiffs' 4. Response (c) This question cannot be answered as phrased, since it asks a medical question in a legal context. The answer will vary depending upon whether the question asks for the first cellular or pathologic illness or injury, diagnosable illness or injury, or the first or the first symptomatic illness or injury of which the individual is aware. If defendants will define what sort of latency period they are referring to, plaintiffs will endeavor to give a more specific response. any event, In such information can be obtained and clarified in the depositions of plaintiffs' experts which will be taken. 12303 -12- Defendants' 4. Interrogatory (d) Fully desc r i b e each scientific th e o r y upon which you base your contention that exposure to each component, ingredient or impurity of Agent Orange causes or contribute s to each such illness or injury. Plaintiffs' Response 4. (d) See answer to 2(d). \ 1L9Kt 0 0\J4MJ -13- Defendants' Interrogatory 10. Do y o u intend to support your claims as to the persons referred to in Interrogatory 1 with evidence that any persons sustained illnesses or injuries by exposure to substances other than Agent Orange? If so: (a) identify each such person; (b) spe c i f y each injury or illness you contend he or she sustained and the date of its onset; (c) s pecify each substance you contend caused each such illness or (d) injury; state all facts as to the amount, manner, type and dates of expos u r e of each such person to each such substance; (e) state all facts as to the amounts and routes of absorption and mann e r and rates of elimination of each such substance by each such person; (f) state all facts as to the medical, and (if applicable) (g) occupational military history of each such person; state what you contend is the minimum time interval be t w e e n exposure to each such substance and the onset of each such illness or injury; (h) fully describe each scientific theory upon which you base your contentions that exposure to each such substance caused each such illness or injury; 1 (i) fully describe each scientific theory upon which you base your contentions that the occurrences of the illnesses or injuries specified in answer to Interrogatory 10(b) support your claims as to the persons referred to in Interrogatory 1. Plaintiffs' 10. Response (a)-(i) The persons who may be referred to by expert witnesses are again generally part of statistical accumulations of cases and incidents. Plaintiffs simply do not have access to revelant individualizing data. The specific other substances will be set out in the expert witness summaries and by the expert witnesses in their depositions, but include at a minimum all the materials set forth in response to Interrogatory 2(a) above as well as other substances which are chemically and/or structually related thereto and/or produce the same sort of results. -26- 12 SOB Defendants* Interrogatory 11. Have you determined that any person referred to in Interrogatory 1 or identified in response to Interrogatories 5(b) or 7 was exposed to Agent Orange manufactured by a particular manufacturer? If so, identify each such pers o n and the manufacturer to whose product you have determined he or she has been exposed, and state all the facts upon which that determination was made. Plaintiffs* 11. Response Nn such determination has been made. -27- 12307 Defendants' Interrogatory 12. State whether plaintiffs contend that the prevalence rate of any illness Interrogatories 1 or 3(a) identified in response to is greater Agent Orange than in other persons. (a) in persons exposed to If so, set forth: a complete description of the population you contend was exposed to Agent Orange; (b) a complete description of the population against which you compare persons exposed to Agent Orange; (c) the increase in the prevalence of the illness in the population identified in (a) above that in the population identified in (b) which you contend resulted from exposure to Agent Orange; (d) the facts upon which you base your response to this interrogatory and the method by which you reached your conclusion. Plaintiffs' 12. Response (a)-(d) there is a higher Obviously plaintiffs do contend that incidence of the stated illnesses in persons exposed to the material than in the general population. General references will be made in the expert witness summaries and any specifics will be furnished in their depositions response to appropriate questions. -28- in ■fOQO-S Defendants' Interrogatory 13. State whether plaintiffs, or any persons acting on their behalf or at their request, have performed or are in the process of performing any tests, experiments, studies or analyses of any description that support plaintiffs' position or contentions or which they intend to introduce at trial. so, for .each such test, experiment, If study or analysis: (a) fully describe it and its results; (b) identify the substance involved, if any, the source from which it was obtained and when it was obtained; (c) experiment, identify each person participating in the test, study or analysis and state the nature of his or her participation; (d) identify all documents referring or relating to or resulting from the test, Plaintiffs' 13. experiment, study or analysis. Response (a)-(d) No such are contemplated. -29- Defendants' Interrogatory Plaintiffs' Response 14-16. No questions so numbered. -30- Defendants' Interrogatory 17. Identify each test, experiment, study or analysis not identified in answer to the preceding interrogatories which you contend supports any fact or contention stated in your answer to any of the preceding interrogatories and specify the fact or contention which the study or analysis supports. Plaintiffs' Response 17. See second sentence to response to 12(a)-(d). < o c jL ^ 1 1 -31- Defendants' Interrogatory 18. Except to the extent identified in answer to one of th preceding interrogatories, identify all documents that support your answers to the preceding interrogatories, that contain information requested by the preceding interrogatories or that you used or consulted in answering the preceding interrogatories. As to each such document, specify the interrogatory to which pertains. Plaintiffs' 18. Response Any relevant and appropriate documents as support the preceding answers, to the extent they are not part of general scientific and/or medical literature or publicly available reports will be identified by plaintiffs' experts in response to appropriate questions at their depositions. *2812 -32- Defendants' Interrogatory 19. Identify each person you intend to call as a trial witness to give evidence other than expert opinion as to any of the facts or contentions stated in your answers to these interrogatories. (a) Plaintiffs' 19. As to each such person: state the substance of his or her testimony; Response (a) To be supplied in expert witness summaries. 12313 -33- Defendants' Interrogatory 19. (b) identify each document you anticipate will be referred to in his or her testimomy. (The court directed that the information sought in Interrogatory number 19 be provided in connection with the Special Master's planned exchange of witness lists. Special Master's planned exchanges of witness lists. See T r . of December 12, 1983 at 24-26). Plaintiffs' Response 19. (b) See answer to 18. -34- w n :■ ;• : f a s h ;:: :5. d i s t r i c t c o u r t r :ft : • 3CT OF n e w y 0 rk MICHAEL F. RYAN and MAUREEN RYAN , his $ spouse, individually and as parents S and next friends of their child, KERRY S RYAN, a minor: CHAP.L0T7F BLACKMON, as § surviving spouse and as the personal $ representative of ORVILLE B. BLACKMON, (5 deceased, individually and as mother € and next friend of their children, $ RF.BECCA BLACKMON, BRENT BLACKMON, € VALERIE BLACKMON and KAREN BLACKMON; |S CAROLYN CHAMPION, as surviving spouse § and as the personal representative € of THOMAS B. CHAMPION, deceased, S individually and as mother and next € friend of their children, THOMAS B. 5 CHAMP IO N , JR. , JOY CHAMPION and C DFDRICK CHAMPION; GEORGE FLA! 7 and C SHF.ILA EWALT, his spouse, individually S and as parents and next friends of S their child, TERA CATHERINE EWALT; (5 DAVID G. LAMBIOTTE; CAROL QUINN, as « surviving spouse and as the personal € representative of BRIAN T. OUINN, 5 deceased, individually and as mother c and next friend of their child, KEVIN S QUINN; DAN G. JORDAN and DONNA JORDAN, S his spouse, individually and as § parents and next friends of their S •children, CHAD JORDAN and MICHAEL « JORDAN; EARLY ROBINSON and SHEILA ANN ¡5 ROBINSON, his spouse, individually S and as parents and next friends of $ their child, MICHAEL ANTHONY POBINSON; S WILLIAM SINGLEY and DIANE SINGLEY, his € spouse, individually and as the sur€ viving parents of their child, WILLIAM; 5 and STEVE ZARDIS; S DOCKET NO. 79 C 7^7 ¡S on behalf si it.ilarly of themselves and all others situated, Plaintiffs -v- now CHEMICAL CON; A’-'Y , a pel evare corpcrat icn; MONSA.N 7’’ COi.rCI-ATI C‘:,a 5 § IS s S c C 5 1Q Dr] a war i corpcrs; h ■ : L : ■ : i c , inCORPORATE D, a Pel a wo m c o: : c r a t ior, ; T-H AGRICULTURE >. r:OT? :: ]r-: cr."p/-t:y , INC., a Delaware corporation: DIAMOND SHAMROCK CORPORATI Or:, a Delaware corporation; UNIROYAL, INC., a New Jersey corporation; THOMPSON CHEMICAL CORPORATION, a Missouri corporation, and THE UNITED STATES OF AMERICA, Defendants. t « s € $ € $ € Ç € ç RESPONSE TO THE COURT CONCERNING EXPERT WITNESSES COME NOW the Plaintiffs in the above entitled and numbere cause and in response expert witnesses by to the order of the Court to furnish a list c the 23rd day of January, 1984, would respect fully show the Court: I. The expert witnesses concerning general causation are b e i m furnished under separate cover by the Honorable Torn Henderson, of the Members of the Plaintiffs Management Committee. The om Court should receive the list cf those experts, together with initial sum­ maries, under such separate cover. 11. With respect to the ether expert witnesses, your Plaintiffs would show finalize that tirn.e and circumstances has made it impossible tc the designs tier, cf those witnesses and to obtain summaries. r\ Howl vt r , youi j 1a set the ic : *,:;:.l care with due diligence experts, pare since cn all to make the Court aspects arrangments of decided in the case, Ft-[ terbe t tc have proceeded for the designation of such in the categories hereinafter listed, and to have them pre­ initial in that i 1 <■, summaries. regard time and within attention sing matters We hope to be able to conclude our efforts the next few days. has presently been of designating As the Court knows, our occupied with the more pres­ the Plaintiffs, obtaining the necessary information in order to finalize a designation of Flaintiffs, final­ izing the general causation witnesses and the Court seers tc have given more priority. other matters to which Therefore, we respect­ fully request the Court that we he permitted at U.i s time tc indicate to the Defendants the various areas of concern relative to which we will probably be designating expert few additional days to actually designate those witnesses in which witnesses and to permit us a and come forward with preliminary reports. Ill. The arc-as of concern relative to which we will in all pro­ bability be designating expert witnesses are as follows: 1. 2. economist - tc testify concerning economic loss with, respect to the various Plaintiffs. Clinical Psychcicist - to testify with respect to the mental anguish, intangible loss, and psychological ef­ fects cc :,ct r r;i no tc the various Plaintiffs. f-iicty Engineer - to safety precautions testily and types with of m card warnings tc proper that wouic have been proper under the circumstances of this case and other aspects relative to safety. Industrial Hygenist - to testify as to safety aspects of production, distribution and dissemination of such pr ducts in general and the kinds of protection that could have been afforded persons on the ground who were ex­ posed to the spraying of the Agent Orange. Hunan Factor Engineer - this expert will regard tc those forseen and/or kind of things, that anticipated by the testify witr should have Defendants bet: in the manufacturing of their product, as to hew it would be used, as to any forseeable misuse, and the other human factor considerations that contribute to the equation of safe or unsafe practices. A team composed botanist, lay out of a mechanical a toxicologist various and alternative engineer, chemist, e a chemical engineer tc means producing a of herbicide tc accomplish the coal which the government sought, that is the defoliation in Vietnam, without the risk of harm and danger posed and sale of the product team will in all probability work together tc core ut sold by by the manufacture the Defendants. This with not only alternative alternative ways rears of defoliation of process 3 rig :n a safer but n.anner the products specified. An expert on governmental authority, lines of authority and responsibilities. respect tives, This person will to various executive orders, regulations, and practices testify with statutes, direc­ of the various g o ­ vernment agencies, which relate to the lines of auth­ ority and as to who had the ultimate legal authority to make decisions with regard to the use and continued use of Agent Orange in Vietnan and with regard to who had authority to negotiate spec 1 fications. Statistician - to provide us with various statistics with regard to exposures, number of veterans serving in Vietnam, and other statistics relavant to the var­ ious factors of the case. A expert on exposure - to utilize the Erbst tapes and maps, and other put together information a profile of from what the amount government of and chemicals was sprayed where, at what tiir.es and on what occasions - that jury and is tc provide the the Court with an organized summary of exposure opportunities. Financial damages, analyst. To testify, concerning punitive about the profits rrade by the Defendants off the sale of the Agent Pi ange to the government provide ether 11. All medical financial doctors Plaintiffs. as may hi who may have relevant. treated any of the It is our understanding that Mr. Henderson will be providing will analyser end to indicate summaries of medical the hinds of treatment records and which opinions of the various treating doctors. However, to the extent that those we be are in more detail not sufficient will specifying those treating doctors we plan to call as witnesses and providing any further summaries that may be required by the Court in that regard. 12. Employees, past and present, of the Defendants and the Government, who may be able to testify about any of the above matters. IV. Plaintiffs recognize their responsibility to provide these names and summaries as soon as possible. Plaintiffs assure the Court that they will be provided in sufficient time for the Defendants to take the depositions of these various experts and to obtain counter­ experts of their own if it would show’ that no prejudice allow an additional is their desire will reasonable be time to cc sustained in which sc. Flaintiffs by either party to provide the to names cf these expert witnesses and sumrriaries in regard thereto. 12320 WHEREFORE, Plairtili* urut the Court tc grant such exte s ion of t i m e . Respectfully submitted, PLAINTIFFS MANAGEMENT COMMITTEE Stephen J. Schlegel, Esq. SCHLEGEL t TRAFELFT One North LaSalle Street Suite 390C Chicago, Illinois 60602 Thomas Henderson, Esq. BASKIN & SEARS Frick Building - 10th Floor Pittsburgh, Pennsylvania 15219 Phillip E. Provn, Esq. HOBERG, FINGER, BROWN , COX i, MOLLIGA 703 Market Street, 16th Floor Sar. Francisco, California 94 1C David Dean, Esq. DEAN AND FALANGA One Old Country Road Carle Place, New York 11514 Stanley Chesley, Esq. WAITE, SCHNIDER, BAYLEFF f, CHESLEY 1318 Central Trust Tower Cincinnati, Ohio 45202 N. R. Peterson, Esq. GREITZER 6 LOCKS 1500 Walnut Street, 22nd Philadelphia, Pennsylvania John O'O'-’inn, Esq. O'QUINN, HAGANS i WETTM.AN3200 Texas Commerce Tower Houston, Texas 77002 Newton B. Schwartz, Esc. NEWTON B. SCHWARTZ, P.C. 723 Main, Suite 325 Houston, Texas 77C:? Floe 1910 1m i . t o’ , Kuss-j ewh, j t t , Lsq. l ;.»: o r n c r s of bekton KUS5LEWHITF, INC. 609 Fannin, Suite 517 Houston, Texas 77002 By: i X >-n-TT Benton Musslewhite 12322 -e- CFKTIFK'ATf I hereby certify that OP SFKV1CF a true and correct copy of the foregoing pleading was forwarded, via Courier, on this the 21st day of January, 1984, to the following: Morton B. Silberman, Esq. CLARK, GAGLIARDI i. MILLER The Inns of Court 99 Court Street White Plains, New York 10601 Howard Lester, Fsq. LESTER. SCHV.’A B , KATZ i DWYER 120 Broadway New York, New York 10271 Wendell B. Alcorn, Jr., Esq. CADWALADER, KlCKERSHAM b TAFT One Wall Street New York, New York 10005 Stephen J. Schlegel, Esq. SCHLEGEL & TRAFELET, LTD. One North LaSalle Street Suite 3900 Chicago, Illinois 60602 John Sabetta, Fso. TOWNLEY k UFD1KE 405 Lexington Avenue New York, New York 10174 Leonard Rivkin, Esq. RIYKiN, LEFF, SHERMAN & RADLER ICC: Garden City Plaza Garden City, New York 11530 William Krohley, Esq. KELLEY, DRYE & WARREN 101 Park Avenue New York, N e w York 10178 Thomas Henderson, Esq. BASKIN fc SEARS Frick Building, 10th Floor Pittsburgh, Pennsylvania 15219 David R. Gross, Esq. BUDD, LARNER, KENT, GROSS, PICILLO & ROSENBAUM 3 3 Washington Avenue Newark, New Jersey 07102 Victor J. Yannacone, Jr., Esq. YANNACONE i YANNACONE Post Office Box 109 Patchogue, New York 11722 Thomas A. Beck, Esq. ARTHUR, DRY & K A L I S H , P.C. 1230 Avenue of the Americas New York, New York 10020 Arvin Maskin, Esq. DEPARTMENT OF JUSTICE Safeway Building Rocn 904 D Washington, D.C. 20530 David Dean, Esq. DEAN AND FALANGA One Old Country Road Carle Place, New York 11514 Sol Schreiber, Esq. Special Master MILBERG, WEISS, BERSHAD i SPFCTHRIE One Pennsylvania Place Peon 4915, 4Sth Floor New York, New York 10019 I&Ù co -9- Judy Spanier, F s q . SHEA i, COULD 3 3C Madison Avo m u 15th Floor New York, New York 10017 Clerk oi the Panel Judicial Panel on Multidistr Li t iga t i on 1120 Vermont Avenue, N.K. Suite 1002 Washington, D.C. 20005 Paul Esposito, Esq. LEWIS, OVERDECK fc FURMAN 135 South La Salle Street Suite 1060 Chicago, Illinois 60603 Newton D. Schwartz, Esq. Houston Bar Center Building 723 Main, Suite 325 Houston, Texas 77002 Stanley Chesley, Esq. WAITE, SCHNIDER, BAYLEFF f. CHESLEY 1318 Central Trust Tower Cincinnati, Ohio 45202 Phillip E. Brown, Esq. ‘ HOBERG, FINGER, BROWN, COX & MOLLIGA 703 Market Street, 18th Floor San Francisco, California 941 John 0. O'Quinn, Esq. O'OUINN, HAGANS & WETTMAN 3200 Texas Commerce Tower Houston, Texas 77002 Robert A. Taylor, Jr., Esq. ASHCRAFT f. GEREL 2000 L Street N.W. , Suite 700 Washington, D.C. 20036 N. P.. Peterson, Esq. CF.E1TZER f> LOCKS 1500 Walnut St., 22nd Floor Philadelphia, Pa. 19102 District Clerk United States District Court Eastern District of New York 220 Cadman Plaza Brooklyn, New York 11201 Benton Musslewhite 12324 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK In re MDL No. 381 "AGENT ORANGE" Product Liability Litigation PRESENT LIST OF PLAINTIFFS’ CAUSATION WITNESSES WITH ATTACHED SUMMARIES IN ACCORDANCE WITH FRCP 26(b)(A)(A)(i) 1. Charles Baron, M.D. Exhibit "A" 2. Deborah Anne Barsotti, Ph.D. Exhibit "B" 3. Ronald Codario, M.D. Exhibit "C" 4. Arthur W. Galston, Ph.D. Exhibit "D” 5. John Garofalo, M.D. Exhibit "E" 6. Lennart Hardell, M.D. Exhibit "F" 7. Maureen C. Hatch, Ph.D. Exhibit "G" 8. Alastair W.M. Hay, Ph.D. Exhibit "H" 9. Herbert Kay, Ph.D. Exhibit "I" 10. Ronald H. Kerman, Ph.D. Exhibit "J" 11. Marvin S. Legator, Ph.D. Exhibit "K" 12. Alan Scott Levin, M.D. Exhibit "L" 13. Peter Orris, M.D., M.P.H. Exhibit "M" 14. Marvin A. Schneiderman, Ph.D. Exhibit "N" 15. Ellen K. Silbergeld, Ph.D. Exhibit "0" ■lfi. Raymond Singer, Ph.D. Exhibit "P" 17. Theodor D. Sterling, Ph.D. Exhibit "Q" 18. Biostatistician/Mathematician (Additional) Exhibit "R" PLAINTIFFS' MANAGEMENT COMMITTEE Thomas W. Henderson, Esquire 12325 Dr. Charles M. in Philadelphia, Baron, M . D . , is a p h y s i a t r i s t pr a c t i c i n g Pennsyl v a n i a . His c u r r i c u l u m v i t a e will be supplied. Dr. B a r o n will t e s t i f y as to the p e r f o r m a n c e and i n t e r p r e t a t i o n of v a r i o u s tests in the veterans. Th e s e will i n c l u d e an e l t r o e n c e p h a l o g r a m on b oth sleep and w a k i n g states with nasopharyngeal leads. He will also p e r f r o m e lectromyograms, ne r v e c o n d u c t i o n v e l o c i t y tests, and somato s e n s o r y evoked p o t e n t i a l s of the up p e r a n d lower extemities. Dr. Ba r o n will by w h i c h toxins p r o d u c e w h a t the various then testify as to the me c h a n i sms the changes noted in the tests and tests a r e ca p a b l e of d e t e r m i n i n g as to the m e d i c a l status of the patient. Then he will r e l a t e the results o b t a i n e d of each plai n t i f f examined, in the testing give opinions as to the c a usation of those results w h e r e p o s s i b l e from the e v i dence r e v e a l e d by the tests, and state the p r o g n o s i s for the individual plaintiff for f u r t h e r d e t e r i o r a t i o n in test results and/or for the individual's c o n d i t i o n as a whole. 12326 Dr. D e b o r a h A n n e B a r sotti is an A s s i s t a n t P r o f e s sor of T o x i c o l o g y in the D e p a r t m e n t of P h a r m a c o l o g y and T o x i cology of the P h i l a d e l p h i a C o l l e g e of P h a r m a c y and Sci e n c e in P h i l a ­ delphia, Pennsylvania. Dr. Her c u r r i c u l u m v i t a e is attached. B a r s o t t i is a tox i c o l o g i s t w h o has done substantial pers o n a l i n v e s t i g a t i v e w o r k w i t h h a l o g e n a t e d a r o m a t i c hydrocarbons. This cat e g o r y of c h e m i c a l s includes various b i p h e n y l s and dioxins, and s p e c i f i c a l l y i n c l u d e s t e t r a c h l o r o d i b e n z o - p - d i o x i n (TCDD). She will t e s t i f y as to the relative chemical s t a b i l i t y and l i p op h i l i c i t y of these chem i c a l s as w e l l as their r e s i s t a n c e to degradation, and w i l l tes t i f y tha t t h e s e qualities are w h a t a c c o u n t for the p e r c e i v e d and d o c u m e n t e d b i o a c c u m u l a t i o n of the c h e m i c a l s in the human system. Dr. Bars o t t i w i l l e m p h a s i z e the d i f f e r e n c e in results between c h r o n ­ ic and ac u t e e x p o s u r e s to these chemicals, t e s t i f y i n g as to the v a r y i n g types of r e s p o n s e s to acute and c h r o n i c exposures. Dr. B a r s o t t i w i l l discuss her o w n w o r k as w ell as r e v i e w the lite r a t u r e in th e s e areas, administration, involved. n o ting d i f f e r e n c e s in routes of a n d in the species and g e n e t i c strain of the a n i mals She w i l l explain these v a r i a t i o n s and wh e r e they p e r m i t e x t r a p o l a t i o n of r e s u l t s from animals to humans. In particular, B a r s o t t i w i l l a l s o tes t if y as to the s i m i l a r i t i e s in response to these c hemicals by rhes u s m o n k e y s and by humans, and w i l l e x p l a i n h o w the s i m i l a r i t i e s perm i t e x t r a p o l a t i o n in this instance. Dr. B a r s o t t i will also discuss r e p r o d u c t i v e toxicity, 12827 Dr. ter a t o l o g y and p o s t - n a t a l toxicity, i n c l u d i n g instances w h e r e no CD gross or c l i n i c a l signes of m a t e r n a l t o x i c i t y could be detected. CURRICULUM VITAE DEBORAH ANNE BARSOTTI ADDRESS: Home - 4818 T r i n i t y Place Ph il a. , PA 19143 2 1 5 -7 24-5387 Business - Phi l a . C o llege o f Pharmacy & Science Dept, o f Pharmacology & Toxicology 43rd & Kingsessing Mall Ph il a. , PA 19104 2 1 5 -5 9 6 -8 9 7 8 CITIZENSHIP: USA BIRTHDATE: September 1 4 , 1949 MARITAL STATUS: M a rrie d ; no c h ild r e n EDUCATION: Humboldt S ta te U n iv e r s it y A r e a ta , C a l i f o r n i a - 1967-1972 Bachelor o f A rts B iology-M edical Technology Humboldt S ta te U n iv e r s it y A r e a ta , C a l i f o r n i a - 1972-1973 Graduate School Coursework: E le c tro n microscopy Endocrinology In s tru m e n ta tio n U n iv e r s it y o f Wisconsin Madison, Wisconsin - 1973-1980 Doctor o f Philosophy Pathology Thesis T i t l e : G ross, C l i n i c a l & Reproductive E f f e c t s o f P o ly c h lo r in a te d Biphenyls (PCBs) in th e Rhesus Monkey EXPERIENCE: Phil a. C o lle g e o f Pharmacy & Science Phil a . , PA - J an u ary, 1983 to Present A sst. P r o fe s s o r , Dept, o f Pharmacology/Toxicology I n s t r u c t B io lo g ic a l Methods in T o x ic o lo g y , T o x ic o lo g y I I I & Techniques in E le c tro n Microscopy Advise undergraduate students F ac u lty a d v is o r f o r Tox Club Member, Ad visory Committe f o r fo u r graduate studen ts Conduct independent research S23 A s s is ta n t S c i e n t i s t - J u ly , 1982 to January, 1983 P ro je c t A s s o c ia te - June, 1980 to June, 1982 U n iv e r s it y o f Wisconsin Dept, o f Pathology Madison, Wisconsin Coordinated m u l t i f a c e t e d research p r o je c ts i n v o l v in g over 120 rhesus monkeys exposed to low l e v e l s o f t o x in s ( h a l o genated a ro m a tic hydrocarbons) and i n te g r a te d the c l i n i c a l data and o b s e rv a tio n s w ith the residue analyses o f tis s u e s and f l u i d s o b ta in e d by gas chromatography (GC) and con­ firm ed by mass spectrometry (MS). Supervised th e c l i n i c a l and reprodu ctive e v a lu a tio n s w ell as th e care o f la b o r a to r y animals. as Developed d a t a management and word processing systems u t i l ­ i z i n g o n - s i t e computers and t i e - i n s to a Sperry Univac 1100 to s o r t , c o l l a t e and s t a t i s t i c a l l y e v a lu a te d a ta . Conducted gross necropsies and m icroscopic e v a lu a t io n s and prepared necropsy re p o rts . Research A s s is t a n t - 1976-1980 U n iv e r s it y o f Wisconsin Dept, o f P athology Madison, Wisconsin Conducted radioimmunoassays f o r serum progesterone and e s t r a d io l f o r use in e v a lu a tin g the re p ro d u c tiv e param eters in rhesus monkeys. Performed c l i n i c a l assessments on la b . hematology and c l i n i c a l ch e m istries . animals in c lu d in g Supervised and e v a lu a te d data and prepared r e p o r t s f o r cont r a c t u r a l work. Separated c e l l u l a r f r a c tio n s o f t is s u e homogenates by u l t r a ­ c e n t r i f u g a t i o n and assayed homogenates and r e s u l t a n t f r a c ­ t io n s f o r c o n te n t o f various components. Provided animal husbandry f o r rhesus monkey and r a t co lonies Supervised u n i t members on protocols f o r e x p e r im e n ta tio n and proper methods o f conducting basic la b o r a t o r y a n a lys es. P re -D o c to ra l Fellow - 1974-1976 U n iv e r s it y o f Wisconsin Dept, o f Pathology Madison, Wisconsin Stocked and o rg an ized a la b o ra to ry f o r the c l i n i c a l d u c tiv e analyses o f la b o r a to r y animals. - 2 - and re p r Prepared protocols f o r lo n g -te rm fe e d in g stu d ies in the la b o r a t o r y animals in c lu d in g those f o r g ro s s , c l i n i c a l and re p ro d u c tiv e assessments. Developed radioimmunoassay procedures f o r serum proges­ te ro n e and e s t r a d i o l . Conducted metabolism and d i s t r i b u t i o n s tu d ie s in r a t s and rhesus monkeys using r a d io la b e le d isomers o f halogenated aro m a tic hydrocarbons and o th e r chem icals. L a b o ra to ry A s s is ta n t - 1970-1972 Humboldt S ta te U n iv e r s it y Student H e a lth Center A re a ta , C a lifo rn ia D u ties included a s s is t in g in r o u t in e c l i n i c a l l a b o r a t o r y p r a c t i c e s in volved in u r i n a l y s i s , gonococcal s c re e n in g , VDRLs, h e t e r o p h ile s f o r m ononucleosis, t h r o a t c u ltu r e s and pregnancy t e s t s . AWARDS/HONORS: N a tio n a l Sea Grant Graduate Student o f th e Year - 1976. PROFESSIONAL SOCIETIES: American S o cie ty f o r P r im a to lo g is ts M i d - A t l a n t i c C h a p te r, S o cie ty o f T o x ic o lo g y SEMINARS/MEETINGS: P a r t i c i p a n t - Fed eration o f American S o c ie t i e s f o r E x p e r i­ mental B iology (FASEB), A t l a n t i c C i t y , NJ, A p r i l , 1976. T o p ic : " E f fe c ts o f p o ly c h lo r in a t e d b ip h e n y ls on re p ro ­ d u c tio n in the p rim a te " . P a r t i c i p a n t - American A s s o c ia tio n o f P a th o lo g is t s and B a c t e r i o l o g i s t s , Boston, MA, March, 1976. Topic: "The A s s o c ia tio n o f T ra n s p la c e n ta l and Mammary Movement o f PCBs w it h In fa n t M o r b id ity and M o r t a l i t y " . I n v i t e d Speaker - 9th Annual Sea G rant A s s o c ia tio n M e e tin g , Los A n g e le s , CA, November, 1976. T o p ic : "Toxicology o f PCBs in th e A d ult and I n f a n t Rhesus Monkey". P a r t i c i p a n t - FASEB, Chicago, I L , A p r i l , 1977. Topic: " E f f e c t s o f p o ly c h lo r in a t e d b ipheny ls in nonhuman p rim a te s " . P a r t i c i p a n t - American Chemical S o c i e t y , 11th Great Lakes Regional M ee tin g , Stevens P o i n t , W I, Ju n e, 1977. T o p ic: "Responses o f i n f a n t prim ates to i n t e r u t e r i n e and neonatal exposure to p o lych T o rin a ted b ip h e n y ls " . I n v i t e d Speaker - Community Meeting on PCBs, U n i v e r s i t y o f W is co n sin , P a rk s id e , March, 1977. - 3 12331 P a r t i c i p a n t - I n t e r n a t io n a l Symposium on Pathobiology o f Environmental P o ll u t a n t s , S t o r r s , CT, June, 1977. Top ics: "Pathology o r rhesus macaques (Macaca m u la tt a ) exposed to t e t r a c h lo r o d ib e n z o - p - d io x in (TCDD)" and "Exposure o f p o ly ­ c h lo r in a t e d biphenyl (PCB) to i n f a n t rhesus macaques (Macaca m u la tta )" . I n v i t e d Speaker - Community Meeting on PCBs, Door County, W I, September, 1977. I n v i t e d Speaker - 45th Annual Convention o f A s s o c ia tio n o f Midwest Fish and W i l d l i f e A gencies, M ilwaukee, W I, J u l y , 1978. T o p ic : "Consequences o f d i e t a r y PCB consumption in rhesus monkeys". I n v i t e d C o n su lta n t - Symposium on PBB L i t i g a t i o n , T rave rse C i t y , M I, J u l y , 1978. Topic: "PBB t o x i c i t y in th e rhesus monkey". I n v i t e d Speaker - Smerkee's Conservation C lu b , Sheboygan, WI, F e b ru a r y , 1979. Topic: "PCBs and t h e i r e f f e c t s on rhesus monkeys". P a r t i c i p a n t - FASEB, D a l l a s , TX, A p r i l , 1979. Top ic: "Residual e f f e c t s o f p o ly c h lo r in a t e d biphenyls on a d u lt nonhuman prim ates and t h e i r o f f s p r i n g " . Expert Witness - S ta te o f North C a r o l i n a , H a l i f a x County; te s tim o n y on t o x i c i t y o f PCBs, June, 1979. P a r t i c i p a n t - Sea Grant Symposium on T o x ic M a t e r i a l s and t h e i r E f f e c t s on Marine Resources, Madison, W I, J u l y , 1979. PUBLICATIONS: B a r s o t t i , D. A. and Van M i l l e r , J. P . : Reproductive assessments o f rhesus monkeys housed in c l im a t e c o n t r o lle d c o n d itio n s . Amer. J. P r i m a t o l . , subm itted 1983. B a r s o t t i , D. A . : Long term r e p ro d u c tiv e assessment o f rhesus monkeys exposed to c h lo r in a t e d b ipheny ls ( A r o c lo r 124 8). Fd. Cosmet. T o x i c o l . , subm itted 1983. B a r s o t t i , D. A. and Van M i l l e r , J. P. : Accumulation o f a commercial p o l y ­ c h lo r in a t e d biphenyl m ix tu r e ( A r o c lo r 1010) in a d u lt rhesus monkeys and t h e i r n u rsin g o f f s p r i n g . T o x ico lo g y . In press. Bowman, R. E. , H eironim us, M. P. and B a r s o t t i , D. A . : Locomotor h y p e r a c t­ i v i t y in PCB-exposed rhesus monkeys. N e u r o to x ic o l. 2 : 2 5 1 - 2 6 8 , 1981. B a r s o t t i , D. A. , Abrahamson, L. J. , M a r l a r , R. J. and A l l e n , J. R . : The e f f e c t o f c lim a te c o n t r o l l e d housing on the r e p ro d u c tiv e p o t e n t i a l o f the rhesus monkey. J. Reprod. F e r t i l . 5 9 : 1 5 - 2 0 , 1980. d B a r s o t t i , D. A. and A l l e n , J. R . : nursing rhesus monkey i n f a n t s . (A b s tra c t). Health i m p lic a t io n s o f A r o c lo r 1016 on T o x ic o l. A p p l. Pharmacol. 5 2 : 1 3 5 , 1980 A l l e n , J. R . , B a r s o t t i , D. A. and C a rs te n s , L. A . : Residual e f f e c t s o f p o ly ­ c h lo r in a t e d b ipheny ls on a d u lt nonhuman p rim ates and t h e i r o f f s p r i n g . J. T o x ic o l. E n viron . H l t h . 6 : 5 5 - 6 6 , 1980. A l l e n , J. R . , B a r s o t t i , D. A. and Van M i l l e r , J. P . : T o x ic o lo g ic a l e f f e c t s o f A r o c lo r 1016 on nonhuman p rim a te s . EPA Report # 6 8 - 0 2 : 2 4 6 4 , 1980. B a r s o t t i , D. A . , Abrahamson, L. J. and A l l e n , J. R. : Hormonal a l t e r a t i o n s in fem ale rhesus monkeys fe d d i e t s c o n ta in in g 2 , 3 , 7 , 8 - t e t r a c h lo r o d ib e n z o ­ l-d io x in . B u l l . E nviron. Contain. T o x ic o l. 2 1 : 4 6 3 - 4 6 9 , 1979. B a r s o t t i , D. A . , C a rs te n s , L. A. and A l l e n , J. R . : Residual e f f e c t s o f p o ly ­ c h lo r in a t e d b ipheny ls on a d u lt nonhuman p rim a tes and t h e i r o f f s p r i n g . Fed. Proc. 3 8 : 1 1 1 9 , 1979 ( A b s t r a c t ) . A l l e n , J. R. , B a r s o t t i , D. A. and Lambrecht, L. K . : R e p ro d u ctive e f f e c t s o f halogenated a ro m a tic hydrocarbons on nonhuman p r im a te s . New York Academy o f S c ie n c e s , 3 2 0 :4 1 9 - 4 2 7 , 1979. A l l e n , J. R . , B a r s o t t i , D. A. macagques (Macaca m u la tt a ) I n t e r n a t i o n a l Symposium on Research C o u n c i l, 3 4 6 -3 5 5 , and Van M i l l e r , J . P . : P a tho logy o f rhesus exposed to t e tr a c h lo r o d ib e n z o - ]D -d io x in (TCDD). Pathology o f Environmental P o l l u t a n t s , N a tio n a l 1979. A l l e n , J. R . , Van M i l l e r , J. P. and B a r s o t t i , D. A . : T o x ic o lo g i c a l responses o f nonhuman p rim ates to 1 , 2 , 4 , 6 ,7 ,8 - h e x a c h l o r o d i b e n z o - £ - d i o x i n (HCDD). T o x ic o l. A p pl. Pharmacol. 4 7 : 1 7 9 , 1979 ( A b s t r a c t ) . C a rs te n s , L. A . , B a r s o t t i , D. A. and A l l e n , J . R . : Exposure o f p o l y c h l o r i n ­ ated biphenyl (PCB) to i n f a n t rhesus macaques (Macaca m u l a t t a ) . In te r­ n a t io n a l Symposium on P ath o b io lo g y o f Environmental P o l l u t a n t s , .N atio n a l Research Council , 3 3 9 -3 4 5 , 1979. S c h a n tz, S. L. , B a r s o t t i , D. A. and A l l e n , J . R . : T o x ic o lo g i c a l e f f e c t s pro­ duced in nonhuman p rim ates c h r o n ic a ll y exposed to f i f t y p a r t s per t r i l l i o n 2 , 3 , 7 , 8 - t e t r a c h l o r o d i b e n z o - p - d i o x i n (TCDD). T o x i c o l . A p p l. Pharmacol. 4 6 : 1 8 0 , 1979 ( A b s t r a c t ) . A l l e n , J. R. , Lambrecht, L. K. and B a r s o t t i , D. A . : Some gen eral e f f e c t s o f polybrom inated biphenyls in nonhuman p rim a te s . J. Am. V e t. Med. Assoc. 173 1 1 : 1 4 8 5 - 1 4 8 9 , 1978. Lambrecht, L. K. , B a r s o t t i , D. A. and A l l e n , J. R. : Responses o f nonhuman p rim ates to a polybrom inated m ix tu re . E n v iro n . H e a lth Perspec. 2 3 :1 3 9 1 4 7 , 1978. A l l e n , J. R. , B a r s o t t i , D. A . , Van M i l l e r , J. P . , Abrahamson, L. J. and L a l i c h , J. J . : Morphological changes in monkeys consuming a d i e t c o n ta in ­ ing low l e v e l s o f 2 , 3 , 7 , 8 - t e t r a c h lo r o d ib e n z o - £ _ - d io x in . Fd. Cosmet. , T o x ic o l. 1 5 : 4 0 1 - 4 1 0 , 1 9 7 7 / A l l e n , J. R. and B a r s o t t i , D. A . : Responses o f i n f a n t primates to i n t e r u t e r i n e and neonatal exposure o f p o ly c h lo r in a t e d b ip h e n y ls . American Chemical So­ c i e t y , Proceedings o f 11th Great Lakes Regional M eeting , June, 1977 (Ab­ s tra c t). A l l e n , J. R . , B a r s o t t i , D. A. and Van M i l l e r , J. t i o n in nonhuman primates exposed to d io x in s . 4 1 : 1 7 9 , 1977 ( A b s t r a c t ) . P . : Reproductive dysfunc­ T o x ic o l. A p pl. Pharmacol. Norback, D. H. and B a r s o t t i , D. A . : E f f e c t s o f p o ly c h lo r in a t e d biphenyls in nonhuman p rim ates. Fed. Proc. 3 6 5 :3 9 6 , 1977 ( A b s t r a c t ) . B a r s o t t i , D. A . , M a r l a r , R. J. and A l l e n , J. R . : Reproductive dysfun ctions in rhesus monkeys exposed to low l e v e l s o f p o ly c h lo r in a t e d biphenyls ( A r o c l o r 1 24 8). Fd. Cosmet. T o x i c o l . 1 4 : 9 9 - 1 0 3 , 1976. B a r s o t t i , D. A. and A l l e n , J. R . : The a s s o c ia tio n o f t r a n s p la c e n ta l and mammary movement o f PCBs w ith i n f a n t m o r b id it y and m o r t a l i t y . Amer. -J. Path. 8 2 : 2 1 a , 1976 ( A b s t r a c t ) . A l l e n , J . R. and B a r s o t t i , D. A . : The e f f e c t s o f tra n s p la c e n ta l and mammary movement o f PCBs on i n f a n t rhesus monkeys. T oxico logy 6 : 3 3 1 -3 4 0 , 1976. A l l e n , J. R. , B a r s o t t i , D. A. and C a r s te n s , L. A . : Residual e f f e c t s o f s h o rt t e r m , low le v e l exposure o f nonhuman p rim ates to p o ly c h lo r in a t e d b ip h e n y ls . T o x ic o l. Ap pl. Pharmacol. 30:440-451 , 1974. - 6 - 3 > ' Dr. R o n a l d Corderio, in Philade l p h i a , M . D . , is an internist p r a c t i c i n g Pennsylvania. His c u r r i c u l u m v i t a e wil l be supplied. Dr. C o r d e r i o will t e s t i f y that he is c u r r e n t l y e n g a g e d in the p r i v a t e p r a c t i c e of m e d i c i n e as an internist. He will testify that he p e r s o n a l l y has e x a m i n e d and/or tr e a t e d over five h u n dre d V i e t n a m v e t e r a n s for c o m p l a i n t s He will t e s t i f y as to the type of with e a c h veteran, have performed, i n t e r v i e w he has c o n d u c t e d the type of tests and the c l i nical r elated to A g e n t Orange. that e ach v e t e r a n should s i g n i f i c a n c e of p o s i t i v e or negative f i n d i n g s on each of those tests. He will a lso discuss how toxins, can cause c h a nges each a n d s p e c i f i c a l l y A g e n t O range, in of the tests and w h a t such c h a n g e s p o r t e n d for the individual. Dr. medical C o r d e r i o will next d i s c u s s some of the a v a i l a b l e literature in b o t h a n i m a l s a n d huma n s to further v a l i d a t e his o w n work. Dr. C o r d e r i o will then o u t l i n e o b t a i n e d f r o m his own e x t e n s i v e in detail the results i n v e s t i g a t i o n into A g e n t O r a n g e toxicity b a s e d u p o n his e x a m i n a t i o n of m o r e than five h u n d r e d veterans, and will p resent those c o n c l u s i o n s w h i c h he feels are re a s o n a b l y a p p r o p r i a t e b a s e d upo n an a n a l y s i s of his investigative work. W i t h this m a t erial as b a c k g r o u n d , Dr. C o r d e r i o will then p r o c e e d to p r e s e n t the test results w h i c h have b e e n o b t a i n e d for eac h c o u r t - a p p r o v e d r e p r e s e n t a t i v e v e t e r a n plaintiff. He will ,¿ai * / inter p r e t e a c h of the test r e s u l t s in terms of those individual plaintiffs. Finally, he will t e s t i f y on g e n e r i c c a u s a t i o n and speci f i c p r o x i m a t e c a u s a t i o n v e t e r a n plaintiff. in r e l a t i o n to each r e p r e s e n t a t i v e He will a lso testify as to p r o g n o s i s for each r e p r e s e n t a t i v e v e t e r a n plaintiff. n 12836 ARTHUR W. GALSTON, Ph.D. Dr. Galston is Eaton Professor of Botany, Department of Biology, at Yale University. His Curriculum Vitae will be supplied. Dr. Galston is a plant physiologist and has personally observed the effect of the spraying of Agent Orange on the Vietnam ecosystem, i.e. the devastation of the Vietnamese countryside. Dr. Galston has been in Vietnam on four occasions between 1971 and 1982, and will describe those observations while in Vietnam, with such pictorial evidence as is available. Dr. Galston will testify to the potential and actual effects of phenoxy herbicides and their contaminants, both in Vietnam and elsewhere, including the United States and Sweden, and other places. The testimony will include the chemistry and the mechanisms of action of such chemicals on plant life. In addition, Dr. Galston will testify to the fate of Agent Orange and other phenoxy herbicides and their contaminants, especially TCDD, in the environment generally and in Vietnam in particular. Dr. Galston will testify to the persistence of such chemicals on plants, in water, and in soil, such that exposure to the phenoxy herbicides and their contaminants, especially TCDD, by the veterans in sprayed areas in Vietnam is presumed. The bases or grounds for Dr. Galston's testimony as to any facts and opinions expressed are a review of the scientific literature and his personal research and experience. 12337 Dr. John Garofalo is a i m m u n o l o g i s t p r a c t i c i n g in Phi l a d e l p h i a , Pennsylvania. His c u r r i c u l u m v i t a e w i l l be supplied. Dr. G a r o f a l o w i l l t e s t i f y to the p e r f o r m a n c e of c e r t a i n tests on the v e t e r a n p l a i n t i f f s and th e i r w i v e s and c h i l d r e n a n d to the i n t e r p r e t a t i o n of those t e s t results. Specifically, for, he w i l l be c o n d u c t i n g p h e n o t y p i n g a s s a y tests a m o n g others, T - h e l p e r cells, B - l y m p h o c y t e s , K cells, T - l y m p h o c y t e s , T - c y t o t o x i c cells, The p u r p o s e of these tests a n t i b o d y levels, and T - s u p p r e s s o r cells. is to dete r m i n e a n t i g e n levels, and the p r e s e n c e of a viral d e f e n s e s and immune s u r v e i l l a n c e s y s t e m s , a n d to identify v a r i o u s types of cells tha t m a y b e i n d i c a t o r s of a n d / o r p r e c u r s o r s of malignancy. N o t o n l y w i l l t h e tests d e t e r m i n e the p r e s e n c e of such f a c t o r s , b u t t hey w i l l also i n c l u d e f u n c t i o n a l assays of each. LENNART HARDELL, M.D. Dr. Hardell is employed by the University Hospital in its Department O of Oncology in Umea, Sweden, where he specializes in internal medicine and oncology. His work includes diagnosis, treatment, and evaluation of possible causes of cancer, and education of medical students. Dr. Hardell will testify to several epidemiological studies which he and colleagues have conducted in Sweden. This research includes investigations concerning the relationship between the risk for different types of cancer and exposure to phenoxy herbicides and chlorophenols. The research has been published in the medical and scientific literature. .These studies utilized the case-control study as the vehicle for investigation. Certain methodological aspects, such as selection of cases, selection of controls, assessment of exposure, and statistical methods, were considered; and then utilization was based upon thoroughly considered aspects of bias, all of which were well controlled. Specifically, these studies, four in number, involved soft tissue sarcomas, malignant lymphomas, and colon cancer. Highly statistically significant risks of soft tissue sarcomas and malignant lymphoma were found, whereas no association was found for colon cancer. In point of fact, the negative finding for colon cancer strongly supports the statistical significance of the increased risk demonstrated for soft tissue sarcomas and malignant lymphomas, i.e. a presumed causal relationship between exposure to phenoxy herbicides and human cancer particularly of soft tissue sarcoma and malignant lymphoma. 12S39 Dr. Hardell has also seen in his clinical practice basal cell carcinoma of persons previously exposed to phenoxy herbicides, with no other known confounding variables. With respect to those cases with soft tissue sarcoma, malignant lymphoma, and basal cell carcinomas, Dr. Hardell will testify that the presumed exposure to Agent Orange caused, in significant part, such neoplastic processes. The bases for Dr. Hardell?s testimony as to various facts and opinion include: educational background; professional training and experience; review of the applicable medical and scientific literature; personal research; and a review of the pertinent medical data of the relevant representative plaintiffs. . K erm an, R ., P eddada, L. and Kahan, B.D.: C o rrelatio n of h y p eracu te rejectio n w ith ‘ .LDA and CDA vs. 5 1 c r-la b e le d donor T and B cell ta rg e ts. P resen ted a t T he A m erican A ssociation fo r C linical H istocom patibility T esting, S t. Louis, M issouri, April 1980. 36. K erm an, R ., Floyd, M., Van Buren, C.T. and K ahan, B.D.: Im proved a llo g raft survival of strong responder-high risk cadaver recip ien ts w ith adjuvant im m unosuppressive th erap y . P re se n te d a t th e Annual M eeting of T he A m erican A ssociation fo r C lin ical H isto com patibility T estin g , April 1980. Pathology G rand Surgical G rand 12360 Bibliography Ronald H. Kerman, Ph.D. 10 37. K erm an, R ., Conklin, R., C ahall, D. and Kahan, B.D.: A ssociation of cytom egalovirus and ren al a llo g ra ft survival. P rese n ted a t the m eeting of the A m erican A ssociation for C linical H istocom patibility T estin g , S t. Louis, Missouri, April 1980. 38. K erm an, R ., Floyd, M., V anB uren, C .T. and Kahan, B.D.: D elineation o f donor sp ecific and nonspecific p re tra n sp lan t im m unocom pétence as a p re d ic to r fo r LRD a llo g ra ft survival. P resen ted a t th e M eeting of The A m erican A ssociation of C linical H isto com patibility T esting, S t. Louis, M issouri, A pril 1980. 39. K erm an, R .H ., Floyd, M., V anB uren, C.T. and Kahan, B.D.: Im proved a llo g ra ft survived of strong immune responder-high risk recip ien ts with adjuvant im m uno­ suppressive therapy. P resented a t the annual m eeting of The A m erican S o c ie ty of T ran sp lan t Surgeons, Chicago, Illinois, May 1980. 40. K erm an, R .H ., Floyd, M., V anB uren, C.T. and Kahan, B.D.: C o rre la tio n of nonspecific im m une m onitoring of renal a llo g ra ft recip ien ts with re je c tio n and im paired renal function. P resen ted a t the Annual M eeting of The A m erican S o ciety of T ransplant Surgeons, Chicago, Illinois, May 1980. 41. K erm an, R ., Floyd, M., V anB uren, C.T. and Kahan, B.D.: Prolonged a llo g ra ft survival of strong p retran sp lan t im m une responders tre a te d with ATG. P re se n te d a t th e Vinth In te rn a tio n a l Congress of T he T ran sp lan tatio n Society, B oston, M assachu­ s e tts , Ju n e 1980. 42. K erm an, R ., Floyd, M., Van B uren, C.T. and Kahan, B.D.: P red ictio n of ren al a llo g ra ft survival based on p re tra n sp lan t non-specific im m unocom pétence. P re se n te d a t The Second In tern atio n al Symposium on Im m unological M onitoring of th e T ran s­ plant R ec ip ien t, Leiden, The N etherlands, S ep tem b er 1980. 43. K erm an, R .H ., Floyd, M., Van B uren, C .T., M cConnell, B .J., M cConnell, R . and Kahan, B.D.: D elineation of renal a llo g raft rejectio n and im paired ren al fu n ctio n by serial m easurem ent of non-specific im m une p a ra m e te rs. P resen ted a t T he Second In te rn a tio n a l Symposium on Im m unological M onitoring of the T ran sp lan t R ec ip ie n t, Leiden, T he N etherlands, S ep tem b er 1980. 44. K erm an, R .H . and Kahan, B.D.: Increased expression of the activ e T-R FC re c e p to r as a m easure of allosensitization following in v itro stim ulation of rec ip ien t lym pho­ c y te s by soluble donor HLA antigens. P re se n te d a t The Second In te rn a tio n a l Symposium on Im m unological M onitoring of th e T ransplant R ecip ien t, L eiden, The N etherlands, S eptem ber 1980. 45. K erm an, R .H ., Floyd, M., Van Buren, C.T. and Kahan, 3.D .: C o rrelatio n of HLA A,B and DR typing to cadaveric and living re la te d ren al allo g raft survival. P re se n te d a t The Second In te rn a tio n a l Symposium on Im m unological M onitoring of th e T ran sp lan t R ecip ien t, L eiden, The N etherlands, S ep tem b er 1980. 46. Floyd, M., K erm an, R ., Woo, J ., Van Buren, C .T . and Kahan, B.D.: R elatio n sh ip s of beta-2-m icroglobulin m etabolism , im m une re a c tiv ity and renal a llo g ra ft re je ctio n . P rese n ted a t T he Second In tern atio n al Symposium on Im m unological M onitoring of the T ran sp lan t R ecipient, Leiden, T he N eth erlan d s, Septem ber 1980. f O ^ -i 1 4 iifcl Bibliography Ronald H. Kerman, Ph.D. 1: 47. K erm an, R .H .: Im m une m onitoring of ren al allo g raft re c ip ien ts. R ounds, U niversity of C hicago, Ju n e 1981. S urgical Grand 48. K erm an, R .H ., Van B uren, C .T., L eG rue, S .J. and K ahan, B.D.: Im m unopharm acological m onitoring of cad av eric ren al a llo g ra ft recip ien ts receiving C yclosporin A. P re s e n te d a t th e Annual M eeting of the A m erican S o ciety of T ran sp lan t Surgeons, C hicago, Illinois, June 1981. 49. K erm an, R .H ., Conklin, R ., C ahall, D ., Van B uren, C .T. and Kahan, B.D.: CMV and re n a l a llo g ra ft re je ctio n . P rese n ted a t a Symposium on H ost D efenses to In tra ­ c e llu la r P athogens, F ranklin P laza H otel, Philadelphia, Pennsylvania, Ju n e 1981. 50. S choenberg, L .P ., K ahan, B.D . and K erm an, R .H .: The use of Cyclosporin A as im m unosuppressive m edication in ren al tra n sp lan tatio n . P rese n ted a t The N ational Kidney Foundation, Inc., W ashington, D .C ., N ovem ber 1981. A m er. J . Kidney D iseases, Program fo r C linical D ialysis and T ran sp lan tatio n Forum , p. 29. 51. E tte n g e r, R ., K erm an, R ., A rn e tt, J ., Jo rd a n , S., Warshaw, B., H arris, R., W assner, S. and F in e, R.: S en sitizatio n following donor-specific transfusions fo r liv e -re la te d re n a l tra n sp lan tatio n . A m erican S o ciety of N ephrology, W ashington, D .C ., N ovem ber 1981. 52. F le c h n e r, S., B oileau, M., Payne, W., Van B uren, C., K erm an, R. and Kahan, B.: The use of Cyclosporin A in stro n g im m une responder, high risk ren al tran sp lan t re c i­ p ien ts. A m erican U rological A ssociation, K ansas C ity, Kansas, 1982. 53. K erm an, R ., Van Buren, C ., Payne, W., F lech n er, S., A gostino, G., C onley, S., B rew er, E. and K ahan, B.: Influence of blood transfusions on im m une responsiveness. P re se n te d a t The T ransfusion and T ran sp lan tatio n C onference, Los A ngeles, C ali­ fo rn ia, Jan u a ry - February 1982. 54. A gostino, G., Kahan, B.D. and K erm an, R .H .: Suppression of mixed le u co c y te cu ltu re using m ononuclear leu k o cy tes from norm als, urém ies and a llo g ra ft recip ien ts. P re ­ sen ted a t th e Annual M eeting of T he A m erican A ssociation of Im m unologists, FASEB, New O rleans, Louisiana, April 1982. 55. A gostino, G .J., Kahan, B.D. and K erm an, R .H .: M easurem ent of suppressor cell s ta tu s in p o te n tia l a llo g ra ft re c ip ien ts. P rese n ted a t th e Annual M eeting of The A m erican A ssociation of C linical H isto co m p atib ility T estin g , San F ran cisco , C ali­ fo rn ia, A pril 1982. 56. K erm an, R .H .: Invited p re se n te r a t tw o workshops on 1) Im m une m onitoring of ■ . a llo g ra ft re c ip ien ts and 2) The e ffe c t of tran sfu sed blood and blood products on urem ic hosts. P rese n ted a t th e Annual M eeting of T he N orth A m erican T ran sp lan t C o o rd in ato rs O rganizatio n , San A ntonio, T ex as, May 1982. 57. K erm an, R .H ., Van B uren, C ., F lech n er, S., A gostino, G., Conley, S., .B rew er, E. and K ahan, B.D .: The influence of p re tra n sp la n t blood transfusions from random donors on im m une p a ra m ete rs a ffe c tin g cad av eric allo g ra ft survival. P rese n ted a t The Annual M eeting of The A m erican S ociety of T ran sp lan t Surgeons, C hicago, Illinois, Ju n e 1982. *-• ***•*** O À > 0 V -w Bibliography Ronald H. Kerman, Ph.D. 12 58. A gostino, G., Kahan, B.D. and K erm an, R.H.: Suppression of mixed le u co cy te culture­ using leu co cy tes from norm al individuals, urem ic individuals, and allo g ra ft re cip ien ts. P re s e n te d a t The Annual M eeting of T he A m erican Society of T ran sp lan t Surgeons, C h icag o , Illinois, Ju n e 1982. 59. K erm an , R .H .: Invited p re se n te r a t a workshop on "Human T lym phocyte subpopula­ tio ns: T h eir role in rejectio n and im m unosuppression." P resen ted a t th e In te rn a tio n a l C ongress of The T ran sp lan tatio n S o ciety , B righton, England, August 1982. 60. K erm an, R.H .: Invited p re se n te r a t a workshop on "M echanisms responsible fo r blood tran sfu sio n e ffe c ts." P rese n ted a t The In tern atio n al C ongress of The T ran sp lan tatio n S o c ie ty , B righton, England, A ugust 1982. 61. E tte n g e r, R.B., K erm an, R ., Jo rd a n , S.C ., W arshaw, B.L., H arris, R. and F ine, R.: S e n sitiz a tio n a fte r donor-specific transfusions fo r liv e -re la te d ren al tran sp lan tatio n . P re s e n te d a t The In te rn a tio n a l C ongress of The T ran sp lan tatio n S o ciety , B righton, E ngland, August 1982. 62. Van B uren, C .T., K erm an, R .H ., A gostino, G., F lech n er, S. Payne, W. and Kahan, B .D .: E ffe c t of cyclosporine on im m unoregulatory cells of renal a llo g ra ft recip ien ts. P re s e n te d a t The In te rn a tio n a l C ongress of T he T ran sp lan tatio n S o ciety , B righton, E ngland, August 1982. 63. K erm an, R .H ., Van B uren, C .T ., P ay n e, W., F lech n er, S. and K ahan, B.D.: M onitoring T c ell subsets and im m une ev en ts in renal a llo g ra ft recipients,. P rese n ted a t T he In te rn a tio n a l C ongress of The T ran sp lan tatio n Society, B righton, England, August 1982. 64. F le c h n e r, S., K erm an, R ., Van B uren, C .T., Payne, W. and Kahan, B.D.: The use of cyclosporine and prednisone for high MLC haploidentical living re la te d renal tra n s­ p la n ts. P resen ted a t The In te rn a tio n a l C ongress of The T ran sp lan tatio n S o ciety , B righton, England, August 1982. 65. A gostino, G., Kahan, B.D. and K erm an, R .: D etectio n of nonspecific suppressor cells from norm al individuals, urem ic p a tie n ts and a llo g ra ft rec ip ien ts. P resen ted a t The In te rn a tio n a l C ongress of The T ran sp lan tatio n S o ciety , B righton, England, August 1982. 66. K erm an, R .H ., A gostino, G., Van Buren, C .T., Payne, W., F lech n er, S., C onley, S., B re w er, E. and Kahan, B.D.: E ffe c t of blood transfusions on g ra ft survival and im m une responsiveness. P rese n ted a t The In tern atio n al C ongress of The T ran sp la n tatio n S ociety, B righton, England, August 1982. 67. K ahan, B .D ., K erm an, R ., Payne, W.D., F lech n er, S. and Van Buren, C.T.: Imm unop h arm acologic studies of c y clo sp o rin e -trea te d renal a llo g ra ft re c ip ien ts. F ifth T r ip a r tite M eeting, S o ciety of U niversity Surgeons, Salzburg, A u stria, S ep tem b er 1982. f 4 JL J» -J1ô »J Bibliography Ronald H. Kerman, Ph.D. 13 68. K erm an, R .H ., F lech n er, S., Van Buren, C .T., Payne, W., and Kahan, B.D.: C yclo­ sporine im proves a llo g ra ft survival in im m unologically high-risk ren al a llo g ra ft re c ip ien ts. P rese n ted a t th e Third In te rn a tio n a l Im m unological M onitoring Sym­ posium , K eyB iscayne, F lo rid a, N ovem ber 1982. 69. K erm an, R .H ., Van B uren, C .T ., Payne, W., F lech n er, S., and Kahan, B.D.: D etectio n of host p resen sitizatio n to donor alloantigens utilizing a com prehensive im m une cro ssm atch . P rese n ted a t th e Third In te rn a tio n a l Im m unological M onitoring Sym­ posium , K eyB iscayne, F lo rid a, N ovem ber 1982. 70. K erm an, R .H ., Payne, W., Van B uren, C .T., F lech n er, S., and Kahan, B.D .: Immune m onitoring of renal a llo g ra ft recip ien ts tre a te d with cyclosporine or azath io p rin e using donor-specific and nonspecific assays as well as m onoclonal T cell reag en ts. P re se n te d a t th e Third In te rn a tio n a l Im m unological M onitoring Symposium, Key B iscayne, F lorida, N ovem ber 1982. 71. K erm an, R .H .: Invited plenary speaker a t the F irst Annual M eeting of The A m erican S o ciety of T ransplant Physicians, "O ptim izing imm unosuppression: Mode of action of cyclosporine." C hicago, D ecem ber 1982. 72. K erm an, R .H ., Van Buren, C .T., Payne, W., F lechner, S., and Kahan, B.D.: Cyclo­ sporine im proves allo g ra ft survival in im m unologically high-risk renal a llo g raft re c ip ie n ts. P resen ted a t The Annual M eeting, N ational Kidney Foundation, C linical D ialysis and T ran sp lan t Forum , C hicago, D ecem ber 1982. 73. K erm an, R .H .: R ole of im m une evaluation in clinical m edicine. C linical Immunology G rand Rounds, T he C hildren's M em orial H ospital, C hicago, Illinois, D ecem ber 1982. 74. K erm an, R .H .: Imm unologic e ffe c ts of toxic m a te ria ls. P resen ted a t Toxicology C linical U pdate, U niversity of Texas M edical B ranch, G alveston, T exas, Jan u ary 1983. 75. K erm an, R .H .: C yclosporine im proves a llo g ra ft survival in im m unologically high risk re n a l a llo g ra ft re c ip ien ts. P rese n ted a t Pathology G rand Rounds, U niversity of P ittsb u rg h School of M edicine, February 1983. 76. K erm an, R .H .: Im m une evaluation of ren al failu re p a tie n ts and allo g ra ft recip ien ts. P re se n te d a t Surgical G rand Rounds, S t. Louis U niversity M edical C en ter, S t. Louis, M issouri, M arch 1983. 77. K erm an, R .H .: Im m unological evaluation of hem ophiliacs. P rese n ted a t a Symposium on C u rre n t Problem s in th e M anagem ent of H em ophiliac C om plications, H ouston, T ex as, A pril 1983. 78. F le c h n er, S ., K erm an, R .H ., Van B uren, C .T ., Payne, W., and Kahan, B.D.: Successful tra n sp la n ta tio n of high m ixed lym phocyte c u ltu re h ap lo -id en tical living re la te d donors using cyclosporine and prednisone. P resen ted a t th e Annual A m erican U rological A ssociation, Las Vegas, N evada, A pril 1983. 79. K erm an, R .H ., F lech n er, S., Van Buren, C .T., Payne, W., and K ahan, B.D.: Imm unolo­ g ical m onitoring of renal a llo g ra ft recip ien ts tre a te d with cyclosporine. P rese n ted a t T he F irs t In te rn a tio n a l C ongress on C yclosporine, Houston, T exas, May 1983. Bibliography Ronald H. Kerman, Ph.D. 14 80. Van Buren, C., K erm an, R ., A gostino, G., F lech n er, S., Payne, W.D., and Kahan, B.: E ffe c t of cyclosporine on im m unoregulatory cells of ren al a llo g raft recip ien ts. P re se n te d a t The F irs t In te rn a tio n a l C ongress on C yclosporine, H ouston, T exas, May 1983. 81. K ahan, B .D ., Van B uren, C ., F le c h n er, S., Payne, W.D., and K erm an, R.: Im proved outcom e of 150 renal a llo g ra fts in im m unologically high risk recip ien ts tre a te d with cyclosporine. P resen ted a t T he F irs t In te rn a tio n a l C ongress on Cyclosporine, H ouston, T exas, May 1983. 82. F lech n er, S.M., Van B uren, C ., K erm an, R .H ., and K ahan, B.D .: The nephrotoxicity of cyclosporine in renal tra n sp la n ta tio n . P resen ted a t The F irs t In tern atio n al Congress on C yclosporine, H ouston, T ex as, May 1983. 83. F lech n er, S.M., Van B uren, C .T ., K erm an, R ., and K ahan, B.D.: The e ffe c t of conversion from cyclosporine to azath io p rin e im m unosuppression for in tra c ta b le nephrotoxicity. P rese n ted a t T he F irs t In te rn a tio n a l C ongress on C yclosporine, H ouston, T exas, May 1983. 84. K erm an, R .H ., F lechner, S., Van B uren, C .T., Payne, W., and Kahan, B.D.: C yclo­ sporine im munosuppression overcom es im m unologic risk fa c to rs fo r recip ien ts of c ad av eric renal a llo g rafts. P rese n ted a t th e Annual M eeting of The A m erican S o ciety of T ransplant Physicians, C hicago, Illinois, Ju n e 1983. 85. F lech n er, S.M., K erm an, R .H ., Van B uren, C .T ., and K ahan, B.D.: The high risk haploidentical living re la te d recip ien t: T ran sp lan tatio n w ithout blood transfusions and stero id w ithdraw al using cyclosporine. P re se n te d a t th e Annual M eeting of The A m erican S ociety of T ran sp la n t Physicians, C hicago, Illinois, Ju n e 1983. 86. K erm an, R.H.: R elationship of im m unocom pétence of hem ophiliac p atien ts and acquired immune deficiency syndrom e (AIDS). P re se n te d a t th e Gulf C oast Hemo­ philia C h ap ter M eeting, H ouston, T exas, O ctober 1983. 87. K erm an, R ., Van B uren, C .T ., F lech n er, S., and K ahan, B.D .: C o rrelatio n of visual, ST-Cr-release and flow c y to m e try crossm atch resu lts to g ra ft survival. P resen ted a t T he F ourth In te rn a tio n a l Symposium: Im m une M onitoring of The T ransplant R e­ c ip ien t, Houston, T exas, N ovem ber 1983. 88. R ogers, A .J., K erm an, R .H ., and Kahan, B.D.: T he p h arm aco k in etic and immunobiological a ctiv ity of cyclosporine in man. P re se n te d a t T he F ourth In tern atio n al Symposium: Imm une M onitoring of The T ran sp lan t R ec ip ie n t, Houston, Texas, N ovem ber 1983. 89. K erm an, R .H ., M anner, C ., Ford, K., and H oots, K.: C om prehensive immune evaluation of 78 hem ophiliacs. P resen ted a t th e New York A cadem y of Sciences Symposium on A cquired Im m une D eficiency Syndrom e, New Y ork, New York, Novem­ b e r 1983. 90. K erm an, R ., Van Buren, C .T ., F lechner, S.M ., and Kahan, B.D.: DRW6 and DR3 phenotypes co rrelatin g w ith im m une response. P re se n te d a t th e Annual M eeting of T he A m erican A ssociation fo r C linical H isto co m p atib ility T estin g , Chicago, Illinois, N ovem ber 1983. Bibliography Ronald H. Kerman, Ph.D. 91. 15 Van Buren, C .T., F lech n er, S.M ., K erm an, R .H ., Vaughn, W., and Kahan, B.D .: C yclosporine im proves outco m e in high risk cad av eric renal a llo g raft re cip ien ts. P rese n ted a t th e F irs t M eeting of T he European S o ciety fo r Organ T ran sp lan tatio n , Zurich, Sw itzerland, N ovem ber 1983. 92. K erm an, R.H .: C yclosporine im m unosuppression fo r renal tran sp lan tatio n . P rese n ted to Sandoz P h a rm a c eu tica ls, Inc., E a st H anover, New Je rse y , D ecem ber 1983. 93. K erm an, R.H .: New horizons in tran sp lan tatio n : Influence of cyclosporine on renal tra n sp lan tatio n . Invited p re se n te r a t th e W estern D ialysis and T ran sp lan tatio n S o ciety , P ark C ity, U tah, Ja n u a ry 1984. 94. S terlin g , R .P ., B radley, B.B., K halil, K.G., K erm an, R .H ., and Conklin, R.H.: C om pari­ son of biopsy proven pneum ocystis pneum onia in acquired im m une deficiency syndrom e (AIDS) p a tie n ts versus renal a llo g ra ft p a tie n ts. P rese n ted a t The S ociety fo r T h o racic Surgeons, San A ntonio, T exas, Ja n u a ry 1984. 95. R ogers, A .J., K erm an, R.H ., and K ahan, B.D.: C o rrelatio n of im m unopharm acokinetic profiles of cy clo sp o rin e -trea te d a llo g ra ft recip ien ts and rejectio n . P resen ted a t T he S ociety for U niversity Surgeons - R esidents' M eeting, Chicago, Illinois, F ebruary 1984. MARVIN S. LEGATOR, Ph.D. Dr. Legator is Professor of Environmental Toxicology, University of Texas Medical School at Galveston. His Curriculum Vitae will be supplied. The subject matter of Dr. Legator's testimony will include: the teratogenic and carcinogenic effects of TCDD, as well as its mutagenic potential; the multi-system effects of TCDD at extremely low concentrations; the demonstrable effects, both gross and more subtle, of TCDD on animals; the extrapolition of the animal studies to humans, that is, the inherent, intended predictive aspects of the animal data to man; and finally to his work as a geneticist with respect to reproductive toxicology, i.e. male (Vietnam Veterans) - mediated birth defects and certain untoward pregnancy outcomes. Dr. Legator will testify to the extreme toxicity of dioxins, particularly 2,3,7,8-TCDD. Specifically, his testimony will indicate that TCDD is a complete carcinogen based upon certain animal studies, and that as a carcinogen, there is no safe level and does not have therefore a so-called no effect level. With respect to that, Dr. Legator will describe the extra­ ordinary precautions which are taken, and the fears of the researchers, in connection with the laboratory use of TCDD. In addition, Dr. Legator will testify to the reproductive toxicological effects, i.e. birth defects, and miscarriages of the children and wives of the exposed Vietnam veterans. The animal data in this regard are positive and consistent and provide a mechanistic linkage which confirms the Vietnamese epidemiological study of Hatch and others. Specifically, therefore Dr. Legator will testify that the X. & iJ 0 8 of Mrs. Dan G. Jordan and the congenital malformations of the children of Dan G. Jordan, as well as those of Kerry Ryan, daughter of Michael F. Ryan, were caused by the presumed exposure of representative plaintiffs Jordan and Ryan to phenoxy herbicides and dioxins - specifically 2,3,7,8-TCDD — while serving in Vietnam. The bases or grounds for such facts and opinions include Dr. Legator's: educational and professional experience; personal researches; review of the applicable medical and scientific literature; and a review of the medical records and/or data of the Jordan and Ryan families. - 7- ALAN SCOTT LEVIN, M.D. Dr. Levin is engaged in tfie practice of medicine in San Francisco, His Curriculum Vitae is attached. Dr. Levin will testify that phenoxy herbicides and their contaminants, including dioxins, most especially 2,3,7,8-TCDD, cause an assortment of immunological responses, i.e. immuno-toxicity, which predispose persons exposed by absorption and/or ingestion and/or inhalation - to such chemicals to a whole host of adverse health effects, such as: chloracne or other skin rashes; various neuro-toxic effects;' reproductive effects; and neoplasm. In connection with the carcinogenic effect, Dr. Levin will state there is no safe level for this or any other carcinogen, and that a single exposure several years earlier can result in human cancer many.years later. The bases for such facts and opinions expressed herein by Dr. Levin include: review of the medical and scientific literature, including both animal and human data; his personal researches; his clinical experiences; and his personal knowledge of the defoliation of Vietnam by such phenoxyherbicides and dioxins, with such chemicals in the presence of the veterans andtheir presumed exposure thereby; and review of all pertinent medical data of the representative plaintiffs. Dr. Levin will discuss the following in his testimony: the immune system, with its organic, cellular, and humoral components - most especially with regard to the latter, T-helper cells, B-cells, plasma cells and immuno­ globulin production; immune response, both beneficial and harmful; the various experimental studies, particularly those demonstrating atrophy of the thymus, weight loss, depletion of lymphoid organs, lymphopenia, hypersensitivity (skin thickness) and altered bacterial cutaneous type delayed immunity. < o n n n In addition, Dr. Levin will discuss the following and their significance: immunology as molecular biology; chemical-induced immune disregulation; T-cells (lymphocytes from thymus) acting as immune modulators, (for which again there is no "no effect" level); immune surveillance; the similarity of the immune, neurologic, and endocrine systems and their significance in the area of immuno-toxicity; the relationship of immune disregulation caused by chemicals and carcinogenicity. Dr. Levin will then testify to the causal relationship of the various Agent Orange/dioxin related adverse health effects of the representative plaintiffs, including: chloracne; neuro-toxic effects, both neurological and psychological; reproductive toxic effects, both miscarriages and birth defects; and such neoplastic processes as soft tissue sarcoma, as here a rhabdomyosarcoma, lymphocytic lymphoma and basal cell carcinoma. <•* f** !*** t*’\ (U -2- r \ CURRICULUM VITAE Alan Scott Levin, M.D. .Born: January 12, 1938. Chicago, Illinois. High School: Austin, Chicago, Illinois College: University of Illinois, Champaign-Urbana, Illinois 1956-1960 B.S. Chemistry in L.A. with Honors. Graduate School: University of Illinois (Chicago Medical Center) M.S. in Biochemistry, 1963. Masters Thesis: Metabolism of Serum Albumin in Rats with Cirrhosis of the Liver, 1963. Medical School: University of Illinois (Chicago Medical Center) M.D. 1964 Alpha Omega Alpha Honor Medical Society, 1963 Internship: Children’s Hospital Medical Center, Boston, Mass. Fellowships: Traineeship Grant, Harvard Medical School 1964 Research Assistant, Children's Hospital Boston, 1965. USPHS Hematology Training Grant, University of California San Francisco, Medical Center 1969-1971 (Pediatric and General Immunology). American Cancer Society Faculty Research Award, 1971— 197— Specialty Board Certifications: 1. Certified Diplomnte American Board of Allergy and Immunology, 1975. 2. Certified Diplomate American Board of Pathology-Ciinicr Pathology, 1977. 3. Fellow in the American College of Emergency Physicians. 4. Fellow College of American Pathologists. 5. Fellow American Society -o'( Clinical Pathologists. 6. Member American Academy of Allergy. 7. Member American Association of Clinical Chemists. Military: USN attached to USMC as Flight Surgeon 1966-1968 Viet Nam Campaign ribbons and unit citation, Navy and Marine Corps Commendation, First through Fourth Air Medals Bronze Scar Medal wich Combat "V", Silver Star Medal, Honorable Discharge November 1969. Marital Status: Married 12371 to Vera S. Byers, P h .D ., fio c h i l d r e n . M.D. f ad emic po intments : I Adjunct Instructor in Pediatrics University of California San Francisco Medical Center 1971 - 1972 Assistant Professor of Immunology in Dermatology University of California San Francisco Medical Center 1972 - 1978 Adjunct Associate Professor of Immunology University of California San Francisco Medical Center 1978 Director of Laboratory of Immunology University of California and Kaiser Foundation Research Institute Joint Program Project San Francisco, California 1971 - 1974 Director of Division of Immunology Western Laboratories 2945 Webster Street Oakland, California 1974 - 1977 Medical Director MML/Sclano Laboratories 2920 Telegraph Avenue Berkeley, California 1977 - 1979 Medical Director Levin Clinical Laboratories, Inc. 326 bth Streex San Francisco, California 1979 - 1981 Private Practice of Medicine 450 Sutter, Suite 1138 San Francisco, California,. 941U8 1981 Member, Medical Quality Review Committee, #4 Board of Medical Quality Assurance State of California I ALAN SCOTT LEVIN, M.D. BIBLIOGRAPHY (Abstracts not included) 1. Levin, A.S., and Jeffay, H.: Metabolism of serum albumin in rats with cirrhosis of the liver. J. Lab & Clin. Med. 63: 776-733, 1964. 2. Klemperer, M.R., Cotoff, S.P., Alper, C.A., Levin, A.S., and Rosen, F.S.: Estimation of serum beta 1-C globulin concentration: Its relation to the serum hemolytic complement titre. Pediatrics 36: 766-769, 1965. 3. Alper, C.A., Levin, A.S., and Rosen, F.S.: Beta-IC-globulin: Metabolism in Glomerulonephritis. Science 153 (3732): 180-182, 1966. 4. Vyas, G.N., Levin, A.S., Fudenberg, H.H.: Intrauterine isoimmunization caused by transplacental passage of maternal IGA. Nature 225: 275-276, 1970 5. Levin, A.S., Pipkins, M.O., and Fudenberg, H.H.: A rapid radioimmunoassay for measuring nanogram levels of antigens. Vox. Sane. 18:459-466, 1970. 6. Levin, A.S., Spitler, L.E., Stites, D.P., and Fudenberg, H.H.: A gene­ tically determined cellular immunologic deficiency: Clinical and laboratory responses to therapy with transfer factor. Proc. Natl. Acad. Sci.USA 67: 321-828, October, 1970. 7. Stites, D.P., Levin, A.S., Austin, K.E., and Fudenberg, H.H.: Immuno­ biology of Human Lymphoid Cell Lines. Immunoglobulin biosyntheseis in cultures from Hypogamma-globulincmias and Paraproteinemia. J. Immunol. 107: 1376-1381, November, 1971 8. Levin, A.S., Fudenberg, H.H., Hopper, J.E., Nisonoff, A., and Wilson, S.K.: Immunofluorescent evidence for control of synthesis of variable regions of light and heavy chains of IgG and IgM by^the same gene. Proc. Natl. Acad. Sci. USA 6 8 : 169-171, 1971 9. Fudenberg, H.H., Wang, A.C., Pink, J.R.L., and Levin, A.S.: Studies of an Unusual Biclonal Gammopnthy. Ann. N.Y. Acad. Sci. 190:501-506, 1971. 10.. Levin, A.S., Fudenberg, H.H., Pete, L.D., and Sharp, G.C.: IgG levels in Cerebrospinal Fluid of Patients with Central Nervous System Lupus. Clin. Immunol, and J. Immunopath. 1: 1-5, 1972 11. Spitler, L.E., Levin, A.S., Huber, H . , and Fudenberg, H.H.: Prediction of Results of Transfer Factor Therapy in the Wiskott-Aldrich Syndrome by Monocyte IgG Receptors. In Proceedings of the Sixth Leukocyte Culture Conference. Academic Press, Inc., New York and London, P.795-803, 1972. 12373 ( 12. Spieler, L.E., Levin, A.S., Stites, D.P., Fudenberg, H.H., Pirofsky, C.S., August, E.R., Stiehm, W.H., Hitzig, H., and Cacti, R.A. : The WiskottAldrich Syndrome Results of Transfer Factor Therapy. J. Clir., Invest. 51: 3216- 3224, 1972 13. Spat'n, P., Garraty, G., Levin, A.S., Petz, L.D. , Fudenberg, H.H.: Immunhematologisc'ne Veränderungen bei Cephalosporin-therapie. Verhandlungen der Duetschen Gesselschaft für innere Medizin, Vol. 78, 914-916, 1972. 14. Fudenberg, H.H., Spitler, L.E., and Levin, A.S.: Treatment of Immune Deficiency Disorders. Amer. J. Pathol. 69:529-536, 1972 15. Stites, D.P., Levin, A.S., Lauer, B., Costora, B.H., Fudenberg, H.H. : Selective "Dysgammaglobulineraia" with elevated serum IgA and chronic salmonellosis. Amer. J. Med. 54:260, 1973 16. Spieler, L.E., Levin, A.S., and Fudenberg, H.H.: Agammaglobulinemia and Lymphopenia without infection: A demonstration of immunologic unknowns. Amer. J. Med. 54: 371-377, 1973. 17. Raubitschek, A.S., Levin, A.S., Stites, D.P., Shaw, E.B., and Fudenberg, H.H.: Normal Granulocyte Infusion Therapy for Aspergillosis in a Patient with Chronic Granulomatous Disease. Pediatrics 51-230-233, February 1973. IS. Wybran, J. , Levin, A.S., Spitler, L.E., and Fudenberg, H.H.: Rosette Forming Cells, Immunological Diseases and Transfer Factor. New England Journal of Med. 228:710-713, 1973. 19. Spitler, L.E., Levin, A.S., and Fudenberg, H.H.: Human Lymphocyte Transfer Factor in "Methods in Cancer Research", H. Busch (ed.) Acad. Press. Ill 5th Ave., New York, N.Y., 59-106, 1973. 20. Levin, A.S., Spitler, L.E., and Fudenberg, H.H.: Transfer Factor Therapy in Immune Deficiency States. Ann. Rev. Med, (invited Review) 2h_: 1973 21. Levin, A.S., Spitler, L.E., and Fudenberg, H.H.: Immune Deficiency States. Introduction to Clinical Allergy (ed.: B. Feingold) Charles Thomas, Springfield, Illinois, Chapcer 19, 346-359, 1973. 22. Spitler, L.E., Levin, A.S., and Fudenberg, H.H.: The Wiskott-Aldrich Syndrome. In the Science and Practice of Clinical Medicine. J.M. Dietschy, L.E. Early, H.H. Fudenberg, A. Renold, C.A. Sanders, and J.P. Sanford (ed.) New York, 1974. 23. Spicier, L.E., Levin, A.S., Fudenberg, H.H.: Transfer.Factor. Clinical Immunology Volume M. (ed. R.A. Good & Bach), 2: 153-175, Academic Press, N.Y. 1974. r r%.t*} A K ... / 24. Fudenberg, H.H., Levin, A.S., Spitler, L.E., Wybran, J.E., and Byers, V.S. Therapeutic Uses of Transfer Factor. llosoital Practice 9:95-104, 1974 \ 25. Levin, A.S., Transfer Factor Therapy: Current Status. So. Med. Journal (invited editorial) _68_, 1465-1466, 1975 26. Fudenberg, H.K., Byers, V.S., Levin, A.S., and Hackett, A.J.: Additional evidence for viral etiology of certain human tumors in A.A. Gottlieb, M.D., Fundamental Aspects of Neoplasia. New York: SpringerVerlag, 1974 27. Fudenberg, H.H., Byers, V.S., and Levin, A.S., : Immunologic Evidence for a Viral Etiology of Certain Malignant Tumors, in Perspectives in Virology (Gustav Stern Symposium), New York, February 4-5, 1974. 28. Levin, A.S., Byers, V.S., Fudenberg, H.H., and Wybran, J.: Immunologic Parameters for monitoring immunotherapy with tumor-specific transfer factor. Trans. Assoc. Amer, Phys.,_8_7, 153-158, 1974 29. -Fudenberg, H.H., Byers, V.S., Levin, A.S., and Hackett, A.J.: Immunologic Evidence for a Viral Etiology of Certain Human Malignant Tumors. Ann. N.Y. Acad. Sci. (In Press, 1975) 30. Wybran, J., Levin, A.S., Fudenberg, H.H., and Goldstein, A.L.: Thymosin: Effects on Normal Human Blood T Cells. Ann. N.Y. Acad. Sci. 249/. 301-307, 1975 31. Carter, J.B., Ponce, B., Byers, V.S., Barr, G.D., Fudenberg, H.H. and Levin, A.S.: Standardization of tissue culture conditions for spontan­ eous thymidine^I^C incorporation by unstimulated lyr.phocytes : Circadian rhythm in Human Lymphocytes. J. of Allergy and Clinical Immunology 56, 191-196, 1975. 32. Byers, V.S., Levin, A.S., Hackett, A.J., and Fudenberg, H.H.: Tumor specific cell mediated immunity in household contacts of cancer patients. J. of Clin. Invest. 55-500-517, 1975. 33. Levin, A.S., Byers, V.S., Fudenberg, H.H., Hacket/:% A.J., Johnston, J.O., and J.E. Wybran: Osteogenic sarcoma: Immunologic' parameters before and during therapy with tumor specific transfer factor. J. Clin. Invest 55: 487-499, 1975. 34. Levin, A.S., Spitler, L.E., and Fudenberg, H.U.p/ Transfer Factor 1. • Methods of Therapy, (end Int. Conf. on Immunodeficiency in Man. St. Petersburg, Fla. 1973), in ETRTII DEFECTS: Original Article Series (Editors: D. Bergsma and R.A. Good), Sinauer, Assoc., Inc., N.Y., 1975. 35. Spitler, L.E., Levin, A.S., and Fudenberg, H.H.: Transfer Factor II. Results of Therapy. (2nd Inc. Conf. on Immunodeficiency Disease in Man, St. Petersburg, Fla., 1973), in BIRTH DEFECTS:. Original Article Series (Editors: D. Eergsmn and R.A. Cood) , Sinauer Assoc., Inc., N.Y., 1975. s s :-* 75 \ 36. Fisher, J., Evers, V.S., Shafrin, M., and Levin, A.S.: Relationship of Cu and Zn levels to metastatic events in human bone sarcomas. Cancer, 37, 356-364, 1976. 37. Spitler, L.E., Levin, A.S., and Fudenberg, H.K.: The Wiskott-Aldrich Syndrome: Immunological Studies in Patients and Family Members Cellular Immunology, 19, 201-218, 1975. 33. Byers, V.S., Levin, A.S., Hackett, A.J., and Johnston, J.W.: Quantitative Immunofluorescent Studies on the Tumor Antigen Bearing Cell in Giant Cell Tumor of Bone and Osteogenic Sarcoma, Cancer Research, 35:2520 2531, 1975. 39. Jones, L.W., Levin, A.S., and Fudenberg, H.K.: Glomerular Antigen Complexes Associated with Transitional Cell Carcinoma. Surgery, Gynecology and Obstetrics 140:896-898, 1975 40. Kaplan, M.A., Byers, V.S., Levin, A.S., German, D., Fudenberg, H.H., and LeCam, L.: Circadian Rhythm in Human Lymphocyte Function. J. Allergy and Clinical Immunology: 58 I, 180-189, 1976. 41. Spitler, L.E., Levin, A.S., and Wybran, J.: Adjuvant Immunotherapy for Malignant Melanoma with BCG and Transfer Factor. Cellular Immunology 21, 1 - 19, 1976. 42. Levin, A.S., Byers, V.S., Hackett, A.J., Johnston, J.O., and LeCam, L.M. Tumor Specific Transfer Factor Therapy in Osteogenic Sarcoma, Immunotherapy in Cancer, Proceedings of ITR-C’ nicago, 1975. 43. Byers, V.S., Levin, A.S., Hackett, A.J., Johnston, J.O., and LeCam, L.M. Tumor Specific Transfer Factor Therapy in Osteogenic Sarcoma, A Two-Year Followup Study, Annals of New York Academy of Science, 277, 621-627, 1976. 44. Byers, V.S. and Levin, A.S., Tumor Immunology, in Easic and Clinical Immunology: Eds. Caldwell, J., Fudenberg, H.H., .-§tites, D.P. and Wang, A.S., Lange Books, 1976. 45. "Levin, A.S., Byers, V.S., LeCam, L.M., and Johnston, J.O., An Unusual , Metastasis in an Osteogenic Sarcoma Patient on Tumor Specific Transfer Factor Therapy, Transfer Factor, 537-542, Academic Press, 1976. *r 46. Byers, V.S., LeCam, L.M., Hackett, A.J., Johnston, J.O. and Levin, A.S.: Familial Incidence of Breast Carcinoma Immunity - A Statistical Survey. Cancer Immunology and Immunotherapy. 2, 163-172, 1977 47. Byers, .S., and Levin, A.S.: Tumor Antigen Density on Osteogenic Sarcoma Cells in Vitro. Cancer Research. 37, 3173-3183, 1977. «*? ^ ^ J,.. ^ \j i O I Chen. Shi-Han, Scott, C.R., Giblctt, E.F,., Levin, A.S.: Adenosine Deaminase Deficiency: Another Family with a "Silent" Ada Allele and Ni:nr.l Ada Activity in Two Hetcrozygotes. American Journal of Human Genetics. Vol. 29, 642-644, 1977. 49. Marmor, M.D., Nelson, J.W., Levin, A.S.,: Copper Metabolism in American Retinitis Pigmentosa Patients: British Journal of Opthalmologv. Vol. 62. 163-171, 1973. 50. Byers, V.S.„ LeCam, L., Levin, A.S., Johnston, J.O., and Hackett, A.J.: Osteogenic Sarcoma: Immunotherapy of Clinically Disease Free Patients with Transfer Factor: Long-Term Follow-up. Cancer Immunology and Ir.munotheranv 243-251, 1979. 51. Byers, V.S., Levin, A.S.: Poison Oak III: Genetic Restriction in T Cell Mediated reaccivity-Journal of Clinical Investigation.-Submitted. 52. Newman, B.R., Byers, V.S., German, D., and Levin, A.S.: Variability of Lymphocyte Function by Serum Factors. Journal of Clinical Laboratory Immunology 2, 151-154, 1979. 53. McGovern, J.J.,Jr., Lazaroni, J.L., Saifer, Phyllis, Levin, A.S., Rapp, D.J., Gardner, R.W.: Clinical Evaluation of the Major Plasma and Cellular Measures of Immunity. Journal of Orthomolecular Psychiatry. VoL. 12, No. 1., 1933. 54 . Byers, V .S., Baldwin. R..W . , Levin, A.S., Embleton, M.J , and Price, M.R.: Monoclonal A.ntibodies : Their Use in the Diagnosis and Treatment of Cancer - In probability Models and Cancer, pp. 15—3^*. L. LeCam and J. Neyman (Eds.) North-Holland, 1932. 55. 56. Binder, R.L., Callaway, E., Levin, A.S., Stites, D.P.: Relationship between Creatine Phosphokinase and Immunoglobulins in Unmedicated Caucasian Schizophrenics. Biological Psychiatry. In Press. 1983. McGovern, J.J.,Jr., Rapp, D.J., Levin, A.S.: • Immune Response During Double-Blind Testing. Phgnol Provokes Abnormal J ,'A,M. A . Submitted 1983. ¿0 f 4 I < ALAN SCOTT LEVIN, M.D. BIBLIOGRAPHY (Abstracts Only) 1. 2 Alper, C.A., Levin, A.S., and Rosen, F.S.: Turnover of an I complement component. J. Clin. Invest. May 1965. labeled 4 Levin, A.S., Pete, L.D., Fudenberg, H.H.: Immunoglobulins and C Levels in Normal and CNS-SLE -'Cerebrospinal fluids using new micro radio immuno­ assays. Abstract presented ASCR Western Regional Meetings. 3. Levin, A.S., Stites, D.P., Spitler, L.E., Sahud, M.A. and Fudenberg, H.H.: Induction of "delayed hypersensitivity" in Wiskott-Aldrich pacient by transfer factor. Clin. Res. 18;426, April, 1970. 4. Vyas, G.N., Levin, A.S., and Fudenberg, H.H.: Isoimmunization to human IgA in pregnancy. Clin. Res. 18:157, April 1970. 5. Levin, A.S., Petz, L., and Fudenberg, H.H.: IgG and C^ levels in CSF of patients with active CNS-SLE. Clin. Res. 19:137, June 1971 6. Levin, A.S., Fudenberg, H.H., Hopper, J.. , and Nisonoff, A.: Immunohistologic investigations of a Eiclonal Camopachy: Detection of identical antigen in variable regions of IgG and IgM producing cells. Presented at ASH Meeting, San Juan, P.R. Blood XXXVI (6), 831, 1970. 7. Spitler, L.W., Levin, A.S., Stites, D.P., and Fudenberg, H.H.: Current status of transfer factor therapy in Wiskott-Aldrich Syndrome. Presented at ASCI Western Regional Meetings, Carmel, Jan. 1971 Clin. Res. XIX (i ) 162, 1971 8. Levin, A.S., Weiner, R.S., Fudenberg, H.H., Spath, and Petz, L.: Granulocytopenia caused by anticep'nalothin antibodies. Clin. Res. XIX (2) 424, 1971 9. Levin, A.S,Spitler, L.E., Stites, D.P., and Fudenberg, H.H.: Molecular intervention in genetically determined cellular immune deficiency disorders. J. Clin. Invest. 50:59a, 1971 10. Spitler, L.E., Levin, A.S., Fudenberg, H.H., Huber, H.: Abnormal monocyte IgG receptors in the Wiskott-Aldrich Syndrome. Sixth Annual Leukocyte Culture Conference. Academic Press, 1972. 11. Spitler, L.E., Levin, A.S., Stites, D.P., Pirofsky, Fudenberg, H.U.: Transfer Factor Therapy in Mucocutaneous Candidiasis. Sixth Annual Leukocyte Culture Conference. Academic Press, 1972 12. Wybran, J., Spitler, L.E., Levin, A.S., and Fudenberg, II.H.: The Rosette Forming Cell ns an Indicator of Successful Transfer Factor Therapy in Immuno Deficiencies. Clin, Res. XX (3), 1972 12878 13. Levin, A.S., Spicier, L.E., Wybran, J., and Fudenberg, H.H. : Treatment: of Osteogenic Sarcoma with Tumor Specific Transfer Factor. Clin. Res. XX (3), 56S, 1972. 1m . Spicier, L.E., Levin, A.S., and Fudenberg, H.H.: Immunologic Evaluation of Patiencs with Micocutaneous Candidiasis and Results of Transfer Factor Therapy. Clin. Res. XX (3), 519, 1972. 15. Spider, L.E., Levin, A.S., Blois, M.S., Epstein, W. , Fudenberg, H.H., Hellstrom, I., and Hellstrom, K.E.: Lymphocyte Responses to Tumor Specific Antigens in Patients with Malignant Melanoma and Results of Transfer Factor Therapy. J. Clin. Invest. 16. Wybran, J., Levin, A.S., Spider, L.E., and Fudenberg, H.H.: The Human Rosette Forming Cell, Transfer Factor and Prognosis of Cancer. Clin. Res. XX, (3) 635, 1972. 17. Fcnes, D.W. , Mogerman, S.N., Spider, L.E., Stites, D.P., Shinefield, H.R., Fudenberg, H.H., and Levin, A.S.: Graft Versus Host (GVH) in A Di George Patient: Probable Accelerated Induction of T Cell Competence. Clin. Res. XXI (2) 309. 13. Mogerman, S.N., Levin, A.S., Spider, L.W. , Scites, D.P., Fudenberg, H.H. and Shinefield, H.R.: Transfer Factor Therapy in X-Linked Recessive Severe Combined Dual System Immune Deficiency Disorder (SCID). Clin. Res. XXI (2) 310. 19. Carter, J.B., Ponce, B.E., Stites, D.P., Levin, A.S., German, D.F., and Fudenberg, H.H.: Spontaneous Thymidine - 2-^-~t C Incorporation by Unstimulaced Normal Human Peripheral Lymphocytes Tn Vitro: Tissue Culture Conditions and Quantitative Measurements. 20. Carter, J.B., Ponce, B.E., Stites, D.P., Levin, A.S., German, D.Z., and Fudenberg, H.H.: Circadian Cycle of Spontaneous Thymidine-2^ C Incorporation by L'nstimulated Normal Human Peripheral Lymphocytes In Vitro. 21. -------Fones, D.W., Levin, A.S., Mogerman, S.M., Spitler, L. E. , Stites, D.P., Shinefield, H.R., and Fudenberg, H.H.: Graft Versus Host Followed by Host Versus Graft: Competence. 22: Evidence for Accelerated Induction of T-Cell /. Levin, A. S',y '»■*•?Q Clin. Res. 19 74 . ' ' X 6 25. Byers, V.S., Levin, A.S., and Fudenberg, H.H.: Detection of Tumor Specific Immunity in Normal Household Contacts of Tumor Bearing Patients. Clin. Res. 1974. 26. Levin, A.S., Byers, V.S., Johnston, J.O., Hackett, A.J., and Fudenberg, H.H.: Host-Tumor Relationships in Giant Cell Sarcoma of Bone (GCS): Measurement by Quantitative Immunofluorescence. Clin. Res. 1974 27. Fudenberg, H.H., Byers, V.S., Levin, A.S., and Hackett, A.J.: for Viral Etiology of Human Hypernophroma and Osteosarcoma. Perspectives in Virology. In Press, 1974 28. Levin, A.S., Byers, V.S., LeCam, L., and Johnston, J.O.: Evidence for Regression in Osteogenic Sarcoma Induced by Tumor Specific Transfer Factor. 2nd International Workshop on Transfer Factor. Frederick, MD., 1975. 29. Hackett, A., Springer, L., Levin, A.S., and Fink, M.: Transmission and Scanning Electron Microscopic Studies on Osteo Sarcoma Before and After Transfer Factor Therapy. Cancer Research 16:193, 1975 30. Levin, A.S., LeCam, L.M., Hackett, A.J. and Johnston, J.O.: Osteosarcoma (O.S.): 5 Year Followup of Epidemiology and Tumor Specific Transfer Factor Therapy (TSTF). Clin. Res. 1976 31. Levin, A.S., LeCam, L.M., and Agraz, J.M.: Dip-Stick Method of Quanti­ tative Immunofluorescence. Clin. Res. 1976, 32. Neuman, B.R., Byers, V.S., Levin, A.S., and Jerman, D.: Circadian Influences on T. Lymphocyte Function Mediacec by Serum Factors. Clin. Res. 1976 33. Levin, A.S., Kassel, S.D., and Flam, M . , A New Diagnostic Index: Collagen Disease vs. Malignancy vs. Infectious Disease. J.A.M.A. 237, 1916, 1977. •> Levin, A.S., and Baldwin, R.W.: Solid Phase Fl'uoroimmunoassay to Detect Serum Immune Complexes. 6th International Congress on Immunofluorescence, Vienna, Austria. 1973 34. 35, Evidence Levin, A.S., McGovern, J.J.,Jr., Miller, J.B., LeCam, L.L., and Lazaroni, J.: Non-Anaphylactic Food Allergies Mediated by Immune Complexes: Ann. Allergy, Abstract in Press. 1981 & 4/' Dr. Illinois. His c u r r i c u l u m v i t a e w i l l be supplied. Dr. d i s eases P e t e r Orris is an i n t e r n i s t p r a c t i c i n g in Chicago, Orris w i l l t e s t i f y as to the c l i nical asp e c t s of the in the r e p r e s e n t a t i v e p l a i n t i f f veterans. w i l l be b a s e d u p o n a m e d i c a l r ecords various His t e s t i m o n y r e v i e w and an a n a lysis of t e s t res u l t s that w i l l h a v e b e e n p e r f o r m e d u p o n the r e p r e ­ s e n t a t i v e plaintiffs. Dr. Orris w i l l also t e s t i f y on g e n e r i c c a u s a t i o n and s p e c i f i c p r o x i m a t e c a u s a t i o n in r e l a t i o n to each r e p r e s e n t a t i v e veteran plaintiff. He w i l l also t e s t i f y as to p r o g n o s i s for each representative veteran plaintiff 12981